{"linksProcessed":0,"homePage":"https://www.gsk.com/","origin":{"https://www.gsk.com/":{"redirectedFrom":"http://www.gsk.com/"},"https://www.gsk.com/en-gb/":{"firstFound":"https://www.gsk.com/","txt":"GSK logo linking to the homepage","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Home | GSK ","meta_decription":"The homepage of the GSK global corporate website"}},"https://www.gsk.com/en-gb/behind-the-science/":{"firstFound":"https://www.gsk.com/","txt":"\n\n                \n                    \n                    Behind the science\n                \n                \n                    \n                        Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs \n                    \n\n                \n                    \n                      \n                      \n                                         \n\n                    \n                    Behind the science\n                \n\n                      \n            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Behind the science | GSK ","meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"http://www.gsk.com/en-gb/contact-us/worldwide/algeria/":{"firstFound":"https://www.gsk.com/","txt":"Algeria (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Algeria | GSK ","meta_decription":"GSK Algeria"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/algeria/"},"http://www.gsk.com/en-gb/contact-us/worldwide/kenya":{"firstFound":"https://www.gsk.com/","txt":"Kenya (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Kenya | GSK ","meta_decription":"GSK Kenya"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/kenya"},"http://www.gsk.com/en-gb/contact-us/worldwide/morocco":{"firstFound":"https://www.gsk.com/","txt":"Morocco (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Morocco | GSK ","meta_decription":"GSK Morocco"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/morocco"},"http://www.gsk.com/en-gb/contact-us/worldwide/south-africa":{"firstFound":"https://www.gsk.com/","txt":"South Africa (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"South Africa | GSK ","meta_decription":"GSK South Africa"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/south-africa"},"http://www.gsk.com/en-gb/contact-us/worldwide/tunisia":{"firstFound":"https://www.gsk.com/","txt":"Tunisia (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Tunisia | GSK ","meta_decription":"GSK Tunisia"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/tunisia"},"http://www.gsk.com/en-gb/contact-us/worldwide/bangladesh":{"firstFound":"https://www.gsk.com/","txt":"Bangladesh (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Bangladesh | GSK ","meta_decription":"GSK Bangladesh"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh"},"http://www.gsk.com/en-gb/contact-us/worldwide/cambodia":{"firstFound":"https://www.gsk.com/","txt":"Cambodia (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Cambodia | GSK ","meta_decription":"GSK Cambodia"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/cambodia"},"http://www.gsk.com/en-gb/contact-us/worldwide/egypt":{"firstFound":"https://www.gsk.com/","txt":"Egypt (EN/AR)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Egypt | GSK ","meta_decription":"GSK Egypt"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt"},"http://www.gsk.com/en-gb/contact-us/worldwide/israel":{"firstFound":"https://www.gsk.com/","txt":"Israel (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Israel | GSK ","meta_decription":"GSK Israel"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/israel"},"http://www.gsk.com/en-gb/contact-us/worldwide/myanmar":{"firstFound":"https://www.gsk.com/","txt":"Myanmar (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Myanmar | GSK ","meta_decription":"GSK Myanmar"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/myanmar"},"http://www.gsk.com/en-gb/contact-us/worldwide/philippines":{"firstFound":"https://www.gsk.com/","txt":"Philippines (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Philippines | GSK ","meta_decription":"GSK Philippines"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/philippines"},"http://www.gsk.com/en-gb/contact-us/worldwide/saudi-arabia":{"firstFound":"https://www.gsk.com/","txt":"Saudi Arabia (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Saudi Arabia | GSK ","meta_decription":"GSK Saudi Arabia"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/saudi-arabia"},"http://www.gsk.com/en-gb/contact-us/worldwide/sri-lanka":{"firstFound":"https://www.gsk.com/","txt":"Sri Lanka (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Sri Lanka | GSK ","meta_decription":"GSK Sri Lanka"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/sri-lanka"},"http://www.gsk.com/en-gb/contact-us/worldwide/thailand":{"firstFound":"https://www.gsk.com/","txt":"Thailand (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Thailand | GSK ","meta_decription":"GSK Thailand"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/thailand"},"http://www.gsk.com/en-gb/contact-us/worldwide/united-arab-emirates":{"firstFound":"https://www.gsk.com/","txt":"United Arab Emirates (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"United Arab Emirates | GSK ","meta_decription":"GSK United Arab Emirates"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/united-arab-emirates"},"http://www.gsk.com/en-gb/contact-us/worldwide/albania/":{"firstFound":"https://www.gsk.com/","txt":"Albania (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Albania | GSK ","meta_decription":"GSK Albania"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/albania/"},"http://www.gsk.com/en-gb/contact-us/worldwide/belarus":{"firstFound":"https://www.gsk.com/","txt":"Belarus (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Belarus | GSK ","meta_decription":"GSK Belarus"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/belarus"},"http://www.gsk.com/en-gb/contact-us/worldwide/bosnia-herz":{"firstFound":"https://www.gsk.com/","txt":"Bosnia and Herzegovina (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Bosnia & Herz. | GSK ","meta_decription":"GSK Bosnia & Herz."},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/bosnia-herz"},"http://www.gsk.com/en-gb/contact-us/worldwide/cyprus":{"firstFound":"https://www.gsk.com/","txt":"Cyprus (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Cyprus | GSK ","meta_decription":"GSK Cyprus"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/cyprus"},"http://www.gsk.com/en-gb/contact-us/worldwide/latvia":{"firstFound":"https://www.gsk.com/","txt":"Latvia (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Latvia | GSK ","meta_decription":"GSK Lativia"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/latvia"},"http://www.gsk.com/en-gb/contact-us/worldwide/lithuania":{"firstFound":"https://www.gsk.com/","txt":"Lithuania (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Lithuania | GSK ","meta_decription":"GSK Lithuania"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/lithuania"},"http://www.gsk.com/en-gb/contact-us/worldwide/macedonia":{"firstFound":"https://www.gsk.com/","txt":"Macedonia (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Macedonia | GSK ","meta_decription":"GSK Macedonia"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/macedonia"},"http://www.gsk.com/en-gb/contact-us/worldwide/malta":{"firstFound":"https://www.gsk.com/","txt":"Malta (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Malta | GSK ","meta_decription":"GSK Malta"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/malta"},"http://www.gsk.com/en-gb/contact-us/worldwide/portugal/":{"firstFound":"https://www.gsk.com/","txt":"Portugal (PT)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Portugal | GSK ","meta_decription":"GSK Portugal"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/portugal/"},"http://www.gsk.com/en-gb/contact-us/worldwide/mexico":{"firstFound":"https://www.gsk.com/","txt":"Mexico (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Mexico | GSK ","meta_decription":"GSK Mexico"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/mexico"},"http://www.gsk.com/en-gb/contact-us/worldwide/caribbean-islands":{"firstFound":"https://www.gsk.com/","txt":"Caribbean Islands (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Caribbean Islands | GSK ","meta_decription":"GSK Caribbean Islands"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/caribbean-islands"},"http://www.gsk.com/en-gb/contact-us/worldwide/chile":{"firstFound":"https://www.gsk.com/","txt":"Chile (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Chile | GSK ","meta_decription":"GSK Chile"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/chile"},"http://www.gsk.com/en-gb/contact-us/worldwide/colombia":{"firstFound":"https://www.gsk.com/","txt":"Colombia (EN/ES)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Colombia | GSK ","meta_decription":"GSK Colombia"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/colombia"},"http://www.gsk.com/en-gb/contact-us/worldwide/costa-rica":{"firstFound":"https://www.gsk.com/","txt":"Costa Rica (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Costa Rica | GSK ","meta_decription":"GSK Costa Rica"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/costa-rica"},"http://www.gsk.com/en-gb/contact-us/worldwide/dominican-republic":{"firstFound":"https://www.gsk.com/","txt":"Dominican Republic (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Dominican Republic | GSK ","meta_decription":"GSK Dominican Republic"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/dominican-republic"},"http://www.gsk.com/en-gb/contact-us/worldwide/ecuador":{"firstFound":"https://www.gsk.com/","txt":"Ecuador (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Ecuador | GSK ","meta_decription":"GSK Ecuador"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/ecuador"},"http://www.gsk.com/en-gb/contact-us/worldwide/el-salvador":{"firstFound":"https://www.gsk.com/","txt":"El Salvador (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"El Salvador | GSK ","meta_decription":"GSK El Salvador"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/el-salvador"},"http://www.gsk.com/en-gb/contact-us/worldwide/guatemala":{"firstFound":"https://www.gsk.com/","txt":"Guatemala (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Guatemala | GSK ","meta_decription":"GSK Guatemala"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/guatemala"},"http://www.gsk.com/en-gb/contact-us/worldwide/honduras":{"firstFound":"https://www.gsk.com/","txt":"Honduras (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Honduras | GSK ","meta_decription":"GSK Honduras"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/honduras"},"http://www.gsk.com/en-gb/contact-us/worldwide/jamaica":{"firstFound":"https://www.gsk.com/","txt":"Jamaica (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Jamaica | GSK ","meta_decription":"GSK Jamaica"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/jamaica"},"http://www.gsk.com/en-gb/contact-us/worldwide/panama":{"firstFound":"https://www.gsk.com/","txt":"Panama (EN/ES)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Panama | GSK ","meta_decription":"GSK Panama"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/panama"},"http://www.gsk.com/en-gb/contact-us/worldwide/peru":{"firstFound":"https://www.gsk.com/","txt":"Peru (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Peru | GSK ","meta_decription":"GSK Peru"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/peru"},"http://www.gsk.com/en-gb/contact-us/worldwide/trinidad-tobago":{"firstFound":"https://www.gsk.com/","txt":"Trinidad & Tobago (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Trinidad & Tobago | GSK ","meta_decription":"GSK Trinidad & Tobago"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/trinidad-tobago"},"http://www.gsk.com/en-gb/contact-us/worldwide/uruguay":{"firstFound":"https://www.gsk.com/","txt":"Uruguay (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Uruguay | GSK ","meta_decription":"GSK Uruguay"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/uruguay"},"http://www.gsk.com/en-gb/contact-us/worldwide/venezuela":{"firstFound":"https://www.gsk.com/","txt":"Venezuela (EN)","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":"Venezuela | GSK ","meta_decription":"GSK Venezuela"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/venezuela"},"https://www.gsk.com/en-gb/contact-us/":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/"},"https://www.gsk.com/en-gb/search/":{"firstFound":"https://www.gsk.com/","txt":"\n                \n                    \n                \n                Search\n            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Search | GSK ","meta_decription":"a"}},"https://www.gsk.com/en-gb/about-us/":{"redirectedFrom":"http://www.gsk.com/en-gb/about-us/"},"https://www.gsk.com/en-gb/about-us/pharmaceuticals/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Pharmaceuticals\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Pharmaceuticals | GSK ","meta_decription":"Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV."}},"https://www.gsk.com/en-gb/about-us/vaccines/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Vaccines\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Vaccines | GSK ","meta_decription":"Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries."}},"https://www.gsk.com/en-gb/about-us/vaccines/why-you-don-t-outgrow-vaccination/":{"firstFound":"https://www.gsk.com/","txt":"Why you don’t outgrow vaccination","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Why you don’t outgrow vaccination | GSK ","meta_decription":"Vaccination plays a vital role in helping to give children a healthy start in life."}},"https://www.gsk.com/en-gb/about-us/consumer-healthcare/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Consumer Healthcare\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Consumer Healthcare | GSK ","meta_decription":"Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories."}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Corporate Executive Team\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Corporate Executive Team | GSK ","meta_decription":"The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Board of Directors\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Board of Directors | GSK ","meta_decription":"The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance."}},"https://www.gsk.com/en-gb/about-us/our-history/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Our history\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Our history | GSK ","meta_decription":"It began when Plough Court Pharmacy was established in 1715. Discover GSK's journey through the centuries that led to the organisation we know today"}},"https://www.gsk.com/en-gb/about-us/our-history/innovative-entrepreneurs-1715-1891/":{"firstFound":"https://www.gsk.com/","txt":"Innovative entrepreneurs: 1715 – 1891","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Innovative entrepreneurs: 1715 – 1891 | GSK ","meta_decription":"The early history of GSK: how a range of entrepreneurs built the foundations of the GSK we know today."}},"https://www.gsk.com/en-gb/about-us/our-history/going-global-1892-1918/":{"firstFound":"https://www.gsk.com/","txt":"Going global: 1892 – 1918","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Going global: 1892 – 1918 | GSK ","meta_decription":"In this period, our legacy companies expanded globally, developing and selling new products worldwide."}},"https://www.gsk.com/en-gb/about-us/our-history/building-brands-1919-1949/":{"firstFound":"https://www.gsk.com/","txt":"Building brands: 1919 – 1949","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Building brands: 1919 – 1949 | GSK ","meta_decription":"An era of landmark scientific breakthroughs, building brand portfolios and product consolidation."}},"https://www.gsk.com/en-gb/about-us/our-history/creating-the-gsk-of-today-1950-1999/":{"firstFound":"https://www.gsk.com/","txt":"Creating the GSK of today: 1950 – 1999","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Creating the GSK of today: 1950 – 1999 | GSK ","meta_decription":"An exciting period of discovery: we developed the first treatment for HIV, enhanced our consumer brands and developed new treatments for asthma."}},"https://www.gsk.com/en-gb/about-us/our-history/gsk-today-2000-present/":{"firstFound":"https://www.gsk.com/","txt":"GSK today: 2000 –  present","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"GSK today: 2000 –  present | GSK ","meta_decription":"With our three global businesses of Pharmaceuticals, Vaccines and Consumer Healthcare, we aim to bring differentiated, high-quality and needed healthcare products to as many people as possible."}},"https://www.gsk.com/en-gb/about-us/our-history/gsk-heritage-archives/":{"firstFound":"https://www.gsk.com/","txt":"GSK heritage archives","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"GSK heritage archives | GSK ","meta_decription":"Find out more about the GSK heritage archives and how to contact our archivists."}},"https://www.gsk.com/en-gb/about-us/governance/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Governance\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Governance | GSK ","meta_decription":"At GSK we are committed to operating at the highest standards of corporate governance. We believe our governance structure underpins our ability to deliver the Group's strategy to create long-term value and benefit for our shareholders and stakeholders."}},"https://www.gsk.com/en-gb/about-us/governance/board-committees/":{"firstFound":"https://www.gsk.com/","txt":"Board Committees","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Board Committees | GSK ","meta_decription":"Discover the details of our various Board Committees, who sits on them and what the committees do"}},"https://www.gsk.com/en-gb/about-us/governance/other-committees/":{"firstFound":"https://www.gsk.com/","txt":"Other committees","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Other committees | GSK ","meta_decription":"Discover the details of our other specific committees, such as the Disclosure Committee, who sits on them and what they do"}},"https://www.gsk.com/en-gb/about-us/governance/shareholders/":{"firstFound":"https://www.gsk.com/","txt":"Shareholders","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Shareholders | GSK ","meta_decription":"Information on reporting to shareholders, such as financial results which are announced on a quarterly basis in April, July, October and February"}},"https://www.gsk.com/en-gb/about-us/governance/sarbanes-oxley-act-2002/":{"firstFound":"https://www.gsk.com/","txt":"Sarbanes-Oxley Act 2002","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Sarbanes-Oxley Act 2002 | GSK ","meta_decription":"The Sarbanes-Oxley Act of 2002 established new standards for corporate accountability in the USA. Find out how GSK ensures compliance with the Sarbanes-Oxley"}},"https://www.gsk.com/en-gb/about-us/governance/global-compliance/":{"firstFound":"https://www.gsk.com/","txt":"Global Ethics and Compliance","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Global Ethics and Compliance | GSK ","meta_decription":"The Global Compliance function is responsible for supporting the development and implementation of practices that comply with laws and Group policy"}},"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/":{"redirectedFrom":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/codes-and-standards/"},"https://www.gsk.com/en-gb/about-us/key-facts/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Key facts\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Key facts | GSK ","meta_decription":"We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. Here are some of our key facts and milestones on the way to achieving our purpose."}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Comic Relief partnership\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Comic Relief partnership | GSK ","meta_decription":"We've joined forces with Comic Relief in a five-year partnership to help strengthen health systems’ ability to tackle malaria"}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/sierra-leone/":{"firstFound":"https://www.gsk.com/","txt":"Sierra Leone","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Sierra Leone | GSK ","meta_decription":"We're working with BBC Media Action, Concern Worldwide, Kings College, London and others in Sierra Leone"}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/ghana/":{"firstFound":"https://www.gsk.com/","txt":"Ghana","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Ghana | GSK ","meta_decription":"We're partnering with the Anglican Diocesan Development and Relief Organisation, Alliance for Reproductive Health Rights and Indepth Network in Ghana"}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/mozambique/":{"firstFound":"https://www.gsk.com/","txt":"Mozambique","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Mozambique | GSK ","meta_decription":"We're working with the Manhica Foundation, Nweti Health Communities, Programa Inter Religioso Contra a Malaria (PIRCOM) and CUAMM (Doctors with Africa)  in Mozambique."}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/tanzania/":{"firstFound":"https://www.gsk.com/","txt":"Tanzania","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Tanzania | GSK ","meta_decription":"We're working with The Tanzania Communication and Development Center, The Association of Private Health Facilities in Tanzania and The Clinton Health Access Initiative in Tanzania."}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/greater-mekong-subregion/":{"firstFound":"https://www.gsk.com/","txt":"Greater Mekong Subregion","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Greater Mekong Subregion | GSK ","meta_decription":"We're working with Malaria Consortium, PSI and Health Poverty Action in the Greater Mekong Subregion"}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/johari-mother-of-four/":{"firstFound":"https://www.gsk.com/","txt":"Johari, mother of four","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Johari, mother of four | GSK ","meta_decription":"In 2009, Johari was one month pregnant with twins when she became seriously ill from malaria."}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/leonard-father-farmer-and-assistant/":{"firstFound":"https://www.gsk.com/","txt":"Leonard, father, farmer and assistant","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Leonard, father, farmer and assistant | GSK ","meta_decription":"When Leonard was 19 years old, his firstborn baby became gravely sick."}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/nsaje-teacher/":{"firstFound":"https://www.gsk.com/","txt":"Nsaje, teacher","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Nsaje, teacher | GSK ","meta_decription":"As many as five students can be absent from Burega secondary school each day due to malaria."}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/johari-mother-of-two/":{"firstFound":"https://www.gsk.com/","txt":"Johari, mother of two","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Johari, mother of two | GSK ","meta_decription":"Johari says that malaria not only wastes her time but is stopping her children from achieving their full potential."}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/jacob-tanzania-communication-and-development-centre/":{"firstFound":"https://www.gsk.com/","txt":"Jacob, Tanzania Communication and Development Centre","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Jacob, Tanzania Communication and Development Centre | GSK ","meta_decription":"Jacob is on the front line of the fight against malaria in Tanzania."}},"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/patrick-malaria-patient/":{"firstFound":"https://www.gsk.com/","txt":"Patrick, malaria patient","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Patrick, malaria patient | GSK ","meta_decription":"In 2016, 13-year-old Patrick started to feel ill while his mother was out farming."}},"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/":{"redirectedFrom":"http://www.gsk.com/en-gb/about-us/save-the-children-partnership/"},"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/overview/":{"firstFound":"https://www.gsk.com/","txt":"Overview","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Save the Children partnership | GSK ","meta_decription":"How we're working with Save the Children to help save the lives of 1 million of the world's most vulnerable children"},"redirectedTo":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/"},"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/meet-the-children/":{"firstFound":"https://www.gsk.com/","txt":"Meet the children","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Save the Children partnership | GSK ","meta_decription":"How we're working with Save the Children to help save the lives of 1 million of the world's most vulnerable children"},"redirectedTo":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/"},"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/2016-healthcare-innovation-award/":{"firstFound":"https://www.gsk.com/","txt":"2016 Healthcare Innovation Award","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Save the Children partnership | GSK ","meta_decription":"How we're working with Save the Children to help save the lives of 1 million of the world's most vulnerable children"},"redirectedTo":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/"},"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/past-healthcare-innovation-awards-winners/":{"firstFound":"https://www.gsk.com/","txt":"Past Healthcare Innovation Awards Winners","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Save the Children partnership | GSK ","meta_decription":"How we're working with Save the Children to help save the lives of 1 million of the world's most vulnerable children"},"redirectedTo":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/"},"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/trek-for-kids/":{"firstFound":"https://www.gsk.com/","txt":"Trek for Kids","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Save the Children partnership | GSK ","meta_decription":"How we're working with Save the Children to help save the lives of 1 million of the world's most vulnerable children"},"redirectedTo":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/"},"https://www.gsk.com/en-gb/about-us/smile-train-partnership/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Smile Train partnership\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Smile Train partnership | GSK ","meta_decription":"With GSK Consumer Healthcare’s heritage in specialist oral health, we know the importance of a healthy mouth, which is why we’re proud to launch a new partnership with Smile Train, a world-leading charity which empowers local medical professionals to provide free, life-changing surgery and comprehensive cleft care to children with cleft lip and palate in more than 85 countries."}},"https://www.gsk.com/en-gb/products/":{"redirectedFrom":"http://www.gsk.com/products.html"},"https://www.gsk.com/en-gb/products/our-prescription-medicines/":{"redirectedFrom":"http://www.gsk.com/en-gb/products/our-prescription-medicines-and-vaccines/"},"https://www.gsk.com/en-gb/products/our-vaccines/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Our vaccines\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Our vaccines | GSK ","meta_decription":"Our vaccines business develops, produces and distributes over 1.9 million vaccines every day to people across over 150 countries"}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Our consumer healthcare products\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Our consumer healthcare products | GSK ","meta_decription":"When you experience discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products are here to help you enjoy life to the full again."}},"https://www.gsk.com/en-gb/products/viiv-healthcare/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            ViiV Healthcare\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"ViiV Healthcare | GSK ","meta_decription":"100% focussed on HIV."}},"https://www.gsk.com/en-gb/products/stiefel-dermatology/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Stiefel dermatology\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Stiefel dermatology | GSK ","meta_decription":"Stiefel has a long history of excellence in dermatology and R&D focused in acne, psoriasis, eczema, atopic dermatitis and superficial skin infections"}},"https://www.gsk.com/en-gb/careers/":{"redirectedFrom":"http://www.gsk.com/en-gb/careers/"},"https://www.gsk.com/en-gb/careers/job-finder/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Job finder\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Job finder | GSK "}},"https://www.gsk.com/en-gb/careers/experienced-professionals/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Experienced professionals\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Experienced professionals | GSK ","meta_decription":"Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies. To achieve this, we strive to attract the best people and create an environment that empowers and inspires. Are you up for the challenge? If so, we invite you to explore the many opportunities currently available."}},"https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/":{"firstFound":"https://www.gsk.com/","txt":"Business operations","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Business operations | GSK ","meta_decription":"Are you looking to help a global company realise its potential? Then join one of our business operations teams."}},"https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/":{"firstFound":"https://www.gsk.com/","txt":"Engineering","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Engineering | GSK ","meta_decription":"Would you like to commission and work on leading-edge manufacturing technologies that make important treatments for patient and consumers? We are looking for adaptable and ambitious engineers."}},"https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/":{"firstFound":"https://www.gsk.com/","txt":"Manufacturing and supply","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Manufacturing and supply | GSK ","meta_decription":"Are you an innovator who appreciates the importance of safety and quality? Then we’d love you to join our manufacturing and supply team!"}},"https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/":{"firstFound":"https://www.gsk.com/","txt":"Marketing and communications","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Marketing and communications | GSK ","meta_decription":"Analyst, creative thinker, collaborator? We want compelling marketers and communicators."}},"https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/":{"firstFound":"https://www.gsk.com/","txt":"Research and development ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Research and development  | GSK ","meta_decription":"Do you have a curious mind with a thirst for innovation? We want scientists with the drive to work at the highest level of medical research."}},"https://www.gsk.com/en-gb/careers/experienced-professionals/sales/":{"firstFound":"https://www.gsk.com/","txt":"Sales","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Sales | GSK ","meta_decription":"Is strategic decision making and relationship building what drives you every day? Then join our Sales team!"}},"https://www.gsk.com/en-gb/careers/physicians/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Physicians\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Physicians | GSK ","meta_decription":"Physicians are vital to our organisation and our mission of helping people do more, feel better, live longer."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/":{"redirectedFrom":"http://www.gsk.com/en-gb/careers/graduates/"},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/school-students-what-next/":{"firstFound":"https://www.gsk.com/","txt":"School students - what next","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"School students - what next | GSK ","meta_decription":"We offer a range of opportunities to undergraduates and students at different stages of education, as well as to school and college leavers"}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/":{"firstFound":"https://www.gsk.com/","txt":"Apprentice programmes","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Apprentice programmes | GSK ","meta_decription":"Find out about becoming an apprentice at GSK."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/work-experience-placements-and-internships/":{"firstFound":"https://www.gsk.com/","txt":"Work experience, placements and internships","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Work experience, placements and internships | GSK ","meta_decription":"Find out about work experience, placements and internships with GSK."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/":{"firstFound":"https://www.gsk.com/","txt":"Future Leaders graduate programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Future Leaders graduate programme | GSK ","meta_decription":"GSK’s world-class programme for ambitious, talented graduates."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/direct-entry/":{"firstFound":"https://www.gsk.com/","txt":"Direct entry","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Direct entry | GSK ","meta_decription":"A rotational development programme isn’t for everyone. Find out more about alternative opportunities."}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Postgraduate opportunities\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Postgraduate opportunities | GSK ","meta_decription":"Medical, financial, research and consulting programmes at GSK for ambitious postgraduates"}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-commercial-pharmaceuticals/":{"firstFound":"https://www.gsk.com/","txt":"Esprit commercial (Pharmaceuticals) ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Esprit commercial (Pharmaceuticals)  | GSK ","meta_decription":"This programme is designed for exceptional MBA postgraduates with previous commercial experience and a passion for working in healthcare."}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-commercial-consumer-healthcare/":{"firstFound":"https://www.gsk.com/","txt":"Esprit commercial (Consumer Healthcare) ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Esprit commercial (Consumer Healthcare)  | GSK ","meta_decription":"This programme provides development opportunities for individuals who will take on stretching challenges and projects that are designed to stretch you, all with the ultimate aim of positively impacting the lives of patients and consumers."}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-commercial-vaccines/":{"firstFound":"https://www.gsk.com/","txt":"Esprit commercial (Vaccines) ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Esprit commercial (Vaccines)  | GSK ","meta_decription":"This programme is designed for exceptional MBA postgraduates with previous commercial experience and a passion for working in healthcare."}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-finance/":{"firstFound":"https://www.gsk.com/","txt":"Esprit finance ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Esprit finance  | GSK ","meta_decription":"Are you looking for a new challenge? Our Esprit Finance programme is open to exceptional MBA or MiF postgraduates from a variety of backgrounds with a passion for finance."}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-procurement/":{"firstFound":"https://www.gsk.com/","txt":"Esprit procurement ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Esprit procurement  | GSK ","meta_decription":"We’re looking for self-driven and ambitious agents of change who will lead how we better invest our over £12bn of external spend."}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/postgraduate-internships/":{"firstFound":"https://www.gsk.com/","txt":"Postgraduate internships","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Postgraduate internships | GSK ","meta_decription":"If you are currently studying towards an MBA, you may be interested in one of our Esprit internship opportunities."}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-rd-leadership-development-programme/":{"firstFound":"https://www.gsk.com/","txt":"Esprit R&D Leadership development programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Esprit R&D Leadership development programme | GSK ","meta_decription":"If you are an ambitious and talented physician this could be your fast-track route to scientific leadership, with one of the world’s leading healthcare companies."}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/postdoctoral-rd/":{"firstFound":"https://www.gsk.com/","txt":"Postdoctoral R&D","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Postdoctoral R&D | GSK ","meta_decription":"Are you an exceptional postdoc or PhD scientist with strategic decision-making skills? If you would like to work on critical R&D challenges in the pre-competitive space then consider joining our postdoctoral R&D programme."}},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/postdoctoral-immunology-catalyst/":{"firstFound":"https://www.gsk.com/","txt":"Postdoctoral Immunology Catalyst ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Postdoctoral Immunology Catalyst  | GSK ","meta_decription":"If you are an exceptional PhD scientist with a background in immunology or a related field, you could join our world-class Immunology Catalyst R&D facility."}},"https://www.gsk.com/en-gb/careers/meet-our-people/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Meet our people\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Meet our people | GSK ","meta_decription":"Meet some of our employees in research and development, manufacturing and supply, sales and marketing and various other roles, and find out what they really think about working life with us."}},"https://www.gsk.com/en-gb/careers/culture-and-values/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Culture and values\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Culture and values | GSK ","meta_decription":"A business with a strong purpose and the values and culture to meet it."}},"https://www.gsk.com/en-gb/careers/career-benefits/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Career benefits\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Career benefits | GSK ","meta_decription":"Happy, motivated people are key to the success of our business, so we do everything we can to make working here rewarding."}},"https://www.gsk.com/en-gb/careers/tips-for-applying/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Tips for applying\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Tips for applying | GSK ","meta_decription":"You have decided you’re ready for a career move, or making the leap into the world of work, but how do you go about applying for a job?"}},"https://www.gsk.com/en-gb/investors/":{"firstFound":"https://www.gsk.com/","txt":"Investors\n                                \n                                    \n                                \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Investors | GSK ","meta_decription":"Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting"}},"https://www.gsk.com/en-gb/investors/shareholder-information/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Shareholder information\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Shareholder information | GSK ","meta_decription":"Information and tools for shareholders including dividend calculator, share management tools, and advice on how to avoid share scams"}},"https://www.gsk.com/en-gb/investors/shareholder-information/dividend-calculator-gbp/":{"firstFound":"https://www.gsk.com/","txt":"Dividend calculator (GBP)","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Dividend calculator (GBP) | GSK ","meta_decription":"This tool allows you to calculate an estimate of your dividend payment, based on the number of shares you owned when the dividend was paid (GBP)"}},"https://www.gsk.com/en-gb/investors/shareholder-information/dividend-calculator-usd/":{"firstFound":"https://www.gsk.com/","txt":"Dividend calculator (USD)","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Dividend calculator (USD) | GSK ","meta_decription":"This tool allows you to calculate an estimate of your dividend payment, based on the number of shares you owned when the dividend was paid (USD)"}},"https://www.gsk.com/en-gb/investors/shareholder-information/dividend-calendar/":{"firstFound":"https://www.gsk.com/","txt":"Dividend calendar","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Dividend calendar | GSK ","meta_decription":"Details of our dividend timetable by quarter"}},"https://www.gsk.com/en-gb/investors/shareholder-information/manage-your-shares/":{"firstFound":"https://www.gsk.com/","txt":"Manage your shares","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Manage your shares | GSK ","meta_decription":"Manage your UK shares and request changes to your details on the Equiniti Shareview website"}},"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/":{"firstFound":"https://www.gsk.com/","txt":"Annual General Meeting","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Annual General Meeting | GSK ","meta_decription":"GSK holds an Annual General Meeting in London each year during May"}},"https://www.gsk.com/en-gb/investors/shareholder-information/general-meeting/":{"firstFound":"https://www.gsk.com/","txt":"General Meeting","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"General Meeting | GSK ","meta_decription":"On 02 March 2015, we announced the completion of our major three-part transaction with Novartis"}},"https://www.gsk.com/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/":{"firstFound":"https://www.gsk.com/","txt":"Corporate sponsored nominee service","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Corporate sponsored nominee service | GSK ","meta_decription":"The GSK corporate sponsored nominee service is a convenient way to manage your GSK shares without a share certificate"}},"https://www.gsk.com/en-gb/investors/shareholder-information/asset-reunification-prosearch/":{"firstFound":"https://www.gsk.com/","txt":"Asset Reunification – ProSearch","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Asset Reunification – ProSearch | GSK ","meta_decription":"We have launched a tracing programme in partnership with ProSearch with the aim of reuniting 'lost' shareholders"}},"https://www.gsk.com/en-gb/investors/shareholder-information/share-scam-alert/":{"firstFound":"https://www.gsk.com/","txt":"Share scam alert","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Share scam alert | GSK ","meta_decription":"Advice regarding unsolicited phone calls or correspondence concerning investment matters"}},"https://www.gsk.com/en-gb/investors/shareholder-information/shareholder-privacy-notice/":{"firstFound":"https://www.gsk.com/","txt":"Shareholder Privacy Notice","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Shareholder Privacy Notice | GSK ","meta_decription":"This privacy notice applies to you if you are an individual and are a current or former registered shareholder of GlaxoSmithKline plc and describes what personal information we collect"}},"https://www.gsk.com/en-gb/investors/quarterly-results/":{"redirectedFrom":"http://www.gsk.com/en-gb/investors/quarterly-results/"},"https://www.gsk.com/en-gb/investors/corporate-reporting/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Corporate reporting\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Corporate reporting | GSK ","meta_decription":"Find out how GSK is performing through our Annual Report and Responsible Business Supplement"}},"https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/":{"firstFound":"https://www.gsk.com/","txt":"Annual Report 2017","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Annual Report 2017 | GSK ","meta_decription":"Access our Annual report 2017 and Responsible Business Supplement 2017"}},"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/":{"firstFound":"https://www.gsk.com/","txt":"Corporate reporting archive","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Corporate reporting archive | GSK ","meta_decription":"Archive of Annual Reports and Corporate Responsibility Reports dating back to 2000"}},"https://www.gsk.com/en-gb/investors/share-price-analysis/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Share price analysis\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Share price analysis | GSK ","meta_decription":"Useful tools to enable investors to analyse current and historical GSK share prices"}},"https://www.gsk.com/en-gb/investors/share-price-analysis/gsk-share-price/":{"firstFound":"https://www.gsk.com/","txt":"GSK share price","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"GSK share price | GSK ","meta_decription":"Details of GSK's share price for stocks quoted on both the London and New York Stock Exchanges"}},"https://www.gsk.com/en-gb/investors/share-price-analysis/share-price-calculator-gbp/":{"firstFound":"https://www.gsk.com/","txt":"Share price calculator (GBP)","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Share price calculator (GBP) | GSK ","meta_decription":"Use our share price calculator for UK shares (GBP)"}},"https://www.gsk.com/en-gb/investors/share-price-analysis/share-price-calculator-usd/":{"firstFound":"https://www.gsk.com/","txt":"Share price calculator (USD)","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Share price calculator (USD) | GSK ","meta_decription":"Use our share price calculator for US shares (USD)"}},"https://www.gsk.com/en-gb/investors/financial-calendar/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Financial calendar\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Financial calendar | GSK ","meta_decription":"View upcoming key dates in our financial calendar"}},"https://www.gsk.com/en-gb/investors/analyst-consensus/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Analyst consensus\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Analyst consensus | GSK ","meta_decription":"The consensus has been collated from estimates submitted by analysts to GlaxoSmithKline using a standard template. The information is provided purely for convenience to users of our website, for information purposes only."}},"https://www.gsk.com/en-gb/investors/debt-investors/":{"redirectedFrom":"https://www.gsk.com/en-gb/investors/debt-investors/contact-details/"},"https://www.gsk.com/en-gb/investors/debt-investors/credit-rating-table/":{"firstFound":"https://www.gsk.com/","txt":"Credit rating table","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Debt investors | GSK ","meta_decription":"GSK’s treasury department monitors and manages the Group’s external and internal funding requirements and financial risks in support of our strategic objectives."},"redirectedTo":"https://www.gsk.com/en-gb/investors/debt-investors/"},"https://www.gsk.com/en-gb/investors/debt-investors/liquidity/":{"firstFound":"https://www.gsk.com/","txt":"Liquidity","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Debt investors | GSK ","meta_decription":"GSK’s treasury department monitors and manages the Group’s external and internal funding requirements and financial risks in support of our strategic objectives."},"redirectedTo":"https://www.gsk.com/en-gb/investors/debt-investors/"},"https://www.gsk.com/en-gb/investors/debt-investors/bond-table/":{"firstFound":"https://www.gsk.com/","txt":"Bond table","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Debt investors | GSK ","meta_decription":"GSK’s treasury department monitors and manages the Group’s external and internal funding requirements and financial risks in support of our strategic objectives."},"redirectedTo":"https://www.gsk.com/en-gb/investors/debt-investors/"},"https://www.gsk.com/en-gb/investors/debt-investors/debt-maturity-profile/":{"firstFound":"https://www.gsk.com/","txt":"Debt maturity profile","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Debt investors | GSK ","meta_decription":"GSK’s treasury department monitors and manages the Group’s external and internal funding requirements and financial risks in support of our strategic objectives."},"redirectedTo":"https://www.gsk.com/en-gb/investors/debt-investors/"},"https://www.gsk.com/en-gb/investors/debt-investors/contact-details/":{"firstFound":"https://www.gsk.com/","txt":"Contact details","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":"Debt investors | GSK ","meta_decription":"GSK’s treasury department monitors and manages the Group’s external and internal funding requirements and financial risks in support of our strategic objectives."},"redirectedTo":"https://www.gsk.com/en-gb/investors/debt-investors/"},"https://www.gsk.com/en-gb/investors/stock-exchange-announcements/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Stock exchange announcements\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Stock exchange announcements | GSK ","meta_decription":"Regulatory announcements including earnings announcements, dividend information and director changes"}},"https://www.gsk.com/en-gb/investors/stock-exchange-announcements/london-rns/":{"firstFound":"https://www.gsk.com/","txt":"London (RNS)","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"London (RNS) | GSK ","meta_decription":"All London Stock Exchange required announcements"}},"https://www.gsk.com/en-gb/investors/stock-exchange-announcements/london-rns-inside-information/":{"firstFound":"https://www.gsk.com/","txt":"London (RNS) inside information","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"London (RNS) inside information | GSK ","meta_decription":"London Stock Exchange announcements containing inside information"}},"https://www.gsk.com/en-gb/investors/stock-exchange-announcements/new-york-sec/":{"firstFound":"https://www.gsk.com/","txt":"New York (SEC)","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"New York (SEC) | GSK ","meta_decription":"All New York Stock Exchange announcements and filings"}},"https://www.gsk.com/en-gb/investors/about-gsk/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            About GSK\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"About GSK | GSK ","meta_decription":"We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products."}},"https://www.gsk.com/en-gb/investors/speeches-presentations/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Speeches & presentations\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Speeches & presentations | GSK ","meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/investors/product-pipeline/":{"redirectedFrom":"https://www.gsk.com/en-gb/investors/product-pipeline/oncology/"},"https://www.gsk.com/en-gb/investors/investors-contact-details/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Investors contact details\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Investors contact details | GSK ","meta_decription":"UK and US contact details for investors"}},"https://www.gsk.com/en-gb/investors/agreement-to-acquire-tesaro/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Agreement to acquire TESARO\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Agreement to acquire TESARO | GSK ","meta_decription":"On 3 December 2018 we announced our agreement to acquire TESARO, an oncology-focused company based in the US for approximately $5.1bn."}},"https://www.gsk.com/en-gb/media/":{"firstFound":"https://www.gsk.com/","txt":"Media\n                                \n                                    \n                                \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Media | GSK ","meta_decription":"Explore the latest news, different ways to stay in touch and available useful resources"}},"https://www.gsk.com/en-gb/media/press-releases/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Press releases\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Press releases | GSK ","meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/social-media/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Social media\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Social media | GSK ","meta_decription":"We use social media as part of our commitment to transparency and to provide timely information to our customers and stakeholders"}},"https://www.gsk.com/en-gb/media/resource-centre/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Resource centre\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Resource centre | GSK ","meta_decription":"The resource centre houses various pieces of information and a useful bank of material for further detail on GSK related stories and news"}},"https://www.gsk.com/en-gb/media/resource-centre/our-approach-to-brexit/":{"firstFound":"https://www.gsk.com/","txt":"Our approach to Brexit","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Our approach to Brexit | GSK ","meta_decription":"We have evaluated the impact of Brexit on our business operations, including our supply chain and quality oversight. Our priority is to maintain continuity of GSK’s supply of medicines, vaccines and health products to our patients and consumers in the UK and the EU."}},"https://www.gsk.com/en-gb/media/resource-centre/pharmaceuticals-resources/":{"firstFound":"https://www.gsk.com/","txt":"Pharmaceuticals resources","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Pharmaceuticals resources | GSK ","meta_decription":"Media resources for HIV, respiratory including asthma and COPD and rare diseases such as lupus."}},"https://www.gsk.com/en-gb/media/resource-centre/quick-facts/":{"firstFound":"https://www.gsk.com/","txt":"Quick facts","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Quick facts | GSK ","meta_decription":"Quick facts for use by the media."}},"https://www.gsk.com/en-gb/media/rss-feeds/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            RSS feeds\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"RSS feeds | GSK ","meta_decription":"Our RSS feeds allow users to see new GSK content as soon as it becomes available. To subscribe you’ll need an RSS feed reader, which will display the contents of the RSS feed in an easy to read format. Then simply choose which of our feeds you would like to subscribe to. You can unsubscribe from either feed at any point."}},"https://www.gsk.com/en-gb/media/image-and-video-library/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Image and video library\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Image and video library | GSK ","meta_decription":"Images can be downloaded in low and high resolution. Our YouTube channel offers a regularly updated collection of GSK videos"}},"https://www.gsk.com/en-gb/media/media-contact-details/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Media contact details\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Media contact details | GSK ","meta_decription":"Media contact details for our global headquarters, USA and Asia Pacific"}},"https://www.gsk.com/en-gb/research/":{"redirectedFrom":"http://www.gsk.com/en-gb/research/"},"https://www.gsk.com/en-gb/research/what-we-are-working-on/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            What we are working on\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"What we are working on | GSK ","meta_decription":"GSK has a deep portfolio of innovation, focussed across six core areas of scientific research and development"}},"https://www.gsk.com/en-gb/research/product-pipeline/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Product pipeline\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Product pipeline | GSK ","meta_decription":"A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III"}},"https://www.gsk.com/en-gb/research/our-approach/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Our approach\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Our approach | GSK ","meta_decription":"Our relentless pursuit to discover and develop new medicines and vaccines"}},"https://www.gsk.com/en-gb/research/our-approach/how-we-discover-new-medicines/":{"firstFound":"https://www.gsk.com/","txt":"How we discover new medicines","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"How we discover new medicines | GSK ","meta_decription":"Researching and developing a new medicine typically goes through several stages from laboratory to patient"}},"https://www.gsk.com/en-gb/research/our-approach/how-we-discover-new-vaccines/":{"firstFound":"https://www.gsk.com/","txt":"How we discover new vaccines","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"How we discover new vaccines | GSK ","meta_decription":"Our vaccines R&D is focused on discovering prophylactic and therapeutic vaccines to protect people against infectious diseases, cancers and chronic disorders."}},"https://www.gsk.com/en-gb/research/our-approach/consumer-healthcare-research/":{"firstFound":"https://www.gsk.com/","txt":"Consumer healthcare research","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Consumer healthcare research | GSK ","meta_decription":"GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business"}},"https://www.gsk.com/en-gb/research/our-approach/open-innovation/":{"firstFound":"https://www.gsk.com/","txt":"Open innovation","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Open innovation | GSK ","meta_decription":"We share expertise, resources, intellectual property and know-how with external researchers and the scientific community to promote change beyond GSK"}},"https://www.gsk.com/en-gb/research/our-approach/sharing-our-research/":{"firstFound":"https://www.gsk.com/","txt":"Sharing our research","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Sharing our research | GSK ","meta_decription":"We are committed to reporting the results of clinical research that evaluates our medicines and vaccines"}},"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/":{"firstFound":"https://www.gsk.com/","txt":"Trials in people","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Trials in people | GSK ","meta_decription":"Find out about our clinical trials process, how we work with doctors and volunteers, and how to become a research volunteer"}},"https://www.gsk.com/en-gb/research/our-approach/our-use-of-animals/":{"firstFound":"https://www.gsk.com/","txt":"Our use of animals","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Our use of animals | GSK ","meta_decription":"At GSK we believe we have a moral responsibility to ensure good welfare and treatment of the animals in our care"}},"https://www.gsk.com/en-gb/research/rd-locations/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            R&D locations\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"R&D locations | GSK ","meta_decription":"Over 11,000 people work in our Pharmaceutical, Vaccines and Consumer Healthcare R&D organisations, in major research centres around the world."}},"https://www.gsk.com/en-gb/responsibility/":{"redirectedFrom":"http://www.gsk.com/responsibility"},"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Access to healthcare\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Access to healthcare | GSK ","meta_decription":"Our part in tackling global health challenges and our aim to extend the benefits of our products to more people"}},"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/access-to-healthcare/":{"firstFound":"https://www.gsk.com/","txt":"Access to healthcare","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Access to healthcare | GSK ","meta_decription":"Utilising our scientific expertise, our partnerships and our global reach to make products available for people who need them, wherever they live"}},"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/tackling-diseases-in-developing-countries/":{"firstFound":"https://www.gsk.com/","txt":"Tackling diseases in developing countries","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Tackling diseases in developing countries | GSK ","meta_decription":"We work to tackle some of the root causes of disease and contribute to healthier communities around the world"}},"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/hiv-aids-and-viiv-healthcare/":{"firstFound":"https://www.gsk.com/","txt":"HIV, AIDS and ViiV Healthcare","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"HIV, AIDS and ViiV Healthcare | GSK ","meta_decription":"Our priority is to develop new medicines for HIV/AIDS and ensure they can be accessed by the people who need them most"}},"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/health-and-well-being-in-communities/":{"firstFound":"https://www.gsk.com/","txt":"Health and well-being in communities","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Health and well-being in communities | GSK ","meta_decription":"Our philosophy is to target support on selected health and educational programmes that are innovative, sustainable and produce tangible results"}},"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/reinvesting-in-healthcare/":{"firstFound":"https://www.gsk.com/","txt":"Reinvesting in healthcare","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Reinvesting in healthcare | GSK ","meta_decription":"We have committed to reinvest 20% of our profits back in to improving the healthcare infrastructure in the world’s Least Developed Countries"}},"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/sustainable-development/":{"firstFound":"https://www.gsk.com/","txt":"Sustainable development","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Sustainable development | GSK ","meta_decription":"We work to develop and expand access to medicines and products that help millions of people around the world"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Operating responsibly\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Operating responsibly | GSK ","meta_decription":"We are changing the way we work to further embed our values in everything we do, including the way we research, develop, sell and market our products"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/ethical-conduct/":{"firstFound":"https://www.gsk.com/","txt":"Ethical conduct","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Ethical conduct | GSK ","meta_decription":"Ethical conduct is a priority for GSK and we are committed to performance with integrity"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/sales-and-marketing-practices/":{"firstFound":"https://www.gsk.com/","txt":"Sales and marketing practices","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Sales and marketing practices | GSK ","meta_decription":"We are changing the way we work and the way our commercial business is set up to further embed our values in everything we do"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/rigorous-patient-and-consumer-safety/":{"firstFound":"https://www.gsk.com/","txt":"Rigorous patient and consumer safety","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Rigorous patient and consumer safety | GSK ","meta_decription":"Patient safety is paramount throughout the development, testing and manufacturing of our products"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/research-practices/":{"firstFound":"https://www.gsk.com/","txt":"Research practices","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Research practices | GSK ","meta_decription":"We make sure we carry out our research to high ethical and quality standards in all the countries in which we operate"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/":{"firstFound":"https://www.gsk.com/","txt":"Engaging with healthcare professionals","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Engaging with healthcare professionals | GSK ","meta_decription":"In all of our interactions with HCPs we aim to be transparent about our work, operate with integrity, and always put the interests of patients first"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/public-policy-and-patient-advocacy/":{"firstFound":"https://www.gsk.com/","txt":"Public policy and patient advocacy","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Public policy and patient advocacy | GSK ","meta_decription":"We aim to demonstrate that all our interactions with political stakeholders and patient advocacy groups are conducted appropriately and ethically"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/human-rights-and-modern-slavery/":{"firstFound":"https://www.gsk.com/","txt":"Human rights and modern slavery","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Human rights and modern slavery | GSK ","meta_decription":"Read our Human Rights Statement and our statement on the Modern Slavery Act"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/working-with-third-parties/":{"firstFound":"https://www.gsk.com/","txt":"Working with third parties","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Working with third parties | GSK ","meta_decription":"We aim to build strong relationships with third parties that support our business and share our values"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/compassionate-use-expanded-access/":{"firstFound":"https://www.gsk.com/","txt":"Compassionate use (Expanded access)","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Compassionate use (Expanded access) | GSK ","meta_decription":"Our policy explains our position and criteria for assessing requests and provides a link for health care professionals’ requests."}},"https://www.gsk.com/en-gb/responsibility/our-people/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Our people\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Our people | GSK ","meta_decription":"Learn how we create an inspiring and supportive work environment that encourages employees to develop capabilities and achieve their best"}},"https://www.gsk.com/en-gb/responsibility/our-people/working-at-gsk/":{"firstFound":"https://www.gsk.com/","txt":"Working at GSK","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Working at GSK | GSK ","meta_decription":"Find out how we aim to create an inclusive, engaging and inspiring working environment"}},"https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/":{"redirectedFrom":"http://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/"},"https://www.gsk.com/en-gb/responsibility/our-people/improving-health-safety-and-resilience/":{"firstFound":"https://www.gsk.com/","txt":"Improving health, safety and resilience","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Improving health, safety and resilience | GSK ","meta_decription":"Our health and safety programmes enable employees to lead healthier, safer lives at work and home"}},"https://www.gsk.com/en-gb/responsibility/environment/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Environment\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Environment | GSK ","meta_decription":"To ensure we deliver high quality products to patients and consumers, we must protect the natural resources we need to make them today"}},"https://www.gsk.com/en-gb/responsibility/environment/carbon/":{"firstFound":"https://www.gsk.com/","txt":"Carbon","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Carbon | GSK ","meta_decription":"We are working to reduce emissions from our entire value chain while extending access to our products for the people who need them"}},"https://www.gsk.com/en-gb/responsibility/environment/water/":{"firstFound":"https://www.gsk.com/","txt":"Water","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Water | GSK ","meta_decription":"By better understanding our water use across the value chain, we can focus our efforts where we can make the biggest difference"}},"https://www.gsk.com/en-gb/responsibility/environment/waste/":{"firstFound":"https://www.gsk.com/","txt":"Waste","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Waste | GSK ","meta_decription":"We aim to halve the amount of operational waste we generate by 2020, shifting perceptions to see waste as a potential resource"}},"https://www.gsk.com/en-gb/responsibility/environment/environmental-stewardship/":{"firstFound":"https://www.gsk.com/","txt":"Environmental stewardship","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Environmental stewardship | GSK ","meta_decription":"We are taking steps to ensure that raw materials, such as wood-based packaging materials and palm oil are sourced responsibly."}},"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/":{"firstFound":"https://www.gsk.com/","txt":"\n                                                            \n                                                            Responsibility reports & data\n                                                                \n                                                                    \n                                                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Responsibility reports & data | GSK ","meta_decription":"Find out about our responsible business performance in our Responsible Business Supplement and other historical resources"}},"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/":{"firstFound":"https://www.gsk.com/","txt":"Reporting archive and resources","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Reporting archive and resources | GSK ","meta_decription":"Access our archive of responsible business reports and resources dating back to 2002"}},"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/charitable-grants/":{"firstFound":"https://www.gsk.com/","txt":"Charitable grants","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Charitable grants | GSK ","meta_decription":"We are transparent about our charitable giving with data being published in our Annual Report and Responsible Business Supplement each year"}},"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/trade-association-memberships/":{"firstFound":"https://www.gsk.com/","txt":"Trade association memberships","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Trade association memberships | GSK ","meta_decription":"GSK is a member of many trade and industry associations that primarily represent pharmaceutical, consumer products and vaccine businesses"}},"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/":{"firstFound":"https://www.gsk.com/","txt":"Patient group funding","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Patient group funding | GSK ","meta_decription":"Patient groups – non-profit organisations founded by patients, care-givers, family members and health professionals"}},"https://www.gsk.com/en-gb/behind-the-science/innovation/how-do-consumer-insights-fuel-our-innovation/":{"firstFound":"https://www.gsk.com/","txt":"\n                                Behind the science\n                            How do consumer insights fuel our innovation?\n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"How do consumer insights fuel our innovation? | GSK ","meta_decription":"By asking our consumers what matters to them, we can keep innovating and evolving our products."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/novamin-the-accidental-curist/":{"firstFound":"https://www.gsk.com/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Behind the science\n                                    How a chance encounter led to a world-first toothpaste\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"How a chance encounter led to a world-first toothpaste | GSK ","meta_decription":"Did you know that NovaMin, one of the key technologies in our toothpaste, is actually a bioactive glass most commonly used to repair bones?"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-to-acquire-tesaro-an-oncology-focused-biopharmaceutical-company/":{"firstFound":"https://www.gsk.com/","txt":"\n                            Latest news\n                            GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company\n                                03 December 2018\n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company | GSK ","meta_decription":"."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-divest-horlicks-and-other-consumer-healthcare-nutrition-products-to-unilever/":{"firstFound":"https://www.gsk.com/","txt":"\n                                    03 December 2018\n                                GSK to divest Horlicks and other Consumer Healthcare nutrition products to Unilever\n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"GSK to divest Horlicks and other Consumer Healthcare nutrition products to Unilever | GSK ","meta_decription":"."}},"https://www.gsk.com/en-gb/media/press-releases/juluca-dolutegravirrilpivirine-the-first-single-pill-2-drug-regimen-for-the-maintenance-treatment-of-hiv-granted-marketing-approval-by-japan-ministry-of-health-labour-and-welfare/":{"firstFound":"https://www.gsk.com/","txt":"\n                                    26 November 2018\n                                Juluca (dolutegravir/rilpivirine), the first single pill, 2-drug regimen, for the maintenance treatment of HIV, granted marketing approval by Japan Ministry of Health, Labour and Welfare\n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Juluca (dolutegravir/rilpivirine), the first single pill, 2-drug regimen, for the maintenance treatment of HIV, granted marketing approval by Japan Ministry of Health, Labour and Welfare | GSK ","meta_decription":"The Ministry of Health, Labour and Welfare (MHLW) has approved Juluca Combination Tablets for the maintenance treatment of human immunodeficiency virus type 1 (HIV-1) infection."}},"https://www.gsk.com/en-gb/terms-of-use/":{"redirectedFrom":"https://www.gsk.com/en-gb/terms-of-use/global-eula-for-mobile-apps-not-using-pii/"},"https://www.gsk.com/en-gb/cookie-policy/":{"firstFound":"https://www.gsk.com/","txt":"Cookie policy","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Cookie policy | GSK ","meta_decription":"GSK uses cookies to improve the experience for visitors to our websites"}},"https://www.gsk.com/en-gb/privacy-notice/":{"firstFound":"https://www.gsk.com/","txt":"Privacy Notice","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Privacy Notice | GSK ","meta_decription":"Information about how GSK protects your privacy"}},"https://www.gsk.com/media/4777/modern-slavery-act-statement-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Modern Slavery Act statement 2017","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/sitemap/":{"redirectedFrom":"http://www.gsk.com/en-gb/sitemap/"},"https://www.gsk.com/en-gb/accessibility/":{"firstFound":"https://www.gsk.com/","txt":"Accessibility","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Accessibility | GSK ","meta_decription":"Information about accessibility for GSK's corporate website"}},"https://www.gsk.com/en-gb/partnerships/":{"firstFound":"https://www.gsk.com/","txt":"Partnerships","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Partnerships | GSK ","meta_decription":"We know that many great ideas can come from outside of GSK, and collaborating with other companies, organisations and academics is fundamental to our business strategy"}},"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/":{"firstFound":"https://www.gsk.com/","txt":"Report a possible side effect","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Report a possible side effect | GSK ","meta_decription":"It is vital for us to continuously monitor the safety of our products and medicines"}},"https://www.gsk.com/en-gb/business-to-business/":{"firstFound":"https://www.gsk.com/","txt":"Business to business","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Business to business | GSK ","meta_decription":"Information on our contract manufacturing services, consulting services, and access to our supplier website for procurement and payment details."}},"https://www.gsk.com/en-gb/contact-us/worldwide/south-africa":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/south-africa"},"https://www.gsk.com/en-gb/contact-us/worldwide/":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/"},"https://www.gsk.com/en-gb/contact-us/worldwide/kenya":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/kenya"},"https://www.gsk.com/en-gb/contact-us/worldwide/algeria/":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/algeria/"},"https://www.gsk.com/en-gb/contact-us/worldwide/myanmar":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/myanmar"},"https://www.gsk.com/en-gb/contact-us/worldwide/philippines":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/philippines"},"https://www.gsk.com/en-gb/contact-us/worldwide/tunisia":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/tunisia"},"https://www.gsk.com/en-gb/behind-the-science/innovation/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                            \n                                \n                            \n                            Innovation\n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Innovation | GSK ","meta_decription":"Read about the innovation behind the science"}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                            \n                                \n                            \n                            Access to healthcare\n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Access to healthcare | GSK ","meta_decription":"Read about access to healthcare"}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                            \n                                \n                            \n                            Patients & consumers\n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Patients & consumers | GSK ","meta_decription":"Read about the patients and consumers behind the science"}},"https://www.gsk.com/en-gb/behind-the-science/our-people/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                            \n                                \n                            \n                            Our people\n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Our people | GSK ","meta_decription":"Read about the people behind the science"}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                            \n                                \n                            \n                            How we do business\n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"How we do business | GSK ","meta_decription":"Find out more about our approach"}},"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                            \n                                \n                            \n                            To challenge, to change\n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"To challenge, to change | GSK ","meta_decription":"Read more stories about to challenge, to change"}},"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                            Browse by tag\n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Tags A-Z | GSK "}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/how-are-we-breaking-through-the-pain-barrier/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                            \n                    Breaking through the pain barrier: our latest research\n                \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Breaking through the pain barrier: our latest research | GSK ","meta_decription":"From a passing headache to chronic back pain, we are working hard to better understand why we experience pain and develop more effective pain relief treatments."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/copd-is-more-than-a-lung-disease/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    COPD is more than a lung disease\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"COPD is more than a lung disease | GSK ","meta_decription":"Ruth Tal-Singer works in respiratory research and development. Here she shares her unique perspective on how the future of COPD treatment is changing."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/cancer-gets-a-sting-with-new-discovery/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Cancer gets a sting with new discovery\n                                        A paper authored by 44 of our scientists was published in the scientific journal Nature, revealing a potential new class of immunotherapy drugs to treat some cancers.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Cancer gets a sting with new discovery | GSK ","meta_decription":"A paper authored by 44 of our scientists was published in the scientific journal Nature, revealing a potential new class of immunotherapy drugs to treat some cancers."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/from-bench-to-bedside-lessons-in-converting-science-into-impact/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    From bench to bedside: lessons in converting science into impact\n                                        Pauline Williams, Head of Global Health R&D, shares a unique perspective on what it takes to research new treatments and deliver them to patients around the world.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"From bench to bedside: lessons in converting science into impact | GSK ","meta_decription":"Pauline Williams, Head of Global Health R&D, shares a unique perspective on what it takes to research new treatments and deliver them to patients around the world."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/tb-uniting-scientists-to-tackle-one-of-the-world-s-biggest-killers/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    TB: uniting scientists to tackle one of the world’s biggest killers\n                                        Tuberculosis – better known as TB – is one of the top ten causes of deaths worldwide. But for the first time in almost 100 years, we have taken a major step towards finding a potential new vaccine against the disease.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"TB: uniting scientists to tackle one of the world’s biggest killers | GSK ","meta_decription":"Tuberculosis – better known as TB – is one of the top ten causes of deaths worldwide. But for the first time in almost 100 years, we have taken a major step towards finding a potential new vaccine against the disease."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/inside-the-open-lab/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Inside the Open Lab\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Inside the Open Lab | GSK ","meta_decription":"How does the Tres Cantos Open Lab offer top international scientists and academics the opportunity to pursue their own projects as part of an integrated team?"}},"https://www.gsk.com/en-gb/behind-the-science/innovation/welcome-to-the-golden-age-of-vaccine-innovation/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    The vaccines of tomorrow\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The vaccines of tomorrow | GSK ","meta_decription":"Join our leading scientists as they go behind the science of vaccine technology."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/you-me-and-23andme-discovering-new-medicines-through-genetics/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    You, me and 23andMe: discovering new medicines through genetics\n                                        Explore how our new collaboration with 23andMe could help unlock the medicines of tomorrow.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"You, me and 23andMe: discovering new medicines through genetics | GSK ","meta_decription":"Explore how our new collaboration with 23andMe could help unlock the medicines of tomorrow."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/overcoming-obstacles-to-end-malaria/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Overcoming obstacles to end malaria\n                                        One of our lead physicians, Justin Green, tells us about the challenges of developing a new treatment for malaria.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Overcoming obstacles to end malaria | GSK ","meta_decription":"One of our lead physicians, Justin Green, tells us about the challenges of developing a new treatment for malaria."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-little-pill-that-could-one-medicine-taking-on-two-neglected-diseases/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    The little pill that could: one medicine taking on two neglected diseases\n                                        This pill is part of the fight against not one – but two – neglected tropical diseases(NTDs) that burden some of the very poorest communities.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The little pill that could: one medicine taking on two neglected diseases | GSK ","meta_decription":"This pill is part of the fight against not one – but two – neglected tropical diseases(NTDs) that burden some of the very poorest communities."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/living-with-severe-asthma/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Severe asthma: when nature’s natural defences work against us\n                                        Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Severe asthma: when nature’s natural defences work against us | GSK ","meta_decription":"Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/complete-the-cycle-how-we-re-recycling-inhalers/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Complete the cycle – how we’re recycling inhalers\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Complete the cycle – how we’re recycling inhalers | GSK ","meta_decription":"When we analysed our carbon footprint in 2010, two things became clear: we needed to take action to reduce it."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/why-are-we-fighting-malaria-in-the-lab-and-on-the-ground/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Fighting malaria in the lab and on the ground\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Fighting malaria in the lab and on the ground | GSK ","meta_decription":"Despite progress to fight malaria, millions of people continue to suffer every year. We’re helping by researching medicines and vaccines, supporting community prevention and health worker training and strengthening access to medicines."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/how-genomics-is-driving-a-new-era-of-drug-discovery/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    How genomics is driving a new era of drug discovery\n                                        We’re in a new era of drug discovery because of a fundamental change in our understanding of human biology.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"How genomics is driving a new era of drug discovery | GSK ","meta_decription":"We’re in a new era of drug discovery because of a fundamental change in our understanding of human biology."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/how-are-we-redefining-research-in-hiv/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    How are we redefining research in HIV?\n                                        Shari Gordon works in the HIV Cure Center in North Carolina, a public-private company with one goal: discovering a cure for HIV/AIDS.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"How are we redefining research in HIV? | GSK ","meta_decription":"Shari Gordon works in the HIV Cure Center in North Carolina, a public-private company with one goal: discovering a cure for HIV/AIDS."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/following-the-journey-of-a-respiratory-medicine/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Following the journey of a respiratory medicine\n                                        Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Following the journey of a respiratory medicine | GSK ","meta_decription":"Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/lupus-the-search-for-a-cure-continues/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Lupus: the search for a cure continues\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Lupus: the search for a cure continues | GSK ","meta_decription":"Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/copd-for-john-just-means-doing-everything-at-a-slower-pace/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    COPD for John just means doing everything at a slower pace\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"COPD for John just means doing everything at a slower pace | GSK ","meta_decription":"Meet John - at 80 years old, he refuses to let COPD get in the way of living the life he wants to."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/making-the-ellipta-inhaler-a-reality/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Making the Ellipta® inhaler a reality\n                                        The story behind the device now used by millions of people globally\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Making the Ellipta® inhaler a reality | GSK ","meta_decription":"The story behind the device now used by millions of people globally"}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/overcoming-the-challenges-of-copd-to-fulfil-a-lifelong-dream/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Overcoming the challenges of COPD to fulfil a lifelong dream\n                                        Joan an 85 year old COPD patient recently achieved her lifelong dream to climb the Great Wall of China. Her daughter Helen tells us Joan’s story.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Overcoming the challenges of COPD to fulfil a lifelong dream | GSK ","meta_decription":"Joan an 85 year old COPD patient recently achieved her lifelong dream to climb the Great Wall of China. Her daughter Helen tells us Joan’s story."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/making-sense-of-what-consumers-want/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Making sense of what consumers want\n                                        As a Principal Sensory Scientist in our Consumer Sensory Lab, Hyung describes how we develop products that spark the sensory reaction consumers want.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Making sense of what consumers want | GSK ","meta_decription":"As a Principal Sensory Scientist in our Consumer Sensory Lab, Hyung describes how we develop products that spark the sensory reaction consumers want."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/the-science-of-shopping/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    The science of shopping\n                                        Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The science of shopping | GSK ","meta_decription":"Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/i-control-my-asthma-it-doesn-t-control-me/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    I control my asthma, it doesn’t control me\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"I control my asthma, it doesn’t control me | GSK ","meta_decription":"Jamie from our Montrose site tells how he managed his asthma to conquer Mount Kenya"}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/thank-you-for-calling-gsk-meet-paul-the-voice-at-the-end-of-the-line/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Thank you for calling GSK. Meet Paul, the voice at the end of the line.\n                                        When you call us, who’s the voice at the end of the line? Paul tells his story from scientist to sympathetic ear.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Thank you for calling GSK. Meet Paul, the voice at the end of the line. | GSK ","meta_decription":"When you call us, who’s the voice at the end of the line? Paul tells his story from scientist to sympathetic ear."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/youll-outgrow-some-childhood-habits-but-vaccination-is-for-life/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    You'll outgrow some childhood habits, but vaccination is for life\n                                        Infectious diseases remain just as serious throughout adulthood and vaccines remain the most effective protection we have against them.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"You'll outgrow some childhood habits, but vaccination is for life | GSK ","meta_decription":"Infectious diseases remain just as serious throughout adulthood and vaccines remain the most effective protection we have against them."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/how-curious-minds-saved-a-medicine-from-being-left-in-the-lab/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    How curious minds saved a medicine from being left in the lab\n                                        See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"How curious minds saved a medicine from being left in the lab | GSK ","meta_decription":"See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/does-lupus-really-know-no-boundaries/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Does lupus really know no boundaries?\n                                        There are no boundaries when it comes to the impact of lupus; it can affect any part of the body in any way at any time, often with unpredictable and life-changing results.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Does lupus really know no boundaries? | GSK ","meta_decription":"There are no boundaries when it comes to the impact of lupus; it can affect any part of the body in any way at any time, often with unpredictable and life-changing results."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/from-tv-to-tackling-lupus-why-alex-moved-from-media-to-medicine/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    From TV to tackling lupus: why Alex moved from media to medicine\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"From TV to tackling lupus: why Alex moved from media to medicine | GSK ","meta_decription":"Alex Liakos on becoming a lupus medic, and listening to the patient"}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/giving-a-bit-back-christine-s-experience-of-clinical-research/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Giving a bit back – Christine’s experience of clinical research\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Giving a bit back – Christine’s experience of clinical research | GSK ","meta_decription":"For Christine even gentle exercise like jogging and walking her dogs around the park were a struggle. She just could not breathe properly."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/healthcare-in-your-pocket/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Healthcare in your pocket\n                                        We are dedicated to supporting patients beyond the medicines we provide and believe that digital technology, has an important role to play in this.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Healthcare in your pocket | GSK ","meta_decription":"We are dedicated to supporting patients beyond the medicines we provide and believe that digital technology, has an important role to play in this."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-race-against-malaria-handing-the-baton-to-the-next-generation/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    The race against malaria: handing the baton to the next generation\n                                        Malaria is a preventable and treatable disease yet it still claims hundreds of thousands of lives each year, mostly in children under five.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The race against malaria: handing the baton to the next generation | GSK ","meta_decription":"Malaria is a preventable and treatable disease yet it still claims hundreds of thousands of lives each year, mostly in children under five."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/win-for-meningitis-harnessing-the-power-of-inspirational-images-to-create-a-win-for-disease-prevention/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Win for Meningitis – harnessing the power of inspirational images  to create a win for disease prevention\n                                        Through our Win for Meningitis campaign, we’re helping to raise awareness of this damaging disease.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Win for Meningitis – harnessing the power of inspirational images  to create a win for disease prevention | GSK ","meta_decription":"Through our Win for Meningitis campaign, we’re helping to raise awareness of this damaging disease."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/setting-the-record-straight-why-we-publish-data-both-positive-and-negative/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Setting the record straight: Why we publish data both positive and negative\n                                        Sharing our trial results, regardless of whether they reflect positively or negatively on our medicines is the right thing to do.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Setting the record straight: Why we publish data both positive and negative | GSK ","meta_decription":"Sharing our trial results, regardless of whether they reflect positively or negatively on our medicines is the right thing to do."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/making-the-switch-how-we-re-improving-access-to-proven-medicines/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Making the switch: how we’re improving access to proven medicines\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Making the switch: how we’re improving access to proven medicines | GSK ","meta_decription":"Switching a medicine from prescription to over-the-counter places the power of managing everyday health conditions with the patient."}},"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/supporting-community-health-across-the-uk/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        To challenge, to change\n                \n            \n                    Supporting community health across the UK\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Supporting community health across the UK | GSK ","meta_decription":"Our GSK IMPACT Awards have been rewarding community health and wellbeing charities for the past 20 years."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/30-years-and-counting-the-fight-against-hiv/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    30 years and counting: the fight against HIV\n                                        How to find a treatment for a disease with no idea what that disease actually is.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"30 years and counting: the fight against HIV | GSK ","meta_decription":"How to find a treatment for a disease with no idea what that disease actually is."}},"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/hiv-research-focus-on-finding-a-cure/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        To challenge, to change\n                \n            \n                    HIV research focus on finding a cure\n                                        With 34 million people around the world living with HIV/AIDS, preventing and treating HIV infection remains an enormous global challenge.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"HIV research focus on finding a cure | GSK ","meta_decription":"With 34 million people around the world living with HIV/AIDS, preventing and treating HIV infection remains an enormous global challenge."}},"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/what-are-bioelectronics/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        To challenge, to change\n                \n            \n                    What are Bioelectronics\n                                        We’re all familiar with the life-saving impact of pacemakers and defibrillators on the heart.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"What are Bioelectronics | GSK ","meta_decription":"We’re all familiar with the life-saving impact of pacemakers and defibrillators on the heart."}},"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/helping-patients-with-respiratory-disease/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        To challenge, to change\n                \n            \n                    Live every breath\n                                        GSK have been innovating to fight respiratory disease for over 45 years.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Live every breath | GSK ","meta_decription":"GSK have been innovating to fight respiratory disease for over 45 years."}},"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/vaccines-for-preventable-diseases/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        To challenge, to change\n                \n            \n                    Vaccines: the most successful health intervention… ever\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Vaccines: the most successful health intervention… ever | GSK ","meta_decription":"Vaccines for preventable diseases"}},"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/joining-forces-to-fight-malaria/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        To challenge, to change\n                \n            \n                    Joining forces to fight malaria\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Joining forces to fight malaria | GSK ","meta_decription":"We’ve been fighting against malaria for the past 100 years and now we’ve joined forces with Comic Relief."}},"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/stem-inspiring-real-world-scientists/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        To challenge, to change\n                \n            \n                    STEM inspiring real world scientists\n                                        GSK STEM Education brings real world science to life in the classroom.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"STEM inspiring real world scientists | GSK ","meta_decription":"GSK STEM Education brings real world science to life in the classroom."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/the-digitalisation-lab-bringing-the-digital-age-to-manufacturing/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    The digitalisation lab: bringing the digital age to manufacturing\n                                        We are developing world-class manufacturing innovation to help us bring medicines and consumer healthcare products to people.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The digitalisation lab: bringing the digital age to manufacturing | GSK ","meta_decription":"We are developing world-class manufacturing innovation to help us bring medicines and consumer healthcare products to people."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/from-academia-to-the-pharmaceutical-industry-one-year-on/":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/our-people/from-academia-to-the-pharmaceutical-industry-one-year-on/"},"https://www.gsk.com/en-gb/behind-the-science/innovation/copd-our-relentless-pursuit-for-better-breathing/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    COPD: Our relentless pursuit for better breathing\n                                        Every person with COPD is different, with different needs, different challenges and different goals. See how we're innovating to determine the right treatment for the right patient.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"COPD: Our relentless pursuit for better breathing | GSK ","meta_decription":"Every person with COPD is different, with different needs, different challenges and different goals. See how we're innovating to determine the right treatment for the right patient."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/taking-action-to-stop-pneumonia/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Taking action to stop pneumonia\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Taking action to stop pneumonia | GSK ","meta_decription":"Pneumonia is a preventable and treatable disease."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/getting-on-target-in-autoimmune-diseases/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Getting on target in autoimmune diseases\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Getting on target in autoimmune diseases | GSK ","meta_decription":"Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs.But what happens when these cells malfunction?"}},"https://www.gsk.com/en-gb/behind-the-science/innovation/how-smart-is-your-inhaler/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    How smart is your inhaler?\n                                        As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"How smart is your inhaler? | GSK ","meta_decription":"As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/maternal-immunisation-helping-protect-mums-and-babies/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Maternal immunisation: Helping protect mums and babies\n                                        Immunisation during pregnancy can help protect the mother, and also help protect the baby before birth and through the critical first few weeks of life.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Maternal immunisation: Helping protect mums and babies | GSK ","meta_decription":"Immunisation during pregnancy can help protect the mother, and also help protect the baby before birth and through the critical first few weeks of life."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/can-social-media-help-us-hear-patients/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Can social media help us hear patients?\n                                        Understanding the benefits and risks of medicine from a patient’s point of view is important to the evaluation of our medicines.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Can social media help us hear patients? | GSK ","meta_decription":"Understanding the benefits and risks of medicine from a patient’s point of view is important to the evaluation of our medicines."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/tackling-tomorrow-s-health-challenges-today/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Tackling tomorrow’s health challenges today\n                                        Our Chief Scientist, Rino Rappuoli, explains how science is helping create the vaccines of tomorrow \n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Tackling tomorrow’s health challenges today | GSK ","meta_decription":"Our Chief Scientist, Rino Rappuoli, explains how science is helping create the vaccines of tomorrow "}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/don-t-forget-the-pharmacists/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Don’t forget the pharmacists\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Don’t forget the pharmacists | GSK ","meta_decription":"Dr. Sharmila Ramachandran and Dr. Aruni Mulgirigama talk about the essential role of pharmacists in asthma care"}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/rabies-educate-vaccinate-eliminate/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Rabies – Educate, Vaccinate, Eliminate.\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Rabies – Educate, Vaccinate, Eliminate. | GSK ","meta_decription":"28 September is World Rabies Day, when organisations across the globe, all with the common goal of eliminating human deaths from rabies by 2030, work together to raise awareness of this ‘neglected tropical disease’ under the theme ‘Educate, Vaccinate, Eliminate’. "}},"https://www.gsk.com/en-gb/behind-the-science/our-people/partnership-for-prevention/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Partnership for Prevention\n                                        Anthony Tropea has been part of the team leading the roll-out of our Partnership for Prevention Programme.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Partnership for Prevention | GSK ","meta_decription":"Anthony Tropea has been part of the team leading the roll-out of our Partnership for Prevention Programme."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/scientists-or-detectives-seeking-new-clues-in-copd/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Scientists or detectives? Seeking new clues in COPD\n                                        It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Scientists or detectives? Seeking new clues in COPD | GSK ","meta_decription":"It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/collaboration-unlocking-a-new-approach-to-clinical-trials/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Collaboration: unlocking a new approach to clinical trials\n                                        The Salford Lung Study is a revolutionary clinical trial carried out in everyday practice that could significantly increase our understanding of the medicines doctors prescribe.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Collaboration: unlocking a new approach to clinical trials | GSK ","meta_decription":"The Salford Lung Study is a revolutionary clinical trial carried out in everyday practice that could significantly increase our understanding of the medicines doctors prescribe."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/helping-to-change-the-world/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Helping to change the world\n                                        FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Helping to change the world | GSK ","meta_decription":"FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/a-new-response-to-humanitarian-crises/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    A new response to humanitarian crises\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"A new response to humanitarian crises | GSK ","meta_decription":"Humanitarian crises are becoming more frequent, more widespread and more complex. It’s clear that a new approach is needed."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/a-partnership-that-is-all-about-the-chemistry/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    A partnership that is all about the chemistry\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"A partnership that is all about the chemistry | GSK ","meta_decription":"See how our trainer trains sub Saharan Africa scientists in analytical chemistry."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/can-an-iphone-transform-the-way-we-monitor-and-improve-patient-health/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Can an iPhone transform the way we monitor and improve patient health?\n                                        We are using digital technologies and channels to improve the efficiency of our research, and to improve patient care.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Can an iPhone transform the way we monitor and improve patient health? | GSK ","meta_decription":"We are using digital technologies and channels to improve the efficiency of our research, and to improve patient care."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    The app that could save lives\n                                        How our partnership with Save the Children is boosting healthcare innovation that supports vulnerable children.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The app that could save lives | GSK ","meta_decription":"How our partnership with Save the Children is boosting healthcare innovation that supports vulnerable children."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/changing-gears-in-a-scientific-career/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Changing gears in a scientific career\n                                        GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier. \n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Changing gears in a scientific career | GSK ","meta_decription":"GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier. "}},"https://www.gsk.com/en-gb/behind-the-science/innovation/inhaler-innovation-more-than-a-simple-piece-of-plastic/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Inhaler innovation: more than a simple piece of plastic\n                                        At first glance, an inhaler may look like a simple piece of plastic. But inside, a complicated process and an internal ‘engine’ operate seamlessly...\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Inhaler innovation: more than a simple piece of plastic | GSK ","meta_decription":"At first glance, an inhaler may look like a simple piece of plastic. But inside, a complicated process and an internal ‘engine’ operate seamlessly..."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/from-microscope-to-telescope-and-beyond-exploring-with-nasas-casis/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    From microscope to telescope and beyond – exploring with NASA's CASIS\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"From microscope to telescope and beyond – exploring with NASA's CASIS | GSK ","meta_decription":"What do space exploration and medical research have in common?  And can they help each other?"}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/meet-baby-mckline-a-special-delivery-from-our-save-the-children-partnership/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Meet Baby Mckline: a special delivery from our Save the Children partnership\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Meet Baby Mckline: a special delivery from our Save the Children partnership | GSK ","meta_decription":"Mckline is a special little boy. Almost two years old, he lives in Kenya with his parents Catherine and Fredrick. They are already saving for his education and have ambitions for him to be an engineer one day."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/pro-mujer-supporting-healthier-lives-in-latin-america/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Pro Mujer: supporting healthier lives in Latin America\n                                        Since 2009, we have been working with Pro Mujer, helping women like Rosa lift themselves and their families out of poverty, and giving them access to high-quality, low-cost healthcare, often for the first time.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Pro Mujer: supporting healthier lives in Latin America | GSK ","meta_decription":"Since 2009, we have been working with Pro Mujer, helping women like Rosa lift themselves and their families out of poverty, and giving them access to high-quality, low-cost healthcare, often for the first time."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/from-academia-to-industry-a-new-challenge/":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/our-people/from-academia-to-industry-a-new-challenge/"},"https://www.gsk.com/en-gb/behind-the-science/our-people/andy-dundon-the-design-behind-the-device/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    The design behind the device\n                                        Andy Dundon leads our R&D Device Engineering team in Ware, UK.  His team focuses on ways to improve the design of our drug delivery devices\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The design behind the device | GSK ","meta_decription":"Andy Dundon leads our R&D Device Engineering team in Ware, UK.  His team focuses on ways to improve the design of our drug delivery devices"}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/an-everyday-world-first-in-clinical-trials/":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/patients-consumers/an-everyday-world-first-in-clinical-trials/"},"https://www.gsk.com/en-gb/behind-the-science/innovation/turning-the-tide-on-antibiotic-resistance/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Turning the tide on antibiotic resistance\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Turning the tide on antibiotic resistance | GSK ","meta_decription":"Picture a world where people routinely die from minor infections. With an alarming rise in antibiotic resistance in recent years, this almost unthinkable scenario could be a reality."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/guardian-article-the-30-year-quest-for-a-malaria-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Guardian article: The 30-year quest for a malaria vaccine\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Guardian article: The 30-year quest for a malaria vaccine | GSK ","meta_decription":"Dr Joe Cohen recalls his experiences of being part of the team to develop what could be the world’s first vaccine against malaria"}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/giving-mothers-and-babies-a-healthier-start/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Giving mothers and babies a healthier start\n                                        Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Giving mothers and babies a healthier start | GSK ","meta_decription":"Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries"}},"https://www.gsk.com/en-gb/behind-the-science/our-people/safety-first-employee-wellbeing-rides-on-it/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Safety first: Employee wellbeing rides on it\n                                        Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.  \n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Safety first: Employee wellbeing rides on it | GSK ","meta_decription":"Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.  "}},"https://www.gsk.com/en-gb/behind-the-science/innovation/vaccine-manufacture-it-s-complicated/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Vaccine manufacture: it’s complicated\n                                        Vaccine manufacture can take anywhere between 6 and 26 months. That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Vaccine manufacture: it’s complicated | GSK ","meta_decription":"Vaccine manufacture can take anywhere between 6 and 26 months. That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/the-power-of-partnerships-transforming-vaccine-coverage-in-mozambique/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    The power of partnerships: transforming vaccine coverage in Mozambique\n                                        More than 35,000 children in the northern Mozambique province of Nampula are now registered with the mVacciNation pilot programme that was rolled out in 2015 by GSK and Vodafone, with funding from GAVI and USAID.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The power of partnerships: transforming vaccine coverage in Mozambique | GSK ","meta_decription":"More than 35,000 children in the northern Mozambique province of Nampula are now registered with the mVacciNation pilot programme that was rolled out in 2015 by GSK and Vodafone, with funding from GAVI and USAID."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-value-of-vaccination/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    The value of vaccination\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The value of vaccination | GSK ","meta_decription":"According to the World Health Organization, only clean drinking water rivals vaccination in its ability to save lives. "}},"https://www.gsk.com/en-gb/behind-the-science/our-people/beyond-manufacturing-in-chile-and-madagascar/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Beyond manufacturing in Chile and Madagascar\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Beyond manufacturing in Chile and Madagascar | GSK ","meta_decription":"In 2015, GSK Vaccines sent two vaccine manufacturing teams to South America and Africa to better understand the impact of their daily work."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/why-i-fightmalaria-lauras-story/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Why I #fightmalaria: Laura's story\n                                        Laura is a scientist and a mum. Here she describes what motivates her to fight against malaria.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Why I #fightmalaria: Laura's story | GSK ","meta_decription":"Laura is a scientist and a mum. Here she describes what motivates her to fight against malaria."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/playing-the-innovation-game/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Playing the innovation game\n                                        Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks. \n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Playing the innovation game | GSK ","meta_decription":"Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks. "}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/living-with-lupus-a-patient-perspective/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Living with lupus – a patient perspective\n                                        Beth, a lupus patient, provides insights into the day-to-day challenges of living with this chronic condition.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Living with lupus – a patient perspective | GSK ","meta_decription":"Beth, a lupus patient, provides insights into the day-to-day challenges of living with this chronic condition."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/take-a-deep-breath-your-lung-microbiome-will-appreciate-it/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Take a deep breath – your lung microbiome will appreciate it\n                                        Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Take a deep breath – your lung microbiome will appreciate it | GSK ","meta_decription":"Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/helping-to-further-science-and-research-howard-s-perspective/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Helping to further science and research – Howard’s perspective\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Helping to further science and research – Howard’s perspective | GSK ","meta_decription":"The Salford Lung Study is a ground breaking clinical trial that explores how effective a treatment for COPD is in everyday life."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/tb-or-not-tb/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    TB or not TB\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"TB or not TB | GSK ","meta_decription":"As recently as 30 years ago, tuberculosis (TB) was believed to be under control. "}},"https://www.gsk.com/en-gb/behind-the-science/innovation/bioelectronics-at-sxsw-2016/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Bioelectronics at SXSW 2016\n                                        SXSW Interactive is a cutting edge technology and digital festival that brings together the brightest minds in emerging technology.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Bioelectronics at SXSW 2016 | GSK ","meta_decription":"SXSW Interactive is a cutting edge technology and digital festival that brings together the brightest minds in emerging technology."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/delivering-support-for-the-most-vulnerable-communities/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Delivering support for the most vulnerable communities\n                                        Healthcare charities tackle some of society’s most difficult and often overlooked challenges.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Delivering support for the most vulnerable communities | GSK ","meta_decription":"Healthcare charities tackle some of society’s most difficult and often overlooked challenges."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/school-leading-the-way-to-inspire-young-scientists/":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/how-we-do-business/school-leading-the-way-to-inspire-young-scientists/"},"https://www.gsk.com/en-gb/behind-the-science/innovation/harnessing-the-electrical-language-of-the-body-to-treat-disease/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Harnessing the electrical language of the body to treat disease\n                                        Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Harnessing the electrical language of the body to treat disease | GSK ","meta_decription":"Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/telegraph-article-science-hasnt-answered-all-the-questions-on-hiv/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Telegraph article: Science hasn't answered all the questions on HIV\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Telegraph article: Science hasn't answered all the questions on HIV | GSK ","meta_decription":"Dr Kimberly Smith, vice president of medical strategy at ViiV Healthcare, shares her experiences of a career spent working to find a cure for the disease."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/igniting-a-revolution-in-scientific-research-and-development/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Igniting a revolution in scientific research and development\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Igniting a revolution in scientific research and development | GSK ","meta_decription":"How can partnerships between science, business and charities help tackle some of the world's most challenging healthcare issues?"}},"https://www.gsk.com/en-gb/behind-the-science/our-people/guardian-article-making-a-change-from-the-inside/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Guardian article: Making a change from the inside\n                                        Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Guardian article: Making a change from the inside | GSK ","meta_decription":"Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/guardian-article-a-different-way-of-doing-business-to-support-kenyan-mothers/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Guardian article: A different way of doing business to support Kenyan mothers\n                                        Find out how we are helping to cut maternal and newborn mortality rates in Kenya.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Guardian article: A different way of doing business to support Kenyan mothers | GSK ","meta_decription":"Find out how we are helping to cut maternal and newborn mortality rates in Kenya."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/see-how-gsk-supports-stem-in-the-real-world/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    See how GSK supports STEM in the real world\n                                        Explore how we invest in the scientists of the future.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"See how GSK supports STEM in the real world | GSK ","meta_decription":"Explore how we invest in the scientists of the future."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/guardian-article-finding-new-ways-to-give-mothers-and-newborns-a-healthier-start/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Guardian article: Finding new ways to give mothers and newborns a healthier start\n                                        Scientist Lori Gavrin has first-hand experience of why we need to find new ways to help protect mothers and their newborn babies\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Guardian article: Finding new ways to give mothers and newborns a healthier start | GSK ","meta_decription":"Scientist Lori Gavrin has first-hand experience of why we need to find new ways to help protect mothers and their newborn babies"}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/turning-waste-into-a-resource/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Turning waste into a resource\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Turning waste into a resource | GSK ","meta_decription":"We set a target to achieve ‘zero waste to landfill’ at all our sites by 2020. Already, over 60% of GSK sites and offices have achieved the target."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/simon-wright-head-of-child-survival-at-save-the-children-gives-a-partnership-perspective/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective | GSK ","meta_decription":"Simon Wright, Head for Child Survival at Save the Children, talks about how we’re working together to make sure the health needs of the world’s poorest children are at the top of everyone’s agenda."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/comic-relief-and-gsk-form-a-partnership-to-fight-malaria/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Comic Relief and GSK form a partnership to fight malaria\n                                        GSK has teamed up with Comic Relief to improve the lives of millions of people in Africa and Asia. Engineer and GSK executive Andy Wright explains.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Comic Relief and GSK form a partnership to fight malaria | GSK ","meta_decription":"GSK has teamed up with Comic Relief to improve the lives of millions of people in Africa and Asia. Engineer and GSK executive Andy Wright explains."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/intrapreneurship-keeping-our-fingers-on-the-pulse/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    Intrapreneurship: keeping our fingers on the PULSE\n                                        We're encouraging our employees to explore new ideas beyond the remit of their role\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Intrapreneurship: keeping our fingers on the PULSE | GSK ","meta_decription":"We're encouraging our employees to explore new ideas beyond the remit of their role"}},"https://www.gsk.com/en-gb/behind-the-science/innovation/turbocharging-the-effect-of-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Turbocharging the effect of vaccines\n                                        When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Turbocharging the effect of vaccines | GSK ","meta_decription":"When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/helping-to-protect-yourself-against-flu/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Helping to protect yourself against flu\n                                        Influenza, commonly called ‘the flu’, is a contagious infection of the respiratory tract, which affects people of all ages.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Helping to protect yourself against flu | GSK ","meta_decription":"Influenza, commonly called ‘the flu’, is a contagious infection of the respiratory tract, which affects people of all ages."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/experimental-medicine/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Experimental medicine\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Experimental medicine | GSK ","meta_decription":"Studies often employ state-of-the art technology to help scientists and doctors track the effect of a potential new medicine in patients’ bodies."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/outgrowing-asthma-rooting-out-the-reasons-for-asthma-remission/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Outgrowing asthma\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Outgrowing asthma | GSK ","meta_decription":"Why is it that some people, particularly children, grow out of their asthma? That’s a question our scientists are asking as part of our research to better understand the disease."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-an-interview-with-curator-christine-mcnab/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    TEDMED 2015: An interview with curator, Christine McNab\n                                        We interview Christine McNab, curator of The Art of Saving a Life.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"TEDMED 2015: An interview with curator, Christine McNab | GSK ","meta_decription":"We interview Christine McNab, curator of The Art of Saving a Life."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/stem-in-the-real-world/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    STEM in the real world\n                                        At Waldegrave School for Girls in Twickenham there is a drive to enthuse pupils about the possibilities and opportunities that STEM subjects can offer.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"STEM in the real world | GSK ","meta_decription":"At Waldegrave School for Girls in Twickenham there is a drive to enthuse pupils about the possibilities and opportunities that STEM subjects can offer."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-art-inspired-by-vaccination/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    TEDMED 2015: Art, inspired by vaccination\n                                        A blank canvas, Unformed clay. An empty petri dish.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"TEDMED 2015: Art, inspired by vaccination | GSK ","meta_decription":"A blank canvas, Unformed clay. An empty petri dish."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/living-every-day-with-copd-jos%C3%A9-s-story/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Living every day with COPD: José’s story\n                                        Simple activities are an everyday struggle for people living with COPD. José gives his perspective on the impact that COPD has on him. \n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Living every day with COPD: José’s story | GSK ","meta_decription":"Simple activities are an everyday struggle for people living with COPD. José gives his perspective on the impact that COPD has on him. "}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/guardian-article-why-i-put-my-signature-on-improving-care-for-kenyas-mothers-and-newborns/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Guardian article: Why I put my signature on improving care for Kenya's mothers and newborns\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Guardian article: Why I put my signature on improving care for Kenya's mothers and newborns | GSK ","meta_decription":"Angela Muriuki finds that combating the high death rates in mothers and newborns in parts of Kenya involves knowledge of the culture of the people involved and the practical problems they face accessing healthcare."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/less-is-more-with-advanced-technologies-in-manufacturing/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Less is more with advanced technologies in manufacturing\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Less is more with advanced technologies in manufacturing | GSK ","meta_decription":"Is ‘continuous manufacturing’ the best way to be greener?"}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/using-biology-to-increase-quality-and-reduce-carbon-footprint/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Using biology to increase quality and reduce carbon footprint\n                                        We've introduced new manufacturing technologies that will help deliver greater numbers of higher quality medicines more effectively to patients\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Using biology to increase quality and reduce carbon footprint | GSK ","meta_decription":"We've introduced new manufacturing technologies that will help deliver greater numbers of higher quality medicines more effectively to patients"}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/five-years-40-000-health-workers-11-million-people/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Five years. 40,000 health workers. 11 million people.\n                                        What happened when GSK committed to reinvest 20% of its profits from the least developed countries back into those nations’ healthcare systems?\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Five years. 40,000 health workers. 11 million people. | GSK ","meta_decription":"What happened when GSK committed to reinvest 20% of its profits from the least developed countries back into those nations’ healthcare systems?"}},"https://www.gsk.com/en-gb/behind-the-science/innovation/targeting-the-immune-system-through-open-innovation/":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/innovation/targeting-the-immune-system-through-open-innovation/"},"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/to-challenge-to-change/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        To challenge, to change\n                \n            \n                    To challenge. To change.\n                                        At GSK we’re taking on some of the world’s biggest healthcare challenges. We're on a mission to help people do more, feel better, live longer.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"To challenge. To change. | GSK ","meta_decription":"At GSK we’re taking on some of the world’s biggest healthcare challenges. We're on a mission to help people do more, feel better, live longer."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/health-workers-fighting-it-on-the-frontline/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Health workers fighting it on the frontline\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Health workers fighting it on the frontline | GSK ","meta_decription":"Almost everyone in Tanzania is at risk of malaria. The mosquito-borne disease is responsible for more than 10% of deaths among children under five in this East African country. "}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/no-silver-bullet-to-tackle-this-disease/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    No 'silver bullet' to tackle this disease\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"No 'silver bullet' to tackle this disease | GSK ","meta_decription":"The combination of increased funding, resources and education to fight malaria have contributed to a reduction in deaths from this mosquito-borne disease."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/on-the-frontline-of-ebola-prevention/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    On the frontline of Ebola prevention\n                                        Read how Robbie worked on the ground to fight Ebola.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"On the frontline of Ebola prevention | GSK ","meta_decription":"Read how Robbie worked on the ground to fight Ebola."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/ebola-our-fast-track-response/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Ebola: our fast track response\n                                        GSK responded to the crisis by contributing humanitarian support and accelerating the development of an investigational Ebola vaccine.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Ebola: our fast track response | GSK ","meta_decription":"GSK responded to the crisis by contributing humanitarian support and accelerating the development of an investigational Ebola vaccine."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/keeping-ahead-of-the-game/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Keeping ahead of the game\n                                        To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Keeping ahead of the game | GSK ","meta_decription":"To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/fluorescent-bacteria-nowhere-to-hide/":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/innovation/fluorescent-bacteria-nowhere-to-hide/"},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/making-our-vaccines-more-accessible/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Making our vaccines more accessible\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Making our vaccines more accessible | GSK ","meta_decription":"We are determined to use our resources, knowledge and expertise to help improve access to immunisation."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/vaccines-coming-in-from-the-cold/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Vaccines - coming in from the cold\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Vaccines - coming in from the cold | GSK ","meta_decription":"‘Thermostability’ - it may sound very technical and complicated, but really it’s all about fridges."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/motivating-a-global-coalition/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Motivating a global coalition\n                                        GSK’s Jon Pender explains why working in partnership was key to addressing the pace of the Ebola outbreak in 2014.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Motivating a global coalition | GSK ","meta_decription":"GSK’s Jon Pender explains why working in partnership was key to addressing the pace of the Ebola outbreak in 2014."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/cell-and-gene-therapy-a-new-era-of-medicine/":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/innovation/cell-and-gene-therapy-a-new-era-of-medicine/"},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/fighting-ebola-highlights-the-need-for-more-health-workers/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Fighting Ebola highlights the need for more health workers\n                                        The Ebola crisis is by far the worst outbreak of the disease the world has ever seen.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Fighting Ebola highlights the need for more health workers | GSK ","meta_decription":"The Ebola crisis is by far the worst outbreak of the disease the world has ever seen."}},"https://www.gsk.com/en-gb/behind-the-science/innovation/the-race-to-richer-data-in-clinical-trials/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    The race to richer data in clinical trials\n                                        Finding new ways to use biosensors and mobile health platforms to improve patient care.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The race to richer data in clinical trials | GSK ","meta_decription":"Finding new ways to use biosensors and mobile health platforms to improve patient care."}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/why-our-transaction-with-novartis-is-different/":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/how-we-do-business/why-our-transaction-with-novartis-is-different/"},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/ebola-vaccine-rd/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Ebola vaccine R&D\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Ebola vaccine R&D | GSK ","meta_decription":"Learn how we are advancing the development of our GSK/NIH Ebola vaccine candidate."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/forming-public-partnerships/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Forming public partnerships\n                                        The Ebola crisis has been an unusual and rapidly changing situation. Find out how we are responding.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Forming public partnerships | GSK ","meta_decription":"The Ebola crisis has been an unusual and rapidly changing situation. Find out how we are responding."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/our-humanitarian-response-to-the-ebola-outbreak/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Our humanitarian response to the Ebola outbreak\n                                        GSK's ongoing efforts to strengthen healthcare infrastructure in the most affected countries.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Our humanitarian response to the Ebola outbreak | GSK ","meta_decription":"GSK's ongoing efforts to strengthen healthcare infrastructure in the most affected countries."}},"https://www.gsk.com/en-gb/behind-the-science/our-people/a-healthier-future-for-africa/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Our people\n                \n            \n                    A healthier future for Africa\n                                        Our VP of east Africa and government affairs, Allan Pamba, explains his desire to improve the health of people in Africa.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"A healthier future for Africa | GSK ","meta_decription":"Our VP of east Africa and government affairs, Allan Pamba, explains his desire to improve the health of people in Africa."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-critical-workers-boosting-children-s-health/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    The critical workers boosting children’s health\n                                        As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The critical workers boosting children’s health | GSK ","meta_decription":"As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/flonase-the-journey-from-prescription-to-otc/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Flonase: the journey from prescription to OTC\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Flonase: the journey from prescription to OTC | GSK ","meta_decription":"Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/africa-s-fight-against-malaria-how-mothers-are-helping-on-the-ground/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Africa’s fight against malaria: how mothers are helping on the ground\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Africa’s fight against malaria: how mothers are helping on the ground | GSK ","meta_decription":"In a critical year in the fight against malaria, it will be community health workers and mothers themselves who play a vital role in helping to defeat the disease in Africa"}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/increasing-access-in-india/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Increasing access in India\n                                        Reaching hard-to-reach villages which currently represent 70% of India’s 1.2 billion population. \n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Increasing access in India | GSK ","meta_decription":"Reaching hard-to-reach villages which currently represent 70% of India’s 1.2 billion population. "}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/helping-women-to-give-birth-safely/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Helping women to give birth safely\n                                        Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Helping women to give birth safely | GSK ","meta_decription":"Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/science-of-a-different-stripe/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Science of a different stripe\n                                        How do the stripes in toothpaste get into the tubes and how is it that they come out of it so uniformly?\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Science of a different stripe | GSK ","meta_decription":"How do the stripes in toothpaste get into the tubes and how is it that they come out of it so uniformly?"}},"https://www.gsk.com/en-gb/behind-the-science/innovation/bacteria-friends-or-foes/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Bacteria: friends or foes?\n                                        What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Bacteria: friends or foes? | GSK ","meta_decription":"What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?"}},"https://www.gsk.com/en-gb/behind-the-science/innovation/can-mosquitoes-prevent-malaria/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Can mosquitoes prevent malaria?\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Can mosquitoes prevent malaria? | GSK ","meta_decription":"Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.\n"}},"https://www.gsk.com/en-gb/behind-the-science/innovation/neuroscience-on-the-brain/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Innovation\n                \n            \n                    Neuroscience: on the brain\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Neuroscience: on the brain | GSK ","meta_decription":"The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-baby-bubble/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    The 'baby bubble'\n                                        The first 48 hours of life can be critical for a newborn baby. Infections like pneumonia, contracted during a baby’s first two days, can prove fatal.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"The 'baby bubble' | GSK ","meta_decription":"The first 48 hours of life can be critical for a newborn baby. Infections like pneumonia, contracted during a baby’s first two days, can prove fatal."}},"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/eggs-in-manufacturing/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Patients & consumers\n                \n            \n                    Eggs in manufacturing\n                                        Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need. \n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Eggs in manufacturing | GSK ","meta_decription":"Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need. "}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/rightsizing-our-tablet-packaging-to-reduce-carbon-emissions/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    'Rightsizing' our tablet packaging to reduce carbon emissions\n                                        How can you fit six tablets into the same space as four – and why would you want to? \n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"'Rightsizing' our tablet packaging to reduce carbon emissions | GSK ","meta_decription":"How can you fit six tablets into the same space as four – and why would you want to? "}},"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/green-chemistry/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        How we do business\n                \n            \n                    Green chemistry\n                                        Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Green chemistry | GSK ","meta_decription":"Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use."}},"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/life-after-polio-fatihas-story/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/","txt":"\n                \n                    \n                        Access to healthcare\n                \n            \n                    Life after polio: Fatiha's story\n                            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":"Life after polio: Fatiha's story | GSK ","meta_decription":"Fatiha describes her experience of polio and why she wanted to work for GSK."}},"https://www.gsk.com/en-gb/contact-us/worldwide/saudi-arabia":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/saudi-arabia"},"https://www.gsk.com/en-gb/contact-us/worldwide/morocco":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/morocco"},"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/bangladesh"},"https://www.gsk.com/media/5175/bangladesh-q3-report-2018.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh Q3 report 2018\n                        PDF - 2.0MB\n                        \n                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/5042/bangladesh-q2-report-2018.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh Q2 report 2018\n                        PDF - 2.0MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4822/bangladesh-q1-2018.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh Q1 report 2018\n                        PDF - 2.6MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4164/q3-2017-financial-statement-gsk.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh Q3 report 2017\n                        PDF - 1.6MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3856/glaxosmithkline-bangladesh-limited-30-june-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh Q2 report 2017\n                        PDF - 1.1MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3665/bangladesh-financial-statement-for-q1-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh Q1 report 2017\n                        PDF - 1.4MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3594/bangladesh-q3-report-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh Q3 report 2016\n                        PDF - 1.5MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3590/bangladesh-q2-report-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh Q2 report 2016\n                        PDF - 1.5MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3591/bangladesh-q1-report-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh Q1 report 2016\n                        PDF - 57.8KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4790/bangladesh-annual-report-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh annual report 2017\n                        PDF - 6.1MB\n                        \n                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/3662/bangladesh-annual-report-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh annual report 2016\n                        PDF - 6.4MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3592/bangladesh-annual-report-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh annual report 2015\n                        PDF - 22.0MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3589/bangladesh-annual-report-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh annual report 2014\n                        PDF - 5.3MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3593/bangladesh-annual-report-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Bangladesh annual report 2013\n                        PDF - 4.6MB\n                        \n                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/4722/price-sensitive-2018-march.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Price Sensitive 2018\n                        PDF - 372.9KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3578/agm-feb-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        AGM Feb 2017\n                        PDF - 2.0MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3579/price-sensitive-2017-march.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        Price Sensitive 2017 March\n                        PDF - 1.4MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5143/egm-2018-psi.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"\n                        EGM 2018-PSI\n                        PDF - 114.9KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/contact-us/worldwide/egypt":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/egypt"},"https://www.gsk.com/media/3919/%D8%AA%D8%B7%D9%88%D8%B1-%D8%B1%D8%A3%D8%B3-%D8%A7%D9%84%D9%85%D8%A7%D9%84.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"تطور رأس المال","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3944/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-31-3-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":" ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3920/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%B9%D8%AF%D8%AF-%D8%A7%D9%84%D8%A7%D8%B3%D9%87%D9%85-%D8%A7%D9%84%D9%85%D9%82%D9%8A%D8%AF%D8%A9.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو عدد الاسهم المقيدة","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3945/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%85%D9%88%D8%B9%D8%AF-%D8%A8%D8%AF%D8%A1-%D8%A7%D9%84%D8%B3%D9%86%D8%A9-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D9%88%D8%A7%D8%B3%D9%85-%D9%85%D8%B1%D8%A7%D9%82%D8%A8-%D8%A7%D9%84%D8%AD%D8%B3%D8%A7%D8%A8%D8%A7%D8%AA.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو موعد بدء السنة المالية واسم مراقب الحسابات","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3921/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%85%D9%88%D8%A7%D8%B9%D9%8A%D8%AF-%D8%A7%D9%84%D8%AC%D9%85%D8%B9%D9%8A%D8%A9-%D8%A7%D9%84%D8%B9%D8%A7%D9%85%D8%A9-%D8%A7%D9%84%D8%B9%D8%A7%D8%AF%D9%8A%D8%A9.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو مواعيد الجمعية العامة العادية","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/3946/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%82%D8%B1%D8%A7%D8%B1%D8%A7%D8%AA-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D8%A7%D9%84%D8%B4%D8%B1%D9%83%D8%A9.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو قرارات مجلس ادارة الشركة","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3922/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D8%B3%D9%85-%D9%85%D8%AF%D9%8A%D8%B1-%D8%B9%D9%84%D8%A7%D9%82%D8%A7%D8%AA-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D8%AB%D9%85%D8%B1%D9%8A%D9%86-%D9%88%D8%B7%D8%B1%D9%82-%D8%A7%D9%84%D9%88%D8%B5%D9%88%D9%84-%D8%A7%D9%84%D9%8A%D9%87.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو اسم مدير علاقات المستثمرين وطرق الوصول اليه","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3947/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%86%D8%A8%D8%B0%D8%A9-%D9%85%D8%AE%D8%AA%D8%B5%D8%B1%D8%A9-4.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو نبذة مختصرة","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3923/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D8%B4%D8%B1%D9%83%D8%A7%D8%AA-%D8%A7%D9%84%D8%B4%D9%82%D9%8A%D9%82%D8%A9-%D9%88%D8%A7%D9%84%D8%AA%D8%A7%D8%A8%D8%B9%D8%A9.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو الشركات الشقيقة والتابعة","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3948/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%AA%D9%81%D8%A7%D8%B5%D9%8A%D9%84-%D8%A7%D9%84%D9%85%D9%88%D9%82%D8%B9-%D8%A7%D9%84%D8%A7%D9%84%D9%83%D8%AA%D8%B1%D9%88%D9%86%D9%89.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو تفاصيل الموقع الالكترونى","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3949/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%AA%D8%A7%D8%B1%D9%8A%D8%AE-%D8%A7%D9%84%D9%82%D9%8A%D8%AF-%D8%A8%D8%A7%D9%84%D8%A8%D9%88%D8%B1%D8%B5%D8%A9-%D9%88%D8%A7%D9%84%D9%82%D9%8A%D9%85%D8%A9-%D8%A7%D9%84%D8%A7%D8%B3%D9%85%D9%8A%D8%A9.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو تاريخ القيد بالبورصة والقيمة الاسمية","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3924/%D8%A7%D9%84%D9%85%D9%8A%D8%B2%D8%A7%D9%86%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-31-12-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2015- 12-31الميزانية-المجمعة-فى- ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3950/%D8%A7%D9%84%D9%85%D9%8A%D8%B2%D8%A7%D9%86%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D8%A9-%D9%81%D9%89-31-12-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2015 -12 -31الميزانية-المستقة-فى ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3925/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-31-12-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2013-جلاكسو القوائم المالية المجمعة فى 31-12-","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3951/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%84%D8%AC%D9%86%D8%A9-%D8%A7%D9%84%D9%85%D8%B1%D8%A7%D8%AC%D8%B9%D8%A9-%D8%A7%D9%84%D8%B1%D8%A8%D8%B9-%D8%A7%D9%84%D8%B1%D8%A7%D8%A8%D8%B9-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"تقرير-لجنة-المراجعة-الربع-الرابع  ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3926/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-31-12-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو القوائم المالية المستقلة فى 31-12-2013","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3965/new-%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D9%81%D9%89-31-3-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- 3- 26 تقرير-مجلس-الادارة-فى ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3927/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D9%81%D9%89-31-12-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2015- 12-31تقرير-مجلس-الادارة-فى","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4008/%D9%85%D8%AD%D8%B6%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D8%B1%D9%82%D9%85-1-%D9%84%D8%B9%D8%A7%D9%85-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016 محضر-مجلس-الادارة-رقم-1-لعا  ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3928/%D9%85%D9%84%D8%AE%D8%B5-%D9%86%D8%AA%D8%A7%D8%A6%D8%AC-%D8%A7%D9%84%D8%A3%D8%B9%D9%85%D8%A7%D9%84-%D9%81%D9%89-31-3-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- 3- 31 ملخص-نتائج-الأعمال-فى","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3952/%D9%85%D9%84%D8%AE%D8%B5-%D9%86%D8%AA%D8%A7%D8%A6%D8%AC-%D8%A7%D9%84%D8%A7%D8%B9%D9%85%D8%A7%D9%84-%D9%81%D9%89-31-12-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2015- 12- 31 ملخص-نتائج-الاعمال-فى-","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3929/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%82%D8%B1%D8%A7%D8%B1%D8%A7%D8%AA-%D8%A7%D9%84%D8%AC%D9%85%D8%B9%D9%8A%D8%A7%D8%AA-%D8%A7%D9%84%D8%B9%D8%A7%D9%85%D8%A9.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو قرارات الجمعيات العامة ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3953/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-30-6-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- 6- 30 القوائم المالية المجمعة فى","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3930/%D8%A3%D9%82%D8%B1%D8%A7%D8%B1-%D9%85%D8%AF%D9%8A%D8%B1-%D8%B9%D9%84%D8%A7%D9%82%D8%A7%D8%AA-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D8%AB%D9%85%D8%B1%D9%8A%D9%86.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"أقرار مدير علاقات المستثمرين ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3954/%D9%86%D9%85%D9%88%D8%B0%D8%AC-%D8%A3%D8%AE%D8%B7%D8%A7%D8%B1-%D8%AA%D8%B9%D8%AF%D9%8A%D9%84-%D8%A8%D9%8A%D8%A7%D9%86%D8%A7%D8%AA-%D8%A7%D9%84%D8%B4%D8%B1%D9%83%D8%A9.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"نموذج-أخطار-تعديل-بيانات-الشركة ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/3931/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-30-6-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016 - 6 - 30 هيكل-المساهمين-فى-","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3955/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-31-3-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"هيكل-المساهمين-فى 2016- 3 -31","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3932/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-31-12-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2015 - 12 - 31 هيكل-المساهمين-فى- ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3956/%D8%A7%D9%84%D8%A3%D8%AD%D8%AF%D8%A7%D8%AB-%D8%A7%D9%84%D8%AC%D9%88%D9%87%D8%B1%D9%8A%D8%A9-%D9%81%D9%89-25-7-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016 - 7- 25 الأحداث-الجوهرية-فى ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/3933/%D8%A7%D9%84%D8%A3%D8%AD%D8%AF%D8%A7%D8%AB-%D8%A7%D9%84%D8%AC%D9%88%D9%87%D8%B1%D9%8A%D8%A9-%D9%81%D9%89-26-7-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016 - 7 - 26 الأحداث-الجوهرية-فى ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/3957/%D8%A7%D9%84%D8%A3%D8%B7%D8%A7%D8%B1-%D8%A7%D9%84%D8%AA%D9%86%D8%B8%D9%8A%D9%85%D9%89-%D9%84%D9%84%D8%B4%D8%B1%D9%83%D8%A9.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"الأطار-التنظيمى-للشركة ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3934/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D9%87-%D9%81%D9%89-31-3-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016 - 3 - 31 القوائم-المالية-المجمعه-فى- ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3958/gsk-agm-15-june-2015x.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"قرارات الجمعية العامة العادية  15 - 6 - 2015","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4009/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-30-9-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- 9- 30 هيكل المساهمين فى","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3959/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-31-12-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"جلاكسو القوائم المالية المجمعة فى 31-12-2014","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3935/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-31-12-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2014- جلاكسو القوائم المالية المستقلة فى 31-12","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3960/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D9%81%D9%89-30-9-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- تقرير مجلس الادارة فى  30 -9","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3936/%D9%85%D9%84%D8%AE%D8%B5-%D9%86%D8%AA%D8%A7%D8%A6%D8%AC-%D8%A7%D9%84%D8%A7%D8%B9%D9%85%D8%A7%D9%84-%D9%81%D9%89-30-9-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016 - 9 - 30 ملخص نتائج الاعمال فى","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3961/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-30-9-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- القوائم المالية المجمعة فى 30 -9","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3937/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-30-9-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- القوائم المالية المستقلة فى 30 -9","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3962/%D9%85%D8%B4%D8%B1%D9%88%D8%B9-%D9%88%D9%86%D9%85%D9%88%D8%B0%D8%AC-%D8%AA%D9%88%D8%B2%D9%8A%D8%B9-%D9%83-14.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"14 مشروع ونموذج توزيع ك","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4007/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%84%D8%AC%D9%86%D8%A9-%D8%A7%D9%84%D9%85%D8%B1%D8%A7%D8%AC%D8%B9%D8%A9-%D8%A7%D9%84%D8%B1%D8%A8%D8%B9-%D8%A7%D9%84%D8%A3%D9%88%D9%84-%D9%88-%D8%A7%D9%84%D8%AB%D8%A7%D9%86%D9%8A-%D9%88-%D8%A7%D9%84%D8%AB%D8%A7%D9%84%D8%AB-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"تقرير لجنة المراجعة الربع الأول و الثاني و الثالث 2016","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3963/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-30-6-2016-1.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- هيكل المساهمين فى 30 -6 ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3939/%D9%85%D9%84%D8%AE%D8%B5-%D9%86%D8%AA%D8%A7%D8%A6%D8%AC-%D8%A7%D9%84%D8%A3%D8%B9%D9%85%D8%A7%D9%84-%D9%81%D9%89-30-6-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- ملخص نتائج الأعمال فى 30 -6 ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3964/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D9%81%D9%89-30-6-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016 - تقرير مجلس الادارة فى 30 -6 ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3940/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-30-6-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"2016- 6- القوائم المالية المستقلة فى 30 ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/contact-us/worldwide/cambodia":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/cambodia"},"https://www.gsk.com/en-gb/contact-us/worldwide/sri-lanka":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/sri-lanka"},"https://www.gsk.com/en-gb/contact-us/worldwide/israel":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/israel"},"https://www.gsk.com/en-gb/contact-us/worldwide/thailand":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/thailand"},"https://www.gsk.com/en-gb/contact-us/worldwide/united-arab-emirates":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/united-arab-emirates"},"https://www.gsk.com/en-gb/contact-us/worldwide/albania/":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/albania/"},"https://www.gsk.com/en-gb/contact-us/worldwide/belarus":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/belarus"},"https://www.gsk.com/en-gb/contact-us/worldwide/bosnia-herz":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/bosnia-herz"},"https://www.gsk.com/en-gb/contact-us/worldwide/cyprus":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/cyprus"},"https://www.gsk.com/en-gb/contact-us/worldwide/lithuania":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/lithuania"},"https://www.gsk.com/en-gb/contact-us/worldwide/latvia":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/latvia"},"https://www.gsk.com/media/3893/standard-terms-conditions-06-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/latvia/","txt":"\n                        Standard terms conditions 2017\n                        PDF - 273.3KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3894/cenas_gsk.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/latvia/","txt":"\n                        Cenas\n                        PDF - 125.7KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3503/latvia.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/latvia/","txt":"\n                        Download our disclosure about transfer of value to patient organisations\n                        PDF - 582.9KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3772/ime-veidlapa.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/latvia/","txt":"\n                        IME Veidlapa\n                        PDF - 82.0KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3773/call-for-ime-proposals.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/latvia/","txt":"\n                        Call for IME proposals\n                        PDF - 256.8KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/contact-us/worldwide/portugal/":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/portugal/"},"https://www.gsk.com/en-gb/contact-us/worldwide/macedonia":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/macedonia"},"https://www.gsk.com/en-gb/contact-us/worldwide/malta":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/malta"},"https://www.gsk.com/en-gb/contact-us/worldwide/mexico":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/mexico"},"https://www.gsk.com/en-gb/contact-us/worldwide/chile":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/chile"},"https://www.gsk.com/en-gb/contact-us/worldwide/caribbean-islands":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/caribbean-islands"},"https://www.gsk.com/en-gb/investors/product-pipeline/immuno-inflammation/3335065/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/caribbean-islands","txt":"Jamaica","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III"},"redirectedTo":"https://www.gsk.com/en-gb/investors/product-pipeline/"},"https://www.gsk.com/en-gb/investors/product-pipeline/respiratory/nemiralisib-3/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/caribbean-islands","txt":"Trinidad & Tobago","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III"},"redirectedTo":"https://www.gsk.com/en-gb/investors/product-pipeline/"},"https://www.gsk.com/en-gb/contact-us/worldwide/colombia":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/colombia"},"http://www.gsk.com/en-gb/contact-us/worldwide/colombia/pol%C3%ADtica-ambiental-y-pol%C3%ADtica-de-protecci%C3%B3n-de-datos-de-gsk-colombia/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/colombia","txt":"Política Ambiental y Política de Protección de Datos de GSK Colombia","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"El cuidado del medio ambiente y la capacidad de producir bienes y servicios para las generaciones actuales sin detrimento de las generaciones futuras"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/colombia/pol%C3%ADtica-ambiental-y-pol%C3%ADtica-de-protecci%C3%B3n-de-datos-de-gsk-colombia/"},"https://www.gsk.com/en-gb/contact-us/worldwide/ecuador":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/ecuador"},"https://www.gsk.com/en-gb/contact-us/worldwide/dominican-republic":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/dominican-republic"},"https://www.gsk.com/en-gb/contact-us/worldwide/costa-rica":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/costa-rica"},"https://www.gsk.com/en-gb/contact-us/worldwide/el-salvador":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/el-salvador"},"https://www.gsk.com/en-gb/contact-us/worldwide/honduras":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/honduras"},"https://www.gsk.com/en-gb/contact-us/worldwide/guatemala":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/guatemala"},"https://www.gsk.com/en-gb/contact-us/worldwide/jamaica":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/jamaica"},"https://www.gsk.com/en-gb/contact-us/worldwide/peru":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/peru"},"https://www.gsk.com/en-gb/contact-us/worldwide/panama":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/panama"},"https://www.gsk.com/en-gb/contact-us/worldwide/trinidad-tobago":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/trinidad-tobago"},"https://www.gsk.com/en-gb/contact-us/worldwide/uruguay":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/uruguay"},"https://www.gsk.com/media/1710/gsk-house-location-building.jpg?anchor=center&mode=crop&quality=90&width=1118&height=710&rnd=131421004840000000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/","txt":"\n                                    \n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/speakup":{"status":"redirected","redirectedTo":"https://gsk.i-sight.com/landing-page/"},"https://www.gsk.com/en-gb/contact-us/headquarters/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/","txt":"Headquarters","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Our global headquarters are in the UK but we also have a significant presence in the USA"}},"https://www.gsk.com/en-gb/contact-us/careers/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/","txt":"Careers","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"If you're a jobseeker, see how you could make contact with us and start your GSK career"}},"https://www.gsk.com/en-gb/contact-us/customerspatients/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/","txt":"Customers/patients","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"More about how to contact us if you are a customer or patient using one of our products or medicines"}},"https://www.gsk.com/en-gb/contact-us/funding-requests/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/","txt":"Funding requests","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK supports community initiatives in both the developed and the developing world"}},"https://www.gsk.com/en-gb/contact-us/partnerships/":{"redirectedFrom":"https://www.gsk.com/en-gb/contact-us/partnerships/business-development/"},"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/","txt":"Privacy contact information","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"If you wish to contact GSK’s data protection officer, or to contact one of the GSK companies listed, please use the contact details provided."}},"https://www.gsk.com/media/4800/english-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/","txt":"\n                        English - Code of Conduct\n                        PDF - 2.8MB\n                        \n                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/en-gb/contact-us/worldwide/venezuela":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/venezuela"},"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/":{"redirectedFrom":"http://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/"},"https://www.gsk.com/media/4601/combinded_graphic.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/vaccines/why-you-don-t-outgrow-vaccination/","txt":"\n                Vaccinate for life infographic PDF - 1.3MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4751/annual-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/","txt":"Annual Report","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4756/responsible-business-supplement-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/","txt":"Responsible Business Supplement","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/4870/gsk_usa16_pa_randd_arthur_groy_0050_v1_rgb_624x416.jpg?anchor=center&mode=crop&quality=90&width=1118&height=710&rnd=131729407890000000":{"firstFound":"https://www.gsk.com/en-gb/about-us/","txt":"\n                                    \n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/1196/gsk-gvap-long-version-vr75.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/vaccines/","txt":"Download PDF ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/emma-walmsley/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Emma Walmsley\n                                        Chief Executive Officer of GSK\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Chief Executive Officer of GSK"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/simon-dingemans/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Simon Dingemans\n                                        Chief Financial Officer\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Chief Financial Officer"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/dr-hal-barron/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Dr Hal Barron\n                                        Chief Scientific Officer and President, R&D\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Chief Scientific Officer and President, R&D"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/roger-connor/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Roger Connor\n                                        President, Global Vaccines\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"President, Global Vaccines"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/james-ford/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    James Ford\n                                        Senior Vice President and General Counsel\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Senior Vice President and General Counsel"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/nick-hirons/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Nick Hirons\n                                        Senior Vice President, Global Ethics and Compliance\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Senior Vice President, Global Ethics and Compliance"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/brian-mcnamara/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Brian McNamara\n                                        CEO, GSK Consumer Healthcare\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"CEO, GSK Consumer Healthcare"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/luke-miels/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Luke Miels\n                                        President, Global Pharmaceuticals\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"President, Global Pharmaceuticals"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/david-redfern/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    David Redfern\n                                        Chief Strategy Officer\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Chief Strategy Officer"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/karenann-terrell/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Karenann Terrell\n                                        Chief Digital & Technology Officer\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Chief Digital & Technology Officer"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/claire-thomas/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Claire Thomas\n                                        Senior Vice President, Human Resources\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Senior Vice President, Human Resources"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/phil-thomson/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Phil Thomson\n                                        President, Global Affairs\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"President, Global Affairs"}},"https://www.gsk.com/en-gb/about-us/corporate-executive-team/regis-simard/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Regis Simard\n                                        President, Pharma Supply Chain\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"President, Pharma Supply Chain"}},"https://www.gsk.com/en-gb/about-us/our-history/meet-jill-a-keeper-of-gsk-s-history/":{"firstFound":"https://www.gsk.com/en-gb/about-us/our-history/gsk-heritage-archives/","txt":"Jill Moretto, Heritage Archivist, GSK","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Jill Moretto is one of our heritage archivists who looks after thousands of items collected throughout GSK’s 300 year history"}},"http://www.gsk.com/en-gb/behind-the-science/how-we-do-business/why-our-transaction-with-novartis-is-different/":{"firstFound":"https://www.gsk.com/en-gb/about-us/our-history/gsk-today-2000-present/","txt":"transaction","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"What makes GSK’'s transaction with Novartis different?"},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/why-our-transaction-with-novartis-is-different/"},"https://www.gsk.com/media/4573/cmyk_final_300yrs-gsk-a3-landscape.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/our-history/","txt":"\n                300 years of GSK at-a-glance PDF - 1.1MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3731/articles-of-association.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/","txt":"\n                        Articles of Association\n                        PDF - 600.1KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3611/gsk-group-company-names-and-addresses.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/","txt":"\n                        GSK Group company names and addresses\n                        PDF - 230.7KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5134/governance-section.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","txt":"\n                        Governance section\n                        PDF - 658.8KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5135/remuneration-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","txt":"\n                        Remuneration report\n                        PDF - 407.4KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1433/remuneration-committee-terms-of-reference.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/","txt":"\n                        Remuneration committee – terms of reference\n                        PDF - 64.3KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/how-we-help-track-antibiotic-resistance/":{"firstFound":"https://www.gsk.com/en-gb/about-us/our-history/building-brands-1919-1949/","txt":"antibiotic medicine","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"In the past 25 years, a steady increase in bacteria immune to antibiotics has become a serious threat to global public health"},"redirectedTo":"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/"},"http://www.gsk.com/speakup":{"status":"redirected","redirectedTo":"https://gsk.i-sight.com/landing-page/"},"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/","txt":"\n            \n                    \n            \n                Ethics and compliance overview\n            The Global Ethics and Compliance function (GEC) delivers clear and integrated compliance solutions that embed GSK's values and expectations in order to build trust        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Overview of how the Global Compliance function supports the development and implementation of practices that comply with laws and Group policy"}},"https://www.gsk.com/media/3340/protection-of-gsk-information.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/sarbanes-oxley-act-2002/","txt":"Protection of GSK Information (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3341/external-communications-to-investors-and-media-external-speaking-engagements-and-publications.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/sarbanes-oxley-act-2002/","txt":"External Communications to Investors and Media; External Speaking Engagements and Publications (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3342/political-contributions.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/sarbanes-oxley-act-2002/","txt":"Political Contributions (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3343/preventing-corrupt-practices-and-maintaining-standards-of-documentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/sarbanes-oxley-act-2002/","txt":"Preventing Corrupt Practices and Maintaining Standards of Documentation (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3344/risk-management-and-legal-compliance.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/sarbanes-oxley-act-2002/","txt":"Risk Management and Legal Compliance (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3345/code-for-dealing-in-securities.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/sarbanes-oxley-act-2002/","txt":"Code for Dealing in Securities (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4557/terms-of-reference-audit-risk-committee.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/board-committees/","txt":"Download the Audit & Risk Committee's terms of reference (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3714/remuneration-policy-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Remuneration Policy","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4558/terms-of-reference-remuneration-committee.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/board-committees/","txt":"Download the Remuneration Committee's terms of reference (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1435/nominations-committee-terms-of-reference.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/board-committees/","txt":"Download the Nominations Committee's terms of reference (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4559/terms-of-reference-science-committee.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/board-committees/","txt":"Download the Science Committee terms of reference (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3610/responsible-business-supplement-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Responsible Business Supplement 2016\n                                PDF - 2.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4560/terms-of-reference-corporate-responsibility-committee.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/board-committees/","txt":"Download the Corporate Responsibility Committee's terms of reference (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1438/corporate-administration-and-transactions-committees-terms-of-reference.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/board-committees/","txt":"Download the Corporate Administration and Transactions Committee's terms of reference (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4074/17in_161208_0123.jpg?anchor=center&mode=crop&quality=90&width=1118&height=710&rnd=131516929520000000":{"firstFound":"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/","txt":"\n                                    \n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/2871/arabic-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Arabic ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2858/chinese-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Chinese - Simplified ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2860/crzech-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Czech ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2861/french-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"French","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2862/german-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"German","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2863/hindi-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Hindi","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2864/hungarian-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Hungarian","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2865/indonesian-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Indonesian ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2866/italian-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Italian","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2867/japanease-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Japanese","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2868/korean-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Korean","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2869/malay-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Malay","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2870/polish-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Polish","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2877/brazil-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Portuguese - Brazil             ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2876/portugal-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Portuguese - EU","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2878/romanian-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Romanian","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2879/russian-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Russian","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2880/spanish-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Spanish - EU","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/2881/thai-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Thai","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/2859/chinese-tradition-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Traditional Chinese","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2872/turkish-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Turkish","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2873/urdu-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Urdu","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2874/vietnamese-code-of-conduct.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Vietnamese","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2976/anti-bribery-and-corruption-policy-v11.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Anti-Bribery and Corruption Policy","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3916/abac-third-party-guidelines.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GSK Anti-Bribery and Corruption Guidelines for Third Parties","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Find out more about GSK’s Binding Corporate Rules","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Information on GSK's Binding Corporate Rules"}},"https://www.gsk.com/media/2498/working-with-third-parties.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Working with third parties","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4552/our-code-of-practice.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GSK Pharma and Vaccine Code of Practice for Promotion and Scientific Engagement","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4871/consumer-healthcare-code-for-promotion-and-scientific-engagement.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GSK Consumer Healthcare Code of Promotion and Scientific Engagement","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2965/technology-transfer-vaccines-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Developing world vaccine production technology transfer","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2958/ip-atm-developing-countries-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"IP and access to medicines in developing countries","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2980/technology-transfer-capacity-building-and-developing-countries.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Technology transfer, capacity building and developing countries","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3833/the-sustainable-development-goals-july17.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"The Sustainable Development Goals","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2938/clinical-trials-in-the-developing-world-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Clinical trials in the developing world","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2942/incentivising-antibacterial-research.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Combating antimicrobial resistance","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2929/cloning-technologies-and-stem-cell-research-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Cloning and Stem Cell Technologies","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2935/biological-diversity-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"The convention on biological diversity","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2946/disclosure-of-clinical-trial-information-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Public disclosure of clinical research","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2936/care-welfare-and-treatment-of-animals-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"The care, welfare and treatment of animals","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2943/incremental-innovation-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Incremental innovation","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4298/compulsory-licensing-nov17.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Compulsory licensing","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2949/evergreening-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Evergreening","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2947/disclosure-requirements-in-patent-applications-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"A disclosure requirement in patent applications","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2957/regulatory-data-protection-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Regulatory data protection","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2939/hazardous-chemicals-management-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Hazardous chemicals management","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2950/genetically-modified-micro-organisms-and-environment-health-safety.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Genetically modified micro-organisms and Environment, Health and Safety (EHS)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2960/nanotechnology-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Nanotechnology","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2962/ozone-depletion-and-mdi-for-asthma-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Ozone depletion and metered-dose inhalers for asthma","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2952/pharmaceuticals-in-the-environment-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Pharmaceuticals in environment","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2937/climate-change-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"The impact of climate change on health","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2956/public-position-on-ozone-depletion-and-ancillary-plant-equipment-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Climate Change and GSK’s Operations","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2977/gsk-and-water-stewardship.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Water stewardship","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2978/gsk-public-policy-on-deforestation-sept16.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Deforestation-free sourcing","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4321/falsified-and-substandard-healthcare-products.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Falsified and Substandard Healthcare products","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2953/pharmacovigilance-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Pharmacovigilance","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2963/paediatric-medicines-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Paediatric medicines","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3369/engagement-with-patient-organisations.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Engagement with patient organisations","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3368/compassionate-use.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Compassionate use","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4859/conflict-minerals.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Conflict minerals","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2930/competitiveness-investment-criteria-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Competitiveness and investment criteria","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4503/human-rights-statement-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Human rights","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2959/marketing-practices-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Marketing practices and scientific engagement","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2955/product-donations-policy.pdf":{"redirectedFrom":"https://www.gsk.com/media/2923/glaxosmithkline-2015-form-sd-conflicts-minerals-disclosure.doc"},"https://www.gsk.com/media/2934/binding-corporate-rules-policy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Safeguarding personal information","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2983/tax-strategy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Tax strategy","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3374/public-policy-on-political-advocacy.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Political Advocacy","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4661/lethal-injections.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Lethal Injections","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3699/modern-slavery-act-statement.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Modern Slavery Act statement 2016","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3742/glaxosmithkline-plc-2017-form-sd-conflict-minerals-disclosure.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline plc - 2017 Form SD Conflict Minerals Disclosure","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3743/glaxosmithkline-plc-2016-form-sd-conflict-minerals-disclosure.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline plc - 2016 Form SD Conflict Minerals Disclosure","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2923/glaxosmithkline-2015-form-sd-conflicts-minerals-disclosure.doc":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline plc - 2015 Form SD Conflict Minerals Disclosure","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/2955/product-donations-policy.pdf"},"https://www.gsk.com/media/2897/glaxosmithkline-plc-2014-form-sd-conflict-minerals-disclosure.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline plc - 2014 Form SD Conflict Minerals Disclosure","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5045/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2018.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline Euro Medium Term Note Programme – Prospectus Document 2018","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3902/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline Euro Medium Term Note Programme – Prospectus Document 2017","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2908/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline Euro Medium Term Note Programme – Prospectus Document 2016","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2921/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline Euro Medium Term Note Programme – Prospectus Document 2015","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3198/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline Euro Medium Term Note Programme – Prospectus Document 2014","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3199/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline Euro Medium Term Note Programme – Prospectus Document 2013","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2885/euro-medium-term-note-programme-registration-document.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline Euro Medium Term Note Programme – Registration Document","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2884/euro-medium-term-note-programme-prospectus-document.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline Euro Medium Term Note Programme – Prospectus Document","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/2886/euro-medium-term-note-programme-supplementry-prospectus-document.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GlaxoSmithKline Euro Medium Term Note Programme - Supplementary Prospectus Document","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5038/2018-half-year-results-and-interim-management-report-glaxosmithkline-capital-plc.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2018 Half Year Results and Interim Management Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4799/glaxosmithkline-capital-plc-annual-report-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2017 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3896/gsk-capital-plc-30-june-17_final.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2017 Half Year Results and Interim Management Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3880/glaxosmithkline-capital-plc-signed-2016-annual-report-and-accounts.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2016 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2909/half-year-results-glaxosmithkline-capital-plc-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2016 Half Year Results and Interim Management Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2911/annual-report-glaxosmithkline-capital-plc-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2015 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2922/half-year-results-glaxosmithkline-capital-plc-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2015 Half Year Results and Interim Management Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2896/annual-report-glaxosmithkline-capital-plc-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2014 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2902/half-year-results-glaxosmithkline-capital-plc-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2014 Half Year Results and Interim Management Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2883/annual-report-glaxosmithkline-capital-plc-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2013 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2891/half-year-results-glaxosmithkline-capital-plc-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2013 Half Year Results and Interim Management Report GlaxoSmithKline Capital plc","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/2882/annual-report-glaxosmithkline-capital-plc-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2012 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2890/half-year-results-glaxosmithkline-capital-plc-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2012 Half Year Results and Interim Management Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2894/annual-report-glaxosmithkline-capital-plc-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2011 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2889/half-year-results-glaxosmithkline-capital-plc-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2011 Half Year Results and Interim Management Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2901/annual-report-glaxosmithkline-capital-plc-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2010 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2893/annual-report-glaxosmithkline-capital-plc-2009.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2009 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2892/annual-report-glaxosmithkline-capital-plc-2008.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"2008 Annual Report GlaxoSmithKline Capital plc","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/3712/gsk-pension-fund-sip.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GSK Pension Fund SIP","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3703/gsk-pension-scheme-sip.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GSK Pension Scheme SIP","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3705/gw-contracted-out-money-purchase-scheme-sip.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"GW Contracted-out Money Purchase Scheme SIP","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3706/sb-senior-executive-pension-plan-sip.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"SB Senior Executive Pension Plan SIP","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3702/sb-pension-plan-sip.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"SB Pension Plan SIP","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3707/corporate-governance-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","txt":"Corporate Governance Report","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/about-us/board-of-directors/membership-of-board-committees/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"See the membership of Board Committees ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Membership of board committees"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/sir-philip-hampton/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Sir Philip Hampton\n                                        Non-Executive Chairman\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Non-Executive Chairman"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/emma-walmsley/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Emma Walmsley\n                                        Chief Executive Officer of GSK\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Chief Executive Officer of GSK"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/simon-dingemans/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Simon Dingemans\n                                        Chief Financial Officer\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Chief Financial Officer"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/dr-hal-barron/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Dr Hal Barron\n                                        Chief Scientific Officer and President, R&D\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Chief Scientific Officer and President, R&D"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/manvinder-singh-vindi-banga/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Manvinder Singh (Vindi) Banga\n                                        Senior Independent Non-Executive Director\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Senior Independent Non-Executive Director"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/dr-vivienne-cox/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Dr Vivienne Cox\n                                        Independent Non-Executive Director\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Independent Non-Executive Director"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/lynn-elsenhans/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Lynn Elsenhans\n                                        Independent Non-Executive Director\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Independent Non-Executive Director"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/dr-laurie-glimcher/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Dr Laurie Glimcher\n                                        Independent Non-Executive Director\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Independent Non-Executive Director"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/dr-jesse-goodman/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Dr Jesse Goodman\n                                        Independent Non-Executive Director\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Independent Non-Executive Director"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/judy-lewent/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Judy Lewent\n                                        Independent Non-Executive Director\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Independent Non-Executive Director"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/urs-rohner/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                                    \n                                        \n                                    \n                                \n                                    Urs Rohner\n                                        Independent Non-Executive Director\n                                    Read more\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Independent Non-Executive Director"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/role-of-the-board/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                            \n                                    \n                            \n                            \n                                    Role of the Board\n                                                                    The Board is accountable to shareholders for ensuring that GSK is appropriately managed and achieves the strategic objectives it sets\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Board is accountable to shareholders for ensuring that GSK is appropriately managed and achieves the strategic objectives it sets"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/independence-of-non-executive-directors/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                            \n                                    \n                            \n                            \n                                    Independence of Non-Executive Directors\n                                                                    Our Board considers all of its Non-Executive Directors to be independent in character and judgement\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Our Board considers all of its Non-Executive Directors to be independent in character and judgement"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/the-roles-of-our-chairman-and-chief-executive-officer/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                            \n                                    \n                            \n                            \n                                    The roles of our Chairman and Chief Executive Officer\n                                                                    Sir Philip Hampton is the Chairman of our Board and Emma Walmsley is our Chief Executive Officer (CEO)\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Sir Philip Hampton is the Chairman of our Board and Emma Walmsley is our Chief Executive Officer (CEO)"}},"https://www.gsk.com/en-gb/about-us/board-of-directors/directors-contracts/":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/","txt":"\n                            \n                                    \n                            \n                            \n                                    Directors' contracts\n                                                                    See our Executive Directors' contracts of service, Non-Executive Directors' letters of appointment and information on document inspection\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"See our Executive Directors' contracts of service, Non-Executive Directors' letters of appointment and information on document inspection"}},"https://www.gsk.com/media/2756/save-the-children-partnership-progress-brochure.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/","txt":"\n                        Save the Children partnership progress brochure\n                        PDF - 5.4MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2988/save-the-children-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/","txt":"\n                        Save the Children partnership infographic\n                        PDF - 574.5KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-call-for-developing-country-innovations-to-enter-1-million-award/":{"firstFound":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/","txt":"Read the full press release","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Save the Children today launched their fourth annual $1 million Healthcare Innovation Award."}},"http://www.gsk.com/en-gb/about-us/corporate-partnerships/save-the-children-partnership/":{"firstFound":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/","txt":"[1]","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/about-us/corporate-partnerships/save-the-children-partnership/"},"https://www.gsk.com/media/1439/disclosure-committee-terms-of-reference.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/other-committees/","txt":"Download the Disclosure Committee's terms of reference (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/careers/career-level/":{"firstFound":"https://www.gsk.com/en-gb/careers/job-finder/","txt":"Begin","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"hello"}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Sensodyne \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Relieving the pain of sensitive teeth."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/polident/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Polident \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Improving comfort for denture wearers."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/parodontax/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    parodontax \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Reducing the anxiety caused by bleeding gums."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/biot%C3%A8ne/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Biotène \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Biotène is the No. 1 dentist and hygienist recommended dry mouth brand."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/aquafresh/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Aquafresh \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Aquafresh is one of the world's largest oral care brands."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/theraflu/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Theraflu \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Powerful relief from colds and flu."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/otrivin/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Otrivin \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Relieving nasal congestion"}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/flonase/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Flonase \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Flonase allergy relief is an allergy medicine that works directly in the nose to help allergy reactions."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/contac/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Contac \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Contac is a nasal decongestant tablet that also relieves pain and reduces a fever."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/nicorette/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Nicorette \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Nicorette, is a nicotine replacement therapy available in gum or lozenge form designed to help smokers quit their nicotine addiction."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/nicotinell/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Nicotinell \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Nicotinell is a smoking cessation treatment range that includes patch, gum and lozenge."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/voltaren/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Voltaren \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Move freely once more."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/panadol/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Panadol \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"One of the world’s most trusted pain relievers."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/excedrin/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Excedrin \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Excedrin brand has been a leader in headache pain relief for more than 50 years"}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/fenbid/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Fenbid \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Fenbid is an ibuprofen pain reliever with a 12-hour sustained-release formula."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/horlicks/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Horlicks \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Horlicks is a nutritional drink made from wheat, milk and malted barley and is sold in powdered form."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/eno/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Eno \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ENO is a range of antacid products that treat the symptoms of heartburn and gastric discomfort."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/tums/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Tums \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Tums is a range of products for the treatment of heartburn and acid indigestion."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/lamisil/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Lamisil \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Lamisil is one of the world’s leading topical anti-fungal treatments designed to cure athlete’s foot and jock itch."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/fenistil/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Fenistil \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Fenistil is an effective treatment for itchiness caused by several irritated skin conditions."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/zovirax/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Zovirax \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Zovirax, which features aciclovir as its active ingredient, is an antiviral treatment for cold sores."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/abreva/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Abreva \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Abreva is the only over-the-counter cold sore medicine approved by the US Food and Drug Administration to shorten healing time and duration of symptoms."}},"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/physiogel/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/","txt":"\n                                                    \n                                                        \n                                                    Physiogel \n                                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Physiogel is a science-based body and facial skincare range, dedicated to the daily care of the most sensitive skin."}},"https://www.gsk.com/en-gb/careers/meet-our-people/dennis-business-operations-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","txt":"Read more","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Dennis is the Team Lead for the Central Finance Support Team in the UK. The nature of his role gives him an insight into GSK’s financial performance. Here, he chats us through his career background, what it’s like to work for us, and tips to follow in his footsteps."}},"https://www.gsk.com/en-gb/careers/meet-our-people/ahsiya-business-operations-usa/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","txt":"\n                        \n                                \n                        \n                            Ahsiya, HR, USA\n                                                    Ahsiya leads our global employee volunteering programmes. She shares her career journey and explains how making brave choices helped her along the way.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Ahsiya leads our global employee volunteering programmes. She shares her career journey and explains how making brave choices helped her along the way."}},"https://www.gsk.com/en-gb/careers/meet-our-people/gavin-business-operations-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","txt":"\n                        \n                                \n                        \n                            Gavin, Tech, UK\n                                                    Gavin works in IT and is a UK operations supervisor, based at our Stevenage site. Here, he talks about teamwork, problem-solving and the best things about his job.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Gavin works in IT and is a UK operations supervisor, based at our Stevenage site. Here, he talks about teamwork, problem-solving and the best things about his job."}},"https://www.gsk.com/en-gb/careers/meet-our-people/boris-business-operations-singapore/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","txt":"\n                        \n                                \n                        \n                            Boris, HR, Singapore\n                                                    Boris moved his HR career from Russia to Singapore, where he now leads a network of around 30 colleagues across Asia as Regional Reward Lead\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Boris moved his HR career from Russia to Singapore, where he now leads a network of around 30 colleagues across Asia as Regional Reward Lead"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","txt":"View more roles","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/heba-manufacturing-and-supply-egypt/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/","txt":"Read more","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Heba is a subject matter expert in our manufacturing and supply chain organisation based in Egypt"}},"https://www.gsk.com/en-gb/careers/meet-our-people/sofia-manufacturing-and-supply-mexico/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/","txt":"\n                        \n                                \n                        \n                            Sofia, Manufacturing and supply, Mexico\n                                                    Sofia is on our Manufacturing Science Future Leaders Programme. She talks about why she was drawn to the healthcare industry and why GSK's values were so important to her decision to join the company.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Sofia is on our Manufacturing Science Future Leaders Programme. She talks about why she was drawn to the healthcare industry and why GSK's values were so important to her decision to join the company."}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/","txt":"View more roles","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/prakhar-marketing-and-communications-india/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","txt":"Read more","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Prakhar is a Brand Manager for Sensodyne in India with one goal: to put a smile on millions of faces in India. He talks us through his life at GSK, how his previous sales background has helped him in a marketing role, and the piece of advice he’d give to aspiring employees."}},"https://www.gsk.com/en-gb/careers/meet-our-people/katharine-marketing-and-communications-singapore/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","txt":"\n                        \n                                \n                        \n                            Katharine, Marketing and communications, Singapore\n                                                    Katharine works in our commercial business, leading our Respiratory franchise for the Asia-Pacific region. She explains how working in several different countries and roles have helped share her knowledge, experience and leadership style.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Katharine works in our commercial business, leading our Respiratory franchise for the Asia-Pacific region. She explains how working in several different countries and roles have helped share her knowledge, experience and leadership style."}},"https://www.gsk.com/en-gb/careers/meet-our-people/martyn-marketing-and-communications-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","txt":"\n                        \n                                \n                        \n                            Martyn, Marketing and communications, UK\n                                                    Meet the man who’s helping to shape the future of eCommerce for GSK Consumer Healthcare.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Meet the man who’s helping to shape the future of eCommerce for GSK Consumer Healthcare."}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","txt":"View more roles","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/jon/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","txt":"Read more","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Jon works in clinical statistics at our Stevenage site in the UK. He explains how a career at GSK has enabled him to work across the R&D business."},"redirectedTo":"https://www.gsk.com/en-gb/careers/meet-our-people/jon-rd-uk/"},"https://www.gsk.com/en-gb/careers/meet-our-people/camelia-rd-belgium/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","txt":"\n                        \n                                \n                        \n                            Camelia, R&D, Belgium\n                                                    Camelia works in the R&D organisation of our Vaccines business. She describes the collaborative culture at GSK and why innovation and new ideas are warmly welcomed.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Camelia works in the R&D organisation of our Vaccines business. She describes the collaborative culture at GSK and why innovation and new ideas are warmly welcomed."}},"https://www.gsk.com/en-gb/careers/meet-our-people/rhiannon-rd-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","txt":"\n                        \n                                \n                        \n                            Rhiannon, R&D, UK\n                                                    Rhiannon is an investigator within Pharmaceuticals R&D. She talks about her varied role; her passion for inspiring children to consider careers in STEM; and how GSK has allowed her to shape her career around her family life.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Rhiannon is an investigator within Pharmaceuticals R&D. She talks about her varied role; her passion for inspiring children to consider careers in STEM; and how GSK has allowed her to shape her career around her family life."}},"https://www.gsk.com/en-gb/careers/meet-our-people/richard-rd-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","txt":"\n                        \n                                \n                        \n                            Richard, R&D, UK\n                                                    Our 60-minute mentor monthly series gives colleagues the chance to interview one of their senior leaders, over the course of an hour, and discover more about their career journey. Dee Tress, R&D Future Leaders programme, was inspired by Richard’s journey at GSK and was keen to know more about the lessons he’s learned along the way to becoming Head of Consumer Healthcare R&D.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Our 60-minute mentor monthly series gives colleagues the chance to interview one of their senior leaders, over the course of an hour, and discover more about their career journey. Dee Tress, R&D Future Leaders programme, was inspired by Richard’s journey at GSK and was keen to know more about the lessons he’s learned along the way to becoming Head of Consumer Healthcare R&D."}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","txt":"View more roles","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/kelly-engineering-usa/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","txt":"Read more","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Kelly is a technical engineer working in R&D in the USA. A recent graduate, this is her first job since completing her degree. Read more about what her role involves; the culture at GSK; and her top tips for success."}},"https://www.gsk.com/en-gb/careers/meet-our-people/lorraine-engineering-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","txt":"\n                        \n                                \n                        \n                            Lorraine, Engineering, UK\n                                                    Lorraine is a chemical engineer at our Ware site. She talks about her varied career at GSK and what she most enjoys about her job.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Lorraine is a chemical engineer at our Ware site. She talks about her varied career at GSK and what she most enjoys about her job."}},"https://www.gsk.com/en-gb/careers/meet-our-people/suzanne-engineering-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","txt":"\n                        \n                                \n                        \n                            Suzanne, Engineering, UK\n                                                    Suzanne is a qualified engineer and leader in our Global Manufacturing and Supply organisation.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Suzanne is a qualified engineer and leader in our Global Manufacturing and Supply organisation."}},"https://www.gsk.com/en-gb/careers/meet-our-people/keith-engineering-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","txt":"\n                        \n                                \n                        \n                            Keith, Engineering, UK\n                                                    Keith is on our Engineering Future Leaders Programme. He explains why the programme is giving him both the technical and leadership skills to thrive in his career.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keith is on our Engineering Future Leaders Programme. He explains why the programme is giving him both the technical and leadership skills to thrive in his career."}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","txt":"View more roles","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Medical%20OR%20Physician":{"firstFound":"https://www.gsk.com/en-gb/careers/physicians/","txt":"View relevant opportunities.","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/monica/":{"firstFound":"https://www.gsk.com/en-gb/careers/physicians/","txt":"\n                        \n                                \n                        \n                            Monica\n                                                    Monica is a Franchise Medical Head, Speciality Pharmaceuticals, who joined GSK in 2014.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Monica is a Franchise Medical Head, Speciality Pharmaceuticals, who joined GSK in 2014."}},"https://www.gsk.com/en-gb/careers/meet-our-people/paulo-physician-brazil/":{"firstFound":"https://www.gsk.com/en-gb/careers/physicians/","txt":"\n                        \n                                \n                        \n                            Paulo \n                                                    Paulo is a physician and leads medical affairs for our Central Nervous System portfolio in Brazil.  He explains that helping improve the lives of people all over the world is what drives him and what prompted him to make the move to industry.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Paulo is a physician and leads medical affairs for our Central Nervous System portfolio in Brazil.  He explains that helping improve the lives of people all over the world is what drives him and what prompted him to make the move to industry."}},"https://www.gsk.com/en-gb/careers/meet-our-people/maria/":{"firstFound":"https://www.gsk.com/en-gb/careers/physicians/","txt":"\n                        \n                                \n                        \n                            Maria\n                                                    Maria is a Regional Medical Lead at GSK Panama, here she talks about her journey to joining GSK and the reasons she’s never looked back.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Maria is a Regional Medical Lead at GSK Panama, here she talks about her journey to joining GSK and the reasons she’s never looked back."}},"https://www.gsk.com/en-gb/careers/meet-our-people/neil/":{"firstFound":"https://www.gsk.com/en-gb/careers/physicians/","txt":"\n                        \n                                \n                        \n                            Neil \n                                                    Global Franchise Medical Head, Respiratory. Joined us in October 2013, based in the UK\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Global Franchise Medical Head, Respiratory. Joined us in October 2013, based in the UK"}},"https://www.gsk.com/en-gb/careers/meet-our-people/thomas/":{"firstFound":"https://www.gsk.com/en-gb/careers/physicians/","txt":"\n                        \n                                \n                        \n                            Thomas \n                                                    Chief Medical Officer of GSK Vaccines joined GSK in 2001.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Chief Medical Officer of GSK Vaccines joined GSK in 2001."}},"https://www.gsk.com/en-gb/careers/meet-our-people/kumaran/":{"firstFound":"https://www.gsk.com/en-gb/careers/physicians/","txt":"\n                        \n                                \n                        \n                            Kumaran\n                                                    Lead - Vaccine Development Leader in GSK Vaccines, joined GSK in 2008.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Lead - Vaccine Development Leader in GSK Vaccines, joined GSK in 2008."}},"https://www.gsk.com/en-gb/careers/meet-our-people/arias-sales-china/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","txt":"Read more","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"As a medical representative for GSK, Arias and his colleagues are the bridge between Healthcare Professionals (HCPs) and our products in China. We interviewed him to find out his daily duties, how he got to where he is now, and his aspirations for the future."}},"https://www.gsk.com/en-gb/careers/meet-our-people/adriana-sales-brazil/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","txt":"\n                        \n                                \n                        \n                            Adriana, Sales, Brazil\n                                                    Adriana works in Pharmaceuticals sales in Brazil. She describes what her role involves and how it ensures that patients remain at the heart of everything we do.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Adriana works in Pharmaceuticals sales in Brazil. She describes what her role involves and how it ensures that patients remain at the heart of everything we do."}},"https://www.gsk.com/en-gb/careers/meet-our-people/rodrigo-sales-mexico/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","txt":"\n                        \n                                \n                        \n                            Rodrigo, Sales, Mexico\n                                                    Rodrigo is the General Manager for Consumer Healthcare in Mexico. Having graduated from a Masters in International Environmental Law, working in healthcare was never part of Rodrigo’s original plan. We spoke to him about his day-to-day role, the challenges he faces and how GSK welcomes people from all kinds of backgrounds.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Rodrigo is the General Manager for Consumer Healthcare in Mexico. Having graduated from a Masters in International Environmental Law, working in healthcare was never part of Rodrigo’s original plan. We spoke to him about his day-to-day role, the challenges he faces and how GSK welcomes people from all kinds of backgrounds."}},"https://www.gsk.com/en-gb/careers/meet-our-people/karandeep-sales-india/":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","txt":"\n                        \n                                \n                        \n                            Karandeep, Sales, India\n                                                    Karandeep works in our Consumer Healthcare business in India as a sales manager and describes how he thrives on taking on new challenges.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Karandeep works in our Consumer Healthcare business in India as a sales manager and describes how he thrives on taking on new challenges."}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","txt":"View more roles","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"http://www.gsk.com/en-gb/careers/students-and-apprentices":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/","txt":"Discover which is the best route for you.","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/careers/students-and-apprentices"},"http://www.gsk.com/en-gb/behind-the-science/how-we-do-business/school-leading-the-way-to-inspire-young-scientists/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/","txt":"\n                \n                        \n                \n                \n                        Can great careers start at school? \n                                            One school is leading the way to inspire young scientists\n                \n            ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Dr Louise Morris wants every student at her school to have the education and opportunity to have a career in STEM."},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/school-leading-the-way-to-inspire-young-scientists/"},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/develop-your-career-at-gsk/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/","txt":"\n                \n                        \n                \n                \n                        Discover the great benefits we offer\n                                            Discover more about the rewards, training, development and mentoring opportunities we offer.\n                \n            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"If you’re a graduate with the talent and ambition to lead others, we’ll equip you with the expertise you need to help us spearhead bold industry initiatives and make healthcare sustainable and accessible to the greatest number of patients and consumers."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/applying-for-our-apprentice-programme/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/","txt":"\n                \n                        \n                \n                \n                        Applying for our apprentice programme\n                                            Thinking about applying to our apprentice programme?  Here’s some useful advice to assist you in the recruitment process.\n                \n            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Thinking about applying to our apprenticeship programme?  Here’s some useful advice to assist you in the recruitment process."}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/direct-entry/","txt":"Search here for all jobs ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/maurizio-vaccines-venezuela/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-commercial-pharmaceuticals/","txt":"\n                        \n                                \n                        \n                            Maurizio, Vaccines, Venezuela\n                                                    \"Prior to joining GSK, I spent 10 years in the Fast Moving Consumer Goods (FMCG) industry, working in Europe, Latin America and Asia.\"\n\nMaurizio explains why the values of the company, and the international nature of the programme make GSK the perfect fit for his career ambitions.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"Prior to joining GSK, I spent 10 years in the Fast Moving Consumer Goods (FMCG) industry, working in Europe, Latin America and Asia.\"\n\nMaurizio explains why the values of the company, and the international nature of the programme make GSK the perfect fit for his career ambitions."}},"https://www.gsk.com/en-gb/careers/meet-our-people/ruiling-finance-us/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-commercial-pharmaceuticals/","txt":"\n                        \n                                \n                        \n                            Ruiling, Finance, US\n                                                    \"I'm in my final year of the programme, working in London on my international rotation.\"\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"I'm in my final year of the programme, working in London on my international rotation.\""}},"https://www.gsk.com/en-gb/careers/meet-our-people/yana-commercial-consumer-healthcare-esprit-programme/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-commercial-pharmaceuticals/","txt":"\n                        \n                                \n                        \n                            Iana, Commercial (Consumer Healthcare), Esprit Programme\n                                                    Yana is on our Esprit programme. She talks about why the flexible nature of the scheme allows her to chose her own career path.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Yana is on our Esprit programme. She talks about why the flexible nature of the scheme allows her to chose her own career path."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/communications-and-government-affairs/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Communications and government affairs\n                                                    Shape our messages and help us to communicate them clearly to governments and consumers and within GSK itself.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Shape our messages and help us to communicate them clearly to governments and consumers and within GSK itself."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/environment-health-safety-and-sustainability/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Environment, health, safety and sustainability\n                                                    Work to reduce our environmental impact and keep our people safe at work.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Work to reduce our environmental impact and keep our people safe at work."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/finance/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Finance\n                                                    Help to manage our operations in a way that supports our strategy and our purpose.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Help to manage our operations in a way that supports our strategy and our purpose."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/human-resources/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Human resources\n                                                    Make sure we find and keep the right people to deliver our strategy, and that they’re well-rewarded and well looked after.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Make sure we find and keep the right people to deliver our strategy, and that they’re well-rewarded and well looked after."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/procurement/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Procurement\n                                                    Join our global procurement team to learn how smart purchasing, strategic thinking and great relationships help a business like ours to thrive.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Join our global procurement team to learn how smart purchasing, strategic thinking and great relationships help a business like ours to thrive."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/technology/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Technology\n                                                    Help us use technology in sustainable and innovative ways so we can meet our strategic objectives.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Help us use technology in sustainable and innovative ways so we can meet our strategic objectives."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/commercial-management-consumer-healthcare/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                                \n                                    \n                                \n                                \n                                        Commercial management (Consumer Healthcare)\n\n                                        Work with household-name products that reach people in more than 100 countries worldwide.\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Work with household-name products that reach people in more than 100 countries worldwide."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/commercial-management-pharmaceuticals/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                                \n                                    \n                                \n                                \n                                        Commercial management (Pharmaceuticals)\n\n                                        Develop and implement strategies that help more people to do more, feel better and live longer, by ensuring the right medicines and vaccines reach the right people in the right places.\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Develop and implement strategies that help more people to do more, feel better and live longer, by ensuring the right medicines and vaccines reach the right people in the right places."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/engineering/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                            \n                                    \n                            \n                            \n                                    Engineering\n                                                                    Help us to devise and implement leading edge manufacturing technologies.\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Help us to devise and implement leading edge manufacturing technologies."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/supply-chain/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                            \n                                    \n                            \n                            \n                                    Supply chain\n                                                                    Join the team whose skill and experience gets our medicines from factory to patient all over the world.\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Join the team whose skill and experience gets our medicines from factory to patient all over the world."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/manufacturing-operations-and-quality-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                            \n                                    \n                            \n                            \n                                    Manufacturing operations and quality (Vaccines)\n                                                                    Work with the team responsible for ensuring that every dose of vaccine we produce, all over the word is of precisely the same high quality.\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Work with the team responsible for ensuring that every dose of vaccine we produce, all over the word is of precisely the same high quality."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/manufacturing-science/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                            \n                                    \n                            \n                            \n                                    Manufacturing science\n                                                                    Help practise the science behind producing four billion packs of medicine a year.\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Help practise the science behind producing four billion packs of medicine a year."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/clinical-programming/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Clinical programming\n                                                    As a Clinical Programmer, you will get hands on experience in the analysis and reporting of clinical trials and play an important role in defining and implementing strategies to modernise data delivery for clinical development.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"As a Clinical Programmer, you will get hands on experience in the analysis and reporting of clinical trials and play an important role in defining and implementing strategies to modernise data delivery for clinical development."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/drug-design-and-selection/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Drug design and selection\n                                                    Contribute to the discovery of new medicines through the identification of targets and selection of molecules for future drug development.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Contribute to the discovery of new medicines through the identification of targets and selection of molecules for future drug development."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/product-development-and-supply/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Product development and supply\n                                                    Help the vital work of moving new drugs forward from discovery through clinical trials and registration to the factory and beyond.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Help the vital work of moving new drugs forward from discovery through clinical trials and registration to the factory and beyond."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/regulatory-affairs/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Regulatory affairs\n                                                    Join the team that collects, collates and evaluates the scientific data which confirms the quality, safety and efficacy of our medicines.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Join the team that collects, collates and evaluates the scientific data which confirms the quality, safety and efficacy of our medicines."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/research-and-development-consumer-healthcare/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Research and development (Consumer Healthcare)\n                                                    You'll make consumers’ lives easier through our targeted science efforts across the globe.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"You'll make consumers’ lives easier through our targeted science efforts across the globe."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/research-and-development-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Research and development (Vaccines)\n                                                    Work with the world’s leading vaccine experts on new medicines to meet global public health needs.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Work with the world’s leading vaccine experts on new medicines to meet global public health needs."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/graduate-stories-future-leaders-on-breadth-assignments/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"Read more","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We want to ensure that our future leaders gain as much breadth of experience as possible. One of the ways we achieve this is through a “Global Assignment” programme; a year-long placement for selected graduates outside of their immediate business area and home market."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apply-now-for-our-future-leaders-graduate-programme/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            Applying for our Future Leaders graduate programme\n                                                    Find out how to apply for our Future Leaders graduate programme, the career paths on offer and the countries where they're available.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out how to apply for our Future Leaders graduate programme, the career paths on offer and the countries where they're available."}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/faqs/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"\n                        \n                                \n                        \n                            FAQs\n                                                    Some of the questions we’re asked about our graduate programme.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Some of the questions we’re asked about our graduate programme."}},"http://www.gsk.com/en-gb/about-us/what-we-do/vaccines/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-commercial-vaccines/","txt":"click here","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/about-us/what-we-do/vaccines/"},"http://www.gsk.com/en-gb/contact-us/worldwide/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/work-experience-placements-and-internships/","txt":"\n            \n                    \n            \n                Not from the UK or the USA? \n            Visit your local country site to find out more about work experience opportunities near you.         ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/worldwide/"},"http://www.gsk.com/en-gb/responsibility/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/","txt":"\n            \n                    \n            \n                Respect for people\n            Read about our commitments to the planet, and its people.        ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Responsible business is how we do business. Our purpose is to help people to do more, feel better, live longer."},"redirectedTo":"https://www.gsk.com/en-gb/responsibility/"},"http://www.gsk.com/en-gb/responsibility/our-behaviour/ethical-conduct/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/","txt":"\n            \n                    \n            \n                Behaving with integrity\n            How we act ethically throughout our business.         ","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/responsibility/our-behaviour/ethical-conduct/"},"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/applying-for-our-esprit-programme/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/","txt":"\n            \n                    \n            \n                Applying for our Esprit programme\n            Thinking about applying to our Esprit programme?  Here’s some useful advice to assist you in the recruitment process.        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Thinking about applying to our Esprit programme?  Here’s some useful advice to assist you in the recruitment process."}},"https://www.gsk.com/en-gb/careers/warning-against-fraudulent-internet-recruitment-activities/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/","txt":"Read more.","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Our attention has been drawn to the fraudulent activities of persons posing as recruitment agencies or GSK employees."}},"https://www.gsk.com/en-gb/careers/meet-our-people/aneesh/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/postdoctoral-rd/","txt":"\n                        \n                                \n                        \n                            Aneesh\n                                                    “I feel like this whole experience has given me direction for my career. There are so many exciting opportunities to apply my skills in industry and serve a social purpose. If I ever want to go back into academia, I know that the skills and exposure I’ve gained will only be of benefit.”\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"“I feel like this whole experience has given me direction for my career. There are so many exciting opportunities to apply my skills in industry and serve a social purpose. If I ever want to go back into academia, I know that the skills and exposure I’ve gained will only be of benefit.”"}},"https://www.gsk.com/en-gb/careers/meet-our-people/ashleigh/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/postdoctoral-rd/","txt":"\n                        \n                                \n                        \n                            Ashleigh\n                                                    “It felt like a big leap into the unknown, but I’m so glad I did it. I’ve always wanted to work close to clinical need, so it feels great to be part of a healthcare company.\"\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"“It felt like a big leap into the unknown, but I’m so glad I did it. I’ve always wanted to work close to clinical need, so it feels great to be part of a healthcare company.\""}},"https://www.gsk.com/en-gb/careers/meet-our-people/jessica/":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/postdoctoral-rd/","txt":"\n                        \n                                \n                        \n                            Jessica\n                                                    \"It’s been two years and 10 months since I began the GSK postdoctoral programme. Now that I’ve finished, I can say with confidence that it was the best choice I made to grow, both as a scientist and as an individual.\"\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"It’s been two years and 10 months since I began the GSK postdoctoral programme. Now that I’ve finished, I can say with confidence that it was the best choice I made to grow, both as a scientist and as an individual.\""}},"https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/":{"firstFound":"https://www.gsk.com/en-gb/careers/culture-and-values/","txt":"\n                \n                        \n                \n                \n                        PULSE volunteer stories\n                                            PULSE is our employee volunteering programme where eligible colleagues are matched to a not-for-profit partner, such as Save the Children, for a three-to-six month assignment.\n                \n            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Follow the journey of a selection of our employees currently on PULSE volunteering assignments"}},"https://www.gsk.com/en-gb/careers/meet-our-people/andrew-legal-us/":{"firstFound":"https://www.gsk.com/en-gb/careers/culture-and-values/","txt":"\n                        \n                                \n                        \n                            Andrew, Legal, US\n                                                    GSK attorney Andrew has been leading the company’s US-based Legal department’s ‘pro bono’ programme since founding it in 2005. As well as the value he adds to various organisations and individuals, he also believes it’s helped him grow professionally.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK attorney Andrew has been leading the company’s US-based Legal department’s ‘pro bono’ programme since founding it in 2005. As well as the value he adds to various organisations and individuals, he also believes it’s helped him grow professionally."}},"https://www.gsk.com/media/5214/oncology_lab.jpg?anchor=center&mode=crop&quality=90&width=1118&height=710&rnd=131883127170000000":{"firstFound":"https://www.gsk.com/en-gb/investors/","txt":"\n                                    \n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/careers/meet-our-people/jon-rd-uk/":{"redirectedFrom":"https://www.gsk.com/en-gb/careers/meet-our-people/jon/"},"https://www.gsk.com/en-gb/careers/meet-our-people/getting-girls-into-science/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Jo, R&D, UK\n                                                    GSK Chemist, Jo Redmond, tells us about her passion for inspiring the next generation into STEM subjects and careers.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Chemist, Jo Redmond, tells us about her passion for inspiring the next generation into STEM subjects and careers."}},"https://www.gsk.com/en-gb/careers/meet-our-people/monica-rd-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Monica, R&D, UK\n                                                    Monica is a global medical expert for our respiratory franchise. She provides a nurse's eye view into the role medical experts play in providing expertise and insights on our medicines.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Monica is a global medical expert for our respiratory franchise. She provides a nurse's eye view into the role medical experts play in providing expertise and insights on our medicines."}},"https://www.gsk.com/en-gb/careers/meet-our-people/teresa-ch-rd-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Teresa, CH R&D, UK\n                                                    Teresa heads up R&D for our global Oral and Skin Health categories at GSK Consumer Healthcare.  She talks to us about why she got into science, how she stays ahead of the competition and advice that she’d give to aspiring leaders.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Teresa heads up R&D for our global Oral and Skin Health categories at GSK Consumer Healthcare.  She talks to us about why she got into science, how she stays ahead of the competition and advice that she’d give to aspiring leaders."}},"https://www.gsk.com/en-gb/careers/meet-our-people/lindsay-rd-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Lindsay, R&D, UK\n                                                    Lindsay, Head of Digital, Data & Analytics for Respiratory in R&D, tells us about his career path from rock ‘n’ roll to healthcare.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Lindsay, Head of Digital, Data & Analytics for Respiratory in R&D, tells us about his career path from rock ‘n’ roll to healthcare."}},"https://www.gsk.com/en-gb/careers/meet-our-people/rizwan-engineering-pakistan/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Rizwan, Engineering, Pakistan\n                                                    Since joining GSK 18 years ago, Rizwan’s career has progressed to the level of Site Director in charge of 1,500 people across two manufacturing sites in Pakistan. In this edition of Meet Our Managers, he shares what he’s learned along the way.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Since joining GSK 18 years ago, Rizwan’s career has progressed to the level of Site Director in charge of 1,500 people across two manufacturing sites in Pakistan. In this edition of Meet Our Managers, he shares what he’s learned along the way."}},"https://www.gsk.com/en-gb/careers/meet-our-people/emma-sales-czech-republic/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Emma, Sales, Czech Republic\n                                                    Emma is the General Manager of our Pharmaceuticals Business in the Czech Republic. She talks to us about the importance of mentoring to personal development and shares her advice on how to make the most of it at work.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Emma is the General Manager of our Pharmaceuticals Business in the Czech Republic. She talks to us about the importance of mentoring to personal development and shares her advice on how to make the most of it at work."}},"https://www.gsk.com/en-gb/careers/meet-our-people/prachaya-sales-thailand/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Prachaya, Sales, Thailand\n                                                    After joining GSK in 2008, as a Medical Representative in Thailand, Prachaya progressed through a variety of product marketing roles within the respiratory business. Currently, he is a Senior Product Manager for the vaccines business. In this edition of Meet Our Managers, Prachaya shares his thoughts on the importance of leading by example.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"After joining GSK in 2008, as a Medical Representative in Thailand, Prachaya progressed through a variety of product marketing roles within the respiratory business. Currently, he is a Senior Product Manager for the vaccines business. In this edition of Meet Our Managers, Prachaya shares his thoughts on the importance of leading by example."}},"https://www.gsk.com/en-gb/careers/meet-our-people/reem-sales-saudi-arabia/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Reem, Sales, Saudi Arabia\n                                                    Reem, a Commercial Graduate based in Saudi Arabia, gives us a behind-the-scenes look at a typical day at GSK.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Reem, a Commercial Graduate based in Saudi Arabia, gives us a behind-the-scenes look at a typical day at GSK."}},"https://www.gsk.com/en-gb/careers/meet-our-people/tarek-sales-oman/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Tarek, Sales, Oman\n                                                    How can we help ensure patients in some of the most remote parts of the world have access to the healthcare they need? Meet Tarek, a passionate medical representative who travels across the valleys and mountains of Oman to support isolated communities.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"How can we help ensure patients in some of the most remote parts of the world have access to the healthcare they need? Meet Tarek, a passionate medical representative who travels across the valleys and mountains of Oman to support isolated communities."}},"https://www.gsk.com/en-gb/careers/meet-our-people/andrea-sales-brazil/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Andrea, Sales, Brazil\n                                                    Andrea is the General Manager of our Consumer Healthcare business in Brazil. She tells us about her experience of being a female leader from Latin America and shares her advice on leadership style and the principles that underpin high performing teams.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Andrea is the General Manager of our Consumer Healthcare business in Brazil. She tells us about her experience of being a female leader from Latin America and shares her advice on leadership style and the principles that underpin high performing teams."}},"https://www.gsk.com/en-gb/careers/meet-our-people/helen-sales-us/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Helen, Sales, US\n                                                    Helen Bemis has been no stranger to volunteering throughout her life. So, it was a natural choice for the senior biologics specialist from the US to take part in our PULSE volunteering programme. She’s halfway through her assignment with the Clinton Health Access Initiative in Laos and, as she tells us, all her expectations have been exceeded.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Helen Bemis has been no stranger to volunteering throughout her life. So, it was a natural choice for the senior biologics specialist from the US to take part in our PULSE volunteering programme. She’s halfway through her assignment with the Clinton Health Access Initiative in Laos and, as she tells us, all her expectations have been exceeded."}},"https://www.gsk.com/en-gb/careers/meet-our-people/veronique-business-operations-belgium/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Veronique, Vaccines, Belgium\n                                                    Véronique, a Senior Manager in our Vaccines distribution business, leads a team of five project managers in Belgium. In this edition of Meet Our Managers, she shares lessons learned from over a decade of developing others in their careers at GSK.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Véronique, a Senior Manager in our Vaccines distribution business, leads a team of five project managers in Belgium. In this edition of Meet Our Managers, she shares lessons learned from over a decade of developing others in their careers at GSK."}},"https://www.gsk.com/en-gb/careers/meet-our-people/rachel-business-operations-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Rachel, Procurement, UK\n                                                    Rachel, a Global Procurement Director based in GSK’s UK headquarters, leads a team of 10. The catch? They’re all in different countries. In this edition of Meet Our Managers, she serves up managerial wisdom with an international flavour.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Rachel, a Global Procurement Director based in GSK’s UK headquarters, leads a team of 10. The catch? They’re all in different countries. In this edition of Meet Our Managers, she serves up managerial wisdom with an international flavour."}},"https://www.gsk.com/en-gb/careers/meet-our-people/anju-business-operations-india/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Anju, Business operations, India\n                                                    Life hasn’t been easy for Anju, an Assistant Manager at GSK’s Consumer Healthcare Nabha manufacturing plant in northern India. But she’s always had a burning desire to help others less fortunate, and through our PULSE volunteering programme, she is able to do just that.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Life hasn’t been easy for Anju, an Assistant Manager at GSK’s Consumer Healthcare Nabha manufacturing plant in northern India. But she’s always had a burning desire to help others less fortunate, and through our PULSE volunteering programme, she is able to do just that."}},"https://www.gsk.com/en-gb/careers/meet-our-people/michal-marketing-and-communications-poland/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Michal, Marketing and communications, Poland\n                                                    Michal, Category Marketing Manager, looks after a team of four and a range of consumer brands including Sensodyne in Poland. In this edition of Meet Our Managers, he shares what it really means to be a people-oriented manager.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Michal, Category Marketing Manager, looks after a team of four and a range of consumer brands including Sensodyne in Poland. In this edition of Meet Our Managers, he shares what it really means to be a people-oriented manager."}},"https://www.gsk.com/en-gb/careers/meet-our-people/larry-marketing-and-communications-us/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Larry, Marketing and communications, US\n                                                    A varied 18-year career with GSK in the US has led Larry to his current role as a Brand Director at ViiV Healthcare, our HIV subsidiary. In this edition of Meet Our Managers, he shares what he’s learned about keeping people focused and fulfilled.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A varied 18-year career with GSK in the US has led Larry to his current role as a Brand Director at ViiV Healthcare, our HIV subsidiary. In this edition of Meet Our Managers, he shares what he’s learned about keeping people focused and fulfilled."}},"https://www.gsk.com/en-gb/careers/meet-our-people/jonathan-marketing-and-communications-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Jonathan, Marketing and communications, UK\n                                                    Jonathan, Global Category Lead Respiratory in Consumer Healthcare, shares his experience at GSK and why keeping an open mind is key to building a great career.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Jonathan, Global Category Lead Respiratory in Consumer Healthcare, shares his experience at GSK and why keeping an open mind is key to building a great career."}},"https://www.gsk.com/en-gb/careers/meet-our-people/adam-rd-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Adam, R&D, UK\n                                                    Meet Adam, one of our GSK apprentices, who is also studying for a foundation degree and hopes to complete a bachelor’s degree – funded by GSK – within five years of joining, by studying alongside his work. What he learns in applied bioscience and technology, he applies directly in the lab.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Meet Adam, one of our GSK apprentices, who is also studying for a foundation degree and hopes to complete a bachelor’s degree – funded by GSK – within five years of joining, by studying alongside his work. What he learns in applied bioscience and technology, he applies directly in the lab."}},"https://www.gsk.com/en-gb/careers/meet-our-people/aslihan-commercial-management-turkey/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Aslihan, Commercial management, Turkey\n                                                    Aslihan is on our Commerical Management FLP in Turkey. She explains why rotating across marketing and sales has helped her understand how decisions in the office translate into the field.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Aslihan is on our Commerical Management FLP in Turkey. She explains why rotating across marketing and sales has helped her understand how decisions in the office translate into the field."}},"https://www.gsk.com/en-gb/careers/meet-our-people/audrey-business-operations-singapore/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Audrey, Business operations, Singapore\n                                                    Audrey is on our Procurement Future Leaders Programme.  She explains why she chose to join GSK and why the rotational nature of the scheme will build her knowledge and capabilities in Procurement.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Audrey is on our Procurement Future Leaders Programme.  She explains why she chose to join GSK and why the rotational nature of the scheme will build her knowledge and capabilities in Procurement."}},"https://www.gsk.com/en-gb/careers/meet-our-people/phon/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Phon, Commercial management, Thailand\n                                                    \"I am proud to be working on consumer healthcare products that I know will make a difference to the quality of life for other people, just like they have for me.\"\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"I am proud to be working on consumer healthcare products that I know will make a difference to the quality of life for other people, just like they have for me.\""}},"https://www.gsk.com/en-gb/careers/meet-our-people/prashant-sales-bangladesh/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Prashant, Sales, Bangladesh\n                                                    General manager Prashant opens up about his learnings, passions and early dreams of becoming a fighter pilot.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"General manager Prashant opens up about his learnings, passions and early dreams of becoming a fighter pilot."}},"https://www.gsk.com/en-gb/careers/meet-our-people/ding-business-operation-china/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Ding, Business operation, China\n                                                    Ding is our head of China Government Affairs and communication. He discusses why taking risks is important, how comfort zones are made to be pushed and his childhood training to become a professional ping pong player.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Ding is our head of China Government Affairs and communication. He discusses why taking risks is important, how comfort zones are made to be pushed and his childhood training to become a professional ping pong player."}},"https://www.gsk.com/en-gb/careers/meet-our-people/victor-sales-spain/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Victor, Sales, Spain\n                                                    28-year journey of our Commercial Director Victor: his memorable first interview, forward-thinking attitude towards leadership and top tips for a life-long, enjoyable career.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"28-year journey of our Commercial Director Victor: his memorable first interview, forward-thinking attitude towards leadership and top tips for a life-long, enjoyable career."}},"https://www.gsk.com/en-gb/careers/meet-our-people/ipek-rd-turkey/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Ipek, R&D, Turkey\n                                                    Area Medical director Ipek discusses her learnings, personal growth and transition from working as a physician to working in the pharmaceutical industry.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Area Medical director Ipek discusses her learnings, personal growth and transition from working as a physician to working in the pharmaceutical industry."}},"https://www.gsk.com/en-gb/careers/meet-our-people/kevin-consumer-healthcare-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Kevin, Consumer Healthcare, UK\n                                                    Kevin, VP, Global Digital Commerce, shares his thoughts on developing a ‘test and learn’ culture, the importance of emotional intelligence and why it’s vital to work outside of your comfort zone to grow your skill set and build your career.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Kevin, VP, Global Digital Commerce, shares his thoughts on developing a ‘test and learn’ culture, the importance of emotional intelligence and why it’s vital to work outside of your comfort zone to grow your skill set and build your career."}},"https://www.gsk.com/en-gb/careers/meet-our-people/cecilia-pharmaceuticals-hong-kong/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Cecilia, Pharmaceuticals, Hong Kong\n                                                    Rex, an Esprit Associate in our Consumer Healthcare team, interviews Cecilia, General Manager, Pharmaceuticals, Hong Kong and Macau, on her breadth of experience in our industry.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Rex, an Esprit Associate in our Consumer Healthcare team, interviews Cecilia, General Manager, Pharmaceuticals, Hong Kong and Macau, on her breadth of experience in our industry."}},"https://www.gsk.com/en-gb/careers/meet-our-people/bryan-sales-malaysia/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Bryan, Sales, Malaysia\n                                                    Tze Yu, a graduate on our Future Leaders programme asks Bryan, General Manager of GSK Malaysia, how his career choices led him to GSK, and what inspires him the most about working here.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Tze Yu, a graduate on our Future Leaders programme asks Bryan, General Manager of GSK Malaysia, how his career choices led him to GSK, and what inspires him the most about working here."}},"https://www.gsk.com/en-gb/careers/meet-our-people/kosuke-pharmaceuticals-japan/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/","txt":"\n                        \n                                \n                        \n                            Kosuke, Pharmaceuticals, Japan\n                                                    Vasantha, a Business Analyst, spent some time with Kosuke, VP and Vice Head of Japan Development in Pharmaceuticals, Japan, to find out what inspires him most about working at GSK.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Vasantha, a Business Analyst, spent some time with Kosuke, VP and Vice Head of Japan Development in Pharmaceuticals, Japan, to find out what inspires him most about working at GSK."}},"https://www.gsk.com/media/4852/2018-gm-voting-and-poll-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4798/circular-to-shareholders-and-notice-of-general-meeting.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/general-meeting/","txt":"Notice of meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-with-novartis-to-acquire-full-ownership-of-consumer-healthcare-business/":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/general-meeting/","txt":"Read the GSK press release dated 27 March 2018","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business"}},"https://www.gsk.com/media/4780/consumer-healthcare-update-analyst-call-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Consumer Healthcare Update  - Analyst call slides\n                                PDF - 929.5KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4783/gsk-consumer-healthcare-update-transcript-27mar18.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Consumer Healthcare Update  - Analyst call transcript\n                                PDF - 65.4KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-major-three-part-transaction-with-novartis/":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/general-meeting/","txt":"GSK/Novartis transaction completion press release","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has acquired Novartis’s global Vaccines business (excluding influenza vaccines) for an initial cash consideration of $5.25 billion"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-three-part-transaction-with-novartis/":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/general-meeting/","txt":"GSK/Novartis transaction press release","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) has today received clearance from the European Commission of its proposed three-part transaction with Novartis"}},"https://www.gsk.com/media/1494/gsk-novartis-general-meeting-results.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/general-meeting/","txt":"GSK/Novartis meeting results (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1493/gsk-novartis-circular.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/general-meeting/","txt":"GSK/Novartis shareholder Circular and Notice of Meeting (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-plc-announces-major-three-part-transaction-with-novartis-to-drive-sustainable-sales-growth-improve-long-term-earnings-and-deliver-increasing-returns-to-shareholders/":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/general-meeting/","txt":"GSK/Novartis transaction press release","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc today announces a major three-part inter-conditional transaction with Novartis AG involving its Consumer Healthcare, Vaccines and Oncology businesses "}},"https://www.gsk.com/media/3347/gsk-and-novartis-transaction-presentation-slides.pdf":{"redirectedFrom":"https://www.gsk.com/media/4791/180328mp-x-requisitioning-a-resolution-at-a-gsk-agm-2019.pptx"},"https://www.gsk.com/media/3348/novartis-transaction-analyst-investor-teleconf-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/general-meeting/","txt":"transcript (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4791/180328mp-x-requisitioning-a-resolution-at-a-gsk-agm-2019.pptx":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Download details on how to requisition a resolution for GSK’s Annual General Meeting","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/3347/gsk-and-novartis-transaction-presentation-slides.pdf"},"https://www.gsk.com/media/4785/gsk-2018-notice-of-agm.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of Meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4853/2018-agm-voting-and-poll-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"here","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4784/annual-summary-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Summary 2017\n                                PDF - 953.4KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3635/gsk-plc-2017-notice-of-meeting.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of Meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3715/agm-votig-and-poll-results-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3202/notice-of-meeting-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3203/voting-poll-results-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2592/agm-notice-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3204/voting-poll-results-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2587/agm-notice-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3205/voting-poll-results-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3206/remuneration-policy-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Remuneration policy ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2584/agm-notice-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2585/agm-voting-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2586/articles-of-association.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Articles of Association","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2580/notice-of-annual-general-meeting.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2582/agm-voting-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2583/articles-of-association.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Articles of Association","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2578/gsk-2011-notice-of-annual-general-meeting.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2579/gsk-results-of-voting-at-the-2011-annual-general-meeting.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll result","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2573/gsk-notice-of-agm-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2575/agm-voting-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2576/articles-of-association.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Articles of Association: adopted 6 May 2010","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2577/annual-general-meeting-aw.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Presentation by Andrew Witty","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2570/gsk-notice-of-agm-2009.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting  ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2572/gsk-agm-letter-to-shareholders-2009.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Letter to shareholders","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2571/gsk-results-of-voting-at-agms-2009.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2564/gsk-notice-of-agm-2008.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2563/gsk-agm-letter-to-shareholders-2008.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Letter to shareholders","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2569/gsk-agm-explanatory-notes-2008.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Explanatory notes ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2568/gsk-memo-articles-of-association.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Agreed Articles of Association","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2567/gsk-2008-agm-poll-results.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2565/2008-annual-general-meeting.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Presentation ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2557/gsk-agm-notice-of-meeting-2007.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2562/gsk-agm-letter-to-shareholders-2007.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Letter to shareholders","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2561/gsk-agm-explanatory-notes-2007.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Explanatory notes ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2560/glaxosmithkline-plc-results-of-agm.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2558/annual-general-meeting-23-may-2007.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Presentation","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2552/gsk-agm-notice-of-meeting-2006.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2556/gsk-agm-letter-to-shareholders-2006.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Letter to shareholders","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2555/gsk-agm-explanatory-notes-2006.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Explanatory notes","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2554/issued-monday-17-may-2004-london-lse-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2547/gsk-agm-notice-of-meeting-2005.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Notice of meeting","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2551/gsk-agm-letter-to-shareholders-2005.pdf":{"redirectedFrom":"https://www.gsk.com/media/4772/xbrl-interactive-data-file-2017.zip"},"https://www.gsk.com/media/2550/gsk-agm-explanatory-notes-2005.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Explanatory notes ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2549/agm-voting-2005.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/","txt":"Voting/Poll results ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4768/20-f-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2017\n                                PDF - 8.9MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4771/20-fa-amendment-no1-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-FA Amendment No.1 2017\n                                PDF - 42.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4772/xbrl-interactive-data-file-2017.zip":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/","txt":"\n                        XBRL interactive data file 2017\n                        ZIP - 685.6KB\n                        \n                    ","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/2551/gsk-agm-letter-to-shareholders-2005.pdf"},"https://www.gsk.com/media/1495/nominee-service-t-c.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/","txt":"terms and conditions (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/corporate-sponsored-nominee-service/":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/","txt":"Confirm you have read the term and conditions by clicking here","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Step 3 of the corporate sponsored nominee service"}},"https://www.gsk.com/media/1496/transfer-shares-to-beneficial-holder.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/","txt":"Download and complete a transfer form (type A) (PDF 50KB)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1497/request-for-share-certificate-in-own-name.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/","txt":"Download and complete a transfer form (type C) (PDF 35KB)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3609/annual-report-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2016\n                                PDF - 7.7MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3636/gsk-plc-2016-annual-summary.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Summary 2016\n                                PDF - 2.7MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3615/2016-20-f.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/new-york-stock-exchange-rules/","txt":"Form 20-F (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3701/glaxosmithkline-annual-report-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                GlaxoSmithKline Capital plc Annual Report 2016\n                                PDF - 511.5KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4697/gsk-annual-report-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2015\n                                PDF - 5.4MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1492/annual-summary-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Summary 2015\n                                PDF - 1.9MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1487/gsk_responsible_business_supplement_2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Responsible Business Supplement 2015\n                                PDF - 5.7MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2717/2015-20f.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2015\n                                PDF - 11.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1486/gsk-capital-plc_31-12-15_final-ar-and-accounts-for-gsk.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                GlaxoSmithKline Capital plc Annual Report 2015\n                                PDF - 690.5KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2711/annual-report-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2014\n                                PDF - 7.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2716/annual-summary-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Summary 2014\n                                PDF - 616.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2739/gsk-responsible-business-supplement-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Responsible Business Supplement 2014\n                                PDF - 3.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2709/20-f-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2014\n                                PDF - 11.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2702/annual-report-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2013\n                                PDF - 6.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2705/annual-summary-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Summary 2013\n                                PDF - 2.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2748/cr-report-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2013\n                                PDF - 5.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2700/20-f-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2013\n                                PDF - 8.2MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2694/annual-report-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2012\n                                PDF - 3.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2698/annual-summary-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Summary 2012\n                                PDF - 721.7KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2737/cr-report-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2012\n                                PDF - 5.2MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2695/20-f-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2012\n                                PDF - 8.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2696/annual-report-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2011\n                                PDF - 7.9MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2692/annual-summary-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Summary 2011\n                                PDF - 314.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2736/cr-report-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2011\n                                PDF - 8.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2693/20-f-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2011\n                                PDF - 3.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2691/annual-report-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2010\n                                PDF - 2.8MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2735/cr-report-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2010\n                                PDF - 2.4MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2690/20-f-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2010\n                                PDF - 3.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2688/annual-report-2009.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2009\n                                PDF - 2.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2689/annual-summary-2009.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Summary 2009\n                                PDF - 2.9MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2733/cr-report-2009.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2009\n                                PDF - 3.9MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2687/20-f-2009.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2009\n                                PDF - 3.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2684/annual-report-2008.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2008\n                                PDF - 3.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2686/annual-summary-2008.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Summary 2008\n                                PDF - 5.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2732/cr-report-2008.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2008\n                                PDF - 3.2MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2685/20-f-2008.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2008\n                                PDF - 4.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2682/annual-report-2007.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2007\n                                PDF - 1.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2683/annual-review-2007.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Review 2007\n                                PDF - 1.7MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2730/cr-report-2007.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2007\n                                PDF - 1.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2681/20-f-2007.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2007\n                                PDF - 2.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2679/annual-report-2006.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2006\n                                PDF - 1.8MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2680/annual-review-2006.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Review 2006\n                                PDF - 1.9MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2729/cr-report-2006.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2006\n                                PDF - 1.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2678/20-f-2006.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2006\n                                PDF - 1.8MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2676/annual-report-2005.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2005\n                                PDF - 2.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2677/annual-review-2005.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Review 2005\n                                PDF - 1.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2727/cr-report-2005.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2005\n                                PDF - 3.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2675/20-f-2005.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2005\n                                PDF - 2.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2673/annual-report-2004.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2004\n                                PDF - 2.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2674/annual-review-2004.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Review 2004\n                                PDF - 628.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2723/cr-report-2004.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2004\n                                PDF - 1.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2672/20-f-2004.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2004\n                                PDF - 2.8MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2669/annual-report-2003.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2003\n                                PDF - 2.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2670/annual-review-2003.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Review 2003\n                                PDF - 839.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3229/cr-report-2003.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2003\n                                PDF - 1.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2668/gsk-2003-form-20f.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                20-F 2003\n                                PDF - 1.8MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2663/annual-report-2002.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2002\n                                PDF - 9.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2666/annual-review-2002.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Review 2002\n                                PDF - 866.8KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2719/cr-report-2002.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Report 2002\n                                PDF - 1.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2659/annual-report-2001.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2001\n                                PDF - 826.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2660/annual-review-2001.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Review 2001\n                                PDF - 881.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4698/annual-report-2000.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Report 2000\n                                PDF - 929.4KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2658/annual-review-2000.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"\n                                Annual Review 2000\n                                PDF - 2.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2018":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2018","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2017":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2017","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2016":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2016","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2015":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2015","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2014":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2014","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2013":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2013","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2012":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2012","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2011":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2011","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2010":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2010","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/media/5166/q3-2018-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2018 results announcement\n                                                        PDF - 1.2MB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-q3-sales-of-81-billion-plus3-aer-plus6-cer/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                            View summary of our results\n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Total EPS 28.8p, +16% AER, +23% CER; Adjusted EPS 35.5p, +10% AER, + 14% CER"}},"https://www.gsk.com/media/5168/infographic-quarterlyresults-landing_773px.jpg?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131854620350000000":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                                                    \n                                                    \n                                                        \n                                                    \n                                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/5173/q3-2018-results-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2018 results slides\n                                                        PDF - 297.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5174/q3-2018-results-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2018 results transcript\n                                                        PDF - 112.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5171/q3-2018-results-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2018 results infographic\n                                                        PDF - 674.8KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/5167/q3-2018-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2018 US dollar translation\n                                                        PDF - 128.6KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/5124/q3-2018-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2018 pre announcement aide memoire\n                                                        PDF - 779.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5011/q2-2018-results-and-rd-update-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q2 2018 results and R&D update announcement\n                                                        PDF - 1.0MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-improvements-in-sales-margins-and-cash-flow-in-q2-2018/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                            View summary of our results and R&D update announcement\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Total EPS 9.0p, >100% AER, >100% CER; Adjusted EPS 28.1p, +3% AER, +10% CER"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-23andme-sign-agreement-to-leverage-genetic-insights-for-the-development-of-novel-medicines/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                            View 23andMe announcement\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Multi-year collaboration expected to identify novel drug targets, tackle new subsets of disease and enable rapid progression of clinical programmes"}},"https://www.gsk.com/media/5014/q2-2018-results-quarterly-results-773px.jpg?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131769890100000000":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                                                    \n                                                    \n                                                        \n                                                    \n                                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/5029/q2-2018-slides-emma-walmsley.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q2 2018 slides - Emma Walmsley\n                                                        PDF - 495.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5030/q2-2018-slides-simon-dingemans.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q2 2018 slides - Simon Dingemans\n                                                        PDF - 131.7KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/5041/rd-update-slides-hal-barron.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        R&D update slides - Hal Barron\n                                                        PDF - 1.9MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5039/q2-2018-results-transcript-part-1.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q2 2018 results transcript - Part 1\n                                                        PDF - 188.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5040/q2-2018-results-transcript-part-2.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q2 2018 results transcript - Part 2\n                                                        PDF - 242.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5012/q2-2018-results-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q2 2018 results infographic\n                                                        PDF - 556.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5013/q2-2018-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q2 2018 US dollar translation\n                                                        PDF - 131.6KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4939/q2-2018-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q2 2018 pre announcement aide memoire\n                                                        PDF - 742.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4832/q1-2018-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q1 2018 results announcement\n                                                        PDF - 1.3MB\n                                                        \n                                                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-q1-sales-of-72-billion-2-aer-plus4-cer/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                            View summary of our results\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Total EPS 11.2p, -48% AER, -33% CER; Adjusted EPS 24.6p, -2% AER, +11% CER"}},"https://www.gsk.com/media/4840/q1-2018-results-773px-3.png?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131691292080000000":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                                                    \n                                                    \n                                                        \n                                                    \n                                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/4838/q1-2018-results-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q1 2018 results slides\n                                                        PDF - 371.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4843/q1-2018-results-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q1 2018 results transcript\n                                                        PDF - 125.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4831/q1-2018-results-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q1 2018 results infographic\n                                                        PDF - 237.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4833/q1-2018-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q1 2018 US dollar translation\n                                                        PDF - 78.3KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/4795/q1-2018-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q1 2018 pre announcement aide memoire\n                                                        PDF - 672.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        FY 2017 results announcement\n                                                        PDF - 1.8MB\n                                                        \n                                                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-improvements-in-sales-margins-and-cash-flow-in-2017/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                            View summary of our results\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Total EPS 31.4p, +67% AER, +36% CER; Adjusted EPS 111.8p, +11% AER, +4% CER"}},"https://www.gsk.com/media/4630/quarterly-results-graphic-press-1118px.jpg?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131624933230000000":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                                                    \n                                                    \n                                                        \n                                                    \n                                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/4628/fy-2017-results-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        FY 2017 results slides\n                                                        PDF - 207.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4631/fy-2017-results-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        FY 2017 results transcript\n                                                        PDF - 70.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4627/fy-2017-results-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        FY 2017 results infographic\n                                                        PDF - 253.6KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4626/fy-2017-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        FY 2017 US dollar translation\n                                                        PDF - 129.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4565/2017-q4-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        FY 2017 pre announcement aide memoire\n                                                        PDF - 782.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4171/q3-2017-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q3 2017 results announcement\n                                                        PDF - 1.3MB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-q3-sales-of-78-billion-plus4-aer-plus2-cer/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                            View summary of our results\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Total EPS 24.8p, +49% AER, +46% CER; Adjusted EPS 32.5p, +3% AER, flat CER"}},"https://www.gsk.com/media/4169/q3-2017-results-infographic-quarterly.png?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131534048370000000":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"\n                                                    \n                                                    \n                                                        \n                                                    \n                                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/4173/q3-2017-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q3 2017 US dollar translation\n                                                        PDF - 126.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4172/q3-2017-results-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q3 2017 results infographic\n                                                        PDF - 377.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4174/q3-2017-results-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q3 2017 results transcript\n                                                        PDF - 61.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4097/q3-2017-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                                        Q3 2017 pre announcement aide memoire\n                                                        PDF - 825.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/investors/quarterly-results/?p=2":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?p=3":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?p=4":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?p=5":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?p=6":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?p=7":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?p=8":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?p=9":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/school-students-what-next/meet-our-students-and-apprentices/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/school-students-what-next/","txt":"Meet our students and apprentices","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Hear personal and honest accounts from our students and apprentices about what it's like to work at GSK"}},"https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus/":{"firstFound":"https://www.gsk.com/en-gb/investors/analyst-consensus/","txt":"Continue","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The consensus estimates are collected by the company and based on the estimates of brokerage firms covering GlaxoSmithKline. Please ensure you have read and acknowledged the disclaimer prior to reviewing the information provided."}},"https://www.gsk.com/media/4821/additional-information-for-investors.docx":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","txt":"\n                        Additional information for investors\n                        DOCX - 16.6KB\n                        \n                    ","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/5174/q3-2018-results-transcript.pdf"},"https://www.gsk.com/media/4758/chairmans-statement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","txt":"Chairman's statement","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4757/ceo-s-statement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","txt":"CEO's statement","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4763/strategic-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","txt":"\n                        Strategic report\n                        PDF - 5.0MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4753/cautionary-statement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","txt":"\n                        Cautionary statement\n                        PDF - 42.6KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-positive-48-week-results-for-second-phase-iii-study-for-novel-long-acting-injectable-hiv-treatment-regimen/":{"firstFound":"https://www.gsk.com/en-gb/investors/stock-exchange-announcements/london-rns-inside-information/","txt":"ViiV Healthcare reports positive 48-week results for second phase III study for novel, long-acting, injectable HIV-treatment regimen","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"FLAIR study meets primary endpoint, showing similar efficacy of a once-a-month, investigational, injectable two-drug regimen of cabotegravir and rilpivirine compared to a daily, oral three-drug, integrase-based regimen in virally-suppressed adults."}},"https://www.gsk.com/media/4909/viiv-healthcare-reports-landmark-phase-iii-studies-for-dolutegravir-and-lamivudine.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/stock-exchange-announcements/london-rns-inside-information/","txt":"ViiV Healthcare reports landmark phase III studies for dolutegravir and lamivudine, demonstrating the ability to control HIV with a two-drug regimen in treatment naïve patients","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/shingrix-approved-in-the-us-for-prevention-of-shingles-in-adults-aged-50-and-over/":{"firstFound":"https://www.gsk.com/en-gb/investors/stock-exchange-announcements/london-rns-inside-information/","txt":"Shingrix approved in the US for prevention of shingles in adults aged 50 and over","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Pooled clinical trial results showed > 90 percent efficacy across all age groups"}},"https://www.gsk.com/media/3463/viiv-announce-phase-iii-results-for-2-drug-regimen.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/stock-exchange-announcements/london-rns-inside-information/","txt":"ViiV announce phase III results for 2-drug regimen","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5230/viiv-meet-the-management-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                ViiV Meet the Management - slides\n                                PDF - 4.9MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5218/gsk-acquisition-of-tesaro-investor-call-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Agreement to acquire TESARO investor call - slides\n                                PDF - 428.3KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/5225/agreement-to-acquire-tesaro-investor-call-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Agreement to acquire TESARO investor call - transcript\n                                PDF - 308.6KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5158/gsk-165-anti-gm-csf-antibody-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                GSK’165: anti-GM-CSF antibody - slides\n                                PDF - 457.7KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/5160/gsk-165-anti-gm-csf-antibody-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                GSK’165: anti-GM-CSF antibody - transcript\n                                PDF - 99.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5106/consumer-healthcare-investor-event-slides-sept-2018.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Consumer Healthcare investor event - slides\n                                PDF - 4.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5107/consumer-healthcare-investor-event-transcript-sept-2018.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Consumer Healthcare investor event - transcript\n                                PDF - 165.6KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5007/gemini-investor-analyst-update.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                GEMINI Investor & Analyst Update\n                                PDF - 777.0KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/5010/gsk-gemini-investor-call-transcript-24july18.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                GEMINI call transcript\n                                PDF - 125.8KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4561/2018-jpm-emma-walmsley-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                2018 JPM Emma Walmsley presentation\n                                PDF - 699.0KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/4612/final-jp-morgan-presentation-transcript-jan-9-2018-jrm-edits.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                2018 JPM Emma Walmsley presentation transcript\n                                PDF - 54.7KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/4613/final-jp-morgan-qa-transcript-jan-9-2018-jrm-edits.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                2018 JPM Emma Walmsley Q&A transcript\n                                PDF - 65.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4483/bcma-investor-event-slides-12-dec-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                GSK Oncology Investor & Analyst Update - slides\n                                PDF - 800.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4493/gsk-bcma-investor-call-12-december-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                GSK Oncology Investor & Analyst Update - transcript\n                                PDF - 235.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4492/citi-conference-axel-hoos-fireside-chat-transcript-dec-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Citi Global Healthcare Conference - transcript\n                                PDF - 145.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4440/evercore-isi-transcript-30-nov-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Evercore conference - transcript\n                                PDF - 88.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4425/ssl-intro-to-gsk-master-sw-29-nov-show-file.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Consumer Healthcare investor event - slides\n                                PDF - 2.2MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4432/gsk-consumerhealthcare.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Consumer Healthcare investor event - transcript\n                                PDF - 92.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3881/emma-walmsley-key-priorities.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Emma Walmsley slides: Key priorities\n                                PDF - 864.3KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/3882/simon-dingemans-q2-and-financial-outlook.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Simon Dingemans slides: Q2 and financial outlook\n                                PDF - 509.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3891/investor-event-full-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Investor event full transcript\n                                PDF - 173.6KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/3599/cowen-37th-annual-healthcare-conference-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Cowen 37th Annual Healthcare Conference - slides\n                                PDF - 1.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3613/cowen-37th-annual-healthcare-conference-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                Cowen 37th Annual Healthcare Conference - transcript\n                                PDF - 84.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3505/hiv-analyst-call-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                HIV analyst call presentation\n                                PDF - 938.4KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3504/croi-analyst-call-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"\n                                CROI analyst call transcript\n                                PDF - 437.5KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?p=2":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?p=3":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?p=4":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-kyowa-hakko-kirin-sign-strategic-commercialisation-deal-in-japan-for-daprodustat-a-potential-new-oral-treatment-for-anaemia-associated-with-chronic-kidney-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                22 November 2018\n            GSK and Kyowa Hakko Kirin sign strategic commercialisation deal in Japan for daprodustat, a potential new oral treatment for anaemia associated with chronic kidney disease\n                Announcing a strategic collaboration for the future commercialisation of daprodustat in Japan.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Announcing a strategic collaboration for the future commercialisation of daprodustat in Japan."}},"https://www.gsk.com/en-gb/media/press-releases/access-to-medicine-index-2018-media-statement/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                20 November 2018\n            Access to Medicine Index 2018 media statement\n                GSK media statement on the results of the Access to Medicine Index 2018\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK media statement on the results of the Access to Medicine Index 2018"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-us-regulatory-filing-to-expand-the-use-of-nucala-in-children-with-severe-eosinophilic-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                19 November 2018\n            GSK submits US regulatory filing to expand the use of Nucala in children with severe eosinophilic asthma\n                Supplemental Biologics License Application (sBLA) filed to the US FDA seeking an additional indic...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Supplemental Biologics License Application (sBLA) filed to the US FDA seeking an additional indication for the use of Nucala (mepolizumab) as an add-on treatment for severe eosinophilic asthma in paediatric patients."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-chmp-positive-opinion-for-tivicay-eu-label-update-with-gemini-study-data-for-the-2-drug-regimen-of-tivicay-plus-lamivudine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                16 November 2018\n            ViiV Healthcare receives CHMP Positive Opinion for Tivicay EU label update with GEMINI study data for the 2-drug regimen of Tivicay + lamivudine\n                Committee for Medicinal Products for Human Use (CHMP) has adopted a Positive Opinion on a Type II...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Committee for Medicinal Products for Human Use (CHMP) has adopted a Positive Opinion on a Type II variation regulatory application for Tivicay (dolutegravir)."}},"https://www.gsk.com/en-gb/media/press-releases/once-daily-trelegy-ellipta-gains-expanded-copd-indication-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                09 November 2018\n            Once-daily Trelegy Ellipta gains expanded COPD indication in Europe\n                Once-daily Trelegy Ellipta now available for COPD patients requiring a step up from dual bronchod...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Once-daily Trelegy Ellipta now available for COPD patients requiring a step up from dual bronchodilation"}},"https://www.gsk.com/en-gb/media/press-releases/statement-gsk-supports-gold-committee-s-efforts-to-further-personalise-copd-management/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                08 November 2018\n            Statement: GSK supports GOLD committee’s efforts to further personalise COPD management\n                Welcoming the updated Global Initiative for Chronic Obstructive Lung Disease (GOLD) Strategy.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Welcoming the updated Global Initiative for Chronic Obstructive Lung Disease (GOLD) Strategy."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-positive-phase-3-results-from-the-brighte-study-of-fostemsavir-at-48-weeks-in-heavily-treatment-experienced-patients-with-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                31 October 2018\n            ViiV Healthcare announces positive phase 3 results from the BRIGHTE study of fostemsavir at 48 weeks in heavily treatment-experienced patients with HIV\n                BRIGHTE study highlights ViiV Healthcare’s commitment to developing innovative medicines for all ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"BRIGHTE study highlights ViiV Healthcare’s commitment to developing innovative medicines for all people living with HIV, including those heavily-treated and failing on current antiretroviral regimens"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-three-year-data-for-investigational-long-acting-injectable-two-drug-hiv-regimen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                29 October 2018\n            ViiV Healthcare presents three-year data for investigational long-acting injectable, two-drug HIV regimen\n                LATTE-2 study shows high rates of virologic response and long-term durability with the long-actin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"LATTE-2 study shows high rates of virologic response and long-term durability with the long-acting, injectable, two-drug regimen over 160 weeks"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-phase-3-results-for-daprodustat-in-patients-with-anaemia-associated-with-chronic-kidney-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                29 October 2018\n            GSK announces positive phase 3 results for daprodustat in patients with anaemia associated with chronic kidney disease\n                Second of three pivotal studies intended to support regulatory filing in Japan in 2019\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Second of three pivotal studies intended to support regulatory filing in Japan in 2019"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-new-efficacy-and-safety-data-of-an-anti-gm-csf-antibody-in-patients-with-rheumatoid-arthritis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                21 October 2018\n            GSK presents new efficacy and safety data of  an anti GM-CSF antibody in patients with rheumatoid arthritis\n                Marked patient benefit observed in phase II study supports further clinical development of GSK319...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Marked patient benefit observed in phase II study supports further clinical development of GSK3196165 for RA."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-submits-new-drug-application-to-us-fda-for-single-tablet-two-drug-regimen-of-dolutegravir-and-lamivudine-for-treatment-of-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                18 October 2018\n            ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV\n                Priority review voucher used with NDA submission with anticipated target action date of six months.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Priority review voucher used with NDA submission with anticipated target action date of six months."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-updates-policy-for-working-with-healthcare-professionals/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                02 October 2018\n            GSK updates policy for working with healthcare professionals\n                We are updating our policy on working with healthcare professionals (HCPs).\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We are updating our policy on working with healthcare professionals (HCPs)."}},"https://www.gsk.com/en-gb/media/press-releases/positive-results-from-harmony-outcomes-study-of-albiglutide-published-in-the-lancet/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                02 October 2018\n            Positive results from Harmony Outcomes study of albiglutide published in The Lancet\n                GSK and the Duke Clinical Research Institute (DCRI) today announced publication of positive resul...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and the Duke Clinical Research Institute (DCRI) today announced publication of positive results from the Harmony Outcomes study which assessed the cardiovascular (CV) safety and efficacy of albiglutide, a GLP-1 receptor agonist, in patients with type 2 diabetes and cardiovascular disease. Results were presented at the European Association for the Study of Diabetes congress 2018 with simultaneous publication in The Lancet."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-candidate-vaccine-helps-prevent-active-pulmonary-tuberculosis-in-hiv-negative-adults-in-phase-ii-study/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                25 September 2018\n            GSK candidate vaccine helps prevent active pulmonary tuberculosis in HIV negative adults in phase II study\n                Positive impact of innovative vaccine technology in clinical trial conducted in tuberculosis ende...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Positive impact of innovative vaccine technology in clinical trial conducted in tuberculosis endemic regions"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-tres-cantos-open-lab-foundation-announce-additional-5m-funding-for-open-innovation-research-in-diseases-impacting-the-developing-world/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"\n                21 September 2018\n            GSK and Tres Cantos Open Lab Foundation announce additional £5m funding for open innovation research in diseases impacting the developing world\n                Additional £5m in GSK funding to support the Foundation’s research and development programmes in ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Additional £5m in GSK funding to support the Foundation’s research and development programmes in diseases of the developing world."}},"https://www.gsk.com/en-gb/media/press-releases/?p=2":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?p=3":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?p=4":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?p=5":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?p=6":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?p=7":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?p=8":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?p=9":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?p=10":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-pneumococcal-vaccine-pricing/":{"firstFound":"https://www.gsk.com/en-gb/media/resource-centre/","txt":"Statement on vaccine pricing","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"For many years we have been working hard, in partnership with others, to develop vaccines against infectious diseases and to get them to those that need them. This is making a difference."}},"https://www.gsk.com/media/4931/gsk-quick-facts.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/","txt":"\n                \n                        \n                \n                \n                        GSK quick facts\n                                            Download and read our quick facts\n                \n            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/rss/":{"firstFound":"https://www.gsk.com/en-gb/media/rss-feeds/","txt":"Press releases RSS feed","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/behind-the-science/rss":{"firstFound":"https://www.gsk.com/en-gb/media/rss-feeds/","txt":"Behind the science RSS feed","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/3210/about-asthma-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/resource-centre/pharmaceuticals-resources/","txt":"\n                About asthma infographic PDF - 831.8KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3211/about-copd.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/resource-centre/pharmaceuticals-resources/","txt":"\n                About COPD infographic PDF - 153.2KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4294/103115003_mythsmisconceptions_infographic_vfinal_long.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/resource-centre/pharmaceuticals-resources/","txt":"\n                COPD: myths and misconceptions PDF - 172.5KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5064/severe-asthma-and-eos_infographic_certified-oct-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/european-commission-approves-nucala-mepolizumab-for-the-treatment-of-children-with-severe-asthma/","txt":"infographic about severe asthma and role of eosinophils","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3298/world-lupus-day-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/does-lupus-really-know-no-boundaries/","txt":"\n                How much do you really know about Lupus infographic PDF - 441.8KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/resource-centre/pharmaceuticals-resources/","txt":"Look back on the past 20 years ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/":{"redirectedFrom":"http://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/"},"https://www.gsk.com/en-gb/research/our-approach/open-innovation/collaborative-approach/":{"firstFound":"https://www.gsk.com/en-gb/research/","txt":"\n                            \n                                    \n                            \n                            \n                                    Collaborative approach\n                                                                    We know that we need to partner with other companies, academic institutions and research charities to discover more\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We know that we need to partner with other companies, academic institutions and research charities to discover more"}},"https://www.gsk.com/en-gb/research/our-approach/open-innovation/non-communicable-diseases-in-africa/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/","txt":"\n                                \n                                        \n                                \n                                \n                                        Non-communicable diseases in Africa\n                                                                            A collaborative approach to helping us to better understand non-communicable diseases (NCDs) in Africa\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A collaborative approach to helping us to better understand non-communicable diseases (NCDs) in Africa"}},"https://www.gsk.com/en-gb/research/our-approach/open-innovation/diseases-of-the-developing-world/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/","txt":"\n                        \n                                \n                        \n                            Diseases of the developing world\n                                                    To achieve sustainable improvements in access to essential care and medicines in the developing world, we need to have a dedicated strategy devoted to it\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"To achieve sustainable improvements in access to essential care and medicines in the developing world, we need to have a dedicated strategy devoted to it"}},"https://www.gsk.com/en-gb/research/our-approach/open-innovation/stevenage-bioscience-hub/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/","txt":"\n                        \n                                \n                        \n                            Stevenage bioscience hub\n                                                    The Stevenage Bioscience Catalyst campus is a major hub for early-stage biotechnology companies\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Stevenage Bioscience Catalyst campus is a major hub for early-stage biotechnology companies"}},"https://www.gsk.com/en-gb/research/our-approach/open-innovation/targeting-the-immune-system-through-open-innovation/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/","txt":"\n                        \n                                \n                        \n                            Targeting the immune system through open innovation\n                                                    We have at least 10 research units focused on immunology across several therapeutic areas and have multiple research programmes underway\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We have at least 10 research units focused on immunology across several therapeutic areas and have multiple research programmes underway"}},"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/data-transparency/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/sharing-our-research/","txt":"Read about our commitment","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We have a long-standing commitment to data transparency."}},"https://www.gsk.com/en-gb/research/our-approach/sharing-our-research/gsk-study-register/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/sharing-our-research/","txt":"\n                        \n                                \n                        \n                            GSK Study Register\n                                                    Being 100% transparent about all of our clinical research is fundamental to the advancement of medical science\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Being 100% transparent about all of our clinical research is fundamental to the advancement of medical science"}},"https://www.gsk.com/en-gb/research/our-approach/sharing-our-research/patient-level-data/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/sharing-our-research/","txt":"\n                        \n                                \n                        \n                            Patient-level data\n                                                    We were the first organisation to develop a system for sharing detailed clinical data to help increase understanding of our medicines\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We were the first organisation to develop a system for sharing detailed clinical data to help increase understanding of our medicines"}},"https://www.gsk.com/en-gb/research/our-approach/our-use-of-animals/the-3rs-in-medicine-research/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/our-use-of-animals/","txt":"\n                        \n                                \n                        \n                            The 3Rs in medicine research\n                                                    Find out more about the 3Rs when animals are used in medicine research\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about the 3Rs when animals are used in medicine research"}},"https://www.gsk.com/en-gb/research/our-approach/our-use-of-animals/use-of-non-human-primates/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/our-use-of-animals/","txt":"\n                        \n                                \n                        \n                            Use of non-human primates\n                                                    Medicines and vaccines need to be studied in an animal where the physiology and disease process is similar to that in humans\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Medicines and vaccines need to be studied in an animal where the physiology and disease process is similar to that in humans"}},"https://www.gsk.com/en-gb/research/our-approach/our-use-of-animals/frequently-asked-questions/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/our-use-of-animals/","txt":"\n                        \n                                \n                        \n                            Frequently asked questions\n                                                    We provide answers to some of the most commonly asked questions about our research involving animals\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We provide answers to some of the most commonly asked questions about our research involving animals"}},"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/clinical-trial-phases/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/","txt":"\n                                \n                                    \n                                \n                                \n                                        Clinical trial phases\n\n                                        Each step of the clinical trial process is carefully monitored by government authorities and our own Global Safety Board (GSB)\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Each step of the clinical trial process is carefully monitored by government authorities and our own Global Safety Board (GSB)"}},"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/become-a-clinical-research-volunteer/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/","txt":"\n                                \n                                    \n                                \n                                \n                                        Become a clinical research volunteer\n\n                                        Our volunteers enable us to assess a compound’s potential to become a new medicine or vaccine\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Our volunteers enable us to assess a compound’s potential to become a new medicine or vaccine"}},"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/independent-clinical-studies/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/","txt":"\n                                \n                                    \n                                \n                                \n                                        Independent clinical studies\n\n                                        At GSK, we carry out a large number of studies on our products and we make this information available in a range of ways\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"At GSK, we carry out a large number of studies on our products and we make this information available in a range of ways"}},"https://www.gsk.com/media/5097/our-approach-to-responsible-business_sept-18.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/","txt":"\n                Our approach to responsible business PDF - 347.7KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2538/gsk-materiality-process.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/","txt":"Our materiality process","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5121/new-board-committees-3.jpg?anchor=center&mode=crop&quality=90&width=1118&height=710&rnd=131831373950000000":{"firstFound":"https://www.gsk.com/en-gb/responsibility/","txt":"\n                                    \n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/1240/woman-office-employee.jpg?anchor=center&mode=crop&quality=90&width=1118&height=710&rnd=131417512350000000":{"firstFound":"https://www.gsk.com/en-gb/responsibility/","txt":"\n                                    \n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/media/press-releases/gsk-leads-access-to-medicine-index-2016/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/access-to-healthcare/","txt":"Our ranking as top of the 2016 Index","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has today been ranked first in the Access to Medicine Index for the fifth consecutive time."}},"https://www.gsk.com/media/2213/sdg-factsheet-june-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/sustainable-development/","txt":"Sustainable Development factsheet (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2211/gsk-and-the-decade-of-vaccines-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/tackling-diseases-in-developing-countries/","txt":"\n                        GSK and the Decade of Vaccines\n                        PDF - 3.2MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3350/albendazole-donation-programme-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/tackling-diseases-in-developing-countries/","txt":"\n                        Albendazole donation programme infographic\n                        PDF - 4.6MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3290/our-commitment-to-health-workers.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/helping-women-to-give-birth-safely/","txt":"\n                Our commitment to health workers PDF - 201.1KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1126/health_worker_trainer_infographic_english_august-2015.jpg":{"firstFound":"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/sustainable-development/","txt":"Health worker training infographic","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/2212/malaria-timeline-full.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/can-mosquitoes-prevent-malaria/","txt":"\n                Our 30-year quest for a malaria vaccine infographic PDF - 505.8KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/codes-and-standards/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/ethical-conduct/","txt":"Code of Conduct","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about the GSK Code of Conduct and our Anti-Bribery and Corruption programme"},"redirectedTo":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/"},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/vaccines-travel-sponsorship/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/","txt":"\n                            \n                                    \n                            \n                            \n                                    Vaccines travel sponsorship\n                                                                    Support for travel sponsorship for global/international independent medical education activities or scientific congresses\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Support for travel sponsorship for global/international independent medical education activities or scientific congresses"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/vaccines-independent-medical-education/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/","txt":"\n                            \n                                    \n                            \n                            \n                                    Vaccines independent medical education\n                                                                    GSK Vaccines: support for independent medical education\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Vaccines: support for independent medical education"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/respiratory-independent-medical-education/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/","txt":"\n                            \n                                    \n                            \n                            \n                                    Respiratory independent medical education\n                                                                    Support for severe asthma independent medical education\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Support for severe asthma independent medical education"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/call-for-ime-proposals-on-systemic-lupus-erythematosus-sle/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/","txt":"\n                            \n                                    \n                            \n                            \n                                    Call for IME proposals on Systemic Lupus Erythematosus (SLE)\n                                                                    Our approach to supporting IME to better understand our standards for educational grant proposals, and details on how to apply.\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Our approach to supporting IME to better understand our standards for educational grant proposals, and details on how to apply."}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/usa/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/","txt":"USA","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We were one of the first pharmaceutical companies in the USA to voluntarily disclose information about our work with physicians"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/","txt":"Europe","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We fully support the EFPIA's Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/rest-of-the-world/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/","txt":"rest of the world","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We continue to support and work towards transparency as industry associations or governments establish specific guidelines for disclosure around the world"}},"https://www.gsk.com/media/4681/uk-gender-pay-gap-report-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/working-at-gsk/","txt":"UK Gender Pay Gap report 2017 (PDF-173KB)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5117/employee-volunteering-annual-impact-report-2017-2018.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering","txt":"\n                        Employee volunteering - annual impact report 2018.pdf\n                        PDF - 15.9MB\n                        \n                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/100-pulse-volunteers-at-save-the-children/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/","txt":"\n                        \n                                \n                        \n                            100 PULSE volunteers at Save the Children\n                                                    Working hand in hand with Save the Children teams, our PULSE volunteers are improving children’s access to basic healthcare.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Working hand in hand with Save the Children teams, our PULSE volunteers are improving children’s access to basic healthcare."}},"https://www.gsk.com/media/4733/gsk-value-chain-carbon-footprint.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/environment/carbon/","txt":"\n                GSK value chain carbon footprint PDF - 2.8MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4774/global-reporting-initiative-gri-index-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Global Reporting Initiative (GRI) Index 2017\n                                PDF - 247.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4754/detailed-environmental-data-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Detailed environmental data 2017\n                                PDF - 309.8KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4752/assurance-statement-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Assurance Statement 2017\n                                PDF - 255.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4792/un-global-compact-communication-on-progress-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                UN Global Compact Communication on Progress 2017\n                                PDF - 384.6KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3633/value-chain-water-footprint.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/environment/water/","txt":"\n                Value chain water footprint PDF - 1.1MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4736/main-trade-associations.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/trade-association-memberships/","txt":"Download Trade Associations Memberships (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4725/charitable-grants-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/charitable-grants/","txt":"Charitable Grants Report (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2540/2015-humanitarian-product-donations-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/charitable-grants/","txt":"Humanitarian Product Donations Report 2015 (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3482/alzheimer-europe-ae.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Alzheimer Europe (AE) (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2222/european-federation-of-allergy-and-airways-diseases-patients-associations-efa.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"European Federation of Allergy and Airways Disease Patients Association (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2223/european-institute-of-womens-health-eiwh.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"European Institute of Women's Health (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3493/european-parkinsons-disease-association-epda.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"European Parkinson's Disease Association (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2215/european-patients-forum-epf.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"European Patients' Forum (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3483/eurordis-rare-disease-unit.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"European Organisation for Rare Diseases (EURORDIS) (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2218/lupus-europe-le.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"LUPUS EUROPE (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2219/pha-europe-rare-disease-unit-pag-disclosure.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"PHA Europe -Pulmonary Hypertension Association (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/contact-us/worldwide/latvia/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Latvia","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Lativia"}},"https://www.gsk.com/en-gb/contact-us/worldwide/lithuania/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Lithuania","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Lithuania"}},"https://www.gsk.com/media/2227/israel.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Israel (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2228/cyprus.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Cyprus (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2226/portugal.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Portugal (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4632/slovakia.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Slovakia (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4633/asthma-uk.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3396/british-lung-foundation.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"British Lung Foundation (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4634/first-steps.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"First Steps (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3399/genetic-alliance-uk.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Genetic Alliance UK (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4635/jos-cervical-cancer-trust.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Jo's Cervical Cancer Trust (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4636/meningitis-now.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Meningitis Now (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3395/meningitis-research-foundation.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Meningitis Research Foundation (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4637/muscular-dystrophy-uk.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Muscular Dystrophy UK (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4638/pulmonary-hypertension-association.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Pulmonary Hypertension Association (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4639/sahir-house.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Sahir House (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4641/sight-cymru.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Sight Cymru (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4640/target-ovarian-cancer.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Target Ovarian Cancer (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3394/wellchild.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"WellChild (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2246/argentina.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Argentina (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2247/chile.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Chile (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2248/ecuadorian.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4647/colombia.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Colombia (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2249/hong-kong.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Hong Kong (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2252/new-zealand.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"New Zealand (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3487/panama.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Panama (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2253/philippines.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4648/russia.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Russia (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2254/thailand.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Thailand (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2255/ukraine.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Ukraine (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/contact-us/worldwide/mexico/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Mexico","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Mexico"}},"https://www.gsk.com/media/2256/confederation-of-meningitis-organisations-como.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Confederation of Meningitis Organisations (CoMO) (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2257/international-alliance-of-patient-organizations-iapo.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"International Alliance of Patient Organisations (IAPO) (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2259/ipopi-rare-disease-unit.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"International Patient Organisation for Primary Immunodeficiencies (IPOPI) (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3720/rainbow-across-borders.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Rainbow Across Borders (RAB) (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4645/global-asthma-and-allergy-patient-platform-gaapp.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Global Asthma and Allergy Patient Platform (GAAPP) (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4646/copd-foundation.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"COPD Foundation (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3684/global-reporting-initiative-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Global Reporting Initiative (GRI) Index 2016\n                                PDF - 103.7KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3612/detailed-environmental-data-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Detailed environmental data 2016\n                                PDF - 54.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3614/assurance-statement-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Assurance Statement 2016\n                                PDF - 157.4KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3749/united-nations-global-compact-communication-on-progress-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                UN Global Compact Communication on Progress 2016\n                                PDF - 250.4KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2543/global-reporting-initiative-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Global Reporting Initiative (GRI) Index 2015\n                                PDF - 103.4KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3213/detailed-environment-data-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Detailed environmental data 2015\n                                PDF - 163.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2528/full-assurance-statement-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Assurance Statement 2015\n                                PDF - 167.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3212/gsk-response-to-assurance-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                GSK response to assurance 2015\n                                PDF - 61.5KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3366/united-nations-global-compact-communication-on-progress-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                UN Global Compact Communication on Progress 2015\n                                PDF - 122.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2532/2014-global-reporting-initiative-index.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Global Reporting Initiative (GRI) Index 2014\n                                PDF - 267.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2530/2014-detailed-environment-metrics.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Detailed environmental data 2014\n                                PDF - 78.7KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3234/assurance-statement-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Assurance Statement 2014\n                                PDF - 162.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2531/2014-response-to-assurance.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                GSK response to assurance 2014\n                                PDF - 63.6KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2533/united-nations-global-compact-communication-on-progress-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                UN Global Compact Communication on Progress 2014\n                                PDF - 124.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2742/gri-index-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Global Reporting Initiative (GRI) Index 2013\n                                PDF - 86.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2751/detailied-environment-data.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Detailed environmental data 2013\n                                PDF - 386.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2749/assurance-statement.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Assurance Statement 2013\n                                PDF - 541.6KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2743/gsk-response-to-assurance.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                GSK response to assurance 2013\n                                PDF - 91.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2738/gri-index-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Global Reporting Initiative (GRI) Index 2012\n                                PDF - 89.6KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2734/cr-review-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Review 2010\n                                PDF - 1.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2731/cr-review-2007.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Review 2007\n                                PDF - 723.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2728/cr-review-2006.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Corporate Responsibility Review 2006\n                                PDF - 1,009.7KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2724/ehs-report-2004.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Environment, Health and Safety Report 2004\n                                PDF - 3.2MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2721/cr-report-2003.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Environment, Health and Safety Report 2003\n                                PDF - 1.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2720/ehs-report-2002.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/reporting-archive-and-resources/","txt":"\n                                Environment, Health and Safety Report 2002\n                                PDF - 6.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Consumer+Healthcare":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/novamin-the-accidental-curist/","txt":"\n                                Consumer Healthcare\n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Patients+and+consumers":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/novamin-the-accidental-curist/","txt":"\n                                Patients and consumers\n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Products":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/novamin-the-accidental-curist/","txt":"\n                                Products\n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Toothpaste":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/novamin-the-accidental-curist/","txt":"\n                                Toothpaste\n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Innovation":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/how-do-consumer-insights-fuel-our-innovation/","txt":"\n                                Innovation\n                            ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/cookie-policy":{"firstFound":"https://www.gsk.com/en-gb/privacy-notice/","txt":"Cookie Policy","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK uses cookies to improve the experience for visitors to our websites"}},"https://www.gsk.com/en-gb/contact-us/partnerships/business-development/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Business development","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"More about how to contact us if you wish to submit a partnership proposal, have an idea or would just like some more information"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/partnerships/"},"https://www.gsk.com/en-gb/contact-us/partnerships/academia/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Academia","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"More about how to contact us if you wish to submit a partnership proposal, have an idea or would just like some more information"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/partnerships/"},"https://www.gsk.com/en-gb/contact-us/partnerships/neglected-tropical-diseases/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Neglected tropical diseases","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"More about how to contact us if you wish to submit a partnership proposal, have an idea or would just like some more information"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/partnerships/"},"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Pharmacovigilance, Medical Information and Product Quality Complaints - Data Privacy Notice","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Data privacy notice - Pharmacovigilance, medical information and product quality complaints"}},"https://www.gsk.com/en-gb/partnerships/our-approach-to-partnering/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Our approach to partnering","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out about the different ways we collaborate with academia, business, charities and individuals"}},"https://www.gsk.com/en-gb/partnerships/our-areas-of-interest/":{"redirectedFrom":"http://www.gsk.com/en-gb/partnerships/our-areas-of-interest/"},"https://www.gsk.com/en-gb/partnerships/what-our-partners-say/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"What our partners say","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out what our current partners have to say about us"}},"https://www.gsk.com/en-gb/partnerships/business-development/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Business development","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out how we collaborate to discover and develop new vaccines, pharmaceutical and consumer healthcare products"}},"https://www.gsk.com/en-gb/partnerships/business-development/why-work-with-us/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Why work with us","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out about the many advantages to collaborating with us"}},"https://www.gsk.com/en-gb/partnerships/business-development/pharmaceutical-collaborations/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Pharmaceutical collaborations","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out what to expect from us and where our expertise lies in pharmaceutical collaborations"}},"https://www.gsk.com/en-gb/partnerships/business-development/vaccines-collaborations/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Vaccines collaborations","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"See our key topics of interest and get in touch about business development and collaborations"}},"https://www.gsk.com/en-gb/partnerships/business-development/consumer-healthcare-collaborations/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Consumer healthcare collaborations","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We look for commercially viable products supported by strong scientific research across four categories"}},"https://www.gsk.com/en-gb/partnerships/academic-collaborations/":{"redirectedFrom":"https://www.gsk.com/en-gb/partnerships/academic-collaborations/discovery-partnerships-with-academia/"},"https://www.gsk.com/en-gb/partnerships/academic-collaborations/why-work-with-us/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Why work with us","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"Find out how we work with academic institutions, and what we offer in terms of mutual benefits to research partner"},"redirectedTo":"https://www.gsk.com/en-gb/partnerships/academic-collaborations/"},"https://www.gsk.com/en-gb/partnerships/academic-collaborations/discovery-partnerships-with-academia/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Discovery Partnerships with Academia","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"Find out how we work with academic institutions, and what we offer in terms of mutual benefits to research partner"},"redirectedTo":"https://www.gsk.com/en-gb/partnerships/academic-collaborations/"},"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/":{"redirectedFrom":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/exploratory-funding-programme/"},"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/overview/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Overview","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"We are seeking to grow and integrate a research network that will become a new bioelectronics community"},"redirectedTo":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/"},"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/exploratory-funding-programme/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Exploratory funding programme","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"We are seeking to grow and integrate a research network that will become a new bioelectronics community"},"redirectedTo":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/"},"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/bioelectronics-innovation-challenge/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Bioelectronics Innovation Challenge","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"We are seeking to grow and integrate a research network that will become a new bioelectronics community"},"redirectedTo":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/"},"https://www.gsk.com/en-gb/partnerships/venture-funds/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Venture funds","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We are currently providing funding for a number of different ventures"}},"https://www.gsk.com/en-gb/partnerships/neglected-tropical-diseases/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Neglected Tropical Diseases","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Our Open Lab at Tres Cantos, Spain is a specialist collaborative research facility concentrating on neglected tropical diseases"}},"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/":{"redirectedFrom":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/academia/"},"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/business-development/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Business development","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"Submit a partnership proposal, an idea or find more information"},"redirectedTo":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/"},"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/academia/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Academia","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"Submit a partnership proposal, an idea or find more information"},"redirectedTo":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/"},"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/neglected-tropical-diseases/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Neglected tropical diseases","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"Submit a partnership proposal, an idea or find more information"},"redirectedTo":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/"},"https://www.gsk.com/en-gb/terms-of-use/overview/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Overview","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"GSK's corporate website terms of use"},"redirectedTo":"https://www.gsk.com/en-gb/terms-of-use/"},"https://www.gsk.com/en-gb/terms-of-use/global-eula-for-mobile-apps-using-pii/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Global EULA for mobile apps using PII","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"GSK's corporate website terms of use"},"redirectedTo":"https://www.gsk.com/en-gb/terms-of-use/"},"https://www.gsk.com/en-gb/terms-of-use/global-eula-for-mobile-apps-not-using-pii/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Global EULA for mobile apps not using PII","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"GSK's corporate website terms of use"},"redirectedTo":"https://www.gsk.com/en-gb/terms-of-use/"},"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Contract manufacturing","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We provide state-of-the-art facilities in many locations worldwide, including fill-finish capabilities"}},"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/active-pharmaceutical-ingredients/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Active pharmaceutical ingredients","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We provide contract services for traditional small molecule active pharmaceutical ingredients."}},"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/steriles-and-clean-liquids/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Steriles and clean liquids","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Production of liquid dosage forms including syringes, vials and ampoules"}},"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/antibiotics/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Antibiotics","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Contract manufacturing services for the production of cephalosporins and penicillins"}},"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/solid-dose/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Solid dose","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Cost-competitive contract manufacturing for production of a wide range of solid dose products"}},"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/platform-technologies/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Platform technologies","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Our platform technologies optimize the development and manufacturing process"}},"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/inhalation/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Inhalation","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We provide contract manufacturing services for inhalation devices"}},"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/biopharm/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"BioPharm","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Supply chain support for biologic projects from clinical supply to launch and post-launch"}},"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/foams-liquids-and-topicals/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Foams, liquids and topicals","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Contract manufacturing for the production of foams, liquids and dermatological topicals"}},"https://www.gsk.com/en-gb/business-to-business/discovery-and-development-consulting/":{"redirectedFrom":"https://www.gsk.com/en-gb/business-to-business/discovery-and-development-consulting/development-insight/"},"https://www.gsk.com/en-gb/business-to-business/discovery-and-development-consulting/development-insight/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Development insight","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"We are committed to discovering and developing innovative medicines to treat a broad range of diseases"},"redirectedTo":"https://www.gsk.com/en-gb/business-to-business/discovery-and-development-consulting/"},"https://www.gsk.com/en-gb/business-to-business/discovery-and-development-consulting/technical-approaches/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Technical approaches","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"We are committed to discovering and developing innovative medicines to treat a broad range of diseases"},"redirectedTo":"https://www.gsk.com/en-gb/business-to-business/discovery-and-development-consulting/"},"https://www.gsk.com/en-gb/business-to-business/discovery-and-development-consulting/open-innovation/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"Open innovation","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"We are committed to discovering and developing innovative medicines to treat a broad range of diseases"},"redirectedTo":"https://www.gsk.com/en-gb/business-to-business/discovery-and-development-consulting/"},"https://www.gsk.com/en-gb/gsk-employees/":{"firstFound":"https://www.gsk.com/en-gb/sitemap/","txt":"GSK employees","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"This page is intended for GSK employees only"}},"https://www.gsk.com/media/3319/collaboration-science-lab.jpg?anchor=center&mode=crop&quality=90&width=1118&height=710&rnd=131302458250000000":{"firstFound":"https://www.gsk.com/en-gb/partnerships/","txt":"\n                                    \n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Bangladesh"}},"https://www.gsk.com/en-gb/contact-us/worldwide/belarus/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Belarus"}},"https://www.gsk.com/en-gb/contact-us/worldwide/bosnia-herz/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Bosnia & Herz."}},"https://www.gsk.com/en-gb/contact-us/worldwide/cambodia/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Cambodia"}},"https://www.gsk.com/en-gb/contact-us/worldwide/caribbean-islands/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Caribbean Islands"}},"https://www.gsk.com/en-gb/contact-us/worldwide/chile/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Chile"}},"https://www.gsk.com/en-gb/contact-us/worldwide/colombia/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Colombia"}},"https://www.gsk.com/en-gb/contact-us/worldwide/costa-rica/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Costa Rica"}},"https://www.gsk.com/en-gb/contact-us/worldwide/cyprus/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Cyprus"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?p=3":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?p=4":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?p=5":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/behind-the-science/?tag=A+view+from+the+lab":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"A view from the lab","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Access+to+healthcare":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Access to healthcare","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Antibiotics":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Antibiotics","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Apprenticeships":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Apprenticeships","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Apps":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Apps","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Asthma":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Asthma","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Bacteria":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Bacteria","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Bioelectronics":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Bioelectronics","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Biosensors":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Biosensors","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Business+Strategy":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Business Strategy","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Careers":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Careers","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Cell+%26+gene+therapy":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Cell & gene therapy","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Clinical+trials":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Clinical trials","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=COPD":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"COPD","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Dementia":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Dementia","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Ebola":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Ebola","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Flu":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Flu","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Frontline+healthcare":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Frontline healthcare","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=GAVI":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"GAVI","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Health+workers":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Health workers","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Healthcare+Innovation+Award":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Healthcare Innovation Award","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Healthcare+professionals":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Healthcare professionals","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=HIV":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"HIV","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=How+we+do+business":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"How we do business","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Immunisation":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Immunisation","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Immuno-inflammation":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Immuno-inflammation","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Investment":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Investment","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Live+every+breath":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Live every breath","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Lupus":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Lupus","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Malaria":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Malaria","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Manufacturing":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Manufacturing","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Meningitis":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Meningitis","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Neuroscience":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Neuroscience","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Newborn+health":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Newborn health","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Our+people":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Our people","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Partnerships":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Partnerships","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Patients":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Patients","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Pharmaceuticals":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Pharmaceuticals","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Polio":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Polio","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Rabies":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Rabies","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Research":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Research","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Research+and+development":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Research and development","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Respiratory":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Respiratory","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Salford+Lung+Study":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Salford Lung Study","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Save+the+Children":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/?tag=Save+the+Children"},"https://www.gsk.com/en-gb/behind-the-science/?tag=Science":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Science","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Severe+asthma":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Severe asthma","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Shopper+science":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Shopper science","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=STEM":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"STEM","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Sustainability":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Sustainability","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Technology":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Technology","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Transparency":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Transparency","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Tropical+diseases":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Tropical diseases","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Vaccines":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Vaccines","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Volunteering":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Volunteering","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/en-gb/behind-the-science/?tag=Women+in+science":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/tags-a-z/","txt":"Women in science","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."}},"https://www.gsk.com/media/3814/global-pain-index-2017-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/voltaren/","txt":"Download the latest Global Pain Index report","status":"done","statusCode":200,"results":{"video":[]}},"http://www.gsk.com/en-gb/research/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/inside-the-open-lab/","txt":"Find out more about our approach and what we're working on ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products through to life-saving medicines and vaccines"},"redirectedTo":"https://www.gsk.com/en-gb/research/"},"https://www.gsk.com/media/4904/gsk-5500-ntd-factsheet-amend-p1_mp_2018-06-13.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-little-pill-that-could-one-medicine-taking-on-two-neglected-diseases/","txt":"\n                        Neglected tropical diseases factsheet 2018\n                        PDF - 1.1MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4903/3562_gsk_ntd-infographic_p11_horiz_final_130618.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-little-pill-that-could-one-medicine-taking-on-two-neglected-diseases/","txt":"\n                        Infographic: our albendazole donation programme\n                        PDF - 1.2MB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-welcomes-launch-of-the-uk-government-s-life-sciences-sector-deal/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/how-genomics-is-driving-a-new-era-of-drug-discovery/","txt":"we announced a new £40 million investment in genomic research","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New £40 million GSK investment in genomic research"}},"https://www.gsk.com/media/4178/enable-survey-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/lupus-the-search-for-a-cure-continues/","txt":"\n                EnABLE Survey – Discrepancies in SLE management: barriers to improved care PDF - 733.3KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/new-multi-country-survey-reveals-need-for-improved-awareness-around-long-term-impact-and-appropriate-use-of-corticosteroids-in-sle-management/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/lupus-the-search-for-a-cure-continues/","txt":"Find out more about the survey and findings","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Results from EnABLE highlight an opportunity for increased awareness on appropriate corticosteroid use and a more proactive approach to the management of SLE."}},"https://www.gsk.com/media/3708/asthma-control-test-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/giving-a-bit-back-christine-s-experience-of-clinical-research/","txt":"\n                The Asthma Control Test infographic PDF - 265.7KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3668/gsk-international-survey-results.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/win-for-meningitis-harnessing-the-power-of-inspirational-images-to-create-a-win-for-disease-prevention/","txt":"\n                GSK international survey results PDF - 1.3MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3732/impact-awards-2017-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/supporting-community-health-across-the-uk/","txt":"\n                GSK Impact Awards 2017 infographic PDF - 271.3KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1509/copd-infographic.jpg":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/helping-patients-with-respiratory-disease/","txt":"chronic obstructive pulmonary disease (COPD)","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/1797/understanding-asthma.jpg":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/helping-patients-with-respiratory-disease/","txt":"people suffer from asthma","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/media/press-releases/gsk-sets-out-further-steps-to-address-emerging-global-health-security-challenges/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/taking-action-to-stop-pneumonia/","txt":"we have committed to supply our essential vaccines to internationally recognised civil society organisations (CSOs)","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK will set out a series of steps to further address emerging global health challenges"}},"http://www.gsk.com/en-gb/behind-the-science/innovation/targeting-the-immune-system-through-open-innovation/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/getting-on-target-in-autoimmune-diseases/","txt":"Immunology Network","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"A functioning immune system is crucial to our health - but what is its role beyond such things as keeping colds at bay and fighting infections?"},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/innovation/targeting-the-immune-system-through-open-innovation/"},"http://www.gsk.com/en-gb/behind-the-science/patients-consumers/an-everyday-world-first-in-clinical-trials/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/scientists-or-detectives-seeking-new-clues-in-copd/","txt":"\n                                    \n        \n            \n                \n            \n            Howard Irvine, a patient with COPD\n        \n\n                    ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS)."},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/an-everyday-world-first-in-clinical-trials/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-expands-graduated-approach-to-patents-and-intellectual-property-to-widen-access-to-medicines-in-the-world-s-poorest-countries/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/helping-to-change-the-world/","txt":"graduated approach to patents and intellectual property","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has a deep commitment to improving healthcare by developing innovative new medicines and widening access to them around the world."}},"https://www.gsk.com/en-gb/media/press-releases/european-agency-endorses-antiseptic-gel-developed-through-gsk-and-save-the-children-partnership-for-newborn-umbilical-cord-infections-in-developing-countries/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/helping-to-change-the-world/","txt":"European regulators endorsed an antiseptic gel","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Major milestone for the GSK and Save the Children partnership and its mission to help save the lives of children in the world’s poorest communities"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-public-tender-agreement-with-botswana-ministry-of-health-for-dolutegravir/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/helping-to-change-the-world/","txt":"ViiV Healthcare agreement with the Botswana Ministry of Health","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Agreement supports the first ‘Treat All’ programme for HIV in sub-Saharan Africa, where 70% of people with HIV live"}},"http://www.gsk.com/en-gb/behind-the-science/?tag=Save+the+Children":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/","txt":"our partnership with Save the Children","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs."},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/?tag=Save+the+Children"},"https://www.gsk.com/media/3180/nasa.jpg?center=0.18047337278106509,0.62666666666666671&mode=crop&quality=90&width=960&height=0&rnd=131465858930000000":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/from-microscope-to-telescope-and-beyond-exploring-with-nasas-casis/","txt":"\n                    \n                    \n                        \n                    \n                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-the-amr-benchmark/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/turning-the-tide-on-antibiotic-resistance/","txt":"Read here ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The new AMR Benchmark provides a useful analysis of the industry’s contribution to addressing the severe public health threat of antimicrobial resistance"}},"https://www.gsk.com/media/3291/the-worlds-first-candidate-vaccine-for-malaria.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/vaccines-coming-in-from-the-cold/","txt":"\n                The world's first candidate vaccine for malaria PDF - 570.4KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3292/delivering-gsks-vaccines.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-value-of-vaccination/","txt":"\n                Delivering GSK's vaccines to the developing world PDF - 432.3KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3293/gsks-contribution.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-value-of-vaccination/","txt":"\n                GSK's contribution to vaccination throughout life PDF - 493.5KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3466/benefits-of-vaccination.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-value-of-vaccination/","txt":"\n                Benefits of vaccination infographic PDF - 1.4MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2419/mobile-at-desk.jpg?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131375155710000000":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/the-power-of-partnerships-transforming-vaccine-coverage-in-mozambique/","txt":"\n                    \n                    \n                        \n                    \n                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/3372/50-years-rd-in-gsk.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/bioelectronics-at-sxsw-2016/","txt":"innovation (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/infographic-impacthealthcare/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/delivering-support-for-the-most-vulnerable-communities/","txt":"View infographic animation","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"http://www.gsk.com/en-gb/responsibility/health-for-all/hiv-aids-and-viiv-healthcare/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/telegraph-article-science-hasnt-answered-all-the-questions-on-hiv/","txt":"HIV, AIDS and healthcare ","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/responsibility/health-for-all/hiv-aids-and-viiv-healthcare/"},"http://www.gsk.com/en-gb/about-us/save-the-children-partnership/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/igniting-a-revolution-in-scientific-research-and-development/","txt":"Save the Children partnership ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"How we're working with Save the Children to help save the lives of 1 million of the world's most vulnerable children"},"redirectedTo":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/"},"https://www.gsk.com/media/3481/inspiring-young-scientists-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/see-how-gsk-supports-stem-in-the-real-world/","txt":"\n                inspiring young scientists infographic PDF - 738.9KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2526/gsk-responsible-business-supplement-2015-march-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/turning-waste-into-a-resource/","txt":"\n                Responsible Business Supplement 2016 PDF - 61.5KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3471/flu-awareness.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/helping-to-protect-yourself-against-flu/","txt":"\n                flu awareness PDF - 1.4MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/where-do-you-start-when-developing-a-new-medicine/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/outgrowing-asthma-rooting-out-the-reasons-for-asthma-remission/","txt":"Open Targets","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A pioneering public-private research initiative between GSK, the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute is to harness the power of ‘big data’ and genome sequencing to improve the success rate for discovering new medicines."}},"http://www.gsk.com/en-gb/behind-the-science/innovation/cell-and-gene-therapy-a-new-era-of-medicine/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/experimental-medicine/","txt":"Cell and gene therapy - a new era of medicine ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?"},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/innovation/cell-and-gene-therapy-a-new-era-of-medicine/"},"https://www.gsk.com/media/3289/tedmed-olafur-eliasson.jpg?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131375155720000000":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-an-interview-with-curator-christine-mcnab/","txt":"\n                    \n                    \n                        \n                    \n                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/2418/mauro_perucchetti_hero.jpg?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131375155710000000":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-an-interview-with-curator-christine-mcnab/","txt":"\n                    \n                    \n                        \n                    \n                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/3273/jonas-salk-s-vision-by-glen-wexler.jpg?center=0.56666666666666665,0.49833333333333335&mode=crop&quality=90&width=960&height=0&rnd=131465856030000000":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-art-inspired-by-vaccination/","txt":"\n                    \n                    \n                        \n                    \n                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/3288/flowers-the-beauty-of-vaccines-by-vik-muniz.jpg?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131375155720000000":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-art-inspired-by-vaccination/","txt":"\n                    \n                    \n                        \n                    \n                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"http://www.gsk.com/en-gb/research/rd-locations/uk/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/targeting-the-immune-system-through-open-innovation/","txt":"R&D facility in Stevenage","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/research/rd-locations/uk/"},"https://www.gsk.com/media/2989/ebola-vaccine-journey-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/our-humanitarian-response-to-the-ebola-outbreak/","txt":"\n                Ebola Vaccine Journey Infographic PDF - 1.2MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/%7BlocalLink:b6c9ef0b-35bc-434e-97fb-7ca10e66ddea%7D":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/why-our-transaction-with-novartis-is-different/","txt":"three core businesses","status":"done","statusCode":400,"results":{"video":[],"title":{}}},"https://www.gsk.com/%7BlocalLink:4d281831-2e10-4451-ae54-6b968deb9d6c%7D":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/why-our-transaction-with-novartis-is-different/","txt":"the transaction","status":"done","statusCode":400,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-first-phase-1-trial-results-of-a-candidate-ebola-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/ebola-vaccine-rd/","txt":"Read the statement here","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First results from a small phase 1 trial published today in the New England Journal of Medicine show that a GSK/NIH Ebola candidate vaccine was well-tolerated and produced an immunological response in each of the 20 healthy adult volunteers in the USA who received it."}},"https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/forming-public-partnerships/","txt":"Read more here","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Unprecedented international consortium assembled to accelerate collaborative multi-site trials of candidate Ebola vaccine"}},"https://www.gsk.com/media/2537/pulse-impact-annual-report-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/a-healthier-future-for-africa/","txt":"\n                PULSE Volunteer Partnership Annual Impact Report 2015 PDF - 7.9MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"http://www.gsk.com/en-gb/behind-the-science/innovation/fluorescent-bacteria-nowhere-to-hide/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/bacteria-friends-or-foes/","txt":"bacteria and micro-organisms","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"How can a new approach known as “bacteria-instructed synthesis” help to tackle bacterial infection?"},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/innovation/fluorescent-bacteria-nowhere-to-hide/"},"http://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/bacteria-friends-or-foes/","txt":"What are we working on? ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"In the past 25 years, a steady increase in bacteria immune to antibiotics has become a serious threat to global public health"},"redirectedTo":"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/"},"https://www.gsk.com/en-gb/media/press-releases/innovative-public-private-collaboration-launches-to-tackle-antibiotic-research/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/neuroscience-on-the-brain/","txt":"Innovative Medicines Initiative","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline and AstraZeneca today welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of effective antibiotics."}},"http://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/neuroscience-on-the-brain/","txt":"Ten years from now, how will we fight disease? ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"A new scientific field that could one day result in a novel class of miniaturised, implantable device medicines"},"redirectedTo":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/"},"https://www.gsk.com/en-gb/contact-us/worldwide/colombia/pol%C3%ADtica-ambiental-y-pol%C3%ADtica-de-protecci%C3%B3n-de-datos-de-gsk-colombia/":{"redirectedFrom":"http://www.gsk.com/en-gb/contact-us/worldwide/colombia/pol%C3%ADtica-ambiental-y-pol%C3%ADtica-de-protecci%C3%B3n-de-datos-de-gsk-colombia/"},"https://www.gsk.com/media/4005/politica-de-datos-gsk-colombia-sa-y-gsk-consumer.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/colombia/pol%C3%ADtica-ambiental-y-pol%C3%ADtica-de-protecci%C3%B3n-de-datos-de-gsk-colombia/","txt":"\n                        Política de Protección de Datos de GSK\n                        PDF - 208.3KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1411/industry-declaration-on-combating-antimicrobial-resistance.pdf":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/","txt":"groundbreaking declaration (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1412/industry-roadmap-for-progress-on-amr.pdf":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/","txt":" industry “Roadmap\" (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/research/what-we-are-working-on/respiratory-research/":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/","txt":"\n                        \n                                \n                        \n                            Respiratory research\n                                                    Building on our 45 year heritage in respiratory research, we remain relentless in our pursuit to improve the outcomes for patients with asthma and COPD\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Building on our 45 year heritage in respiratory research, we remain relentless in our pursuit to improve the outcomes for patients with asthma and COPD"}},"https://www.gsk.com/en-gb/about-us/governance/global-compliance/complying-with-the-uk-corporate-governance-code/":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"Complying with the UK corporate governance code","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK's 2015 Annual Report sets out details of the audit contract tender process undertaken during 2016."}},"https://www.gsk.com/en-gb/about-us/governance/global-compliance/new-york-stock-exchange-rules/":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"New York Stock Exchange rules","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosing the differences between GSK's domestic corporate governance practices and those applying to US domestic issuers"}},"https://www.gsk.com/en-gb/about-us/governance/global-compliance/california-compliance-law/":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"California compliance law","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Adopting a Comprehensive Compliance Program in accordance with the US Department of Health and Human Services"}},"https://www.gsk.com/media/4897/binding-corporate-rules-policy_bulgarian.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Bulgarian\n                        PDF - 146.6KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4879/binding-corporate-rules-policy_croatian.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Croatian\n                        PDF - 133.4KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4878/binding-corporate-rules-policy_czech.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Czech\n                        PDF - 142.6KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4906/binding-corporate-rules-policy_danish.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Danish\n                        PDF - 79.7KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4898/binding-corporate-rules-policy_estonian.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Estonian\n                        PDF - 75.1KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4881/binding-corporate-rules-policy_finnish.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Finnish\n                        PDF - 76.2KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4882/binding-corporate-rules-policy_french.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        French\n                        PDF - 83.5KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4910/binding-corporate-rules-policy_german.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        German\n                        PDF - 79.5KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4873/binding-corporate-rules-policy_greek.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Greek\n                        PDF - 185.5KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4880/binding-corporate-rules-policy_hungarian.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Hungarian\n                        PDF - 170.0KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4872/binding-corporate-rules-policy_italian.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Italian\n                        PDF - 79.0KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4899/binding-corporate-rules-policy_latvian.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Latvian\n                        PDF - 153.8KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4900/binding-corporate-rules-policy_lithuanian.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Lithuanian\n                        PDF - 146.8KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4907/binding-corporate-rules-policy_maltese.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Maltese\n                        PDF - 162.9KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4877/binding-corporate-rules-policy_dutch.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Netherlands\n                        PDF - 78.9KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4876/binding-corporate-rules-policy_polish.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Polish\n                        PDF - 146.3KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4874/binding-corporate-rules-policy_portuguese.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Portuguese\n                        PDF - 75.9KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4889/public_policy_on_gsk_s_bcrs-15may2018_romanian.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Romanian\n                        PDF - 140.5KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4875/binding-corporate-rules-policy_slovak.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Slovak\n                        PDF - 163.4KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4890/public_policy_on_gsk_s_bcrs-15may2018_slovenian.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Slovenian\n                        PDF - 129.8KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4891/public_policy_on_gsk_s_bcrs-15may2018_spanish.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Spanish\n                        PDF - 79.6KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4892/public_policy_on_gsk_s_bcrs-15may2018_swedish.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"\n                        Swedish\n                        PDF - 78.0KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4241/halbarron.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/dr-hal-barron/","txt":"download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/1183/manvinder-singh-vindi-banga-gsk.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/manvinder-singh-vindi-banga/","txt":"download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/3792/33641498076_e0ffc32128_o.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/simon-dingemans/","txt":"download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/1180/sir-philip-hampton-gsk.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/sir-philip-hampton/","txt":"download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/3900/dr-laurie-glimcher-independent-non-executive-director.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/dr-laurie-glimcher/","txt":"download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/1182/urs-rohner.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/urs-rohner/","txt":"download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/1166/dr-vivienne-cox-gsk.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/dr-vivienne-cox/","txt":"download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/3631/emma-walmsley-1.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/emma-walmsley/","txt":" download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/2500/emma-walmsley-contract-of-service.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/directors-contracts/","txt":"Download Emma Walmsley's contract of service (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3750/simon-dingemans-contract-of-service.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/directors-contracts/","txt":"Download Simon Dingemans' contract of service (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4539/hal-barron-contract-of-service.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/directors-contracts/","txt":"Download Dr Hal Barron's contract of service (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1174/judy-lewent-gsk.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/judy-lewent/","txt":"download image ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/home/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-call-for-developing-country-innovations-to-enter-1-million-award/","txt":"www.gsk.com/about-us/","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The homepage of the GSK global corporate website"}},"https://www.gsk.com/media/1173/dr-jesse-goodman-gsk.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/dr-jesse-goodman/","txt":"download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/about-us/corporate-partnerships/save-the-children-partnership/":{"redirectedFrom":"http://www.gsk.com/en-gb/about-us/corporate-partnerships/save-the-children-partnership/"},"http://www.gsk.com/en-gb/sitemap/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-partnerships/save-the-children-partnership/","txt":"sitemap","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{}},"redirectedTo":"https://www.gsk.com/en-gb/sitemap/"},"https://www.gsk.com/media/1175/lynn-elsenhanns-gsk.jpg":{"firstFound":"https://www.gsk.com/en-gb/about-us/board-of-directors/lynn-elsenhans/","txt":"download image","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"http://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/ahsiya-business-operations-usa/","txt":"PULSE","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"See how our employees devote their time and expertise to create positive change in communities around the world"},"redirectedTo":"https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/"},"https://www.gsk.com/en-gb/careers/careers-search/?bu=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"\n                            business operations \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/claire/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/keith-engineering-uk/","txt":"\n                            \n                                    \n                            \n                            \n                                    Claire, Manufacturing operations and quality (vaccines), Belgium\n                                                                    \"After a few years of working in aerospace Research and Development (R&D), I just felt like something was missing.\"\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"After a few years of working in aerospace Research and Development (R&D), I just felt like something was missing.\""}},"https://www.gsk.com/en-gb/careers/meet-our-people/hewan-commercial-management-turkey/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/keith-engineering-uk/","txt":"\n                            \n                                    \n                            \n                            \n                                    Hewan, Commercial Management, Turkey\n                                                                    \"Since joining the GSK Future Leaders Programme (FLP) three years ago, I’ve grown in professional maturity very quickly.\"\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"Since joining the GSK Future Leaders Programme (FLP) three years ago, I’ve grown in professional maturity very quickly.\""}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Medical%20OR%20Physician","txt":"\n                        Medical OR Physician \n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Medical%20OR%20Physician&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Medical%20OR%20Physician","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/students-and-apprentices":{"redirectedFrom":"http://www.gsk.com/en-gb/careers/students-and-apprentices"},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&+Government+Affairs&r=usa&r=gbr%2cusa&city=&city=&et=&et=&prog=graduate&prog=graduate&cl=8680&bu":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/communications-and-government-affairs/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2C+Safety+%26+Sustainability&bu=&r=gbr&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/environment-health-safety-and-sustainability/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel,chn,gbr,usa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/finance/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/merve-human-resources-turkey/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/human-resources/","txt":"\n                                    \n        \n            \n                \n            \n            Merve MacitHuman resourcesTurkey\n        \n\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"There were two main reasons why I chose GSK. The first was because of the quality of the Future Leaders programme. The second reason was that I felt GSK had the best cultural fit with my own values."}},"https://www.gsk.com/en-gb/careers/meet-our-people/carolina-human-resources-argentina/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/human-resources/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"I’m Carolina, I studied Human Resources at university and I first joined GSK on an internship whilst at university."}},"https://www.gsk.com/en-gb/careers/meet-our-people/alvin-hr-singapore/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/human-resources/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"Now I’m one year into my Future Leaders Programme (FLP) experience, I can say it’s been a steep learning curve, but I’ve enjoyed every minute.\""}},"https://www.gsk.com/en-gb/careers/careers-search/?q=human+resources&cl=8680&bu=&r=&city=&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/human-resources/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/ben-procurement-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/procurement/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"I’m Ben and I’m on the Procurement Future Leaders programme, based at GSK House. Deciding to work for GSK was a natural choice for me, they are a pharmaceutical company who proudly lead the way with their culture and values."}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/procurement/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/clare-technology-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/technology/","txt":"\n                                    \n        \n            \n                \n            \n            ClareTechnologyUK\n        \n\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"I am an Agile Coach in Consumer Healthcare Tech and I studied Biochemistry at the University of Bath."}},"https://www.gsk.com/en-gb/careers/meet-our-people/jeffery-technology-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/technology/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"I’m Jeffery, I studied Biomedical Science at Nottingham Trent University and graduated three years ago."}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/technology/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/susie-commercial-management-consumer-south-korea/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/commercial-management-consumer-healthcare/","txt":"\n                                    \n        \n            \n                \n            \n            SusieCommercial management (Consumer)South Korea\n        \n\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"I’m Susie, from South Korea. I always liked the fact that GSK has a lot of original products that contribute to people’s lives, products that are very popular in Korea."}},"https://www.gsk.com/en-gb/careers/meet-our-people/preethi-commercial-management-consumer-india/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/commercial-management-consumer-healthcare/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"My name is Preethi and I joined GSK in 2014, on the Future Leaders programme in India. It's nice working at GSK because they're rooted so much in science and it feels like there's a clear association with what I studied at undergraduate level."}},"https://www.gsk.com/en-gb/careers/meet-our-people/rehanul/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/commercial-management-consumer-healthcare/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"When I was making decisions about my career, what I wanted most was to do meaningful work that would help to improve people’s lives.\""}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing%20and%20communications&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/commercial-management-consumer-healthcare/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/alicia/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/engineering/","txt":"\n                                    \n        \n            \n                \n            \n            Alicia Sanchez EspinEngineerUK\n        \n\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"At the moment, although it is my first rotation, I have been sent to Panama. It is a huge project and it is really challenging.\""}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/engineering/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/kiran-commercial-management-pharmaceuticals-india/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/commercial-management-pharmaceuticals/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"My name is Kiran, I'm from India and I joined the Future Leaders programme in 2015. I’m a graduate in mechanical engineering, but I’m on the Global Pharma Commercial Future Leaders programme."}},"https://www.gsk.com/en-gb/careers/meet-our-people/aaron-commercial-management-pharmaceuticals-uk/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/commercial-management-pharmaceuticals/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"I’m Aaron. I’m from the US and grew up in York, Pennsylvania. I work in ViiV Healthcare, which is a global specialist HIV company, majority owned by GSK."}},"https://www.gsk.com/en-gb/careers/meet-our-people/summer/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/commercial-management-pharmaceuticals/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"Honestly, this path took me a little by surprise. Throughout my undergraduate and master’s degree in biochemistry, I had accumulated a lot of lab experience – it’s what I knew.\""}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/supply-chain/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing%20and%20supply&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/manufacturing-operations-and-quality-vaccines/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Analytical+Chemistry+Microbiology+pharmaceutical+Science&r=&city=&et=&prog=graduate&cl=8680&ps=100":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/manufacturing-science/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=drug+design+and+selection&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/drug-design-and-selection/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/dee/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/product-development-and-supply/","txt":"\n                                    \n        \n            \n                \n            \n            Dee TressFuture Leaders ProgrammeUK\n        \n\n                    ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Meet Dee - a mechanical engineering graduate on the Future Leaders Programme who is helping to develop user-friendly devices to administer treatments safely."},"redirectedTo":"https://www.gsk.com/en-gb/careers/meet-our-people/dee-rd-uk/"},"https://www.gsk.com/en-gb/careers/careers-search/?q=Clinical+programming&r=&city=&et=&prog=graduate&cl=8680&ps=100":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/clinical-programming/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/regulatory-affairs/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"http://www.gsk.com/en-gb/contact-us/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/regulatory-affairs/","txt":"\n                \n                        \n                \n                \n                        Contact us\n                                            Whether you're a customer, job seeker, health professional or an investor, you can fin the best way to contact us here.\n                \n            ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Whether you’re a customer, job seeker, health professional or an investor, find the best way to contact us"},"redirectedTo":"https://www.gsk.com/en-gb/contact-us/"},"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/research-and-development-consumer-healthcare/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/andres/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/research-and-development-vaccines/","txt":"\n                                    \n        \n            \n                \n            \n            Andres MaldonadoR&D (Vaccines)\n        \n\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"When I finished my doctoral studies in bio-engineering, my next step wasn’t clear to me. I felt I had achieved my goals within academia and I knew I wanted to transition into a corporate environment.\""}},"https://www.gsk.com/en-gb/careers/meet-our-people/juan/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/research-and-development-vaccines/","txt":"Read more ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"When I first started looking for career opportunities, I considered various industries – consulting, the public sector and pharmaceuticals.\""}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research%20and%20development&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/research-and-development-vaccines/","txt":"Search for programme","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"http://www.gsk.com/en-gb/careers/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/faqs/","txt":"GSK","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"We are a  global company delivering billions of healthcare products a year. Choose your path."},"redirectedTo":"https://www.gsk.com/en-gb/careers/"},"https://www.gsk.com/en-gb/about-us/what-we-do/vaccines/":{"redirectedFrom":"http://www.gsk.com/en-gb/about-us/what-we-do/vaccines/"},"https://www.gsk.com/en-gb/responsibility/our-behaviour/ethical-conduct/":{"redirectedFrom":"http://www.gsk.com/en-gb/responsibility/our-behaviour/ethical-conduct/"},"https://www.gsk.com/media/4066/pulse-and-global-volunteering-2016-annual-impact-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/100-pulse-volunteers-at-save-the-children/","txt":"\n                PULSE Volunteer Partnership Annual Impact Report 2016 PDF - 10.6MB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","txt":"PULSE project","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"See how our employees devote their time and expertise to create positive change in communities around the world"}},"http://www.gsk.com/en-gb/behind-the-science/our-people/from-academia-to-the-pharmaceutical-industry-one-year-on/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/monica-rd-uk/","txt":"\n                \n                        \n                \n                \n                        From academia to the pharmaceutical industry - one year on\n                                            Professor Ronald Dahl joined GSK as a Global Medical Expert in the GSK Global Respiratory Franchise. Here he talks about his career journey one year on and how the pharmaceutical industry continues to evolve.\n                \n            ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Professor Ronald Dahl recently joined GSK as a Global Medical Expert in the GSK Global Respiratory Franchise."},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/our-people/from-academia-to-the-pharmaceutical-industry-one-year-on/"},"http://www.gsk.com/en-gb/behind-the-science/our-people/from-academia-to-industry-a-new-challenge/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/monica-rd-uk/","txt":"\n                \n                        \n                \n                \n                        From academia to industry: a new challenge\n                                            Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry.\n                \n            ","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry."},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/our-people/from-academia-to-industry-a-new-challenge/"},"https://www.gsk.com/en-gb/behind-the-science/innovation/how-smart-is-your-inhaler":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/lindsay-rd-uk/","txt":"respiratory inhalers","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide."}},"https://www.gsk.com/en-gb/careers/meet-our-people/debleena-marketing-and-communications-india/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/larry-marketing-and-communications-us/","txt":"\n                        \n                                \n                        \n                            Debleena, Marketing and communications, India\n                                                    Debleena leads marketing of our Sensodyne toothpaste and toothbrushes in India.  She explains why the science and values-led nature of the company is important to her, as is the global nature of the company for career development.\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Debleena leads marketing of our Sensodyne toothpaste and toothbrushes in India.  She explains why the science and values-led nature of the company is important to her, as is the global nature of the company for career development."}},"https://www.gsk.com/en-gb/careers/meet-our-people/tooba/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/phon/","txt":"\n                        \n                                \n                        \n                            Tooba, Commercial management, Pakistan\n                                                    \"The programme has helped me develop my personal skills through Development Workshops. I love that all the trainees in the region come together and we learn so much from each other.\"\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"The programme has helped me develop my personal skills through Development Workshops. I love that all the trainees in the region come together and we learn so much from each other.\""}},"http://www.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-with-novartis-to-acquire-full-ownership-of-consumer-healthcare-business/","txt":"www.gsk.com","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"The homepage of the GSK global corporate website"},"redirectedTo":"https://www.gsk.com/"},"https://www.gsk.com/en-gb/settings/global-country-feed/africa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-major-three-part-transaction-with-novartis/","txt":"about us section","status":"done","statusCode":404,"results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-fourth-quarter-2014/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2014","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers 2014 core EPS of 95.4p (-1% CER excluding divestments) and dividend of 80 pence per share (+3%)"}},"https://www.gsk.com/media/2158/q4-2014-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q4 2014 results announcement\n                                                        PDF - 1.3MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2162/q4-2014-analyst-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q4 2014 analyst presentation\n                                                        PDF - 828.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2156/q4-2014-analyst-presentation-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q4 2014 analyst presentation transcript\n                                                        PDF - 215.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2159/q4-2014-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q4 2014 actual growth schedules\n                                                        PDF - 158.6KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2161/q4-2014-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q4 2014 US dollar translation\n                                                        PDF - 136.0KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2157/q4-2014-pre-announcement-aide-memoire.pdf":{"redirectedFrom":"https://www.gsk.com/media/2149/restated-finanical-information.xlsx"},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-third-quarter-2014/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2014","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces Q3 core EPS of 27.9p +5% CER excluding divestments and dividend of 19 pence per share"}},"https://www.gsk.com/media/2152/q3-2014-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q3 2014 results announcement\n                                                        PDF - 698.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2155/q3-2014-analyst-webcast-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q3 2014 analyst webcast transcript\n                                                        PDF - 218.1KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2154/q3-2014-launch-metrics-and-pipeline-progress.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q3 2014 launch metrics and pipeline progress\n                                                        PDF - 150.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2149/restated-finanical-information.xlsx":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q3 2014 restated finanical Information\n                                                        XLSX - 51.2KB\n                                                        \n                                                    ","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/2157/q4-2014-pre-announcement-aide-memoire.pdf"},"https://www.gsk.com/media/2151/q3-2014-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q3 2014 actual growth schedules\n                                                        PDF - 163.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2153/q3-2014-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q3 2014 US dollar translation\n                                                        PDF - 143.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2150/q3-2014-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q3 2014 pre announcement aide memoire\n                                                        PDF - 980.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-second-quarter-2014/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2014","txt":"\n                            Results announcement for the second quarter 2014\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers Q2 2014 turnover £5.6 billion (-4%) and core EPS 19.1p (-12%) on ex-divestment basis (both CER). Q2 dividend 19p (+6%)."}},"https://www.gsk.com/media/2146/q2-2014-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q2 2014 results announcement\n                                                        PDF - 266.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2144/q2-2014-analyst-webcast-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q2 2014 analyst webcast transcript\n                                                        PDF - 106.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2145/q2-2014-launch-metrics-and-pipeline-progress.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q2 2014 launch metrics and pipeline progress\n                                                        PDF - 115.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2143/q2-2014-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q2 2014 actual growth schedules\n                                                        PDF - 164.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2147/q2-2014-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q2 2014 US dollar translation\n                                                        PDF - 141.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2148/q2-2014-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q2 2014 pre announcement aide memoire\n                                                        PDF - 978.2KB\n                                                        \n                                                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-first-quarter-2014/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2014","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Q1 turnover £5.6 billion, -2% (CER) on an ex-divestment* basis."}},"https://www.gsk.com/media/2141/q1-2014-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q1 2014 results announcement\n                                                        PDF - 202.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2138/q1-2014-analyst-webcast-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q1 2014 analyst webcast transcript\n                                                        PDF - 143.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2139/q1-2014-launch-metrics-and-pipeline-progress.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q1 2014 launch metrics and pipeline progress\n                                                        PDF - 116.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2137/q1-2014-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q1 2014 actual growth schedules\n                                                        PDF - 86.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2142/q1-2014-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q1 2014 US dollar translation\n                                                        PDF - 80.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2140/q1-2014-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q1 2014 pre announcement aide memoire\n                                                        PDF - 932.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-fourth-quarter-2015/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2015","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers further progress against strategy with 2015 sales of £24 billion (+6%), core EPS 75.7p (-15%) and total EPS 174.3p, +>100% CER\n\n2016 core EPS percentage growth expected to reach double digits (CER"}},"https://www.gsk.com/media/2545/full-year-2015-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q4 2015 results announcement\n                                                        PDF - 1.7MB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2184/fy-2015-results-analyst-slides-v1-1.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q4 2015 analyst slide presentation\n                                                        PDF - 970.6KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2183/fy-2015-analysts-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q4 2015 analyst presentation transcript\n                                                        PDF - 271.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2190/full-year-2015-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q4 2015 actual growth schedules\n                                                        PDF - 125.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2187/q4-2015-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q4 2015 US dollar translation\n                                                        PDF - 129.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2546/full-year-2015-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q4 2015 pre announcement aide memoire\n                                                        PDF - 916.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-third-quarter-2015/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2015","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Q3 sees continued progress in execution of Group strategy\nSales of £6.1 billion (+11% CER) and core EPS of 23.0p (-13% CER)"}},"https://www.gsk.com/media/2181/q3-2015-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2015 results announcement\n                                                        PDF - 831.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2182/q3-2015-results-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2015 results transcript\n                                                        PDF - 120.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2179/q3-2015-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2015 actual growth schedules\n                                                        PDF - 126.6KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2180/q3-2015-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2015 US dollar translation\n                                                        PDF - 128.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2178/q3-2015-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q3 2015 pre announcement aide memoire\n                                                        PDF - 933.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-second-quarter-2015/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2015","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers Q2 Group sales of £5.9 billion +7% CER and core EPS of 17.3p (flat CER) in first full quarter of performance since transaction"}},"https://www.gsk.com/media/2171/q2-2015-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q2 2015 results announcement\n                                                        PDF - 1.7MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2174/q2-2015-analyst-slide-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q2 2015 analyst slide presentation\n                                                        PDF - 437.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2175/q2-2015-results-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q2 2015 results transcript\n                                                        PDF - 201.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2172/q2-2015-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q2 2015 actual growth schedules\n                                                        PDF - 128.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2173/q2-2015-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q2 2015 US dollar translation\n                                                        PDF - 129.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2170/q2-2015-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q2 2015 pre announcement aide memoire\n                                                        PDF - 928.6KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-first-quarter-2015/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2015","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK reports Q1 sales of £5.6 billion; Core EPS of 17.3p (-16%) CER"}},"https://www.gsk.com/media/2168/q1-2015-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q1 2015 results announcement\n                                                        PDF - 1.1MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2169/q1_2015_results_transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q1 2015 results transcript\n                                                        PDF - 357.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2177/q1-2015-announcement-sales-tables.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q1 2015 actual growth schedules announcement\n                                                        PDF - 70.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2176/q1-2015-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q1 2015 US dollar translation\n                                                        PDF - 75.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2164/q1-2015-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                                                        Q1 2015 pre announcement aide memoire\n                                                        PDF - 873.9KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-fourth-quarter-2016/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2016","txt":"\n                            View summary of our results\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"View full Q4 2016 Results (PDF)"}},"https://www.gsk.com/media/3461/q4-2016-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q4 2016 results announcement\n                                                        PDF - 1.8MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3459/q4-2016-analyst-slide-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q4 2016 analyst slide presentation\n                                                        PDF - 606.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3462/q4-2016-analysts-call-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q4 2016 results transcript\n                                                        PDF - 76.6KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/3518/q4-results-infographics_final_landscape.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q4 2016 results highlights infographic\n                                                        PDF - 895.6KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3458/q4-2016-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q4 2016 US dollar translation\n                                                        PDF - 128.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3460/q4-2016-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q4 2016 actual growth schedules\n                                                        PDF - 132.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2496/2016-q4-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q4 2016 pre announcement aide memoire\n                                                        PDF - 1,020.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-third-quarter-2016/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2016","txt":"\n                            View summary of our results\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers sales growth, improved cash flow and sustained pipeline progression in Q3."}},"https://www.gsk.com/media/2206/q3-2016-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q3 2016 results announcement\n                                                        PDF - 2.6MB\n                                                        \n                                                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/2208/q3-2016-highlights.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q3 2016 results highlights infographic\n                                                        PDF - 234.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2207/gsk-q3-analysts-26oct16.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q3 2016 results transcript\n                                                        PDF - 202.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2205/q3-2016-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q3 2016 US dollar translation\n                                                        PDF - 126.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2204/q3-2016-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q3 2016 actual growth schedules\n                                                        PDF - 138.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2203/2016-q3-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q3 2016 pre announcement aide memoire\n                                                        PDF - 1,020.6KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-second-quarter-2016-and-half-yearly-financial-report-for-the-half-year-2016/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2016","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers further progress against strategy with strong Q2 performance"}},"https://www.gsk.com/media/4441/sir-andrew-witty-ceo-discusses-gsk-s-second-quarter-results-2016.mp3":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/media/2201/q2-2016-27-july-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q2 2016 results announcement\n                                                        PDF - 384.1KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2544/q2-2016-results-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q2 2016 analyst slide presentation\n                                                        PDF - 590.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2202/q2-2016-results-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q2 2016 results transcript\n                                                        PDF - 165.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2200/q2-2016-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q2 2016 US dollar translation\n                                                        PDF - 127.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2199/q2-2016-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q2 2016 actual growth schedules\n                                                        PDF - 134.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2198/q2-2016-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q2 2016 pre announcement aide memoire\n                                                        PDF - 972.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-first-quarter-2016/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2016","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers strong Q1 performance with sales of £6.2 billion (+8% CER), core EPS 19.8p (+8% CER); dividend of 19p\n2016 core EPS percentage growth now expected to be 10-12% CER"}},"https://www.gsk.com/media/2194/q1-2016-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q1 2016 results announcement\n                                                        PDF - 586.1KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2197/q1-2016-results-transcript-1.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q1 2016 results transcript\n                                                        PDF - 204.6KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2195/q1-2016-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q1 2016 US dollar translation\n                                                        PDF - 79.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2193/q1-2016-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q1 2016 actual growth schedules\n                                                        PDF - 76.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2192/2016-q1-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                                        Q1 2016 pre announcement aide memoire\n                                                        PDF - 953.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-fourth-quarter-2012/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2012","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers 2012 core EPS of 112.7p and returns £6.3bn to shareholders"}},"https://www.gsk.com/media/2106/q4-2012-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q4 2012 results announcement\n                                                        PDF - 286.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2107/q4-2012-results-analyst-presentation-colour.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q4 2012 results analyst presentation colour\n                                                        PDF - 408.1KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2109/q4-2012-analyst-presentation-bandw.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q4 2012 analyst presentation bandw\n                                                        PDF - 351.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2108/q4-2012-analyst-presentation-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q4 2012 analyst presentation transcript\n                                                        PDF - 68.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2110/q4-2012-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q4 2012 actual growth schedules\n                                                        PDF - 35.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2105/q4-2012-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q4 2012 US dollar translation\n                                                        PDF - 31.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2103/q3-2012-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q3 2012 results announcement\n                                                        PDF - 293.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2102/q3-2012-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q3 2012 actual growth schedules\n                                                        PDF - 32.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2104/q3-2012-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q3 2012 US dollar translation\n                                                        PDF - 31.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-second-quarter-2012/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2012","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers Q2 core EPS of 26.4p and dividend of 17p\n\n"}},"https://www.gsk.com/media/2100/q2-2012-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q2 2012 results announcement\n                                                        PDF - 301.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2099/q2-2012-analyst-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q2 2012 analyst presentation\n                                                        PDF - 2.2MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2098/q2-2012-analyst-presentation-bandw-for-printing.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q2 2012 analyst presentation (printable version)\n                                                        PDF - 1.0MB\n                                                        \n                                                    ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/2097/q2-2012-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q2 2012 actual growth schedules\n                                                        PDF - 37.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2101/q2-2012-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q2 2012 US dollar translation\n                                                        PDF - 32.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2094/q1-2012-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q1 2012 results announcement\n                                                        PDF - 258.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2095/q1-2012-simon-dingemans-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q1 2012 Simon Dingemans transcript\n                                                        PDF - 35.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2093/q1-2012-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q1 2012 actual growth schedules\n                                                        PDF - 22.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2096/q1-2012-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q1 2012 US dollar translation\n                                                        PDF - 24.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-fourth-quarter-2013/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2013","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces core EPS of 112.2p and dividend of 78p."}},"https://www.gsk.com/media/2132/q4-2013-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q4 2013 results announcement\n                                                        PDF - 272.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2135/q4-2013-analyst-slide-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q4 2013 analyst slide presentation\n                                                        PDF - 2.0MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2130/q4-2013-analyst-presentation-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q4 2013 analyst presentation transcript\n                                                        PDF - 61.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2129/q4-2013-analyst-investor-tc-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q4 2013 analyst investor call transcript\n                                                        PDF - 196.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2128/q4-2013-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q4 2013 actual growth schedules\n                                                        PDF - 195.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2133/q4-2013-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q4 2013 US dollar translation\n                                                        PDF - 135.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2131/q4-2013-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q4 2013 pre announcement aide memoire\n                                                        PDF - 848.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-third-quarter-2013/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2013","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces Q3 core EPS growth of 16% and dividend of 19p"}},"https://www.gsk.com/media/2126/q3-2013-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q3 2013 results announcement\n                                                        PDF - 314.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2125/q3-2013-interview-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q3 2013 interview transcript\n                                                        PDF - 122.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2124/q3-2013-analyst-webcast-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q3 2013 analyst webcast transcript\n                                                        PDF - 210.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2123/q3-2013-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q3 2013 actual growth schedules\n                                                        PDF - 31.2KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2127/q3-2013-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q3 2013 US dollar translation\n                                                        PDF - 29.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2134/q3-2013-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                                                        Q3 2013 pre announcement aide memoire\n                                                        PDF - 746.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-second-quarter-2013/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2013","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces Q2 core EPS growth of 4% and dividend of 18p"}},"https://www.gsk.com/media/2118/q2-2013-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q2 2013 results announcement\n                                                        PDF - 308.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2120/q2-2013-interview-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q2 2013 interview transcript\n                                                        PDF - 157.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2122/q2-2013-analyst-webcast-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q2 2013 analyst webcast transcript\n                                                        PDF - 150.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2121/q2-2013-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q2 2013 actual growth schedules\n                                                        PDF - 30.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2117/q2-2013-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q2 2013 US dollar translation\n                                                        PDF - 30.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2119/q2-2013-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q2 2013 pre announcement aide memoire\n                                                        PDF - 698.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-first-quarter-2013/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2013","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers Q1 2013 core EPS of 26.9p and dividend of 18p"}},"https://www.gsk.com/media/2115/q1-2013-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q1 2013 results announcement\n                                                        PDF - 255.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2113/q1-2013-analyst-presentation-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q1 2013 analyst presentation transcript\n                                                        PDF - 76.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2114/q1-2013-analyst-webcast-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q1 2013 analyst webcast transcript\n                                                        PDF - 28.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2112/q1-2013-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q1 2013 actual growth schedules\n                                                        PDF - 35.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2116/q1-2013-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q1 2013 US dollar translation\n                                                        PDF - 23.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2136/q1-2013-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                                                        Q1 2013 pre announcement aide memoire\n                                                        PDF - 534.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2090/q4-2011-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q4 2011 results announcement\n                                                        PDF - 331.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2087/q4-2011-andrew-witty-video-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q4 2011 Andrew Witty video transcript\n                                                        PDF - 104.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2089/q4-2011-simon-dingemans-video-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q4 2011 Simon Dingemans video transcript\n                                                        PDF - 27.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2085/q4-2011-analyst-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q4 2011 analyst presentation\n                                                        PDF - 1.8MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2091/q4-2011-restated-quarterly-product-analysis.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q4 2011 restated quarterly product analysis\n                                                        PDF - 96.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2086/q4-2011-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q4 2011 actual growth schedules\n                                                        PDF - 47.4KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2088/q4-2011-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q4 2011 US dollar translation\n                                                        PDF - 45.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2082/q3-2011-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q3 2011 results announcement\n                                                        PDF - 294.9KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2083/q3-2011-simon-dingemans-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q3 2011 Simon Dingemans transcript\n                                                        PDF - 71.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2081/q3-2011-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q3 2011 actual growth schedules\n                                                        PDF - 46.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2084/q3-2011-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                                                        Q3 2011 US dollar translation\n                                                        PDF - 45.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2079/q2-2011-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q2 2011 results announcement\n                                                        PDF - 302.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2080/q2-2011-analyst-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q2 2011 analyst presentation\n                                                        PDF - 3.5MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2076/q2-2011-analyst-presentation-bw.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q2 2011 Analyst Presentation Bw\n                                                        PDF - 2.8MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2077/q2-2011-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q2 2011 actual growth schedules\n                                                        PDF - 46.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2078/q2-2011-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q2 2011 US dollar translation\n                                                        PDF - 43.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2073/q1-2011-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q1 2011 results announcement\n                                                        PDF - 175.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2074/q1-2011-andrew-witty-video-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q1 2011 Andrew Witty video transcript\n                                                        PDF - 49.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2075/q1-2011-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q1 2011 actual growth schedules\n                                                        PDF - 29.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2072/q1-2011-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q1 2011 US dollar translation\n                                                        PDF - 28.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2017","txt":"\n                            View summary of our results\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Q2 was another quarter of progress for GSK with Group sales up 3% to £7.3 billion and Adjusted EPS of 27.2p."}},"https://www.gsk.com/media/3866/press-release-gsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group-26-july-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q2 2017 results announcement\n                                                        PDF - 1.9MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3888/investor-event-emma-walmsley-and-simon-dingemans-presentation-transcripts.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                            Emma Walmsley Simon Dingemans presentation transcript\n                                                            PDF - 74.1KB\n                                \n                        ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/3892/investor-event-qa-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                            Investor event Q&A transcript\n                                                            PDF - 106.6KB\n                                \n                        ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3863/quarterly-results-graphic-website.jpg?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131456200050000000":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2017","txt":"\n                                                    \n                                                    \n                                                        \n                                                    \n                                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/3867/q2-2017-results-video-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q2 2017 results video transcript\n                                                        PDF - 177.6KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3861/q2-2017-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q2 2017 US dollar translation\n                                                        PDF - 121.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3865/q2-2017-results-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q2 2017 results infographic\n                                                        PDF - 862.6KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3811/2017-q2-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q2 2017 pre announcement aide memoire\n                                                        PDF - 795.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-another-quarter-of-continued-progress/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2017","txt":"\n                            View summary of our results\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers another quarter of continued progress\nQ1 sales of £7.4 billion, +19% AER, + 5% CER\nTotal EPS of 21.4p >100% AER, >100% CER; Adjusted EPS of 25.0p, +31% AER, +9% CER"}},"https://www.gsk.com/media/3696/q1-2017-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q1 2017 results announcement\n                                                        PDF - 253.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3740/2017-q1-results-infographics.jpg?center=0.48,0.495&mode=crop&quality=90&width=960&height=0&rnd=131406276860000000":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2017","txt":"\n                                                    \n                                                    \n                                                        \n                                                    \n                                                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/3698/gsk-q1-2017-analyst-call-transcript-final.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q1 2017 results transcript\n                                                        PDF - 204.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3691/q1-2017-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q1 2017 US dollar translation\n                                                        PDF - 80.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3655/q1-2017-pre-announcement-aide-memoire.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q1 2017 pre announcement aide memoire\n                                                        PDF - 742.7KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3694/q1-2017-results-infographic.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                                        Q1 2017 results infographic\n                                                        PDF - 8.4MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2069/q4-2010-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q4 2010 results announcement\n                                                        PDF - 226.9KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2068/q4-2010-analyst-presentation-bw.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q4 2010 analyst presentation bw\n                                                        PDF - 1.6MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2067/q4-2010-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q4 2010 actual growth schedules\n                                                        PDF - 43.2KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2070/q4-2010-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q4 2010 US dollar translation\n                                                        PDF - 43.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-q3-results-for-2010/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2010","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Q3 EPS before major restructuring of 28.2p\n"}},"https://www.gsk.com/media/2065/q3-2010-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q3 2010 results announcement\n                                                        PDF - 238.5KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2064/q3-2010-andrew-witty-video-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q3 2010 Andrew Witty video transcript\n                                                        PDF - 65.3KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2063/q3-2010-analyst-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q3 2010 analyst presentation\n                                                        PDF - 234.1KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2062/q3-2010-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q3 2010 actual growth schedules\n                                                        PDF - 42.2KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2066/q3-2010-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                                                        Q3 2010 US dollar translation\n                                                        PDF - 38.4KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-q2-results-for-2010/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2010","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Q2 EPS before major restructuring* 2.6p (29.3p excluding pre-announced legal charge) \n\n\n\n"}},"https://www.gsk.com/media/2058/q2-2010-results-announcement-1.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                                                        Q2 2010 results announcement\n                                                        PDF - 226.3KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2060/q2-2010-analyst-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                                                        Q2 2010 analyst presentation\n                                                        PDF - 2.3MB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2059/q2-2010-restated-quarterly-product-analysis.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                                                        Q2 2010 restated quarterly product analysis\n                                                        PDF - 980.4KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2061/q2-2010-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                                                        Q2 2010 actual growth schedules\n                                                        PDF - 42.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2057/q2-2010-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                                                        Q2 2010 US dollar translation\n                                                        PDF - 45.1KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-q1-results-for-2010/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?y=2010","txt":"\n                            View the press release\n                                \n                                                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers Q1 EPS of 30.7p +16% CER before major restructuring \n\n"}},"https://www.gsk.com/media/2055/q1-2010-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                                                        Q1 2010 results announcement\n                                                        PDF - 198.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2054/q1-2010-andrew-witty-video-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                                                        Q1 2010 Andrew Witty video transcript\n                                                        PDF - 49.0KB\n                                                        \n                                                    ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2053/q1-2010-actual-growth-schedules.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                                                        Q1 2010 actual growth schedules\n                                                        PDF - 37.0KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2056/q1-2010-us-dollar-translation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                                                        Q1 2010 US dollar translation\n                                                        PDF - 31.8KB\n                                                        \n                                                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=3":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=4","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?p=1":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=4","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=5":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=4","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=7":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=6","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=1":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=8":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=9","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=2":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=4":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=6":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=7","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=9":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?p=8","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/media/2497/jpm-2017-pv-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                2017 JPM Patrick Vallance presentation\n                                PDF - 1.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3365/patrick-vallance-presentation-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                2017 JPM Patrick Vallance transcript\n                                PDF - 176.9KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/1688/2016-gsk-vaccines-meet-the-management-slides.pdf":{"redirectedFrom":"https://www.gsk.com/media/3246/leerink-partners-5th-annual-global-healthcare-conference-transcript.docx"},"https://www.gsk.com/media/3241/2016-gsk-vaccines-meet-the-management-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                GSK vaccines meet the management transcript\n                                PDF - 325.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2652/gold-man-sachs-seminar-on-hic-and-viiv-healtcare-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Goldman Sachs seminar on HIV and ViiV healthcare presentation\n                                PDF - 1.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2655/gold-man-sachs-seminar-on-hic-and-viiv-healtcare-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Goldman Sachs seminar on HIV and ViiV healthcare transcript\n                                PDF - 439.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2654/meet-the-respiratory-management-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Meet the respiratory management presentation\n                                PDF - 3.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2653/meet-the-respiratory-management-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Meet the respiratory management transcript\n                                PDF - 282.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3243/goldman-sachs-37th-annual-global-healthcare-conference-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Goldman Sachs 37th annual global healthcare conference transcript\n                                PDF - 120.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3244/dr-axel-hoos-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Dr Axel hoos transcript\n                                PDF - 863.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3246/leerink-partners-5th-annual-global-healthcare-conference-transcript.docx":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Leerink Partners 5th annual global healthcare conference transcript\n                                DOCX - 29.4KB\n                                \n                            ","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/1688/2016-gsk-vaccines-meet-the-management-slides.pdf"},"https://www.gsk.com/media/3247/andrew-whitty-jp-morgan-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Andrew Witty JP Morgan presentation\n                                PDF - 920.7KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3248/andrew-whitty-jp-morgan-transcription.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Andrew Witty JP Morgan transcript\n                                PDF - 304.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3249/viiv-bms-investor-transcript-pdf.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                ViiV-BMS investor transcript\n                                PDF - 173.8KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1441/r-and-d-event-full-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                R&D event full presentation\n                                PDF - 4.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1442/randd-day-transcript-full.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                R&D event full transcript\n                                PDF - 528.4KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1443/randd-day-ceo-introduction.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                R&D event Andrew Witty introduction presentation\n                                PDF - 564.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1444/gsk-rd-day-part1-welcome-and-opening-remarks-sir-andrew-witty_final.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                R&D event Andrew Witty introduction transcript\n                                PDF - 37.7KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1445/randd-day-pharma-session-1.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Dr Patrick Vallance HIV, infectious diseases, respiratory, PHI presentation\n                                PDF - 1.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1446/gsk-rd-day-part1-hiv-infectious-diseases-respiratory-phi-patrick-vallance-_final.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Dr Patrick Vallance HIV, infectious diseases, respiratory, PHI transcript\n                                PDF - 238.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1448/randd-day-pharma-session-2.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Dr Patrick Vallance immuno-inflammation, oncology, rare diseases presentation\n                                PDF - 2.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1449/gsk-rd-day-part3-immuno-inflammation-oncology-rare-diseases-patrick-vallance_-final.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Dr Patrick Vallance immuno-inflammation, oncology, rare diseases transcript\n                                PDF - 168.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1451/randd-day-vaccines-session.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Dr Moncef Slaoui vaccines business presentation\n                                PDF - 736.7KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1452/gsk-rdday-part2-vaccines-dr-moncef-slaoui_-final.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Dr Moncef Slaoui vaccines business transcript\n                                PDF - 101.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1471/gsk-investor-event.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Investor event full presentation\n                                PDF - 3.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1472/investor-event-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Investor event full transcript\n                                PDF - 305.5KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3511/andrew-witty-investor-event-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Andrew Witty strategic outlook presentation\n                                PDF - 382.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3512/andrew-witty-investor-event-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Andrew Witty strategic outlook transcript\n                                PDF - 35.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1477/moncef-slaoui-investor-event-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Dr Moncef Slaoui vaccines business presentation\n                                PDF - 949.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1478/moncef-slaoui-investor-event-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Dr Moncef Slaoui vaccines business transcript\n                                PDF - 67.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1479/abbas-hussain-investor-event-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Abbas Hussain pharmaceuticals business presentation\n                                PDF - 890.5KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/1480/abbas-hussain-investor-event-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Abbas Hussain pharmaceuticals business transcript\n                                PDF - 44.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1481/emma-walmsley-investor-event-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Emma Walmsley consumer healthcare presentation\n                                PDF - 1.4MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1482/emma-walmsley-investor-event-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Emma Walmsley consumer healthcare transcript\n                                PDF - 41.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1483/simon-dingemans-investor-event-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Simon Dingemans financial outlook presentation\n                                PDF - 321.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/1484/simon-dingemans-investor-event-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Simon Dingemans financial outlook transcript\n                                PDF - 37.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3513/jpmorgan-healthcare-conference-2015.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                33rd Annual JP Morgan healthcare conference full presentation\n                                PDF - 1.4MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3514/jp-morgan-healthcare-conference-2015-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                33rd Annual JP Morgan healthcare conference full transcript\n                                PDF - 98.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2605/bank-of-america-healthcare-conderence.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Bank of America healthcare conference\n                                PDF - 683.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2603/ers-investor-briefing-slides.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                ERS investor briefing presentation\n                                PDF - 1.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2604/ers-ir-broadcast-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                ERS investor briefing transcript\n                                PDF - 327.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2602/jpmorgan-healthcare-conference-2014.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                JP Morgan healthcare conference 2014 presentation\n                                PDF - 555.9KB\n                                \n                            ","status":"done","statusCode":206,"results":{"video":[]}},"https://www.gsk.com/media/2601/jpmorgan-healthcare-conference-2014-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                JP Morgan healthcare conference 2014 transcript\n                                PDF - 83.6KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2600/jpmorgan-healthcare-conference-2014-transcript-qa.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                JP Morgan healthcare conference 2014 transcript Q&A\n                                PDF - 114.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2608/leerink-swann-polarxpress-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                Leerink Swann polarxpress 2013\n                                PDF - 1.9MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2609/north-carolina-ceo-forum-speech-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                North Carolina CEO forum speech 2013\n                                PDF - 74.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2606/ats-analyst-and-investor-event-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"\n                                ATS analyst and investor event 2013\n                                PDF - 998.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?&p=1":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?p=1":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?p=2","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?&p=3":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/media/2624/david-redfern-economist-pharma-summit-10-february-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                David Redfern Economist pharma summit 10 February 2011\n                                PDF - 1.0MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2622/gsk-deirdre-connelly-cbi-annual-pharma-compliance-congress.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                GSK Deirdre Connelly CBI annual pharma compliance congress\n                                PDF - 279.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2626/jp-morgan-2011-healthcare-conference.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                JP Morgan 2011 healthcare conference\n                                PDF - 4.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2647/gsks-eddie-gray-speaks-at-ft-pharmaceutical-conference.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                GSK's Eddie Gray speaks at FT pharmaceutical conference\n                                PDF - 339.8KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2640/clsa-emerging-markets-mark-reilly.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                CLSA emerging markets  Mark Reilly\n                                PDF - 461.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2645/gsks-andrew-witty-features-in-the-economists-the-world-in-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                GSK's Andrew Witty features in the Economist's the world in 2011\n                                PDF - 113.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2634/mind-the-medicine-gap-transcript.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Mind the medicine gap transcript\n                                PDF - 39.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2644/andrew-witty-ceo-gsk-presentation-at-credit-suisse-nov-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Andrew Witty, CEO, GSK presentation at Credit Suisse - Nov 2010\n                                PDF - 754.5KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3260/deirdre-connellys-credit-suisse-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Deirdre Connelly's Credit Suisse presentation\n                                PDF - 754.5KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2643/cowen-healthcare-conference-julian-heslp-cfp.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Cowen healthcare conference Julian Heslp CFP\n                                PDF - 1.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2638/merrill-lynch-conference-julian-heslp-cfo.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Merrill Lynch conference Julian Heslp CFO\n                                PDF - 1.8MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2649/investor-meetings-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Investor meetings 2010\n                                PDF - 2.5MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3261/dr-thomas-breuers-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Dr Thomas Breuer's presentation\n                                PDF - 2.3MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3262/martin-andrews-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Martin Andrew's presentation\n                                PDF - 3.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3263/vincent-bruchards-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Vincent Bruchard's presentation\n                                PDF - 1.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2648/simon-harford-gsk-emerging-markets.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                Simon Harford GSK emerging markets\n                                PDF - 579.5KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2633/28th-a-l-h-lth-c-f-annual-healthcare-conference-jp-morgan.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"\n                                28th annual healthcare conference JP Morgan\n                                PDF - 1.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2607/late-stage-pipeline-review-2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                Late stage pipeline review 2013\n                                PDF - 664.5KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2613/late-stage-pipeline-review.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                Late stage pipeline review\n                                PDF - 2.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2620/gsk-deirdre-connelly-pharmehr-summit-speech-21-march-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                GSK Deirdre Connelly pharmEHR summit speech 21 March 2012\n                                PDF - 108.7KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2618/esmo-analyst-presentation-1-oct-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                ESMO analyst presentation 1 Oct 2012\n                                PDF - 573.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2619/iac-analyst-presentation.pdf":{"redirectedFrom":"https://www.gsk.com/media/3258/gsk-core-reporting-historical-restatements.xls"},"https://www.gsk.com/media/2615/ada-analyst-meeting-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                Ada analyst meeting 2012\n                                PDF - 290.3KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2610/deirdre-connelly-na-pharma-gsk-world-affairs-council-15-may-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                Deirdre Connelly North America pharma, GSK, world affairs council - 15 May 2012.pdf\n                                PDF - 124.0KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2614/rd-seminar.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                R&D Seminar\n                                PDF - 2.6MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2611/gsk-simon-dingemans-jp-morgan-10-jan-2012.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                GSK - Simon Dingemans JP Morgan 10 Jan 2012\n                                PDF - 4.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3257/gsk-core-reporting-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                GSK core reporting announcement\n                                PDF - 272.6KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2629/gsk-core-reporting-presentation-1-dec-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                GSK core reporting presentation 1 Dec 2011\n                                PDF - 313.8KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/3258/gsk-core-reporting-historical-restatements.xls":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                GSK core reporting historical restatements\n                                XLS - 162.5KB\n                                \n                            ","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/2619/iac-analyst-presentation.pdf"},"https://www.gsk.com/media/2631/credit-suisse-2011-healthcare-conference.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                Credit Suisse 2011 healthcare conference\n                                PDF - 846.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2627/gsks-ad-rawcliffe-presentation-at-bernstein-pharma-long-view-conference.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                GSK's Ad rawcliffe presentation at bernstein pharma long view conference\n                                PDF - 451.1KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3259/martin-andrews-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                Martin Andrews' presentation\n                                PDF - 2.1MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2623/summary-of-remarks-made-by-gsk-ceo-the-role-of-innovation-in-addressing-global-health.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                Summary of remarks made by GSK CEO the role of innovation in addressing global health\n                                PDF - 165.1KB\n                                \n                            ","status":"done","statusCode":304,"results":{"video":[]}},"https://www.gsk.com/media/2632/abbas-hussain-emerging-markets.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                Abbas Hussain emerging markets\n                                PDF - 1.9MB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2630/gsks-patrick-vallance-presentation-at-cowen-healthcare-conference.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                GSK's Patrick Vallance presentation at Cowen healthcare conference\n                                PDF - 475.9KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2621/life-science-conference-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"\n                                Life science conference 2011\n                                PDF - 273.2KB\n                                \n                            ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?&p=2":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?&p=4":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-receives-positive-chmp-opinion-supporting-expanded-copd-indication-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                21 September 2018\n            Trelegy Ellipta receives positive CHMP opinion supporting expanded COPD indication in Europe\n                European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issue...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion today supporting the use of Trelegy Ellipta (fluticasone furoate/umeclidinium/ vilanterol ‘FF/UMEC/VI’) in a broader group of patients with moderate to severe chronic obstructive pulmonary disease (COPD) and that labelling, if approved, will be updated to further reflect its effect on exacerbations of COPD."}},"https://www.gsk.com/en-gb/media/press-releases/kozenis-tafenoquine-approved-by-the-australian-therapeutic-goods-administration-for-the-radical-cure-of-p-vivax-malaria/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                21 September 2018\n            Kozenis (tafenoquine) approved by the Australian Therapeutic Goods Administration for the radical cure of P. vivax malaria\n                Approval marks a major step in global eradication efforts and will support registrations in malar...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Approval marks a major step in global eradication efforts and will support registrations in malaria-endemic countries"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-submits-regulatory-application-to-european-medicines-agency-for-single-tablet-two-drug-regimen-of-dolutegravir-and-lamivudine-for-treatment-of-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                14 September 2018\n            ViiV Healthcare submits regulatory application to European Medicines Agency for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV\n                ViiV Healthcare today announced submission of a marketing authorisation application (MAA) to the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced submission of a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for a single-tablet, two-drug regimen of dolutegravir (DTG) and lamivudine (3TC) for the treatment of HIV-1 infection."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-data-presented-at-ers-further-supports-its-industry-leading-respiratory-medicines-portfolio/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                10 September 2018\n            GSK data presented at ERS further supports its industry-leading respiratory medicines portfolio\n                GlaxoSmithKline plc (GSK) will profile the growing evidence base that supports its broad respirat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) will profile the growing evidence base that supports its broad respiratory medicines portfolio at the European Respiratory Society (ERS) congress in Paris, France, 15-19 September 2018."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-results-of-indirect-treatment-comparisons-of-nucala-to-benralizumab-and-reslizumab-for-severe-eosinophilic-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                10 September 2018\n            GSK announces results of indirect treatment comparisons of Nucala to benralizumab and reslizumab for severe eosinophilic asthma\n                Nucala demonstrated greater reduction in exacerbations and improved asthma control.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Nucala demonstrated greater reduction in exacerbations and improved asthma control."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-complete-response-letter-from-us-fda-for-use-of-mepolizumab-in-copd-patients/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                07 September 2018\n            GSK receives complete response letter from US FDA for use of mepolizumab in COPD patients\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today received a complete response letter (CRL) from the US F...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today received a complete response letter (CRL) from the US FDA regarding its application for mepolizumab as an add-on treatment to inhaled corticosteroid-based maintenance treatment for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD), guided by blood eosinophil counts."}},"https://www.gsk.com/en-gb/media/press-releases/european-commission-approves-nucala-mepolizumab-for-the-treatment-of-children-with-severe-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                30 August 2018\n            European Commission approves Nucala (mepolizumab) for the treatment of children with severe asthma\n                First anti-IL-5 biologic treatment for paediatric patients with severe eosinophilic asthma in Europe\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First anti-IL-5 biologic treatment for paediatric patients with severe eosinophilic asthma in Europe"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-positive-48-week-results-for-first-pivotal-phase-iii-study-for-novel-long-acting-injectable-hiv-treatment-regimen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                15 August 2018\n            ViiV Healthcare reports positive 48-week results for first pivotal, phase III study for novel, long-acting, injectable HIV-treatment regimen\n                ATLAS study meets primary endpoint, showing similar efficacy of a once-a-month, investigational, ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ATLAS study meets primary endpoint, showing similar efficacy of a once-a-month, investigational, injectable two-drug regimen of cabotegravir and rilpivirine compared to a standard of care, daily, oral three-drug regimen."}},"https://www.gsk.com/en-gb/media/press-releases/iain-mackay-appointed-gsk-chief-financial-officer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                07 August 2018\n            Iain Mackay appointed GSK Chief Financial Officer\n                GSK today announced that Iain Mackay has been appointed GSK’s next CFO.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that Iain Mackay has been appointed GSK’s next CFO."}},"https://www.gsk.com/en-gb/media/press-releases/chmp-recommend-nucala-mepolizumab-for-the-treatment-of-severe-eosinophilic-asthma-paediatric-patients-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                27 July 2018\n            CHMP recommend Nucala (mepolizumab) for the treatment of severe eosinophilic asthma paediatric patients in Europe\n                GSK announced that the EMA's CHMP has issued a positive opinion recommending Nucala (mepolizumab)...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced that the EMA's CHMP has issued a positive opinion recommending Nucala (mepolizumab) as an add-on treatment for severe refractory eosinophilic asthma in paediatric patients aged six up to 17 years."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-reports-on-outcome-of-the-fda-advisory-committee-on-mepolizumab-for-the-treatment-of-copd-patients-on-maximum-inhaled-therapy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                25 July 2018\n            GSK reports on outcome of the FDA Advisory Committee on mepolizumab for the treatment of COPD patients on maximum inhaled therapy\n                Advisory Committee provide non-binding recommendation for consideration by the FDA\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Advisory Committee provide non-binding recommendation for consideration by the FDA"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-adaptimmune-complete-transition-of-ny-eso-spear-t-cell-therapy-programme-to-gsk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                24 July 2018\n            GSK and Adaptimmune complete transition of NY-ESO SPEAR T-cell therapy programme to GSK\n                GlaxoSmithKline plc and Adaptimmune Therapeutics plc (Nasdaq:ADAP), today announced the transitio...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc and Adaptimmune Therapeutics plc (Nasdaq:ADAP), today announced the transition of the development programme for GSK3377794 (GSK ‘794), an NY-ESO SPEAR T-cell therapy, to GSK.  As a result of the transition, GSK assumes full responsibility for future research, development, and potential commercialisation of this pioneering therapy, and Adaptimmune received $27.5 million (£21.2 million) from GSK."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-sword-100-week-data-for-juluca-dolutegravirrilpivirine-at-aids-2018/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                24 July 2018\n            ViiV Healthcare announces SWORD 100-week data for Juluca (dolutegravir/rilpivirine) at AIDS 2018\n                Juluca, the first 2-drug regimen, once daily, single pill regimen, maintains viral suppression th...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Juluca, the first 2-drug regimen, once daily, single pill regimen, maintains viral suppression through 100 weeks."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-phase-iii-data-at-aids-2018-from-landmark-gemini-studies/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                24 July 2018\n            ViiV Healthcare presents phase III data at AIDS 2018 from landmark GEMINI studies showing two-drug regimen of dolutegravir and lamivudine has similar efficacy to a three-drug regimen in treatment naïve HIV patients, with no emergence of resistance\n                GEMINI 1 & 2 studies meet primary endpoint, showing two-drug regimen to be effective across high ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GEMINI 1 & 2 studies meet primary endpoint, showing two-drug regimen to be effective across high and low viral loads."}},"https://www.gsk.com/en-gb/media/press-releases/us-fda-approves-krintafel-tafenoquine-for-the-radical-cure-of-p-vivax-malaria/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                20 July 2018\n            US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria\n                US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-shares-data-from-landmark-2-drug-regimen-trials-at-aids-2018/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                18 July 2018\n            ViiV Healthcare shares data from landmark 2-drug regimen trials at AIDS 2018\n                ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Sh...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community."}},"https://www.gsk.com/en-gb/media/press-releases/us-fda-advisory-committee-endorses-the-effectiveness-and-safety-of-single-dose-tafenoquine-for-the-radical-cure-of-p-vivax-malaria/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                12 July 2018\n            US FDA Advisory Committee endorses the effectiveness and safety of single-dose tafenoquine for the radical cure of P. vivax malaria\n                GSK and Medicines for Malaria Venture (MMV) today announced that the Antimicrobial Drugs Advisory...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Medicines for Malaria Venture (MMV) today announced that the Antimicrobial Drugs Advisory Committee (AMDAC) of the United States Food and Drug Administration (FDA) voted that there is substantial evidence of the effectiveness (13 for; 0 against) and adequate evidence of the safety (12 for; 1 against) of single-dose tafenoquine for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria in patients 16 years of age and older."}},"https://www.gsk.com/en-gb/media/press-releases/james-ford-appointed-gsk-general-counsel/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                12 July 2018\n            James Ford appointed GSK General Counsel\n                James Ford, currently SVP and General Counsel for Global Pharma, will succeed Dan Troy as General...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"James Ford, currently SVP and General Counsel for Global Pharma, will succeed Dan Troy as General Counsel, GSK."}},"https://www.gsk.com/en-gb/media/press-releases/?&p=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?p=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=3":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-update-regarding-pfizer-inc-consumer-healthcare/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                23 March 2018\n            GSK update regarding Pfizer Inc. Consumer Healthcare\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today confirms it has withdrawn from the process relating to ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today confirms it has withdrawn from the process relating to Pfizer’s Consumer Healthcare business."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-of-benlysta-and-rituximab-combination-in-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                20 March 2018\n            GSK starts phase III study of Benlysta and rituximab combination in systemic lupus erythematosus\n                GSK today announced the start of a phase III study investigating Benlysta (belimumab) in combinat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with systemic lupus erythematosus (SLE)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-eu-approval-for-labelling-update-to-relvar-ellipta-in-patients-with-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                08 March 2018\n            GSK announces positive EU approval for labelling update to Relvar Ellipta in patients with asthma\n                GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the Eur...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has approved a label update for the use of once-daily Relvar Ellipta (fluticasone furoate/vilanterol, FF/VI)"}},"https://www.gsk.com/en-gb/media/press-releases/new-clinical-data-demonstrate-high-vaccine-efficacy-of-fluarix-tetra-influenza-vaccine-in-children-6-35-months-of-age/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                06 March 2018\n            New clinical data demonstrate high vaccine efficacy of Fluarix Tetra (Influenza Vaccine) in children 6-35 months of age\n                New data published in The Lancet Child & Adolescent Health from a Phase III clinical trial with F...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New data published in The Lancet Child & Adolescent Health from a Phase III clinical trial with Fluarix Tetra which prevented influenza A and B in children six to 35 months of age"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-positive-new-dolutegravir-data-for-the-treatment-of-people-living-with-hiv-co-infected-with-tuberculosis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                05 March 2018\n            ViiV Healthcare announces positive new dolutegravir data for the treatment of people living with HIV co-infected with tuberculosis\n                INSPIRING study results contribute to extensive body of evidence for dolutegravir\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"INSPIRING study results contribute to extensive body of evidence for dolutegravir"}},"https://www.gsk.com/en-gb/media/press-releases/nucala-mepolizumab-improved-asthma-control-in-patients-uncontrolled-on-xolair-omalizumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                05 March 2018\n            Nucala (mepolizumab) improved asthma control in patients uncontrolled on Xolair (omalizumab)\n                Positive clinical study outcomes observed for severe eosinophilic asthma patients uncontrolled on...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Positive clinical study outcomes observed for severe eosinophilic asthma patients uncontrolled on omalizumab when switched to mepolizumab in an open-label single arm study"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-approval-for-expanded-indication-for-fluarix-tetra-influenza-vaccine-for-ages-six-months-and-older/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                15 February 2018\n            GSK receives European approval for expanded indication for Fluarix Tetra (Influenza Vaccine) for ages six months and older\n                GSK announced the expanded indication for Fluarix Tetra has been approved in Europe.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced the expanded indication for Fluarix Tetra has been approved in Europe."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-landmark-impact-data-to-european-medicines-agency-to-support-expanded-label-for-trelegy-ellipta/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                14 February 2018\n            GSK submits landmark IMPACT data to European Medicines Agency to support expanded label for Trelegy Ellipta\n                GlaxoSmithKline plc and Innoviva, Inc. announce submission of landmark IMPACT data to the Europea...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc and Innoviva, Inc. announce submission of landmark IMPACT data to the European Medicines Agency as part of a type II variation to support an expanded label for Trelegy Ellipta in Europe."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-eighth-phase-iii-study-in-two-drug-regimen-programme-for-hiv-1-treatment/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                08 February 2018\n            ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment\n                Today ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Today ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced the start of a phase III study designed to establish if adults with HIV-1 with current virologic suppression on a tenofovir alafenamide fumarate (TAF)-based regimen of at least three drugs are able to maintain viral suppression upon switching to a two-drug regimen (2DR) of dolutegravir (TIVICAY) and lamivudine (EPIVIR). TANGO will seek to enrol approximately 550 adults with HIV-1, from clinical trial sites in North America, Europe, Australia, and Japan."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-files-patent-infringement-litigation-against-gilead-sciences-inc-over-bictegravir/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                07 February 2018\n            ViiV Healthcare files patent infringement litigation against Gilead Sciences Inc. over bictegravir\n                ViiV Healthcare announces it has filed patent infringement litigation against Gilead Sciences Inc...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare announces it has filed patent infringement litigation against Gilead Sciences Inc. over bictegravir in the United States and Canada."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-meningitis-b-vaccine-bexsero-receives-breakthrough-therapy-designation-from-us-fda-for-prevention-of-invasive-meningococcal-disease-in-children-2-10-years-of-age/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                07 February 2018\n            GSK’s meningitis B vaccine Bexsero receives Breakthrough Therapy Designation from US FDA for prevention of Invasive Meningococcal Disease in children 2-10 years of age\n                GlaxoSmithKline plc announced that it has received Breakthrough Therapy Designation from the U.S....\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc announced that it has received Breakthrough Therapy Designation from the U.S. FDA for its meningitis B vaccine Bexsero"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-shingrix-receives-positive-opinion-from-the-chmp-in-europe-for-the-prevention-of-shingles-in-adults-aged-50-and-over/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                26 January 2018\n            GSK’s Shingrix receives positive opinion from the CHMP in Europe for the prevention of shingles in adults aged 50 and over\n                Shingrix is a non-live, recombinant subunit adjuvanted vaccine given intramuscularly in two doses...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Shingrix is a non-live, recombinant subunit adjuvanted vaccine given intramuscularly in two doses, with a two-to-six month interval between doses."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-chmp-positive-opinion-for-labelling-update-to-relvar-ellipta-in-patients-with-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                26 January 2018\n            GSK announces CHMP positive opinion for labelling update to Relvar Ellipta in patients with asthma\n                A positive CHMP opinion is one of the final steps before marketing authorisation is updated by th...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A positive CHMP opinion is one of the final steps before marketing authorisation is updated by the European Commission."}},"https://www.gsk.com/en-gb/media/press-releases/fda-approves-us-label-update-on-icslaba-combinations-in-asthma-based-on-review-of-safety-data/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                21 December 2017\n            FDA approves US label update on ICS/LABA combinations in asthma, based on review of safety data\n                Boxed warning removed from ICS/LABA combination products, including BREO ELLIPTA, ADVAIR DISKUS a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Boxed warning removed from ICS/LABA combination products, including BREO ELLIPTA, ADVAIR DISKUS and ADVAIR HFA."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-regulatory-application-for-single-dose-tafenoquine-for-the-treatment-of-plasmodium-vivax-malaria-to-australia-s-therapeutic-goods-administration/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                14 December 2017\n            GSK submits regulatory application for single-dose tafenoquine for the treatment of Plasmodium vivax malaria to Australia’s Therapeutic Goods Administration\n                Innovative science drives progress in developing medicines for infectious diseases.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Innovative science drives progress in developing medicines for infectious diseases."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-achieves-approval-for-nucala-mepolizumab-for-the-treatment-of-eosinophilic-granulomatosis-with-polyangiitis-egpa-for-adults-in-the-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                12 December 2017\n            GSK achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US\n                First targeted treatment approved for this rare eosinophil-driven disease\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First targeted treatment approved for this rare eosinophil-driven disease"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-promising-new-data-for-priority-bcma-asset-from-its-emerging-oncology-pipeline-at-59th-ash-meeting/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                11 December 2017\n            GSK presents promising new data for priority BCMA asset from its emerging Oncology pipeline at 59th ASH meeting\n                Data from dose expansion phase of DREAMM-1 study\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Data from dose expansion phase of DREAMM-1 study"}},"https://www.gsk.com/en-gb/media/press-releases/new-data-supports-the-safety-and-efficacy-of-gsk-s-shingrix-in-preventing-shingles-in-autologous-haematopoietic-stem-cell-transplant-patients/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                06 December 2017\n            New data supports the safety and efficacy of GSK’s Shingrix in preventing shingles in autologous haematopoietic stem cell transplant patients\n                New data supports the safety and efficacy of GSK’s Shingrix in preventing shingles in autologous ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New data supports the safety and efficacy of GSK’s Shingrix in preventing shingles in autologous haematopoietic stem cell transplant patients"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=5":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=4","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-start-of-phase-iii-study-of-long-acting-cabotegravir-for-hiv-prevention-in-women/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                30 November 2017\n            ViiV Healthcare announces start of phase III study of long-acting cabotegravir for HIV prevention in women\n                The HPTN 084 study will evaluate injections given every two months\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The HPTN 084 study will evaluate injections given every two months"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-us-regulatory-application-for-single-dose-tafenoquine-for-plasmodium-vivax-malaria/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                28 November 2017\n            GSK submits US regulatory application for  single-dose tafenoquine for Plasmodium vivax malaria\n                Regulatory milestone affirms GSK's strong commitment and scientific capabilities to fighting infe...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Regulatory milestone affirms GSK's strong commitment and scientific capabilities to fighting infectious diseases"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-uk-industrial-strategy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                27 November 2017\n            GSK responds to UK Industrial Strategy\n                Read our response to the UK Industrial Strategy White Paper.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Read our response to the UK Industrial Strategy White Paper."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-starts-third-phase-iii-hiv-treatment-study-investigating-long-acting-two-drug-regimen-of-cabotegravir-plus-rilpivirine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                27 November 2017\n            ViiV Healthcare starts third phase III HIV treatment study investigating long-acting two-drug regimen of cabotegravir plus rilpivirine\n                ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Sh...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced the start of a phase III study with a two-drug regimen of long-acting, injectable cabotegravir (ViiV Healthcare) and long-acting injectable rilpivirine (Janssen Sciences Ireland UC) in virally suppressed adults with HIV-1 infection."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-landmark-impact-data-to-us-regulatory-authority-to-support-expanded-label-for-trelegy-ellipta/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                23 November 2017\n            GSK submits landmark IMPACT data to US regulatory authority to support expanded label for Trelegy Ellipta\n                GSK submits landmark IMPACT data to US regulatory authority to support expanded label for Trelegy...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK submits landmark IMPACT data to US regulatory authority to support expanded label for Trelegy Ellipta"}},"https://www.gsk.com/en-gb/media/press-releases/juluca-approved-in-us-as-first-2-drug-regimen-once-daily-single-pill/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                21 November 2017\n            Juluca® (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection\n                ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfize...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Juluca®, indicated as a complete regimen for the maintenance treatment of HIV-1 infection in adults who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral (ART) regimen for at least six months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Juluca.¹"}},"https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-once-daily-single-inhaler-triple-therapy-gains-marketing-authorisation-in-europe-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                16 November 2017\n            Trelegy Ellipta once-daily single inhaler triple therapy gains marketing authorisation in Europe for the treatment of COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the Eu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has granted marketing authorisation for Trelegy Ellipta"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-marketing-authorisation-for-self-injectable-formulation-of-benlysta-for-the-treatment-of-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                13 November 2017\n            GSK receives European marketing authorisation for self-injectable formulation of Benlysta for the treatment of systemic lupus erythematosus\n                The approval is for a single-dose prefilled syringe and a single-dose prefilled pen (autoinjector...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The approval is for a single-dose prefilled syringe and a single-dose prefilled pen (autoinjector) presentation, administered as a once weekly injection of 200mg."}},"https://www.gsk.com/en-gb/media/press-releases/patrick-vallance-president-rd-gsk-to-become-uk-governments-chief-scientific-adviser/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                08 November 2017\n            Patrick Vallance, President, R&D, GSK to become UK Government's Chief Scientific Adviser\n                Patrick Vallance, President, R&D, GSK to become UK Government’s Chief Scientific Adviser\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Patrick Vallance, President, R&D, GSK to become UK Government’s Chief Scientific Adviser"}},"https://www.gsk.com/en-gb/media/press-releases/dr-hal-barron-appointed-chief-scientific-officer-and-president-research-development-gsk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                08 November 2017\n            Dr Hal Barron appointed Chief Scientific Officer and President, Research & Development, GSK\n                Dr Hal Barron appointed Chief Scientific Officer and President, Research & Development, GSK\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Dr Hal Barron appointed Chief Scientific Officer and President, Research & Development, GSK"}},"https://www.gsk.com/en-gb/media/press-releases/first-long-term-efficacy-analysis-on-the-effect-of-gsk-s-benlysta-on-rate-of-organ-damage-progression-in-sle-versus-standard-therapy-alone/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                08 November 2017\n            First long-term efficacy analysis on the effect of GSK’s Benlysta on rate of organ damage progression in SLE versus standard therapy alone\n                GSK today announced results of the first study assessing levels of organ damage in patients with ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced results of the first study assessing levels of organ damage in patients with active systemic lupus erythematosus (SLE) treated with Benlysta (belimumab) plus standard of care (SoC) versus SoC alone."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-us-regulatory-application-for-mepolizumab-in-eosinophilic-chronic-obstructive-pulmonary-disease-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                07 November 2017\n            GSK submits US regulatory application for mepolizumab in eosinophilic chronic obstructive pulmonary disease (COPD)\n                GlaxoSmithKline plc today announced the submission of a supplemental Biologics License Applicatio...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc today announced the submission of a supplemental Biologics License Application (sBLA) to the United States Food and Drug Administration (FDA"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-investigational-bcma-antibody-drug-conjugate-receives-breakthrough-therapy-designation-from-us-fda-for-relapsed-and-refractory-multiple-myeloma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                02 November 2017\n            GSK’s investigational BCMA antibody-drug conjugate receives Breakthrough Therapy Designation from US FDA for relapsed and refractory multiple myeloma\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has received Breakthrough Therapy Des...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for GSK2857916 monotherapy in patients with multiple myeloma who have failed at least three prior lines of therapy, including an anti-CD38 antibody and are refractory to a proteasome inhibitor and an immunomodulatory agent."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-study-demonstrates-superiority-of-anoro-ellipta-to-stiolto-respimat-in-improving-lung-function-in-chronic-obstructive-pulmonary-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                01 November 2017\n            GSK study demonstrates superiority of Anoro Ellipta to Stiolto Respimat in improving lung function in chronic obstructive pulmonary disease\n                GlaxoSmithKline plc and Innoviva, Inc. today announced positive data from a study comparing a onc...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc and Innoviva, Inc. today announced positive data from a study comparing a once-daily long-acting muscarinic antagonist (LAMA) and a long-acting beta agonist"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-positive-phase-3-results-from-the-brighte-study-of-fostemsavir-in-heavily-treatment-experienced-patients-with-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                27 October 2017\n            ViiV Healthcare announces positive phase 3 results from the BRIGHTE study of fostemsavir in heavily treatment-experienced patients with HIV\n                ViiV Healthcare, today announced results from the phase III BRIGHTE study of fostemsavir in heavi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare, today announced results from the phase III BRIGHTE study of fostemsavir in heavily treatment-experienced (HTE) patients with HIV-1 infection."}},"https://www.gsk.com/en-gb/media/press-releases/public-private-consortium-aims-to-cut-preclinical-cancer-drug-discovery-from-six-years-to-just-one/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                27 October 2017\n            Public-private consortium aims to cut preclinical cancer drug discovery from six years to just one\n                Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and University of California San Francisco will combine vast data stores, supercomputing, and scientific expertise to reinvent discovery process for cancer medicines"}},"https://www.gsk.com/en-gb/media/press-releases/cdc-s-advisory-committee-on-immunization-practices-recommends-shingrix-as-the-preferred-vaccine-for-the-prevention-of-shingles-for-adults-aged-50-and-up/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                25 October 2017\n            CDC’s Advisory Committee on Immunization Practices recommends Shingrix as the preferred vaccine for the prevention of shingles for adults aged 50 and up\n                Committee recommends immunization for up to 62 million additional adults in the US\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Committee recommends immunization for up to 62 million additional adults in the US"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=4":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=6":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=5","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/roivant-subsidiary-dermavant-sciences-signs-agreement-with-gsk-to-purchase-rights-to-tapinarof/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                12 July 2018\n            Roivant subsidiary Dermavant Sciences signs agreement with GSK to purchase rights to tapinarof\n                GSK today announced that Dermavant Sciences, a subsidiary of Roivant Sciences, has agreed to purc...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that Dermavant Sciences, a subsidiary of Roivant Sciences, has agreed to purchase the rights to tapinarof, an investigational therapeutic aryl hydrocarbon receptor modulating agent (TAMA) for the treatment of psoriasis and atopic dermatitis and back-up programmes for a total consideration of £250 million, including an initial payment of £150 million and a potential future milestone payment of £100 million."}},"https://www.gsk.com/en-gb/media/press-releases/infants-may-now-be-protected-against-meningitis-b-with-fewer-doses-adding-flexibility-to-vaccination-schedules/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                27 June 2018\n            Infants may now be protected against Meningitis B with fewer doses, adding flexibility to vaccination schedules\n                Healthcare professionals now have more options to help protect infants from invasive meningococca...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Healthcare professionals now have more options to help protect infants from invasive meningococcal disease (IMD) caused by serogroup B, after European Commission approval  of an alternative Bexsero (rDNA, component, adsorbed)1 immunisation schedule requiring one less injection."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-landmark-phase-iii-studies-for-dolutegravir-and-lamivudine-demonstrating-the-ability-to-control-hiv-with-a-two-drug-regimen-in-treatment-na%C3%AFve-patients/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                14 June 2018\n            ViiV Healthcare reports landmark phase III studies for dolutegravir and lamivudine, demonstrating the ability to control HIV with a two-drug regimen in treatment naïve patients\n                GEMINI 1&2 studies meet primary endpoint, demonstrating similar efficacy of two-drug regimen comp...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GEMINI 1&2 studies meet primary endpoint, demonstrating similar efficacy of two-drug regimen compared to standard three-drug regimen"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-new-results-showing-low-rates-of-organ-damage-with-long-term-use-of-benlysta/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                13 June 2018\n            GSK presents new results showing low rates of organ damage with long term use of Benlysta\n                GSK today announced results from two new analyses showing low rates of organ damage progression i...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced results from two new analyses showing low rates of organ damage progression in patients with active systemic lupus erythematosus (SLE) treated with Benlysta (belimumab). These data will be presented at the 2018 Annual European College of Rheumatology (EULAR)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-changes-to-vaccines-and-global-manufacturing-supply-leadership/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                12 June 2018\n            GSK announces changes to Vaccines and Global Manufacturing & Supply leadership\n                Luc Debruyne, President, Vaccines, is to leave GSK at the end of the year.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Luc Debruyne, President, Vaccines, is to leave GSK at the end of the year."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-consumer-healthcare-buyout/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                01 June 2018\n            GSK completes Consumer Healthcare buyout\n                GSK has completed the buyout of Novartis’ 36.5% stake in its Consumer Healthcare Joint Venture fo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has completed the buyout of Novartis’ 36.5% stake in its Consumer Healthcare Joint Venture for $13 billion (£9.3 billion*)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-regulatory-application-in-japan-for-once-daily-single-inhaler-triple-therapy-ffumecvi-for-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                29 May 2018\n            GSK submits regulatory application in Japan for once-daily single inhaler triple therapy FF/UMEC/VI for patients with COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the submiss...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the submission of a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI 100/62.5/25 mcg) under the proposed brand name of Trelegy Ellipta"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-eu-marketing-authorisation-for-juluca-dolutegravirrilpivirine-the-first-2-drug-regimen-once-daily-single-pill-for-the-treatment-of-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                21 May 2018\n            ViiV Healthcare receives EU marketing authorisation for Juluca (dolutegravir/rilpivirine), the first 2-drug regimen, once-daily, single-pill for the treatment of HIV\n                Juluca maintains viral suppression with two drugs in the smallest single pill regimen\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Juluca maintains viral suppression with two drugs in the smallest single pill regimen"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-us-approval-of-arnuity-ellipta-for-use-in-children-from-5-years-old-who-suffer-from-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                21 May 2018\n            GSK receives US approval of Arnuity Ellipta for use in children from 5 years old who suffer from asthma\n                GSK today announced it has received approval from the US Food and Drug Administration (FDA) for t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced it has received approval from the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoate) a once-daily inhaled corticosteroid (ICS) medicine for the maintenance treatment of asthma in children from as young as 5 years. This makes Arnuity one of the few once-daily treatments for asthma licenced in the US in this younger age group, where there remains a significant need for convenient and effective treatment options."}},"https://www.gsk.com/en-gb/media/press-releases/nucala-mepolizumab-study-reports-long-term-safety-data-consistent-exacerbation-reduction-and-improved-asthma-control/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                21 May 2018\n            Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control\n                New study showed one third of patients had no exacerbations on long-term treatment with Nucala.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New study showed one third of patients had no exacerbations on long-term treatment with Nucala."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-industry-leading-respiratory-research-and-scientific-innovation-showcased-at-ats-conference/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                16 May 2018\n            GSK’s industry-leading respiratory research and scientific innovation showcased at ATS conference\n                GlaxoSmithKline plc (GSK) will present extensive data from across its respiratory portfolio, pipe...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) will present extensive data from across its respiratory portfolio, pipeline and early phase research programmes at the American Thoracic Society (ATS) conference in San Diego, USA, 19-23 May 2018."}},"https://www.gsk.com/en-gb/media/press-releases/simon-dingemans-chief-financial-officer-to-retire-from-gsk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                09 May 2018\n            Simon Dingemans, Chief Financial Officer, to retire from GSK\n                Simon Dingemans, Chief Financial Officer (CFO), GSK, has informed the Board of his intention to r...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Simon Dingemans, Chief Financial Officer (CFO), GSK, has informed the Board of his intention to retire from the Company and to step down from the Board in May 2019."}},"https://www.gsk.com/en-gb/media/press-releases/once-daily-trelegy-ellipta-gains-expanded-indication-in-the-us-for-the-treatment-of-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                24 April 2018\n            Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD\n                Expanded indication approved for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol ‘FF...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Expanded indication approved for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol ‘FF/UMEC/VI’)"}},"https://www.gsk.com/en-gb/media/press-releases/landmark-impact-study-published-in-nejm-shows-significant-benefits-of-trelegy-ellipta-for-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                18 April 2018\n            Landmark IMPACT study published in NEJM shows significant benefits of Trelegy Ellipta for patients with COPD\n                Once-daily single inhaler triple therapy superior to Relvar/Breo Ellipta and Anoro Ellipta across...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Once-daily single inhaler triple therapy superior to Relvar/Breo Ellipta and Anoro Ellipta across multiple endpoints including exacerbations, lung function and quality of life."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-appoints-kevin-sin-as-new-svp-and-head-of-worldwide-business-development-for-rd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                18 April 2018\n            GSK appoints Kevin Sin as new SVP and Head of Worldwide Business Development for R&D\n                Kevin Sin appointed as Senior Vice President and Head of Worldwide Business Development for Pharm...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Kevin Sin appointed as Senior Vice President and Head of Worldwide Business Development for Pharmaceuticals Research & Development."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-strategic-agreement-to-transfer-rare-disease-gene-therapy-portfolio-to-orchard-therapeutics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                12 April 2018\n            GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics\n                Agreement strengthens Orchard’s position as a global leader in gene therapy for rare diseases. GS...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Agreement strengthens Orchard’s position as a global leader in gene therapy for rare diseases. GSK takes 19.9% equity stake in Orchard and seat on board."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-gains-chmp-positive-opinion-for-juluca-dolutegravirrilpivirine-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                23 March 2018\n            ViiV Healthcare gains CHMP positive opinion for Juluca (dolutegravir/rilpivirine) in Europe\n                ViiV Healthcare today announced that the European Committee for Medicinal Products for Human Use ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced that the European Committee for Medicinal Products for Human Use has issued a Positive Opinion recommending marketing authorisation for Juluca."}},"https://www.gsk.com/en-gb/media/press-releases/shingrix-approved-in-europe-and-japan-for-the-prevention-of-shingles-in-adults-aged-50-and-over/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                23 March 2018\n            Shingrix approved in Europe and Japan for the prevention of shingles in adults aged 50 and over\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the European Commission has approved Shi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the European Commission has approved Shingrix for the prevention of shingles (herpes zoster) and post-herpetic neuralgia (PHN) in adults aged 50 years or older.[i] The Japanese Ministry of Health, Labour and Welfare (MHLW) has also approved Shingrix for the prevention of shingles (herpes zoster) in adults aged 50 years or older."}},"https://www.gsk.com/en-gb/media/press-releases/?&p=2":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-world-health-organization-prequalification-for-synflorix-pneumococcal-vaccine-four-dose-vial/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                18 October 2017\n            GSK receives World Health Organization Prequalification for Synflorix pneumococcal vaccine four-dose vial\n                The World Health Organization (WHO) has awarded prequalification for the new four-dose vial prese...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The World Health Organization (WHO) has awarded prequalification for the new four-dose vial presentation of Synflorix pneumococcal vaccine targeted mainly for countries that receive support from Gavi"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-first-approval-of-shingrix-in-canada/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                13 October 2017\n            GSK announces first approval of Shingrix in Canada\n                The only shingles vaccine to achieve ≥90% efficacy in adults aged 50 and over\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The only shingles vaccine to achieve ≥90% efficacy in adults aged 50 and over"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-approval-for-benlysta-in-japan-for-the-treatment-of-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                27 September 2017\n            GSK receives approval for Benlysta in Japan for the treatment of systemic lupus erythematosus\n                GSK announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic lupus erythematosus (SLE) who are inadequate responders to existing therapies."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-innoviva-report-positive-headline-results-from-impact-study-showing-single-inhaler-triple-therapy-trelegy-ellipta-reduced-copd-exacerbations/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                20 September 2017\n            GSK and Innoviva report positive headline results from IMPACT study showing single inhaler triple therapy Trelegy Ellipta reduced COPD exacerbations\n                Trelegy Ellipta met study primary endpoint demonstrating reduction in exacerbations compared with...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Trelegy Ellipta met study primary endpoint demonstrating reduction in exacerbations compared with the dual therapies Anoro Ellipta and Relvar/Breo Ellipta in patients with COPD"}},"https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-approved-as-the-first-once-daily-single-inhaler-triple-therapy-for-the-treatment-of-appropriate-patients-with-copd-in-the-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                18 September 2017\n            Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under the brand name Trelegy Ellipta, for the long-term, once-daily, maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, who are on a fixed-dose combination of fluticasone furoate and vilanterol for airflow obstruction and reducing exacerbations in whom additional treatment of airflow obstruction is desired or for patients who are already receiving umeclidinium and a fixed-dose combination of fluticasone furoate and vilanterol. Trelegy Ellipta is not indicated for relief of acute bronchospasm or the treatment of asthma."}},"https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-once-daily-single-inhaler-triple-therapy-receives-positive-opinion-from-the-chmp-in-europe-for-appropriate-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                15 September 2017\n            Trelegy Ellipta once-daily single inhaler triple therapy receives positive opinion from the CHMP in Europe for appropriate patients with COPD\n                EMA CHMP issues positive opinion for Trelegy Ellipta.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"EMA CHMP issues positive opinion for Trelegy Ellipta."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-chmp-positive-opinion-for-self-injectable-formulation-of-benlysta-for-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                15 September 2017\n            GSK receives CHMP positive opinion for self-injectable formulation of Benlysta for systemic lupus erythematosus\n                GSK today announced that the European Medicines Agency’s Committee for Medicinal Products for Hum...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion"}},"https://www.gsk.com/en-gb/media/press-releases/fda-advisory-committee-votes-unanimously-for-shingrix-hzsu-in-the-us-for-prevention-of-herpes-zoster-shingles-in-adults-ages-50-and-over/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                13 September 2017\n            FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over\n                GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the Vaccines and Related Biological Prod...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted unanimously that the data support the efficacy and safety of Shingrix for the prevention of herpes zoster (shingles) in adults ages 50 and over. FDA Advisory Committees provide non-binding recommendations for consideration by the FDA, with the final decision on approval made by the FDA."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-iii-results-published-in-nejm-of-mepolizumab-in-patients-with-eosinophilic-copd-at-risk-of-exacerbations/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                12 September 2017\n            GSK announces phase III results published in NEJM of mepolizumab in patients with eosinophilic COPD at risk of exacerbations\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the publication of full results from the \nph...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the publication of full results from the \nphase III studies for mepolizumab in chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/positive-results-from-pioneering-salford-lung-study-in-asthma-published-in-the-lancet-and-presented-at-european-respiratory-congress/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                11 September 2017\n            Positive results from pioneering Salford Lung Study in asthma published in The Lancet, and presented at European Respiratory Congress\n                Relvar Ellipta was superior to usual care treatment in improving asthma control for patients in S...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Relvar Ellipta was superior to usual care treatment in improving asthma control for patients in Salford Lung Study."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-exercises-option-on-phase-iii-ny-eso-t-cell-therapy-gsk3377794/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                07 September 2017\n            GSK exercises option on phase I/II NY-ESO T-cell therapy (GSK3377794)\n                Today GSK announced that it has exercised the option to obtain an exclusive global license from A...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Today GSK announced that it has exercised the option to obtain an exclusive global license from Adaptimmune for an investigational SPEAR T-cell receptor therapy targeting NY-ESO-1 (GSK3377794)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-respiratory-data-from-pipeline-to-clinical-practice-at-ers/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                04 September 2017\n            GSK presents respiratory data from pipeline to clinical practice at ERS\n                45 abstracts will be shared adding to clinical and scientific knowledge about current and future ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"45 abstracts will be shared adding to clinical and scientific knowledge about current and future treatments for patients with respiratory diseases"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-uk-life-sciences-industrial-strategy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                30 August 2017\n            GSK responds to UK Life Sciences Industrial Strategy \n                Read our response to the UK Life Sciences Industrial Strategy.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Read our response to the UK Life Sciences Industrial Strategy."}},"https://www.gsk.com/en-gb/media/press-releases/karenann-terrell-appointed-chief-digital-technology-officer-gsk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                25 July 2017\n            Karenann Terrell appointed Chief Digital & Technology Officer, GSK\n                GSK today announced that Karenann Terrell has been appointed Chief Digital & Technology Officer\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that Karenann Terrell has been appointed Chief Digital & Technology Officer"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-superior-efficacy-of-dolutegravir-versus-lopinavirritonavir-in-second-line-hiv-treatment-in-resource-limited-settings/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                25 July 2017\n            ViiV Healthcare announces superior efficacy of dolutegravir versus lopinavir/ritonavir in second-line HIV treatment in resource-limited settings\n                ViiV Healthcare, the global specialist HIV company, majority owned by GSK, with Pfizer Inc. and S...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare, the global specialist HIV company, majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive interim results from DAWNING."}},"https://www.gsk.com/en-gb/media/press-releases/switching-to-a-dolutegravir-regimen-from-a-boosted-protease-inhibitor-regimen-maintained-viral-suppression-and-improved-lipid-fractions-in-patients-with-hiv-and-high-cardiovascular-risk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                25 July 2017\n            Switching to a dolutegravir regimen from a boosted protease inhibitor regimen maintained viral suppression and improved lipid fractions in patients with HIV and high cardiovascular risk\n                ViiV Healthcare and NEAT-ID announced results from the NEAT 022 study of more than 400 patients w...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare and NEAT-ID announced results from the NEAT 022 study of more than 400 patients with HIV and high cardiovascular risk"}},"https://www.gsk.com/en-gb/media/press-releases/phase-ii-study-results-showed-comparable-viral-suppression-rates-at-96-weeks/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                24 July 2017\n            Phase II study results showed comparable viral suppression rates at 96 weeks for a two-drug regimen of long-acting cabotegravir and rilpivirine and a three-drug regimen in patients with HIV\n                LATTE-2 study results published in The Lancet and presented at International AIDS Society Meeting\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"LATTE-2 study results published in The Lancet and presented at International AIDS Society Meeting"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-us-regulatory-filing-of-arnuity-ellipta-in-children-with-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                24 July 2017\n            GSK submits US regulatory filing of Arnuity Ellipta in children with asthma\n                GSK today announced the filing of a supplementary New Drug Application (sNDA) to the US Food and ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the filing of a supplementary New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoate) as maintenance treatment of asthma as prophylactic therapy in children aged 5 to 11 years (inclusive). The sNDA is seeking approval for a dose of 50mcg once-daily, delivered using the Ellipta inhaler in this group of patients."}},"https://www.gsk.com/en-gb/media/press-releases/?&p=7":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=6","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-board-and-committee-changes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                21 July 2017\n            GSK announces Board and Committee changes\n                GSK today announces that Dr Laurie Glimcher has been appointed to the Board of the Company as a N...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announces that Dr Laurie Glimcher has been appointed to the Board of the Company as a Non-Executive Director and has been deemed a Scientific and Medical Expert."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-eu-filing-for-extended-use-of-relvar-ellipta-in-patients-with-controlled-asthma-on-an-icslaba-combination/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                21 July 2017\n            GSK submits EU filing for extended use of Relvar Ellipta in patients with controlled asthma on an ICS/LABA combination\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced a submissio...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced a submission to the European Medicines Agency (EMA) for the extended use of once-daily Relvar Ellipta (fluticasone furoate/vilanterol, FF/VI), an inhaled corticosteroid (ICS) / long-acting β2-agonist (LABA) combination, in patients already adequately controlled on an ICS/LABA combination."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-approval-for-a-new-self-injectable-formulation-of-benlysta-belimumab-for-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                21 July 2017\n            GSK receives FDA approval for a new self-injectable formulation of Benlysta (belimumab) for systemic lupus erythematosus\n                GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneou...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients with active, autoantibody positive SLE who are receiving standard therapy. Systemic Lupus Erythematosus (SLE) is the most common form of lupus, a chronic, incurable autoimmune disease producing autoantibodies that can attack almost any system in the body. The approval marks the first subcutaneous self-injection treatment option for patients with SLE."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-shares-data-from-its-innovative-portfolio-with-hiv-community-at-ias-2017/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                20 July 2017\n            ViiV Healthcare shares data from its innovative portfolio with HIV community at IAS 2017\n                ViiV Healthcare shares data from its innovative portfolio with HIV community at IAS 2017\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare shares data from its innovative portfolio with HIV community at IAS 2017"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-updates-on-uk-manufacturing-network/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                19 July 2017\n            GSK updates on UK manufacturing network\n                GSK today set out several announcements made by the company to improve the efficiency and competi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today set out several announcements made by the company to improve the efficiency and competitiveness of its manufacturing network."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-for-mepolizumab-in-eosinophilic-granulomatosis-with-polyangiitis-egpa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                28 June 2017\n            GSK announces US regulatory submission for mepolizumab in Eosinophilic Granulomatosis with Polyangiitis (EGPA)\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a supplemental Biologics Li...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a supplemental Biologics License Application (sBLA) to the United States Food and Drug Administration (FDA), seeking approval of mepolizumab, an interleukin-5 (IL-5) antagonist, as an add-on therapy to corticosteroids for the treatment of adult patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-nasal-polyps/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                27 June 2017\n            GSK starts phase III study with mepolizumab in patients with nasal polyps\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a phase III study with mepolizum...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a phase III study with mepolizumab, an interleukin 5 (IL-5) antagonist, in patients with severe bilateral nasal polyps.."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-chmp-positive-opinion-for-synflorix-pneumococcal-vaccine-four-dose-vial/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                27 June 2017\n            GSK receives CHMP positive opinion for Synflorix pneumococcal vaccine four-dose vial\n                New presentation designed to significantly reduce storage requirements in developing countries.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New presentation designed to significantly reduce storage requirements in developing countries."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-positive-results-from-phase-iii-revaccination-study-of-its-candidate-shingles-vaccine-shingrix-at-cdc-s-advisory-meeting/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                21 June 2017\n            GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC’s Advisory Meeting\n                Study conducted in individuals who had previously received current standard of care\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Study conducted in individuals who had previously received current standard of care"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-results-from-10-year-continuation-study-showing-sustained-disease-control-with-benlysta-belimumab-in-sle/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                16 June 2017\n            GSK announces results from 10-year continuation study showing sustained disease control with Benlysta (belimumab) in SLE\n                GSK today announced results from a 10-year continuation study, which showed that Benlysta (belimu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced results from a 10-year continuation study, which showed that Benlysta (belimumab) plus standard of care prolonged control of disease activity in patients with active systemic lupus erythematosus (SLE). Benlysta is a biologic medicine specifically developed and approved for SLE and this is the longest study to measure efficacy and safety of an SLE therapy."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-mmv-announce-positive-headline-phase-iii-results-showing-single-dose-tafenoquine-reduces-risk-of-relapse-in-patients-with-plasmodium-vivax-malaria/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                12 June 2017\n            GSK and MMV announce positive headline phase III results showing single-dose tafenoquine reduces risk of relapse in patients with Plasmodium vivax malaria\n                GSK and Medicines for Malaria Venture (MMV) today announced positive results from two phase III s...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Medicines for Malaria Venture (MMV) today announced positive results from two phase III studies of tafenoquine, an investigational 8-aminoquinoline, for the prevention of relapse of Plasmodium vivax (P.vivax) malaria."}},"https://www.gsk.com/en-gb/media/press-releases/four-innovations-to-tackle-under-five-deaths-win-us-1-million-healthcare-innovation-award-from-gsk-and-save-the-children/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                05 June 2017\n            Four innovations to tackle under-five deaths win US$1 million Healthcare Innovation Award from GSK and Save the Children\n                Organisations in Pakistan, Colombia, India and Nigeria recognised for innovations helping the har...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Organisations in Pakistan, Colombia, India and Nigeria recognised for innovations helping the hardest-to-reach children\nHealthcare Innovation Award (HIA) is a major initiative within five-year partnership to help save one million children’s lives"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                01 June 2017\n            ViiV Healthcare\n                ViiV Healthcare submits regulatory applications for the first HIV maintenance regimen comprising ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare submits regulatory applications for the first HIV maintenance regimen comprising only two medicines"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-submits-regulatory-applications-for-the-first-hiv-maintenance-regimen-comprising-only-two-medicines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                01 June 2017\n            ViiV Healthcare submits regulatory applications for the first HIV maintenance regimen comprising only two medicines\n                ViiV Healthcare submits regulatory applications for the first HIV maintenance regimen comprising ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare submits regulatory applications for the first HIV maintenance regimen comprising only two medicines"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-data-at-ats-on-treatment-effect-of-nucala-mepolizumab-in-severe-asthma-according-to-blood-eosinophil-level/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                22 May 2017\n            GSK presents data at ATS on treatment effect of Nucala (mepolizumab) in severe asthma according to blood eosinophil level\n                GlaxoSmithKline plc (LSE/NYSE:GSK) today presented data from a post-hoc analysis of the phase III...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE:GSK) today presented data from a post-hoc analysis of the phase IIIb MUSCA study in which first-in-class biologic Nucala (mepolizumab) consistently improved health-related quality of life and lung function in patients with severe asthma across blood eosinophil levels of 150 cells/µL and above."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-nejm-publication-of-positive-phase-iii-study-investigating-mepolizumab-in-patients-with-eosinophilic-granulomatosis-with-polyangiitis-egpa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                17 May 2017\n            GSK announces NEJM publication of positive phase III study investigating mepolizumab in patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA)\n                GSK announces NEJM publication of positive phase III study investigating mepolizumab in patients ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces NEJM publication of positive phase III study investigating mepolizumab in patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA)"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-headline-phase-iii-results-of-mepolizumab-in-patients-with-severe-chronic-obstructive-pulmonary-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                10 May 2017\n            GSK announces headline phase III results of mepolizumab in patients with severe chronic obstructive pulmonary disease\n                GlaxoSmithKline plc (LSE/NYSE:GSK) today announced preliminary results of two pivotal phase III s...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE:GSK) today announced preliminary results of two pivotal phase III studies evaluating the efficacy and safety of mepolizumab, an IL-5 antagonist monoclonal antibody, as an investigational add on treatment for adults who have chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype."}},"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-significantly-improved-asthma-control-in-salford-lung-study-patients-compared-with-their-usual-care/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                05 May 2017\n            Relvar Ellipta significantly improved asthma control in Salford Lung Study patients compared with their usual care\n                Primary endpoint showed patients initiated with Relvar Ellipta had twice the odds of achieving an...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Primary endpoint showed patients initiated with Relvar Ellipta had twice the odds of achieving an improvement in asthma control compared with patients continuing usual care."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-regulatory-submission-in-japan-of-its-candidate-vaccine-for-prevention-of-shingles/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                18 April 2017\n            GSK announces regulatory submission in Japan of its candidate vaccine for prevention of shingles\n                Follows regulatory submissions in US, EU and Canada\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Follows regulatory submissions in US, EU and Canada"}},"https://www.gsk.com/en-gb/media/press-releases/?p=11":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=8":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=7","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/togo-becomes-first-country-in-africa-to-validate-the-elimination-of-lymphatic-filariasis-as-a-public-health-problem/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                18 April 2017\n            Togo becomes first country in Africa to validate the elimination of lymphatic filariasis as a public health problem\n                LF, commonly known as elephantiasis, is a debilitating disease caused by a parasite transmitted t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"LF, commonly known as elephantiasis, is a debilitating disease caused by a parasite transmitted to humans through the bites of mosquitoes."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-makes-change-to-financial-reporting-framework/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                11 April 2017\n            GSK makes change to financial reporting framework\n                GSK keeps its financial reporting framework under regular review to ensure that it remains curren...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK keeps its financial reporting framework under regular review to ensure that it remains current and in line with both the latest regulatory requirements and developing best practice within the Pharmaceutical industry. As a result of its latest review, GSK will be making the following change to its financial reporting from Q1 2017."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-severe-hypereosinophilic-syndrome/":{"redirectedFrom":"http://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-severe-hypereosinophilic-syndrome/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-scholarships-to-recognise-retiring-ceo-sir-andrew-witty-s-contribution-to-global-health/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                29 March 2017\n            GSK announces new scholarships to recognise retiring CEO Sir Andrew Witty’s contribution to global health\n                GSK today announced a new partnership with the London School of Hygiene & Tropical Medicine to es...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced a new partnership with the London School of Hygiene & Tropical Medicine to establish the Sir Andrew Witty GSK Scholarships."}},"https://www.gsk.com/en-gb/media/press-releases/uk-biobank-gsk-and-regeneron-announce-largest-gene-sequencing-initiative-on-world-s-most-detailed-health-database-to-improve-drug-discovery-and-disease-diagnosis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                23 March 2017\n            UK Biobank, GSK and Regeneron announce largest gene sequencing initiative on world’s most detailed health database to improve drug discovery and disease diagnosis\n                Groundbreaking UK/US initiative will deliver first data within a year\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Groundbreaking UK/US initiative will deliver first data within a year"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-musca-study-shows-nucala-mepolizumab-significantly-improves-quality-of-life-and-lung-function-in-severe-asthma-patients-with-an-eosinophilic-phenotype/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                06 March 2017\n            GSK’s MUSCA study shows Nucala® (mepolizumab) significantly improves quality of life and lung function in severe asthma patients with an eosinophilic phenotype\n                MUSCA study shows asthma patients achieved improvements in their health-related quality of life a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"MUSCA study shows asthma patients achieved improvements in their health-related quality of life and lung function with Nucala® (mepolizumab)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-confirms-closure-of-agreement-to-divest-anaesthesia-portfolio-to-aspen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                01 March 2017\n            GSK confirms closure of agreement to divest anaesthesia portfolio to Aspen\n                GSK today announced the closure of an agreement with Aspen aligned with GSK’s strategy of simplif...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the closure of an agreement with Aspen aligned with GSK’s strategy of simplification through focusing on core therapeutic areas."}},"https://www.gsk.com/en-gb/media/press-releases/positive-results-for-relvar-ellipta-lung-function-study-in-patients-with-well-controlled-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                23 February 2017\n            Positive results for Relvar® Ellipta® lung function study in patients with well-controlled asthma\n                Positive headline results from a non-inferiority lung function study\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Positive headline results from a non-inferiority lung function study"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-detailed-positive-phase-iii-results-for-investigational-two-drug-regimen-of-dolutegravir-and-rilpivirine-for-hiv-treatment/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                13 February 2017\n            ViiV Healthcare announces detailed positive phase III results for investigational two-drug regimen of dolutegravir and rilpivirine for HIV treatment\n                Headline results were announced in December 2016 and detailed study results are being presented a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Headline results were announced in December 2016 and detailed study results are being presented at the annual Conference"}},"https://www.gsk.com/en-gb/media/press-releases/abbas-hussain-to-leave-gsk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                19 January 2017\n            Abbas Hussain to leave GSK\n                Abbas Hussain, President, Global Pharmaceuticals has decided to leave the company.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Abbas Hussain, President, Global Pharmaceuticals has decided to leave the company."}},"https://www.gsk.com/en-gb/media/press-releases/luke-miels-appointed-president-global-pharmaceuticals-gsk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                19 January 2017\n            Luke Miels appointed President, Global Pharmaceuticals, GSK\n                Luke Miels has been appointed President, Global Pharmaceuticals, GSK.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Luke Miels has been appointed President, Global Pharmaceuticals, GSK."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-confirms-closure-of-agreement-to-divest-non-core-assets-to-aspen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                03 January 2017\n            GSK confirms closure of agreement to divest non-core assets to Aspen\n                GlaxoSmithKline today announced the closure of one of its series of agreements with Aspen Pharmac...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline today announced the closure of one of its series of agreements with Aspen Pharmacare Holdings Limited (JSE: APN) and certain of its subsidiaries (“Aspen”), which were the subject of announcements by both companies on 12 September 2016."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-start-of-phase-iii-study-evaluating-long-acting-cabotegravir-for-hiv-prevention/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                20 December 2016\n            ViiV Healthcare announces start of phase III study evaluating long-acting cabotegravir for HIV prevention\n                First injectable to be studied for efficacy in pre-exposure prophylaxis\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First injectable to be studied for efficacy in pre-exposure prophylaxis"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-of-once-daily-closed-triple-combination-therapy-ffumecvi-in-patients-with-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                19 December 2016\n            GSK starts phase III study of once-daily closed triple combination therapy FF/UMEC/VI in patients with asthma\n                The start of a phase III study investigating the effects of once-daily closed triple combination ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The start of a phase III study investigating the effects of once-daily closed triple combination therapy (FF/UMEC/VI)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-board-changes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                19 December 2016\n            GSK announces Board changes\n                the creation of a new Board committee and a number of changes to the membership of the Board and ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"the creation of a new Board committee and a number of changes to the membership of the Board and its committees"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-positive-results-from-first-phase-iii-studies-of-two-drug-hiv-treatment-regimen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                19 December 2016\n            ViiV Healthcare announces positive results from first phase III studies of two-drug HIV treatment regimen\n                First phase III studies to show efficacy of two-drug regimen as maintenance therapy\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First phase III studies to show efficacy of two-drug regimen as maintenance therapy"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-chmp-positive-opinion-to-lower-the-age-and-weight-limit-for-tivicay-dolutegravir-in-children-and-adolescents-living-with-hiv-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                16 December 2016\n            ViiV Healthcare Announces CHMP positive opinion to lower the age and weight limit for Tivicay® (dolutegravir) in children and adolescents living with HIV in Europe\n                The CHMP has adopted a positive opinion to reduce the weight and age limit for the treatment of H...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The CHMP has adopted a positive opinion to reduce the weight and age limit for the treatment of HIV with Tivicay."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-regulatory-application-in-japan-for-belimumab-in-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                13 December 2016\n            GSK submits regulatory application in Japan for belimumab in systemic lupus erythematosus\n                Belimumab is a human monoclonal antibody that selectively targets B-lymphocyte stimulator an impo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Belimumab is a human monoclonal antibody that selectively targets B-lymphocyte stimulator an important factor in the survival of B cells."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-opens-new-global-vaccines-rd-center-in-rockville-md-usa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                13 December 2016\n            GSK opens new global vaccines R&D center in Rockville, MD, USA\n                New state-of-the-art facility will house 450 scientists and support staff, creating up to 200 new...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New state-of-the-art facility will house 450 scientists and support staff, creating up to 200 new jobs."}},"https://www.gsk.com/en-gb/media/press-releases/?p=12":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=9":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=8","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/dominique-limet-to-step-down-as-ceo-of-viiv-healthcare-deborah-waterhouse-to-succeed-him/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                05 December 2016\n            Dominique Limet to step down as CEO of ViiV Healthcare; Deborah Waterhouse to succeed him\n                After seven years as CEO of ViiV Healthcare, Dr Dominique Limet will step down at the end of Marc...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"After seven years as CEO of ViiV Healthcare, Dr Dominique Limet will step down at the end of March 2017."}},"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-10025-mcg-gains-approval-in-japan-for-use-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                02 December 2016\n            Relvar® Ellipta® 100/25 mcg gains approval in Japan for use in patients with COPD\n                Relvar is a combination of the inhaled corticosteroid, fluticasone furoate, and the long-acting b...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Relvar is a combination of the inhaled corticosteroid, fluticasone furoate, and the long-acting beta2 agonist, vilanterol ‘VI’."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-files-eu-regulatory-submission-for-once-daily-closed-triple-combination-therapy-ffumecvi-for-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                02 December 2016\n            GSK files EU regulatory submission for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD\n                The filing by GSK of a regulatory submission closed triple combination therapy FF/UMEC/VI 100/62....\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The filing by GSK of a regulatory submission closed triple combination therapy FF/UMEC/VI 100/62.5/25 mcg for patients with COPD."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-eu-regulatory-submission-of-candidate-vaccine-for-prevention-of-shingles-follows-regulatory-submissions-in-us-and-canada/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                25 November 2016\n            GSK announces EU regulatory submission of candidate vaccine for prevention of shingles -\tFollows regulatory submissions in US and Canada\n                Tthe regulatory submission of a MMA to the EMA seeking approval for ShingrixTM.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Tthe regulatory submission of a MMA to the EMA seeking approval for ShingrixTM."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-programme-with-daprodustat-for-anaemia-associated-with-chronic-kidney-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                24 November 2016\n            GSK starts phase III programme with daprodustat for anaemia associated with chronic kidney disease\n                The start of a phase III development programme investigating daprodustat as a treatment for anaem...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The start of a phase III development programme investigating daprodustat as a treatment for anaemia associated with CKD."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-lll-study-of-mepolizumab-meets-co-primary-endpoints-and-all-secondary-endpoints-in-patients-with-eosinophilic-granulomatosis-with-polyangiitis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                23 November 2016\n            GSK announces phase lll study of mepolizumab meets co-primary endpoints and all secondary endpoints in patients with eosinophilic granulomatosis with polyangiitis\n                Both co-primary endpoints and all secondary endpoints were met in a pivotal phase III study.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Both co-primary endpoints and all secondary endpoints were met in a pivotal phase III study."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-files-regulatory-submission-in-us-for-once-daily-closed-triple-combination-therapy-ffumecvi-for-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                21 November 2016\n            GSK files regulatory submission in US for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD\n                COPD is a disease of the lungs that includes chronic bronchitis, emphysema or both.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"COPD is a disease of the lungs that includes chronic bronchitis, emphysema or both."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-phase-iii-programme-to-evaluate-a-long-acting-injectable-hiv-treatment-regimen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                18 November 2016\n            ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen\n                ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Sh...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-approval-for-expanded-indication-for-flulaval-quadrivalent-influenza-vaccine-for-infants-6-months-and-older/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                18 November 2016\n            GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older\n                An approval from the US Food and Drug Administration’s (FDA) Center\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"An approval from the US Food and Drug Administration’s (FDA) Center"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-data-from-phase-iii-studies-of-sirukumab-in-adult-patients-with-moderately-to-severely-active-rheumatoid-arthritis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                16 November 2016\n            GSK announces new data from phase III studies of sirukumab in adult patients with moderately to severely active rheumatoid arthritis\n                Sirukumab is being co-developed as part of a collaboration with Janssen Biologics (Ireland) [Jans...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Sirukumab is being co-developed as part of a collaboration with Janssen Biologics (Ireland) [Janssen]."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-benlysta-belimumab-shows-sustained-benefits-in-patients-with-sle/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                16 November 2016\n            GSK’s Benlysta® (belimumab) shows sustained benefits in patients with SLE\n                GSK today announced results from a 7-year safety and efficacy continuation study for Benlysta® (b...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced results from a 7-year safety and efficacy continuation study for Benlysta® (belimumab)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-results-in-fourth-consecutive-pivotal-trial-of-benlysta-belimumab-in-sle/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                13 November 2016\n            GSK announces positive results in fourth consecutive pivotal trial of Benlysta® (belimumab) in SLE\n                Data in Japan, China and South Korea will form basis of new regulatory submissions for Benlysta\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Data in Japan, China and South Korea will form basis of new regulatory submissions for Benlysta"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-in-response-to-new-york-times-article-on-china/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                02 November 2016\n            GSK statement in response to New York Times article on China\n                These matters relating to our operations in China were deeply disappointing to GSK.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"These matters relating to our operations in China were deeply disappointing to GSK."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-new-data-for-shingles-candidate-vaccine-at-idweek-scientific-conference/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                27 October 2016\n            GSK presents new data for shingles candidate vaccine at IDWeek scientific conference\n                GSK today announced new data for its shingles candidate vaccine ShingrixTM.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced new data for its shingles candidate vaccine ShingrixTM."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-of-candidate-vaccine-for-prevention-of-shingles/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                24 October 2016\n            GSK announces US regulatory submission of candidate vaccine for prevention of shingles\n                Regulatory submissions in the EU and Canada remain on track for 2016\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Regulatory submissions in the EU and Canada remain on track for 2016"}},"https://www.gsk.com/en-gb/media/press-releases/new-data-published-for-gsk-s-nucala-investigating-hospitalisation-reduction-in-severe-asthma-patients-with-an-eosinophilic-phenotype/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                07 October 2016\n            New data published for GSK’s Nucala investigating hospitalisation reduction in severe asthma patients with an eosinophilic phenotype\n                The risk of hospitalisations or emergency room visits caused by asthma attacks was halved (51% re...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The risk of hospitalisations or emergency room visits caused by asthma attacks was halved (51% reduction p<0.001) in severe asthma patients"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-appoints-brian-mcnamara-as-ceo-of-gsk-consumer-healthcare/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                29 September 2016\n            GlaxoSmithKline plc appoints Brian McNamara as CEO of GSK Consumer Healthcare\n                Brian join GSK’s Corporate Executive Team and will continue as a member of the Board of the Consu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Brian join GSK’s Corporate Executive Team and will continue as a member of the Board of the Consumer Healthcare Joint Venture with Novartis."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-completes-sale-of-remaining-aspen-shares/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                29 September 2016\n            GlaxoSmithKline completes sale of remaining Aspen shares\n                GSK has agreed to the sale of 28.2 million ordinary shares in Aspen Pharmacare Holdings Ltd (\"Asp...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has agreed to the sale of 28.2 million ordinary shares in Aspen Pharmacare Holdings Ltd (\"Aspen\") at a price of ZAR 300 per share."}},"https://www.gsk.com/en-gb/media/press-releases/?p=13":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=10":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=9","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announces-intention-to-sell-remaining-holding-in-aspen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                28 September 2016\n            GlaxoSmithKline announces intention to sell remaining holding in Aspen\n                GSK intends to sell its remaining stake in Aspen Pharmacare Holdings Ltd (\"Aspen\").\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK intends to sell its remaining stake in Aspen Pharmacare Holdings Ltd (\"Aspen\")."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-for-sirukumab-in-rheumatoid-arthritis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                23 September 2016\n            GSK announces US regulatory submission for sirukumab in rheumatoid arthritis\n                Sirukumab is being co-developed for RA as part of a collaboration with Janssen Biologics (Ireland...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Sirukumab is being co-developed for RA as part of a collaboration with Janssen Biologics (Ireland) [Janssen], an affiliate of JBI."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-regulatory-submissions-for-subcutaneous-formulation-of-benlysta-belimumab-for-patients-with-systemic-lupus-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                23 September 2016\n            GSK announces regulatory submissions for subcutaneous formulation of Benlysta® (belimumab) for patients with systemic lupus disease\n                It has filed regulatory submissions in the US and Europe for Benlysta® (belimumab) for approval.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"It has filed regulatory submissions in the US and Europe for Benlysta® (belimumab) for approval."}},"https://www.gsk.com/en-gb/media/press-releases/emma-walmsley-to-succeed-andrew-witty-as-chief-executive-officer-of-glaxosmithkline/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                20 September 2016\n            Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline\n                Emma Walmsley, currently CEO of GSK’s Consumer Healthcare division, is appointed GSK CEO Designat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Emma Walmsley, currently CEO of GSK’s Consumer Healthcare division, is appointed GSK CEO Designate and will succeed Andrew Witty as GSK CEO."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-candidate-shingles-vaccine-shows-high-efficacy-against-shingles-and-its-complications-in-adults-aged-70-years-and-over-in-phase-iii-study-published-in-nejm/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                14 September 2016\n            GSK’s candidate shingles vaccine shows high efficacy against shingles and its complications in adults aged 70 years and over in phase III study published in NEJM\n                GSK on track to file regulatory applications in 2016\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK on track to file regulatory applications in 2016"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-eu-regulatory-submission-for-sirukumab-in-rheumatoid-arthritis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                12 September 2016\n            GSK announces EU regulatory submission for sirukumab in rheumatoid arthritis\n                Sirukumab is being co-developed for RA as part of a collaboration with Janssen Biologics (Ireland...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Sirukumab is being co-developed for RA as part of a collaboration with Janssen Biologics (Ireland) [Janssen]."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-divests-non-core-assets-to-aspen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                12 September 2016\n            GSK divests non-core assets to Aspen\n                A series of agreements Between Aspen and GSK through focusing on core therapeutic areas\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A series of agreements Between Aspen and GSK through focusing on core therapeutic areas"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-positive-results-from-phase-iii-fulfil-study-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-copd-at-ers-international-congress/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                06 September 2016\n            GSK presents positive results from phase III FULFIL study of closed triple combination therapy FF/UMEC/VI versus Symbicort® Turbohaler® in COPD at ERS International Congress\n                Improvements in lung function and health-related quality of life supported by statistically signi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Improvements in lung function and health-related quality of life supported by statistically significant reductions in exacerbations"}},"https://www.gsk.com/en-gb/media/press-releases/real-world-data-shows-83-percent-effectiveness-for-bexsero-in-infants-in-first-year-of-uk-national-meningitis-b-immunisation-programme/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                05 September 2016\n            ‘Real world’ data shows 83 percent effectiveness for Bexsero® in infants in first year of UK national meningitis B immunisation programme\n                Cases of meningitis B halved after ten months\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Cases of meningitis B halved after ten months"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announce-positive-results-from-the-copd-salford-lung-study-published-in-the-nejm-and-presented-at-european-respiratory-congress/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                04 September 2016\n            GSK announce positive results from the COPD Salford Lung Study published in the NEJM and presented at European Respiratory Congress\n                The results from the pioneering Salford Lung Study (SLS) have been published in the New England J...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The results from the pioneering Salford Lung Study (SLS) have been published in the New England Journal of Medicine (NEJM)."}},"https://www.gsk.com/en-gb/media/press-releases/nejm-publishes-results-of-gsk-s-long-term-laba-safety-study-of-advair-diskus-in-children-aged-4-11-years-with-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                01 September 2016\n            NEJM publishes results of GSK’s long-term LABA safety study of Advair® Diskus® in children aged  4-11 years with asthma\n                Headline results reported in March, demonstrated that the study had achieved its primary endpoint.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Headline results reported in March, demonstrated that the study had achieved its primary endpoint."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-continued-commitment-to-innovative-respiratory-research-demonstrated-in-european-respiratory-society-congress-data-presentations/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                27 August 2016\n            GSK’s continued commitment to innovative respiratory research demonstrated in European Respiratory Society congress data presentations\n                More than 30 abstracts from the company will be featured at the meeting.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"More than 30 abstracts from the company will be featured at the meeting."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-phase-iii-programme-evaluating-a-two-drug-regimen-combining-dolutegravir-and-lamivudine-for-hiv-1-treatment/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                16 August 2016\n            ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment\n                HIV care is a long-term prospect for those living with the disease, requiring life-long adherence...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"HIV care is a long-term prospect for those living with the disease, requiring life-long adherence to treatment."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-verily-to-establish-galvani-bioelectronics-a-new-company-dedicated-to-the-development-of-bioelectronic-medicines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                01 August 2016\n            GSK and Verily to establish Galvani Bioelectronics – a new company dedicated to the development of bioelectronic medicines\n                GSK will hold a 55% equity interest in the new jointly owned company and Verily will hold 45%.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK will hold a 55% equity interest in the new jointly owned company and Verily will hold 45%."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-in-licenses-anti-il-33r-monoclonal-antibody-for-severe-asthma-from-janssen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                27 July 2016\n            GSK in-licenses anti-IL-33R monoclonal antibody for severe asthma from Janssen \n                Agreement further strengthens respiratory pipeline of targeted biological therapies\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Agreement further strengthens respiratory pipeline of targeted biological therapies"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-significant-new-investment-in-uk-manufacturing-network/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                27 July 2016\n            GSK announces significant new investment in UK manufacturing network\n                GSK today announced £275 million of new investments at three of its manufacturing sites in the UK...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced £275 million of new investments at three of its manufacturing sites in the UK to boost production and support delivery of its latest innovative respiratory and large molecule biological medicines. The vast majority of these products will be for export to global markets."}},"https://www.gsk.com/en-gb/media/press-releases/aria-study-shows-superior-efficacy-of-triumeq-for-treatment-na%C3%AFve-women-living-with-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                18 July 2016\n            ARIA study shows superior efficacy of Triumeq® for treatment-naïve women living with HIV\n                ViiV Healthcare today presented 48-week data from the phase IIIb, open-label, international, mult...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior efficacy for Triumeq® (dolutegravir/abacavir/lamivudine) compared with atazanavir boosted with ritonavir (ATV/r) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in 495 treatment-naïve women living with HIV."}},"https://www.gsk.com/en-gb/media/press-releases/?p=14":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=11":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=10","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-commits-further-funding-to-advance-bioelectronics-research-with-creation-of-5-million-innovation-challenge-fund/":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"$5m Innovation Challenge Fund","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced a $5 million ICF to further encourage and advance collaborative research as part of its effort to develop bioelectronic medicines."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-launches-50-million-venture-capital-fund-to-invest-in-pioneering-bioelectronic-medicines-and-technologies/":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"$50m venture capital fund","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the launch of Action Potential Venture Capital Limited, a new $50 million strategic venture capital fund that will invest in companies that pioneer bioelectronic medicines and technologies.\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-1-million-innovation-prize-for-bioelectronics-research/":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"$1m innovation prize for bioelectronics research","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK is announcing today a $1 million dollar prize for innovation in the emerging area of bioelectronics research."}},"https://www.gsk.com/media/3208/efpia-self-certification.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"EFPIA Disclosure Code 2018 Self-Certification Scheme","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Austria","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Austria"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/belgium/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Belgium","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Belgium"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Bulgaria","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Bulgaria"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Croatia","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Croatia"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Cyprus","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Cyprus"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Czech Republic","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in the Czech Republic"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/denmark/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Denmark","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Denmark"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Estonia","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Estonia"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Finland","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Finland"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"France","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Publication des transferts de valeurs consentis aux professionnels de santé en France"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Germany","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Offenlegung von Zahlungen an medizinische Fachkräfte in Deutschland"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Greece","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of transfers of value by GlaxoSmithKline A.E.B.E., in accordance with article 66 par. 7a of Law 4316/2014, SFEE and EFPIA Disclosure Code."}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Hungary","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Hungary"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ireland/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Ireland","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Ireland"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Italy","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of the transfers of value to healthcare professionals in Italy"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Latvia","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Latvia"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Lithuania","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Lithuania"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Luxembourg","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Luxembourg"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/malta/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Malta","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Malta"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/netherlands/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Netherlands","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in The Netherlands"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Norway","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Norway"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Poland","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Poland"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/portugal/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Portugal","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Portugal"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Romania","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Romania"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Russia","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Russia"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Serbia and Montenegro","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Serbia"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Slovakia","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Slovakia"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Slovenia","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs and HCOs in Slovenia"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Spain","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Publicación de las transferencias de valor realizadas a los profesionales y organizaciones sanitarias en España"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Sweden","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Sweden"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Switzerland","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Switzerland"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/turkey/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Turkey","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"EFPIA-AIFD PUBLIC STATEMENT"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"Ukraine","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in Ukraine"}},"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/united-kingdom/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/","txt":"United Kingdom","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Disclosure of payments made to HCPs in the UK"}},"https://www.gsk.com/media/4964/data-privacy-notice_austria.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Austria","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4965/data-privacy-notice_belgium_dutch.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Belgium (Dutch)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4966/data-privacy-notice_belgium_french.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Belgium (French)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4967/data-privacy-notice_bulgaria.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Bulgaria","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4968/data-privacy-notice_croatia.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Croatia","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4969/data-privacy-notice_cyprus.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Cyprus","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4970/data-privacy-notice_czechia.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Czechia","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4971/data-privacy-notice_denmark.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Denmark","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5049/data-privacy-notice_estonia.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Estonia","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4972/data-privacy-notice_finland.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Finland","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4973/data-privacy-notice_france.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"France","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4974/data-privacy-notice_germany.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Germany","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4975/data-privacy-notice_greece.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Greece","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4976/data-privacy-notice_hungary.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Hungary","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4977/data-privacy-notice_ireland.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Ireland","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/5046/data-privacy-notice_italy.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Italy","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4978/data-privacy-notice_latvia.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Latvia","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4979/data-privacy-notice_lithuania.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Lithuania","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4980/data-privacy-notice_malta.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Malta","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4981/data-privacy-notice_norway.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Norway","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4982/data-privacy-notice_poland.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Poland","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4983/data-privacy-notice_portugal.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Portugal","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4984/data-privacy-notice_romania.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Romania","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4985/data-privacy-notice_slovakia.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Slovakia","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4986/data-privacy-notice_slovenia.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Slovenia","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4987/data-privacy-notice_spain.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Spain","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4988/data-privacy-notice_sweden.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"Sweden","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4989/data-privacy-notice_the_netherlands.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"The Netherlands","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4990/data-privacy-notice_united_kingdom.pdf":{"firstFound":"https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","txt":"United Kingdom","status":"done","statusCode":200,"results":{"video":[]}},"http://www.gsk.com/en-gb/partnerships/our-areas-of-interest/":{"firstFound":"https://www.gsk.com/en-gb/partnerships/business-development/vaccines-collaborations/","txt":"our areas of interest","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Find out about the key therapeutic areas we are interested in collaborating on"},"redirectedTo":"https://www.gsk.com/en-gb/partnerships/our-areas-of-interest/"},"https://www.gsk.com/media/2755/bioelectronics-million-dollar-challenge-success-criteria.pdf":{"firstFound":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","txt":"Download the success criteria (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3320/capacity-and-capabilities-presentation.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/active-pharmaceutical-ingredients/","txt":"Download capacity and capabilities presentation (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3321/high-containment-capability-presentation.pdf":{"redirectedFrom":"https://www.gsk.com/media/3325/jurong-site-brochure.docx"},"https://www.gsk.com/media/3322/nanomilling-overview.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/active-pharmaceutical-ingredients/","txt":"Download nanomilling overview (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3323/manufacturing-brochure.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/active-pharmaceutical-ingredients/","txt":"Download manufacturing brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3324/ulverston-site-brochure.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/active-pharmaceutical-ingredients/","txt":"Download Ulverston site brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/3325/jurong-site-brochure.docx":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/active-pharmaceutical-ingredients/","txt":"Download Jurong site brochure","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/3321/high-containment-capability-presentation.pdf"},"https://www.gsk.com/media/2765/gms-product-and-service-information-brochure.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/foams-liquids-and-topicals/","txt":"Download product and service information guide (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2773/sterile-ampoule-facility.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/steriles-and-clean-liquids/","txt":"Download sterile ampoule facility brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2769/nasal-spray-brochure.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/steriles-and-clean-liquids/","txt":"Download nasal spray unit brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2767/sterile-high-contrainment-facility-leaflet.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/steriles-and-clean-liquids/","txt":"Download sterile high-containment facility brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2768/freeze-drying-facility-leaflet.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/steriles-and-clean-liquids/","txt":"Download freeze dry facility brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2772/small-scale-sterile-facility-leaflet.pdf":{"redirectedFrom":"https://www.gsk.com/media/2778/presentation-pack-2012.ppt"},"https://www.gsk.com/media/2770/oral-high-containment-facility.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/steriles-and-clean-liquids/","txt":"Download oral high-containment facility brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2766/tablet-production-leaflet.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/steriles-and-clean-liquids/","txt":"Download tablet production brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2757/cephs-customer-catalogue.pdf":{"redirectedFrom":"https://www.gsk.com/media/2775/biopharm-capabilites-2013.pptx"},"https://www.gsk.com/media/2780/worthing-and-mayenne-product-catalogue.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/antibiotics/","txt":"Download product catalogue (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2779/product-pack-brief.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/antibiotics/","txt":"Download product guide (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2778/presentation-pack-2012.ppt":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/antibiotics/","txt":"Download Verona site brochure (PDF)","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/2772/small-scale-sterile-facility-leaflet.pdf"},"https://www.gsk.com/media/2781/diffcore-development-flyer.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/platform-technologies/","txt":"Download information brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2758/liquid-dispensing-technology-leaflet.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/platform-technologies/","txt":"Download information brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2775/biopharm-capabilites-2013.pptx":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/biopharm/","txt":"Download manufacturing capabilities brochure (PDF)","status":"redirected","error":{},"results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/2757/cephs-customer-catalogue.pdf"},"https://www.gsk.com/media/2759/dermatologicals-leaflet.pdf":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/foams-liquids-and-topicals/","txt":"Download site brochure (PDF)","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/contact-us/worldwide/dominican-republic/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Dominican Republic"}},"https://www.gsk.com/en-gb/contact-us/worldwide/ecuador/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Ecuador"}},"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Egypt"}},"https://www.gsk.com/en-gb/contact-us/worldwide/el-salvador/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK El Salvador"}},"https://www.gsk.com/en-gb/contact-us/worldwide/estonia/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Estonia"}},"https://www.gsk.com/en-gb/contact-us/worldwide/guatemala/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Guatemala"}},"https://www.gsk.com/en-gb/contact-us/worldwide/honduras/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Honduras"}},"https://www.gsk.com/en-gb/contact-us/worldwide/israel/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Israel"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=1":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?p=1":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=3":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/jamaica/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=3","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Jamaica"}},"https://www.gsk.com/en-gb/contact-us/worldwide/kenya/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=3","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Kenya"}},"https://www.gsk.com/en-gb/contact-us/worldwide/macedonia/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=3","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Macedonia"}},"https://www.gsk.com/en-gb/contact-us/worldwide/malta/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=3","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Malta"}},"https://www.gsk.com/en-gb/contact-us/worldwide/morocco/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=3","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Morocco"}},"https://www.gsk.com/en-gb/contact-us/worldwide/myanmar/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=3","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Myanmar"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=2":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=4":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/trinidad-tobago/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=5","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Trinidad & Tobago"}},"https://www.gsk.com/en-gb/contact-us/worldwide/tunisia/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=5","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Tunisia"}},"https://www.gsk.com/en-gb/contact-us/worldwide/united-arab-emirates/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=5","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK United Arab Emirates"}},"https://www.gsk.com/en-gb/contact-us/worldwide/uruguay/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=5","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Uruguay"}},"https://www.gsk.com/en-gb/contact-us/worldwide/venezuela/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=5","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Venezuela"}},"https://www.gsk.com/en-gb/contact-us/worldwide/panama/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=4","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Panama"}},"https://www.gsk.com/en-gb/contact-us/worldwide/peru/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=4","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Peru"}},"https://www.gsk.com/en-gb/contact-us/worldwide/philippines/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=4","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Philippines"}},"https://www.gsk.com/en-gb/contact-us/worldwide/saudi-arabia/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=4","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Saudi Arabia"}},"https://www.gsk.com/en-gb/contact-us/worldwide/south-africa/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=4","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK South Africa"}},"https://www.gsk.com/en-gb/contact-us/worldwide/sri-lanka/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=4","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Sri Lanka"}},"https://www.gsk.com/en-gb/contact-us/worldwide/thailand/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=4","txt":"More info","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK Thailand"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=5":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?p=4","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/responsibility/health-for-all/hiv-aids-and-viiv-healthcare/":{"redirectedFrom":"http://www.gsk.com/en-gb/responsibility/health-for-all/hiv-aids-and-viiv-healthcare/"},"https://www.gsk.com/en-gb/research/rd-locations/uk/":{"redirectedFrom":"http://www.gsk.com/en-gb/research/rd-locations/uk/"},"http://www.gsk.com/en-gb/behind-the-science/supporting-community-health/":{"firstFound":"https://www.gsk.com/en-gb/media/infographic-impacthealthcare/","txt":"GSK","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/behind-the-science/supporting-community-health/"},"https://www.gsk.com/en-gb/behind-the-science/supporting-community-health/":{"redirectedFrom":"http://www.gsk.com/en-gb/behind-the-science/supporting-community-health/"},"https://www.gsk.com/content/gsk/en.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/media/1802/respiratory-pipeline.jpg?anchor=center&mode=crop&quality=90&width=960&height=0&rnd=131293179630000000":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/respiratory-research/","txt":"\n                    \n                    \n                        \n                    \n                ","status":"done","statusCode":200,"results":{"video":[],"title":{}}},"https://www.gsk.com/media/1410/product-pipeline-march-2016.pdf":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/respiratory-research/","txt":"\n                Product pipeline march 2016 PDF - 814.1KB\n                \n              ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4993/2018-gsk-compliance-program-us-operations.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/california-compliance-law/","txt":"\n                        GSK ethics & compliance program - US Operations\n                        PDF - 195.1KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/4992/2018-ca-annual-declaration-of-compliance.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/california-compliance-law/","txt":"\n                        California Annual Declaration of Compliance\n                        PDF - 85.7KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/media/2503/safe-needle-disposal-plan-july-1-2010.pdf":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/california-compliance-law/","txt":"\n                        Safe needle disposal plan\n                        PDF - 32.4KB\n                        \n                    ","status":"done","statusCode":200,"results":{"video":[]}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=2","txt":"\n                            business operations \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=10","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/henry/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/hewan-commercial-management-turkey/","txt":"\n                        \n                                \n                        \n                            Henry\n                                                    \"It gives me a good feeling knowing that my work is actually helping people.\"\n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"\"It gives me a good feeling knowing that my work is actually helping people.\""}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=engineering&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&+Government+Affairs&r=usa&r=gbr%2cusa&city=&city=&et=&et=&prog=graduate&prog=graduate&cl=8680&bu","txt":"\n                        Communications \n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&+Government+Affairs&r=usa&r=gbr%2cusa&city=&city=&et=&et=&prog=graduate&prog=graduate&cl=8680&bu","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&+Government+Affairs&r=usa&r=gbr%2cusa&city=&city=&et=&et=&prog=graduate&prog=graduate&cl=8680&bu","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&+Government+Affairs&r=usa&r=gbr%2cusa&city=&city=&et=&et=&prog=graduate&prog=graduate&cl=8680&bu","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&+Government+Affairs&r=usa&r=gbr%2cusa&city=&city=&et=&et=&prog=graduate&prog=graduate&cl=8680&bu","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2C+Safety+%26+Sustainability&bu=&r=gbr&city=&et=&prog=graduate&cl=8680","txt":"\n                        Environmental Health, Safety & Sustainability \n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety+%26+Sustainability&bu=&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2C+Safety+%26+Sustainability&bu=&r=gbr&city=&et=&prog=graduate&cl=8680","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety+%26+Sustainability&bu=&r=gbr&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2C+Safety+%26+Sustainability&bu=&r=gbr&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental%20Health,%20Safety%20&%20Sustainability&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2C+Safety+%26+Sustainability&bu=&r=gbr&city=&et=&prog=graduate&cl=8680","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel,chn,gbr,usa&city=&cl=8680&et=&prog=graduate","txt":"\n                        finance \n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel,chn,gbr,usa&city=&cl=8680&et=&prog=graduate","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel,chn,gbr,usa&city=&cl=8680&et=&prog=graduate","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel,chn,gbr,usa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel,chn,gbr,usa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel,chn,gbr,usa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel,chn,gbr,usa&city=&cl=8680&et=&prog=graduate","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=human+resources&cl=8680&bu=&r=&city=&et=&prog=graduate","txt":"\n                        human resources \n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=human+resources&cl=8680&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=human+resources&cl=8680&bu=&r=&city=&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=human%20resources&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=human+resources&cl=8680&bu=&r=&city=&et=&prog=graduate","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=graduate","txt":"\n                        procurement \n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=graduate","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=graduate","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing%20and%20communications&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            marketing and communications \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing%20and%20communications&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                        engineering \n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=graduate&cl=8680","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=graduate&cl=8680","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing%20and%20supply&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680&ps=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Analytical+Chemistry+Microbiology+pharmaceutical+Science&r=&city=&et=&prog=graduate&cl=8680&ps=100","txt":"\n                        Analytical Chemistry Microbiology pharmaceutical Science \n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Analytical+Chemistry+Microbiology+pharmaceutical+Science&r=&city=&et=&prog=&cl=8680&ps=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Analytical+Chemistry+Microbiology+pharmaceutical+Science&r=&city=&et=&prog=graduate&cl=8680&ps=100","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Analytical%20Chemistry%20Microbiology%20pharmaceutical%20Science&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Analytical+Chemistry+Microbiology+pharmaceutical+Science&r=&city=&et=&prog=graduate&cl=8680&ps=100","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=drug+design+and+selection&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=drug+design+and+selection&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=drug%20design%20and%20selection&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=drug+design+and+selection&r=&city=&et=&prog=graduate&cl=8680","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Clinical+programming&r=&city=&et=&prog=&cl=8680&ps=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Clinical+programming&r=&city=&et=&prog=graduate&cl=8680&ps=100","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Clinical%20programming&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Clinical+programming&r=&city=&et=&prog=graduate&cl=8680&ps=100","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/meet-our-people/dee-rd-uk/":{"redirectedFrom":"https://www.gsk.com/en-gb/careers/meet-our-people/dee/"},"http://www.gsk.com/en-gb/careers/graduates/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/dee-rd-uk/","txt":"GSK’s graduate scheme","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Student and graduate opportunities with one of the world's leading global healthcare companies."},"redirectedTo":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/"},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory%20affairs&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=graduate&cl=8680","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&r=&city=&et=&prog=graduate&cl=8680","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research%20and%20development&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/media/841910/q3-2015-results-announcement.pdf":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"http://www.gsk.com/en-gb/investors/quarterly-results/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-third-quarter-2015/","txt":"quarterly results","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"},"redirectedTo":"https://www.gsk.com/en-gb/investors/quarterly-results/"},"http://www.gsk.com/media/3696/q1-2017-results-announcement.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-another-quarter-of-continued-progress/","txt":"Download full results announcement (PDF)","status":"redirected","statusCode":"200,301","results":{"video":[]},"redirectedTo":"https://www.gsk.com/media/3696/q1-2017-results-announcement.pdf"},"http://www.gsk.com/investors/reports/q32010/q32010.pdf":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=3","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=3","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=3","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=3","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=3","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=3","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?&p=5","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Discover our latest financial performance announcement and search for historical quarterly results materials"}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?&p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?&p=3","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?&p=1","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Search through our archive of speeches and presentations from conferences and events"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=2":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=1","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=3":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=1","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=4":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=1","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=5":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=1","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=6":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=1","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=7":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=1","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=8":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=1","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=9":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=1","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=10":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=1","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/products/index.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/umbraco/about%20us":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-data-supports-the-safety-and-efficacy-of-gsk-s-shingrix-in-preventing-shingles-in-autologous-haematopoietic-stem-cell-transplant-patients/","txt":"about us","status":"done","statusCode":502,"results":{"video":[],"title":{}}},"https://www.gsk.com/umbraco/Cautionary%20statement%20regarding%20forward-looking%20statements%20GSK%20cautions%20investors%20that%20any%20forward-looking%20statements%20or%20projections%20made%20by%20GSK,%20including%20those%20made%20in%20this%20announcement,%20are%20subject%20to%20risks%20and%20uncertainties%20that%20may%20cause%20actual%20results%20to%20differ%20materially%20from%20those%20projected.%20Such%20factors%20include,%20but%20are%20not%20limited%20to,%20those%20described%20under%20Item%203.D%20Principal%20risks%20and%20uncertainties%20in%20the%20company's%20Annual%20Report%20on%20Form%2020-F%20for%202017.%20%20Innoviva%20forward-looking%20statements%20This%20press%20release%20contains%20certain%20%22forward-looking%22%20statements%20as%20that%20term%20is%20defined%20in%20the%20Private%20Securities%20Litigation%20Reform%20Act%20of%201995%20regarding,%20among%20other%20things,%20statements%20relating%20to%20goals,%20plans,%20objectives%20and%20future%20events,%20including%20the%20development,%20regulatory%20and%20commercial%20plans%20for%20closed%20triple%20combination%20therapy%20and%20the%20potential%20benefits%20and%20mechanisms%20of%20action%20of%20closed%20triple%20combination%20therapy.%20Innoviva%20intends%20such%20forward-looking%20statements%20to%20be%20covered%20by%20the%20safe%20harbor%20provisions%20for%20forward-looking%20statements%20contained%20in%20Section%2021E%20of%20the%20Securities%20Exchange%20Act%20of%201934%20and%20the%20Private%20Securities%20Litigation%20Reform%20Act%20of%201995.%20Such%20forward-looking%20statements%20involve%20substantial%20risks,%20uncertainties%20and%20assumptions.%20These%20statements%20are%20based%20on%20the%20current%20estimates%20and%20assumptions%20of%20the%20management%20of%20Innoviva%20as%20of%20the%20date%20of%20this%20press%20release%20and%20are%20subject%20to%20risks,%20uncertainties,%20changes%20in%20circumstances,%20assumptions%20and%20other%20factors%20that%20may%20cause%20the%20actual%20results%20of%20Innoviva%20to%20be%20materially%20different%20from%20those%20reflected%20in%20the%20forward-looking%20statements.%20Important%20factors%20that%20could%20cause%20actual%20results%20to%20differ%20materially%20from%20those%20indicated%20by%20such%20forward-looking%20statements%20are%20described%20under%20the%20headings%20%22Risk%20Factors%22%20and%20%22Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations%22%20contained%20in%20Innoviva's%20Annual%20Report%20on%20Form%2010-K%20for%20the%20year%20ended%20December%2031,%202017%20and%20Innoviva%E2%80%99s%20Quarterly%20Report%20on%20Form%2010-Q%20for%20the%20quarter%20ended%20March%2031,%202018,%20both%20of%20which%20are%20on%20file%20with%20the%20Securities%20and%20Exchange%20Commission%20(SEC)%20and%20available%20on%20the%20SEC's%20website%20at%20www.sec.gov.%20In%20addition%20to%20the%20risks%20described%20above%20and%20in%20Innoviva's%20other%20filings%20with%20the%20SEC,%20other%20unknown%20or%20unpredictable%20factors%20also%20could%20affect%20Innoviva's%20results.%20No%20forward-looking%20statements%20can%20be%20guaranteed%20and%20actual%20results%20may%20differ%20materially%20from%20such%20statements.%20Given%20these%20uncertainties,%20you%20should%20not%20place%20undue%20reliance%20on%20these%20forward-looking%20statements.%20The%20information%20in%20this%20press%20release%20is%20provided%20only%20as%20of%20the%20date%20hereof,%20and%20Innoviva%20assumes%20no%20obligation%20to%20update%20its%20forward-looking%20statements%20on%20account%20of%20new%20information,%20future%20events%20or%20otherwise,%20except%20as%20required%20by%20law.%20(INVA-G)%20%20%20References%20(accessed%20April%202018)%20%201.Fukuchi%20Y%20et%20al.%20Prevalence%20of%20COPD%20in%20Japan:%20results%20from%20the%20NIPPON%20COPD%20epidemiology%20(NICE)%20study.%20Eur%20Respir%20J.%202001.%20%202.Lipson%20DA%20et%20al.%20FULFIL%20Trial:%20Once-Daily%20Triple%20Therapy%20for%20Patients%20with%20Chronic%20Obstructive%20Pulmonary%20Disease.%20Am%20J%20Resp%20Crit%20Care%20Med.%202017.%203.Lipson%20DA%20et%20al.%20Once-Daily%20Single%20Inhaler%20Triple%20Versus%20Dual%20Therapy%20in%20Patients%20with%20COPD.%20New%20England%20Journal%20of%20Medicine.%202018.%20%204.Global%20Strategy%20for%20the%20Diagnosis,%20Management%20and%20Prevention%20of%20COPD,%20Global%20Initiative%20for%20Chronic%20Obstructive%20Lung%20Disease%20(GOLD)%202017.%20Available%20from:%20http:/goldcopd.org.%205.Diagnosis%20of%20COPD.%20World%20Health%20Organization.%20Available%20at:%20http:/www.who.int/respiratory/copd/diagnosis/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-regulatory-application-in-japan-for-once-daily-single-inhaler-triple-therapy-ffumecvi-for-patients-with-copd/","txt":"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Trelegy/pdf/TRELEGY-PI-MG-IFU.PDF","status":"done","statusCode":502,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=11":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/new-phase-iii-data-shows-greater-treatment-response-with-gsk-s-benlysta-belimumab-vs-placebo-in-patients-with-highly-active-sle/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-approval-for-a-new-self-injectable-formulation-of-benlysta-belimumab-for-systemic-lupus-erythematosus/","txt":"\n                            \n                            \n                            \n                                    New Phase III data shows greater treatment response with GSK’s Benlysta® (belimumab) vs placebo in patients with highly active SLE\n                                                                    BLISS-SC builds on an extensive clinical trial programme for belimumab, which is the largest clinical programme in SLE to date.\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"BLISS-SC builds on an extensive clinical trial programme for belimumab, which is the largest clinical programme in SLE to date."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-results-from-phase-iii-bliss-sc-study-of-benlysta-belimumab-administered-subcutaneously-in-patients-with-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-approval-for-a-new-self-injectable-formulation-of-benlysta-belimumab-for-systemic-lupus-erythematosus/","txt":"\n                            \n                            \n                            \n                                    GSK announces positive results from phase III BLISS-SC study of Benlysta® (belimumab) administered subcutaneously in patients with systemic lupus erythematosus\n                                                                    GSK announces positive results from phase III BLISS-SC study of Benlysta® (belimumab) administered subcutaneously in patients with systemic lupus erythematosus\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces positive results from phase III BLISS-SC study of Benlysta® (belimumab) administered subcutaneously in patients with systemic lupus erythematosus"}},"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-receives-positive-opinion-from-the-chmp-in-europe-for-the-treatment-of-asthma-and-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-eu-filing-for-extended-use-of-relvar-ellipta-in-patients-with-controlled-asthma-on-an-icslaba-combination/","txt":"\n                            \n                            \n                            \n                                    RELVAR™ ELLIPTA™ receives positive opinion from the CHMP in Europe for the treatment of asthma and COPD\n                                                                    GSK and Theravance, Inc. today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for fluticasone furoate/vilanterol (FF/VI) under the proposed brand name RELVAR™ ELLIPTA™.\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for fluticasone furoate/vilanterol (FF/VI) under the proposed brand name RELVAR™ ELLIPTA™."}},"http://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-severe-hypereosinophilic-syndrome/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-for-mepolizumab-in-eosinophilic-granulomatosis-with-polyangiitis-egpa/","txt":"phase III","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"GSK starts phase III study with mepolizumab in patients with severe hypereosinophilic syndrome"},"redirectedTo":"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-severe-hypereosinophilic-syndrome/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-phase-lll-study-for-mepolizumab-in-patients-with-eosinophilic-granulomatosis-with-polyangiitis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-for-mepolizumab-in-eosinophilic-granulomatosis-with-polyangiitis-egpa/","txt":"\n                            \n                            \n                            \n                                    GSK announces start of Phase lll study for mepolizumab in patients with Eosinophilic Granulomatosis with Polyangiitis\n                                                                    GSK today announced the start of a Phase III study to evaluate the efficacy and safety of mepolizumab, an investigational IL-5 antagonist.\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the start of a Phase III study to evaluate the efficacy and safety of mepolizumab, an investigational IL-5 antagonist."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-marketing-authorisation-for-nucala-mepolizumab-in-31-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-nasal-polyps/","txt":"\n                            \n                            \n                            \n                                    GSK receives European marketing authorisation for Nucala® (mepolizumab) in 31 countries\n                                                                    GlaxoSmithKline (LSE/NYSE: GSK) today announced that the European Commission has granted marketing authorisation for Nucala® (mepolizumab) as an add-on treatment for severe refractory eosinophilic asthma in adult patients. As a result Nucala is now approved for use in the 31 European countries covered by the European Medicines Agency (EMA).\n                            \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (LSE/NYSE: GSK) today announced that the European Commission has granted marketing authorisation for Nucala® (mepolizumab) as an add-on treatment for severe refractory eosinophilic asthma in adult patients. As a result Nucala is now approved for use in the 31 European countries covered by the European Medicines Agency (EMA)."}},"http://www.gsk.com/en-gb/media/press-releases/2016/gsk-announces-phase-lll-study-of-mepolizumab-meets-co-primary-endpoints-and-all-secondary-endpoints-in-patients-with-eosinophilic-granulomatosis-with-polyangiitis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-headline-phase-iii-results-of-mepolizumab-in-patients-with-severe-chronic-obstructive-pulmonary-disease/","txt":"phase III","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/media/press-releases/2016/gsk-announces-phase-lll-study-of-mepolizumab-meets-co-primary-endpoints-and-all-secondary-endpoints-in-patients-with-eosinophilic-granulomatosis-with-polyangiitis/"},"https://www.gsk.com/en-gb/media/press-releases/update-on-gsk-s-response-to-the-zika-virus-disease-outbreak/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                07 July 2016\n            Update on GSK’s response to the Zika virus disease outbreak\n                Since the outbreak of Zika virus disease began in the Americas late last year, GSK has been asses...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Since the outbreak of Zika virus disease began in the Americas late last year, GSK has been assessing how we can best help to respond."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-phase-i-oncology-study-with-its-icos-agonist-antibody/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                30 June 2016\n            GSK announces start of phase I oncology study with its ICOS agonist antibody\n                The start of a phase I clinical trial with GSK3359609, an investigational inducibile T-cell costi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The start of a phase I clinical trial with GSK3359609, an investigational inducibile T-cell costimulator (ICOS) agonist antibody"}},"https://www.gsk.com/en-gb/media/press-releases/fulfil-study-shows-superiority-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-improving-lung-function-and-health-related-quality-of-life-in-copd-patients/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                20 June 2016\n            FULFIL study shows superiority of closed triple combination therapy FF/UMEC/VI versus Symbicort® Turbohaler® in improving lung function and health-related quality of life in COPD patients\n                FULFIL - Lung FUnction and quality of LiFe assessment in COPD with closed trIpLe therapy\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"FULFIL - Lung FUnction and quality of LiFe assessment in COPD with closed trIpLe therapy"}},"https://www.gsk.com/en-gb/media/press-releases/executive-director-change/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                14 June 2016\n            Executive Director Change\n                Dr Moncef Slaoui, Chairman, Vaccines, has indicated to the Board his intention to retire from the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Dr Moncef Slaoui, Chairman, Vaccines, has indicated to the Board his intention to retire from the Company in 2017."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-fda-approval-to-lower-the-weight-limit-for-dolutegravir-in-children-and-adolescents-living-with-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                10 June 2016\n            ViiV Healthcare announces FDA approval to lower the weight limit for dolutegravir in children and adolescents living with HIV\n                The US Food and Drug Administration has approved a supplemental New Drug Application (sNDA) for d...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The US Food and Drug Administration has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg oral tablets."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-iii-study-of-sirukumab-meets-both-co-primary-endpoints-in-patients-with-rheumatoid-arthritis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                08 June 2016\n            GSK announces phase III study of sirukumab meets both co-primary endpoints in patients with rheumatoid arthritis\n                The results from the positive SIRROUND-D study are being presented at the Annual European Congres...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The results from the positive SIRROUND-D study are being presented at the Annual European Congress of Rheumatology (EULAR 2016) in London."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-us-filing-plans-for-closed-triple-combination-therapy-ffumecvi-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                02 June 2016\n            Regulatory update on US filing plans for closed triple combination therapy FF/UMEC/VI in patients with COPD\n                Acceleration of filing of US New Drug Application now expected by end of 2016\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Acceleration of filing of US New Drug Application now expected by end of 2016"}},"https://www.gsk.com/en-gb/media/press-releases/board-and-committee-changes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                27 May 2016\n            Board and Committee changes\n                Dr Vivienne Cox, CBE, has been appointed to the Board of the Company as a Non-Executive Director ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Dr Vivienne Cox, CBE, has been appointed to the Board of the Company as a Non-Executive Director with effect from 1 July 2016."}},"https://www.gsk.com/en-gb/media/press-releases/strimvelistm-receives-european-marketing-authorisation-to-treat-very-rare-disease-ada-scid/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                27 May 2016\n            StrimvelisTM receives European marketing authorisation to treat very rare disease, ADA-SCID\n                GSK, Fondazione Telethon and Ospedale San Raffaele gain approval to provide life-saving gene ther...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK, Fondazione Telethon and Ospedale San Raffaele gain approval to provide life-saving gene therapy to patients."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-ospedale-san-raffaele-announce-publication-of-pivotal-safety-and-efficacy-of-gene-therapy-for-children-with-ada-scid/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                25 May 2016\n            GSK, Fondazione Telethon and Ospedale San Raffaele announce publication of pivotal safety and efficacy of gene therapy for children with ADA-SCID\n                GSK today announced the publication in BLOOD of the long-term safety and efficacy data from an an...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the publication in BLOOD of the long-term safety and efficacy data from an analysis of 18 children with ADA-SCID"}},"https://www.gsk.com/en-gb/media/press-releases/salford-lung-study-results-show-copd-patients-treated-with-relvar-ellipta-achieve-superior-reduction-in-exacerbations-compared-with-usual-care/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                24 May 2016\n            Salford Lung Study results show COPD patients treated with Relvar® Ellipta® achieve superior reduction in exacerbations compared with ‘usual care’\n                Pioneering GSK study provides important new data on the effectiveness of Relvar Ellipta (FF/VI) w...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Pioneering GSK study provides important new data on the effectiveness of Relvar Ellipta (FF/VI) when used in everyday clinical practice."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-new-data-from-breo-ellipta-summit-study-in-patients-with-copd-at-ats-conference/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                18 May 2016\n            GSK presents new data from Breo® Ellipta® SUMMIT study in patients with COPD at ATS Conference\n                GSK presents new data at the American Thoracic Society Conference from two pre-specified analyses...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK presents new data at the American Thoracic Society Conference from two pre-specified analyses from the Study to Understand Mortality and MorbidITy (SUMMIT) trial"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-efficacy-data-for-anoro-ellipta-in-copd-patients-who-remained-symptomatic-on-tiotropium/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                18 May 2016\n            GSK presents efficacy data for Anoro® Ellipta® in COPD patients who remained symptomatic on tiotropium\n                GSK and Innoviva, Inc. announce results from data presented at the American Thoracic Society 2016...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Innoviva, Inc. announce results from data presented at the American Thoracic Society 2016 conference investigating the efficacy and safety of Anoro® Ellipta®"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-bexsero-achieves-primary-and-secondary-endpoints-with-reduced-3-dose-schedule-2plus1-in-safety-and-immunogenicity-study-in-infants-and-children/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                13 May 2016\n            GSK’s Bexsero®▼achieves primary and secondary endpoints with reduced 3-dose schedule (2+1) in safety and immunogenicity study in infants and children\n                GSK today presented new data for its meningococcal group B vaccine, Bexsero®,1  [Meningococcal gr...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today presented new data for its meningococcal group B vaccine, Bexsero®,1  [Meningococcal group B Vaccine (rDNA, component, adsorbed)] comparing safety and immunogenicity with different dosing schedules in infants and young children, at the annual meeting of the European Society for Paediatric Infectious Diseases (ESPID)."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-extends-medicines-patent-pool-licence-agreement-for-dolutegravir-to-cover-all-lower-middle-income-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                25 April 2016\n            ViiV Healthcare extends Medicines Patent Pool licence agreement for dolutegravir to cover all lower middle-income countries\n                Follows announcement by majority shareholder GSK to expand graduated approach to patents and inte...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Follows announcement by majority shareholder GSK to expand graduated approach to patents and intellectual property (IP) to widen access to medicines in the world’s poorest countries."}},"https://www.gsk.com/en-gb/media/press-releases/?p=15":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=12":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=11","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=12":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/media/3654/gsk-makes-change-to-financial-reporting-framework-11-april-2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-makes-change-to-financial-reporting-framework/","txt":"View full details on changes to financial reporting framework","status":"done","statusCode":200,"results":{"video":[]}},"http://www.gsk.com/en-gb/about-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-severe-hypereosinophilic-syndrome/","txt":"www.gsk.com/aboutus","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer."},"redirectedTo":"https://www.gsk.com/en-gb/about-us/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-a-phase-ii-study-to-evaluate-an-anti-gm-csf-antibody-for-inflammatory-hand-osteoarthritis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                18 April 2016\n            GSK announces start of a phase II study to evaluate an anti GM-CSF antibody for inflammatory hand osteoarthritis\n                GSK announces the start of a phase II study to evaluate the efficacy and safety of an investigati...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces the start of a phase II study to evaluate the efficacy and safety of an investigational anti-granulocyte macrophage colony-stimulating factor monoclonal (anti GM-CSF) antibody, in patients with inflammatory hand osteoarthritis."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-opens-new-state-of-the-art-respiratory-manufacturing-facility-in-ware-uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                18 April 2016\n            GSK opens new state of the art respiratory manufacturing facility in Ware, UK\n                GSK today opens a £56 million state of the art manufacturing facility, creating 150 new jobs in t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today opens a £56 million state of the art manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory medicines delivered by the innovative Ellipta inhaler."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion-in-europe-for-strimvelis-the-first-gene-therapy-to-treat-very-rare-disease-ada-scid/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                01 April 2016\n            GSK receives positive CHMP opinion in Europe for Strimvelis™, the first gene therapy to treat very rare disease, ADA-SCID\n                GSK announces a positive opinion recommending marketing authorisation for Strimvelis to treat pat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces a positive opinion recommending marketing authorisation for Strimvelis to treat patients with a very rare disease called ADA-SCID"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-for-nucala-mepolizumab-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                29 March 2016\n            GSK receives marketing authorisation for Nucala® (mepolizumab) in Japan\n                GSK announces that the Japanese Ministry of Health, Labour and Welfare has granted approval for N...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces that the Japanese Ministry of Health, Labour and Welfare has granted approval for Nucala® (mepolizumab) as a treatment for bronchial asthma."}},"https://www.gsk.com/en-gb/media/press-releases/sir-andrew-witty-to-retire-from-gsk-in-march-2017/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                17 March 2016\n            Sir Andrew Witty to retire from GSK in March 2017\n                In the publication of its 2015 Annual Report to shareholders, GSK plc today announced that Sir An...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In the publication of its 2015 Annual Report to shareholders, GSK plc today announced that Sir Andrew Witty, CEO, has indicated to the Board his intention to retire from the company in early 2017"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-the-company-directorate-changes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                17 March 2016\n            GlaxoSmithKline plc (the “Company”) Directorate changes\n                The Company today announces that Sir Deryck Maughan, Dr Stephanie Burns, Dr Daniel Podolsky and H...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Company today announces that Sir Deryck Maughan, Dr Stephanie Burns, Dr Daniel Podolsky and Hans Wijers will not stand for re-election to the Board at GSK’s Annual General Meeting on 5 May 2016."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-advair-diskus-achieves-primary-endpoint-in-laba-safety-study-of-children-aged-4-11-years-with-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                17 March 2016\n            GSK’s Advair® Diskus® achieves primary endpoint in LABA safety study of children aged 4-11 years with asthma\n                GSK today announced results from the paediatric ‘LABA’ (long acting beta2-agonist) safety study.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced results from the paediatric ‘LABA’ (long acting beta2-agonist) safety study."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-miltenyi-biotec-establish-cell-and-gene-therapy-collaboration/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                16 March 2016\n            GSK and Miltenyi Biotec establish cell and gene therapy collaboration\n                Collaboration includes discovery programme for CAR-T cell-based oncology therapies\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Collaboration includes discovery programme for CAR-T cell-based oncology therapies"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-data-at-aaaai-on-efficacy-of-nucala-mepolizumab-in-severe-asthma-patients-stratified-by-eosinophil-levels/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                07 March 2016\n            GSK presents data at AAAAI on efficacy of Nucala® (mepolizumab) in severe asthma patients stratified by eosinophil levels\n                GSK today presented results at the American Academy of Allergy, Asthma & Immunology annual meetin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Positive clinical study outcomes observed for severe eosinophilic asthma patients uncontrolled on omalizumab when switched to mepolizumab in an open-label single arm study"}},"https://www.gsk.com/en-gb/media/press-releases/nejm-publishes-results-of-gsk-s-long-term-laba-safety-study-of-advair-diskus-in-adults-and-adolescents-with-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                06 March 2016\n            NEJM publishes results of GSK’s long-term LABA safety study of Advair ® Diskus® in adults and adolescents with asthma\n                GSK today announced publication of results from the ‘LABA’ (long acting beta2-agonist) safety stu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced publication of results from the ‘LABA’ (long acting beta2-agonist) safety study, AUSTRI (SAS115359) in the New England Journal of Medicine."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-new-data-on-the-long-term-efficacy-safety-of-nucala-for-the-treatment-of-severe-asthma-with-an-eosinophilic-phenotype/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                05 March 2016\n            GSK presents new data on the long-term efficacy & safety of Nucala® for the treatment of severe asthma with an eosinophilic phenotype\n                GSK today presented new safety and efficacy data for Nucala® (mepolizumab) from the open-label CO...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today presented new safety and efficacy data for Nucala® (mepolizumab) from the open-label COSMOS (MEA115661) study at the American Academy of Allergy, Asthma & Immunology annual meeting."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-names-winners-of-2015-discovery-fast-track-challenge/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                04 March 2016\n            GSK names winners of 2015 Discovery Fast Track Challenge\n                Six winning proposals were selected from 378 entries submitted from 21 countries across Europe an...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Six winning proposals were selected from 378 entries submitted from 21 countries across Europe and North America"}},"https://www.gsk.com/en-gb/media/press-releases/new-long-term-organ-damage-analysis-published-for-gsk-s-benlysta-belimumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                03 March 2016\n            New long-term organ damage analysis published for GSK’s Benlysta® (belimumab)\n                Patients with SLE are at risk of irreversible organ damage which will accrue over time and is ass...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Patients with SLE are at risk of irreversible organ damage which will accrue over time and is associated with increased risk of death1."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-first-phase-ii-hiv-prevention-study-results-for-investigational-long-acting-injectable-cabotegravir/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                24 February 2016\n            ViiV Healthcare announces first phase II HIV prevention study results for investigational long-acting injectable cabotegravir\n                Results were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in B...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Results were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                23 February 2016\n            ViiV Healthcare announces phase II study results for first two drug, long-acting injectable regimen for HIV-1 treatment\n                32 week maintenance data presented at CROI showed comparable viral suppression rates between inje...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"32 week maintenance data presented at CROI showed comparable viral suppression rates between injectable regimen and three drug oral regimen"}},"https://www.gsk.com/en-gb/media/press-releases/four-inspiring-innovations-which-help-reduce-child-deaths-in-developing-countries-share-1-million-prize-from-gsk-and-save-the-children/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                23 February 2016\n            Four inspiring innovations which help reduce child deaths in developing countries share $1 million prize from GSK and Save the Children\n                Healthcare Innovation Award is a major initiative within five-year partnership to help save one m...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Healthcare Innovation Award is a major initiative within five-year partnership to help save one million children’s lives"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-global-hiv-business-viiv-healthcare-completes-transactions-to-acquire-bristol-myers-squibb-s-rd-hiv-assets/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                22 February 2016\n            GSK’s global HIV business ViiV Healthcare completes transactions to acquire Bristol-Myers Squibb’s R&D HIV assets\n                ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Sh...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has completed two previously announced transactions with Bristol-Myers Squibb to acquire its late-stage HIV R&D assets and its portfolio of preclinical and discovery stage HIV research assets"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-seeking-expanded-indication-for-flulaval-quadrivalent-influenza-vaccine-for-infants-6-mosplus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                02 February 2016\n            GSK announces US regulatory submission seeking expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 mos+\n                This vaccine is currently approved for active immunisation against influenza A subtype viruses an...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"This vaccine is currently approved for active immunisation against influenza A subtype viruses and type B viruses"}},"https://www.gsk.com/en-gb/media/press-releases/?p=16":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=13":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=12","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=13":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/en-gb/media/press-releases/2016/gsk-presents-positive-results-from-phase-iii-fulfil-study-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-copd-at-ers-international-congress/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-files-eu-regulatory-submission-for-once-daily-closed-triple-combination-therapy-ffumecvi-for-patients-with-copd/","txt":"data from the phase III FULFIL study","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/media/press-releases/2016/gsk-presents-positive-results-from-phase-iii-fulfil-study-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-copd-at-ers-international-congress/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-adaptimmune-expand-strategic-immunotherapy-collaboration/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                02 February 2016\n            GSK and Adaptimmune expand strategic immunotherapy collaboration\n                GSK and Adaptimmune Therapeutics have expanded the terms of their strategic collaboration agreeme...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Adaptimmune Therapeutics have expanded the terms of their strategic collaboration agreement to accelerate Adaptimmune’s lead clinical cancer programme"}},"https://www.gsk.com/en-gb/media/press-releases/global-pharmaceutical-industry-calls-on-governments-to-work-with-them-to-beat-the-rising-threat-of-drug-resistance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                21 January 2016\n            Global pharmaceutical industry calls on governments to work with them to beat the rising threat of drug resistance\n                Leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, call on governments and industry to work in parallel in taking comprehensive action against drug-resistant infections"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-to-progress-collaboration-with-janssen-to-develop-the-first-long-acting-two-drug-injectable-regimen-for-treatment-of-hiv-1-infection/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                07 January 2016\n            ViiV Healthcare to progress collaboration with Janssen to develop the first long-acting, two drug injectable regimen for treatment of HIV-1 infection\n                ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as sh...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as shareholders, today formalised its collaboration with Janssen Sciences Ireland UC (Janssen) for the phase III investigation and commercialisation of the long-acting, injectable formulations of cabotegravir (ViiV Healthcare) and rilpivirine (Janssen) for the treatment of HIV-1 infection."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-appoints-dr-jesse-goodman-to-the-board-as-a-non-executive-director/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                23 December 2015\n            GSK appoints Dr Jesse Goodman to the Board as a Non-Executive Director\n                The Company announces that Dr Jesse Goodman has been appointed to the Board of the Company as a N...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Company announces that Dr Jesse Goodman has been appointed to the Board of the Company as a Non-Executive Director and Scientific and Medical Expert with effect from 1 January 2016."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-divestment-of-rights-to-ofatumumab-for-auto-immune-indications-to-novartis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                21 December 2015\n            GSK completes divestment of rights to ofatumumab for auto-immune indications to Novartis\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the completion of its transaction to divest i...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the completion of its transaction to divest its rights to ofatumumab for auto-immune indications to Novartis Pharma AG (“Novartis Pharma”), a subsidiary of Novartis AG, following regulatory approval."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-global-hiv-business-viiv-healthcare-to-acquire-bristol-myers-squibb-s-rd-hiv-assets/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                18 December 2015\n            GSK’s global HIV business ViiV Healthcare to acquire Bristol-Myers Squibb’s R&D HIV assets\n                Two transactions further strengthen HIV pipeline and outlook\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Two transactions further strengthen HIV pipeline and outlook"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-top-line-results-from-sirukumab-phase-iii-programme-supporting-regulatory-filings-for-rheumatoid-arthritis-in-2016/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                16 December 2015\n            GSK receives positive top-line results from sirukumab phase III programme supporting regulatory filings for rheumatoid arthritis in 2016\n                GSK today announced it has received positive top-line results from the phase III programme invest...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced it has received positive top-line results from the phase III programme investigating sirukumab"}},"https://www.gsk.com/en-gb/media/press-releases/comic-relief-and-gsk-form-five-year-partnership-to-fight-malaria-and-strengthen-health-systems/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                15 December 2015\n            Comic Relief and GSK form five-year partnership to fight malaria and strengthen health systems\n                A five-year partnership to fight malaria and improve health in five countries worst affected by t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A five-year partnership to fight malaria and improve health in five countries worst affected by the disease has today been launched by Comic Relief and GSK. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-phase-iii-study-of-sirukumab-in-giant-cell-arteritis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                25 November 2015\n            GSK announces start of phase III study of sirukumab in Giant Cell Arteritis\n                GSK today announced that dosing has commenced in a phase III study evaluating sirukumab, a human ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that dosing has commenced in a phase III study evaluating sirukumab, a human anti-interleukin (IL)-6 monoclonal antibody, for the treatment of patients with giant cell arteritis (GCA)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-marketing-authorisation-to-expand-indication-for-volibris-in-treatment-of-pulmonary-arterial-hypertension/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                24 November 2015\n            GSK receives European marketing authorisation to expand indication for Volibris® in treatment of pulmonary arterial hypertension\n                GSK today announced that the European Commission has approved a variation to expand the current t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the European Commission has approved a variation to expand the current therapeutic indication for Volibris® (ambrisentan) to include its use in combination treatment for patients with pulmonary arterial hypertension (PAH). Volibris is indicated for treatment of PAH in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-nucala-mepolizumab-receives-approval-from-us-fda/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                04 November 2015\n            GSK’s Nucala® (mepolizumab) receives approval from US FDA\n                First anti-IL5 treatment for adults and adolescents with severe asthma with an eosinophilic pheno...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First anti-IL5 treatment for adults and adolescents with severe asthma with an eosinophilic phenotype"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-positive-headline-results-from-a-study-of-two-drug-injectable-regimen-for-hiv-maintenance-therapy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                03 November 2015\n            ViiV Healthcare announces positive headline results from a study of two drug injectable regimen for HIV maintenance therapy\n                ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as sh...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as shareholders, today announced that the Phase IIb study LATTE 2 (NCT02120352) met its primary endpoint at 32 weeks"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-merck-to-study-immunotherapy-combination-as-potential-cancer-treatment/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                03 November 2015\n            GSK and Merck to study immunotherapy combination as potential cancer treatment\n                Phase I first-in-human study to evaluate GSK’s OX40 agonist GSK3174998 as monotherapy and in comb...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Phase I first-in-human study to evaluate GSK’s OX40 agonist GSK3174998 as monotherapy and in combination with Merck’s anti-PD-1 therapy, Keytruda® (pembrolizumab) "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-profiles-innovative-rd-portfolio-to-investors/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                03 November 2015\n            GSK profiles innovative R&D portfolio to investors\n                40 potential new medicines and vaccines offer significant opportunity to drive long-term performa...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"40 potential new medicines and vaccines offer significant opportunity to drive long-term performance and deliver new benefits to patients and consumers "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-candidate-shingles-vaccine-demonstrates-90-efficacy-against-shingles-in-people-70-years-of-age-and-over/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                27 October 2015\n            GSK’s candidate shingles vaccine demonstrates 90% efficacy against shingles in people 70 years of age and over\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the second pivotal phase III study of it...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the second pivotal phase III study of its candidate vaccine Shingrix™ in adults aged 70 years and over (known as ZOE-70) successfully met its primary objective, demonstrating 90% (95% confidence interval: 84–94) efficacy against shingles compared to placebo."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-latitude-timi-60-losmapimod-cardiovascular-study/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                27 October 2015\n            GSK provides update on LATITUDE-TIMI 60 (losmapimod cardiovascular study)\n                GSK today announced that, as per the stepwise trial design of its losmapimod phase III study, LAT...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that, as per the stepwise trial design of its losmapimod phase III study, LATITUDE-TIMI 60, an interim review of data from part A of the study (an initial cohort of 3,503 patients) did not indicate efficacy against the primary endpoint and did not support investment in the larger part B of the study as currently designed. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-advair-diskus-achieves-primary-endpoint-in-laba-safety-study-of-patients-with-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                27 October 2015\n            GSK’s Advair® Diskus® achieves primary endpoint in LABA safety study of patients with asthma\n                GlaxoSmithKline plc (GSK) today announced results from the ‘LABA’ (long acting beta2-agonist) saf...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced results from the ‘LABA’ (long acting beta2-agonist) safety study, AUSTRI (SAS115359)."}},"https://www.gsk.com/en-gb/media/press-releases/?p=17":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=14":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=13","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=14":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/en-gb/media/press-releases/2016/fulfil-study-shows-superiority-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-improving-lung-function-and-health-related-quality-of-life-in-copd-patients/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-positive-results-from-phase-iii-fulfil-study-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-copd-at-ers-international-congress/","txt":"which reported headline results in June","status":"redirected","statusCode":"414,301","results":{"video":[],"title":{}},"redirectedTo":"https://www.gsk.com/en-gb/media/press-releases/2016/fulfil-study-shows-superiority-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-improving-lung-function-and-health-related-quality-of-life-in-copd-patients/"},"http://www.gsk.com/en-gb/media/resource-centre/bioelectronics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-verily-to-establish-galvani-bioelectronics-a-new-company-dedicated-to-the-development-of-bioelectronic-medicines/","txt":"http://www.gsk.com/en-gb/media/resource-centre/bioelectronics/","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/media/resource-centre/bioelectronics/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-chmp-positive-opinion-to-expand-indication-for-volibris-in-pulmonary-arterial-hypertension/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                23 October 2015\n            GSK receives CHMP positive opinion to expand indication for Volibris® in pulmonary arterial hypertension\n                GSK receives CHMP positive opinion to expand indication for Volibris® in pulmonary arterial hyper...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK receives CHMP positive opinion to expand indication for Volibris® in pulmonary arterial hypertension"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-new-data-comparing-incruse-ellipta-to-tiotropium-and-glycopyrronium-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                20 October 2015\n            GSK announces positive new data comparing Incruse® Ellipta® to tiotropium and glycopyrronium in patients with COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced positive results from two head-to-head studie...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced positive results from two head-to-head studies directly comparing the efficacy and safety of Incruse® Ellipta® (umeclidinium) to two available bronchodilator treatments, tiotropium (study 201316) or glycopyrronium (study 201315), when used by patients with COPD."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-regulatory-application-for-chlorhexidine-gel-for-the-prevention-of-umbilical-cord-infections-in-newborn-babies/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                12 October 2015\n            GSK submits regulatory application for chlorhexidine gel for the prevention of umbilical cord infections in newborn babies\n                GSK today announced that it has submitted a regulatory application to the European Medicines Agen...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it has submitted a regulatory application to the European Medicines Agency (EMA) for its antiseptic chlorhexidine gel (7.1% chlorhexidine digluconate gel, equivalent to 4% chlorhexidine) for the prevention of umbilical cord infections (omphalitis) in newborn babies."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-post-hoc-analysis-of-anoro-ellipta-data-assessing-markers-of-copd-deterioration-compared-to-tiotropium-or-placebo-using-a-novel-composite-endpoint/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                27 September 2015\n            GSK presents post-hoc analysis of Anoro® Ellipta® data assessing markers of COPD deterioration compared to tiotropium or placebo using a novel composite endpoint\n                GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced data presented by G...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced data presented by GSK at the European Respiratory Society (ERS) International Congress (poster PA1001)"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-and-theravance-announce-intention-to-file-relvar-ellipta-for-copd-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                24 September 2015\n            Regulatory update: GSK and Theravance announce intention to file Relvar® Ellipta® for COPD in Japan\n                GlaxoSmithKline (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the intention...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the intention to file a supplemental Japanese New Drug Application (sJNDA) for Relvar® Ellipta® (fluticasone furoate “FF”/vilanterol “VI” or “FF/VI”) for the treatment of chronic obstructive pulmonary disease (COPD) with the Japanese regulatory authority during the first quarter of 2016."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion-in-europe-for-novel-anti-il5-biological-nucala-mepolizumab-for-the-treatment-of-patients-with-severe-refractory-eosinophilic-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                24 September 2015\n            GSK receives positive CHMP opinion in Europe for novel anti-IL5 biological Nucala (mepolizumab) for the treatment of patients with severe refractory eosinophilic asthma\n                GlaxoSmithKline (LSE/NYSE: GSK) today announced that the Committee for Medicinal Products for Hum...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (LSE/NYSE: GSK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending marketing authorisation for mepolizumab, which will be commercialised under the brand name Nucala, as an add-on treatment for severe refractory eosinophilic asthma in adult patients."}},"https://www.gsk.com/en-gb/media/press-releases/new-phase-iiibiv-data-show-switching-to-once-daily-triumeq-maintains-hiv-viral-suppression/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                23 September 2015\n            New Phase IIIb/IV data show switching to once-daily Triumeq® maintains HIV viral suppression\n                ViiV Healthcare today announced 24-week data from the Phase IIIb/IV STRIIVING study\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced 24-week data from the Phase IIIb/IV STRIIVING study"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-build-of-its-largest-indian-tablet-manufacturing-pharmaceutical-factory-in-vemgal-karnataka/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                08 September 2015\n            GSK starts build of its largest Indian tablet manufacturing pharmaceutical factory in Vemgal, Karnataka\n                Hon’ble Chief Minister of Karnataka, Shri Siddaramaiah lays the foundation stone of the new pharm...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Hon’ble Chief Minister of Karnataka, Shri Siddaramaiah lays the foundation stone of the new pharmaceutical factory"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-results-from-the-summit-copd-cv-survival-study/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                08 September 2015\n            GSK and Theravance announce results from the SUMMIT COPD CV Survival Study\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced initial r...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced initial results from the Study to Understand Mortality and MorbidITy in COPD (SUMMIT) for Relvar®/Breo® Ellipta® 100/25mcg (fluticasone furoate ‘FF’/vilanterol ‘VI’ or ‘FF/VI’)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-nejm-publication-of-phase-3b4-study-of-ambrisentan-and-tadalafil-as-first-line-combination-treatment-in-patients-with-pulmonary-arterial-hypertension/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                26 August 2015\n            GSK announces NEJM publication of Phase 3b/4 study of ambrisentan and tadalafil as first-line combination treatment in patients with pulmonary arterial hypertension\n                GSK today announced publication of the AMBITION study, the first outcomes study to compare the sa...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced publication of the AMBITION study, the first outcomes study to compare the safety and efficacy of investigational first-line combination therapy of Volibris® (ambrisentan) and Adcirca® (tadalafil) to first-line monotherapy of either treatment alone in treatment-naïve patients with pulmonary arterial hypertension (PAH)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-divest-ofatumumab-for-auto-immune-indications-to-novartis-for-up-to-1-billion-plus-royalties/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                21 August 2015\n            GSK to divest ofatumumab for auto-immune indications to Novartis for up to $1 billion plus royalties\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced an agreement with Novartis Pharma AG (“Novart...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced an agreement with Novartis Pharma AG (“Novartis Pharma”), a subsidiary of Novartis AG, to divest its rights in ofatumumab for auto-immune indications, including multiple sclerosis."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-synflorix-receives-chmp-positive-opinion-for-major-label-extension/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                27 July 2015\n            GSK’s Synflorix™ receives CHMP positive opinion for major label extension\n                GSK today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the expansion of the SynflorixTM European label"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-malaria-candidate-vaccine-mosquirix-rts-s-receives-positive-opinion-from-european-regulators-for-the-prevention-of-malaria-in-young-children-in-sub-saharan-africa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                24 July 2015\n            GSK’s malaria candidate vaccine, Mosquirix™ (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa\n                GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine Mosquirix."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-launch-2015-call-for-developing-country-healthcare-innovations-to-reduce-child-deaths/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                15 July 2015\n            GSK and Save the Children launch 2015 call for developing country healthcare innovations to reduce child deaths\n                GSK and Save the Children announce the launch of their third annual $1 million Healthcare Innovat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Save the Children announce the launch of their third annual $1 million Healthcare Innovation Award that rewards innovations in healthcare that have helped to reduce child deaths in developing countries."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-the-francis-crick-institute-join-forces-in-collaboration-to-forge-new-scientific-discoveries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                14 July 2015\n            GSK and the Francis Crick Institute join forces in collaboration to forge new scientific discoveries\n                The Francis Crick Institute, the UK’s newest biomedical research facility, and GSK, the UK’s larg...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Francis Crick Institute, the UK’s newest biomedical research facility, and GSK, the UK’s largest pharmaceutical company, are to partner on an open innovation collaboration exploring new avenues of medical research and drug discovery across a broad range of diseases, with a view to achieving breakthroughs in the understanding of human disease"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-divestment-of-nimenrix-and-mencevax/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                22 June 2015\n            Regulatory update on divestment of Nimenrix and Mencevax\n                GlaxoSmithKline plc (LSE/NYSE: GSK) is divesting its meningitis vaccines Nimenrix and Mencevax to...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) is divesting its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals (a subsidiary of Pfizer Inc)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-create-independent-research-institute-with-goal-of-radically-changing-and-improving-medicines-development/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                16 June 2015\n            GSK to create independent research institute with goal of radically changing and improving medicines development\n                Seattle-based Altius Institute for Biomedical Sciences to pioneer new understanding of cell “oper...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Seattle-based Altius Institute for Biomedical Sciences to pioneer new understanding of cell “operating systems”"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-outcome-of-us-fda-advisory-committee-recommending-approval-of-mepolizumab-for-the-treatment-of-adults-with-severe-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                11 June 2015\n            GSK announces outcome of US FDA Advisory Committee recommending approval of mepolizumab for the treatment of adults with severe asthma\n                GlaxoSmithKline plc (LSE: GSK) today announced the outcome of the meeting of the Pulmonary Allerg...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) today announced the outcome of the meeting of the Pulmonary Allergy Drugs Advisory Committee of the United States (US) Food and Drug Administration (FDA) regarding the Biologics Licence Application (BLA) for mepolizumab as an add-on maintenance treatment for severe asthma with eosinophilic inflammation."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-japan-regulatory-application-for-mepolizumab-in-severe-eosinophilic-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                22 May 2015\n            GSK submits Japan regulatory application for mepolizumab in severe eosinophilic asthma\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a regulatory application to...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for mepolizumab as an add-on maintenance treatment for patients with severe eosinophilic asthma who experience exacerbations on standard treatment."}},"https://www.gsk.com/en-gb/media/press-releases/?p=18":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=15":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=14","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=15":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/content/gsk/en/partnerships-backup-8-May/innovation-and-investment.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/content/gsk/en/research/research-funding3/bioelectronics.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"http://www.gsk.com/en-gb/research/research-funding/bioelectronics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-1-million-innovation-prize-for-bioelectronics-research/","txt":"http://www.gsk.com/en-gb/research/research-funding/bioelectronics/","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/research/research-funding/bioelectronics/"},"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=3","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=3","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=3","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?&p=1","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Find out more about GSK around the world"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=13","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=graduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=graduate&cl=8680","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety+%26+Sustainability&bu=&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety+%26+Sustainability&bu=&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental%20Health,%20Safety%20&%20Sustainability&bu=&r=&city=&et=&prog=","txt":"\n                        Environmental Health, Safety \n                    ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental%20Health,%20Safety&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental%20Health,%20Safety%20&%20Sustainability&bu=&r=&city=&et=&prog=","txt":"\n            \n                \n                Search\n            \n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety+&=+Sustainability&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental%20Health,%20Safety%20&%20Sustainability&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=graduate","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=graduate","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=graduate&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=graduate&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=graduate&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=graduate&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply%20chain&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680&ps=100","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory%20affairs&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory%20affairs&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory%20affairs&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research%20and%20development&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"http://www.gsk.com/products.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-receives-positive-opinion-from-the-chmp-in-europe-for-the-treatment-of-asthma-and-copd/","txt":"us.gsk.com","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare"},"redirectedTo":"https://www.gsk.com/en-gb/products/"},"http://www.gsk.com/en-gb/media/resource-centre/respiratory/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-marketing-authorisation-for-nucala-mepolizumab-in-31-countries/","txt":"infographic about severe asthma and role of eosinophils","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/media/resource-centre/respiratory/"},"https://www.gsk.com/en-gb/media/press-releases/2016/gsk-announces-phase-lll-study-of-mepolizumab-meets-co-primary-endpoints-and-all-secondary-endpoints-in-patients-with-eosinophilic-granulomatosis-with-polyangiitis/":{"redirectedFrom":"http://www.gsk.com/en-gb/media/press-releases/2016/gsk-announces-phase-lll-study-of-mepolizumab-meets-co-primary-endpoints-and-all-secondary-endpoints-in-patients-with-eosinophilic-granulomatosis-with-polyangiitis/"},"https://www.gsk.com/www.clinicaltrials.gov":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/investors/product-pipeline/oncology/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-phase-i-oncology-study-with-its-icos-agonist-antibody/","txt":"\n                            \n                                    \n                            \n                            \n                                    Oncology\n                                                            \n                        ","status":"redirected","statusCode":"200,302","results":{"video":[{},{}],"title":{},"meta_decription":"A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III"},"redirectedTo":"https://www.gsk.com/en-gb/investors/product-pipeline/"},"https://www.gsk.com/GSK%20%E2%80%93%20one%20of%20the%20world%E2%80%99s%20leading%20research-based%20pharmaceutical%20and%20healthcare%20companies%20%E2%80%93%20is%20committed%20to%20improving%20the%20quality%20of%20human%20life%20by%20enabling%20people%20to%20do%20more,%20feel%20better%20and%20live%20longer.%20For%20further%20information%20please%20visit%20www.gsk.com.%20Innoviva%20-%20Innoviva%20is%20focused%20on%20bringing%20compelling%20new%20medicines%20to%20patients%20in%20areas%20of%20unmet%20need%20by%20leveraging%20its%20significant%20expertise%20in%20the%20development,%20commercialization%20and%20financial%20management%20of%20bio-pharmaceuticals.%20Innoviva's%20portfolio%20is%20anchored%20by%20the%20respiratory%20assets%20partnered%20with%20Glaxo%20Group%20Limited%20(GSK),%20including%20RELVAR%C2%AE/BREO%C2%AE%20ELLIPTA%C2%AE%20and%20ANORO%C2%AE%20ELLIPTA%C2%AE,%20which%20were%20jointly%20developed%20by%20Innoviva%20and%20GSK.%20Under%20the%20agreement%20with%20GSK,%20Innoviva%20is%20eligible%20to%20receive%20associated%20royalty%20revenues%20from%20RELVAR%C2%AE/BREO%C2%AE%20ELLIPTA%C2%AE,%20ANORO%C2%AE%20ELLIPTA%C2%AE%20and,%20if%20approved%20and%20commercialized,%20VI%20monotherapy,%20as%20well.%20In%20addition,%20Innoviva%20retains%20a%2015%20percent%20economic%20interest%20in%20future%20payments%20made%20by%20GSK%20for%20earlier-stage%20programs%20partnered%20with%20Theravance%20BioPharma,%20Inc.%20For%20more%20information,%20please%20visit%20Innoviva's%20website%20at%20www.inva.com.%20RELVAR%C2%AE,%20BREO%C2%AE,%20ANORO%C2%AE%20and%20ELLIPTA%C2%AE%20are%20trademarks%20of%20the%20GlaxoSmithKline%20group%20of%20companies.":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/salford-lung-study-results-show-copd-patients-treated-with-relvar-ellipta-achieve-superior-reduction-in-exacerbations-compared-with-usual-care/","txt":"www.clinicaltrials.gov","status":"done","statusCode":502,"results":{"video":[],"title":{}}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-support-training-of-frontline-health-workers-across-ghana-kenya-and-nigeria/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                22 May 2015\n            GSK to support training of frontline health workers across Ghana, Kenya and Nigeria\n                GSK is to support the training of more than 9,000 health workers in Ghana, Kenya and Nigeria over...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK is to support the training of more than 9,000 health workers in Ghana, Kenya and Nigeria over the next three years. This marks a significant step in the strategy announced in March 2014 to increase access to healthcare and deliver long-term economic growth across Africa, by stimulating research; increasing capacity in local medicine supply; and strengthening healthcare infrastructure."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-data-at-ats-on-the-role-of-blood-eosinophil-levels-as-a-potential-biomarker-in-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                19 May 2015\n            GSK presents data at ATS on the role of blood eosinophil levels as a potential biomarker in the treatment of COPD\n                GSK today presented two abstracts at the American Thoracic Society (ATS) meeting that provide dat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today presented two abstracts at the American Thoracic Society (ATS) meeting that provide data on the role of blood eosinophils as a potential biomarker to determine responsiveness to treatment with an inhaled corticosteroid (ICS) in patients with COPD."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-eclipse-study-shows-association-between-improving-health-status-and-reduced-morbidity-and-mortality-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                18 May 2015\n            GSK’s ECLIPSE study shows association between improving health status and reduced morbidity and mortality in patients with COPD\n                The latest findings from the landmark GSK-sponsored ECLIPSE (Evaluation of COPD Longitudinally to...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The latest findings from the landmark GSK-sponsored ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) study, published in this month’s issue of Thorax, demonstrate that improving or keeping stable health status in patients with obstructive pulmonary disease (COPD) significantly reduces the likelihood of having an exacerbation of COPD, hospital admission and dying."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-latest-report-from-the-o-neill-review-on-antibiotic-resistance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                14 May 2015\n            GSK responds to latest report from the O’Neill Review on antibiotic resistance\n                It is essential that we find new ways to increase antibiotics R&D and create a future pipeline of...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"It is essential that we find new ways to increase antibiotics R&D and create a future pipeline of new treatments."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-unc-chapel-hill-announce-novel-partnership-to-accelerate-search-for-hiv-cure/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                10 May 2015\n            GSK and UNC-Chapel Hill announce novel partnership to accelerate search for HIV cure\n                Unique public-private collaboration will create HIV Cure center and a new company to bring togeth...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Unique public-private collaboration will create HIV Cure center and a new company to bring together academic and pharmaceutical research scientists"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-announces-board-and-committee-changes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                07 May 2015\n            GlaxoSmithKline plc announces Board and Committee changes\n                GlaxoSmithKline plc (the ‘Company’) today announces that Manvinder Singh (Vindi) Banga will join ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (the ‘Company’) today announces that Manvinder Singh (Vindi) Banga will join GSK’s Board as a Non-Executive Director on 1 September 2015."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-begins-phase-iii-programme-with-dolutegravirrilpivirine-combination-for-hiv-maintenance-therapy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                06 May 2015\n            ViiV Healthcare begins phase III programme with dolutegravir/rilpivirine combination for HIV maintenance therapy\n                ViiV Healthcare today announced the start of a phase III clinical trial programme to evaluate the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced the start of a phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay®) and rilpivirine (Edurant®1.) as maintenance therapy for adult patients with HIV."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-ospedale-san-raffaele-announce-eu-regulatory-submission-for-gene-therapy-to-treat-rare-disease-ada-scid/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                05 May 2015\n            GSK, Fondazione Telethon and Ospedale San Raffaele announce EU regulatory submission for gene therapy to treat rare disease ADA-SCID\n                GSK, Fondazione Telethon (Telethon) and Ospedale San Raffaele (OSR) today announced the submissio...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK, Fondazione Telethon (Telethon) and Ospedale San Raffaele (OSR) today announced the submission of a marketing application to the European Medicines Agency (EMA) for a gene therapy (GSK2696273) to treat patients with a rare disease, adenosine deaminase severe combined immunodeficiency syndrome (ADA-SCID), for whom no suitable human leukocyte antigen (HLA)-matched related stem cell donor is available."}},"https://www.gsk.com/en-gb/media/press-releases/fda-approves-breo-ellipta-for-the-treatment-of-adults-with-asthma-in-the-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                30 April 2015\n            FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the US\n                GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Fo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO® ELLIPTA® (fluticasone furoate/vilanterol [FF/VI]) for the once-daily treatment of asthma in patients aged 18 years and older. Breo Ellipta is not indicated for the relief of acute bronchospasm."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-candidate-vaccine-for-the-prevention-of-shingles-demonstrates-overall-efficacy-of-972-which-does-not-diminish-in-the-age-groups-studied/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                28 April 2015\n            GSK candidate vaccine for the prevention of shingles demonstrates overall efficacy of 97.2 which does not diminish in the age groups studied\n                Shingles is a significant public health burden, more than 90% of adults aged 50 years and over ar...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Shingles is a significant public health burden, more than 90% of adults aged 50 years and over are at risk."}},"https://www.gsk.com/en-gb/media/press-releases/malaria-vaccine-candidate-has-demonstrated-efficacy-over-3-4-years-of-follow-up/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                24 April 2015\n            Malaria vaccine candidate has demonstrated efficacy over 3-4 years of follow-up\n                Final results from a large-scale Phase III trial of the RTS,S malaria vaccine candidate, includin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Final results from a large-scale Phase III trial of the RTS,S malaria vaccine candidate, including the impact of a booster dose, published today in The Lancet."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-establish-global-vaccines-rd-centre-in-the-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                02 April 2015\n            GSK to establish global vaccines R&D centre in the US\n                New hub based in Rockville, MD expands GSK’s global vaccines R&D footprint\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New hub based in Rockville, MD expands GSK’s global vaccines R&D footprint"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-meningitis-vaccination-in-the-uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                29 March 2015\n            GSK statement on meningitis vaccination in the UK\n                GSK is delighted to have reached an agreement with the UK’s Department of Health that will enable...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK is delighted to have reached an agreement with the UK’s Department of Health that will enable babies in the UK to receive its meningitis B vaccine through the NHS immunisation schedule."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-approval-for-encruse-ellipta-in-japan-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                26 March 2015\n            GSK receives approval for Encruse® Ellipta® in Japan for the treatment of COPD\n                Two further GSK products, Duac® Combination Gel and Synflorix™, also gain approval in Japan.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Two further GSK products, Duac® Combination Gel and Synflorix™, also gain approval in Japan."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-2015-discovery-fast-track-challenge-seeks-early-drug-discovery-partnerships-with-academics-in-europe-canada-and-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                24 March 2015\n            GSK’s 2015 Discovery Fast Track Challenge seeks early drug discovery partnerships with academics in Europe, Canada and US\n                GSK is encouraging academic scientists in Europe, Canada and the US to submit their novel early d...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK is encouraging academic scientists in Europe, Canada and the US to submit their novel early drug discovery research proposals into its third annual Discovery Fast Track Challenge"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-outcome-of-us-fda-advisory-committee-on-breo-ellipta-in-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                19 March 2015\n            GSK and Theravance announce outcome of US FDA Advisory Committee on BREO® ELLIPTA® in asthma\n                GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the outcome of...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the outcome of the joint meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee of the United States (US) Food and Drug Administration (FDA) regarding the supplemental New Drug Application (sNDA) for BREO® ELLIPTA® (fluticasone furoate/vilanterol [FF/VI]) as a once-daily inhaled treatment for asthma in patients aged 12 years and older."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-phase-iii-programme-to-evaluate-retosiban-for-spontaneous-preterm-labour/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                17 March 2015\n            GSK announces start of phase III programme to evaluate retosiban for spontaneous preterm labour\n                GSK today announced the start of a phase III programme to evaluate the efficacy and safety of ret...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the start of a phase III programme to evaluate the efficacy and safety of retosiban, an investigational oxytocin antagonist."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-becomes-partner-in-new-global-fund-to-accelerate-dementia-research/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                17 March 2015\n            GSK becomes partner in new global fund to accelerate dementia research\n                Company makes $25m (approx £17m) investment in first-of-its-kind venture capital fund focused on ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Company makes $25m (approx £17m) investment in first-of-its-kind venture capital fund focused on dementia "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-transaction/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                13 March 2015\n            GSK transaction\n                The information to which this gatepost gives access is exclusively intended for persons who are n...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The information to which this gatepost gives access is exclusively intended for persons who are not residents of the United States and who are not physically present in the United States."}},"https://www.gsk.com/en-gb/media/press-releases/?p=19":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=16":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=15","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=16":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=17":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-transaction-launch/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                12 March 2015\n            GSK transaction launch\n                The information to which this gatepost gives access is exclusively intended for persons who are n...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The information to which this gatepost gives access is exclusively intended for persons who are not residents of the United States and who are not physically present in the United States"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-major-new-commitment-to-asia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                10 March 2015\n            GSK announces major new commitment to Asia\n                GlaxoSmithKline (GSK) is strengthening its presence in Singapore by establishing a new global hea...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) is strengthening its presence in Singapore by establishing a new global headquarters for Asia"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-announces-changes-to-its-board/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                26 February 2015\n            GlaxoSmithKline plc announces changes to its Board\n                GlaxoSmithKline plc (the ‘Company’) today announces that Sir Christopher Gent will step down as C...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (the ‘Company’) today announces that Sir Christopher Gent will step down as Chairman of GSK at the Company’s Annual General Meeting on 7 May 2015"}},"https://www.gsk.com/en-gb/media/press-releases/update-on-three-part-transaction-with-novartis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                25 February 2015\n            Update on three-part transaction with Novartis\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that, following good progress on obtaining cl...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that, following good progress on obtaining clearances and approvals to enable completion of its three-part transaction with Novartis"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-strengthens-early-stage-vaccine-pipeline-with-acquisition-of-glycovaxyn-ag/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                11 February 2015\n            GSK strengthens early stage vaccine pipeline with acquisition of GlycoVaxyn AG\n                GSK today announced that it has acquired GlycoVaxyn AG, a specialist vaccine biopharmaceutical co...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it has acquired GlycoVaxyn AG, a specialist vaccine biopharmaceutical company based in Switzerland."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-start-of-phase-iii-lung-function-study-with-closed-triple-combination-treatment-ffumecvi-for-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                09 February 2015\n            GSK and Theravance announce start of phase III lung function study with ‘closed’ triple combination treatment FF/UMEC/VI for COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start of a second global phase III study"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-overall-survival-results-from-phase-iii-combi-d-study-of-dabrafenib-tafinlar-and-trametinib-mekinist-combination/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                06 February 2015\n            GSK announces positive overall survival results from phase III COMBI-d study of dabrafenib (Tafinlar™) and trametinib (Mekinist™) combination\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced overall survival (OS) results from COMBI-d wh...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced overall survival (OS) results from COMBI-d which demonstrate a statistically significant reduction in the risk of death (Hazard Ratio [HR] 0.71 [95% Confidence Interval (CI): 0.55, 0.92], p=0.011) for the combination of dabrafenib (Tafinlar™) and trametinib (Mekinist™)"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-eu-regulatory-submission-seeking-additional-indication-for-eltrombopag-revolade/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                06 February 2015\n            GSK announces EU regulatory submission seeking additional indication for eltrombopag (Revolade™)\n                GSK today announced the submission to the European Medicines Agency (EMA) of a variation to the M...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the submission to the European Medicines Agency (EMA) of a variation to the Marketing Authorisation for eltrombopag (Revolade)"}},"https://www.gsk.com/en-gb/media/press-releases/four-initiatives-from-across-africa-win-share-of-global-us-1-million-healthcare-innovation-award/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                29 January 2015\n            Four initiatives from across Africa win share of global US$1 million Healthcare Innovation Award\n                Organisations from South Africa, Zambia, Kenya and Uganda recognised by GSK and Save the Children...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Organisations from South Africa, Zambia, Kenya and Uganda recognised by GSK and Save the Children for innovations proven to help reduce deaths in under-fives"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-oxford-university-phase-i-trial-results-of-an-ebola-candidate-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                28 January 2015\n            GSK statement on Oxford University phase I trial results of an Ebola candidate vaccine\n                Results from a phase I trial published today by Oxford University in the New England Journal of M...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Results from a phase I trial published today by Oxford University in the New England Journal of Medicine (NEJM) show that a GSK/NIH Ebola candidate vaccine demonstrated an acceptable safety profile"}},"https://www.gsk.com/en-gb/media/press-releases/board-committee-change/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                27 January 2015\n            Board Committee change\n                GSK announces that Sir Philip Hampton has been appointed Chairman of the Nominations Committee (t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces that Sir Philip Hampton has been appointed Chairman of the Nominations Committee (the “Committee”) with effect from today"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-its-price-freeze-commitment-to-ten-years-for-countries-graduating-from-gavi-support/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                26 January 2015\n            GSK extends its price-freeze commitment to ten years for countries graduating from Gavi support\n                New extended price freeze commitment enables countries that graduate from Gavi support to continu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New extended price freeze commitment enables countries that graduate from Gavi support to continue to pay the same discounted price for GSK vaccines for a decadefrom end of GAVI support"}},"https://www.gsk.com/en-gb/media/press-releases/major-milestone-for-gsknih-candidate-ebola-vaccine-as-first-doses-shipped-to-liberia-for-use-in-phase-iii-clinical-trial/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                23 January 2015\n            Major milestone for GSK/NIH candidate Ebola vaccine as first doses shipped to Liberia for use in phase III clinical trial\n                Healthcare workers among those to be vaccinated in large-scale trial involving up to 30,000 peopl...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Healthcare workers among those to be vaccinated in large-scale trial involving up to 30,000 people due to start in the coming weeks"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-confronts-copd-to-deliver-new-insights-from-across-the-globe-to-promote-improved-management-of-chronic-lung-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                22 January 2015\n            GSK ‘confronts COPD’ to deliver new insights from across the globe to promote improved management of chronic lung disease\n                Data published today in The International Journal of COPD from a global survey conducted by GSK s...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Data published today in The International Journal of COPD from a global survey conducted by GSK suggest that while physicians believe that the long-term health outlook for patients with chronic obstructive pulmonary disease (COPD) has improved compared to ten years ago."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-seeking-additional-indication-for-eltrombopag-promacta/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                22 December 2014\n            GSK announces US regulatory submission seeking additional indication for eltrombopag (Promacta™)\n                GSK today announced the submission of a supplemental New Drug Application (sNDA) to the US Food a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration for eltrombopag (Promacta™)"}},"https://www.gsk.com/en-gb/media/press-releases/pivotal-phase-iii-study-of-gsk-shingles-candidate-vaccine-meets-its-primary-endpoint/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                18 December 2014\n            Pivotal phase III study of GSK shingles candidate vaccine meets its primary endpoint\n                GSK today announced that a pivotal phase III study to assess the efficacy of HZ/su, an investigat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that a pivotal phase III study to assess the efficacy of HZ/su, an investigational vaccine for the prevention of shingles, has met its primary endpoint."}},"https://www.gsk.com/en-gb/media/press-releases/new-european-consortium-formed-to-help-further-advance-development-of-a-gsknih-ebola-candidate-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                16 December 2014\n            New European consortium formed to help further advance development of a GSK/NIH Ebola candidate vaccine\n                Consortium includes GSK and research partners from University of Oxford, Centre Hospitalier Unive...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Consortium includes GSK and research partners from University of Oxford, Centre Hospitalier Universitaire Vaudois in Lausanne and the Bernhard-Nocht Institute, and is backed by funding from the European Commission (EC)"}},"https://www.gsk.com/en-gb/media/press-releases/?p=20":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=17":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=16","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/2016/gsk-presents-positive-results-from-phase-iii-fulfil-study-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-copd-at-ers-international-congress/":{"redirectedFrom":"http://www.gsk.com/en-gb/media/press-releases/2016/gsk-presents-positive-results-from-phase-iii-fulfil-study-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-copd-at-ers-international-congress/"},"https://www.gsk.com/en-gb/media/press-releases/2015/gsk-to-divest-ofatumumab-for-auto-immune-indications-to-novartis-for-up-to-1-billion-plus-royalties/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-divestment-of-rights-to-ofatumumab-for-auto-immune-indications-to-novartis/","txt":"transaction to divest its rights","status":"done","statusCode":404,"results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."}},"http://www.gsk.com/en-gb/investors/investor-event":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-profiles-innovative-rd-portfolio-to-investors/","txt":"www.gsk.com/en-gb/investors/investor-event","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/en-gb/investors/investor-event"},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-eu-regulatory-submission-seeking-extended-indication-for-ambrisentan-volibris-in-pulmonary-arterial-hypertension/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                11 December 2014\n            GSK announces EU regulatory submission seeking extended indication for ambrisentan (Volibris®) in pulmonary arterial hypertension\n                GSK today announced that it has filed a regulatory submission to the European Medicines Agency (E...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it has filed a regulatory submission to the European Medicines Agency (EMA) for a variation to the Marketing Authorisation for ambrisentan (Volibris®)"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-established-products-portfolio/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                04 December 2014\n            GSK statement on Established Products Portfolio\n                As announced at the Company’s 2nd quarter results in July, GSK started a process to consider the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"As announced at the Company’s 2nd quarter results in July, GSK started a process to consider the divestment of certain North American and European brands in its Established Products Portfolio."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-names-winners-of-2014-discovery-fast-track-challenge/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                01 December 2014\n            GSK names winners of 2014 Discovery Fast Track Challenge\n                GSK has announced the winners of its second Discovery Fast Track Challenge - a programme designed...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has announced the winners of its second Discovery Fast Track Challenge - a programme designed to combine the expertise of academic researchers with that of drug discovery scientists at GSK, to accelerate the search for new medicines."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-transaction-with-novartis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                26 November 2014\n            Regulatory update on transaction with Novartis\n                GlaxoSmithKline plc (LSE/NYSE: GSK) is today providing this update to its announcement of 22 Apri...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) is today providing this update to its announcement of 22 April 2014 relating to the major three-part transaction with Novartis AG (the Original Announcement)."}},"https://www.gsk.com/en-gb/media/press-releases/publication-of-circular-and-notice-of-general-meeting-relating-to-the-proposed-major-transaction-with-novartis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                24 November 2014\n            Publication of Circular and Notice of General Meeting relating to the proposed major transaction with Novartis\n                On 22 April 2014, GlaxoSmithKline plc (the “Company”, “GSK”) announced a major three-part inter-c...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"On 22 April 2014, GlaxoSmithKline plc (the “Company”, “GSK”) announced a major three-part inter-conditional transaction with Novartis AG involving its Consumer Healthcare, Vaccines and Oncology businesses (the “Transaction”)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-leads-access-to-medicine-index-2014/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                17 November 2014\n            GSK leads Access to Medicine Index 2014\n                The Access to Medicines Index published today has ranked GSK top for the fourth consecutive time.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Access to Medicines Index published today has ranked GSK top for the fourth consecutive time."}},"https://www.gsk.com/en-gb/media/press-releases/new-england-journal-of-medicine-publishes-positive-results-from-combi-v-study-of-trametinib-mekinist-and-dabrafenib-tafinlar-combination/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                16 November 2014\n            New England Journal of Medicine publishes positive results from COMBI-v study of trametinib (Mekinist™) and dabrafenib (Tafinlar™) combination\n                Results published today in the New England Journal of Medicine show that treatment with the combi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Results published today in the New England Journal of Medicine show that treatment with the combination of trametinib (Mekinist™) and dabrafenib (Tafinlar™) significantly improved overall survival (OS) compared to vemurafenib monotherapy in previously untreated patients with BRAF V600E/K mutation-positive metastatic melanoma, without increased overall toxicity."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-launches-first-call-for-proposals-for-research-in-to-non-communicable-diseases-in-sub-saharan-africa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                14 November 2014\n            GSK launches first call for proposals for research in to non-communicable diseases in sub-Saharan Africa\n                GSK today launched the first call for proposals for its Africa NCD Open Lab, to support much-need...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today launched the first call for proposals for its Africa NCD Open Lab, to support much-needed scientific research into non-communicable diseases (NCDs) in Africa."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-eu-regulatory-submission-seeking-additional-indication-for-eltrombopag-revolade-1/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                12 November 2014\n            GSK announces EU regulatory submission seeking additional indication for eltrombopag (Revolade™) (1)\n                GSK today announced the submission to the European Medicines Agency (EMA) of a variation to the M...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the submission to the European Medicines Agency (EMA) of a variation to the Marketing Authorisation for eltrombopag (Revolade™), seeking an additional indication for the treatment of adult patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-regulatory-submissions-for-mepolizumab-in-severe-eosinophilic-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                05 November 2014\n            GSK announces regulatory submissions for mepolizumab in severe eosinophilic asthma\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has filed regulatory submissions in t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has filed regulatory submissions in the USA and Europe for mepolizumab for approval as a maintenance treatment for patients with severe eosinophilic asthma"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-update-on-current-development-status-of-the-gsknih-ebola-vaccine-candidate/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                18 October 2014\n            GSK update on current development status of the GSK/NIH Ebola vaccine candidate\n                With the Ebola crisis in west Africa continuing, GSK is working closely with the World Health Org...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"With the Ebola crisis in west Africa continuing, GSK is working closely with the World Health Organization (WHO), regulators and other partners to respond to the outbreak, toaccelerate development of our investigational Ebola vaccine and to ramp up production as quickly as possible"}},"https://www.gsk.com/en-gb/media/press-releases/data-published-on-anoro-ellipta-demonstrate-improved-lung-function-compared-to-tiotropium/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                17 October 2014\n            Data published on Anoro® Ellipta® demonstrate improved lung function compared to tiotropium\n                Respiratory Medicine has published positive results from a third lung function study comparing th...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Respiratory Medicine has published positive results from a third lung function study comparing the efficacy and safety of Anoro® Ellipta®  with the LAMA tiotropium, in patients with chronic obstructive pulmonary disease (COPD). "}},"https://www.gsk.com/en-gb/media/press-releases/stiefel-a-gsk-company-announces-start-of-phase-iii-study-of-subcutaneous-ofatumumab-for-pemphigus-vulgaris/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                07 October 2014\n            Stiefel, a GSK company, announces start of  phase III study of subcutaneous ofatumumab for pemphigus vulgaris\n                Stiefel, a GSK company, today announced the start of a phase III study to evaluate the efficacy a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Stiefel, a GSK company, today announced the start of a phase III study to evaluate the efficacy and safety of subcutaneous ofatumumab in patients with pemphigus vulgaris, a rare autoimmune skin disorder."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-appoints-mr-urs-rohner-to-its-board-as-a-non-executive-director/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                03 October 2014\n            GSK appoints Mr Urs Rohner to its Board as a  Non-Executive Director\n                GlaxoSmithKline plc (LSE: GSK) today announced the appointment of Mr Urs Rohner to its Board as a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) today announced the appointment of Mr Urs Rohner to its Board as a Non-Executive Director, effective 1 January 2015."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-overall-survival-results-from-phase-iii-break-3-study-of-tafinlar-dabrafenib-in-patients-with-braf-v600e-mutant-metastatic-melanoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                29 September 2014\n            GSK announces overall survival results from phase III BREAK-3 study of Tafinlar® (dabrafenib) in patients with BRAF V600E-mutant metastatic melanoma\n                GSK today announced updated results for Tafinlar® (dabrafenib) from a planned analysis of the pha...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced updated results for Tafinlar® (dabrafenib) from a planned analysis of the phase III BREAK-3 study in 250 patients with BRAF V600E mutant metastatic melanoma."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-appoints-sir-philip-hampton-to-the-board-of-directors/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                25 September 2014\n            GlaxoSmithKline plc appoints Sir Philip Hampton to the Board of Directors\n                GIaxoSmithKline plc (GSK) today announced that Sir Philip Hampton will join the Board of the comp...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GIaxoSmithKline plc (GSK) today announced that Sir Philip Hampton will join the Board of the company as Non-Executive Director from 1 January 2015 and will become Deputy Chairman with effect from 1 April 2015. "}},"https://www.gsk.com/en-gb/media/press-releases/international-collaboration-to-develop-inhaled-form-of-oxytocin-to-manage-bleeding-after-childbirth-in-developing-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                25 September 2014\n            International collaboration to develop inhaled form of oxytocin to manage bleeding after childbirth  in developing countries\n                GSK, Monash University, McCall MacBain Foundation, Grand Challenges Canada and Planet Wheeler Fou...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK, Monash University, McCall MacBain Foundation, Grand Challenges Canada and Planet Wheeler Foundation join forces to develop oxytocin dry powder inhaler"}},"https://www.gsk.com/en-gb/media/press-releases/?p=21":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=18":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=17","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=18":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/2016/fulfil-study-shows-superiority-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-improving-lung-function-and-health-related-quality-of-life-in-copd-patients/":{"redirectedFrom":"http://www.gsk.com/en-gb/media/press-releases/2016/fulfil-study-shows-superiority-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-improving-lung-function-and-health-related-quality-of-life-in-copd-patients/"},"https://www.gsk.com/en-gb/media/resource-centre/bioelectronics/":{"redirectedFrom":"http://www.gsk.com/en-gb/media/resource-centre/bioelectronics/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-china-investigation-outcome/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                19 September 2014\n            GSK China Investigation Outcome\n                GlaxoSmithKline plc (GSK) today announced that the Changsha Intermediate People’s Court in Hunan ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that the Changsha Intermediate People’s Court in Hunan Province, China ruled that GSK China Investment Co. Ltd (GSKCI) has, according to Chinese law, offered money or property to non-government personnel in order to obtain improper commercial gains, and been found guilty of bribing non-government personnel."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-joins-with-research-councils-in-uk-and-south-africa-to-tackle-non-communicable-diseases-in-africa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                09 September 2014\n            GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa\n                GSK today announced a £5m collaboration with the UK and South African Medical Research Councils, ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced a £5m collaboration with the UK and South African Medical Research Councils, to support much-needed research into non-communicable diseases (NCDs) in Africa, as part of GSK’s Africa NCD Open Lab initiative. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-data-presented-at-ers-demonstrate-potential-of-blood-eosinophil-levels-to-help-inform-copd-treatment-decisions/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                08 September 2014\n            GSK data presented at ERS demonstrate potential of blood eosinophil levels to help inform COPD treatment decisions\n                GSK today presented data at the European Respiratory Society (ERS) Congress that show blood eosin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today presented data at the European Respiratory Society (ERS) Congress that show blood eosinophil levels may help predict those patients with COPD who will have a greater reduction in exacerbation rates when receiving an inhaled corticosteroid (ICS) containing regimen..."}},"https://www.gsk.com/en-gb/media/press-releases/new-england-journal-of-medicine-and-ers-publish-positive-results-from-gsk-phase-iii-studies-of-mepolizumab-in-patients-with-severe-eosinophilic-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                08 September 2014\n            New England Journal of Medicine and ERS publish positive results from GSK phase III studies of mepolizumab in patients with severe eosinophilic asthma\n                Results published today in the New England Journal of Medicine (NEJM) and presented at the Europe...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Results published today in the New England Journal of Medicine (NEJM) and presented at the European Respiratory Society (ERS) congress provide further data from the two pivotal Phase III asthma studies of mepolizumab, an investigational IL-5 antagonist monoclonal antibody."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-first-line-combination-of-ambrisentan-and-tadalafil-reduces-risk-of-clinical-failure-compared-to-monotherapy-in-pulmonary-arterial-hypertension-outcomes-study/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                08 September 2014\n            GSK announces first-line combination of ambrisentan and tadalafil reduces risk of clinical failure compared to monotherapy in pulmonary arterial hypertension outcomes study\n                GSK today announced that the first phase IIIb/IV study, conducted in collaboration with Gilead Sc...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the first phase IIIb/IV study, conducted in collaboration with Gilead Sciences Inc., to investigate combination therapy of ambrisentan and tadalafil in treatment naïve patients..."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-gold-and-the-copd-foundation-announce-formation-of-a-new-external-expert-governance-board-for-the-copd-assessment-test-cat/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                08 September 2014\n            GSK, GOLD and the COPD Foundation announce formation of a new external expert Governance Board for the COPD Assessment Test (CAT)\n                As part of activities at the European Respiratory Society (ERS) International Congress in Germany...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"As part of activities at the European Respiratory Society (ERS) International Congress in Germany, GSK, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) ..."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-eu-marketing-authorisation-for-triumeq-dolutegravirabacavirlamivudine-a-new-once-daily-single-pill-regimen-for-the-treatment-of-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                03 September 2014\n            ViiV Healthcare receives EU marketing authorisation for Triumeq® (dolutegravir/abacavir/lamivudine), a new once-daily single-pill regimen for the treatment of HIV\n                ViiV Healthcare announced today that the European Commission (EC) has granted marketing authorisa...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare announced today that the European Commission (EC) has granted marketing authorisation for Triumeq® (dolutegravir 50mg / abacavir 600mg / lamivudine 300mg) tablets for the treatment of HIV in adults and adolescents aged 12 years and older and weighing at least 40kg. "}},"https://www.gsk.com/en-gb/media/press-releases/gsks-promacta-eltrombopag-receives-fda-approval-of-an-additional-indication/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                26 August 2014\n            GSK's Promacta® (eltrombopag) receives FDA approval of an additional indication\n                New first-in-class treatment option for this previously treated SAA patient population\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New first-in-class treatment option for this previously treated SAA patient population"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-fda-approval-for-triumeq-abacavir-dolutegravir-and-lamivudine-a-new-single-pill-regimen-for-the-treatment-of-hiv-1-infection/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                22 August 2014\n            ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection\n                ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Trium...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq® (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-approval-for-arnuity-ellipta-fluticasone-furoate-in-the-usa-for-the-treatment-of-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                20 August 2014\n            GSK receives FDA approval for Arnuity™  Ellipta® (fluticasone furoate) in the USA for the treatment of asthma\n                GlaxoSmithKline plc today announced that the Food and Drug Administration has approved Arnuity™ E...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc today announced that the Food and Drug Administration has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older. Arnuity is not indicated for relief of acute bronchospasm."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-announce-positive-interim-result-for-phase-iii-study-of-ofatumumab-as-maintenance-therapy-for-relapsed-cll/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                31 July 2014\n            GSK and Genmab announce positive interim result for phase III study of ofatumumab as maintenance therapy for relapsed CLL\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Genmab A/S (OMX: GEN) announced today that an Independent...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Genmab A/S (OMX: GEN) announced today that an Independent Data Monitoring Committee (IDMC) interim analysis of a phase III study, PROLONG (OMB 112517), reached the predefined significance level for efficacy (p≤0.001)."}},"https://www.gsk.com/en-gb/media/press-releases/fda-approves-flonase-allergy-relief-for-sale-over-the-counter-in-the-united-states/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                24 July 2014\n            FDA approves Flonase allergy relief for sale over-the-counter in the United States\n                No. 1 prescribed allergy treatment ingredient1 to be available OTC\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"No. 1 prescribed allergy treatment ingredient1 to be available OTC"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-eu-regulatory-submission-for-malaria-vaccine-candidate-rts-s/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                24 July 2014\n            GSK announces EU regulatory submission for malaria vaccine candidate RTS,S\n                GSK announced today that it has submitted a regulatory application to the European Medicines Agen...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that it has submitted a regulatory application to the European Medicines Agency (EMA) for its malaria vaccine candidate, RTS,S."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-phase-iii-data/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                22 July 2014\n            ViiV Healthcare presents phase III data\n                An investigational two drug-regimen of maraviroc dosed once daily, combined with darunavir/ritona...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"An investigational two drug-regimen of maraviroc dosed once daily, combined with darunavir/ritonavir (DRV/r) showed inferior efficacy compared to emtricitabine/tenofovir (FTC/TDF) with DRV/r."}},"https://www.gsk.com/en-gb/media/press-releases/trametinib-mekinist-and-dabrafenib-tafinlar-combination-demonstrated-overall-survival-benefit-compared-to-vemurafenib-phase-iii-braf-v600-mutant-metastatic-melanoma-study-stopped-early/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                17 July 2014\n            Trametinib (Mekinist™) and dabrafenib (Tafinlar™) combination demonstrated overall survival benefit compared to vemurafenib; phase III BRAF V600-mutant metastatic melanoma study stopped early\n                GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the Independent Data Monitoring Committe...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the Independent Data Monitoring Committee (IDMC)  recommended COMBI-v (MEK116513), a phase III study of its MEK inhibitor, trametinib (Mekinist™), in combination with its BRAF inhibitor, dabrafenib (Tafinlar™), compared to vemurafenib in patients with BRAF V600E or V600K mutation-positive unresectable or metastatic cutaneous melanoma be stopped early."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-initiation-of-phase-iii-programme-with-fixed-dose-triple-combination-treatment-ffumecvi-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                16 July 2014\n            GSK and Theravance announce initiation of phase III programme with fixed dose triple combination treatment FF/UMEC/VI in patients with COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start of a global phase III study, known as IMPACT, to evaluate the efficacy and safety of the ‘closed’ triple combination of FF/UMEC/VI in patients with chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/anoro-ellipta-umeclidiniumvilanterol-gains-approval-in-japan-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                04 July 2014\n            Anoro® Ellipta® (umeclidinium/vilanterol) gains approval in Japan for the treatment of COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Anoro® Ellipta® (umeclidinium/vilanterol) for the relief of various symptoms due to airway obstruction with chronic obstructive pulmonary diseases (chronic bronchitis, pulmonary emphysema) (in the case where concurrent use of long-acting inhaled muscarinic antagonist and long-acting inhaled beta2 agonist is required)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-eu-marketing-authorisation-for-mekinist-trametinib-for-patients-with-unresectable-or-metastatic-melanoma-with-a-braf-v600-mutation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                04 July 2014\n            GSK receives EU marketing authorisation for Mekinist™ (trametinib) for patients with unresectable or metastatic melanoma with a BRAF V600 mutation\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the European Commission (EC) has granted...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the European Commission (EC) has granted marketing authorisation for Mekinist™ (trametinib) as a single agent in the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation."}},"https://www.gsk.com/en-gb/media/press-releases/?p=22":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=19":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=18","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=19":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/research/research-funding/bioelectronics/":{"redirectedFrom":"http://www.gsk.com/en-gb/research/research-funding/bioelectronics/"},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=13","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=2","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=2","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=4","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=5","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=6","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=6","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=9","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=graduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=graduate&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=graduate&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=graduate&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=graduate&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental%20Health,%20Safety&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety+&=+Sustainability&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety+&=+Sustainability&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&cl=8680&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=procurement&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=graduate&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=graduate&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=graduate&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=10","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=9","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&r=&city=&et=&prog=&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=supply+chain&bu=&r=&city=&et=&prog=&p=8","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=10","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&r=&city=&et=&prog=&cl=8680&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=regulatory+affairs&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=8","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/media/resource-centre/respiratory/":{"redirectedFrom":"http://www.gsk.com/en-gb/media/resource-centre/respiratory/"},"http://www.gsk.com/discoveryfasttrack":{"status":"redirected","redirectedTo":"http://openinnovation.gsk.com/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-eu-authorisation-for-arzerra/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                03 July 2014\n            GSK and Genmab receive EU authorisation for Arzerra\n                GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the European Commis...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the European Commission (EC) has granted marketing authorisation for a new indication for the use of Arzerra™ (ofatumumab)..."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-in-response-to-recent-media-coverage-related-to-our-china-business/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                03 July 2014\n            GSK statement in response to recent media coverage related to our China business\n                Following media coverage, GSK has issued the below statement.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Following media coverage, GSK has issued the below statement."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-uk-government-initiated-review-of-antibiotic-resistance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                02 July 2014\n            GSK statement on UK Government-initiated review of antibiotic resistance\n                We welcome today’s announcement of a review to explore the economic issues surrounding antimicrob...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"We welcome today’s announcement of a review to explore the economic issues surrounding antimicrobial resistance. This is a positive step towards addressing this global public health threat."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-offer-1-million-award-for-healthcare-innovations-in-developing-countries-that-reduce-child-deaths/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                30 June 2014\n            GSK and Save the Children offer $1 million award for healthcare innovations in developing countries that reduce child deaths\n                GSK and Save the Children today announced the launch of their second annual $1 million Healthcare...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Save the Children today announced the launch of their second annual $1 million Healthcare Innovation Award at the Partnership for Maternal, Newborn and Child Health meeting in South Africa. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-submission-to-us-regulatory-authorities-for-fluticasone-furoatevilanterol-in-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                30 June 2014\n            GSK and Theravance announce submission to US regulatory authorities for fluticasone furoate/vilanterol in asthma\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for a fixed dose combination of the inhaled corticosteroid, fluticasone furoate and the long-acting beta2 agonist, vilanterol (FF/VI) as a once-daily treatment for asthma in patients aged 12 years and older, with the brand name of Breo® Ellipta®."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-recent-media-coverage-related-to-our-china-business/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                30 June 2014\n            GSK statement on recent media coverage related to our China business\n                Following media coverage this weekend, GSK has issued the following statement.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Following media coverage this weekend, GSK has issued the following statement."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-announce-top-line-results-from-a-phase-iii-study-of-ofatumumab-versus-physicians-choice-for-bulky-fludarabine-refractory-cll/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                27 June 2014\n            GSK and Genmab announce top-line results from a Phase III study of ofatumumab versus physicians’ choice for bulky fludarabine-refractory CLL\n                GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the Phase III study...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the Phase III study of ofatumumab (Arzerra™) versus physicians’ choice in patients with bulky fludarabine-refractory chronic lymphocytic leukaemia (CLL) did not meet its primary endpoint of progression free survival (PFS)."}},"https://www.gsk.com/en-gb/media/press-releases/triumeq-dolutegravirabacavirlamivudine-single-tablet-regimen-receives-positive-chmp-opinion-in-europe-for-the-treatment-of-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                27 June 2014\n            Triumeq® (dolutegravir/abacavir/lamivudine) single-tablet regimen receives positive CHMP opinion in Europe for the treatment of HIV\n                ViiV Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending marketing authorisation for Triumeq® (dolutegravir/abacavir/lamivudine) for the treatment of HIV infection in adults and adolescents  aged 12 years and older and weighing at least 40kg."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-the-start-of-a-phase-iii-study-with-eltrombopag-in-patients-with-myelodysplastic-syndromes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                25 June 2014\n            GSK announces the start of a phase III study with eltrombopag in patients with myelodysplastic syndromes\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a Phase III study, SUPPORT (TRC1...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a Phase III study, SUPPORT (TRC112121), to evaluate the platelet supportive care effects of eltrombopag (Promacta™/Revolade™) in combination with azacitidine (the current standard of care) versus placebo in combination with azacitidine in intermediate-1, intermediate-2 or high risk patients with myelodysplastic syndromes (MDS)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-new-data-for-once-weekly-tanzeumeperzan-albiglutide-showing-blood-glucose-lowering-up-to-three-years-in-type-2-diabetes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                14 June 2014\n            GSK presents new data for once-weekly Tanzeum/Eperzan (albiglutide) showing blood glucose lowering up to three years in type 2 diabetes\n                New data from secondary analyses of four randomised phase III studies being presented at the 74th...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New data from secondary analyses of four randomised phase III studies being presented at the 74th Scientific Sessions of the American Diabetes Association (ADA) in San Francisco show that patients enrolled in the studies who remained on Tanzeum/Eperzan (albiglutide), a once-weekly glucagon-like peptide (GLP-1) receptor agonist, continued to show blood glucose lowering at three years, consistent with results at the one year (52 week) primary endpoint."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-results-of-phase-iii-petit2-study-of-eltrombopag-promacta-revolade-in-paediatric-patients-with-chronic-immune-thrombocytopenia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                13 June 2014\n            GSK announces results of Phase III PETIT2 study of eltrombopag (Promacta™/Revolade™) in paediatric patients with chronic immune thrombocytopenia\n                GlaxoSmithKline (GSK) plc today announced the results from the Phase III PETIT2 study evaluating ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) plc today announced the results from the Phase III PETIT2 study evaluating the efficacy of eltrombopag vs. placebo in paediatric patients with chronic immune (idiopathic) thrombocytopenic purpura (cITP)."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-new-collaboration-with-janssen-to-investigate-single-tablet-regimen-for-maintenance-treatment-of-hiv-1/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                12 June 2014\n            ViiV Healthcare announces new collaboration with Janssen to investigate single-tablet regimen for maintenance treatment of HIV-1\n                ViiV Healthcare today announced that they have entered into an agreement with Janssen R&D Ireland...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced that they have entered into an agreement with Janssen R&D Ireland Ltd (Janssen) for the development and commercialisation of a single-tablet combining dolutegravir (Tivicay®) and Janssen’s non-nucleoside reverse transcriptase inhibitor rilpivirine (Edurant®)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-data-from-two-studies-evaluating-the-efficacy-and-safety-of-incruse-ellipta-when-added-to-relvar-breo-ellipta-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                11 June 2014\n            GSK and Theravance announce positive data from two studies evaluating the efficacy and safety of Incruse™ Ellipta® when added to Relvar®/Breo® Ellipta® in patients with COPD\n                GlaxoSmithKline plc (LSE/NYSE:GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive r...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE:GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from two phase III studies, which showed that patients with chronic obstructive pulmonary disease (COPD) who received the anticholinergic, Incruse™ Ellipta® (umeclidinium (UMEC) 62.5mcg), or umeclidinium 125mcg (an unlicensed dose) in addition to Relvar®/Breo® Ellipta® (fluticasone furoate/vilanterol, “FF/VI”), an inhaled corticosteroid / long-acting beta2-agonist combination, achieved an additional improvement in lung function (FEV1) compared to patients receiving FF/VI plus placebo. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-phase-iii-cardiovascular-outcomes-study-with-losmapimod-in-patients-with-acute-coronary-syndrome/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                05 June 2014\n            GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a pivotal phase III study, LATIT...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a pivotal phase III study, LATITUDE-TIMI 60, to evaluate the effects of losmapimod in patients presenting with acute coronary syndrome. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-iii-altto-results-for-anti-her2-therapy-combination-in-the-adjuvant-breast-cancer-treatment-setting/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                01 June 2014\n            GSK announces Phase III ALTTO results for anti-HER2 therapy combination in the adjuvant breast cancer treatment setting\n                GlaxoSmithKline plc (LSE: GSK) today announced that the Phase III study of two anti-HER2 agents, ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) today announced that the Phase III study of two anti-HER2 agents, lapatinib (Tykerb™/Tyverb™) and trastuzumab, did not meet the primary endpoint of improved disease free survival (DFS) compared to single agent therapy with trastuzumab as adjuvant treatment for HER2 positive early breast cancer."}},"https://www.gsk.com/en-gb/media/press-releases/serious-fraud-office-investigation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                27 May 2014\n            Serious Fraud Office Investigation\n                GlaxoSmithKline plc (LSE/NYSE: GSK) has today been informed by the UK’s Serious Fraud Office (SFO...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) has today been informed by the UK’s Serious Fraud Office (SFO) that it has opened a formal criminal investigation into the Group’s commercial practices."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-fda-approval-for-arzerra-ofatumumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                23 May 2014\n            GSK and Genmab receive FDA approval for Arzerra® (ofatumumab)\n                GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the Committee for M...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending a variation to the terms of the marketing authorisation for Arzerra™ (ofatumumab)..."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-regulatory-submission-for-umeclidinium-monotherapy-for-copd-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                23 May 2014\n            GSK announces regulatory submission for umeclidinium monotherapy for COPD in Japan\n                GlaxoSmithKline plc (LSE: GSK) today announced the submission of a regulatory application to the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) today announced the submission of a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for umeclidinium (UMEC), a long-acting muscarinic antagonist (LAMA), administered using the Ellipta™ dry powder inhaler."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-commitment-to-improve-access-to-vaccines-with-5-year-price-freeze-for-countries-graduating-from-gavi-alliance-support/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                20 May 2014\n            GSK announces new commitment to improve access to vaccines with 5-year price freeze for countries graduating from GAVI Alliance support\n                GSK announced today that it will freeze the prices of its vaccines for five years for developing ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that it will freeze the prices of its vaccines for five years for developing countries that graduate from GAVI Alliance support."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-positive-data-at-ats-2014-from-study-evaluating-efficacy-and-safety-of-incruse-ellipta-added-to-advair-diskus-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                19 May 2014\n            GSK presents positive data at ATS 2014 from study evaluating efficacy and safety of Incruse™ Ellipta® added to Advair® Diskus® in patients with COPD\n                GlaxoSmithKline plc (LSE:GSK) today presented data at the American Thoracic Society (ATS) from a ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE:GSK) today presented data at the American Thoracic Society (ATS) from a late-stage clinical study."}},"https://www.gsk.com/en-gb/media/press-releases/?p=23":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=20":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=19","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=20":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=21":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/motherapy-for-the-treatment-of-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                19 May 2014\n            motherapy for the treatment of relapsed or refractory diffuse large b-cell lymphoma\n                GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the Phase III study...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the Phase III study (ORCHARRD) of ofatumumab (Arzerra™) plus chemotherapy versus rituximab plus chemotherapy to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) did not meet its primary endpoint as there was no statistically significant difference in progression free survival (PFS) between the treatment arms."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-comment-china-investigation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                14 May 2014\n            GSK comment: China investigation\n                Following media coverage today related to the investigation being conducted by the Chinese author...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Following media coverage today related to the investigation being conducted by the Chinese authorities into GSK China Ltd..."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-iii-study-with-darapladib-did-not-meet-primary-endpoint-in-patients-following-an-acute-coronary-syndrome/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                13 May 2014\n            GSK announces phase III study with darapladib did not meet primary endpoint in patients following an acute coronary syndrome\n                GlaxoSmithKline (LSE/NYSE: GSK) today announced headline results from its second phase III study ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (LSE/NYSE: GSK) today announced headline results from its second phase III study with darapladib, SOLID-TIMI 52, evaluating the efficacy of its investigational Lp-PLA2 inhibitor in adults following an acute coronary syndrome."}},"https://www.gsk.com/en-gb/media/press-releases/anoro-umeclidiniumvilanterol-gains-marketing-authorisation-in-europe-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                08 May 2014\n            Anoro® (umeclidinium/vilanterol) gains marketing authorisation in Europe for the treatment of COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the European Commission has granted marketing authorisation for Anoro (umeclidinium/vilanterol) as a once-daily, maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-approval-for-incruse-ellipta-umeclidinium-in-the-us-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                30 April 2014\n            GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Incruse™ Ellipta® (umeclidinium) as an anticholinergic indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-phase-iii-programme-for-mepolizumab-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                29 April 2014\n            GSK announces start of phase III programme for mepolizumab in patients with COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a phase III programme to evaluat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the start of a phase III programme to evaluate the efficacy and safety of mepolizumab as an adjunctive therapy for adults who have severe chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-mmv-announce-start-of-phase-iii-programme-of-tafenoquine-for-plasmodium-vivax-malaria/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                28 April 2014\n            GSK and MMV announce start of phase III programme of tafenoquine for Plasmodium vivax malaria\n                GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced the start of a phas...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced the start of a phase III global programme to evaluate the efficacy and safety of tafenoquine, an investigational medicine which is being developed for the treatment and relapse prevention (radical cure) of Plasmodium vivax (P. vivax) malaria."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-eu-marketing-authorisation-for-incruse-umeclidinium-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                28 April 2014\n            GSK receives EU marketing authorisation for Incruse (umeclidinium) for the treatment of COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the European Commission has granted mark...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the European Commission has granted marketing authorisation for Incruse® (umeclidinium) as a once-daily, maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion-for-mekinist-trametinib-in-metastatic-melanoma-with-a-braf-v600-mutation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                25 April 2014\n            GSK receives positive CHMP opinion for Mekinist™ (trametinib) in metastatic melanoma with a BRAF V600 mutation\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the Committee for Medicinal Products for...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending marketing authorisation for Mekinist™ (trametinib) as a single agent in the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-phase-iii-study-of-fluticasone-furoatevilanterol-in-copd-commenced-to-support-potential-future-filing-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                22 April 2014\n            GSK and Theravance announce phase III study of fluticasone furoate/vilanterol in COPD commenced to support potential future filing in Japan\n                GlaxoSmithKline (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start of ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start of a Phase III efficacy and safety study of a combination treatment of the inhaled corticosteroid (ICS), fluticasone furoate and long-acting beta2 agonist (LABA), vilanterol (FF/VI). "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-fda-approval-for-arzerra/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                17 April 2014\n            GSK and Genmab receive FDA approval for Arzerra\n                GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the U.S. Food and D...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-approval-in-canada-for-incruse-ellipta-umeclidinium-as-a-treatment-for-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                17 April 2014\n            GSK announces approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Incruse™ Ellipta™ (umeclidinium, as umec...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Incruse™ Ellipta™ (umeclidinium, as umeclidinium bromide) has received market authorisation in Canada for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-media-reports/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                16 April 2014\n            GSK statement on media reports\n                There has been recent publicity on cases of alleged misconduct by GSK employees in a number of co...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"There has been recent publicity on cases of alleged misconduct by GSK employees in a number of countries. This is a result of details of these cases being made available to the media"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-us-approval-for-once-weekly-type-2-diabetes-treatment-tanzeum-albiglutide/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                15 April 2014\n            GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum™ (albiglutide)\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved TanzeumTM (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-bbc-panorama-programme/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                14 April 2014\n            GSK statement on BBC Panorama programme\n                GSK issued the following statement in response to claims by BBC Panorama related to GSK in Poland...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK issued the following statement in response to claims by BBC Panorama related to GSK in Poland, to be broadcast on Monday April 14 2014"}},"https://www.gsk.com/en-gb/media/press-releases/update-on-phase-iii-clinical-trial-of-investigational-mage-a3-antigen-specific-cancer-immunotherapeutic-in-non-small-cell-lung-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                02 April 2014\n            Update on phase III clinical trial of investigational MAGE-A3 antigen-specific cancer immunotherapeutic in non-small cell lung cancer\n                GSK announced its decision to stop the MAGRITi trial, a Phase III trial of its MAGE-A3ii cancer i...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced its decision to stop the MAGRITi trial, a Phase III trial of its MAGE-A3ii cancer immunotherapeuticiii in non-small cell lung cancer (NSCLC) patients, after establishing that it will not be possible to identify a sub-population of gene-signature positive NSCLC patients that may benefit from the treatment."}},"https://www.gsk.com/en-gb/media/press-releases/results-from-phase-iii-patient-preference-study-of-gsk-s-votrient-pazopanib-vs-sutent-sunitinib-in-advanced-renal-cell-carcinoma-published-in-journal-of-clinical-oncology/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                01 April 2014\n            Results from phase III patient preference study of GSK’s Votrient® (pazopanib) vs. Sutent® (sunitinib) in advanced renal cell carcinoma published in Journal of Clinical Oncology\n                Data from the first patient preference study in advanced renal cell carcinoma have been published...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Data from the first patient preference study in advanced renal cell carcinoma have been published in the Journal of Clinical Oncology."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-new-initiatives-to-improve-access-to-dolutegravir-licence-to-the-medicines-patent-pool/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                01 April 2014\n            ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool\n                ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV medicine, dolutegravir (marketed under the name Tivicay®), just two months after its approval by the European Medicines Agency (EMA) and eight months after approval by the US Food and Drug Administration (FDA)."}},"https://www.gsk.com/en-gb/media/press-releases/?p=24":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=21":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=20","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/investors/investor-event":{"redirectedFrom":"http://www.gsk.com/en-gb/investors/investor-event"},"http://www.gsk.com/africa-ncd-openlab":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-launches-first-call-for-proposals-for-research-in-to-non-communicable-diseases-in-sub-saharan-africa/","txt":"www.gsk.com/africa-ncd-openlab","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/africa-ncd-openlab"},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-strategic-investments-in-africa-to-increase-access-to-medicines-build-capacity-and-deliver-sustainable-growth/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                31 March 2014\n            GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth\n                GSK today announced a series of new investments in sub-Saharan Africa designed to address pressin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced a series of new investments in sub-Saharan Africa designed to address pressing health needs and contribute to long-term business growth. "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-votrient-pazopanib-as-maintenance-therapy-for-advanced-ovarian-cancer-in-the-eu/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                31 March 2014\n            Regulatory update: Votrient® (pazopanib) as maintenance therapy for advanced ovarian cancer in the EU\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has withdrawn its application to the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has withdrawn its application to the European Medicines Agency (EMA) for a variation to the Marketing Authorisation for Votrient® (pazopanib)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-data-from-phase-iii-stability-study-of-darapladib-in-patients-with-chronic-coronary-heart-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                30 March 2014\n            GSK presents data from Phase III STABILITY study of darapladib in patients with chronic coronary heart disease\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today presented data from the pivotal Phase III STABILITY stu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today presented data from the pivotal Phase III STABILITY study of darapladib at the American College of Cardiology 63rd Annual Scientific Session in Washington, DC"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-acquires-full-ownership-of-its-indonesian-consumer-healthcare-business/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                28 March 2014\n            GSK acquires full ownership of its Indonesian Consumer Healthcare business\n                GlaxoSmithKline (GSK) has acquired full ownership of its Indonesian Consumer Healthcare business ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) has acquired full ownership of its Indonesian Consumer Healthcare business in a transaction which also includes the company divesting a non-core brand and a manufacturing facility in the country. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-authorisation-for-once-weekly-type-2-diabetes-treatment-eperzan-albiglutide/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                26 March 2014\n            GSK receives European authorisation for once-weekly type 2 diabetes treatment, Eperzan® (albiglutide)\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the European Commission has granted mark...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the European Commission has granted marketing authorisation for its once-weekly diabetes treatment, Eperzan® (albiglutide).  "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-combined-use-of-mekinist-trametinib-and-tafinlar-dabrafenib-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                26 March 2014\n            Regulatory update: combined use of Mekinist™ (trametinib) and Tafinlar® (dabrafenib) in Europe\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has withdrawn its Marketing Authorisa...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has withdrawn its Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for the use of Mekinist (trametinib) in combination with the previously approved BRAF inhibitor Tafinlar (dabrafenib). "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-historical-quarterly-restated-financial-information/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                21 March 2014\n            GSK publishes historical quarterly restated financial information\n                As previously announced, for 2014, GlaxoSmithKline (LSE:GSK) will adopt a revised presentation fo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"As previously announced, for 2014, GlaxoSmithKline (LSE:GSK) will adopt a revised presentation for the analysis of its Pharmaceuticals and Vaccines turnover by segment, product and therapeutic area that identifies revenues from an Established Products Portfolio as a new segment. This new segment comprises a portfolio of over 50 tail brands.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/investigational-mage-a3-antigen-specific-cancer-immunotherapeutic-does-not-meet-first-co-primary-endpoints-in-magrit-a-phase-iii-non-small-cell-lung-cancer-clinical-trial/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                20 March 2014\n            Investigational MAGE-A3 antigen-specific cancer immunotherapeutic does not meet first co-primary endpoints in MAGRIT, a phase III non-small cell lung cancer clinical trial\n                GSK announced that analysis of the MAGRITi trial, a phase III trial of its MAGE-A3 cancer immunot...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced that analysis of the MAGRITi trial, a phase III trial of its MAGE-A3 cancer immunotherapeuticii in NSCLC patients, showed that the trial did not meet its first or second co-primary endpoint as it did not significantly extend DFSiii when compared to placebo in either the overall MAGE-A3 positive population or in those MAGE-A3-positive patients who did not receive chemotherapy. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-results-from-studies-comparing-anoro-ellipta-with-seretide-diskus-and-advair-diskus-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                14 March 2014\n            GSK and Theravance announce positive results from studies comparing ANORO™ ELLIPTA™ with SERETIDE® DISKUS® and ADVAIR® DISKUS® in patients with COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from three phase III studies."}},"https://www.gsk.com/en-gb/media/press-releases/patient-recruitment-completes-in-landmark-relvar-breo-ellipta-study-to-understand-mortality-and-morbidity-summit-in-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                13 March 2014\n            Patient recruitment completes in landmark RELVAR®/ BREO® ELLIPTA® Study to Understand Mortality and MorbidITy (SUMMIT) in COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that recr...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that recruitment of patients into the “Study to Understand Mortality and MorbidITy”, known as SUMMIT, has completed enrolment.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-results-from-phase-iii-studies-for-mepolizumab-in-severe-eosinophilic-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                12 March 2014\n            GSK announces positive results from phase III studies for mepolizumab in severe eosinophilic asthma\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that a pivotal phase III study of mepolizumab...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that a pivotal phase III study of mepolizumab, an investigational IL-5 antagonist monoclonal antibody, met its primary endpoint"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-increases-stake-in-indian-pharmaceuticals-subsidiary-to-75-per-cent-after-open-offer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                10 March 2014\n            GSK increases stake in Indian Pharmaceuticals subsidiary to 75 per cent after Open Offer\n                GlaxoSmithKline plc announced today that, following the voluntary Open Offer undertaken by its su...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc announced today that, following the voluntary Open Offer undertaken by its subsidiary, GlaxoSmithKline Pte Ltd, it has successfully increased its stake in its publicly-listed pharmaceuticals subsidiary in India."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-submission-to-us-regulatory-authorities-for-promacta-eltrombopag-for-severe-aplastic-anaemia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                28 February 2014\n            GSK announces submission to U.S. regulatory authorities for Promacta™ (eltrombopag) for severe aplastic anaemia\n                GlaxoSmithKline plc (LSE:GSK) announced today the submission of a supplemental New Drug Applicati...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE:GSK) announced today the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for Promacta™ (eltrombopag)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-kicks-off-2014-discovery-fast-track-challenge-for-academic-drug-hunters-in-europe-canada-and-usa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                25 February 2014\n            GSK kicks off 2014 Discovery Fast Track Challenge for academic drug hunters in Europe, Canada and USA\n                GSK is inviting academic scientists to enter their most innovative drug research proposals into i...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK is inviting academic scientists to enter their most innovative drug research proposals into its 2014 Discovery Fast Track Challenge."}},"https://www.gsk.com/en-gb/media/press-releases/anoro-umeclidinium-vilanterol-receives-positive-opinion-from-the-chmp-in-europe-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                20 February 2014\n            Anoro® (umeclidinium / vilanterol) receives positive opinion from the CHMP in Europe for the treatment of COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for umeclidinium/vilanterol (UMEC/VI) under the proposed brand name Anoro® "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion-for-incruse-umeclidinium-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                20 February 2014\n            GSK receives positive CHMP opinion for Incruse® (umeclidinium) for the treatment of COPD\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the European Medicines Agency’s (EMA) Co...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for umeclidinium under the proposed brand name Incruse® as a once-daily, maintenance treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-gains-fda-breakthrough-therapy-designation-for-promacta-revolade-eltrombopag-for-severe-aplastic-anaemia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                03 February 2014\n            GSK gains FDA Breakthrough Therapy designation for Promacta®/Revolade® (eltrombopag) for severe aplastic anaemia\n                GlaxoSmithKline plc (LSE:GSK) announced today that the U.S. Food and Drug Administration (FDA) ha...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE:GSK) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Promacta®/Revolade® (eltrombopag)."}},"https://www.gsk.com/en-gb/media/press-releases/?p=25":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=22":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=21","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=22":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/media/press-releases/2014/gsk-announces-eu-regulatory-submission-for-malaria-vaccine-candi.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-headline-results-for-phase-iii-study-of-the-combination-of-tafinlar-dabrafenib-and-mekinist-trametinib-in-metastatic-melanoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                24 January 2014\n            GSK announces headline results for Phase III study of the combination of Tafinlar® (dabrafenib) and Mekinist® (trametinib) in metastatic melanoma\n                GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that a Phase III study of the combination of ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that a Phase III study of the combination of Tafinlar® (dabrafenib) and Mekinist® (trametinib), compared to single agent therapy with Tafinlar in patients with BRAF V600 E or K mutation positive unresectable or metastatic melanoma, met its primary endpoint of Progression Free Survival (PFS) (p<0.05)"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-opinion-from-the-chmp-in-europe-for-once-weekly-eperzantm-albiglutide-for-the-treatment-of-type-2-diabetes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                24 January 2014\n            GSK receives positive opinion from the CHMP in Europe for once-weekly EperzanTM (albiglutide) for the treatment of type 2 diabetes\n                GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the Committee for Medicinal Products for...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending marketing authorisation for albiglutide, under the brand name EperzanTM.  "}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-s-new-hiv-medicine-tivicaytm-dolutegravir-is-approved-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                21 January 2014\n            ViiV Healthcare’s new HIV medicine TivicayTM (dolutegravir) is approved in Europe\n                ViiV Healthcare today announced that the European Commission has approved TivicayTM (dolutegravir).\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced that the European Commission has approved TivicayTM (dolutegravir)."}},"https://www.gsk.com/en-gb/media/press-releases/prosensa-regains-rights-to-drisapersen-from-gsk-and-retains-rights-to-all-other-programmes-for-the-treatment-of-duchenne-muscular-dystrophy-dmd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                13 January 2014\n            Prosensa regains rights to drisapersen from GSK and retains rights to all other programmes for the treatment of Duchenne muscular dystrophy (DMD)\n                Prosensa Holding N.V. (NASDAQ: RNA) and GlaxoSmithKline (GSK) today announced that Prosensa has r...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Prosensa Holding N.V. (NASDAQ: RNA) and GlaxoSmithKline (GSK) today announced that Prosensa has regained all rights from GSK to drisapersen."}},"https://www.gsk.com/en-gb/media/press-releases/tafinlar-receives-fda-breakthrough-therapy-designation-for-non-small-cell-lung-cancer-with-braf-mutation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                13 January 2014\n            Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation\n                GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has granted ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Tafinlar® (dabrafenib)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-gains-accelerated-fda-approval-for-combination-use-of-mekinist-trametinib-and-tafinlar-dabrafenib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                09 January 2014\n            GSK gains accelerated FDA approval for combination use of Mekinist® (trametinib) and Tafinlar® (dabrafenib)\n                GlaxoSmithKline plc [LSE/NYSE: GSK ] announced today that the U.S. Food and Drug Administration (...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc [LSE/NYSE: GSK ] announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-adds-detailed-clinical-trial-data-to-multi-sponsor-request-system-as-part-of-continued-commitment-to-data-transparency/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                02 January 2014\n            GSK adds detailed clinical trial data to multi-sponsor request system as part of continued commitment to data transparency\n                GlaxoSmithKline (GSK) has added its anonymised patient-level data from the online request system ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) has added its anonymised patient-level data from the online request system it launched in May 2013 to a new multi-sponsor request system."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-divestment-of-thrombosis-brands-and-related-manufacturing-site-to-aspen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                31 December 2013\n            GSK completes divestment of thrombosis brands and related manufacturing site to Aspen\n                GlaxoSmithKline (GSK) today completed the previously announced divestment of its thrombosis brand...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today completed the previously announced divestment of its thrombosis brands, ArixtraTM and FraxiparineTM."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-divestment-of-lucozade-and-ribena-to-suntory/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                31 December 2013\n            GSK completes divestment of Lucozade and Ribena to Suntory\n                GlaxoSmithKline (GSK) today completed the previously announced divestment of its nutritional drin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today completed the previously announced divestment of its nutritional drinks brands Lucozade and Ribena."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-cervarix-two-dose-schedule-receives-european-marketing-authorisation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                20 December 2013\n            GSK Cervarix® two-dose schedule receives European marketing authorisation\n                GSK announced today that the European Commission has granted marketing authorisation for its cerv...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the European Commission has granted marketing authorisation for its cervical cancer vaccine Cervarix."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-mmv-announce-fda-breakthrough-therapy-designation-for-tafenoquine-for-plasmodium-vivax-malaria/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                20 December 2013\n            GSK and MMV announce FDA Breakthrough Therapy designation for tafenoquine for Plasmodium vivax malaria\n                GSK and Medicines for Malaria Venture (MMV) announced today that the FDA has granted Breakthrough...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Medicines for Malaria Venture (MMV) announced today that the FDA has granted Breakthrough Therapy designation for tafenoquine."}},"https://www.gsk.com/en-gb/media/press-releases/update-on-patent-ruling-on-viiv-healthcares-epzicom-and-trizivir/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                18 December 2013\n            Update on Patent Ruling on ViiV Healthcare's EPZICOM® and TRIZIVIR®\n                Update on Patent Ruling on ViiV Healthcare's EPZICOM® and TRIZIVIR®\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Update on Patent Ruling on ViiV Healthcare's EPZICOM® and TRIZIVIR®"}},"https://www.gsk.com/en-gb/media/press-releases/anoro-ellipta-approved-as-first-once-daily-dual-bronchodilator-for-the-treatment-of-copd-in-the-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                18 December 2013\n            ANORO™ ELLIPTA™ approved as first once-daily dual bronchodilator for the treatment of COPD in the US\n                GlaxoSmithKline plc and Theravance, Inc. today announced that the US Food and Drug Administration...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc and Theravance, Inc. today announced that the US Food and Drug Administration (FDA) has approved ANORO ELLIPTA."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-changes-to-its-global-sales-and-marketing-practices-to-further-ensure-patient-interests-come-first/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                17 December 2013\n            GSK announces changes to its global sales and marketing practices to further ensure patient interests come first\n                GSK today set out plans to evolve the way it sells and markets its products to healthcare profess...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today set out plans to evolve the way it sells and markets its products to healthcare professionals."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-priority-review-from-fda-for-arzerra-ofatumumab-as-1st-line-treatment-for-chronic-lymphocytic-leukaemia-cll/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                17 December 2013\n            GSK and Genmab Receive Priority Review from FDA for Arzerra® (ofatumumab) as 1st Line Treatment for Chronic Lymphocytic Leukaemia (CLL)\n                GSK and Genmab Receive Priority Review from FDA for Arzerra® (ofatumumab) as 1st Line Treatment f...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Genmab Receive Priority Review from FDA for Arzerra® (ofatumumab) as 1st Line Treatment for Chronic Lymphocytic Leukaemia (CLL)"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-voluntary-open-offer-to-increase-stake-in-its-pharmaceuticals-subsidiary-in-india/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                16 December 2013\n            GSK initiates voluntary open offer to increase stake in its pharmaceuticals subsidiary in India\n                GSK today announced a Voluntary Open Offer to increase its stake in its publicly-listed pharmaceu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced a Voluntary Open Offer to increase its stake in its publicly-listed pharmaceuticals subsidiary in India."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-200-million-investment-in-uk-advanced-manufacturing-and-science/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                11 December 2013\n            GSK announces £200 million investment in UK advanced manufacturing and science\n                GSK today announced a series of investments totalling approximately £200 million which will suppo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced a series of investments totalling approximately £200 million which will support the delivery of the company's pipeline of new medicines and create a centre for pharmaceutical manufacturing innovation in the UK."}},"https://www.gsk.com/en-gb/media/press-releases/update-regarding-2010-nature-medicine-study/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                06 December 2013\n            Update regarding 2010 Nature Medicine study\n                A GSK research paper published in 2010 that was found earlier this year to contain incorrect data...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A GSK research paper published in 2010 that was found earlier this year to contain incorrect data has now been retracted by Nature Medicine."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-results-from-pivotal-phase-iii-study-for-fluticasone-furoatevilanterol-in-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                06 December 2013\n            GSK and Theravance announce positive results from pivotal phase III study for fluticasone furoate/vilanterol in asthma\n                GSK and Theravance, Inc. today announced positive results from a phase III efficacy and safety st...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced positive results from a phase III efficacy and safety study of fluticasone furoate “FF”/vilanterol “VI”."}},"https://www.gsk.com/en-gb/media/press-releases/?p=26":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=23":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=22","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=23":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=1","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=1","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=graduate&cl=8680&p=2","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=graduate&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=graduate&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=gbr&city=&et=&prog=&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Environmental+Health%2c+Safety&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=4","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=10","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=12","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=marketing+and+communications&r=&city=&et=&prog=&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&r=&city=&et=&prog=&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=engineering&bu=&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&ps=100&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/media/press-releases/synflorix-receives-european-marketing-authorisation-for-additional-pneumonia-indication/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                05 December 2013\n            Synflorix™ receives European marketing authorisation for additional pneumonia indication\n                GSK today announced that the European Commission (EC) has granted marketing authorisation for an ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the European Commission (EC) has granted marketing authorisation for an additional indication for Synflorix™"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-launches-global-consortium-with-six-renowned-cancer-research-centres/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                05 December 2013\n            GSK launches global consortium with six renowned cancer research centres\n                GSK announced today the formation of the Oncology Clinical and Translational Consortium (OCTC)\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today the formation of the Oncology Clinical and Translational Consortium (OCTC)"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-receives-positive-chmp-opinion-for-cervarix-two-dose-schedule/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                28 November 2013\n            Regulatory Update - GSK receives positive CHMP opinion for Cervarix™ two-dose schedule\n                GSK announces that the European Medicines Agency's Committee for Medicinal Products for Human Use...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) is recommending marketing authorisation for a two-dose schedule in 9-14 year old girls for its cervical cancer vaccine, Cervarix™."}},"https://www.gsk.com/en-gb/media/press-releases/h5n1-vaccine-approved-by-the-us-fda-as-pandemic-influenza-preparedness-measure/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                25 November 2013\n            H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure\n                GSK announced today that the U.S. Food and Drug Administration (FDA) has approved its  pandemic I...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the U.S. Food and Drug Administration (FDA) has approved its  pandemic Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (also referred to as Q-Pan H5N1 influenza vaccine) for the immunisation of adults 18 and older for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-fda-decision-on-avandia-rosiglitazone/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                25 November 2013\n            GSK Responds to FDA Decision on Avandia (rosiglitazone)\n                GSK announced today that the U.S. Food and Drug Administration (FDA) has eased restrictions on pa...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the U.S. Food and Drug Administration (FDA) has eased restrictions on patient access to Avandia (rosiglitazone), following an FDA Advisory Committee review in June 2013."}},"https://www.gsk.com/en-gb/media/press-releases/tivicay-dolutegravir-receives-positive-chmp-opinion-in-europe-for-the-treatment-of-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                22 November 2013\n            Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV\n                ViiV Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending marketing authorisation for Tivicay® (dolutegravir). "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-amicus-therapeutics-announce-revised-fabry-agreement/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                20 November 2013\n            GSK and Amicus Therapeutics announce revised Fabry agreement\n                GSK and Amicus Therapeutics today announced that Amicus has obtained global rights to develop and...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Amicus Therapeutics today announced that Amicus has obtained global rights to develop and commercialise the investigational pharmacological chaperone migalastat HCl as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease."}},"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-receives-european-marketing-authorisation-for-the-treatment-of-asthma-and-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                18 November 2013\n            RELVAR® ELLIPTA® receives European marketing authorisation for the treatment of asthma and COPD\n                GSK and Theravance, Inc. announced today that the European Commission has granted marketing autho...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. announced today that the European Commission has granted marketing authorisation for RELVAR® ELLIPTA®."}},"https://www.gsk.com/en-gb/media/press-releases/five-inspirational-organisations-from-malawi-bangladesh-mali-kenya-and-colombia-recognised-by-gsk-and-save-the-children/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                14 November 2013\n            Five inspirational organisations from Malawi, Bangladesh, Mali, Kenya, and Colombia recognised by GSK and Save the Children\n                A simple low-cost device that helps newborn babies to breathe and has the potential to transform ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A simple low-cost device that helps newborn babies to breathe and has the potential to transform the life chances for thousands of African babies has been awarded the highest fund in the first GSK and Save the Children $1million Healthcare Innovation Award"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-top-line-results-from-pivotal-phase-iii-study-of-darapladib-in-chronic-coronary-heart-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                12 November 2013\n            GSK announces top-line results from pivotal Phase III study of darapladib in chronic coronary heart disease\n                Study did not meet the primary endpoint measure.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Study did not meet the primary endpoint measure."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-names-inaugural-winners-in-unique-competition-for-academic-drug-hunters/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                06 November 2013\n            GSK names inaugural winners in unique competition for academic drug hunters\n                GSK today announced the selection of eight winners in its first Discovery Fast Track competition,...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the selection of eight winners in its first Discovery Fast Track competition, designed to translate academic research into starting points for new potential medicines. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-apprentice-and-graduate-engineering-opportunities-in-the-uk-during-tomorrow-s-engineers-week/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                05 November 2013\n            GSK announces new apprentice and graduate engineering opportunities in the UK during Tomorrow’s Engineers Week\n                GSK today announced the recruitment of 140 new apprentices over the next two years in the UK - of...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the recruitment of 140 new apprentices over the next two years in the UK - of which a third will be in engineering."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-data-to-support-cervarix-two-dose-schedule-for-the-prevention-of-cervical-cancer-in-9-14-year-old-girls/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                04 November 2013\n            GSK announces data to support Cervarix® two-dose schedule for the prevention of cervical cancer in 9-14 year old girls\n                GSK today announced the results of a Phase III study of its HPV vaccine, Cervarix.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the results of a Phase III study of its HPV vaccine, Cervarix."}},"https://www.gsk.com/en-gb/media/press-releases/new-partnership-between-gsk-and-the-bill-melinda-gates-foundation-to-accelerate-research-into-vaccines-for-global-health-needs/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                29 October 2013\n            New partnership between GSK and the Bill & Melinda Gates Foundation to accelerate research into vaccines for global health needs\n                GSK and the Bill & Melinda Gates Foundation (BMGF) today announced the launch of a new joint init...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and the Bill & Melinda Gates Foundation (BMGF) today announced the launch of a new joint initiative that will endeavour to make vaccines more resistant to heat, thus reducing the need for refrigeration."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-create-a-new-centre-of-excellence-for-sustainable-chemistry-in-brazil/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                25 October 2013\n            GSK to create a new Centre of Excellence for Sustainable Chemistry in Brazil\n                GSK today announced it has formed a new collaboration with the São Paulo Research Foundation (FAP...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced it has formed a new collaboration with the São Paulo Research Foundation (FAPESP) to create a new Centre of Excellence for Sustainable Chemistry in Brazil. "}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-european-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                25 October 2013\n            ViiV Healthcare announces European regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV\n                ViiV Healthcare today announced the submission of a regulatory application in Europe for its inve...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced the submission of a regulatory application in Europe for its investigational single-tablet regimen (STR) combining dolutegravir (DTG), abacavir (ABC) and lamivudine (3TC) for the treatment of people living with HIV."}},"https://www.gsk.com/en-gb/media/press-releases/synflorix-receives-positive-opinion-from-the-chmp-in-europe-for-additional-pneumonia-indication/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                25 October 2013\n            Synflorix™ receives positive opinion from the CHMP in Europe for additional pneumonia indication\n                GSK today announced that the European Medicines Agency's Committee for Medicinal Products for Hum...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending an additional indication for Synflorix™, a paediatric pneumococcal conjugate vaccine."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-for-fluticasone-furoate-monotherapy-for-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                23 October 2013\n            GSK announces US regulatory submission for fluticasone furoate monotherapy for asthma\n                GSK today announced the submission of a New Drug Application in the US for the once daily inhaled...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the submission of a New Drug Application in the US for the once daily inhaled corticosteroid (ICS) treatment, fluticasone furoate (FF), administered using the ELLIPTA™ dry powder inhaler."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                22 October 2013\n            ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV\n                ViiV Healthcare today announced the submission of a regulatory application in the US for its inve...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced the submission of a regulatory application in the US for its investigational single-tablet regimen (STR) combining dolutegravir, abacavir and lamivudine for the treatment of people living with HIV-1."}},"https://www.gsk.com/en-gb/media/press-releases/?p=27":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=24":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=23","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=24":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=25":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/media/press-releases/2014/gsk-and-genmab-receive-fda-approval-for-arzerra-ofatumumab.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-and-genmab-announce-submission-to-us-regulatory-authorities-for-arzerra-ofatumumab-as-1st-line-treatment-of-chronic-lymphocytic-leukaemia-cll/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                18 October 2013\n            Regulatory update – GSK and Genmab announce submission to US regulatory authorities for Arzerra® (ofatumumab) as 1st line treatment of Chronic Lymphocytic Leukaemia (CLL)\n                GSK and Genmab A/S announced today the submission of a supplemental Biologics License Application...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Genmab A/S announced today the submission of a supplemental Biologics License Application to the US Food and Drug Administration (FDA) for the use of Arzerra® (ofatumumab) in combination with an alkylator-based therapy, to be used for treatment of CLL patients who have not received prior treatment and are inappropriate for fludarabine-based therapy."}},"https://www.gsk.com/en-gb/media/press-releases/malaria-vaccine-candidate-reduces-disease-over-18-months-of-follow-up-in-late-stage-study-of-more-than-15-000-infants-and-young-children/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                08 October 2013\n            Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children\n                Results from a large-scale Phase III trial, presented today in Durban, show that the most clinica...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Results from a large-scale Phase III trial, presented today in Durban, show that the most clinically advanced malaria vaccine candidate, RTS,S, continued to protect young children and infants from clinical malaria up to 18 months after vaccination."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-and-genmab-announce-european-submission-to-regulatory-authorities-for-arzerra-ofatumumab-as-1st-line-treatment-of-chronic-lymphocytic-leukaemia-cll/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                04 October 2013\n            Regulatory update – GSK and Genmab announce European submission to regulatory authorities for Arzerra® (ofatumumab) as 1st line treatment of Chronic Lymphocytic Leukaemia (CLL)\n                GSK and Genmab A/S announced today the submission of a variation to the Marketing Authorisation t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Genmab A/S announced today the submission of a variation to the Marketing Authorisation to the European Medicines Agency (EMA) for the use of Arzerra (ofatumumab) in combination with an alkylator-based therapy, to be used for treatment of CLL patients who have not received prior treatment and are inappropriate for fludarabine-based therapy."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-reaches-agreement-with-aspen-to-divest-thrombosis-brands-and-related-manufacturing-site-for-07-billion/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                30 September 2013\n            GlaxoSmithKline reaches agreement with Aspen to divest thrombosis brands and related manufacturing site for £0.7 billion\n                Divestment supports strategic focus and delivery of pipeline.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Divestment supports strategic focus and delivery of pipeline."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-barclays-form-partnership-to-increase-access-to-healthcare-and-promote-economic-development-in-zambia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                27 September 2013\n            GSK and Barclays form partnership to increase access to healthcare and promote economic development in Zambia\n                GSK and Barclays have formed a new partnership which aims to increase access to affordable health...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Barclays have formed a new partnership which aims to increase access to affordable healthcare and medicines for people in Zambia, while helping to create improved economic conditions for growth."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-from-the-european-commission-for-additional-revolade/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                24 September 2013\n            GSK receives marketing authorisation from the European Commission for additional Revolade™\n                GSK announced today that the European Commission has granted an additional indication for Revolad...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the European Commission has granted an additional indication for Revolade™ (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection."}},"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-gains-approval-in-japan-for-the-treatment-of-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                20 September 2013\n            RELVAR™ ELLIPTA™ gains approval in Japan for the treatment of asthma\n                GSK and Theravance, Inc. today announced that the Japanese Ministry of Health, Labour and Welfare...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved RELVAR™ ELLIPTA™ for the treatment of bronchial asthma. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-prosensa-announce-primary-endpoint-not-met-in-phase-iii-study-of-drisapersen-in-patients-with-duchenne-muscular-dystrophy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                20 September 2013\n            GSK and Prosensa announce primary endpoint not met in Phase III study of drisapersen in patients with Duchenne Muscular Dystrophy\n                GSK and Prosensa today announced that GSK's Phase III clinical study of drisapersen, an investiga...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Prosensa today announced that GSK's Phase III clinical study of drisapersen, an investigational antisense oligonucleotide, for the treatment of Duchenne Muscular Dystrophy (DMD) patients with an amenable mutation, did not meet the primary endpoint."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-a-multi-year-agreement-with-barda-to-supply-the-us-government-with-anthrax-treatment/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                19 September 2013\n            GSK signs a multi-year agreement with BARDA to supply the US government with anthrax treatment\n                GlaxoSmithKline (GSK) plc today announced a new four year contract with the Biomedical Advanced R...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) plc today announced a new four year contract with the Biomedical Advanced Research and Development Authority (BARDA). "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-priority-review-from-fda-for-dabrafenibtrametinib-combination-in-metastatic-melanoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                16 September 2013\n            GSK receives Priority Review from FDA for dabrafenib/trametinib combination in metastatic melanoma\n                GSK today announced that the US Food and Drug Administration (FDA) has granted Priority Review de...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation to its supplemental New Drug Applications (sNDAs) for combined use of Tafinlar® (dabrafenib) and Mekinist® (trametinib) for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 E or K mutation."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-in-response-to-patent-ruling-reversal-on-lovaza/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                13 September 2013\n            GSK statement in response to patent ruling reversal on Lovaza\n                GSK confirmed today that the Court of Appeals for the Federal Circuit has ruled against Pronova B...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK confirmed today that the Court of Appeals for the Federal Circuit has ruled against Pronova Biopharma Norge AS in its patent litigation regarding Lovaza® (omega-3-acid ethyl esters)."}},"https://www.gsk.com/en-gb/media/press-releases/fda-grants-gsk-and-genmab-s-arzerra-ofatumumab-breakthrough-therapy-designation-for-previously-untreated-chronic-lymphocytic-leukaemia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                13 September 2013\n            FDA grants GSK and Genmab’s Arzerra® (ofatumumab) Breakthrough Therapy designation for previously untreated chronic lymphocytic leukaemia\n                GSK and Genmab A/S announced today that the US Food and Drug Administration (FDA) has granted Bre...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Genmab A/S announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Arzerra® (ofatumumab) in combination with chlorambucil for the treatment of patients with chronic lymphocytic leukaemia (CLL) who have not received prior treatment and are inappropriate for fludarabine-based therapy."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-positive-data-from-phase-iiibiv-study-of-dolutegravir-vs-darunavir-in-treatment-na%C3%AFve-adults-with-hiv-1/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                12 September 2013\n            ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naïve Adults with HIV-1\n                ViiV Healthcare today announced initial results from the Phase IIIb/IV FLAMINGO (ING114915) study. \n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced initial results from the Phase IIIb/IV FLAMINGO (ING114915) study. "}},"https://www.gsk.com/en-gb/media/press-releases/fda-advisory-committee-recommends-approval-in-us-of-umeclidiniumvilanterol-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                10 September 2013\n            FDA Advisory Committee recommends approval in US of umeclidinium/vilanterol for the treatment of COPD\n                GSK and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee (PAD...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee (PADAC) to the US Food and Drug Administration (FDA) voted 11 yes to 2 no that the efficacy and safety data provide substantial evidence to support approval of umeclidinium/vilanterol (UMEC/VI, 62.5/25mcg dose) for the long-term, once-daily, maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-to-divest-lucozade-and-ribena-for-135-billion/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                09 September 2013\n            GSK reaches agreement to divest Lucozade and Ribena for £1.35 billion\n                GSK today announced it has reached agreement to sell its nutritional drinks brands Lucozade and R...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced it has reached agreement to sell its nutritional drinks brands Lucozade and Ribena to Suntory Beverage & Food Ltd."}},"https://www.gsk.com/en-gb/media/press-releases/the-investigational-mage-a3-antigen-specific-cancer-immunotherapeutic-does-not-meet-first-co-primary-endpoint-in-phase-iii-melanoma-clinical-trial/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                05 September 2013\n            The investigational MAGE-A3 antigen-specific cancer immunotherapeutic does not meet first co-primary endpoint in Phase III melanoma clinical trial\n                In line with the Independent Data Monitoring Committee's (IDMC) unanimous recommendation,  GSK wi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In line with the Independent Data Monitoring Committee's (IDMC) unanimous recommendation,  GSK will continue the DERMA trial until the second co-primary endpoint is assessed."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-from-the-european-commission-for-tafinlar/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                02 September 2013\n            GSK receives marketing authorisation from the European Commission for Tafinlar™\n                GSK announced today that the European Commission has granted marketing authorisation for Tafinlar...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the European Commission has granted marketing authorisation for Tafinlar™ (dabrafenib)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-iii-study-of-vercirnon-in-patients-with-moderate-to-severe-crohn-s-disease-did-not-meet-its-primary-endpoint/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                23 August 2013\n            GSK announces phase III study of vercirnon in patients with moderate-to-severe Crohn’s disease did not meet its primary endpoint\n                GSK announced that the first of four Phase III studies, the SHIELD-1 study, investigating vercirn...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced that the first of four Phase III studies, the SHIELD-1 study, investigating vercirnon - an investigational CCR9 antagonist - in adult patients with moderately-to-severely active Crohn's disease did not achieve the primary endpoint of improvement in clinical response and the key secondary endpoint of clinical remission."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-from-the-european-commission-for-additional-indication-tyverb-lapatinib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                14 August 2013\n            GSK receives marketing authorisation from the European Commission for additional indication: Tyverb™ (lapatinib)\n                GlaxoSmithKline announced today that the European Commission has granted an additional indication...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline announced today that the European Commission has granted an additional indication for Tyverb™ (lapatinib) to be used in combination with trastuzumab."}},"https://www.gsk.com/en-gb/media/press-releases/?p=28":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=25":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=24","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/africa-ncd-openlab":{"redirectedFrom":"http://www.gsk.com/africa-ncd-openlab"},"https://www.gsk.com/media/456576/gsk-publishes-historical-quarterly-restated-financial-information.pdf":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/media/583635/restated-finanical-information.xlsx":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/settings/global-country-feed/asia-the-middle-east/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-gains-fda-breakthrough-therapy-designation-for-promacta-revolade-eltrombopag-for-severe-aplastic-anaemia/","txt":"http://www.gsk.com/products/","status":"done","statusCode":404,"results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-approval-of-tivicay-dolutegravir-for-the-treatment-of-hiv-1/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                13 August 2013\n            ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1\n                ViiV Healthcare is pleased to announce today that the U.S. Food and Drug Administration (FDA) has...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare is pleased to announce today that the U.S. Food and Drug Administration (FDA) has approved Tivicay® (dolutegravir) 50-mg tablets. "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-eu-submission-seeking-additional-indication-for-votrient-as-maintenance-therapy-for-advanced-ovarian-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                07 August 2013\n            Regulatory Update - GSK announces EU submission seeking additional indication for Votrient® as maintenance therapy for advanced ovarian cancer\n                GSK today announced submission to the European Medicines Agency of a variation to the Marketing A...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced submission to the European Medicines Agency of a variation to the Marketing Authorisation for Votrient® (pazopanib)"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-eu-submission-for-cervarix-two-dose-schedule/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                07 August 2013\n            Regulatory update – GSK announces EU submission for Cervarix® two dose schedule\n                GSK today announced the submission of a regulatory application in the European Union for a two do...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the submission of a regulatory application in the European Union for a two dosing schedule in 9-14 year old girls for its cervical cancer vaccine."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-albiglutide-us-pdufa-date-extended-by-three-months/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                02 August 2013\n            Regulatory update: albiglutide US PDUFA date extended by three months\n                GSK today announced that the US Prescription Drug User Fee Act (PDUFA) goal date for albiglutide,...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the US Prescription Drug User Fee Act (PDUFA) goal date for albiglutide, an investigational once-weekly treatment for adult patients with type 2 diabetes, has been extended by three months."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-adds-to-its-commitment-to-gavi-alliance-to-help-protect-millions-more-children-against-infectious-diseases/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                29 July 2013\n            GSK adds to its commitment to GAVI Alliance to help protect millions more children against infectious diseases\n                New extension of Synflorix vaccine supply agreement will help protect an additional 80 million ch...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New extension of Synflorix vaccine supply agreement will help protect an additional 80 million children in the world&#8217;s poorest countries from pneumococcal disease."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion-for-revolade-in-thrombocytopenia-associated-with-chronic-hepatitis-c-infection/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                26 July 2013\n            GSK receives positive CHMP opinion for REVOLADE in thrombocytopenia associated with chronic hepatitis C infection\n                GSK announced a positive opinion from the European Medicines Agency's Committee for Medicinal Pro...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommending marketing authorisation for Revolade™ (eltrombopag)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-regarding-recent-meeting-with-chinese-authorities/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                22 July 2013\n            GSK statement regarding recent meeting with Chinese authorities\n                Following a meeting with the Chinese Ministry of Public Security to discuss their investigation i...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Following a meeting with the Chinese Ministry of Public Security to discuss their investigation into GSK, Abbas Hussain, President International - Europe, Japan, Emerging Markets & Asia Pacific made the following statement."}},"https://www.gsk.com/en-gb/media/press-releases/update-on-gsk-consumer-nigeria-plc-scheme-of-arrangement/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                22 July 2013\n            Update on GSK Consumer Nigeria plc Scheme of Arrangement\n                GlaxoSmithKline plc and GlaxoSmithKline Consumer Nigeria PLC today announced that they have agree...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc and GlaxoSmithKline Consumer Nigeria PLC today announced that they have agreed that the scheme of arrangement proposed to GSK Nigeria's shareholders in the scheme document dated 24 June 2013, under which it was proposed that GSK would increase its indirect ownership in GSK Nigeria to 75%, will be withdrawn."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-response-to-china-investigation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                15 July 2013\n            GSK response to China investigation\n                In response to the ongoing investigations by government authorities in China regarding our busine...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In response to the ongoing investigations by government authorities in China regarding our business in the country, GSK has issued the following statement."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-fluticasone-furoatevilanterol-submission-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                12 July 2013\n            Regulatory update: fluticasone furoate/vilanterol submission in Japan\n                GSK and Theravance, Inc. announce that the licence application for the use of fluticasone furoate...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. announce that the licence application for the use of fluticasone furoate (FF) and vilanterol (VI) (proposed brand name RELVAR™ ELLIPTA™) in patients with chronic obstructive pulmonary disease (COPD) has been withdrawn from the current Japanese New Drug Application (JNDA)."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-us-submission-for-dabrafenibtrametinib-combination-in-metastatic-melanoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                09 July 2013\n            Regulatory update – GSK announces US submission for dabrafenib/trametinib combination in metastatic melanoma\n                GSK today announced submission of supplemental New Drug Applications (NDAs) to the US Food and Dr...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced submission of supplemental New Drug Applications (NDAs) to the US Food and Drug Administration for use of dabrafenib, a BRAF inhibitor, in combination with trametinib, a MEK inhibitor."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-receives-positive-chmp-opinions-for-tafinlar-dabrafenib-and-tyverb-lapatinib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                28 June 2013\n            Regulatory Update - GSK receives positive CHMP opinions for Tafinlar® (dabrafenib) and Tyverb® (lapatinib)\n                GSK announces that the European Medicines Agency's Committee for Medicinal Products for Human Use...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) is recommending marketing authorisation for two cancer drugs."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-launch-1-million-award-to-discover-new-healthcare-innovations-for-reducing-child-deaths/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                27 June 2013\n            GSK and Save the Children launch $1 million award to discover new healthcare innovations for reducing child deaths\n                The Healthcare Innovation Award is the first joint initiative announced following the launch of a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Healthcare Innovation Award is the first joint initiative announced following the launch of an ambitious new partnership between GSK and Save the Children "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-s-drisapersen-previously-gsk2402968pro051-to-receive-food-and-drug-administration-breakthrough-therapy-designation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                27 June 2013\n            GlaxoSmithKline’s drisapersen (previously GSK2402968/PRO051) to receive Food and Drug Administration Breakthrough Therapy designation\n                Breakthrough Therapy designation is one of several programmes created by the FDA to expedite the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Breakthrough Therapy designation is one of several programmes created by the FDA to expedite the development and review of drugs for serious or life-threatening conditions."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-data-from-five-phase-iii-studies-of-albiglutide-an-investigational-once-weekly-treatment-for-type-2-diabetes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                24 June 2013\n            GSK announces data from five Phase III studies of albiglutide, an investigational once-weekly treatment for type 2 diabetes\n                Data from five long-term Phase III studies comparing albiglutide to placebo and a range of active...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Data from five long-term Phase III studies comparing albiglutide to placebo and a range of active comparators were presented at the American Diabetes Association Meeting (ADA) in Chicago (21-25th June)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-offer-for-its-thrombosis-brands-and-related-manufacturing-site/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                18 June 2013\n            GSK receives offer for its thrombosis brands and related manufacturing site\n                GSK has today received an offer for its thrombosis brands and Notre-Dame de Bondeville (NDB) site...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has today received an offer for its thrombosis brands and Notre-Dame de Bondeville (NDB) site from Aspen Global Incorporated and Aspen Pharmacare Holdings Limited."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-regarding-2010-nature-medicine-study/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                10 June 2013\n            GSK statement regarding 2010 Nature Medicine study\n                GSK and Nature Medicine recently became aware of allegations of misrepresentation of data in a re...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Nature Medicine recently became aware of allegations of misrepresentation of data in a research paper written by scientists at GSK's China research centre and published in Nature Medicine in 2010."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-in-response-to-fda-advisory-committee-s-vote-on-availability-of-avandia-rosiglitazone/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                06 June 2013\n            GSK statement in response to FDA Advisory Committee’s vote on availability of Avandia (rosiglitazone)\n                GSK confirmed today that a joint advisory committee to the FDA voted to continue to make Avandia ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK confirmed today that a joint advisory committee to the FDA voted to continue to make Avandia (rosiglitazone) available to appropriate patients with the majority of the members voting to either modify (13) or remove (7) the Risk Evaluation and Mitigation Strategy (REMS) program in place. Remaining members voted to continue the REMS (5) or withdraw (1) Avandia from the US market."}},"https://www.gsk.com/en-gb/media/press-releases/?p=29":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=26":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=25","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=26":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/en-gb/products/our-prescription-medicines-and-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-cervarix-two-dose-schedule-receives-european-marketing-authorisation/","txt":"http://www.gsk.com/en-gb/products/our-prescription-medicines-and-vaccines/","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Our pharmaceuticals business discovers, develops and makes medicines to treat a broad range of the world's most common acute and chronic diseases"},"redirectedTo":"https://www.gsk.com/en-gb/products/our-prescription-medicines/"},"https://www.gsk.com/content/gsk/en/media/press-releases/2013/gsk-statement-regarding-2010-nature-medicine-study.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-iii-data-for-tykerbtyverb-lapatinib-in-combination-with-chemotherapy-for-advanced-her2-positive-gastric-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                03 June 2013\n            GSK announces Phase III data for TYKERB/TYVERB® (lapatinib) in combination with chemotherapy for advanced HER2-positive gastric cancer\n                GSK today announced that its study of TYKERB/TYVERB® (lapatinib) in combination with chemotherapy...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that its study of TYKERB/TYVERB® (lapatinib) in combination with chemotherapy in patients with HER2-positive advanced gastric cancer did not meet the primary endpoint of improved overall survival compared to chemotherapy alone."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-late-stage-clinical-data-for-votrient-pazopanib-following-chemotherapy-in-women-with-advanced-epithelial-ovarian-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                01 June 2013\n            GSK announces late-stage clinical data for VOTRIENT® (pazopanib) following chemotherapy in women with advanced epithelial ovarian cancer\n                GSK today announced that its Phase III clinical trial of VOTRIENT (pazopanib) met the primary obj...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that its Phase III clinical trial of VOTRIENT (pazopanib) met the primary objective of a statistically significant improvement in the time to disease progression or death  (progression-free survival, PFS) compared to placebo."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-strengthens-vaccines-business-with-acquisition-of-okairos/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                29 May 2013\n            GSK strengthens vaccines business with acquisition of Okairos\n                GSK today announced that it has acquired Okairos AG (Okairos), a specialist developer of vaccine ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it has acquired Okairos AG (Okairos), a specialist developer of vaccine platform technologies for €250 million (approximately £215 million/$325 million) in cash."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-announce-positive-top-line-results-from-pivotal-trial-of-arzerra-ofatumumab-combined-with-chlorambucil-in-previously-untreated-chronic-lymphocytic-leukaemia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                29 May 2013\n            GSK and Genmab announce positive top-line results from pivotal trial of ARZERRA® (ofatumumab) combined with chlorambucil in previously untreated chronic lymphocytic leukaemia\n                GSK and Genmab announce that their Phase III study of ARZERRA® (ofatumumab) in combination with c...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Genmab announce that their Phase III study of ARZERRA® (ofatumumab) in combination with chlorambucil versus chlorambucil alone in patients with previously untreated chronic lymphocytic leukaemia (CLL) met its primary endpoint of progression free survival (PFS) as assessed by an independent review committee (IRC)."}},"https://www.gsk.com/en-gb/media/press-releases/two-new-gsk-oral-oncology-treatments-braf-inhibitor-tafinlar-dabrafenib-capsules-and-the-first-mek-inhibitor-mekinist-trametinib-tablets-approved-by-fda-as-single-agent-therapies/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                29 May 2013\n            Two new GSK oral oncology treatments, BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets, approved by FDA as single-agent therapies\n                GSK announced today that the FDA has approved both TAFINLAR® (dabrafenib) and MEKINIST™ (trametin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the FDA has approved both TAFINLAR® (dabrafenib) and MEKINIST™ (trametinib)."}},"https://www.gsk.com/en-gb/media/press-releases/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers-in-sub-saharan-africa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                24 May 2013\n            Grant to Help Coordinate Campaign to Train One Million Community Health Workers in sub-Saharan Africa\n                In an effort to broadly expand the reach of health care services in sub-Saharan Africa, GSK will ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In an effort to broadly expand the reach of health care services in sub-Saharan Africa, GSK will contribute $750,000 to the One Million Community Health Workers Campaign. "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-awarded-up-to-200-million-by-us-government-to-develop-new-antibiotics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                22 May 2013\n            GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics\n                GSK and the Biomedical Advanced Research and Development Authority (BARDA), have agreed to a firs...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and the Biomedical Advanced Research and Development Authority (BARDA), have agreed to a first of its kind collaboration that will support the development of several antibiotics to fight antibiotic resistance and bioterrorism."}},"https://www.gsk.com/en-gb/media/press-releases/breo-ellipta-gains-us-approval-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                10 May 2013\n            BREO™ ELLIPTA™ gains US approval for the treatment of COPD\n                GSK and Theravance today announced that the FDA has approved BREO™ ELLIPTA™ as an inhaled long-te...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance today announced that the FDA has approved BREO™ ELLIPTA™ as an inhaled long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-enters-new-commitment-with-the-gavi-alliance-to-supply-cervical-cancer-vaccine-for-girls-in-the-world-s-poorest-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                09 May 2013\n            GSK enters new commitment with the GAVI Alliance to supply cervical cancer vaccine for girls in the world’s poorest countries\n                GSK today announced a new commitment to the GAVI Alliance to supply its cervical cancer vaccine t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced a new commitment to the GAVI Alliance to supply its cervical cancer vaccine to help protect girls in the world's poorest countries."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-form-unique-partnership-to-save-the-lives-of-one-million-children/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                09 May 2013\n            GSK and Save the Children form unique partnership to save the lives of one million children\n                An ambitious new partnership to save the lives of a million of the poorest children in the world ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"An ambitious new partnership to save the lives of a million of the poorest children in the world has been launched by GSK and Save the Children."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-gives-update-on-plans-to-share-detailed-clinical-trial-data-as-part-of-its-commitment-to-transparency/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                07 May 2013\n            GSK gives update on plans to share detailed clinical trial data as part of its commitment to transparency\n                GSK today announced progress on its commitment to share more detailed data from its clinical tria...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced progress on its commitment to share more detailed data from its clinical trials. "}},"https://www.gsk.com/en-gb/media/press-releases/funding-boost-for-gsk-s-open-innovation-research-into-diseases-affecting-the-developing-world/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                03 May 2013\n            Funding boost for GSK’s open innovation research into diseases affecting the developing world\n                GSK today announced a funding injection of up to £5m from the Wellcome Trust to support its open ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discovering and developing new treatments for diseases of the developing world."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-trametinib-us-pdufa-date-extended-to-3-september-2013/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                01 May 2013\n            Regulatory update: Trametinib US PDUFA date extended to 3 September 2013\n                GSK today announced that the US Prescription Drug User Fee Act (PDUFA) goal date for trametinib, ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the US Prescription Drug User Fee Act (PDUFA) goal date for trametinib, its MEK inhibitor, has been extended by 3 months to 3 September 2013."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-regulatory-submission-for-umeclidinium-monotherapy-in-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                30 April 2013\n            GSK announces regulatory submission for umeclidinium monotherapy in US\n                GSK today announced the submission of a regulatory application in the US for the investigational ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the submission of a regulatory application in the US for the investigational once-daily medicine, umeclidinium bromide (UMEC), for patients with chronic obstructive pulmonary disease (COPD). "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-impax-pharmaceuticals-terminate-their-collaboration-on-ipx066/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                29 April 2013\n            GlaxoSmithKline and Impax Pharmaceuticals terminate their collaboration on IPX066\n                GSK and Impax Pharmaceuticals today announced that they are terminating their collaboration for t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Impax Pharmaceuticals today announced that they are terminating their collaboration for the development and commercialisation of IPX066 outside the United States and Taiwan."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-regulatory-submission-for-umeclidinium-monotherapy-in-european-union/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                26 April 2013\n            GSK announces regulatory submission for umeclidinium monotherapy in European Union\n                GSK today announced the submission of a regulatory application in the European Union for the inve...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the submission of a regulatory application in the European Union for the investigational once-daily medicine, umeclidinium bromide (UMEC), for patients with chronic obstructive pulmonary disease (COPD). "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-regulatory-submission-for-anoro-ellipta-umecvi-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                22 April 2013\n            GSK and Theravance announce regulatory submission for ANORO™ ELLIPTA™ (UMEC/VI) in Japan\n                GSK and Theravance, Inc. today announced the submission of a regulatory application to the Japane...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced the submission of a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI, for patients with chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-in-response-to-oft-statement-of-objections/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                19 April 2013\n            GSK statement in response to OFT Statement of Objections\n                GSK supports fair competition and we very strongly believe that we acted within the law, as the h...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK supports fair competition and we very strongly believe that we acted within the law, as the holder of valid patents for paroxetine, in entering the agreements under investigation."}},"https://www.gsk.com/en-gb/media/press-releases/fda-advisory-committee-recommends-approval-of-breo-tm-ellipta-tm-for-the-treatment-of-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                17 April 2013\n            FDA Advisory Committee recommends approval of BREO(TM) ELLIPTA(TM) for the treatment of COPD\n                GSK and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee (PAD...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee (PADAC) to the US Food and Drug Administration (FDA) voted that the efficacy and safety data provide substantial evidence to support approval of  BREO™ ELLIPTA™ as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD)"}},"https://www.gsk.com/en-gb/media/press-releases/?p=30":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=27":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=26","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=27":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=sales&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=graduate%2cgraduate&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=12","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=13","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=14","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=10","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications&bu=&r=&city=&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=1","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=1","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=1","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=4","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=4","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=3","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=4","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=3","txt":"1","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=5","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&cl=8680&bu=&r=&city=&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Technology&bu=&r=&city=&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&r=&city=&et=&prog=&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=research+and+development&bu=&r=&city=&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=research+and+development&r=&city=&et=&prog=&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/content/gsk/en/products.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-first-four-strain-seasonal-influenza-vaccine-granted-marketing-authorisation-in-germany-and-the-uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                03 April 2013\n            GSK announces first four-strain seasonal influenza vaccine granted marketing authorisation in Germany and the UK\n                GSK has announced the marketing authorisation of its quadrivalent (four-strain) influenza vaccine...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has announced the marketing authorisation of its quadrivalent (four-strain) influenza vaccine in Germany and the UK."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announces-start-of-phase-iii-study-of-benlysta-belimumab-in-patients-with-vasculitis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                03 April 2013\n            GlaxoSmithKline announces start of phase III study of Benlysta® (belimumab ) in patients with vasculitis\n                GSK today announced the start of a Phase III study to evaluate Benlysta® (belimumab) in patients ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the start of a Phase III study to evaluate Benlysta® (belimumab) in patients with ANCA (Anti-neutrophil Cytoplasmic Antibodies) positive vasculitis - a condition that involves inflammation of the blood vessels."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-glaxosmithkline-receives-complete-response-from-fda-for-candidate-pandemic-h5n1-adjuvanted-influenza-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                25 March 2013\n            Regulatory update: GlaxoSmithKline receives complete response from FDA for candidate pandemic H5N1 adjuvanted influenza vaccine\n                GSK announced today that it has received a Complete Response letter from the FDA in response to t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that it has received a Complete Response letter from the FDA in response to the Biologics License Application (BLA) for its Pandemic Influenza A Virus Monovalent Adjuvanted candidate vaccine, referred to as Q-Pan H5N1."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-2012-corporate-responsibility-report/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                20 March 2013\n            GSK publishes 2012 Corporate Responsibility report\n                Report sets out 23 forward-looking commitments to help measure future performance\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Report sets out 23 forward-looking commitments to help measure future performance"}},"https://www.gsk.com/en-gb/media/press-releases/500-000-endowment-gift-from-the-glaxosmithkline-foundation-expands-program-to-help-patients-with-cancer-and-their-families-at-the-children-s-hospital-of-philadelphia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                18 March 2013\n            $500,000 Endowment Gift from The GlaxoSmithKline Foundation Expands Program to Help Patients with Cancer and their Families at The Children’s Hospital of Philadelphia\n                The Children’s Hospital of Philadelphia is proud to announce a $500,000 gift from the GSK Foundat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Children’s Hospital of Philadelphia is proud to announce a $500,000 gift from the GSK Foundation."}},"https://www.gsk.com/en-gb/media/press-releases/young-scientists-challenged-by-gsk-and-mclaren-to-help-drive-science-behind-formula-1/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                13 March 2013\n            Young scientists challenged by GSK and McLaren to help drive science behind Formula 1™\n                GSK and the McLaren Group announce new science education initiative to inspire young people into ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and the McLaren Group announce new science education initiative to inspire young people into science and engineering careers"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-regulatory-submission-for-albiglutide-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                07 March 2013\n            Regulatory update – GSK announces regulatory submission for albiglutide in Europe\n                GSK today announced the submission of a Marketing Authorisation Application (MAA) for albiglutide...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the submission of a Marketing Authorisation Application (MAA) for albiglutide, with the proprietary name EPERZAN, to the European Medicines Agency (EMA).  "}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-data-from-phase-iii-study-of-dolutegravir-vs-raltegravir-in-treatment-experienced-adults-with-hiv-1/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                06 March 2013\n            ViiV Healthcare presents data from Phase III study of dolutegravir vs raltegravir in treatment-experienced adults with HIV-1\n                ViiV Healthcare presents 24-week interim results from Phase III SAILING study at the 20th Confere...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare presents 24-week interim results from Phase III SAILING study at the 20th Conference on Retroviruses and Opportunistic Infections (CROI)"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-a-voluntary-licence-agreement-with-the-medicines-patent-pool-to-increase-access-to-hiv-medicines-for-children/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                27 February 2013\n            ViiV Healthcare announces a voluntary licence agreement with the Medicines Patent Pool to increase access to HIV medicines for children\n                Agreement brings the number of voluntary licences granted by ViiV Healthcare to 14.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Agreement brings the number of voluntary licences granted by ViiV Healthcare to 14."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-fda-acceptance-of-new-drug-application-nda-submission-in-the-us-for-anoro-elliptatm-for-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                19 February 2013\n            GSK and Theravance announce FDA acceptance of New Drug Application (NDA) submission in the US for ANORO ELLIPTATM for COPD\n                GSK and Theravance, Inc. today announced that the New Drug Application (NDA) for the investigatio...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced that the New Drug Application (NDA) for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI, for patients with chronic obstructive pulmonary disease (COPD), has been accepted by the FDA."}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-fda-priority-review-designation-for-dolutegravir-as-a-potential-treatment-for-hiv-infection/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                15 February 2013\n            ViiV Healthcare announces FDA priority review designation for dolutegravir as a potential treatment for HIV infection\n                ViiV Healthcare today announced that the FDA has granted a priority review designation to doluteg...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"ViiV Healthcare today announced that the FDA has granted a priority review designation to dolutegravir submitted for the treatment of HIV infection."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-european-submission-for-mek-monotherapy-and-brafmek-combination-therapy-in-metastatic-melanoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                07 February 2013\n            Regulatory update – GSK announces European submission for MEK monotherapy and BRAF/MEK combination therapy in metastatic melanoma\n                GlaxoSmithKline (GSK) plc today announced submission of a Marketing Authorisation Application to ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) plc today announced submission of a Marketing Authorisation Application to the European Medicines Agency (EMA) for trametinib (MEK) as monotherapy and in combination with dabrafenib (BRAF) for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-increases-stake-in-its-publicly-listed-consumer-healthcare-subsidiary-in-india-to-725-per-cent/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                05 February 2013\n            GSK increases stake in its publicly-listed Consumer Healthcare subsidiary in India to 72.5 per cent\n                GSK announced today that, pursuant to the voluntary open offer undertaken by its subsidiary, Glax...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that, pursuant to the voluntary open offer undertaken by its subsidiary, GlaxoSmithKline Pte. Ltd, GSK has successfully increased its stake in GlaxoSmithKline Consumer Healthcare Ltd, its publicly-listed Consumer Healthcare subsidiary in India, from 43.2% to 72.5%"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-support-for-alltrials-campaign-for-clinical-data-transparency/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                05 February 2013\n            GSK announces support for AllTrials campaign for clinical data transparency\n                Campaign calls for full disclosure of clinical trial results and clinical study reports to help d...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Campaign calls for full disclosure of clinical trial results and clinical study reports to help drive scientific understanding."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-starts-phase-iii-study-to-test-combined-brafmek-inhibition-in-patients-with-braf-positive-melanoma-following-surgery/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                01 February 2013\n            GlaxoSmithKline starts Phase III study to test combined BRAF/MEK inhibition in patients with BRAF positive melanoma following surgery\n                GSK today announced the start of COMBI-AD, a  Phase III study evaluating the combination of dabra...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the start of COMBI-AD, a  Phase III study evaluating the combination of dabrafenib, its BRAF inhibitor and trametinib, its MEK inhibitor as adjuvant therapy for melanoma.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-response-to-news-article-in-the-guardian-on-uk-legal-proceedings-related-to-avandia-rosiglitazone/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                30 January 2013\n            GSK response to news article in The Guardian on UK legal proceedings related to Avandia (rosiglitazone)\n                Responding to a news article in The Guardian this morning on UK legal proceedings related to our ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Responding to a news article in The Guardian this morning on UK legal proceedings related to our type 2 diabetes medicine Avandia (rosiglitazone), we would like to make the following points:"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-biological-e-announce-joint-venture-to-develop-combination-vaccine-for-india-and-other-developing-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                28 January 2013\n            GSK and Biological E. announce joint venture to develop combination vaccine for India and other developing countries\n                GlaxoSmithKline (GSK) and Biological E Limited (Biological E.), a leading Indian vaccines company...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Biological E Limited (Biological E.), a leading Indian vaccines company, today announced an agreement to form a 50/50 joint venture (JV) for the early stage research and development of a six-in-one combination paediatric vaccine to help protect children in India and other developing countries from polio and other infectious diseases."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-appoints-hans-wijers-to-its-board-as-a-non-executive-director/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                24 January 2013\n            GSK appoints Hans Wijers to its Board as a Non-Executive Director\n                GlaxoSmithKline plc (LSE: GSK) today announced the appointment of Hans Wijers to its Board as a N...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) today announced the appointment of Hans Wijers to its Board as a Non-Executive Director, effective 1st April 2013."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-up-to-uk-government-s-public-health-responsibility-deal/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                22 January 2013\n            GSK signs up to UK Government’s Public Health Responsibility Deal\n                Pledge to reduce the sugar and calorie content of Lucozade Energy and Ribena products.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Pledge to reduce the sugar and calorie content of Lucozade Energy and Ribena products."}},"https://www.gsk.com/en-gb/media/press-releases/?p=31":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=28":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=27","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=28":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=29":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submission-of-albiglutide-bla-to-the-us-fda-for-the-treatment-of-type-2-diabetes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                14 January 2013\n            Regulatory update – GSK announces submission of albiglutide BLA to the US FDA for the treatment of type 2 diabetes\n                GlaxoSmithKline (GSK) plc today announced a regulatory submission to the US Food and Drug Adminis...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) plc today announced a regulatory submission to the US Food and Drug Administration (US FDA) for albiglutide, an investigational once-weekly treatment for adult patients with type 2 diabetes."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-regulatory-submission-for-anoro-umecvi-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                09 January 2013\n            GSK and Theravance announce regulatory submission for ANORO™ (UMEC/VI) in Europe\n                GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a regulatory application in the European Union for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI, for patients with chronic obstructive pulmonary disease (COPD). "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-regulatory-submission-for-umecvi-lamalaba-in-the-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                18 December 2012\n            GSK and Theravance announce regulatory submission for UMEC/VI (LAMA/LABA) in the US\n                GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a regulatory application in the US for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI, for patients with chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/fda-approves-glaxosmithkline-s-four-strain-seasonal-influenza-vaccine-for-use-in-the-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                17 December 2012\n            FDA Approves GlaxoSmithKline’s four-strain seasonal influenza vaccine for use in the US\n                GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX&#174; QUADRIVALENT (Influenza Virus Vaccine) for the immunisation of children (three years and older) and adults to help prevent disease caused by seasonal influenza (flu) virus subtypes A and type B contained in the vaccine. "}},"https://www.gsk.com/en-gb/media/press-releases/results-from-five-phase-iii-studies-presented-for-gsk-s-two-candidate-quadrivalent-influenza-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                22 October 2012\n            Results from five phase III studies presented for GSK’s two candidate quadrivalent influenza vaccines\n                GSK today announced that results from five Phase III studies investigating its two candidate quad...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that results from five Phase III studies investigating its two candidate quadrivalent influenza vaccines were presented at the Influenza Vaccines for the World congress in Valencia, Spain and the Infectious Diseases week  congress in San Diego, USA in October."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-further-initiatives-to-advance-openness-and-collaboration-to-help-tackle-global-health-challenges/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                11 October 2012\n            GSK announces further initiatives to advance openness and collaboration to help tackle global health challenges\n                Speaking at a meeting hosted by the Wellcome Trust in London today, GSK CEO Sir Andrew Witty will...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Speaking at a meeting hosted by the Wellcome Trust in London today, GSK CEO Sir Andrew Witty will outline new steps to build on the encouraging signs of progress resulting from GSK open innovation approach to R&D, designed to help develop new solutions for the worlds most serious health challenges."}},"https://www.gsk.com/en-gb/media/press-releases/millions-of-children-in-pakistan-to-be-protected-against-pneumococcal-disease-with-gsk-s-synflorix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                09 October 2012\n            Millions of children in Pakistan to be protected against pneumococcal disease with GSK’s Synflorix\n                GlaxoSmithKline (GSK) welcomes today&#8217;s announcement from the GAVI Alliance that its pneumoc...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) welcomes today&#8217;s announcement from the GAVI Alliance that its pneumococcal vaccine, SynflorixTM, is to be introduced into the national immunisation programme in Pakistan."}},"https://www.gsk.com/en-gb/media/press-releases/shionogi-viiv-healthcare-announces-completion-of-initial-clinical-registration-package-for-dolutegravir-in-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                04 October 2012\n            Shionogi-ViiV Healthcare announces completion of initial clinical registration package for dolutegravir in HIV\n                Shionogi-ViiV Healthcare LLC today announced that the phase III data required for initial regulat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Shionogi-ViiV Healthcare LLC today announced that the phase III data required for initial regulatory filings of the investigational integrase inhibitor dolutegravir in adults infected with HIV are in house. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-fda-acceptance-of-ffvi-new-drug-application-nda-submission-in-the-us-for-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                26 September 2012\n            GSK and Theravance announce FDA acceptance of FF/VI New Drug Application (NDA) submission in the US for COPD\n                GSK and Theravance, Inc. today announced that the New Drug Application for the once-daily investi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced that the New Drug Application for the once-daily investigational medicine fluticasone furoate /vilanterol for patients with chronic obstructive pulmonary disease, has been accepted by the US Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-announces-changes-to-its-board-and-committees/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                26 September 2012\n            GlaxoSmithKline plc announces changes to its Board and Committees\n                GlaxoSmithKline plc today announces the following changes to its Board and Committee structure.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc today announces the following changes to its Board and Committee structure."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submission-for-a-new-indication-for-synflorix-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                17 September 2012\n            Regulatory Update: GSK announces submission for a new indication for Synflorix™ in Europe\n                GlaxoSmithKline plc (GSK) announced today that it has submitted a regulatory application in the E...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) announced today that it has submitted a regulatory application in the European Union (EU) seeking approval of an additional indication for Synflorix, a paediatric pneumococcal vaccine, for the active immunisation against pneumonia caused by Streptococcus pneumoniae in infants and children from 6 weeks up to 5 years of age."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-acquire-five-million-shares-in-response-genetics-for-us-110-per-share-in-cash/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                13 September 2012\n            GSK to acquire five million shares in Response Genetics for US$1.10 per share in cash\n                GlaxoSmithKline plc (LSE: GSK) today announces that it has acquired five million newly issued sha...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) today announces that it has acquired five million newly issued shares of Response Genetics Inc. (RGI) (NASDAQ: RGDX) common stock at a purchase price of US$1.10 per share in cash."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-completion-of-the-phase-iii-programme-for-once-daily-lamalaba-umecvi-in-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                24 August 2012\n            GSK and Theravance announce completion of the Phase III programme for once-daily LAMA/LABA (UMEC/VI) in COPD\n                GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the completion of t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the completion of the phase III programme of an investigational LAMA/LABA involving approximately 6,000 patients with chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-phase-iii-programme-of-sirukumab-in-rheumatoid-arthritis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                23 August 2012\n            GSK announces start of Phase III programme of sirukumab in rheumatoid arthritis\n                GlaxoSmithKline plc (GSK) today announced that - as part of their collaboration with Janssen Biol...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that - as part of their collaboration with Janssen Biologics (Ireland) - the Phase III programme evaluating sirukumab (CNTO 136), a human anti-interleukin (IL)-6 monoclonal antibody in the treatment of patients with moderately to severely active rheumatoid arthritis (RA), has commenced dosing. "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-reaches-agreement-to-divest-majority-of-classic-brands-in-australia-for-172m/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                15 August 2012\n            GlaxoSmithKline reaches agreement to divest majority of Classic Brands in Australia for £172m\n                GlaxoSmithKline plc (GSK) today announced that it has reached agreement to divest the majority of...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that it has reached agreement to divest the majority of its Classic Brands (25 non-promoted and genericised products) in Australia to Aspen Global Incorporated (Aspen) for approximately £172 million in cash."}},"https://www.gsk.com/en-gb/media/press-releases/european-commission-grants-marketing-authorisation-for-pazopanib-votrient-in-the-treatment-of-certain-advanced-soft-tissue-sarcoma-subtypes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                07 August 2012\n            European Commission grants marketing authorisation for pazopanib (Votrient®) in the treatment of certain advanced soft tissue sarcoma subtypes\n                GlaxoSmithKline plc announced today that the European Commission has granted pazopanib marketing ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc announced today that the European Commission has granted pazopanib marketing authorisation for the treatment of patients with advanced soft tissue sarcoma (aSTS) who have received prior chemotherapy or have progressed within 12 months after (neo) adjuvant therapy."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submissions-in-the-eu-and-us-for-dabrafenib-and-trametinib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                03 August 2012\n            Regulatory update – GSK announces submissions in the EU and US for dabrafenib and trametinib\n                GlaxoSmithKline (GSK) plc today announced regulatory submissions in the European Union and United...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) plc today announced regulatory submissions in the European Union and United States (US) related to single-agent use of its BRAF inhibitor dabrafenib and MEK inhibitor trametinib to treat patients with BRAF V600 mutation positive metastatic melanoma. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-acquisition-of-human-genome-sciences/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                03 August 2012\n            GSK completes acquisition of Human Genome Sciences\n                GlaxoSmithKline plc (LSE: GSK) today announced that it has completed its acquisition of Human Gen...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) today announced that it has completed its acquisition of Human Genome Sciences (NASDAQ: HGSI) for US$3.6 billion on an equity basis, or approximately US$3 billion net of cash and debt. All outstanding shares of HGS were acquired for US$14.25 per share in cash.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-acquisition-of-79-of-human-genome-sciences-shares-commences-subsequent-offering-period/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                30 July 2012\n            GSK announces acquisition of 79% of Human Genome Sciences shares; commences subsequent offering period\n                GlaxoSmithKline plc (LSE: GSK) today announced the results of its initial tender offer for all ou...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) today announced the results of its initial tender offer for all outstanding shares of Human Genome Sciences (NASDAQ: HGSI) for US$14.25 per share in cash, valuing HGS at approximately US$3.6 billion on an equity basis, or approximately US$3 billion net of cash and debt. "}},"https://www.gsk.com/en-gb/media/press-releases/maximuscle-powers-vodafone-mclaren-mercedes-drivers-through-the-2012-formula-1-season/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                27 July 2012\n            Maximuscle powers Vodafone McLaren Mercedes drivers through the 2012 Formula 1™ season\n                Leading sports nutrition brand continues its presence with on-car logos in Hungary\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Leading sports nutrition brand continues its presence with on-car logos in Hungary"}},"https://www.gsk.com/en-gb/media/press-releases/?p=32":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=29":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=28","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-pre-broadcast-statement-on-bbc-panorama-the-truth-about-sports-products-19-july-2012/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                19 July 2012\n            GSK pre-broadcast statement on BBC Panorama: “The truth about Sports Products”, 19 July 2012\n                GlaxoSmithKline today issued the following statement in anticipation of the BBC Panorama programm...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline today issued the following statement in anticipation of the BBC Panorama programme. The truth about sports products, which is scheduled to be aired this evening. \n\n\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-amicus-therapeutics-expand-fabry-disease-collaboration/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                17 July 2012\n            GlaxoSmithKline and Amicus Therapeutics expand Fabry disease collaboration\n                Glaxo Group Limited (GSK) and Amicus Therapeutics (Nasdaq: FOLD) today announced an expansion of ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Glaxo Group Limited (GSK) and Amicus Therapeutics (Nasdaq: FOLD) today announced an expansion of their collaboration to develop and commercialise the investigational pharmacological chaperone migalastat HCl for Fabry disease."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-celebrates-its-role-in-supporting-the-biggest-anti-doping-operation-in-the-history-of-the-olympic-games/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                16 July 2012\n            GlaxoSmithKline celebrates its role in supporting the biggest anti-doping operation in the history of the Olympic Games\n                GSK today marks its role as Official Laboratory Services Provider for the London 2012 Olympic and...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today marks its role as Official Laboratory Services Provider for the London 2012 Olympic and Paralympic Games by launching its first UK advertising campaign to celebrate the role that anti-doping science will play in helping ensure this summer's Games are the cleanest possible. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-acquire-human-genome-sciences-for-us-1425-per-share-in-cash/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                16 July 2012\n            GSK to acquire Human Genome Sciences for US$14.25 per share in cash\n                GlaxoSmithKline plc (LSE: GSK) and Human Genome Sciences (NASDAQ: HGSI) today announced that the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) and Human Genome Sciences (NASDAQ: HGSI) today announced that the companies have entered into a definitive agreement under which GSK will acquire HGS for US$14.25 per share in cash.  "}},"https://www.gsk.com/en-gb/media/press-releases/us-regulatory-update-tykerb-lapatinib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                12 July 2012\n            US Regulatory Update – Tykerb® (lapatinib)\n                GSK plc announced today that it has withdrawn a supplemental NDA to the US FDA for Tykerb (lapati...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK plc announced today that it has withdrawn a supplemental NDA to the US FDA for Tykerb (lapatinib) in combination with trastuzumab for the treatment of patients with HER2 (ErbB2)-positive metastatic breast cancer who have received  prior trastuzumab therapy. "}},"https://www.gsk.com/en-gb/media/press-releases/shionogi-viiv-healthcare-announces-positive-initial-data-from-phase-iii-study-of-dolutegravir-based-regimen-vs-atripla-in-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                11 July 2012\n            Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV\n                Shionogi-ViiV Healthcare LLC today announced that initial results have been received from the Pha...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Shionogi-ViiV Healthcare LLC today announced that initial results have been received from the Phase III SINGLE (ING114467) study of the investigational integrase inhibitor dolutegravir in treatment-naive adults with HIV-1. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-data-from-harmony-8-and-completion-of-clinical-registration-package-for-albiglutide-in-type-2-diabetes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                11 July 2012\n            GSK announces positive data from Harmony 8 and completion of clinical registration package for albiglutide in type 2 diabetes\n                GSK today announced that data have been received from the Phase III Harmony 8 study and from the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that data have been received from the Phase III Harmony 8 study and from the event driven meta-analysis for assessment of cardiovascular safety conducted across the albiglutide clinical programme.  "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-concludes-previously-announced-agreement-in-principle-to-resolve-multiple-investigations-with-us-government-and-numerous-states/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                02 July 2012\n            GlaxoSmithKline concludes previously announced agreement in principle to resolve multiple investigations with US Government and numerous states\n                GSK today announced that it has reached an agreement with the US Government, multiple states and ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it has reached an agreement with the US Government, multiple states and the District of Columbia to conclude the Companys most significant ongoing Federal government investigations.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-sets-20-july-for-expiration-of-tender-offer-to-acquire-human-genome-sciences/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                29 June 2012\n            GSK sets 20 July for expiration of tender offer to acquire Human Genome Sciences\n                GlaxoSmithKline plc (LSE: GSK) today announced it has extended its tender offer to acquire all of...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (LSE: GSK) today announced it has extended its tender offer to acquire all of the outstanding shares of Human Genome Sciences (NASDAQ: HGSI) for US$13.00 per share in cash to 5:00 p.m. New York City time on 20 July 2012."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-continues-with-tender-offer-to-acquire-all-outstanding-shares-of-human-genome-sciences/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                15 June 2012\n            GSK continues with tender offer to acquire all outstanding shares of Human Genome Sciences\n                GSK today confirmed that it has received a renewed invitation from Human Genome Sciences to parti...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today confirmed that it has received a renewed invitation from Human Genome Sciences to participate in its strategic alternatives review process which started in April.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-approval-for-menhibrix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                14 June 2012\n            GSK receives FDA approval for MenHibrix\n                GSK plc announced today that the US FDA has approved the vaccine MenHibrix [Meningococcal Groups ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK plc announced today that the US FDA has approved the vaccine MenHibrix [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine]. "}},"https://www.gsk.com/en-gb/media/press-releases/stiefel-signs-worldwide-acquisition-and-license-agreement-for-toctino/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                11 June 2012\n            Stiefel signs worldwide acquisition and license agreement for Toctino®\n                Stiefel, a GSK company, today announced that it has entered into a worldwide agreement to acquire...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Stiefel, a GSK company, today announced that it has entered into a worldwide agreement to acquire Toctino (alitretinoin) from Basilea Pharmaceutica Ltd. (Basilea). "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-52-week-data-from-phase-iii-study-of-once-weekly-albiglutide-in-type-2-diabetes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                09 June 2012\n            GSK announces new 52-week data from phase III study of once-weekly albiglutide in type 2 diabetes\n                Detailed findings from a Phase III study comparing the investigational GLP-1 receptor agonist alb...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Detailed findings from a Phase III study comparing the investigational GLP-1 receptor agonist albiglutide to Lispro, were presented today at the ADA Meeting in Philadelphia, USA."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-tender-offer-for-all-outstanding-shares-of-human-genome-sciences/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                08 June 2012\n            GSK extends tender offer for all outstanding shares of Human Genome Sciences\n                GSK today announced it has extended its tender offer to acquire all of the outstanding shares of ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced it has extended its tender offer to acquire all of the outstanding shares of Human Genome Sciences for US$13.00 per share in cash to 5:00 pm New York City time on Friday 29 June 2012. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-xenoport-receive-fda-approval-for-horizant-for-postherpetic-neuralgia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                07 June 2012\n            GSK and XenoPort receive FDA approval for Horizant® for postherpetic neuralgia\n                GlaxoSmithKline plc (GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced today that the United State...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant; (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia (PHN) in adults."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-expiration-of-hart-scott-rodino-waiting-period-for-tender-offer-for-hgs/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                01 June 2012\n            GSK announces expiration of Hart-Scott-Rodino waiting period for tender offer for HGS\n                GSK today announced that the waiting period under the HSR Act, as amended, has expired with respe...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that the waiting period under the HSR Act, as amended, has expired with respect to GSK tender offer for all the outstanding shares of Human Genome Sciences.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-epsrc-announce-creation-of-new-chair-in-sustainable-chemistry-at-the-university-of-nottingham/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                31 May 2012\n            GSK and EPSRC announce creation of new Chair in Sustainable Chemistry at the University of Nottingham\n                GSK and The Engineering and Physical Sciences Research Council today announced that they will joi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and The Engineering and Physical Sciences Research Council today announced that they will jointly contribute to the funding for a Chair in Sustainable Chemistry to be based at the planned GSK Carbon Neutral Laboratory for Sustainable Chemistry at the University of Nottingham. "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submissions-in-the-eu-us-for-new-indications-for-promacta-revolade/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                30 May 2012\n            Regulatory Update – GSK announces submissions in the EU & US for new indications for Promacta®/Revolade®\n                GSK announced today that it has submitted regulatory applications in the EU and US related to elt...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that it has submitted regulatory applications in the EU and US related to eltrombopag (Promacta&#174;/Revolade&#174; ) and its use to increase platelet counts in patients with chronic hepatitis C virus infection and low platelets. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-secures-future-of-local-playing-fields-with-fields-in-trust-as-part-of-london-2012-legacy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                29 May 2012\n            GSK secures future of local playing fields with Fields in Trust as part of London 2012 legacy\n                GSK has today entered a partnership with Fields in Trust (FIT) to secure the future of its Swynco...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has today entered a partnership with Fields in Trust (FIT) to secure the future of its Swyncombe Avenue Playing Fields, where hundreds of local people already enjoy sport, by placing them into trust in perpetuity. "}},"https://www.gsk.com/en-gb/media/press-releases/?p=33":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=30":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=29","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=30":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-start-of-phase-iii-programme-for-combination-of-dabrafenib-gsk2118436-and-trametinib-gsk1120212-in-braf-v600-mutation-positive-metastatic-cutaneous-melanoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                29 May 2012\n            GSK announces start of Phase III programme for combination of dabrafenib (GSK2118436) and trametinib (GSK1120212) in BRAF V600 mutation-positive metastatic cutaneous melanoma\n                GlaxoSmithKline plc. today announced the start of a Phase III programme evaluating the combinatio...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc. today announced the start of a Phase III programme evaluating the combination of dabrafenib, its BRAF inhibitor, and trametinib, its MEK inhibitor, in patients with BRAF mutation-positive metastatic cutaneous melanoma. "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-confirms-us-district-court-ruling-in-pronova-biopharma-s-favour-on-lovaza-patents/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                29 May 2012\n            GlaxoSmithKline confirms US District Court ruling in Pronova BioPharma’s favour on Lovaza™ patents\n                GlaxoSmithKline plc (GSK) which has the marketing rights for Lovaza (omega-3-acid ethyl esters) i...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) which has the marketing rights for Lovaza (omega-3-acid ethyl esters) in the US and Puerto Rico, confirmed that U.S. District Judge Sue Lewis Robinson, the presiding judge in the U.S. District Court for the District of Delaware..."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-opinion-from-european-chmp-for-pazopanib-in-the-treatment-of-patients-with-certain-advanced-soft-tissue-sarcomas/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                25 May 2012\n            GSK receives positive opinion from European CHMP for pazopanib in the treatment of patients with certain advanced soft tissue sarcomas\n                GSK announced that the EMA CHMP has issued a positive opinion recommending marketing authorisatio...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced that the EMA CHMP has issued a positive opinion recommending marketing authorisation for Votrient for the treatment of adult patients with selective subtypes of advanced STS. "}},"https://www.gsk.com/en-gb/media/press-releases/two-overall-winners-announced-at-prestigious-national-award-ceremony-in-london-s-science-museum/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                18 May 2012\n            Two overall winners announced at prestigious national award ceremony in London’s Science Museum\n                For the first time in its 15 year history the judges of the GlaxoSmithKline (GSK) IMPACT Awards c...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"For the first time in its 15 year history the judges of the GlaxoSmithKline (GSK) IMPACT Awards could not choose one overall winner for the awards so instead awarded two prizes. The accolade was received by both the Cornish Women&#8217;s Rape and Sexual Abuse Centre (WRSAC) and Target Ovarian Cancer."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-tender-offer-to-acquire-human-genome-sciences/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                17 May 2012\n            GSK statement on tender offer to acquire Human Genome Sciences\n                GSK today commented on Human Genome Sciences Board of Directors decision to recommend against GSK...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today commented on Human Genome Sciences Board of Directors decision to recommend against GSK's tender offer to acquire all of the outstanding shares of HGS for US$13.00 per share in cash. "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-completes-transaction-to-increase-its-ownership-in-theravance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                16 May 2012\n            GlaxoSmithKline completes transaction to increase its ownership in Theravance\n                Following approval by Theravance, Inc. stockholders at their Annual Meeting held on 15 May 2012, ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Following approval by Theravance, Inc. stockholders at their Annual Meeting held on 15 May 2012, GSKs acquisition of 10,000,000 shares of Theravance common stock has now completed."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-to-fully-acquire-cellzome-for-61-million/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                15 May 2012\n            GlaxoSmithKline to fully acquire Cellzome for £61 million\n                GSK today announced that it has entered into an agreement to acquire those shares it does not cur...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it has entered into an agreement to acquire those shares it does not currently own in Cellzome, a leader in the development and advancement of proteomics technologies, for &#163;61 million (US$99 million) in cash. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-bbc-panorama-broadcast-the-truth-about-tax/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                14 May 2012\n            GSK statement on BBC Panorama broadcast: ‘the truth about tax’\n                GSK issued the following statement in response to the BBC Panorama programme related to Corporati...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK issued the following statement in response to the BBC Panorama programme related to Corporation Tax payments in the UK and Luxembourg broadcast tonight, Monday 14 May 2012. "}},"https://www.gsk.com/en-gb/media/press-releases/stiefel-receives-us-fda-approval-of-fabior-foam-01/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                11 May 2012\n            Stiefel receives US FDA approval of Fabior™ Foam, 0.1%\n                Stiefel, a GSK company, today announced that the US Food and Drug Administration has approved the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Stiefel, a GSK company, today announced that the US Food and Drug Administration has approved the New Drug Application for Fabior (tazarotene) Foam, 0.1%. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-commences-tender-offer-to-acquire-human-genome-sciences-for-us-1300-per-share-in-cash/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                10 May 2012\n            GSK commences tender offer to acquire Human Genome Sciences for US $13.00 per share in cash\n                GSK today announced that it has commenced its previously announced tender offer to acquire all of...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it has commenced its previously announced tender offer to acquire all of the outstanding shares of Human Genome Sciences for US$13.00 per share in cash.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-commence-tender-offer-to-acquire-human-genome-sciences-for-us-1300-per-share-in-cash/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                09 May 2012\n            GSK to commence tender offer to acquire Human Genome Sciences for US $13.00 per share in cash\n                GSK today announced that it will not participate in Human Genome Sciences strategic alternatives ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it will not participate in Human Genome Sciences strategic alternatives review process and will instead commence a tender offer this week to acquire all of the outstanding shares of HGS for US$13.00 per share in cash.  "}},"https://www.gsk.com/en-gb/media/press-releases/james-shannon-named-glaxosmithkline-chief-medical-officer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                04 May 2012\n            James Shannon named GlaxoSmithKline Chief Medical Officer\n                James Shannon has been named GSK's Chief Medical Officer (CMO), effective 1 May.  James will repo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"James Shannon has been named GSK's Chief Medical Officer (CMO), effective 1 May.  James will report to R&amp;D Chairman Moncef Slaoui and be based in London.  He will be accountable for medical governance and patient safety for all of GSK: Pharmaceuticals, Consumer Healthcare, Vaccines and the global businesses."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-appoints-two-non-executive-directors-to-its-board/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                03 May 2012\n            GlaxoSmithKline plc appoints two Non-Executive Directors to its Board\n                GSK announces that Ms. Lynn Elsenhans and Ms. Jing Ulrich will join the Board of the Company with...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announces that Ms. Lynn Elsenhans and Ms. Jing Ulrich will join the Board of the Company with effect from 1 July 2012 as Non-Executive Directors. "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-yale-university-establish-drug-discovery-collaboration-to-design-potential-new-class-of-medicines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                01 May 2012\n            GlaxoSmithKline and Yale University establish drug discovery collaboration to design potential new class of medicines\n                GlaxoSmithKline plc (GSK) and Yale University have established a drug discovery research collabor...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) and Yale University have established a drug discovery research collaboration to design a potential new class of medicines that degrade disease-causing proteins. "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-european-authorisation-for-nimenrix-meningococcal-group-a-c-w-135-and-y-conjugate-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                27 April 2012\n            GlaxoSmithKline receives European authorisation for Nimenrix™ (Meningococcal group A, C, W-135 and Y conjugate vaccine)\n                GlaxoSmithKline plc (GSK) announced today that the European Commission has granted marketing auth...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) announced today that the European Commission has granted marketing authorisation for Nimenrix (Meningococcal group A, C, W-135 and Y conjugate vaccine) for active immunisation against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                26 April 2012\n            GSK and University of Nottingham collaborate to create Centre of Excellence for sustainable chemistry\n                GSK and the University of Nottingham today formalised a collaboration to establish a new laborato...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and the University of Nottingham today formalised a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory. "}},"https://www.gsk.com/en-gb/media/press-releases/children-in-ghana-to-be-vaccinated-against-diarrhoeal-disease-with-the-introduction-of-gsk-s-rotarix-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                26 April 2012\n            Children in Ghana to be vaccinated against diarrhoeal disease with the introduction of GSK’s Rotarix™ vaccine\n                GSK welcomes today's GAVI announcement that GSK's rotavirus vaccine, Rotarix, will be introduced ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK welcomes today's GAVI announcement that GSK's rotavirus vaccine, Rotarix, will be introduced into the newly started national vaccination programme in Ghana. "}},"https://www.gsk.com/en-gb/media/press-releases/fda-approves-votrient-for-treatment-of-patients-with-certain-types-of-advanced-soft-tissue-sarcoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                26 April 2012\n            FDA approves Votrient® for treatment of patients with certain types of advanced soft tissue sarcoma\n                GSK announced today that the U.S. FDA has approved Votrient (pazopanib) for the treatment of pati...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the U.S. FDA has approved Votrient (pazopanib) for the treatment of patients with advanced soft tissue sarcoma who have received prior chemotherapy. "}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-first-quarter-2012/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                25 April 2012\n            Results announcement for the first quarter 2012\n                - Sales growth of +2% CER\n- Further R&amp;D delivery, operational leverage and continued returns...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"- Sales growth of +2% CER\n- Further R&amp;D delivery, operational leverage and continued returns to shareholders\n- Core EPS 27.3p (+7%), dividend up 6% to 17p"}},"https://www.gsk.com/en-gb/media/press-releases/?p=34":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=31":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=30","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=31":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=business+operations&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=15","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=16","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=17","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=18","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate","txt":"\n                            graduate \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=1","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=graduate&p=1","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=8","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=9","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=1","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=graduate&p=1","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=17","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=manufacturing+and+supply&r=&city=&et=&prog=&cl=8680&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/settings/global-country-feed/south-central-america/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-2012-corporate-responsibility-report/","txt":"here","status":"done","statusCode":404,"results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."}},"https://www.gsk.com/content/gsk/en/media/press-releases/2012/regulatory-update-synflorix.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/?=&p=32":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-reaches-agreement-to-divest-non-core-over-the-counter-otc-brands-in-international-markets-for-164-million/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                20 April 2012\n            GlaxoSmithKline reaches agreement to divest non-core over-the-counter (OTC) brands in international markets for £164 million\n                GlaxoSmithKline Plc (GSK) today announced that it has reached agreement to divest the previously ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline Plc (GSK) today announced that it has reached agreement to divest the previously identified non-core OTC brands in its international markets to Aspen Pharmacare Holdings Limited (Aspen) for &#163;164 million in cash. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-confirms-offer-to-acquire-human-genome-sciences-for-us-1300-per-share-in-cash/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                19 April 2012\n            GSK confirms offer to acquire Human Genome Sciences for US$13.00 per share in cash\n                GlaxoSmithKline plc today confirms that it made an offer to the Board of Directors of Human Genom...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc today confirms that it made an offer to the Board of Directors of Human Genome Sciences on 11th April proposing to acquire all of the outstanding shares of HGS for US$13.00 per share in cash, representing a 81 percent premium to yesterday&#8217;s closing share price. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-corporate-responsibility-commitments-in-2011-report/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                11 April 2012\n            GSK provides update on corporate responsibility commitments in 2011 report\n                GSK has today published its Corporate Responsibility Report, in which the company reiterates its ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has today published its Corporate Responsibility Report, in which the company reiterates its commitment to operate responsibly, openly and transparently and sets out advances made on this agenda during 2011. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-further-data-from-phase-lll-studies-of-albiglutide-in-type-2-diabetes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                03 April 2012\n            GSK receives further data from phase lll studies of albiglutide in type 2 diabetes\n                GSK today announced that topline results have been received from seven of the eight &#8216;Harmon...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that topline results have been received from seven of the eight &#8216;Harmony&#8217; Phase III studies investigating the use of albiglutide in type 2 diabetes.  Albiglutide is an investigational once weekly glucagon-like peptide-1 (GLP-1) agonist. "}},"https://www.gsk.com/en-gb/media/press-releases/shionogi-viiv-healthcare-announces-initial-data-from-pivotal-phase-iii-study-of-dolutegravir-in-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                02 April 2012\n            Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV\n                SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir compared to raltegravir ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir compared to raltegravir over 48 weeks in treatment-na&#239;ve HIV patients."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-to-increase-its-ownership-in-theravance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                02 April 2012\n            GlaxoSmithKline to increase its ownership in Theravance\n                GSK and Theravance, Inc. announced they have entered into a stock purchase agreement, under which...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. announced they have entered into a stock purchase agreement, under which Theravance will issue, and GSK will acquire, 10,000,000 shares of Theravance common stock at a price of $21.2887 per share, for a total investment of $212,887,000."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-completion-of-the-relovair-star-registrational-programme-and-topline-results-from-relovair-vs-advair-phase-iii-studies-in-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                23 March 2012\n            GSK and Theravance announce completion of the Relovair™* registrational programme and topline results from Relovair™ vs. Advair® phase III studies in COPD\n                GSK and Theravance, Inc. today announced the registrational programme for Relovair&#8482; is now ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced the registrational programme for Relovair&#8482; is now complete. In addition, results from two studies for the once-daily investigational medicine Relovair&#8482; in patients with COPD and results from a study to evaluate the efficacy and safety of FF and FP compared to placebo in the treatment of persistent asthma in adults and adolescents were announced."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-confirms-significant-investments-in-uk-manufacturing-ulverston-in-cumbria-selected-as-site-of-new-biopharmaceutical-factory/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                22 March 2012\n            GSK confirms significant investments in UK manufacturing: Ulverston in Cumbria selected as site of new biopharmaceutical factory\n                GSK today confirmed that it will invest more than &#163;500m in the UK across its manufacturing s...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today confirmed that it will invest more than &#163;500m in the UK across its manufacturing sites to increase production of key active ingredients for its pharmaceutical products and vaccines.  "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-vote-from-fda-panel-for-pazopanib-in-certain-advanced-soft-tissue-sarcomas/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                20 March 2012\n            GSK announces positive vote from FDA panel for pazopanib in certain advanced soft tissue sarcomas\n                GSK announced today that the Oncologic Drugs Advisory Committee (ODAC) to the US FDA voted 11 to ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the Oncologic Drugs Advisory Committee (ODAC) to the US FDA voted 11 to 2 that evidence from clinical studies support a favourable benefit; risk assessment for use of Votrient in treating patients with advanced soft tissue sarcoma."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-provides-further-update-on-divestment-of-non-core-over-the-counter-otc-brands/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                15 March 2012\n            GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands\n                In February 2011, GSK announced its intention to divest non-core Consumer Healthcare OTC products...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In February 2011, GSK announced its intention to divest non-core Consumer Healthcare OTC products predominantly in the United States and Europe with aggregate sales of approximately &#163;500 million. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-reinforces-commitment-to-youth-training-with-launch-of-new-uk-apprenticeship-programme/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                09 March 2012\n            GSK reinforces commitment to youth training with launch of new UK apprenticeship programme\n                GSK today announced the launch of a new multi-disciplinary apprenticeship scheme. The programme, ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced the launch of a new multi-disciplinary apprenticeship scheme. The programme, which will sit alongside GSK's established graduate and undergraduate recruitment schemes, is aimed at 16-24 year olds. "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submissions-for-two-influenza-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                05 March 2012\n            Regulatory Update: GSK announces submissions for two influenza vaccines\n                GlaxoSmithKline [GSK] announced today that it has submitted regulatory files for two of its influ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [GSK] announced today that it has submitted regulatory files for two of its influenza vaccines currently in development."}},"https://www.gsk.com/en-gb/media/press-releases/innovative-uk-research-project-to-study-the-value-medicines-bring-to-patients-in-the-real-world/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                02 March 2012\n            Innovative UK research project to study the value medicines bring to patients in the real world\n                Unique collaboration to ensure medicines under development meet patient and healthcare system needs.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Unique collaboration to ensure medicines under development meet patient and healthcare system needs."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-daiichi-sankyo-vaccines-joint-venture-to-become-largest-vaccines-company-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                01 March 2012\n            GSK and Daiichi Sankyo vaccines joint venture to become largest vaccines company in Japan\n                GlaxoSmithKline (GSK) today announced that it has signed an agreement with Daiichi Sankyo Co., Lt...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that it has signed an agreement with Daiichi Sankyo Co., Ltd. to form a Joint Venture (JV) which is expected to create the number one vaccines company in Japan."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-positive-opinion-in-europe-from-the-chmp-for-nimenrixreg/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                17 February 2012\n            GlaxoSmithKline receives positive opinion in Europe from the CHMP for Nimenrix&reg;\n                GSK announced that the EMA&apos;s Committee for Medicinal Products for Human Use has issued a pos...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced that the EMA&apos;s Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorisation for Nimenrix&#174; for active immunisation against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y."}},"https://www.gsk.com/en-gb/media/press-releases/eu-and-us-regulatory-update-tykerbtyverb-lapatinib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                16 February 2012\n            EU and US Regulatory Update – Tykerb/Tyverb® (lapatinib)\n                GlaxoSmithKline announced today that it has submitted regulatory applications in Europe and the U...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline announced today that it has submitted regulatory applications in Europe and the US related to Tykerb/ Tyverb (lapatinib) and its use in combination with trastuzumab to treat patients with HER2 (ErbB2)-positive metastatic breast cancer. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-results-announcement-for-q4-and-full-year-2011/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                07 February 2012\n            GSK results announcement for Q4 and full year 2011\n                GSK delivers continued underlying sales growth*, R&amp;D progress and improving financial returns...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK delivers continued underlying sales growth*, R&amp;D progress and improving financial returns to shareholders"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-joins-new-global-partnership-to-help-defeat-ten-neglected-tropical-diseases-by-2020/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                30 January 2012\n            GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020\n                GSK today announced it has joined other global pharmaceutical companies and leading organisations...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced it has joined other global pharmaceutical companies and leading organisations including the WHO, the Bill &amp; Melinda Gates Foundation, the UK Department for International Development and the USAID in a new united effort to support developing countries to defeat neglected tropical diseases. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-changes-to-the-board/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                27 January 2012\n            GSK announces changes to the Board\n                GlaxoSmithKline plc today announced that at the company&#8217;s Annual General Meeting (AGM) in 2...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc today announced that at the company&#8217;s Annual General Meeting (AGM) in 2013, following nine years of respective service to the GSK Board, Sir Crispin Davis, Sir Robert Wilson and Mr Larry Culp will not stand for re-election to the Board. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-the-recent-court-ruling-on-the-compas-study-in-mendoza-argentina/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                11 January 2012\n            GSK responds to the recent court ruling on the COMPAS study in Mendoza, Argentina\n                GlaxoSmithKline respectfully disagrees with the recent court ruling in favour of the ANMAT on the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline respectfully disagrees with the recent court ruling in favour of the ANMAT on the fine issued to GSK regarding the administrative conduct of the COMPAS study in Mendoza, Argentina.  "}},"https://www.gsk.com/en-gb/media/press-releases/?p=35":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=32":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=31","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=33":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-initial-outcomes-from-pivotal-phase-iii-studies-for-once-daily-relovair-star-in-copd-and-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                09 January 2012\n            GSK and Theravance announce initial outcomes from pivotal Phase III studies for once-daily Relovair™* in COPD and asthma\n                GSK and Theravance, Inc. today announced the completion of the phase III registration programme f...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced the completion of the phase III registration programme for the once-daily investigational medicine Relovair&#8482;* in patients with COPD and of all but one of the pivotal studies in patients with asthma. "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-provides-update-on-divestment-of-non-core-over-the-counter-otc-brands/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                20 December 2011\n            GlaxoSmithKline provides update on divestment of non-core over-the-counter (OTC) brands\n                Agreement reached to divest brands in USA and Canada to Prestige Brands Holdings, Inc. for £426m ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Agreement reached to divest brands in USA and Canada to Prestige Brands Holdings, Inc. for £426m ($660m). Process continues for divesting brands outside these markets and global rights for alli."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-pneumococcal-vaccine-agreement-with-gavi-alliance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                15 December 2011\n            GSK extends pneumococcal vaccine agreement with GAVI Alliance\n                GSK today announced it has expanded its agreement with the GAVI Alliance in a move to help protec...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced it has expanded its agreement with the GAVI Alliance in a move to help protect millions more children in the world&apos;s poorest countries from pneumococcal disease. Pneumococcal disease can lead to pneumonia, meningitis and sepsis and is a leading cause of death in children under the age of five in developing countries."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-initiate-phase-iii-trial-of-belimumab-benlystareg-administered-subcutaneously-in-subjects-with-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                15 December 2011\n            GlaxoSmithKline and Human Genome Sciences initiate phase III trial of belimumab (Benlysta&reg;) administered subcutaneously in subjects with systemic lupus erythematosus\n                GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that dosing ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that dosing has been initiated in BLISS-SC, a new Phase III trialto evaluate the efficacy, safety and tolerability of BENLYSTA&#174;  (belimumab) administered subcutaneously (SC) once-weekly to autoantibody-positive adults with active systemic lupus erythematosus (SLE)."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-phase-lll-data-for-lapatinib-at-san-antonio-breast-cancer-symposium/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                08 December 2011\n            GSK presents phase lll data for lapatinib at San Antonio breast cancer symposium\n                Improvement in disease-free survival does not reach statistical significance in study of delayed ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Improvement in disease-free survival does not reach statistical significance in study of delayed adjuvant therapy with lapatinib (Tykerb or Tyverb) monotherapy in HER2 positive breast cancer.\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-help-for-heroes-partner-to-support-the-rehabilitation-of-wounded-servicemen-and-women-in-the-uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                07 December 2011\n            GSK and Help for Heroes partner to support the rehabilitation of wounded servicemen and women in the UK\n                GSK and Help for Heroes today announced a new partnership to help support injured British armed f...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Help for Heroes today announced a new partnership to help support injured British armed forces personnel successfully transition back into civilian life. The partnership will focus on the creation of a specialist &apos;Wellness Centre&apos; at Tedworth House, a Personnel Recovery and Assessment Centre located in Wiltshire. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-in-response-to-the-prime-minister-s-speech-on-life-sciences/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                05 December 2011\n            GSK statement in response to the Prime Minister’s speech on life sciences\n                &quot;The Government&#8217;s strategy for Life Sciences is a very important next step on the jour...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"&quot;The Government&#8217;s strategy for Life Sciences is a very important next step on the journey to make the UK the best place in the world to locate pharmaceutical investment. The actions on research and manufacturing will further strengthen the attractiveness of the UK and most importantly the results of the Innovation Review should ensure that the NHS is a stronger adopter of innovative medicines and technology, ensuring that all patients can benefit from cost-effective treatments and interventions approved by NICE. "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-glaxosmithkline-submits-additional-information-for-candidate-meningococcal-and-hib-combination-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                01 December 2011\n            Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine\n                GlaxoSmithKline [NYSE:GSK] today submitted additional information to the U.S. Food and Drug Admin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [NYSE:GSK] today submitted additional information to the U.S. Food and Drug Administration (FDA) in support of the Biologics License Application (BLA) for the candidate meningococcal and Hib combination vaccine MenHibrix&#174; (Hib-MenCY-TT). This information was submitted in response to the September 2011 Complete Response letter received from the FDA."}},"https://www.gsk.com/en-gb/media/press-releases/reporting-on-a-core-earnings-basis-will-begin-with-effect-from-q1-2012/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                01 December 2011\n            Reporting on a core earnings basis will begin with effect from Q1 2012\n                Go to the Presentations and webcasts page for the full announcement.\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Go to the Presentations and webcasts page for the full announcement."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-welcomes-gavi-alliance-decision-to-introduce-vaccines-against-cervical-cancer-and-rubella-in-the-world-s-poorest-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                17 November 2011\n            GSK welcomes GAVI Alliance decision to introduce vaccines against cervical cancer and rubella in the world’s poorest countries\n                GlaxoSmithKline today welcomed the decision of the GAVI Board to provide funding to facilitate th...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline today welcomed the decision of the GAVI Board to provide funding to facilitate the provision of cervical cancer immunisation programmes and rubella vaccination, across the world's poorest countries. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-welcomes-innovative-knowledge-sharing-collaboration-to-break-deadlock-in-antibiotic-discovery-and-development/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                17 November 2011\n            GlaxoSmithKline welcomes innovative knowledge-sharing collaboration to break deadlock in antibiotic discovery and development\n                GlaxoSmithKline (GSK) today welcomes the European Commission&#8217;s commitment to promote collab...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today welcomes the European Commission&#8217;s commitment to promote collaborative research efforts to develop new antibiotics against the growing threat from resistant bacteria."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-initial-data-from-the-first-completed-phase-lll-study-of-albiglutide-in-type-2-diabetes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                16 November 2011\n            GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes\n                Head-to-head study primary end point did not meet non-inferiority, but results support progressio...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Head-to-head study primary end point did not meet non-inferiority, but results support progression towards registration"}},"https://www.gsk.com/en-gb/media/press-releases/data-published-in-the-lancet-oncology-support-high-efficacy-previously-demonstrated-by-cervarixreg-hpv-16-and-18-vaccine-against-precancerous-cervical-lesions/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                09 November 2011\n            Data published in The Lancet Oncology support high efficacy previously demonstrated by Cervarix&reg; (HPV 16 and 18 vaccine) against precancerous cervical lesions\n                An analysis published today in TheLancet Oncology reinforces previous findings showing that Glaxo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"An analysis published today in TheLancet Oncology reinforces previous findings showing that GlaxoSmithKline's Cervarix, provided protection against advanced precancerous lesions (CIN3+), above that expected from a vaccine that protects against human papillomavirus (HPV) types 16 and 18."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-phase-iii-results-for-eltrombopag-in-hepatitis-c-virus-related-thrombocytopenia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                07 November 2011\n            GSK presents phase III results for eltrombopag in hepatitis C virus related thrombocytopenia\n                Full results from ENABLE 1 and initial data from ENABLE 2 presented at the 62nd Annual Meeting of...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Full results from ENABLE 1 and initial data from ENABLE 2 presented at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-reaches-agreement-in-principle-to-resolve-multiple-investigations-with-us-government/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                03 November 2011\n            GlaxoSmithKline reaches agreement in principle to resolve multiple investigations with US Government\n                GlaxoSmithKline plc (GSK) today announced that it has reached an agreement in principle with the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that it has reached an agreement in principle with the US Government to conclude the Company’s most significant ongoing Federal government investigations"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-with-underlying-sales-growth-of-6-and-reported-sales-growth-of-3/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                26 October 2011\n            GSK delivers strong Q3 performance with underlying sales growth of 6% and reported sales growth of 3%\n                Full details of GSK's results for the third quarter of 2011 can be found in the Investors section...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Full details of GSK's results for the third quarter of 2011 can be found in the Investors section of GSK.com. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-joins-wipo-research-open-innovation-platform-as-part-of-its-commitment-to-tackling-diseases-of-the-developing-world/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                26 October 2011\n            GSK joins WIPO Re:Search open innovation platform as part of its commitment to tackling diseases of the developing world\n                GlaxoSmithKline (GSK) today announced it has joined WIPO Re:Search as part of its open innovation...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced it has joined WIPO Re:Search as part of its open innovation strategy to help accelerate the development of new and better treatments against neglected tropical diseases (NTDs) which affect more than a billion people in the world&#8217;s poorest countries each year."}},"https://www.gsk.com/en-gb/media/press-releases/first-results-from-ongoing-phase-iii-trial-show-malaria-vaccine-candidate-rts-sstar-reduces-the-risk-of-malaria-by-half-in-african-children-aged-5-to-17-months/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                18 October 2011\n            First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months\n                Half the world&#8217;s population is at risk of malaria which is responsible for close to 800,000...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Half the world&#8217;s population is at risk of malaria which is responsible for close to 800,000 deaths each year, most of whom are children under five in sub-Saharan Africa"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-glaxosmithkline-receives-complete-response-letter-from-fda-for-candidate-meningococcal-and-hib-combination-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                23 September 2011\n            Regulatory Update: GlaxoSmithKline receives Complete Response letter from FDA for candidate meningococcal and Hib combination vaccine\n                GlaxoSmithKline [NYSE:GSK] announced today that it has received a Complete Response letter from t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [NYSE:GSK] announced today that it has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for the candidate meningococcal and Hib combination vaccine, MenHibrix&#174; (Hib-MenCY-TT).  The proposed indication for this combination vaccine is active immunization of infants and toddlers 6 weeks through 15 months of age for the prevention of invasive diseases caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b (Hib).   "}},"https://www.gsk.com/en-gb/media/press-releases/lucozade-to-help-drive-vodafone-mclaren-mercedes-performance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                22 September 2011\n            Lucozade to help drive Vodafone McLaren Mercedes performance\n                Ahead of this weekend&#8217;s Singapore Grand Prix, Lucozade &#8211; the UK&#8217;s leading sport...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Ahead of this weekend&#8217;s Singapore Grand Prix, Lucozade &#8211; the UK&#8217;s leading sports and energy drink &#8211; today announces an innovative performance partnership with the Vodafone McLaren Mercedes Formula 1 team."}},"https://www.gsk.com/en-gb/media/press-releases/?p=36":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=33":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=32","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/media/pressreleases/2012/2012-pressrelease-1125260.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/content/gsk/en/media/press-releases/2012/gsk-announces-new-52-week-data-from-phase-iii-study-of-once-weekly-albiglutide-in-type-2-diabetes.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-gsk-and-mclaren-group-announce-innovative-strategic-partnership/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                15 September 2011\n            GlaxoSmithKline (GSK) and McLaren Group announce innovative strategic partnership\n                GlaxoSmithKline (GSK) today announced that it has formed a long term strategic partnership with M...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that it has formed a long term strategic partnership with McLaren Group.  The partnership, which will run initially until 2016, brings together two UK companies focused on innovation and high-tech research."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-gsk-commits-1-million-in-cervical-cancer-vaccine-to-new-cooperative-effort-aimed-at-reducing-deaths-from-womens-cancers/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                13 September 2011\n            GlaxoSmithKline (GSK) commits $1 million in cervical cancer vaccine to new cooperative effort aimed at reducing deaths from women's cancers\n                GlaxoSmithKline (GSK) today announced that it has committed $1 million in Cervarix&#174; cervical...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that it has committed $1 million in Cervarix&#174; cervical cancer vaccine to the Pink Ribbon Red Ribbon partnership over the next five years. GSK has also pledged $50,000 to support the program operations.   As a result of this donation, more than 10,000 girls and women will have access to vaccination"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-amicus-therapeutics-commence-second-phase-iii-study-of-amigal-for-fabry-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                12 September 2011\n            GlaxoSmithKline and Amicus Therapeutics commence second phase III study of Amigal™ for Fabry disease\n                GlaxoSmithKline (GSK) and Amicus Therapeutics today announced the first patient has commenced dos...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Amicus Therapeutics today announced the first patient has commenced dosing in a Phase III global registration study (Study 012) to compare the safety and efficacy of Amigal&#8482; (migalastat HCl) and enzyme replacement therapy (ERT) for the treatment of Fabry disease. The randomised, open-label, 18-month study will provide longer-term clinical data comparing migalastat HCl to ERT in patients with Fabry disease, a rare inherited lysosomal storage disorder. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-gives-update-on-agreement-with-world-health-organization-to-support-de-worming-of-school-age-children-in-endemic-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                12 September 2011\n            GSK gives update on agreement with World Health Organization to support de-worming of school age children in endemic countries\n                First African countries, Togo and Rwanda, receive albendazole donations to scale-up school based ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First African countries, Togo and Rwanda, receive albendazole donations to scale-up school based de-worming programmes for children at risk of intestinal worms. Donations to go beyond Africa to include endemic countries in Asia Pacific and Latin America."}},"https://www.gsk.com/en-gb/media/press-releases/lapatinib-clinical-trial-update/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                09 September 2011\n            Lapatinib clinical trial update\n                A planned interim review of early data from ALTTO a Phase III, four arm study of adjuvant lapatin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A planned interim review of early data from ALTTO a Phase III, four arm study of adjuvant lapatinib (Tykerb/Tyverb&#174;), trastuzumab, their sequence and their combination in patients with HER2 positive early stage breast cancer, has resulted in a change to the ongoing study. The independent data monitoring committee that carried out the review has recommended that three of the trial arms continue without modification. However, the committee has indicated that the lapatinib alone arm is unlikely to meet the pre-specified criteria to demonstrate non-inferiority to trastuzumab alone with respect to disease-free survival.  Consequent to this finding, patients assigned to the lapatinib alone arm of the trial will discontinue lapatinib and discuss treatment options with their study physician.  This study is fully recruited and the remaining three arms of the trial will continue as planned. \n\nUse of lapatinib in an adjuvant setting is not approved anywhere in the world. \n"}},"https://www.gsk.com/en-gb/media/press-releases/jens-eckstein-named-president-of-sr-one-gsk-s-venture-healthcare-group/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                07 September 2011\n            Jens Eckstein named President of SR One, GSK’s venture healthcare group\n                Jens Eckstein has been named President of SR One, GSK&#8217;s independent healthcare venture orga...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Jens Eckstein has been named President of SR One, GSK&#8217;s independent healthcare venture organisation, effective 1 October.   Jens will report to R&amp;D Chairman Moncef Slaoui and be based in Boston.  He replaces Christoph Westphal, who will be leaving GSK at the end of the year to focus on external business interests, including the Longwood Founder&#8217;s Fund, in which GSK is an investor."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-gsk-shows-sign-of-things-to-come-at-london-2012-olympic-and-paralympic-games/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                07 September 2011\n            GlaxoSmithKline (GSK) shows sign of things to come at London 2012 Olympic and Paralympic Games\n                2012 provider, GSK, unveils sign celebrating its scientific contribution to the Games\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"2012 provider, GSK, unveils sign celebrating its scientific contribution to the Games"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-awarded-contract-by-barda-to-support-research-on-potential-novel-antibiotic/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                06 September 2011\n            GSK awarded contract by BARDA to support research on potential novel antibiotic\n                GSK and the Biomedical Advanced Research and Development Authority (BARDA) have agreed to a contr...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and the Biomedical Advanced Research and Development Authority (BARDA) have agreed to a contract that will support the development by GSK of a potentially new antibiotic against both hospital Gram negative and biothreat pathogens."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-takes-minority-stake-in-new-spin-out-autifony-therapeutics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                22 August 2011\n            GSK takes minority stake in new spin out Autifony Therapeutics\n                GlaxoSmithKline plc today announced that its wholly-owned subsidiary Glaxo Group Limited (GSK) wi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc today announced that its wholly-owned subsidiary Glaxo Group Limited (GSK) will receive a 25.4% minority equity stake, representing a &#163;1,250,000 investment, in Autifony Therapeutics Limited, a UK-based biotechnology start up created through a funding round of up to &#163;10 million alongside investors Imperial Innovations and SV Life Sciences."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-impax-announce-positive-topline-results-of-ascend-pd-phase-iii-study-of-ipx066-in-advanced-parkinson-s-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                15 August 2011\n            GSK and Impax announce positive topline results of ASCEND-PD Phase III study of IPX066 in Advanced Parkinson’s disease\n                - IPX066 demonstrated statistically significant improvement over carbidopa-levodopa plus entacapo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"- IPX066 demonstrated statistically significant improvement over carbidopa-levodopa plus entacapone in reducing the percentage of &#8220;off time&#8221; during waking hours"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-enigma-diagnostics-announce-collaboration-on-assay-development-and-commercialisation-of-enigma-s-ml-platform/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                10 August 2011\n            GSK and Enigma Diagnostics announce collaboration on assay development and commercialisation of Enigma’s ML platform\n                GlaxoSmithKline (GSK) and Enigma Diagnostics Limited today announced that they have signed agreem...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Enigma Diagnostics Limited today announced that they have signed agreements for the supply and commercialisation on an exclusive basis of the Enigma&#174; ML system in Europe and other designated key countries, including India, Brazil and Russia. The agreements include development by Enigma of an initial range of respiratory tests for use on its real-time Polymerase Chain Reaction (PCR) technology platform, and provide GSK the opportunity to generate revenues from further test developments in infectious diseases and in other therapeutic areas relevant to its healthcare business. "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-and-xenoport-submit-supplemental-new-drug-application-to-fda-for-horizant-in-postherpetic-neuralgia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                09 August 2011\n            Regulatory Update: GSK and XenoPort submit supplemental New Drug Application to FDA for Horizant™ in postherpetic neuralgia\n                GlaxoSmithKline (NYSE and LSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced today that a supp...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE and LSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced today that a supplemental New Drug Application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting approval of Horizant&#8482; (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia (PHN) in adults.  The sNDA has been submitted to the FDA by GSK. "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-stiefel-a-gsk-company-files-nda-for-tazarotene-foam/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                03 August 2011\n            Regulatory update – Stiefel, a GSK company, files NDA for tazarotene foam\n                Stiefel, a GSK company, announced today that it has submitted a New Drug Application (NDA) to the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Stiefel, a GSK company, announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), for tazarotene foam for the topical treatment of facial acne vulgaris in patients 12 years of age or older. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q2-performance-with-underlying-sales-growthstar-of-5-increased-pipeline-visibility-and-dividend-of-16p-up-7/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                26 July 2011\n            GSK delivers strong Q2 performance with underlying sales growth* of 5%, increased pipeline visibility and dividend of 16p, up 7%\n                Full details of GSK&apos;s results for the second quarter of 2011 can be found in the \n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Full details of GSK&apos;s results for the second quarter of 2011 can be found in the "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-european-regulatory-update-on-pandemrix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                21 July 2011\n            GlaxoSmithKline European regulatory update on Pandemrix™\n                GlaxoSmithKline (GSK) announced today that the European Medicines Agency's (EMA) Committee for Me...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended an update to the product label for the H1N1 influenza vaccine, Pandemrix."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-receive-european-authorisation-for-benlysta-belimumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                14 July 2011\n            GlaxoSmithKline and Human Genome Sciences receive European authorisation for Benlysta® (belimumab)\n                GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that the Eur...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that the European Commission (EC) has granted marketing authorisation for Benlysta(belimumab) 10mg/kg as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus (SLE), with a high degree of disease activity (e.g. positive anti-dsDNA and low complement), despite standard therapy1. "}},"https://www.gsk.com/en-gb/media/press-releases/eu-and-us-regulatory-update-votrientreg-pazopanib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                06 July 2011\n            EU and US Regulatory Update - Votrient&reg; (pazopanib)\n                GlaxoSmithKline (GSK) announced today that it has submitted a variation to the Marketing Authoris...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that it has submitted a variation to the Marketing Authorisation Application to the European Medicines Agency for Votrient (pazopanib) for the treatment of patients with advanced soft tissue sarcoma who have received prior chemotherapy, or for patients who are unsuited for such therapy.  \n"}},"https://www.gsk.com/en-gb/media/press-releases/london-2012-partner-glaxosmithkline-shares-scientific-expertise-with-world-anti-doping-agency-to-help-fight-against-abuse-of-drugs-in-sport/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                04 July 2011\n            London 2012 partner, GlaxoSmithKline, shares scientific expertise with World Anti-Doping Agency to help fight against abuse of drugs in sport\n                London 2012 partner GlaxoSmithKline (GSK) today signed a long-term agreement with the World Anti-...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"London 2012 partner GlaxoSmithKline (GSK) today signed a long-term agreement with the World Anti-Doping Agency (WADA) that will help the agency create early detection methods for medicines that have performance-enhancing potential in sport. \n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-new-approval-for-rotarix-and-significant-new-indication-for-lamictalreg-lamotrigine-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                01 July 2011\n            GlaxoSmithKline receives new approval for Rotarix and significant new indication for Lamictal&reg; (lamotrigine) in Japan\n                &#8211;   GSK&#8217;s rotavirus vaccine approved for use in babies for the prevention of rotaviru...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"&#8211;   GSK&#8217;s rotavirus vaccine approved for use in babies for the prevention of rotavirus gastroenteritis \n\n&#8211;   Lamotrigine becomes the first treatment to be approved in Japan for adult bipolar disorder \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-welcomes-external-scientists-to-diseases-of-the-developing-world-research-campus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                28 June 2011\n            GSK welcomes external scientists to diseases of the developing world research campus\n                GSK will provide support, expertise and facilities as part of our open innovation strategy to spu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK will provide support, expertise and facilities as part of our open innovation strategy to spur global collaboration in research"}},"https://www.gsk.com/en-gb/media/press-releases/?p=37":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=34":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=33","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=34":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/media/pressreleases/2012/2012-pressrelease-1086739.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/content/gsk/en/media/press-releases/2012/stiefel-receives-us-fda-approval-of-fabior-foam-01.html":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-university-of-east-anglia-study-examining-health-impacts-of-anticholinergic-medicines-for-over-65s/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                24 June 2011\n            GSK statement on University of East Anglia study examining health impacts of anticholinergic medicines for over 65s\n                Research led by the University of East Anglia has been published in the Journal of the American G...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Research led by the University of East Anglia has been published in the Journal of the American Geriatrics Society i examining the long term health impacts of anticholinergic medicines, a wide-ranging group of drugs frequently taken by older people. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-agreements-with-state-attorneys-general-on-former-cidra-manufacturing-facility/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                23 June 2011\n            GSK statement on agreements with State Attorneys General on former Cidra manufacturing facility\n                GlaxoSmithKline (GSK) has agreed to pay $40.75 million, which will be divided among 37 states and...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) has agreed to pay $40.75 million, which will be divided among 37 states and the District of Columbia, as part of an agreement reached related to events during the early 2000s at its former manufacturing facility in Cidra, Puerto Rico.   "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-purchase-shenzhen-neptunus-stake-in-previously-formed-joint-venture-for-influenza-vaccines-in-china/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                14 June 2011\n            GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China\n                GlaxoSmithKline (GSK) announced today that it has entered into an agreement to acquire the remain...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that it has entered into an agreement to acquire the remaining 51% equity interest of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd (Neptunus) in the joint venture (JV) company, Shenzhen GSK-Neptunus Biologicals Co. Ltd. (GSKNB), for a total cash consideration of £ million (US$39 million). After approval of this agreement by the Peoples Republic of China&#8217;s authorities, GSK will become the sole owner of GSKNB."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-valeant-announce-us-fda-approval-of-potiga-ezogabine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                13 June 2011\n            GlaxoSmithKline and Valeant announce US FDA approval of Potiga™ (ezogabine)\n                GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) annou...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga&#8482; (ezogabine) Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older. "}},"https://www.gsk.com/en-gb/media/press-releases/millions-of-children-in-the-world-s-poorest-countries-could-receive-vaccination-against-rotavirus-diarrhoeal-disease-under-new-offer-made-by-gsk-to-the-gavi-alliance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                06 June 2011\n            Millions of children in the world’s poorest countries could receive vaccination against rotavirus diarrhoeal disease under new offer made by GSK to the GAVI Alliance\n                GSK today announced that it has made a new offer to supply its rotavirus vaccine, Rotarix, to the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it has made a new offer to supply its rotavirus vaccine, Rotarix, to the GAVI Alliance at $2.50 per dose, a small fraction of developed world prices. "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-s-pazopanib-improved-progression-free-survival-in-adults-with-certain-soft-tissue-sarcomas/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                04 June 2011\n            GlaxoSmithKline’s pazopanib improved progression free survival in adults with certain soft tissue sarcomas\n                Results of the PALETTE (PAzopanib ExpLorEd in SofT-Tissue Sarcoma) study presented at the 2011 An...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Results of the PALETTE (PAzopanib ExpLorEd in SofT-Tissue Sarcoma) study presented at the 2011 Annual Meeting of the American Society for Clinical Oncology demonstrated a statistically significant improvement in the time to first occurrence of tumour progression or death (progression free survival or PFS) for study patients treated with the multi-tyrosine kinase inhibitor pazopanib, compared to placebo.  PALETTE is a randomised, double-blind, placebo controlled Phase III trial in patients with metastatic soft tissue sarcomas (excluding gastrointestinal stromal tumours and adipocytic sarcomas) and was jointly conducted by GlaxoSmithKline and the European Organisation for Research and Treatment of Cancer (EORTC) in collaboration with cancer centres across the world.  Use of pazopanib to treat soft tissue sarcomas is investigational and subject to evaluation of benefits and risks by regulatory authorities before being made available for that use. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-results-of-two-pivotal-phase-iii-studies-for-relovair-in-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                02 June 2011\n            GSK and Theravance announce results of two pivotal Phase III studies for Relovair in COPD\n                GSK and Theravance, Inc. today announced the results of two pivotal 6-month efficacy and safety p...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced the results of two pivotal 6-month efficacy and safety phase III studies of Relovair for patients with COPD."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-forms-partnership-with-three-leading-ngos-to-address-shortage-of-frontline-healthcare-workers-in-least-developed-countries-ldcs/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                24 May 2011\n            GSK forms partnership with three leading NGOs to address shortage of frontline healthcare workers in Least Developed Countries LDCs\n                - Agreements signed with AMREF, CARE International UK and Save the Children as part of commitment...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"- Agreements signed with AMREF, CARE International UK and Save the Children as part of commitment to reinvest 20% of profits in LDCs\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-receive-positive-opinion-in-europe-from-the-chmp-for-benlysta-belimumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                20 May 2011\n            GlaxoSmithKline and Human Genome Sciences receive positive opinion in Europe from the CHMP for Benlysta® belimumab\n                GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that the Eur...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that the European Medicines Agency&#8217;s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending marketing authorisation for Benlysta&#174; (belimumab) as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity (e.g. positive anti-dsDNA and low complement), despite standard therapy. "}},"https://www.gsk.com/en-gb/media/press-releases/young-peoples-health-charity-steps-forward-to-claim-top-accolade-and-35-000/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                13 May 2011\n            Young peoples health charity steps forward to claim top accolade and 35,000\n                Tower Hamlets-based charity, Step Forward, has beaten more than 400 organisations from around the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Tower Hamlets-based charity, Step Forward, has beaten more than 400 organisations from around the UK to be crowned the overall winner of this year&#8217;s GlaxoSmithKline (GSK) IMPACT Awards, run in partnership with health think-tank The King&#8217;s Fund. The charity picked up their award and &#163;35,000 prize at a ceremony last night, held at London&#8217;s Science Museum. "}},"https://www.gsk.com/en-gb/media/press-releases/pharmaceutical-industry-and-university-create-manchester-collaborative-centre-for-inflammation-research/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                12 May 2011\n            pharmaceutical industry and university create manchester collaborative centre for inflammation research\n                GlaxoSmithKline (GSK), The University of Manchester, and AstraZeneca announce today the creation ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK), The University of Manchester, and AstraZeneca announce today the creation of the Manchester Collaborative Centre for Inflammation Research (MCCIR), a unique collaboration to establish a world-leading translational centre for inflammatory diseases. The project starts out w ith an initial investment of £163.5M from each partner over a three year period. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-q1-performance-demonstrates-continued-progress-with-delivery-of-underlying-sales-growth-cash-generation-and-pipeline-visibility/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                27 April 2011\n            GSK Q1 performance demonstrates continued progress with delivery of underlying sales growth, cash generation and pipeline visibility\n                Reported sales -10%; underlying sales* +4% EPS before major restructuring* 32.2p (+9%); dividend ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Reported sales -10%; underlying sales* +4% EPS before major restructuring* 32.2p (+9%); dividend 16p (+7%)\n\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-and-valeant-respond-to-fda-on-ezogabine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                18 April 2011\n            Regulatory update – GSK and Valeant respond to FDA on ezogabine\n                GSK and Valeant Pharmaceuticals International, Inc. submitted on 15 April 2011 the response to th...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Valeant Pharmaceuticals International, Inc. submitted on 15 April 2011 the response to the U.S. FDA Complete Response letter received on 30 November 2010 for the NDA for ezogabine. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-welcomes-key-agreement-to-support-global-preparedness-against-pandemic-influenza/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                18 April 2011\n            GSK welcomes key agreement to support global preparedness against pandemic influenza\n                GlaxoSmithKline (GSK) welcomes the agreement reached at the Open Ended Working Group (OEWG) coord...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) welcomes the agreement reached at the Open Ended Working Group (OEWG) coordinated by the World Health Organisation (WHO) on a Framework to support global preparedness for a future influenza pandemic. The agreement establishes the principles of an improved process for influenza virus and benefit-sharing between the WHO GISN (Global Influenza Surveillance Network) and industry. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-european-regulatory-update-on-pandemrix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                15 April 2011\n            GSK European regulatory update on Pandemrix™\n                GlaxoSmithKline (GSK) announced today that the European Medicines Agency&#8217;s (EMA) Committee ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that the European Medicines Agency&#8217;s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended changes to the product label for Pandemrix. The amendment includes prescribing advice based on information on a potential increased risk of narcolepsy in children or adolescents. This is based onpreliminary results from epidemiological studies on the risk of narcolepsy from Finland, Sweden and France. This does not apply to adults where to date no data support such a change. The EMA state that this is an interim measure pending the outcome of the European review expected to conclude in July 2011. "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-tyverbreg-lapatinib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                15 April 2011\n            Regulatory Update - Tyverb&reg; lapatinib\n                GlaxoSmithKline plc (GSK) announced today that it has submitted a Marketing Authorisation Applica...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Tyverb (lapatinib) in combination with paclitaxel for the treatment of patients with metastatic breast cancer whose tumours over-express HER2 (ErbB2). "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announces-non-core-otc-products-to-be-divested/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                14 April 2011\n            GlaxoSmithKline announces non-core OTC products to be divested\n                GSK today identified the non-core OTC brands that it intends to divest as the company focuses its...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today identified the non-core OTC brands that it intends to divest as the company focuses its Consumer Healthcare business around a portfolio of fast-growing priority brands and the emerging markets.  GSK&#8217;s intention to divest its non-core Consumer assets was announced at the company&#8217;s fourth quarter 2010 results on 3rd February 2011. "}},"https://www.gsk.com/en-gb/media/press-releases/unique-research-alliance-expands-collaboration-opportunities-at-state-of-the-art-medical-imaging-centre/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                12 April 2011\n            Unique research alliance expands collaboration opportunities at state-of-the-art medical imaging centre\n                The UK research community will soon have access to world-class medical imaging facilities in Lond...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The UK research community will soon have access to world-class medical imaging facilities in London with the signing of an agreement today between an alliance of leading London-based universities, the Medical Research Council (MRC) and the pharmaceutical company GlaxoSmithKline (GSK)."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-xenoport-receive-fda-approval-for-horizant/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                06 April 2011\n            GlaxoSmithKline and XenoPort receive FDA approval for Horizant™\n                GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced Wednesday that the U.S. F...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved Horizant&#8482; (gabapentin enacarbil) Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome in adults.  Horizant is not recommended for patients who are required to sleep during the daytime and remain awake at night. The efficacy of Horizant in the treatment of patients with moderate-to-severe primary Restless Legs Syndrome was demonstrated in two 12-week clinical trials in adults. It is the first medication in its class to be approved for the treatment of moderate-to-severe primary Restless Legs Syndrome. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-payments-for-research-consulting-and-advising-by-us-healthcare-professionals/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                31 March 2011\n            GSK publishes payments for research consulting and advising by US healthcare professionals\n                GlaxoSmithKline (NYSE:GSK) today published a list of payments made during 2010 for clinical resea...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE:GSK) today published a list of payments made during 2010 for clinical research studies led by U.S. healthcare professionals. Clinical trials are an important step in the lengthy process of discovering and developing new medicines. GSK works with these independent institutions and healthcare professionals because they have considerable expertise in conducting research that contributes to the body of knowledge about diseases and potential new treatments."}},"https://www.gsk.com/en-gb/media/press-releases/?p=38":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=35":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=34","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=35":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=28","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=12","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=19","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=20","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=21","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=22","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=Communications+&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"2","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"3","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=4":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"4","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=5":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"5","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=6":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"6","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"7","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"8","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"9","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=10":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=","txt":"10","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=graduate&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=11","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=21","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=36":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-confirms-pronova-biopharma-reaches-agreement-with-apotex-regarding-lovaza-us-patent-litigation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                30 March 2011\n            GlaxoSmithKline confirms Pronova BioPharma reaches agreement with Apotex regarding Lovaza™ US patent litigation\n                GlaxoSmithKline (GSK), which has the marketing rights for Lovaza (omega-3-acid ethyl esters) in t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK), which has the marketing rights for Lovaza (omega-3-acid ethyl esters) in the US and Puerto Rico, confirmed today that Pronova BioPharma Norge AS, which owns the patents for Lovaza, has entered into an agreement with Apotex Corp. and Apotex Inc. (collectively “Apotex”), to settle their patent litigation in the United States related to Lovaza."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-valeant-receive-european-authorisation-for-trobalt-retigabine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                29 March 2011\n            GSK and Valeant receive European authorisation for Trobalt (retigabine)\n                GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) announced...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) announced today that the European Commission has granted marketing authorisation for Trobalt(retigabine) as an adjunctive (add-on) treatment of partial onset seizures (a form of epilepsy where a seizure begins in a specific area in one side of the brain), with or without secondary generalisation in adults aged 18 years and above with epilepsy."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-2010-corporate-responsibility-report/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                27 March 2011\n            GSK publishes 2010 Corporate Responsibility Report\n                In its Corporate Responsibility Report published today, GlaxoSmithKline (GSK) reiterated its comm...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In its Corporate Responsibility Report published today, GlaxoSmithKline (GSK) reiterated its commitment to building its business on strong values and ethical standards.  The Report covers key responsibility issues including access to medicines, research and business ethics, environmental sustainability, employment practices, stakeholder engagement and investment in communities"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-avodart-dutasteride-for-prostate-cancer-risk-reduction/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                23 March 2011\n            GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction\n                GlaxoSmithKline (GSK) announced today that it will no longer pursue global approval (marketing au...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that it will no longer pursue global approval (marketing authorisation) for the use of Avodart (dutasteride) to reduce the risk of prostate cancer. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-launches-london-2012-initiative-with-king-s-college-london-to-inspire-young-people-into-science-careers/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                22 March 2011\n            GSK launches London 2012 initiative with King’s College London to inspire young people into science careers\n                At the launch of the new 'Scientists in Sport' education programme designed to inspire young peop...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"At the launch of the new 'Scientists in Sport' education programme designed to inspire young people into a range of scientific careers, a study has found that eight out of 10 secondary school pupils are now worried about getting a job in the future."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-supports-recovery-efforts-to-help-those-affected-by-the-japan-earthquake/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                18 March 2011\n            GSK supports recovery efforts to help those affected by the Japan earthquake\n                In response to events in Japan as a result of the Tohoku Kanto Earthquake and tsunami that devast...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In response to events in Japan as a result of the Tohoku Kanto Earthquake and tsunami that devastated Japan's north east coastline region, GlaxoSmithKline (GSK) is supporting the ongoing relief efforts by working with the Japanese authorities, the Japan Pharmaceutical Manufacturers Association and local NGOs to assist medical support and pharmaceutical donation needs."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-topline-results-of-phase-lll-study-of-ipx066-in-advanced-parkinson-s-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                14 March 2011\n            GSK announces positive topline results of Phase lll study of IPX066 in advanced Parkinson’s disease\n                GlaxoSmithKline (GSK) today announced positive, top-line results of the ADVANCE-Parkinson’s Disea...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced positive, top-line results of the ADVANCE-Parkinson’s Disease (PD) Phase III clinical study, conducted by Impax Pharmaceuticals, of IPX066 versus immediate-release (IR) carbidopa-levodopa (CD-LD) in advanced PD patients experiencing motor fluctuations."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-tolerx-announce-phase-iii-defend-1-study-of-otelixizumab-in-type-1-diabetes-did-not-meet-its-primary-endpoint/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                11 March 2011\n            GlaxoSmithKline and Tolerx announce phase III DEFEND-1 study of otelixizumab in type 1 diabetes did not meet its primary endpoint\n                GlaxoSmithKline (GSK) and Tolerx, Inc. today announced that the Phase III DEFEND-1 study of oteli...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Tolerx, Inc. today announced that the Phase III DEFEND-1 study of otelixizumab, an investigational humanised anti-CD3 monoclonal antibody, did not meet the primary efficacy endpoint of change in C-peptide at month 12 in patients with new-onset autoimmune type 1 diabetes. "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-fda-approval-of-benlystareg-belimumab-for-the-treatment-of-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                09 March 2011\n            GlaxoSmithKline and Human Genome Sciences announce FDA approval of Benlysta&reg; (belimumab) for the treatment of systemic lupus erythematosus\n                GlaxoSmithKline plc (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that the U.S. Food and Drug Administration (FDA) has approved Benlysta (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-appoints-two-non-executive-directors-to-its-board-1/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                04 March 2011\n            GlaxoSmithKline plc appoints two Non-Executive Directors to its Board (1)\n                GlaxoSmithKline plc (GSK) announces that Ms. Judy Lewent and Ms. Stacey Cartwright have been appo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) announces that Ms. Judy Lewent and Ms. Stacey Cartwright have been appointed as Non-Executive Directors and will join the Board of the Company with effect from 1st April 2011. "}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-nimenrixreg-menacwy-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                02 March 2011\n            Regulatory update: Nimenrix&reg; (MenACWY vaccine)\n                GlaxoSmithKline (GSK) announced today that it has submitted a Marketing Authorisation Application...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for its candidate conjugate meningitis vaccine, Nimenrix&#174;, for active immunisation against invasive meningococcal diseases caused by Neisseria meningitidis serogroups A, C, W-135 and Y."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-outlines-new-plan-to-drive-recruitment-and-attract-graduate-talent-in-the-uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                02 March 2011\n            GSK outlines new plan to drive recruitment and attract graduate talent in the UK\n                GlaxoSmithKline (GSK) today outlined new plans to encourage talented students graduating from UK ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today outlined new plans to encourage talented students graduating from UK universities to consider pursuing a career within the company.  These measures are part of the company&#8217;s ongoing efforts, as one of the leading FTSE companies and employers in the UK, to ensure the ongoing success of the business."}},"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                01 March 2011\n            Reward for charities bridging gaps in health care provision\n                Ten UK charities have each won £25,000 in recognition of their outstanding contribution to improv...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Ten UK charities have each won £25,000 in recognition of their outstanding contribution to improving health care.  The charities beat more than 400 entrants to become winners of this year's GlaxoSmithKline (GSK) IMPACT Awards, run in partnership with The King's Fund."}},"https://www.gsk.com/en-gb/media/press-releases/world-s-first-everyday-fluoride-toothpaste-with-novamin-technology-that-can-repair-sensitive-teeth/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                01 March 2011\n            World’s first everyday fluoride toothpaste with NovaMin® technology that can repair sensitive teeth\n                GlaxoSmithKline Consumer Healthcare, the maker of leading sensitive toothpaste brand Sensodyne, t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline Consumer Healthcare, the maker of leading sensitive toothpaste brand Sensodyne, today announced a breakthrough in dental care with the launch of new Sensodyne Repair & Protect.  The breakthrough formulation, which the company will launch in over 50 European and International markets during 2011, is the first everyday fluoride toothpaste to contain patented NovaMin technology, which is scientifically proven to repair* sensitive teeth by forming a tooth-like layer over exposed dentine to help continually repair and protect sensitive areas."}},"https://www.gsk.com/en-gb/media/press-releases/david-redfern-appointed-as-new-chairman-of-viiv-healthcare/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                25 February 2011\n            David Redfern appointed as new Chairman of ViiV Healthcare\n                GlaxoSmithKline (GSK), ViiV Healthcare, and Pfizer today announced the appointment of David Redfe...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK), ViiV Healthcare, and Pfizer today announced the appointment of David Redfern as the new Chairman of the Board for ViiV Healthcare with effect from 1st April 2011, following the retirement of Julian Heslop.  David will continue to serve as Chief Strategy Officer at GSK, which owns a majority share in ViiV Healthcare. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-european-regulatory-update-on-pandemrix-1/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                18 February 2011\n            GSK European regulatory update on Pandemrix™ (1)\n                CHMP concludes that data are insufficient to establish a causal relationship between Pandemrix an...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"CHMP concludes that data are insufficient to establish a causal relationship between Pandemrix and narcolepsy."}},"https://www.gsk.com/en-gb/media/press-releases/first-african-country-introduces-gsk-s-pneumococcal-vaccine-through-innovative-financing-mechanism/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                11 February 2011\n            First African country introduces GSK’s pneumococcal vaccine through innovative financing mechanism\n                GlaxoSmithKline (GSK) announced the incorporation of its pneumococcal vaccine into the Kenyan nat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced the incorporation of its pneumococcal vaccine into the Kenyan national immunisation programme. Kenya is the first African country to receive pneumococcal vaccines through the innovative financing mechanism known as the Advance Market Commitment (AMC), which is designed to bring heavily discounted vaccines to children living in the world&#8217;s poorest countries."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-moving-to-new-building-at-philadelphia-navy-yard/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                08 February 2011\n            GlaxoSmithKline moving to new building at Philadelphia Navy Yard\n                GlaxoSmithKline (NYSE:GSK), a leading worldwide research-based pharmaceutical company, and Libert...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE:GSK), a leading worldwide research-based pharmaceutical company, and Liberty Property Trust (NYSE:LRY) today announced that GSK has signed a 15.5-year lease for a new building to be developed by Liberty Property Trust and Synterra Partners."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-revises-us-avandia-label-to-include-new-restrictions-on-use/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                07 February 2011\n            GSK revises US Avandia label to include new restrictions on use\n                GlaxoSmithKline (GSK) today announced revised US prescribing information and medication guides fo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced revised US prescribing information and medication guides for all rosiglitazone-containing medicines (Avandia, Avandamet; and Avandaryl) to include additional safety information and restrictions on the use of these medicines."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-publication-of-bliss-52-phase-lll-study-results-for-benlysta-in-the-lancet/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                07 February 2011\n            GlaxoSmithKline and Human Genome Sciences announce publication of BLISS-52 phase lll study results for Benlysta® in The Lancet\n                GlaxoSmithKline (GSK)  and Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK)  and Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication of the BLISS-52 study of Benlysta (belimumab) in autoantibody-positive patients with active systemic lupus erythematosus (SLE) in The Lancet . "}},"https://www.gsk.com/en-gb/media/press-releases/?p=39":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=36":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=35","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=37":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/media/280477/q3-2011-results-announcement.pdf":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"http://www.gsk.com/media/pressreleases/2011/2011-pressrelease-676305.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-results-announcement-for-the-fourth-quarter/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                03 February 2011\n            GSK results announcement for the fourth quarter\n                Strategic progress drives positive underlying sales growth*,increasing pipeline potential and imp...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Strategic progress drives positive underlying sales growth*,increasing pipeline potential and improved cash generation.\n\nIncreased dividend and new long-term share buy-back programme enhance returns to shareholders.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-progression-of-lamalaba-combination-treatment-into-phase-iii-development-for-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                03 February 2011\n            GSK and Theravance announce progression of LAMA/LABA combination treatment into Phase III development for COPD\n                GSK and Theravance, Inc. today announced major milestones in two clinical development programmes ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK and Theravance, Inc. today announced major milestones in two clinical development programmes focused on new treatments for patients with COPD, a leading cause of chronic illness and death worldwide."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-the-sale-of-its-entire-shareholding-in-quest-diagnostics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                01 February 2011\n            GSK announces the sale of its entire shareholding in Quest Diagnostics\n                GlaxoSmithKline plc (GSK) announces that it has sold its entire holding of 30,755,151 shares of c...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) announces that it has sold its entire holding of 30,755,151 shares of common stock in Quest Diagnostics Inc. (Quest).  "}},"https://www.gsk.com/en-gb/media/press-releases/update-on-pandemrix-and-interim-finnish-report-on-narcolepsy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                01 February 2011\n            Update on Pandemrix™ and interim Finnish report on narcolepsy\n                GSK is aware of today's interim report by the Finnish National narcolepsy committee on their inve...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK is aware of today's interim report by the Finnish National narcolepsy committee on their investigation into reported cases of narcolepsy in Finland."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-actelion-discontinue-clinical-development-of-almorexant/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                28 January 2011\n            GSK and Actelion discontinue clinical development of almorexant\n                GlaxoSmithKline (GSK) and Actelion Ltd (SIX: ATLN) today announced that clinical development of t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Actelion Ltd (SIX: ATLN) today announced that clinical development of the Phase III investigational dual orexin receptor antagonist, almorexant, has been discontinued.  This decision follows a review of data from additional clinical studies, which were conducted to further establish the clinical profile of almorexant, including the tolerability profile."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-complete-response-letter-for-avodart-for-prostate-cancer-risk-reduction-supplemental-indication/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                26 January 2011\n            GSK receives FDA Complete Response letter for Avodart for prostate cancer risk reduction supplemental indication\n                GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter fr...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart&#174; (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA)."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announces-start-of-two-phase-iii-studies-in-advancedmetastatic-melanoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                24 January 2011\n            GlaxoSmithKline announces start of two phase III studies in advanced/metastatic melanoma\n                GlaxoSmithKline (GSK) announced today the start of two global Phase III studies in advanced or me...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today the start of two global Phase III studies in advanced or metastatic melanoma patients with a BRAF V600 mutation. The studies will separately assess the efficacy and safety of two investigational agents, GSK2118436 and GSK1120212, to determine their individual ability to stop or slow the progression of skin cancer in patients whose tumours contain a BRAF V600 mutation, which occurs in 50 to 60 percent of melanoma patients."}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-and-valeant-receive-positive-opinion-in-europe-from-the-chmp-for-trobalt-retigabine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                21 January 2011\n            Regulatory update - GSK and Valeant receive positive opinion in Europe from the CHMP for Trobalt (retigabine)\n                GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) announced...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending marketing authorisation for Trobalt (retigabine) as an adjunctive (add-on) treatment of partial onset seizures (a form of epilepsy where a seizure begins in a specific area in one side of the brain), with or without secondary generalisation in adults aged 18 years and above with epilepsy."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-prosensa-announce-start-of-phase-iii-study-of-investigational-duchenne-muscular-dystrophy-medication/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                19 January 2011\n            GSK and Prosensa announce start of Phase III study of investigational Duchenne Muscular Dystrophy medication\n                GlaxoSmithKline (GSK) and Prosensa today announced that the first patient has commenced treatment...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Prosensa today announced that the first patient has commenced treatment in the Phase III clinical study investigating GSK2402968 (`968), in ambulant boys with Duchenne Muscular Dystrophy (DMD), who have a dystrophin gene mutation amenable to an exon 51 skip (up to 13% of boys with DMD). "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-commences-phase-iii-study-of-intravenous-zanamivir-for-hospitalised-patients-with-influenza/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                19 January 2011\n            GlaxoSmithKline commences Phase III study of intravenous zanamivir for hospitalised patients with influenza\n                GlaxoSmithKline (GSK) announced today that the first patient has received treatment in a pivotal ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that the first patient has received treatment in a pivotal Phase III study of hospitalised patients with influenza which compares intravenous (IV) zanamivir to oral oseltamivir. The primary endpoint of this study is time to clinical response in patients with confirmed influenza."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announces-q4-2010-legal-charge/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                17 January 2011\n            GlaxoSmithKline announces Q4 2010 legal charge\n                GlaxoSmithKline (GSK) today announces that it expects to record a legal charge for the fourth qua...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announces that it expects to record a legal charge for the fourth quarter of 2010 of £2.2 billion ($3.4 billion) (equating to an after tax cost of £1.8 billion)."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-chemocentryx-announce-initiation-of-phase-iii-study-of-gsk-786-formerly-traficet-en-for-the-treatment-of-crohn-s-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                12 January 2011\n            GlaxoSmithKline and ChemoCentryx announce initiation of Phase III study of GSK’786, formerly Traficet-EN™, for the treatment of Crohn’s disease\n                GlaxoSmithKline (GSK) and ChemoCentryx, Inc. announced today that the first patient with Crohn's ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and ChemoCentryx, Inc. announced today that the first patient with Crohn's disease has initiated treatment in the initial pivotal induction study comparing Traficet-EN, now designated GSK1605786, to placebo."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-dentsply-international-sign-global-agreement-to-create-a-portfolio-of-co-branded-professional-oral-care-products/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                07 January 2011\n            GlaxoSmithKline and DENTSPLY International sign global agreement to create a portfolio of co-branded professional oral care products\n                GlaxoSmithKline (GSK) and DENTSPLY International, a global leader in professional dental products...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and DENTSPLY International, a global leader in professional dental products, today announced that they have entered into an agreement to create a portfolio of co-branded oral care products to be used in the dental office by patients suffering from tooth sensitivity, a problem which is estimated to affect 1 in 3 people."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-60-minutes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                01 January 2011\n            GSK responds to 60 Minutes\n                GlaxoSmithKline [GSK] issued the following response regarding a 60 Minutes program on January 2 t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [GSK] issued the following response regarding a 60 Minutes program on January 2 that focused on a manufacturing facility in Puerto Rico which was formerly owned by the company"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-theravance-commence-maba-phase-iib-copd-study/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                20 December 2010\n            GlaxoSmithKline and Theravance commence MABA Phase IIb COPD study\n                GlaxoSmithKline (GSK) and Theravance (NASDAQ:  THRX) announced today that the first patient has s...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Theravance (NASDAQ:  THRX) announced today that the first patient has started treatment with an investigational inhaled bifunctional compound GSK961081 (&#8216;081) in a Phase IIb study to evaluate efficacy and safety in patients with moderate to severe chronic obstructive pulmonary disease (COPD)."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-impax-pharmaceuticals-enter-global-agreement-to-develop-and-commercialise-a-late-stage-compound-for-parkinson-s-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                15 December 2010\n            GlaxoSmithKline and Impax Pharmaceuticals enter global agreement to develop and commercialise a late stage compound for Parkinson’s Disease\n                GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratorie...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialisation of IPX066, Impax&#8217;s novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinsons Disease (PD), is currently in Phase III clinical trials."}},"https://www.gsk.com/en-gb/media/press-releases/andrew-witty-appointed-lead-non-executive-board-member-for-the-department-for-business-innovation-and-skills-bis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                15 December 2010\n            Andrew Witty appointed Lead Non-Executive Board Member for the Department for Business, Innovation and Skills (BIS)\n                The UK Government today announced that Andrew Witty has been appointed as the Lead Non-Executive ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The UK Government today announced that Andrew Witty has been appointed as the Lead Non-Executive Board Member for the Department for Business, Innovation and Skills. This appointment forms part of a wider announcement by the Government to create Boards for each Department, including representation from the commercial private sector."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-strengthen-nutritional-healthcare-business-with-acquisition-of-maxinutrition/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                13 December 2010\n            GSK to strengthen Nutritional Healthcare business with acquisition of Maxinutrition\n                GlaxoSmithKline (GSK) and Maxinutrition Group Holdings Limited today announced they have entered ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Maxinutrition Group Holdings Limited today announced they have entered into an agreement for GSK to acquire Maxinutrition, a UK company that manufactures protein-enhanced functional nutrition products, from Darwin Private Equity.  Subject to approval from the Office of Fair Trading, GSK will acquire 100 per cent of the shares of Maxinutrition for a cash consideration of approximately £162 million including the repayment of outstanding debt. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/phase-iii-study-in-her2-positive-advanced-breast-cancer-shows-overall-survival-benefit-when-tykerb-is-combined-with-paclitaxel/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                09 December 2010\n            Phase III study in HER2-positive advanced breast cancer shows overall survival benefit when Tykerb is combined with paclitaxel\n                In a blinded, randomised, Phase III study, women with previously untreated HER2-positive metastat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In a blinded, randomised, Phase III study, women with previously untreated HER2-positive metastatic breast cancer achieved a statistically-significant improvement in overall survival when treated with an investigational combination of Tykerb&#174; (lapatinib) plus paclitaxel, a widely used chemotherapy agent.[i] The results of the Phase III study in HER2-positve metastatic breast cancer were presented during the 33rd annual meeting of the CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (8-12 December 2010)."}},"https://www.gsk.com/en-gb/media/press-releases/data-from-tykerb-investigational-phase-iii-studies-in-neo-adjuvant-her2-positive-breast-cancer-presented-at-breast-cancer-symposium/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                09 December 2010\n            Data from Tykerb investigational phase III studies in neo-adjuvant HER2-positive breast cancer presented at breast cancer symposium\n                Topline results were presented today from two Phase III studies examining the effect of Tykerb (l...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Topline results were presented today from two Phase III studies examining the effect of Tykerb (lapatinib) in the neo-adjuvant setting of HER2-positive breast cancer.i, ii The combination of lapatinib and trastuzumab, with standard chemotherapy, was compared to standard chemotherapy plus either lapatinib or trastuzumab in a trial called NeoALTTO. In another trial, known as GeparQuinto, lapatinib plus standard chemotherapy was compared to trastuzumab plus standard chemotherapy. The studies were conducted and presented by international cooperative groups, with research being funded in part by GlaxoSmithKline. Data findings from both trials were presented at the 33rd annual meeting of the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), held in San Antonio, Texas (8-12 December 2010).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?p=40":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=37":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=36","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/media/280468/q2-2011-results-announcement.pdf":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/?=&p=38":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-agreement-to-acquire-nanjing-meirui-pharmaceuticals-in-china/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                06 December 2010\n            GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals in China\n                GlaxoSmithKline plc (GSK) today announced that it has entered into an agreement to acquire Nanjin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that it has entered into an agreement to acquire Nanjing MeiRui Pharma Co., Ltd (MeiRui) for a cash consideration of approximately $70 million. Ninety per cent of the share capital of MeiRui is to be acquired from Pagoda Pharmaceuticals Limited and the remaining ten per cent from Allergon AB in a move to further expand GSK's presence in China, one of the fastest-growing and most significant of the emerging markets.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-fda-extension-of-benlysta-pdufa-target-date-to-10th-march-2011/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                02 December 2010\n            GlaxoSmithKline and Human Genome Sciences announce FDA extension of Benlysta® PDUFA target date to 10th March 2011\n                GlaxoSmithKline PLC (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline PLC (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target date for its priority review of the Biologics License Application (BLA) for Benlysta&#174; (belimumab) as a potential treatment for systemic lupus erythematosus (SLE) from 9th December 2010 to 10th March 2011.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/avodart-reviewed-by-fda-advisory-committee-for-prostate-cancer-risk-reduction/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                30 November 2010\n            Avodart reviewed by FDA advisory committee for prostate cancer risk reduction\n                GlaxoSmithKline (NYSE: GSK) today announced the results of a U.S. Food and Drug Administration (F...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA). When asked if the dutasteride risk/benefit profile is favorable for reduction in the risk of prostate cancer in this target population, the ODAC voted 14 against, 2 in favor, and 2 abstentions.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-valeant-announce-receipt-of-us-fda-complete-response-letter-for-ezogabine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                30 November 2010\n            GSK and Valeant announce receipt of U.S. FDA Complete Response letter for ezogabine\n                GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) annou...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) announced receipt of a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for ezogabine*, an investigational anti-epileptic drug being studied for the adjunctive treatment of adults with partial-onset seizures.\n"}},"https://www.gsk.com/en-gb/media/press-releases/government-patent-box-proposals-transform-uk-attractiveness-for-investment/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                28 November 2010\n            Government patent box proposals ‘transform’ UK attractiveness for investment\n                GSK welcomes the publication today of the Governments proposals to establish a patent box.  The m...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK welcomes the publication today of the Governments proposals to establish a patent box.  The measure is designed to encourage investment in R&amp;D and related manufacturing in the UK by introducing a lower rate of corporation tax on profits generated from UK-owned intellectual property. Specific details of how the mechanism will work are now the subject of consultation"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-to-increase-its-shareholding-in-theravance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                28 November 2010\n            GlaxoSmithKline to increase its shareholding in Theravance\n                GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) (the &#8220;Company&#8221;) announc...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) (the &#8220;Company&#8221;) announced today that GSK will increase its shareholding in Theravance through the purchase of Theravance common stock in a private placement.  GSK and Theravance have entered into a stock purchase agreement for GSK to purchase 5,750,000 shares of Theravance common stock at a price of $22.50 per share, for a total investment of $129,375,000.   The transaction is scheduled to close later today.  Following this purchase, GSK will own 15,151,499 shares of Theravance common stock and Class A common stock, which represent approximately 19% of the total outstanding capital stock of Theravance.  The most recent five-day volume-weighted average price per share of Theravance common stock was $22.35.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-jsc-binnopharm-enter-vaccine-production-alliance-in-russia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                25 November 2010\n            GlaxoSmithKline and JSC Binnopharm enter vaccine production alliance in Russia\n                GlaxoSmithKline (GSK) and JSC Binnopharm (Binnopharm) today announced an alliance to enable the l...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and JSC Binnopharm (Binnopharm) today announced an alliance to enable the local secondary manufacture of a number of GSK vaccines in Russia. The agreement was signed in Moscow during the session of the Russian-British Intergovernmental Steering Committee (ISC) for Trade and Investment.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/human-genome-sciences-and-glaxosmithkline-announce-vote-of-fda-advisory-committee-to-recommend-approval-of-benlysta-for-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                15 November 2010\n            Human Genome Sciences and GlaxoSmithKline announce vote of FDA advisory committee to recommend approval of Benlysta® for systemic lupus erythematosus\n                 Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that th...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":" Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 2 to recommend that the FDA approve BENLYSTA (belimumab) for the treatment of autoantibody-positive patients with active systemic lupus erythematosus (SLE).\n"}},"https://www.gsk.com/en-gb/media/press-releases/new-study-findings-show-no-benefit-of-prescription-omega-3-fatty-acids-in-prevention-of-recurrent-symptomatic-atrial-fibrillation-in-affected-patients/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                14 November 2010\n            New study findings show no benefit of prescription omega-3 fatty acids in prevention of recurrent symptomatic atrial fibrillation in affected patients\n                Findings from a new study show, compared to placebo, treatment with high-dose prescription omega-...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Findings from a new study show, compared to placebo, treatment with high-dose prescription omega-3 fatty acids did not reduce the recurrence of symptomatic atrial fibrillation (AF) among patients with symptomatic paroxysmal AF or persistent AF who have no evidence of substantial structural heart disease.  The study was presented today at the American Heart Associations Scientific Sessions and also published online in The Journal of the American Medical Association."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-fiocruz-extend-innovative-collaboration-to-research-and-develop-new-medicines-for-neglected-tropical-diseases/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                11 November 2010\n            GlaxoSmithKline and Fiocruz extend innovative collaboration to research and develop new medicines for neglected tropical diseases\n                GlaxoSmithKline and the Oswald Cruz Foundation (Fiocruz) have today announced a unique collaborat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline and the Oswald Cruz Foundation (Fiocruz) have today announced a unique collaboration to research and develop new and innovative medicines to treat diseases which disproportionately affect people living in the worlds poorest countries.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-approval-in-japan-for-two-medicines-revolade-and-xyzal/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                28 October 2010\n            GlaxoSmithKline receives approval in Japan for two medicines: Revolade and Xyzal\n                GlaxoSmithKline (GSK) announced that it has received approval in Japan from the Ministry of Healt...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced that it has received approval in Japan from the Ministry of Health, Labour and Welfare for Revolade (eltrombopag) for the treatment of the blood disorder, chronic idiopathic thrombocytopenic purpura (ITP), and for Xyzal (levocetirizine dihydrochloride), the first new anti-histamine to be made available in Japan for eight years"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-amicus-therapeutics-enter-exclusive-worldwide-agreement-to-develop-and-commercialise-amigal-for-fabry-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                28 October 2010\n            GSK and Amicus Therapeutics enter exclusive worldwide agreement to develop and commercialise Amigal™ for Fabry disease\n                GlaxoSmithKline (GSK) and Amicus Therapeutics (Amicus) today announced a definitive agreement to ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Amicus Therapeutics (Amicus) today announced a definitive agreement to develop and commercialise AmigalTM (migalastat HCl), currently in Phase 3 for the treatment of Fabry disease, a rare inherited disorder. Under the terms of the agreement, GSK will receive an exclusive worldwide license to develop, manufacture and commercialise migalastat HCl. Additionally, as part of the agreement, GSK and Amicus also intend to advance clinical studies exploring the co-administration of migalastat HCl with enzyme replacement therapy (ERT) for the treatment of Fabry disease.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-previously-reported-settlement-with-us-department-of-justice-regarding-former-manufacturing-plant/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                25 October 2010\n            GSK completes previously reported settlement with U.S. Department of Justice regarding former manufacturing plant\n                GlaxoSmithKline today announced that it has finalized a previously reported agreement in principl...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline today announced that it has finalized a previously reported agreement in principle with the U.S. Attorneys Office for the District of Massachusetts and the  U.S. Department of Justice (DOJ) with respect to the investigation of the companys former manufacturing facility in Cidra, Puerto Rico.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-outlines-approach-to-delivering-advances-in-the-treatment-of-rare-diseases/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                17 October 2010\n            GSK outlines approach to delivering advances in the treatment of rare diseases\n                Creating an environment that fosters innovation, intuition and scientific acumen to deliver break...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Creating an environment that fosters innovation, intuition and scientific acumen to deliver breakthrough thinking and new medicines \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-fondazione-san-raffaele-to-collaborate-on-gene-therapy-for-rare-diseases/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                17 October 2010\n            GSK, Fondazione Telethon and Fondazione San Raffaele to collaborate on gene therapy for rare diseases\n                GlaxoSmithKline PLC (GSK), Fondazione Telethon and Fondazione San Raffaele today announced a new ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline PLC (GSK), Fondazione Telethon and Fondazione San Raffaele today announced a new strategic alliance to research and develop novel treatments to address rare genetic disorders, using gene therapy carried out on stem cells taken from the patients bone marrow (ex vivo). The alliance capitalises on research performed at the San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), a joint venture between Fondazione Telethon and Fondazione San Raffaele established since 1995"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-increases-support-for-who-strategy-to-improve-children-s-health-with-new-5-year-commitment-to-expand-donations-of-albendazole-medicine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                13 October 2010\n            GSK increases support for WHO strategy to improve children’s health with new 5-year commitment to expand donations of albendazole medicine\n                At the launch of the World Health Organizations (WHO) first report on Neglected Tropical Diseases...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"At the launch of the World Health Organizations (WHO) first report on Neglected Tropical Diseases today, GSK announced a new five year commitment to expand the donation of its medicine albendazole to treat children at risk of intestinal worms, known as soil-transmitted helminths (STH).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-takes-minority-stake-in-newly-formed-convergence-pharmaceuticals/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                03 October 2010\n            GSK takes minority stake in newly formed Convergence Pharmaceuticals\n                GlaxoSmithKline plc (GSK) today announced that it has taken an 18% minority equity stake in Conve...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that it has taken an 18% minority equity stake in Convergence Pharmaceuticals Limited, a new biotechnology company that will focus on the development of new analgesic compounds. Convergence Pharmaceuticals, which was officially launched today, recently raised around $35.4 million in Series A financing from a syndicate of leading European and US life science investors.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-herpevac-trial-for-women-evaluating-simplirix-herpes-simplex-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                29 September 2010\n            GSK provides update on Herpevac trial for women evaluating Simplirix™ (Herpes Simplex Vaccine)\n                GlaxoSmithKline (GSK) has made the decision not to pursue further worldwide development of Simpli...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) has made the decision not to pursue further worldwide development of Simplirix&#8482; (Herpes Simplex Vaccine), an experimental vaccine intended to prevent genital herpes disease in women"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-eu-approval-for-a-new-therapeutic-indication-for-arixtra-fondaparinux/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                29 September 2010\n            GlaxoSmithKline receives EU approval for a new therapeutic indication for Arixtra® (fondaparinux)\n                GlaxoSmithKline (GSK) confirmed today that the European Commission (EC) has granted an amendment ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) confirmed today that the European Commission (EC) has granted an amendment of their marketing authorisation for their anti-clotting agent (antithrombotic) Arixtra&#174; (fondaparinux) in the European Union for a new therapeutic indication. Fondaparinux 1.5 and 2.5 mg is now indicated for thetreatment of adults with acute symptomatic spontaneous superficial-vein thrombosis of the lower limbs without concomitant deep-vein thrombosis. It is the only anti-clotting agent to have this indication.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?p=41":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=38":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=37","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=39":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-regulatory-update-on-avandia-following-ema-and-fda-reviews/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                22 September 2010\n            GSK regulatory update on Avandia following EMA and FDA reviews\n                GlaxoSmithKline (GSK) confirms that following a review of Avandia&#174; (rosiglitazone maleate) b...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) confirms that following a review of Avandia&#174; (rosiglitazone maleate) by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), each agency has today announced their individual regulatory decisions and the resulting actions. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-eu-regulatory-update-on-pandemrix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                22 September 2010\n            GSK EU regulatory update on Pandemrix™\n                GlaxoSmithKline (GSK) today confirmed that on behalf of the European Medicines Agency (EMA), the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today confirmed that on behalf of the European Medicines Agency (EMA), the Committee for Medicinal Products for Human Use (CHMP) has concluded that the available data are insufficient to demonstrate a causal relationship between Pandemrix and the observed cases of narcolepsy. The CHMP has further concluded that any temporary restriction on the use of Pandemrix is not considered warranted"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-combination-icslaba-phase-ii-results-in-the-relovair-development-programme/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                21 September 2010\n            GSK and Theravance announce combination ICS/LABA Phase II results in the Relovair™ development programme\n                Additional data presentations for fluticasone furoate and vilanterol trifenatate support the pote...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Additional data presentations for fluticasone furoate and vilanterol trifenatate support the potential of developmental combination treatment, Relovair, in COPD and asthma \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-refocus-development-programme-for-ofatumumab-in-autoimmune-indications/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                15 September 2010\n            GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications\n                Following the 1st July announcement by GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) of an amen...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Following the 1st July announcement by GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) of an amendment to the collaborative agreement for ofatumumab in which GSK assumed development responsibility for autoimmune indications, GSK and Genmab announced today plans to refocus the development programme of ofatumumab in autoimmune indications.  After review of the programme&#8217;s full development strategy, GSK will focus development efforts on the subcutaneous delivery of ofatumumab in autoimmune indications and will stop further development work on the intravenous route of administration in autoimmune disease. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/three-year-results-from-eclipse-study-indicate-that-copd-patients-may-require-prevention-strategies-to-manage-exacerbations-regardless-of-disease-severity/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                14 September 2010\n            Three-year results from ECLIPSE study indicate that COPD patients may require prevention strategies to manage exacerbations, regardless of disease severity\n                Today the New England Journal of Medicine published results from ECLIPSE (Evaluation of COPD* Lon...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Today the New England Journal of Medicine published results from ECLIPSE (Evaluation of COPD* Longitudinally to Identify Predictive Surrogate End-points), an extensive research programme sponsored by GlaxoSmithKline (GSK) designed to advance understanding of the underlying mechanisms of Chronic Obstructive Pulmonary Disease (COPD), a disease which accounts for 2.75 million deaths worldwide each year1, as well as define markers of disease progression"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-bjd-collaborate-on-a-new-educational-programme-to-reduce-global-burden-of-joint-pain/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                10 September 2010\n            GSK and BJD collaborate on a new educational programme to reduce global burden of joint pain\n                The Bone and Joint Decade (BJD) international initiative and GlaxoSmithKline (GSK) today announce...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Bone and Joint Decade (BJD) international initiative and GlaxoSmithKline (GSK) today announced the launch of the LIBERATE&#8482; joint pain management programme during the BJD&#8217;s World Conference in Lund, Sweden. The BJD, which is endorsed by the United Nation&#8217;s World Health Organisation, and GSK have partnered to develop the global programme that provides information on practical and clinically proven techniques that people can use to self-manage their joint pain.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/audio-recording-of-meeting-between-gsk-and-dr-nissen-to-discuss-avandia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                10 September 2010\n            Audio recording of meeting between GSK and Dr Nissen to discuss Avandia\n                Audio recording of meeting between GSK and Dr Nissen to discuss Avandia\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Audio recording of meeting between GSK and Dr Nissen to discuss Avandia"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-announce-start-of-ofatumumab-phase-iii-combination-study-in-non-hodgkin-s-lymphoma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                07 September 2010\n            GlaxoSmithKline and Genmab announce start of ofatumumab Phase III combination study in non-Hodgkin’s lymphoma\n                GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today the start of a Phase III study in...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today the start of a Phase III study in patients with indolent B-cell non-Hodgkin&#8217;s lymphoma (B-NHL) who did not respond to or progressed during, or within 6 months of a rituximab containing regimen.  Under the terms of Genmans collaboration with GlaxoSmithKline (GSK), Genmab will receive a milestone payment of approximately DKK 116 million (approximately USD 20 million), triggered by the treatment of the first patient in the study"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-succession-plan-for-chief-financial-officer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                07 September 2010\n            GSK announces succession plan for Chief Financial Officer\n                GlaxoSmithKline plc (GSK) today announces that Julian Heslop is to retire as Chief Financial Offi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announces that Julian Heslop is to retire as Chief Financial Officer and Executive Director of the company at the end of March 2011.  He will be succeeded by Simon Dingemans who is appointed Chief Financial Officer designate and Executive Director effective 4 January 2011.\n"}},"https://www.gsk.com/en-gb/media/press-releases/galapagos-reaches-agreement-to-acquire-glaxosmithkline-research-centre-in-zagreb-croatia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                07 September 2010\n            Galapagos reaches agreement to acquire GlaxoSmithKline research centre in Zagreb, Croatia\n                R&D operations in Zagreb fulfil Galapagos; growing R&D capacity requirements \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"R&D operations in Zagreb fulfil Galapagos; growing R&D capacity requirements \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-agreement-with-lonza-to-secure-capacity-and-expertise-in-biological-manufacturing-to-support-ongoing-development-of-gsk-s-biopharmaceuticals-portfolio/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                07 September 2010\n            GSK signs agreement with Lonza to secure capacity and expertise in biological manufacturing to support ongoing development of GSK’s biopharmaceuticals portfolio\n                GlaxoSmithKline (GSK) and Lonza today announced that they have entered into a new agreement under...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Lonza today announced that they have entered into a new agreement under which Lonza will support the ongoing development of GSK&#8217;s biopharmaceutical pipeline by supplying manufacturing capacity for five early stage monoclonal antibodies.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/bbc-panorama-6-september-2010/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                05 September 2010\n            BBC Panorama – 6 September 2010\n                Patient safety is our first priority. We strongly refute any allegation that our actions have put...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Patient safety is our first priority. We strongly refute any allegation that our actions have put patients at risk.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-pre-broadcast-statement-bbc-panorama-6-september-2010/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                05 September 2010\n            GlaxoSmithKline pre-broadcast statement: BBC Panorama, 6 September 2010\n                GlaxoSmithKline today issued the following statement in anticipation of the BBC Panorama programm...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline today issued the following statement in anticipation of the BBC Panorama programme, A risk worth taking which is scheduled to be aired this evening.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-responds-to-british-medical-journal-article-regarding-avandia-rosiglitazone/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                05 September 2010\n            GlaxoSmithKline responds to British Medical Journal article regarding Avandia® (rosiglitazone)\n                GlaxoSmithKline (GSK) continues to work in the best interest of diabetes patients who face this c...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) continues to work in the best interest of diabetes patients who face this chronic and serious disease. Patients taking Avandia should speak with their doctor about their treatment and any questions they may have regarding their medicine.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/reports-of-narcolepsy-in-europe-following-vaccination-with-pandemrix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                01 September 2010\n            Reports of narcolepsy in Europe following vaccination with Pandemrix™\n                GSK initially became aware of possible cases of narcolepsy following vaccination with the adjuvan...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK initially became aware of possible cases of narcolepsy following vaccination with the adjuvanted H1N1 pandemic vaccine Pandemrix through adverse event reports received by the Swedish Medical Products Agency, and subsequently via media reports in Finland."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-valeant-announce-new-us-fda-pdufa-goal-date-for-ezogabine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                29 August 2010\n            GSK and Valeant announce new U.S. FDA PDUFA goal date for ezogabine\n                GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International (NYSE: VRX) announced today...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International (NYSE: VRX) announced today the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for ezogabine* to 30 November 2010.  The original goal date was 30 August 2010.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-commences-phase-iii-clinical-trials-to-develop-herpes-zoster-vaccine-for-the-prevention-of-shingles/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                22 August 2010\n            GSK commences Phase III clinical trials to develop herpes zoster vaccine for the prevention of shingles\n                GlaxoSmithKline confirmed today that the company has commenced the Phase III clinical trials prog...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline confirmed today that the company has commenced the Phase III clinical trials programme of its candidate herpes zoster vaccine currently being developed for the prevention of shingles. The phase III clinical trials will study more than 30,000 patients globally and will evaluate the efficacy, safety and immunogenicity of the candidate vaccine.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-fda-priority-review-designation-for-benlysta-belimumab-as-a-potential-treatment-for-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                18 August 2010\n            GlaxoSmithKline and Human Genome Sciences announce FDA priority review designation for Benlysta® (belimumab) as a potential treatment for systemic lupus erythematosus\n                GlaxoSmithKline PLC (GSK) and Human Genome Sciences, Inc. today announced that the U.S. Food and ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline PLC (GSK) and Human Genome Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted a priority review designation to Benlysta (belimumab) as a potential treatment for systemic lupus erythematosus (SLE).  A priority review designation is granted to drugs that, if approved, offer major advances in treatment or provide a treatment where no adequate therapy exists.  The FDA has assigned belimumab a Prescription Drug User Fee Act (PDUFA) target date of 9 December 2010."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-announce-topline-results-from-the-concluded-pivotal-trial-of-arzerra-ofatumumab-in-fludarabine-and-alemtuzumab-refractory-chronic-lymphocytic-leukemia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                08 August 2010\n            GSK and Genmab announce topline results from the concluded pivotal trial of Arzerra (ofatumumab) in fludarabine and alemtuzumab refractory chronic lymphocytic leukemia\n                GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today top line results from the conclud...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today top line results from the concluded pivotal trial of ofatumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/image-of-new-antibiotic-in-action-opens-up-new-opportunities-to-combat-antibacterial-resistance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                03 August 2010\n            Image of new antibiotic in action opens up new opportunities to combat antibacterial resistance\n                Detailed pictures have been published today showing how a new type of experimental antibiotic can...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Detailed pictures have been published today showing how a new type of experimental antibiotic can kill bacteria already resistant to existing treatments. The findings could ultimately help scientists to develop new antibiotics to tackle the bacteria responsible for many hospital and community-acquired infections.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?p=42":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=39":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=38","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=23","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=24","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=25","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=26","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=24","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"11","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"12","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"13","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=10","txt":"14","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=16","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=16","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=40":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-exercises-option-on-anacor-s-novel-antibiotic-for-the-treatment-of-gram-negative-infections/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                28 July 2010\n            GSK exercises option on Anacor’s novel antibiotic for the treatment of gram-negative infections\n                GlaxoSmithKline PLC (GSK) and Anacor Pharmaceuticals today announced that GSK has exercised its o...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline PLC (GSK) and Anacor Pharmaceuticals today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052, formerly known as AN3365.  \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-chmp-positive-opinion-for-a-new-indication-for-arixtra/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                22 July 2010\n            GSK receives CHMP positive opinion for a new indication for Arixtra\n                GlaxoSmithKline (GSK) today announced that the European Medicines Agencys Committee for Medicinal...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that the European Medicines Agencys Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Arixtra (fondaparinux),an anti-clotting drug (antithrombotic) for the treatment of adults with acute symptomatic spontaneous superficial-vein thrombosis (SVT) of the lower limbs without concomitant deep-vein thrombosis."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-statement-in-response-to-fda-announcement-on-tide-trial/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                20 July 2010\n            GlaxoSmithKline statement in response to FDA announcement on TIDE trial\n                 GlaxoSmithKline [NYSE: GSK] confirmed today that it will suspend enrollment of new patients in t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":" GlaxoSmithKline [NYSE: GSK] confirmed today that it will suspend enrollment of new patients in the Thiazolidinedione Intervention with Vitamin D Evaluation (TIDE) clinical trial at the request of the U.S. Food and Drug Administration (FDA) pending FDA  review of recommendations from its  Advisory Committee meeting July 13-14. Patients already enrolled may continue in the trial. \n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-legal-update/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                14 July 2010\n            GlaxoSmithKline legal update\n                GlaxoSmithKline (GSK) today announces that it expects to record a legal charge for the second qua...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announces that it expects to record a legal charge for the second quarter of 2010 of £1.57billion ($2.36 billion) (equating to an after tax cost of £1.35 billion).   The charge includes settlements, agreements in principle to settle, and other provisioning for long-standing legal cases.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-statement-in-response-to-fda-advisory-committees-vote-on-safety-of-avandia-rosiglitazone/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                13 July 2010\n            GlaxoSmithKline statement in response to FDA Advisory Committees’ vote on safety of Avandia® (rosiglitazone)\n                GlaxoSmithKline [NYSE: GSK] confirmed today that a joint advisory committee to the U.S. Food and ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [NYSE: GSK] confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions (20) to withdrawal from the U.S. market (12).  \n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-gsk-responds-to-senate-finance-committee-letter-of-12-july-to-fda/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                12 July 2010\n            GlaxoSmithKline (GSK) responds to Senate Finance Committee letter of 12 July to FDA\n                The Senate Finance Committee (SFC) has released a small subset of the 14 million pages of documen...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Senate Finance Committee (SFC) has released a small subset of the 14 million pages of documents provided to plaintiffs&apos; counsel in the product liability litigation.  They include drafts and other documents taken out of context, which therefore are incomplete and misleading.  The documents do not offer new clinically relevant scientific information, and do not provide the full extent of GSK&#8217;s studies and evaluation of Avandia. GSK has been diligent in providing its safety data on Avandia to the FDA and in publishing its clinical trial data in peer-reviewed journals or on its clinical trial website.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/data-support-avandia-rosiglitazone-maleate-cardiovascular-safety-profile/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                08 July 2010\n            Data support Avandia (rosiglitazone maleate) cardiovascular safety profile\n                The U.S. Food and Drug Administration (FDA) today posted a comprehensive review conducted by Glax...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The U.S. Food and Drug Administration (FDA) today posted a comprehensive review conducted by GlaxoSmithKline (GSK) of the cardiovascular safety data on Avandia (rosiglitazone maleate). GSKs review supports the overall positive benefit-risk profile of rosiglitazone as an important medicine for patients with type 2 diabetes.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-eu-regulatory-update-on-avandia-rosiglitazone/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                08 July 2010\n            GSK EU regulatory update on Avandia (rosiglitazone)\n                GlaxoSmithKline (GSK) today confirmed that on behalf of the European Medicines Agency (EMA), the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today confirmed that on behalf of the European Medicines Agency (EMA), the Committee for Medicinal Products for Human Use (CHMP) is to review the benefit/risk profile of Avandia (rosiglitazone).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-edb-commit-35-million-usd-in-funding-to-support-research-in-green-and-sustainable-manufacturing-in-singapore/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                01 July 2010\n            GSK and EDB commit $35 million (USD) in funding to support research in green and sustainable manufacturing in Singapore\n                GlaxoSmithKline (GSK) and the Singapore Economic Development Board (EDB), the government agency r...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and the Singapore Economic Development Board (EDB), the government agency responsible for economic growth and development, today jointly awarded funding for eight research projects based in Singapore aimed at growing local capabilities and talent in green and sustainable manufacturing.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-announce-amendment-to-ofatumumab-agreement/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                30 June 2010\n            GlaxoSmithKline and Genmab announce amendment to Ofatumumab agreement\n                GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today an amendment to the ofatumumab co...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today an amendment to the ofatumumab co-development and commercialisation agreement.  Under the terms of the amendment, GSK will take responsibility for developing ofatumumab in autoimmune indications whilst continuing to jointly develop ofatumumab with Genmab in oncology indications"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-creates-a-new-operating-unit-dedicated-to-expanding-access-to-medicines-for-people-living-in-the-world-s-poorest-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                30 June 2010\n            GlaxoSmithKline creates a new operating unit dedicated to expanding access to medicines for people living in the world’s poorest countries\n                As part of its commitment to further transform the company&#8217;s approach to diseases that disp...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"As part of its commitment to further transform the company&#8217;s approach to diseases that disproportionately affect the world&#8217;s poorest people, GlaxoSmithKline (GSK) today announced that it is creating a new operating unit dedicated to the Least Developed Countries (LDCs*).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-aptuit-finalise-agreement-for-aptuit-to-acquire-gsk-s-research-operations-in-italy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                30 June 2010\n            GSK and Aptuit finalise agreement for Aptuit to acquire GSK’s research operations in Italy\n                Augments Aptuit's global, integrated scientific and operational capabilities and preserves scient...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Augments Aptuit's global, integrated scientific and operational capabilities and preserves scientific expertise at the centre"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-eu-authorisation-for-a-new-therapeutic-indication-for-tyverb-lapatinib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                22 June 2010\n            GlaxoSmithKline receives EU authorisation for a new therapeutic indication for Tyverb® (lapatinib)\n                GlaxoSmithKline (GSK) confirmed today that the European Commission (EC) has granted a variation t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) confirmed today that the European Commission (EC) has granted a variation to the conditional marketing authorisation for Tyverb&#174; (lapatinib) in the European Union for a new therapeutic indication. Tyverb, in combination with an aromatase inhibitor, is indicated for the treatment of post-menopausal women with hormone receptor-positive, HER2 (ErbB2) over-expressing metastatic breast cancer and for whom chemotherapy is currently not intended. The patients in the registration study were not previously treated with trastuzumab or an aromatase inhibitor.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-enters-agreement-with-medivir-for-exclusive-rights-to-cold-sore-treatment-xerclear/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                22 June 2010\n            GlaxoSmithKline enters agreement with Medivir for exclusive rights to cold sore treatment Xerclear™\n                GlaxoSmithKline (GSK) and Medivir (STO: MVIR-B) today announced an exclusive agreement for the co...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Medivir (STO: MVIR-B) today announced an exclusive agreement for the commercialisation of cold sore treatment, Xerclear&#8482; (acyclovir and hydrocortisone) for non-prescription use (OTC) in key global markets. Xerclear is the first and only topical herpes labialis (cold sores) treatment clinically proven to help prevent cold sore lesions appearing.[i] \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-conditional-marketing-authorisation-in-the-eu-for-votrient-pazopanib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                14 June 2010\n            GlaxoSmithKline receives conditional marketing authorisation in the EU for Votrient® (pazopanib)\n                GlaxoSmithKline (GSK) confirmed today that the European Commission (EC) has granted a conditional...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) confirmed today that the European Commission (EC) has granted a conditional marketing authorisation for Votrient (pazopanib) for the first-line treatment of advanced Renal Cell Carcinoma (RCC) and for patients who have received prior cytokine therapy for advanced disease. As part of these conditions, GSK will provide data from ongoing clinical studies.\n\n\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/fda-approves-jalyn-a-fixed-dose-combination-of-dutasteride-and-tamsulosin-for-symptomatic-bph-in-men-with-an-enlarged-prostate/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                13 June 2010\n            FDA approves Jalyn™, a fixed-dose combination of dutasteride and tamsulosin, for symptomatic BPH in men with an enlarged prostate\n                Administration (FDA) has approved Jalyn, a single-capsule combination of dutasteride (0.5 mg) and...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Administration (FDA) has approved Jalyn, a single-capsule combination of dutasteride (0.5 mg) and tamsulosin (0.4 mg) to treat symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.  BPH is one of the most common prostate disorders, affecting nearly half of all men 50 years of age or older in the U.S.  In a clinical study of nearly 5,000 men, co-administration of these two medicines significantly improved symptoms of BPH compared to either medicine taken alone.  GSK expects to make the product available during the second half of 2010."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-complete-response-from-fda-for-candidate-meningococcal-and-hib-combination-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                10 June 2010\n            GlaxoSmithKline Receives Complete Response from FDA for Candidate Meningococcal and Hib Combination Vaccine\n                GlaxoSmithKline [NYSE:GSK] announced today that it has received a Complete Response letter from t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [NYSE:GSK] announced today that it has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for the candidate meningococcal and Hib combination vaccine, MenHibrix (Hib-MenCY).  The proposed indication for this combination vaccine is immunization of infants and toddlers against meningococcal serogroups C &amp; Y, and Haemophilus influenzae type b (Hib) diseases at two, four, six and 12-15 months of age. Meningococcal and Hib diseases are caused by potentially deadly bacteria that can lead to meningitis and other very serious complications.\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-drives-latin-america-growth-strategy-with-acquisition-of-laboratorios-phoenix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                09 June 2010\n            GSK drives Latin America growth strategy with acquisition of Laboratorios Phoenix\n                GlaxoSmithKline plc (GSK) today announced that it has acquired Laboratorios Phoenix S.A.C.yF (Pho...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that it has acquired Laboratorios Phoenix S.A.C.yF (Phoenix), a leading Argentine pharmaceutical business, for a cash consideration of approximately $253 million. Under the terms of the transaction, GSK will gain full ownership of Phoenix in a move to accelerate sales growth and further extend its pharmaceutical portfolio in Argentina and the Latin America region.\n\n\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-bla-filed-for-benlysta-belimumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                09 June 2010\n            Regulatory update – BLA filed for Benlysta® (belimumab)\n                GlaxoSmithKline PLC (GSK) announced today that Human Genome Sciences, Inc. (HGS) has submitted a ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline PLC (GSK) announced today that Human Genome Sciences, Inc. (HGS) has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), for Benlysta (belimumab) for reducing disease activity in adult patients with autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standardtherapy.  Benlysta is being developed by GSK and HGS under a co-development and commercialisation agreement entered into in 2006.\n\n\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?p=43":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=40":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=39","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=41":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-benlysta-belimumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                06 June 2010\n            Regulatory update - Benlysta® (belimumab)\n                GlaxoSmithKline PLC (GSK) announced today that it has submitted a Marketing Authorisation Applica...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline PLC (GSK) announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA), for Benlysta (belimumab) for reducing disease activity in adult patients with autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standardtherapy.  The submission was made in collaboration with Human Genome Sciences, Inc (HGS).  Benlysta is being developed by GSK and HGS under a co-development and commercialisation agreement entered into in 2006."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-revised-product-labels-for-serevent-and-advair/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                01 June 2010\n            GSK announces revised product labels for Serevent and Advair\n                GlaxoSmithKline [NYSE:GSK] today announced that it has received a letter from the U.S. Food and D...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [NYSE:GSK] today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling for its respiratory products Serevent and Advair. The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of asthma, including salmeterol, the active ingredient in Serevent and one of the active ingredients in Advair. The changes communicated by the FDA reflect class labeling for all LABA containing products and are specific to product labels in the U.S.\n"}},"https://www.gsk.com/en-gb/media/press-releases/european-medicines-agency-maintains-position-on-the-continued-use-of-rotarix-rotavirus-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                20 May 2010\n            European Medicines Agency maintains position on the continued use of Rotarix™ (rotavirus vaccine)\n                GlaxoSmithKline (GSK) today confirmed that following a meeting of the Committee for Medicinal Pro...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today confirmed that following a meeting of the Committee for Medicinal Products for Human Use (CHMP), the European Medicines Agency (EMA) has maintained its position that there is no evidence that the presence of porcine circovirus (PCV) in Rotarix presents a risk to public health and that there is no need to restrict its use in the European Union. This announcement is in line with the assessment of the US Food and Drug Administration earlier this month which stated that the benefits of the rotavirus vaccines are substantial, and include prevention of death in some parts of the world and hospitalisation for severe rotavirus disease in the United States."}},"https://www.gsk.com/en-gb/media/press-releases/viani-seretide-german-patent-litigation-update/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                19 May 2010\n            Viani (Seretide): German patent litigation update\n                GlaxoSmithKline (GSK) today confirmed that the Federal Patents Court in Munich, Germany, has rule...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today confirmed that the Federal Patents Court in Munich, Germany, has ruled in patent litigation regarding GSKs product Viani, an inhaled respiratory treatment for asthma and COPD. The Court ruled in favour of the claimants Mylan dura GmbH, Hexal AG, Neolab Ltd., and IVAX International B.V. in deciding that under German law GSKs German combination patent for Viani (relating to the combination of the active ingredients salmeterol and fluticasone propionate) was not valid"}},"https://www.gsk.com/en-gb/media/press-releases/new-research-identifies-promising-leads-to-follow-in-search-for-medicines-to-fight-malaria/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                18 May 2010\n            New research identifies promising leads to follow in search for medicines to fight malaria\n                New research conducted by GlaxoSmithKline (GSK) was today published in Nature1 identifying promis...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New research conducted by GlaxoSmithKline (GSK) was today published in Nature1 identifying promising potential leads to develop new medicines to treat malaria. The research comes from a year-long screening of more than 2 million compounds in GSKs chemical library to seek out those that could inhibit the malaria parasite, P. falciparum, and reports on an analysis of the more than 13,500 compounds, or hits, that showed greatest activity"}},"https://www.gsk.com/en-gb/media/press-releases/fda-says-healthcare-providers-can-resume-use-of-rotarix-rotavirus-vaccine-live-oral/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                13 May 2010\n            FDA says Healthcare Providers can resume use of Rotarix (Rotavirus Vaccine, Live, Oral)\n                GlaxoSmithKline (NYSE: GSK) announced that the Food and Drug Administration (FDA) has determined ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) announced that the Food and Drug Administration (FDA) has determined that U.S. healthcare practitioners can resume the use of Rotarix (Rotavirus Vaccine, Live, Oral), effective immediately. This action supersedes the FDA recommendation from March 22, 2010 and reflects the agencys assessment that the presence of porcine circovirus type 1 (PCV-1) in the vaccine poses no safety risk.\n\n\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/patrick-vallance-appointed-to-gsk-executive-leadership-team/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                10 May 2010\n            Patrick Vallance appointed to GSK executive leadership team\n                GlaxoSmithKline (GSK) today announced the appointment of Patrick Vallance, as Senior Vice Preside...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced the appointment of Patrick Vallance, as Senior Vice President, Medicines Discovery and Development and as a member of the company Corporate Executive Team both with effect from 1st July 2010.\n\n\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-presence-in-asia-with-new-strategic-alliance-in-south-korea/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                10 May 2010\n            GSK extends presence in Asia with new strategic alliance in South Korea\n                GlaxoSmithKline (GSK) today entered into a strategic alliance with Dong-A Pharmaceuticals Co., Lt...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today entered into a strategic alliance with Dong-A Pharmaceuticals Co., Ltd. (Dong-A), the number one pharmaceutical and OTC Company in South Korea.  As part of the transaction, GSK will acquire a 9.9 percent minority equity shareholding in Dong-A for &#163;73.9m (KRW 142.9bn).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-fda-advisory-committee-meeting-on-rotavirus-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                07 May 2010\n            GSK Statement on FDA Advisory Committee meeting on Rotavirus vaccines\n                GlaxoSmithKline (NYSE: GSK) today participated in a U.S. Food and Drug Administration (FDA) advis...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) today participated in a U.S. Food and Drug Administration (FDA) advisory committee meeting convened to discuss recent findings of porcine circovirus (PCV) in rotavirus vaccines. Although the committee did not issue any formal recommendations, members widely acknowledged that the benefits of vaccinating infants worldwide against rotavirus disease clearly outweigh the theoretical risks associated with the presence of porcine circovirus type 1 (PCV-1) in the vaccines.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-topline-76-week-results-of-phase-3-trial-of-benlysta-in-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                19 April 2010\n            GlaxoSmithKline and Human Genome Sciences announce topline 76-week results of phase 3 trial of Benlysta™ in systemic lupus erythematosus\n                GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) and today announced topline ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. (Nasdaq: HGSI) and today announced topline secondary endpoints from BLISS-76, the second of two pivotal Phase 3 trials of Benlysta (belimumab) in seropositive patients with systemic lupus erythematosus (SLE).  Benlysta 10 mg/kg already met its primary efficacy endpoint at Week 52 in both BLISS-52 and BLISS-76, as announced in July and November 2009.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-conditional-marketing-authorisation-in-the-eu-for-arzerra-ofatumumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                18 April 2010\n            GlaxoSmithKline receives conditional marketing authorisation in the EU for Arzerra® (ofatumumab)\n                GlaxoSmithKline (GSK) and Genmab AS confirmed today that the European Commission (EC) has granted...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Genmab AS confirmed today that the European Commission (EC) has granted a conditional marketing authorisation for Arzerra (ofatumumab) for the treatment of refractory chronic lymphocytic leukaemia (CLL). Ofatumumab is indicated for the treatment of CLL in patients who are refractory (have not responded) to fludarabine and alemtuzumab. Fludarabine and alemtuzumab are standard therapies currently used to treat CLL.\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-isis-pharmaceuticals-collaborate-on-rna-therapeutics-for-rare-and-infectious-diseases/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                30 March 2010\n            GSK and Isis Pharmaceuticals collaborate on RNA therapeutics for rare and infectious diseases\n                GSK has right to license and commercialise compounds at clinical proof-of-concept \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has right to license and commercialise compounds at clinical proof-of-concept \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-approval-for-duodart/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                30 March 2010\n            GSK receives European approval for Duodart®\n                The first fixed dose combination medicine for benign prostatic hyperplasia \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The first fixed dose combination medicine for benign prostatic hyperplasia \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-regulatory-update-avodart-dutasteride/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                28 March 2010\n            GSK regulatory update – Avodart (dutasteride)\n                GlaxoSmithKline (GSK) announced today that it has re-submitted the supplemental New Drug Applicat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that it has re-submitted the supplemental New Drug Application (sNDA) for Avodart (dutasteride) for prostate cancer risk reduction among men at increased risk of developing the disease to the US Food and Drug Administration (FDA). \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/updated-glaxosmithkline-statement-on-european-regulatory-guidance-relating-to-manufacture-of-rotarix-rotavirus-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                25 March 2010\n            Updated GlaxoSmithKline statement on European regulatory guidance relating to manufacture of Rotarix (rotavirus vaccine)\n                GlaxoSmithKline (GSK) today confirmed that the European Medicines Agency (EMA) has maintained its...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today confirmed that the European Medicines Agency (EMA) has maintained its position that it sees no safety concerns with the Rotarix oral vaccine and healthcare practitioners in the European Union should continue to use Rotarix as indicated.  This follows a meeting of the Committee for Medicinal Products for Human Use (CHMP) held on 25th March 2010 to further review all available data relating to the presence of material from PCV-1 in the vaccine. Having done so, the CHMP has reconfirmed its position which is in line with previous communications by WHO, FDA, other national regulatory agencies as well as GSK that the presence of the material does not present a safety risk.\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-update-government-orders-for-pandemic-h1n1-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                25 March 2010\n            GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine\n                GlaxoSmithKline has been working closely with governments around the world to respond to their pa...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline has been working closely with governments around the world to respond to their pandemic needs since the start of the H1N1 pandemic. We recognise that pandemics are unpredictable and that government needs and plans have evolved as understanding of the H1N1 pandemic has increased. We are committed to working with them to respond their needs as the pandemic evolves and find appropriate and fair solutions."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-joins-global-vaccine-alliance-to-help-prevent-millions-of-children-from-contracting-pneumococcal-disease-in-the-world-s-poorest-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                22 March 2010\n            GSK joins global vaccine alliance to help prevent millions of children from contracting pneumococcal disease in the world’s poorest countries\n                Unique finance mechanism ensures vaccinations will begin in 2010 - Up to 300 million doses to be ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Unique finance mechanism ensures vaccinations will begin in 2010 - Up to 300 million doses to be supplied over ten years - Synflorix supplied at around 90% reduction of cost in developed markets \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-succession-plan-for-leadership-of-consumer-healthcare-business/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                21 March 2010\n            GSK announces succession plan for leadership of Consumer Healthcare business\n                Emma Walmsley appointed President, Consumer Healthcare Europe and President Designate, Worldwide ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Emma Walmsley appointed President, Consumer Healthcare Europe and President Designate, Worldwide Consumer Healthcare \n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-statement-on-new-information-relating-to-manufacture-of-rotarix-rotavirus-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                21 March 2010\n            GlaxoSmithKline statement on new information relating to manufacture of Rotarix (rotavirus vaccine)\n                GlaxoSmithKline (GSK) today confirmed  that it has notified regulatory authorities of the presenc...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today confirmed  that it has notified regulatory authorities of the presence of material from a virus called PCV-1 in its oral rotavirus vaccine, Rotarix.  PCV-1 does not multiply in humans and is not known to cause illness in humans.1, 2. It is found in everyday meat products and is frequently eaten with no resulting disease or illness.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?p=44":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=41":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=40","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=42":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/collaborations/tres-cantos.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announces-swiss-approval-of-duodart/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                21 March 2010\n            GlaxoSmithKline announces Swiss approval of Duodart®\n                 The first fixed dose combination medicine for benign prostatic hyperplasia \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":" The first fixed dose combination medicine for benign prostatic hyperplasia \n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-commences-relovair-phase-iii-asthma-programme/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                18 March 2010\n            GlaxoSmithKline commences Relovair Phase III asthma programme\n                GlaxoSmithKline (GSK) announced today that the first asthma patient has commenced treatment with ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that the first asthma patient has commenced treatment with Relovair (fluticasone furoate/vilanterol trifenatate) in an asthma exacerbation study, marking the start of the Phase III clinical development programme with this once daily therapy, for this serious and chronic disease.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-2009-corporate-responsibility-report/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                15 March 2010\n            GSK publishes 2009 Corporate Responsibility Report\n                In its 2009 Corporate Responsibility Report published online today, GSK reiterated its commitment...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In its 2009 Corporate Responsibility Report published online today, GSK reiterated its commitment to running its business responsibly and to making the company more responsive, more flexible and more open to the expectations of society"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-marketing-authorisation-in-the-eu-for-revolade-eltrombopag/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                11 March 2010\n            GlaxoSmithKline receives marketing authorisation in the EU for Revolade® (eltrombopag)\n                GlaxoSmithKline (GSK) confirmed today that the European Commission (EC) has granted marketing aut...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) confirmed today that the European Commission (EC) has granted marketing authorisation for Revolade &#174; (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP). Eltrombopag is indicated for adult chronic ITP splenectomised patients who are refractory (have not responded) to other treatments, such as corticosteroids and immunoglobulins. Eltrombopag may also be considered as second-line treatment for adult non plenectomised patients where surgery is contraindicated."}},"https://www.gsk.com/en-gb/media/press-releases/gsk-commences-succession-plan-for-management-of-vaccines-business/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                11 March 2010\n            GSK commences succession plan for management of vaccines business\n                GlaxoSmithKline (GSK) today announced management changes related to its Vaccines business as part...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced management changes related to its Vaccines business as part of a planned succession strategy.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-ceo-andrew-witty-dedicates-albendazole-facility-in-nashik-to-who-s-global-programme-to-eliminate-lf/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                07 March 2010\n            GSK CEO Andrew Witty dedicates albendazole facility in Nashik to WHO’s Global Programme to Eliminate LF\n                GlaxoSmithKline (GSK) CEO Andrew Witty today dedicated a new production facility at its Nashik si...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) CEO Andrew Witty today dedicated a new production facility at its Nashik site in India to the manufacture of albendazole, part of a combination treatment used within the World Health Organization (WHO) Global Programme to Eliminate Lymphatic Filariasis (LF).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-responds-to-us-senate-committee-on-finance-report-on-avandia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                23 February 2010\n            GlaxoSmithKline responds to US Senate Committee on Finance report on Avandia\n                Today, GlaxoSmithKline (GSK) responded to the recently released Senate Committee on Finance  Janu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Today, GlaxoSmithKline (GSK) responded to the recently released Senate Committee on Finance  January 2010 Staff Report on GlaxoSmithKline and the Diabetes Drug Avandia (the Staff Report) by releasing a White Paper.  \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-rejects-conclusions-of-senate-committee-on-finance-staff-report-on-avandia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                19 February 2010\n            GSK rejects conclusions of Senate Committee on Finance Staff Report on Avandia\n                The Staff Report of the Senate Committee on Finance draws conclusions on the safety of Avandia (r...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The Staff Report of the Senate Committee on Finance draws conclusions on the safety of Avandia (rosiglitazone) that are based on analyses that are not consistent with the rigorous scientific evidence supporting the safety of the drug.  In addition, the report cherry-picks information from documents, which mischaracterizes GlaxoSmithKline's comprehensive efforts to research Avandia and communicate those findings to regulators, physicians and patients.  In fact, the safety and effectiveness of Avandia is well characterized in the label approved by the FDA. \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-rejects-conclusions-reported-in-the-new-york-times-story-on-avandia/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                19 February 2010\n            GSK rejects conclusions reported in The New York Times story on Avandia\n                GlaxoSmithKline (GSK) rejects the conclusions about the safety of Avandia (rosiglitazone) reporte...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) rejects the conclusions about the safety of Avandia (rosiglitazone) reported in the February 20, 2010, New York Times story.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-opinions-in-europe-for-tyverb-lapatinib-and-votrient-pazopanib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                18 February 2010\n            GSK receives positive opinions in Europe for Tyverb® (lapatinib) and Votrient™ (pazopanib)\n                GlaxoSmithKline (GSK) announced today that the European Medicines Agency&#8217;s Committee for Me...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that the European Medicines Agency&#8217;s Committee for Medicinal Products for Human Use (CHMP) has issued two positive opinions in the European Union for two of its cancer medicines.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-fda-s-proposed-label-revisions-for-some-asthma-medicines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                17 February 2010\n            GSK statement on FDA’s proposed label revisions for some asthma medicines\n                GlaxoSmithKline is reviewing label changes proposed today by the US Food and Drug Administration ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline is reviewing label changes proposed today by the US Food and Drug Administration (FDA) for asthma medications containing long-acting beta-agonists (LABAs), such as GSK&#8217;s Advair (salmeterol / fluticasone propionate). GSK and makers of the other affected medicines containing LABAs have 30 days to agree with the proposed changes or state why they are not warranted.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-consumer-healthcare-warns-consumers-of-potential-health-risks-associated-with-long-term-excessive-use-of-zinc-containing-denture-adhesives/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                17 February 2010\n            GSK Consumer Healthcare warns consumers of potential health risks associated with long-term excessive use of zinc-containing denture adhesives\n                Because the safety and health of our consumers is our primary concern, GlaxoSmithKline (GSK) Cons...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Because the safety and health of our consumers is our primary concern, GlaxoSmithKline (GSK) Consumer Healthcare is issuing a Consumer Advisory warning consumers about the potential health risks associated with long-term excessive use of zinc-containing denture adhesives.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-xenoport-receive-fda-complete-response-letter-for-horizant-gsk1838262xp13512-for-rls/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                16 February 2010\n            GlaxoSmithKline and XenoPort receive FDA Complete Response letter for Horizant™ (GSK1838262/XP13512) for RLS\n                GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) Wednesday received a Complete Respo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant&#8482;(gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS). \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-launches-new-specialist-unit-to-research-and-develop-medicines-for-rare-diseases/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                03 February 2010\n            GSK launches new specialist unit to research and develop medicines for rare diseases\n                GSK today announces the formation of a new standalone unit specialising in the development and co...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announces the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-appointment-of-philippe-fauchet-as-president-of-gsk-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                03 February 2010\n            GSK announces appointment of Philippe Fauchet as President of GSK Japan\n                GSK today announces the appointment of Philippe Fauchet as President of GSK Japan.  Philippe will...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announces the appointment of Philippe Fauchet as President of GSK Japan.  Philippe will report to Marc Dunoyer, who takes the new role as Chairman of GSK Japan.  Marc will continue to take overall leadership responsibility for GSK&#8217;s Pharmaceuticals business across the Asia Pacific/ Japan Region.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-fourth-quarter-2009/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                03 February 2010\n            Results announcement for the fourth quarter 2009\n                See the quarterly results page for more information\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"See the quarterly results page for more information"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-tykerb-receives-accelerated-approval-for-first-line-combination-treatment-of-hormone-receptor-positive-her2pluserbb2plus-metastatic-breast-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                28 January 2010\n            GSK’s Tykerb® receives accelerated approval for first-line combination treatment of hormone receptor positive, HER2+/ErbB2+ metastatic breast cancer\n                GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has granted acce...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using Tykerb&#174; (lapatinib) as a first-line, all-oral treatment for women with metastatic breast cancer.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/rotarix-significantly-reduced-severe-rotavirus-gastroenteritis-in-african-babies-during-their-first-year-of-life/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                26 January 2010\n            Rotarix™ significantly reduced severe rotavirus gastroenteritis in African babies during their first year of life\n                The New England Journal of Medicine (NEJM) today published the first study demonstrating that Rot...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The New England Journal of Medicine (NEJM) today published the first study demonstrating that Rotarix&#8482;, GlaxoSmithKline&#8217;s rotavirus vaccine, significantly prevented severe rotavirus gastroenteritis during the first year of life in African babies. In the study Rotarix prevented the disease in 61.2% of these infants. The study also showed that Rotarix. provided broad protection against diverse circulating rotavirus strains. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-open-innovation-strategy-to-help-deliver-new-and-better-medicines-for-people-living-in-the-world-s-poorest-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                19 January 2010\n            GSK announces ‘open innovation’ strategy to help deliver new and better medicines for people living in the world’s poorest countries\n                &apos;Open Lab&apos; established with $8m seed funding for new research \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"&apos;Open Lab&apos; established with $8m seed funding for new research \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-contributes-to-haiti-relief-efforts/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                17 January 2010\n            GSK contributes to Haiti relief efforts\n                In keeping with GSK&#8217;s response to previous natural disasters, we have initiated a program o...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"In keeping with GSK&#8217;s response to previous natural disasters, we have initiated a program of support for Haiti.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?p=45":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=42":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=41","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=43":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/content/dam/gsk/globals/videos/media/avandia-nissen-64k.mp3":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-exercises-option-to-progress-development-of-chemocentryx-s-traficet-en-for-the-treatment-of-inflammatory-bowel-diseases/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                10 January 2010\n            GSK exercises option to progress development of ChemoCentryx’s Traficet-EN for the treatment of inflammatory bowel diseases\n                GlaxoSmithKline(GSK) andChemoCentryx Inc. today announced that GSK has exercised its option to ob...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline(GSK) andChemoCentryx Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialisation of Traficet-EN&#8482; (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn&#8217;s disease. The option also encompasses two further identified backup compounds and represents the first product licensing opportunity resulting from the original collaboration with ChemoCentryx through GSK&#8217;s Centre of Excellence for External Drug Discovery (CEEDD).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/revolade-eltrombopag-receives-positive-opinion-in-europe-for-chronic-immune-thrombocytopenic-purpura/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                17 December 2009\n            Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura\n                GlaxoSmithKline (GSK) announced today that the European Medicines Agency&#8217;s Committee for Me...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that the European Medicines Agency&#8217;s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Revolade (eltrombopag), for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-nanobio-announce-otc-licensing-agreement-for-cold-sore-treatment/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                15 December 2009\n            GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment\n                Next advance in the treatment of cold sores - Strengthens a key OTC franchise \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Next advance in the treatment of cold sores - Strengthens a key OTC franchise \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-speaking-consulting-fees-paid-to-us-healthcare-professionals/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                13 December 2009\n            GSK publishes speaking, consulting fees paid to US healthcare professionals\n                Company progresses commitments to increase transparency\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Company progresses commitments to increase transparency"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-study-showed-targeted-therapy-combination-achieved-14-month-overall-survival-in-patients-with-advanced-breast-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                10 December 2009\n            GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer\n                London UK, Philadelphia, PA &#8211; In a clinical study, women with an aggressive form of breast ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"London UK, Philadelphia, PA &#8211; In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB&#174; (lapatinib) plus HERCEPTIN&#174; (trastuzumab). The results of the Phase III study in ErbB2-positive metastatic breast cancer were presented during the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 &#8211; 13).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-intercell-form-strategic-alliance-to-develop-and-commercialise-innovative-needle-free-patch-based-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                10 December 2009\n            GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines\n                GlaxoSmithKline Biologicals SA (GSK) and Intercell today announced an agreement to form a strateg...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline Biologicals SA (GSK) and Intercell today announced an agreement to form a strategic alliance to accelerate the development and commercialisation of needle-free, patch-based vaccines. The agreement will include Intercell&#8217;s candidate vaccine for travellers&#8217; diarrhoea (TD) and an investigational single application pandemic influenza vaccine, as well as the use of the patch technology for other vaccines in GSK&#8217;s portfolio.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/pre-budget-report-response-gsk-comments-on-patent-box/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                09 December 2009\n            Pre-Budget Report response - GSK comments on patent box\n                GlaxoSmithKline (GSK) welcomes the introduction of a new measure &#8211; the &#8216;patent box&#8...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) welcomes the introduction of a new measure &#8211; the &#8216;patent box&#8217; &#8211; announced in the Pre-Budget Report to stimulate future investment in the UK"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-second-pivotal-phase-iii-trial-for-investigational-cardiovascular-medication-darapladib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                09 December 2009\n            GSK initiates second pivotal Phase III trial for investigational cardiovascular medication Darapladib\n                GlaxoSmithKline today announced initiation of the second large-scale Phase III clinical trial to ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline today announced initiation of the second large-scale Phase III clinical trial to evaluate long-term treatment with the investigational Lp-PLA2 inhibitor"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-update-gsk-s-arepanrix-h1n1-pandemic-vaccine-prequalified-by-the-world-health-organization/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                30 November 2009\n            GSK Update: GSK’s Arepanrix™ H1N1 pandemic vaccine prequalified by the World Health Organization\n                First prequalification for an H1N1 pandemic vaccine \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First prequalification for an H1N1 pandemic vaccine \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-extension-of-strategic-collaboration-with-aspen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                30 November 2009\n            GSK completes extension of strategic collaboration with Aspen\n                GSK announced that yesterday it completed the extension of its strategic relationship with Aspen ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced that yesterday it completed the extension of its strategic relationship with Aspen Pharmacare Holdings Limited (Aspen) and the acquisition of a minority shareholding in the South African based pharmaceuticals company.  This is part of a wide ranging agreement which includes combining commercial activities in Sub-Saharan Africa and the divestment of several assets to Aspen"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announced-as-tier-3-sponsor-as-london-2012-anti-doping-plans-confirmed/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                29 November 2009\n            GlaxoSmithKline announced as Tier 3 Sponsor as London 2012 anti-doping plans confirmed\n                GSK becomes Laboratory Services Provider \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK becomes Laboratory Services Provider \n"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-files-rotarix-for-prevention-of-rotavirus-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                29 November 2009\n            Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan\n                GlaxoSmithKline (GSK) announced today that it has filed its vaccine for the prevention of rotavir...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that it has filed its vaccine for the prevention of rotavirus gastroenteritis (approved as Rotarix &#174; in a number of countries outside of Japan).  The candidate vaccine, which is given orally, is the first to be filed for approval for the prevention of rotavirus gastroenteritis in infants in Japan.  Rotavirus infection is the leading cause of severe acute gastroenteritis in infants. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-gilead-announce-agreement-to-commercialise-viread-for-chronic-hepatitis-b-in-key-asian-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                23 November 2009\n            GlaxoSmithKline and Gilead announce agreement to commercialise Viread® for chronic hepatitis B in key Asian countries\n                GlaxoSmithKline (GSK) and Gilead Sciences, Inc. (Nasdaq:  GILD) today announced a licensing agree...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Gilead Sciences, Inc. (Nasdaq:  GILD) today announced a licensing agreement to commercialise Viread&#174; (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B (HBV) infection in adults in five countries in Asia.   The companies&#8217; combined commercialisation activities will expand access to tenofovir for the treatment of HBV, once approved, to patients "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-regulatory-update-avodart/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                22 November 2009\n            GSK Regulatory Update: Avodart\n                GlaxoSmithKline (GSK) announced today that in order to provide an update to the application, the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that in order to provide an update to the application, the company is withdrawing its US Supplemental New Drug Application (sNDA) for Avodart&#174; (dutasteride) for prostate cancer risk reduction among men at increased risk of developing the disease.  GSK expects to resubmit the file shortly.  This action is not the result of new findings related to safety or efficacy"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-2009-influenza-update-pandemrix-data-in-children-and-adolescents-from-3-to-17-years-of-age/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                22 November 2009\n            Pandemic 2009 Influenza Update: Pandemrix™ data in children and adolescents from 3 to 17 years of age\n                GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programmes. GSK also announced new results from the clinical trial assessing the use of Pandemrix&#8482; in children and adolescents aged 3 to 17 years of age. The trial, which is ongoing, shows that after the first dose of adjuvanted vaccine, a strong immune response was demonstrated in all age groups. The immune response elicited by Pandemrix exceeded the immunogenicity criteria, as defined by international licensing authorities for a pandemic influenza vaccine. All study participants in this trial received 3.75 micrograms of GSK&#8217;s adjuvanted H1N1 vaccine which is equivalent to the full adult dose.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-nabi-announce-agreement-for-nicvax-a-vaccine-for-nicotine-addiction/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                16 November 2009\n            GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction\n                GlaxoSmithKline Biologicals SA (GSK) and Nabi Biopharmaceuticals (Nabi) today announcedan exclusi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline Biologicals SA (GSK) and Nabi Biopharmaceuticals (Nabi) today announcedan exclusive worldwide option and licensing agreement for a nicotine conjugate candidate vaccine (NicVAX&#174;), an investigational vaccine for the treatment of nicotine addiction and the prevention of smoking relapse, as well as for the development of a second generation nicotine vaccine"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-2009-influenza-update-us-fda-approves-gsk-s-pandemic-h1n1-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                09 November 2009\n            Pandemic 2009 Influenza Update: US FDA approves GSK’s pandemic H1N1 vaccine\n                GlaxoSmithKline (GSK) today announced that the US Food and Drug Administration (FDA) has approved...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that the US Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA) for its unadjuvanted influenza A (H1N1) pandemic vaccine.  The approval of the sBLA, which was filed as a strain change supplement to GSK&#8217;s FluLaval seasonal flu vaccine, allows the company to manufacture a flu vaccine for use in adults to prevent influenza caused by the 2009 pandemic H1N1 influenza A strain. "}},"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-agreement-with-the-who-to-donate-50-million-doses-of-pandemic-h1n1-vaccine-for-distribution-to-developing-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                09 November 2009\n            GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries\n                GlaxoSmithKline (GSK) today announced that it has signed an agreement with the World Health Organ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that it has signed an agreement with the World Health Organization (WHO) to donate 50 million doses of its adjuvanted pandemic H1N1 influenza vaccine to WHO for distribution to developing countries most in need. GSK is working with WHO and health authorities to prepare for initial shipments of the vaccine to developing countries by the end of November.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-2009-influenza-update-pandemrix-data-on-co-administration-with-annual-seasonal-influenza-vaccine-fluarix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                09 November 2009\n            Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®)\n                GlaxoSmithKline (GSK) today announced the results from the clinical trial assessing Pandemrix&#84...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced the results from the clinical trial assessing Pandemrix&#8482;, GSK&#8217;s adjuvanted H1N1 pandemic influenza vaccine, administered at the same time as the annual seasonal influenza vaccine, Fluarix &#174; .  The trial showed that co-administration of one dose of both vaccines in separate arms, induced a strong response in adults for both the H1N1 pandemic vaccine as well as the seasonal vaccine. The trial involves 168 adults aged over 60 years of age, and was designed to evaluate the tolerability and immunogenicity of the co-administration of Pandemrix and Fluarix.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-xenoport-announce-extension-of-gsk1838262-xp13512-fda-review-date-to-9-february-2010/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                05 November 2009\n            GlaxoSmithKline and XenoPort announce extension of GSK1838262 (XP13512) FDA review date to 9 February 2010\n                GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S. Food ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S. Food and Drug Administration (FDA) has extended the original Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application (NDA) for GSK1838262/XP13512 (gabapentin enacarbil) to February 9, 2010.  The NDA currently under review by FDA is for the treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).  The original PDUFA date for this NDA review was November 9, 2009.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?p=46":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=43":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=42","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=27","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=28","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=29","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=30","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=30","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"15","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"16","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"17","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"18","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=24","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=30","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=30","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=30","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=28","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=28","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=30","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=44":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"http://www.gsk.com/media/avandia-resource-releases.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/media/press-releases/world-health-organization-grants-prequalification-for-global-use-to-gsk-s-10-valent-synflorix-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                05 November 2009\n            World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ Vaccine\n                First prequalification for pneumococcal disease vaccine - a life-threatening disease affecting ma...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First prequalification for pneumococcal disease vaccine - a life-threatening disease affecting many children; follows first-ever World Pneumonia Day \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/world-s-largest-malaria-vaccine-trial-now-underway-in-seven-african-countries/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                02 November 2009\n            World’s largest malaria vaccine trial now underway in seven African countries\n                Pivotal testing of RTS,S is on track for target enrollment of 16,000 children \n\n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Pivotal testing of RTS,S is on track for target enrollment of 16,000 children \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-a-new-specialist-hiv-company-dedicated-to-delivering-advances-in-hiv-treatment-and-care/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                02 November 2009\n            ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care\n                CEO promises &#8216;relentless pursuit&#8217; of new treatments \n\n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"CEO promises &#8216;relentless pursuit&#8217; of new treatments \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/retigabine-regulatory-update/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                02 November 2009\n            Retigabine Regulatory Update\n                GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (VRX) announced today that, on 30...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (VRX) announced today that, on 30 October, they filed a New Drug Application with the US Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA) with the European Medicines Agency (EMEA), for retigabine, used as adjunctive therapy to treat adult epilepsy patients with partial-onset seizures"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-positive-results-in-second-of-two-phase-3-trials-of-benlysta-in-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                01 November 2009\n            GlaxoSmithKline and Human Genome Sciences announce positive results in second of two phase 3 trials of Benlysta in systemic lupus erythematosus\n                Benlysta (belimumab) 10 mg/kg plus standard of care met its primary efficacy endpoint by achievin...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Benlysta (belimumab) 10 mg/kg plus standard of care met its primary efficacy endpoint by achieving a statistically significant improvement in patient response rate versus placebo plus standard of care at Week 52 in BLISS-76 \n"}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-third-quarter-2009/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                28 October 2009\n            Results announcement for the third quarter 2009\n                See the quarterly results page for more information.\n \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"See the quarterly results page for more information.\n \n"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-2009-influenza-update-pandemrix-data-in-an-elderly-population/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                27 October 2009\n            Pandemic 2009 Influenza Update: Pandemrix™ data in an elderly population\n                GlaxoSmithKline (GSK) today announced that this week, approximately half a million people will ha...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that this week, approximately half a million people will have received its pandemic H1N1 vaccine, Pandemrix&#8482;, as part of Government initiated vaccination programmes across Europe, which commenced earlier this month. GSK also announced new results from a clinical trial assessing the use of Pandemrix in adults aged 18 to 85 years of age. The trial, which is ongoing, shows that after the first dose of adjuvanted vaccine, a strong immune response was demonstrated, inclusive of the over 60 age group.  The immune response elicited by Pandemrix in all age groups exceeded the immunogenicity criteria as defined by international licensing authorities for a pandemic influenza vaccine. The adjuvanted vaccine in this trial contains the dose of H1N1 antigen (3.75 &#181;g) which is the EMEA approved final formulation"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-theravance-commence-phase-iii-horizon-programme-to-develop-a-next-generation-treatment-for-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                27 October 2009\n            GlaxoSmithKline and Theravance commence Phase III Horizon programme to develop a next-generation treatment for COPD\n                GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the first patient ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the first patient has commenced treatment as part of the Phase III programme being undertaken to develop a next-generation combination treatment for patients with chronic obstructive pulmonary disorder (COPD), a leading cause of chronic illness and death.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-accelerated-approval-for-arzerra/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                26 October 2009\n            GSK and Genmab receive accelerated approval for Arzerra™\n                Today, GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced the accelerated approval of Arze...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Today, GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced the accelerated approval of Arzerra TM (ofatumumab) from the US Food and Drug Administration for use in patients with chronic lymphocytic leukemia (CLL) that is refractory to fludarabine and alemtuzumab.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-h1n1-2009-influenza-update-experience-of-gsk-s-h1n1-adjuvanted-vaccine-pandemrix-and-preliminary-paediatric-results/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                23 October 2009\n            Pandemic (H1N1) 2009 Influenza Update: Experience of GSK’s H1N1 adjuvanted vaccine, Pandemrix™, and preliminary paediatric results\n                GlaxoSmithKline (GSK) today announced that, to date, more than 150,000 people have received GSK&a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that, to date, more than 150,000 people have received GSK&apos;s pandemic H1N1 vaccine, Pandemrix&#8482;, as part of Government initiated vaccination programmes across Europe which commenced last week. Additionally, over 2,000 people have received Pandemrix in clinical trials which are ongoing.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-full-presentation-at-acr-of-positive-phase-3-study-results-for-benlysta-in-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                19 October 2009\n            GlaxoSmithKline and Human Genome Sciences announce full presentation at ACR of positive phase 3 study results for Benlysta in systemic lupus erythematosus\n                Benlysta (belimumab) significantly reduced SLE disease activity, disease flare rates and fatigue;...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Benlysta (belimumab) significantly reduced SLE disease activity, disease flare rates and fatigue; significantly delayed time-to-first SLE disease flare; reduced prednisone use and improved health-related patient quality of life in the BLISS-52 study \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/fda-approves-glaxosmithkline-s-votrient-for-advanced-renal-cell-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                19 October 2009\n            FDA approves GlaxoSmithKline’s Votrient™ for advanced renal cell cancer\n                GlaxoSmithKline [NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved Votrient&#8482; (pazopanib) to treat patients with advanced renal cell carcinoma (RCC), a form of kidney cancer. Approximately 57,700 people in the U.S. will be diagnosed with kidney cancer this year, and 13,000 people will die from this disease.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/fda-approves-cervarix-glaxosmithkline-s-cervical-cancer-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                15 October 2009\n            FDA approves Cervarix, GlaxoSmithKline’s cervical cancer vaccine\n                GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration (FDA)  has appro...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration (FDA)  has approved Cervarix&#174; [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-h1n1-2009-influenza-update-results-from-second-clinical-trial-of-gsk-s-h1n1-adjuvanted-vaccine-confirm-immune-response-and-tolerability/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                15 October 2009\n            Pandemic (H1N1) 2009 Influenza Update: Results from second clinical trial of GSK’s H1N1 adjuvanted vaccine confirm immune response and tolerability\n                GlaxoSmithKline (GSK) today announced results from a second clinical trial of its pandemic (H1N1)...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced results from a second clinical trial of its pandemic (H1N1) adjuvanted vaccine, which demonstrate that one dose of the vaccine can provide a strong immune response which exceeds criteria as defined by international licensing authorities using the lowest dose of antigen available in pandemic vaccines.  The data from GSK&#8217;s H1N1 trials announced to date demonstrate the vaccine is generally well tolerated. The vaccine in this trial contains 3.75 &#181;g of H1N1 antigen, which is the EMEA approved final formulation"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-cervarix-becomes-the-first-cervical-cancer-vaccine-to-gain-approval-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                15 October 2009\n            GSK’s Cervarix® becomes the first cervical cancer vaccine to gain approval in Japan\n                Landmark approval paves the way for access to the vaccine for women in Japan \n\n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Landmark approval paves the way for access to the vaccine for women in Japan \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-prosensa-form-alliance-to-fight-duchenne-muscular-dystrophy/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                13 October 2009\n            GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy\n                GlaxoSmithKline plc (GSK) announced today that it has entered into a unique partnership with the ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) announced today that it has entered into a unique partnership with the UK Government, The Wellcome Trust and the East of England Development Agency (EEDA) to develop an innovative new biotechnology science park located at GSK&#8217;s site at Stevenage.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-partners-with-uk-government-and-wellcome-trust-to-stimulate-innovation-through-the-creation-of-a-world-class-science-park/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                13 October 2009\n            GSK partners with UK Government and Wellcome Trust to stimulate innovation through the creation of a world-class science park\n                GlaxoSmithKline (NYSE: GSK) announced today the U.S. Food and Drug Administration (FDA) has not y...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) announced today the U.S. Food and Drug Administration (FDA) has not yet completed the review of the Biologics License Application (BLA) for CERVARIX&#174; [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant], the Company&#8217;s candidate cervical cancer vaccine.  As a result of this, the review will continue beyond the September 29, 2009, action date"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-avodart-tamsulosin-combination-showed-benefits-for-men-with-prostate-enlargement/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                12 October 2009\n            GSK’s Avodart® / tamsulosin combination showed benefits for men with prostate enlargement\n                GlaxoSmithKline (GSK) announced today that it has filed a supplemental New Drug Application (sNDA...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that it has filed a supplemental New Drug Application (sNDA) for Avodart&#174; (dutasteride) with the US Food and Drug Administration (FDA) for prostate cancer risk reduction among men at increased risk of developing the disease.  EU filings also are underway via the European Mutual Recognition Variation Procedure, with Sweden acting as the Reference Member State.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-us-patent-and-trademark-office-file-a-motion-to-dismiss-litigation-over-final-regulations/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                08 October 2009\n            GlaxoSmithKline and U.S. Patent and Trademark Office file a motion to dismiss litigation over Final Regulations\n                GlaxoSmithKline (GSK) and Prosensa, the Dutch based biopharmaceutical company focusing on RNA mod...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Prosensa, the Dutch based biopharmaceutical company focusing on RNA modulating therapeutics, today announced that they have entered into an exclusive worldwide collaboration for the development and commercialisation of RNA based therapeutics for Duchenne Muscular Dystrophy (DMD). DMD is a severely debilitating childhood neuromuscular disease that affects one in 3,500 newborn boys. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-update-government-orders-for-pandemic-h1n1-2009-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                06 October 2009\n            GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine\n                GSK is committed to supporting governments and health authorities around the world respond to the...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK is committed to supporting governments and health authorities around the world respond to the pandemic (H1N1) 2009 influenza strain.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?p=47":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=44":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=43","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=45":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/media/pressreleases/2010/2010_pressrelease_10029.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-expands-presence-in-china-through-strategic-cooperation-to-form-a-joint-venture-on-paediatric-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                05 October 2009\n            GSK expands presence in China through strategic cooperation to form a joint venture on paediatric vaccines\n                GlaxoSmithKline (GSK) and Jiangsu Walvax Biotech Company (Walvax) today announced a cooperation a...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Jiangsu Walvax Biotech Company (Walvax) today announced a cooperation agreement to form a long-term Joint Venture (JV) to develop and manufacture paediatric vaccines for use in China. The JV will produce vaccines for measles, mumps, and rubella (MMR) (Priorix&#8482;) and potentially other paediatric vaccines. GSK will also transfer the technology to enable the JV to manufacture the vaccines locally over time.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/positive-phase-ii-results-for-gsk1838262-xp13512-reported-for-subjects-with-post-herpetic-neuralgia-and-a-history-of-inadequate-response-to-gabapentin/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                05 October 2009\n            Positive phase II results for GSK1838262 (XP13512) reported for subjects with post-herpetic neuralgia and a history of inadequate response to gabapentin\n                GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today announced top-line results fr...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today announced top-line results from a Phase II clinical trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in adult patients with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.  In this double-blind, two-period cross-over study, 3600 mg/day of GSK 1838262 demonstrated a statistically significant improvement over 1200 mg/day of GSK1838262 on the primary endpoint, which was the change from baseline to the end of the treatment period in the 24-hour average pain intensity score.  A greater reduction in the 24-hour average pain score was observed for the 3600 "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-unanimous-fda-panel-approval-recommendation-for-votrient/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                05 October 2009\n            GlaxoSmithKline receives unanimous FDA Panel approval recommendation for Votrient™\n                GlaxoSmithKline [NYSE: GSK] today announced that the United States Food and Drug Administration&#...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [NYSE: GSK] today announced that the United States Food and Drug Administration&#8217;s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted unanimously in support of the approval of Votrient&#8482; (pazopanib). Specifically, the panel voted that the benefit-to-risk profile is acceptable for patients with advanced renal cell carcinoma (RCC). Pazopanib is an investigational, oral treatment for patients with advanced RCC.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/avodart-dutasteride-regulatory-update/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                01 October 2009\n            Avodart (dutasteride) regulatory update\n                GlaxoSmithKline (GSK) announced today that it has filed a supplemental New Drug Application (sNDA...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that it has filed a supplemental New Drug Application (sNDA) for Avodart&#174; (dutasteride) with the US Food and Drug Administration (FDA) for prostate cancer risk reduction among men at increased risk of developing the disease.  EU filings also are underway via the European Mutual Recognition Variation Procedure, with Sweden acting as the Reference Member State.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-h1n1-2009-influenza-update-gsk-s-h1n1-pandemrix-vaccine-receives-european-commission-approval/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                30 September 2009\n            Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives European Commission Approval\n                GlaxoSmithKline (GSK) confirmed today that the European Commission has granted marketing authoris...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) confirmed today that the European Commission has granted marketing authorisation of GSK&#8217;s pandemic (H1N1) adjuvanted vaccine Pandemrix&#8482; for protection against pandemic H1N1 2009 influenza.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-update-on-fda-review-of-cervarix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                29 September 2009\n            GlaxoSmithKline update on FDA review of Cervarix\n                GlaxoSmithKline (NYSE: GSK) announced today the U.S. Food and Drug Administration (FDA) has not y...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) announced today the U.S. Food and Drug Administration (FDA) has not yet completed the review of the Biologics License Application (BLA) for CERVARIX&#174; [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant], the Company&#8217;s candidate cervical cancer vaccine.  As a result of this, the review will continue beyond the September 29, 2009, action date"}},"https://www.gsk.com/en-gb/media/press-releases/fatality-reported-in-uk-hpv-vaccine-immunisation-programme/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                28 September 2009\n            Fatality reported in UK HPV vaccine immunisation programme\n                GSK was notified by the UK&#8217;s Department of Health on Monday 28 September of the death of a ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK was notified by the UK&#8217;s Department of Health on Monday 28 September of the death of a 14 year old girl, Natalie Morton, who was vaccinated at a school in Coventry with GSK&#8217;s cervical cancer vaccine, Cervarix, as part of the national HPV immunisation programme.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-upch-to-launch-lucozade-across-china/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                27 September 2009\n            GSK and UPCH to launch Lucozade across China\n                GlaxoSmithKline (GSK) today announced an exclusive agreement with President (Shanghai) Trading Co...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced an exclusive agreement with President (Shanghai) Trading Co. Ltd, a wholly-owned trading arm of Uni-President China Holdings Ltd (UPCH), one of the leading food and beverage companies in China, to launch GSK&apos;s highly successful Lucozade drinks franchise across China.  GSK and UPCH are also in the early stages of discussions on a range of additional opportunities.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-regulatory-filings-for-zunrisarezonic/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                27 September 2009\n            GSK provides update on regulatory filings for Zunrisa/Rezonic\n                GlaxoSmithKline (GSK) has made the difficult decision to discontinue the regulatory filings for Z...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) has made the difficult decision to discontinue the regulatory filings for Zunrisa/Rezonic (casopitant), which was being developed for chemotherapy-induced and post-operative nausea and vomiting. Regulatory applications were filed in a number of countries worldwide and GSK is currently communicating with those authorities and all study investigators.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-h1n1-2009-influenza-update-gsk-s-h1n1-pandemrix-vaccine-receives-positive-opinion-from-european-regulators/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                24 September 2009\n            Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives positive opinion from European Regulators\n                GlaxoSmithKline (GSK) announced today that the European Committee for Medicinal Products for Huma...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion and recommends approval of GSK&#8217;s candidate pandemic (H1N1) adjuvanted vaccine Pandemrix&#8482;. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-h1n1-2009-influenza-update-initial-results-from-first-clinical-trial-of-gsk-s-h1n1-adjuvanted-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                14 September 2009\n            Pandemic (H1N1) 2009 Influenza Update: Initial results from first clinical trial of GSK’s H1N1 adjuvanted vaccine\n                GlaxoSmithKline (GSK) today announced results from its first clinical trial assessing use of its ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced results from its first clinical trial assessing use of its pandemic (H1N1) adjuvanted vaccine. The results demonstrate that after one dose the candidate vaccine can provide a strong immune response which exceeds the immunogenicity criteria as defined by international licensing authorities for a pandemic influenza vaccine.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/antiviral-activity-of-sgsk1265744-a-once-daily-unboosted-integrase-inhibitor-in-clinical-development-evaluated-in-phase-1-2a-study-in-healthy-and-hiv-infected-subjects/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                13 September 2009\n            Antiviral Activity of S/GSK1265744, a Once-Daily, Unboosted Integrase Inhibitor in Clinical Development, Evaluated in Phase 1-2a Study in Healthy and HIV-Infected Subjects\n                Shionogi-GlaxoSmithKline Pharmaceuticals, LLC announced today results from a Phase 1-2a study eva...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Shionogi-GlaxoSmithKline Pharmaceuticals, LLC announced today results from a Phase 1-2a study evaluating the pharmacokinetics (PK), safety and antiviral activity of its investigational integrase inhibitor (INI) S/GSK1265744 in healthy subjects and HIV-infected patients.  The data showed a significant decline in viral load in HIV-infected patients, as well as favorable pharmacokinetic and short-term safety profiles in healthy subjects and HIV-infected patients.  The results of this study were presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)held this week in San Francisco, California.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/fda-advisory-committee-makes-favorable-recommendation-for-cervarix-glaxosmithkline-s-candidate-cervical-cancer-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                08 September 2009\n            FDA Advisory Committee makes favorable recommendation for Cervarix, GlaxoSmithKline’s candidate cervical cancer vaccine\n                GSK announced today that the US FDA&apos;s Vaccines and Related Biological Products Advisory Comm...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the US FDA&apos;s Vaccines and Related Biological Products Advisory Committee voted that clinical data support both the efficacy and safety of Cervarix&#174;,  the company&#8217;s candidate cervical cancer vaccine (12-1 and 11-1, respectively).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-announce-results-from-a-study-of-arzerra-in-rituximab-refractory-follicular-nhl/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                16 August 2009\n            GlaxoSmithKline and Genmab announce results from a study of Arzerra in rituximab refractory follicular NHL\n                GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today top-line results from an internat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today top-line results from an international multi-center study of Arzerra&#8482; (ofatumumab) in rituximab refractory follicular non-Hodgkin&#8217;s lymphoma (NHL).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-brazil-s-fiocruz-form-partnership-for-new-rd-effort-and-increased-vaccine-access/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                16 August 2009\n            GSK and Brazil’s Fiocruz form partnership for new R&D effort and increased vaccine access\n                GlaxoSmithKline plc (GSK) announced today that it has launched a unique partnership with Brazil&#...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) announced today that it has launched a unique partnership with Brazil&#8217;s Oswaldo Cruz Foundation (Fiocruz) to develop and manufacture vaccines for pressing public health priorities in Brazil.  The agreement will establish a new research and development collaboration programme at Fiocruz to develop a vaccine for dengue fever, a mosquito-borne disease that globally places 2.5 billion people at risk of infection[i].\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/pandemic-h1n1-2009-influenza-update/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                13 August 2009\n            Pandemic (H1N1) 2009 influenza update\n                GSK today issued an update on its progress to develop a vaccine against the Pandemic (H1N1) 2009 ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today issued an update on its progress to develop a vaccine against the Pandemic (H1N1) 2009 influenza virus, and announced that it has commenced the clinical development programme for its adjuvanted pandemic vaccine. Enrolment into this first study has been completed.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/shionogi-glaxosmithkline-pharmaceuticals-acknowledges-position-of-the-european-aids-treatment-group/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                13 August 2009\n            Shionogi-GlaxoSmithKline Pharmaceuticals acknowledges position of the European AIDS Treatment Group\n                Shionogi-GlaxoSmithKline Pharmaceuticals, LLC, in collaboration with the European AIDS Treatment ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Shionogi-GlaxoSmithKline Pharmaceuticals, LLC, in collaboration with the European AIDS Treatment Group (EATG) and the Drug Development Committee (DDC) of the AIDS Treatment Activists Coalition (ATAC), today announces plans to revise inclusion criteria for Study ING112276.  The ING112276 study is a dose-ranging study of the investigational integrase inhibitor S/GSK1349572 in antiretroviral therapy-na&#239;ve patients."}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-announce-top-line-results-for-ofatumumab-in-rheumatoid-arthritis/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                28 July 2009\n            GlaxoSmithKline and Genmab announce top-line results for ofatumumab in rheumatoid arthritis\n                GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today preliminary top-line results from...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today preliminary top-line results from a Phase III study of ofatumumab administered  intravenously for the treatment of rheumatoid arthritis (RA) in patients who had an inadequate response to methotrexate.  The study met the primary endpoint, ACR20 at 24 weeks, which indicates a 20 percent or greater improvement in the number of swollen and tender joints, as well as improvements in other disease-activity measures.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-mepolizumab-for-the-treatment-of-hypereosinophilic-syndrome-hes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                28 July 2009\n            Regulatory update: mepolizumab for the treatment of hypereosinophilic syndrome (HES)\n                GSK today announced that it has notified the European Medicines Agency of its decision to withdra...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK today announced that it has notified the European Medicines Agency of its decision to withdraw the Marketing Authorisation Application (MAA) in the EU for mepolizumab for the treatment of hypereosinophilic syndrome (HES).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/amgen-to-collaborate-with-gsk-to-commercialize-denosumab-in-europe-for-postmenopausal-osteoporosis-pmo/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                26 July 2009\n            Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis (PMO)\n                Amgen to retain full rights for denosumab in the United States and Canada and for oncology indica...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Amgen to retain full rights for denosumab in the United States and Canada and for oncology indications in Europe. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=45":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=44","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=46":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/responsibility":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-2009-corporate-responsibility-report/","txt":"www.gsk.com/responsibility","status":"redirected","statusCode":"200,301","results":{"video":[{},{}],"title":{},"meta_decription":"Responsible business is how we do business. Our purpose is to help people to do more, feel better, live longer."},"redirectedTo":"https://www.gsk.com/en-gb/responsibility/"},"https://www.gsk.com/content/dam/gsk/globals/documents/pdf/media/GSK-White-Paper-Avandia-23-Feb-2010.pdf":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"http://www.gsk.com/media/denture-adhesive.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"http://www.gsk.com/investors/quarterly_results.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"http://www.gsk.com/media/developing-world.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"http://www.gsk.com/media/downloads/BRC-Haiti-20-Jan-10.pdf":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-completes-acquisition-of-stiefel/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                21 July 2009\n            GlaxoSmithKline completes acquisition of Stiefel\n                GSK creates new world-leading specialist dermatology business with revenues of approximately $1.5...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK creates new world-leading specialist dermatology business with revenues of approximately $1.5 billion \n"}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-second-quarter-2009/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                21 July 2009\n            Results announcement for the second quarter 2009\n                See the quarterly results page for more information\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"See the quarterly results page for more information"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-enigma-diagnostics-announce-commercial-partnership-to-develop-point-of-care-influenza-diagnostics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                20 July 2009\n            GSK and Enigma Diagnostics announce commercial partnership to develop point-of-care influenza diagnostics\n                GlaxoSmithKline (GSK) and Enigma Diagnostics Limited today announced that they have signed worldw...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Enigma Diagnostics Limited today announced that they have signed worldwide agreements to develop and supply the first point-of-care diagnostic influenza tests to identify specific influenza virus strains using its real-time Polymerase Chain Reaction (PCR) technology platform, the Enigma ML (Mini Laboratory).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/antiviral-activity-of-sgsk1349572-the-only-once-daily-unboosted-integrase-inhibitor-in-clinical-development-evaluated-in-phase-2-study/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                20 July 2009\n            Antiviral activity of S/GSK1349572, the only once-daily, unboosted integrase inhibitor in clinical development, evaluated in phase 2 study\n                Shionogi-GlaxoSmithKline Pharmaceuticals, LLC announced today results from a Phase 2a study evalu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Shionogi-GlaxoSmithKline Pharmaceuticals, LLC announced today results from a Phase 2a study evaluating antiviral activity of its investigational integrase inhibitor (INI), S/GSK1349572. The results of this study were presented at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention held this week in Cape Town, South Africa.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/human-genome-sciences-and-glaxosmithkline-announce-positive-phase-3-study-results-for-benlysta-in-systemic-lupus-erythematosus/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                20 July 2009\n            Human Genome Sciences and GlaxoSmithKline announce positive Phase 3 study results for Benlysta™ in systemic lupus erythematosus\n                Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that Ben...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that Benlysta&#8482; (belimumab, formerly LymphoStat-B&#174;) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE).  In the placebo-controlled BLISS-52 study, the results showed that belimumab plus standard of care achieved a clinically and statistically significant improvement in patient response rate at Week 52, compared with standard of care alone.  Study results also showed that belimumab was generally well tolerated, with adverse event rates comparable between belimumab and placebo treatment groups.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-commitments-to-fight-hivaids-in-sub-saharan-africa-special-focus-on-care-and-treatment-of-children/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                14 July 2009\n            GSK announces new commitments to fight HIV/AIDS in Sub-Saharan Africa - special focus on care and treatment of children\n                New &apos;Positive Action for Children&#8217; Fund created with &#163;50 million ($80 million) av...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"New &apos;Positive Action for Children&#8217; Fund created with &#163;50 million ($80 million) available over 10 years to help prevent mother-to-child transmission of HIV and to support orphans and vulnerable children \n"}},"https://www.gsk.com/en-gb/media/press-releases/who-grants-prequalification-to-cervarix-gsk-s-vaccine-to-help-combat-cervical-cancer-in-developing-nations/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                08 July 2009\n            WHO grants prequalification to Cervarix®: GSK’s vaccine to help combat cervical cancer in developing nations\n                The World Health Organization (WHO) has awarded prequalification to Cervarix&#174;, GlaxoSmithKli...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The World Health Organization (WHO) has awarded prequalification to Cervarix&#174;, GlaxoSmithKline&#8217;s cervical cancer vaccine. The WHO decision is necessary for UN agencies and the GAVI Alliance to purchase the vaccine in partnership with developing countries and will help speed access to Cervarix globally.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/alnylam-joins-gsk-in-donating-intellectual-property-to-patent-pool-for-neglected-tropical-diseases/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                07 July 2009\n            Alnylam joins GSK in donating intellectual property to patent pool for neglected tropical diseases\n                First company to join the pool since creation in March 2009\n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"First company to join the pool since creation in March 2009\n"}},"https://www.gsk.com/en-gb/media/press-releases/landmark-study-for-gsk-s-cervical-cancer-vaccine-published-in-the-lancet/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                06 July 2009\n            Landmark study for GSK’s cervical cancer vaccine published in The Lancet\n                Largest efficacy trial of a cervical cancer vaccine showed Cervarix&#174; protects against the fi...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Largest efficacy trial of a cervical cancer vaccine showed Cervarix&#174; protects against the five most common cancer-causing virus types \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-further-extends-its-product-portfolio-in-the-middle-east-and-north-africa/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                01 July 2009\n            GSK further extends its product portfolio in the Middle East and North Africa\n                GlaxoSmithKline plc (GSK) today announced that it has acquired the branded generics business of B...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that it has acquired the branded generics business of Bristol Myers Squibb (BMS) in Lebanon, Jordan, Syria, Libya and Yemen for a cash consideration of $23.2m (&#163;14.2m). The business comprises a portfolio of 13 branded pharmaceuticals with annual sales in 2008 of $11.8m.  This purchase is another step forward in GSK&#8217;s strategy to accelerate growth in emerging markets and signals a strong commitment to provide quality medicines to patients in the Middle East and North Africa.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/seretide-irish-patent-litigation-update/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                25 June 2009\n            Seretide: Irish patent litigation update\n                GlaxoSmithKline (GSK) today announced that the Commercial Court in Dublin, Ireland, ruled in pate...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that the Commercial Court in Dublin, Ireland, ruled in patent litigation regarding GSK&#8217;s product Seretide, an inhaled respiratory treatment for asthma and COPD.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-for-rezonic-casopitant-mesylate/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                22 June 2009\n            Regulatory update for REZONIC™ (casopitant mesylate)\n                GlaxoSmithKline (NYSE: GSK) confirmed today that it has received a complete response letterfrom t...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) confirmed today that it has received a complete response letterfrom the FDA related to the application for casopitant"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-chroma-therapeutics-form-alliance-to-develop-novel-macrophage-targeted-drugs/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                22 June 2009\n            GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs\n                GlaxoSmithKline (LSE: GSK) and Chroma Therapeutics Limited announced today a collaboration to dev...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (LSE: GSK) and Chroma Therapeutics Limited announced today a collaboration to develop macrophage-targeted compounds using Chroma&#8217;s proprietary esterase-sensitive motif (ESM) technology, which adds amino acid esters to compounds with the aim of targeting the compounds to specific cells in the inflammatory disease process"}},"https://www.gsk.com/en-gb/media/press-releases/fda-extends-review-of-arzerra-ofatumumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                16 June 2009\n            FDA extends review of Arzerra™ (ofatumumab)\n                GlaxoSmithKline and Genmab A/S today announced that the United States Food and Drug Administratio...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline and Genmab A/S today announced that the United States Food and Drug Administration (FDA) informed the companies that the agency has extended the action date for the ofatumumab BLA application by three months. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-a-strategic-alliance-with-dr-reddy-s-to-further-accelerate-sales-growth-in-emerging-markets/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                14 June 2009\n            GSK announces a strategic alliance with Dr. Reddy’s to further accelerate sales growth in emerging markets\n                GlaxoSmithKline plc (GSK) today announced an agreement with Dr. Reddy&#8217;s Laboratories Ltd (D...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced an agreement with Dr. Reddy&#8217;s Laboratories Ltd (Dr. Reddy&#8217;s) to develop and market selected products across an extensive number of emerging markets, excluding India.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-update-a-h1n1-influenza/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                11 June 2009\n            GlaxoSmithKline update: A (H1N1) influenza\n                WHO raises influenza pandemic alert to phase 6 \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"WHO raises influenza pandemic alert to phase 6 \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-shenzhen-neptunus-create-new-alliance-to-develop-and-manufacture-influenza-vaccines-in-china/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                08 June 2009\n            GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China\n                GlaxoSmithKline plc (GSK) today announced it has entered into a definitive agreement to form a ne...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced it has entered into a definitive agreement to form a new Joint Venture with Shenzhen Neptunus Interlong Bio-Technique Co. Ltd (Shenzhen Neptunus) focused on developing and manufacturing influenza vaccines for the Chinese market.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/large-long-term-study-shows-avandia-has-no-increased-overall-cardiovascular-risk-compared-to-other-commonly-used-diabetes-medicines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                04 June 2009\n            Large, long-term study shows Avandia has no increased overall cardiovascular risk compared to other commonly used diabetes medicines\n                RECORD trial also demonstrates durable blood sugar control over time with Avandia \n\n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"RECORD trial also demonstrates durable blood sugar control over time with Avandia \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/world-health-organization-grants-global-prequalification-to-gsk-s-rotarix-vaccine/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                04 June 2009\n            World Health Organization grants Global Prequalification to GSK’s Rotarix™ vaccine\n                Opens access to Asia and Africa &#8211; potential to save hundreds of thousands of lives \n\n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Opens access to Asia and Africa &#8211; potential to save hundreds of thousands of lives \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/positive-results-with-revolade-and-arzerra-for-difficult-to-treat-blood-disorders/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                04 June 2009\n            Positive results with Revolade™ and Arzerra™ for difficult-to-treat blood disorders\n                GlaxoSmithKline (GSK) Oncology today announced further encouraging data for their investigational...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) Oncology today announced further encouraging data for their investigational products Revolade&#8482; (eltrombopag) and Arzerra&#8482; (ofatumumab) at the 14th Congress of European Hematology meeting, organised by The European Hematology Association (EHA). The results demonstrate the potential of these drugs to improve patient outcomes and quality of life (QoL) in two haematological conditions.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=46":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=45","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/media/press-releases/?=&p=47":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"http://www.gsk.com/responsibility/index.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"http://www.gsk.com/media/pandemic-flu.htm":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"http://www.gsk.com/media/downloads/olympics.wmv":{"status":"redirected","redirectedTo":"chrome-error://chromewebdata/"},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-concert-pharmaceuticals-form-alliance-to-develop-novel-deuterium-modified-drugs/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                01 June 2009\n            GSK and Concert Pharmaceuticals form alliance to develop novel deuterium-modified drugs\n                GlaxoSmithKline (NYSE: GSK) and Concert Pharmaceuticals announced today that they will collaborat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (NYSE: GSK) and Concert Pharmaceuticals announced today that they will collaborate to develop and commercialise deuterium-containing medicines. The deal includes three of Concert&#8217;s research and development programs; namely, CTP-518, a protease inhibitor for the treatment of HIV expected to enter Phase I clinical trials in the second half of 2009, a preclinical compound for chronic renal disease, and a third research product in Concert&#8217;s pipeline.  Concert will also provide GSK with deuterium-modified versions of three GSK pipeline compounds for GSK to develop.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-pazopanib-significantly-delayed-tumor-progression-in-patients-with-advanced-kidney-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                31 May 2009\n            GSK’s Pazopanib significantly delayed tumor progression in patients with advanced kidney cancer\n                Today, GlaxoSmithKline announced the results of a Phase III study demonstrating that pazopanib re...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Today, GlaxoSmithKline announced the results of a Phase III study demonstrating that pazopanib reduced the risk of tumor progression or death by 54 percent compared to placebo.1 \n"}},"https://www.gsk.com/en-gb/media/press-releases/fda-advisory-panel-makes-favorable-recommendation-for-arzerra-ofatumumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                28 May 2009\n            FDA advisory panel makes favorable recommendation for ARZERRA (ofatumumab)\n                GlaxoSmithKline [NYSE: GSK] and Genmab A/S [OMX: GEN] today announced that the United States Food...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline [NYSE: GSK] and Genmab A/S [OMX: GEN] today announced that the United States Food and Drug Administration&#8217;s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 10 to three that the ARZERRA&#8482; (ofatumumab) data are reasonably likely to predict clinical benefit for patients with chronic lymphocytic leukemia (CLL) whose disease is refractory to fludarabine and alemtuzumab. Ofatumumab is an investigational treatment.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/us-department-of-health-and-human-services-hhs-purchases-gsk-s-a-h1n1-influenza-antigen-and-proprietary-adjuvant-system/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                21 May 2009\n            US Department of Health and Human Services (HHS) purchases GSK’s A (H1N1) influenza antigen and proprietary adjuvant system\n                GSK announced today that the US Department of Health and Human Services (HHS) has placed initial ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK announced today that the US Department of Health and Human Services (HHS) has placed initial orders for A (H1N1) influenza vaccine antigen and the company&#8217;s proprietary adjuvant system, AS03, to support its pandemic influenza preparation efforts. \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-update-a-h1n1-influenza-vaccine-development/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                14 May 2009\n            GlaxoSmithKline update: A (H1N1) influenza vaccine development\n                GSK has received orders from several governments aiming to stockpile a new candidate A (H1N1) adj...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has received orders from several governments aiming to stockpile a new candidate A (H1N1) adjuvanted influenza vaccine as a precautionary measure \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-strategic-collaboration-with-aspen/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                11 May 2009\n            GSK extends strategic collaboration with Aspen\n                GSK to acquire 16% shareholding in Aspen in exchange for transfer of specialist products and manu...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK to acquire 16% shareholding in Aspen in exchange for transfer of specialist products and manufacturing facility in Bad Oldesloe, Germany \n"}},"https://www.gsk.com/en-gb/media/press-releases/community-healthcare-charities-receive-300-000-from-glaxosmithkline-in-recognition-of-their-work/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                07 May 2009\n            Community healthcare charities receive £300,000 from GlaxoSmithKline in recognition of their work\n                Twenty local healthcare charities were formally acknowledged last night for their community-based...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Twenty local healthcare charities were formally acknowledged last night for their community-based work, as GlaxoSmithKline awards a total of &#163;300,000 at the annual GlaxoSmithKline IMPACT Awards, run in partnership with the independent health charity, The King&#8217;s Fund.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-to-divest-us-rights-for-wellbutrin-xl-to-biovail-for-510-million/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                05 May 2009\n            GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million\n                GlaxoSmithKline plc (GSK) today announced that it has entered into an agreement to divest full co...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that it has entered into an agreement to divest full commercial rights to Wellbutrin XL&#174; in the United States to Biovail International Laboratories SRL, a subsidiary of Biovail Corporation (NYSE, TSX: BVF), for $510 million (&#163;340 million).    The agreement is subject to Hart-Scott-Rodino regulatory clearance in the United States.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-update-influenza-a-h1n1/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                30 April 2009\n            GlaxoSmithKline update: influenza A (H1N1)\n                GlaxoSmithKline (GSK) is committed to supporting governments and health authorities around the wo...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) is committed to supporting governments and health authorities around the world to respond to the emergence of the new influenza A (H1N1) strain.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/large-long-term-study-shows-dutasteride-reduced-prostate-cancer-risk-in-men-at-increased-risk-of-the-disease/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                26 April 2009\n            Large, long-term study shows dutasteride reduced prostate cancer risk in men at increased risk of the disease\n                Primary endpoint achieved in REDUCE study as presented at American Urological Association \n\n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Primary endpoint achieved in REDUCE study as presented at American Urological Association \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/emergence-of-a-new-h1n1-influenza-a-strain-swine-influenza/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                26 April 2009\n            Emergence of a new H1N1 influenza A strain (swine influenza)\n                GlaxoSmithKline (GSK) is closely monitoring the situation regarding the emergence of a new influe...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) is closely monitoring the situation regarding the emergence of a new influenza A (H1N1) strain in Mexico, the United States of America, Canada, France, Spain and New Zealand.  The World Health Organization (WHO) has stated that the current situation constitutes a public health emergency of international concern and they have raised their level of influenza surveillance globally.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-launches-alli-orlistat-60-mg/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                19 April 2009\n            GlaxoSmithKline launches alli® (orlistat 60 mg)\n                GSK has today announced that alli &#8211; the first clinically proven over the counter weight los...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GSK has today announced that alli &#8211; the first clinically proven over the counter weight loss aid &#8211; is available in pharmacies across Europe.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-stiefel-to-create-new-world-leading-specialist-dermatology-business/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                19 April 2009\n            GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business\n                Stiefel, the world&#8217;s largest independent dermatology company, acquired by GSK in deal value...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Stiefel, the world&#8217;s largest independent dermatology company, acquired by GSK in deal valued at up to $3.6 billion"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-pfizer-announce-innovative-agreement-to-create-a-new-world-leading-specialist-hiv-company/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                16 April 2009\n            GlaxoSmithKline and Pfizer announce innovative agreement to create a new world-leading, specialist HIV company\n                Creates a new focused HIV business with the independence and sustainability to deliver significan...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Creates a new focused HIV business with the independence and sustainability to deliver significant improvements in treatment, access and shareholder value \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-tyverb-tykerb-lapatinib-for-first-line-treatment-of-metastatic-breast-cancer-in-europe-us/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                31 March 2009\n            GSK submits Tyverb®/Tykerb® (lapatinib) for first-line treatment of metastatic breast cancer in Europe, US\n                GlaxoSmithKline (GSK) today announced the submission of two simultaneous regulatory applications ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced the submission of two simultaneous regulatory applications to expand the use of Tyverb&#174;/Tykerb&#174; (lapatinib).  If authorised, lapatinib could be used as a first-line therapy regimen combined with anti-hormonal therapy for patients with hormone-sensitive, metastatic (or advanced) breast cancer in Europe and the United States.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/synflorix-glaxosmithkline-s-pneumococcal-vaccine-receives-european-authorisation/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                31 March 2009\n            Synflorix™, GlaxoSmithKline’s pneumococcal vaccine, receives European authorisation\n                Protection now possible against three pneumococcal strains not covered by currently available vac...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Protection now possible against three pneumococcal strains not covered by currently available vaccine \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/cervarix-us-regulatory-update/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                29 March 2009\n            Cervarix® U.S. regulatory update\n                GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine \n\n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-2008-corporate-responsibility-report/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                23 March 2009\n            GSK publishes 2008 Corporate Responsibility Report\n                 Details on new proposals to tackle diseases of the developing world \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":" Details on new proposals to tackle diseases of the developing world \n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announces-sale-of-shares-in-quest-diagnostics-inc/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                19 March 2009\n            GlaxoSmithKline announces sale of shares in Quest Diagnostics Inc.\n                GlaxoSmithKline plc (the &#8220;Group&#8221;) announces today that it has sold 5,749,157 shares o...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (the &#8220;Group&#8221;) announces today that it has sold 5,749,157 shares of common stock, par value of $0.01 per share (the &#8220;Shares&#8221;), of Quest Diagnostics Inc. (&#8220;Quest&#8221;).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-submits-european-marketing-authorisation-application-for-pazopanib-in-advanced-kidney-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                04 March 2009\n            GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer\n                GlaxoSmithKline (GSK) today announced the submission of a Marketing Authorisation Application (MA...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced the submission of a Marketing Authorisation Application (MAA) tothe European Medicines Agency (EMEA) for pazopanib as an oral therapy for patients with advanced and/or metastatic renal cell carcinoma (RCC).\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/?&p=47":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=46","txt":"\n                                    \n                                        \n                                    \n                                ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Keep up to date with our news and recent announcements"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=44","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=31","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=31","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=32","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=32","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=33","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=33","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=34","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=34","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=33","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"19","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"20","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"21","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"22","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=28","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=29","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=30","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"http://www.gsk.com/media":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/world-health-organization-grants-prequalification-for-global-use-to-gsk-s-10-valent-synflorix-vaccine/","txt":"www.gsk.com/media","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/media"},"https://www.gsk.com/en-gb/media/press-releases/nice-refuses-funding-for-advanced-breast-cancer-treatment-tyverb-lapatinib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                04 March 2009\n            NICE refuses funding for advanced breast cancer treatment, Tyverb® (lapatinib)\n                NICE today issued its final appraisal determinationadvising against NHS funding for Tyverb&#174; ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"NICE today issued its final appraisal determinationadvising against NHS funding for Tyverb&#174; (lapatinib), a treatment for an aggressive form of advanced breast cancer (ErbB2-positive).1  Lapatinib (in combination with Xeloda&#174; [capecitebine]) offers a new treatment option for women whose disease has returned despite treatment with standard chemotherapies and Herceptin&#174; (trastuzumab).2 There are very few treatment options available for these women and lapatinib offers a chance of additional time without their disease progressing.3 Lapatinib is the only licensed ErbB2 targeted treatment* for these patients"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-phase-iii-programme-for-novel-type-2-diabetes-medication-syncria-albiglutide/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                17 February 2009\n            GSK initiates phase III programme for novel type 2 diabetes medication, Syncria® (albiglutide)\n                GlaxoSmithKline today announced initiation and dosing of the first patient of the Phase III clini...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline today announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety and tolerability of the investigational GLP-1 (Glucagon-like peptide 1) agonist Syncria&#174; (albiglutide) in men and women with type 2 diabetes.  The Phase III programme will include more than 4,000 patients.   "}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-idenix-pharmaceuticals-sign-worldwide-license-agreement-for-idx899-a-novel-nnrti-for-the-treatment-of-hiv/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                05 February 2009\n            GlaxoSmithKline and Idenix Pharmaceuticals sign worldwide license agreement for IDX899, a novel NNRTI for the treatment of HIV\n                GlaxoSmithKline and Idenix Pharmaceuticals, Inc.today announced the execution of a license agreem...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline and Idenix Pharmaceuticals, Inc.today announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899.  IDX899 is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) in Phase II clinical development being developed by Idenix for the treatment of HIV/AIDS.  New NNRTIs are needed to address the increasing prevalence of viral resistance and side effects associated with this drug class.  To date, IDX899 has demonstrated high potency with low milligram doses, a high barrier to drug resistance, favourable risk/benefit profile, and the convenience of once-a-day administration.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-seek-european-marketing-authorisation-of-arzerra-ofatumumab-in-advanced-stage-blood-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                05 February 2009\n            GlaxoSmithKline and Genmab seek European marketing authorisation of Arzerra™ (ofatumumab) in advanced stage blood cancer\n                GlaxoSmithKline and Genmab A/S announced today the submission of a Marketing Authorisation Applic...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline and Genmab A/S announced today the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for Arzerra&#8482; (ofatumumab) for the treatment of chronic lymphocytic leukaemia (CLL).  If approved, ofatumumab would be indicated for the treatment of patients with CLL who have previously failed, or are inappropriate for, standard therapies.  Ofatumumab targets a distinct binding site on the CD20 molecule of B-cells and it could become the first monoclonal antibody targeted to CD20 available for these patients.  GSK and Genmab announced the submission of a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) on Friday 30 January 2009.\n"}},"https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-fourth-quarter-2008/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                04 February 2009\n            Results announcement for the fourth quarter 2008\n                See the quarterly results page for more information.\n \n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"See the quarterly results page for more information.\n \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-phase-2b-results-for-once-daily-fluticasone-furoate-in-the-treatment-of-asthma/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                03 February 2009\n            GSK and Theravance announce positive phase 2b results for once-daily fluticasone furoate in the treatment of asthma\n                Data increase confidence in the Horizon development programme \n\n\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Data increase confidence in the Horizon development programme \n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-announces-board-changes/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                02 February 2009\n            GlaxoSmithKline plc, announces board changes\n                GlaxoSmithKline plc (GSK) announces that Mr. James Murdoch has been appointed as a Non-Executive ...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) announces that Mr. James Murdoch has been appointed as a Non-Executive Director and will join the Board of the Company with effect from 20th May 2009. On appointment, James will also become a member of GSK&#8217;s Corporate Responsibility Committee. James is Chairman and Chief Executive of News Corporation Europe and Asia.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-submit-arzerra-ofatumumab-application-to-fda-for-the-treatment-of-advanced-stage-blood-cancer/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                29 January 2009\n            GlaxoSmithKline and Genmab submit Arzerra (Ofatumumab) application to FDA for the treatment of advanced stage blood cancer\n                GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today the submission of a Biologics Lic...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today the submission of a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Arzerra&#8482;(ofatumumab) to treat patients whose chronic lymphocytic leukaemia (CLL) is resistant (refractory) to previous therapies. If approved, ofatumumab would be the first anti-CD20 monoclonal antibody available for this patient population.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/deirdre-connelly-to-join-gsk-as-president-north-american-pharmaceuticals/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                29 January 2009\n            Deirdre Connelly to join GSK as President, North American Pharmaceuticals\n                GlaxoSmithKline (GSK) today announced that Deirdre Connelly will join the company as President, N...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline (GSK) today announced that Deirdre Connelly will join the company as President, North American Pharmaceuticals, effective Monday 9 February 2009.  She will report to Andrew Witty, Chief Executive Officer and become a member of GSK&#8217;s Corporate Executive Team"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-charges-for-legal-matters/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                28 January 2009\n            GSK announces charges for legal matters\n                GlaxoSmithKline plc (GSK) today announced that it will record a legal charge in the fourth quarte...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that it will record a legal charge in the fourth quarter of 2008 of $400 million (&#163;278 million) relating to an ongoing investigation initiated by the US Attorney&#8217;s Office in Colorado into the Group&#8217;s US marketing and promotional practices for several products for the period 1997 to 2004. This charge is in addition to legal charges for other matters to be taken in the fourth quarter.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/the-uk-government-signs-influenza-pandemic-contract-with-glaxosmithkline-for-relenza/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                28 January 2009\n            The UK Government signs influenza pandemic contract with GlaxoSmithKline for Relenza®\n                The UK is now one of the world&#8217;s leading countries in stockpiling antivirals for treating i...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"The UK is now one of the world&#8217;s leading countries in stockpiling antivirals for treating infected individuals in the event of an influenza pandemic \n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-to-drive-growth-in-emerging-markets-with-acquisition-of-ucb-products/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                22 January 2009\n            GSK to drive growth in emerging markets with acquisition of UCB products\n                GlaxoSmithKline plc (GSK) today announced that it has signed an agreement with UCB S.A to acquire...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline plc (GSK) today announced that it has signed an agreement with UCB S.A to acquire its current marketed product portfolio across certain territories in Africa, the Middle East, Asia Pacific and Latin America, for a cash consideration of &#8364;515 million (&#163;483 million.)\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-s-paediatric-pneumococcal-candidate-vaccine-synflorix-receives-positive-opinion-in-europe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                21 January 2009\n            GSK’s paediatric pneumococcal candidate vaccine Synflorix™ receives positive opinion in Europe\n                Serotypes included in the vaccine are responsible for up to 90% of invasive pneumoccal disease in...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Serotypes included in the vaccine are responsible for up to 90% of invasive pneumoccal disease in young children in Europe. 1,2,3"}},"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-european-commission-approval-to-market-alli-orlistat-60mg/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                20 January 2009\n            GlaxoSmithKline receives European Commission approval to market alli® (orlistat 60mg)\n                A decision made by the European Commission today opens access to a treatment that could help peop...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"A decision made by the European Commission today opens access to a treatment that could help people who are overweight and obese.  GlaxoSmithKline (GSK) has received a non-prescription licence for alli (orlistat 60mg); the first time the European Commission has approved a non-prescription product for weight loss. The centrally approved marketing authorisation means GSK can now introduce alli for adults with a BMI of 28 kg/m2 or more, in all 27 EU member countries. Plans are underway to launch alli in the coming months.\n\n"}},"https://www.gsk.com/en-gb/media/press-releases/gsk-and-xenoport-resubmit-new-drug-application-for-solzira-in-restless-legs-syndrome/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/?p=47","txt":"\n                08 January 2009\n            GSK and Xenoport resubmit new drug application for Solzira™ in restless legs syndrome\n                GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Applicat...\n            Read more\n        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira&#8482; (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS)."}},"http://www.gsk.com/community":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/community-healthcare-charities-receive-300-000-from-glaxosmithkline-in-recognition-of-their-work/","txt":"www.gsk.com/community","status":"redirected","statusCode":"404,301","results":{"video":[{},{}],"title":{},"meta_decription":"We’re sorry – the page you requested cannot be found and has been reported."},"redirectedTo":"https://www.gsk.com/community"},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=46","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=44","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=35","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=35","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=36","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=36","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=37","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=37","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=38","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=38","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"23","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"24","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"25","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"26","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=31","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=32","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=33","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=34","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/media":{"redirectedFrom":"http://www.gsk.com/media"},"https://www.gsk.com/community":{"redirectedFrom":"http://www.gsk.com/community"},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=49","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2cgbr%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=39","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2c%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=usa%2cgbr%2cusa&city=%2c&et=%2c&prog=%2c&cl=8680&p=39","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"27","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"28","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"29","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"30","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=35","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=36","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=37","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=42","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=38","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"31","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"32","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"33","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"34","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"35","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"36","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"37","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"38","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=40","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=66","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=66","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=60","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=62","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"39","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"40","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"41","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"42","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=45","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=46","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=65","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"43","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"44","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"45","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"46","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=48","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=47","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=48","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=49","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=50","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=58","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=53","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=56","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"47","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"48","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"49","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"50","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=53","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=51","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=52","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=53","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=54","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=74","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"51","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"52","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"53","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"54","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=55","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=56","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=57","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=58","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            Belgium \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=78","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"55","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"56","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"57","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"58","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=59","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=60","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=61","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=62","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            China \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2c&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"59","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"60","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"61","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"62","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=63","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=64","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=65","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United Kingdom \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=66","txt":"\n                            United States \n                        ","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=72","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"63","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"64","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"65","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"66","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"67","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"68","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"69","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"70","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=93","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"71","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"72","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"73","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"74","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"75","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"76","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"77","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"78","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=104","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"79","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"80","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"81","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"82","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=93","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=93","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=92","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=104","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=108","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=105","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"83","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"84","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"85","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"86","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=108","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=113","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=109","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=92","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"87","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"88","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"89","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"90","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=113","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=113","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=104","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"91","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"92","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"93","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"94","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=104","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=104","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=104","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=105","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=122","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=116","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=99","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=104","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=108","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"95","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"96","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"97","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"98","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=109","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=109","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=109","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=108","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=108","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=104","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=108","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=114","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"99","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"100","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"101","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"102","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=113","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=113","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=113","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=113","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=113","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=108","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=117","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=114","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"103","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"104","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"105","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"106","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=113","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"107","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"108","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"109","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"110","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"111","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"112","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"113","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"114","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"115","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"116","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"117","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"118","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Sustainability&bu=&r=&city=&et=&prog=&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&cl=8680&bu=&r=&city=&et=&prog=&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&cl=8680&r=&city=&et=&prog=&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?bu=&r=&city=&et=&prog=&cl=8680&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&r=&city=&et=&prog=&cl=8680&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"119","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"120","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"121","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"122","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"123","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"124","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"125","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"126","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"127","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"128","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"129","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"130","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"131","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"132","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"133","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}},"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"134","status":"done","statusCode":200,"results":{"video":[{},{}],"title":{},"meta_decription":"Careers search results"}}},"originMedia":{"https://www.gsk.com/media/4777/modern-slavery-act-statement-2017.pdf":{},"https://www.gsk.com/media/5175/bangladesh-q3-report-2018.pdf":{},"https://www.gsk.com/media/5042/bangladesh-q2-report-2018.pdf":{},"https://www.gsk.com/media/4822/bangladesh-q1-2018.pdf":{},"https://www.gsk.com/media/4164/q3-2017-financial-statement-gsk.pdf":{},"https://www.gsk.com/media/3856/glaxosmithkline-bangladesh-limited-30-june-2017.pdf":{},"https://www.gsk.com/media/3665/bangladesh-financial-statement-for-q1-2017.pdf":{},"https://www.gsk.com/media/3594/bangladesh-q3-report-2016.pdf":{},"https://www.gsk.com/media/3590/bangladesh-q2-report-2016.pdf":{},"https://www.gsk.com/media/3591/bangladesh-q1-report-2016.pdf":{},"https://www.gsk.com/media/4790/bangladesh-annual-report-2017.pdf":{},"https://www.gsk.com/media/3662/bangladesh-annual-report-2016.pdf":{},"https://www.gsk.com/media/3592/bangladesh-annual-report-2015.pdf":{},"https://www.gsk.com/media/3589/bangladesh-annual-report-2014.pdf":{},"https://www.gsk.com/media/3593/bangladesh-annual-report-2013.pdf":{},"https://www.gsk.com/media/4722/price-sensitive-2018-march.pdf":{},"https://www.gsk.com/media/3578/agm-feb-2017.pdf":{},"https://www.gsk.com/media/3579/price-sensitive-2017-march.pdf":{},"https://www.gsk.com/media/5143/egm-2018-psi.pdf":{},"https://www.gsk.com/media/3919/%D8%AA%D8%B7%D9%88%D8%B1-%D8%B1%D8%A3%D8%B3-%D8%A7%D9%84%D9%85%D8%A7%D9%84.pdf":{},"https://www.gsk.com/media/3944/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-31-3-2016.pdf":{},"https://www.gsk.com/media/3920/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%B9%D8%AF%D8%AF-%D8%A7%D9%84%D8%A7%D8%B3%D9%87%D9%85-%D8%A7%D9%84%D9%85%D9%82%D9%8A%D8%AF%D8%A9.pdf":{},"https://www.gsk.com/media/3945/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%85%D9%88%D8%B9%D8%AF-%D8%A8%D8%AF%D8%A1-%D8%A7%D9%84%D8%B3%D9%86%D8%A9-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D9%88%D8%A7%D8%B3%D9%85-%D9%85%D8%B1%D8%A7%D9%82%D8%A8-%D8%A7%D9%84%D8%AD%D8%B3%D8%A7%D8%A8%D8%A7%D8%AA.pdf":{},"https://www.gsk.com/media/3921/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%85%D9%88%D8%A7%D8%B9%D9%8A%D8%AF-%D8%A7%D9%84%D8%AC%D9%85%D8%B9%D9%8A%D8%A9-%D8%A7%D9%84%D8%B9%D8%A7%D9%85%D8%A9-%D8%A7%D9%84%D8%B9%D8%A7%D8%AF%D9%8A%D8%A9.pdf":{},"https://www.gsk.com/media/3946/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%82%D8%B1%D8%A7%D8%B1%D8%A7%D8%AA-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D8%A7%D9%84%D8%B4%D8%B1%D9%83%D8%A9.pdf":{},"https://www.gsk.com/media/3922/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D8%B3%D9%85-%D9%85%D8%AF%D9%8A%D8%B1-%D8%B9%D9%84%D8%A7%D9%82%D8%A7%D8%AA-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D8%AB%D9%85%D8%B1%D9%8A%D9%86-%D9%88%D8%B7%D8%B1%D9%82-%D8%A7%D9%84%D9%88%D8%B5%D9%88%D9%84-%D8%A7%D9%84%D9%8A%D9%87.pdf":{},"https://www.gsk.com/media/3947/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%86%D8%A8%D8%B0%D8%A9-%D9%85%D8%AE%D8%AA%D8%B5%D8%B1%D8%A9-4.pdf":{},"https://www.gsk.com/media/3923/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D8%B4%D8%B1%D9%83%D8%A7%D8%AA-%D8%A7%D9%84%D8%B4%D9%82%D9%8A%D9%82%D8%A9-%D9%88%D8%A7%D9%84%D8%AA%D8%A7%D8%A8%D8%B9%D8%A9.pdf":{},"https://www.gsk.com/media/3948/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%AA%D9%81%D8%A7%D8%B5%D9%8A%D9%84-%D8%A7%D9%84%D9%85%D9%88%D9%82%D8%B9-%D8%A7%D9%84%D8%A7%D9%84%D9%83%D8%AA%D8%B1%D9%88%D9%86%D9%89.pdf":{},"https://www.gsk.com/media/3949/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%AA%D8%A7%D8%B1%D9%8A%D8%AE-%D8%A7%D9%84%D9%82%D9%8A%D8%AF-%D8%A8%D8%A7%D9%84%D8%A8%D9%88%D8%B1%D8%B5%D8%A9-%D9%88%D8%A7%D9%84%D9%82%D9%8A%D9%85%D8%A9-%D8%A7%D9%84%D8%A7%D8%B3%D9%85%D9%8A%D8%A9.pdf":{},"https://www.gsk.com/media/3924/%D8%A7%D9%84%D9%85%D9%8A%D8%B2%D8%A7%D9%86%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-31-12-2015.pdf":{},"https://www.gsk.com/media/3950/%D8%A7%D9%84%D9%85%D9%8A%D8%B2%D8%A7%D9%86%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D8%A9-%D9%81%D9%89-31-12-2015.pdf":{},"https://www.gsk.com/media/3925/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-31-12-2013.pdf":{},"https://www.gsk.com/media/3951/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%84%D8%AC%D9%86%D8%A9-%D8%A7%D9%84%D9%85%D8%B1%D8%A7%D8%AC%D8%B9%D8%A9-%D8%A7%D9%84%D8%B1%D8%A8%D8%B9-%D8%A7%D9%84%D8%B1%D8%A7%D8%A8%D8%B9-2015.pdf":{},"https://www.gsk.com/media/3926/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-31-12-2013.pdf":{},"https://www.gsk.com/media/3965/new-%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D9%81%D9%89-31-3-2016.pdf":{},"https://www.gsk.com/media/3927/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D9%81%D9%89-31-12-2015.pdf":{},"https://www.gsk.com/media/4008/%D9%85%D8%AD%D8%B6%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D8%B1%D9%82%D9%85-1-%D9%84%D8%B9%D8%A7%D9%85-2016.pdf":{},"https://www.gsk.com/media/3928/%D9%85%D9%84%D8%AE%D8%B5-%D9%86%D8%AA%D8%A7%D8%A6%D8%AC-%D8%A7%D9%84%D8%A3%D8%B9%D9%85%D8%A7%D9%84-%D9%81%D9%89-31-3-2016.pdf":{},"https://www.gsk.com/media/3952/%D9%85%D9%84%D8%AE%D8%B5-%D9%86%D8%AA%D8%A7%D8%A6%D8%AC-%D8%A7%D9%84%D8%A7%D8%B9%D9%85%D8%A7%D9%84-%D9%81%D9%89-31-12-2015.pdf":{},"https://www.gsk.com/media/3929/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D9%82%D8%B1%D8%A7%D8%B1%D8%A7%D8%AA-%D8%A7%D9%84%D8%AC%D9%85%D8%B9%D9%8A%D8%A7%D8%AA-%D8%A7%D9%84%D8%B9%D8%A7%D9%85%D8%A9.pdf":{},"https://www.gsk.com/media/3953/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-30-6-2016.pdf":{},"https://www.gsk.com/media/3930/%D8%A3%D9%82%D8%B1%D8%A7%D8%B1-%D9%85%D8%AF%D9%8A%D8%B1-%D8%B9%D9%84%D8%A7%D9%82%D8%A7%D8%AA-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D8%AB%D9%85%D8%B1%D9%8A%D9%86.pdf":{},"https://www.gsk.com/media/3954/%D9%86%D9%85%D9%88%D8%B0%D8%AC-%D8%A3%D8%AE%D8%B7%D8%A7%D8%B1-%D8%AA%D8%B9%D8%AF%D9%8A%D9%84-%D8%A8%D9%8A%D8%A7%D9%86%D8%A7%D8%AA-%D8%A7%D9%84%D8%B4%D8%B1%D9%83%D8%A9.pdf":{},"https://www.gsk.com/media/3931/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-30-6-2016.pdf":{},"https://www.gsk.com/media/3955/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-31-3-2016.pdf":{},"https://www.gsk.com/media/3932/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-31-12-2015.pdf":{},"https://www.gsk.com/media/3956/%D8%A7%D9%84%D8%A3%D8%AD%D8%AF%D8%A7%D8%AB-%D8%A7%D9%84%D8%AC%D9%88%D9%87%D8%B1%D9%8A%D8%A9-%D9%81%D9%89-25-7-2016.pdf":{},"https://www.gsk.com/media/3933/%D8%A7%D9%84%D8%A3%D8%AD%D8%AF%D8%A7%D8%AB-%D8%A7%D9%84%D8%AC%D9%88%D9%87%D8%B1%D9%8A%D8%A9-%D9%81%D9%89-26-7-2016.pdf":{},"https://www.gsk.com/media/3957/%D8%A7%D9%84%D8%A3%D8%B7%D8%A7%D8%B1-%D8%A7%D9%84%D8%AA%D9%86%D8%B8%D9%8A%D9%85%D9%89-%D9%84%D9%84%D8%B4%D8%B1%D9%83%D8%A9.pdf":{},"https://www.gsk.com/media/3934/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D9%87-%D9%81%D9%89-31-3-2016.pdf":{},"https://www.gsk.com/media/3958/gsk-agm-15-june-2015x.pdf":{},"https://www.gsk.com/media/4009/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-30-9-2016.pdf":{},"https://www.gsk.com/media/3959/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-31-12-2014.pdf":{},"https://www.gsk.com/media/3935/%D8%AC%D9%84%D8%A7%D9%83%D8%B3%D9%88-%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-31-12-2014.pdf":{},"https://www.gsk.com/media/3960/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D9%81%D9%89-30-9-2016.pdf":{},"https://www.gsk.com/media/3936/%D9%85%D9%84%D8%AE%D8%B5-%D9%86%D8%AA%D8%A7%D8%A6%D8%AC-%D8%A7%D9%84%D8%A7%D8%B9%D9%85%D8%A7%D9%84-%D9%81%D9%89-30-9-2016.pdf":{},"https://www.gsk.com/media/3961/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%AC%D9%85%D8%B9%D8%A9-%D9%81%D9%89-30-9-2016.pdf":{},"https://www.gsk.com/media/3937/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-30-9-2016.pdf":{},"https://www.gsk.com/media/3962/%D9%85%D8%B4%D8%B1%D9%88%D8%B9-%D9%88%D9%86%D9%85%D9%88%D8%B0%D8%AC-%D8%AA%D9%88%D8%B2%D9%8A%D8%B9-%D9%83-14.pdf":{},"https://www.gsk.com/media/4007/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%84%D8%AC%D9%86%D8%A9-%D8%A7%D9%84%D9%85%D8%B1%D8%A7%D8%AC%D8%B9%D8%A9-%D8%A7%D9%84%D8%B1%D8%A8%D8%B9-%D8%A7%D9%84%D8%A3%D9%88%D9%84-%D9%88-%D8%A7%D9%84%D8%AB%D8%A7%D9%86%D9%8A-%D9%88-%D8%A7%D9%84%D8%AB%D8%A7%D9%84%D8%AB-2016.pdf":{},"https://www.gsk.com/media/3963/%D9%87%D9%8A%D9%83%D9%84-%D8%A7%D9%84%D9%85%D8%B3%D8%A7%D9%87%D9%85%D9%8A%D9%86-%D9%81%D9%89-30-6-2016-1.pdf":{},"https://www.gsk.com/media/3939/%D9%85%D9%84%D8%AE%D8%B5-%D9%86%D8%AA%D8%A7%D8%A6%D8%AC-%D8%A7%D9%84%D8%A3%D8%B9%D9%85%D8%A7%D9%84-%D9%81%D9%89-30-6-2016.pdf":{},"https://www.gsk.com/media/3964/%D8%AA%D9%82%D8%B1%D9%8A%D8%B1-%D9%85%D8%AC%D9%84%D8%B3-%D8%A7%D9%84%D8%A7%D8%AF%D8%A7%D8%B1%D8%A9-%D9%81%D9%89-30-6-2016.pdf":{},"https://www.gsk.com/media/3940/%D8%A7%D9%84%D9%82%D9%88%D8%A7%D8%A6%D9%85-%D8%A7%D9%84%D9%85%D8%A7%D9%84%D9%8A%D8%A9-%D8%A7%D9%84%D9%85%D8%B3%D8%AA%D9%82%D9%84%D8%A9-%D9%81%D9%89-30-6-2016.pdf":{},"https://www.gsk.com/media/3893/standard-terms-conditions-06-2017.pdf":{},"https://www.gsk.com/media/3894/cenas_gsk.pdf":{},"https://www.gsk.com/media/3503/latvia.pdf":{},"https://www.gsk.com/media/3772/ime-veidlapa.pdf":{},"https://www.gsk.com/media/3773/call-for-ime-proposals.pdf":{},"https://www.gsk.com/media/4800/english-code-of-conduct.pdf":{},"https://www.gsk.com/media/4601/combinded_graphic.pdf":{},"https://www.gsk.com/media/4751/annual-report.pdf":{},"https://www.gsk.com/media/4756/responsible-business-supplement-2017.pdf":{},"https://www.gsk.com/media/1196/gsk-gvap-long-version-vr75.pdf":{},"https://www.gsk.com/media/4573/cmyk_final_300yrs-gsk-a3-landscape.pdf":{},"https://www.gsk.com/media/3731/articles-of-association.pdf":{},"https://www.gsk.com/media/3611/gsk-group-company-names-and-addresses.pdf":{},"https://www.gsk.com/media/5134/governance-section.pdf":{},"https://www.gsk.com/media/5135/remuneration-report.pdf":{},"https://www.gsk.com/media/1433/remuneration-committee-terms-of-reference.pdf":{},"https://www.gsk.com/media/3340/protection-of-gsk-information.pdf":{},"https://www.gsk.com/media/3341/external-communications-to-investors-and-media-external-speaking-engagements-and-publications.pdf":{},"https://www.gsk.com/media/3342/political-contributions.pdf":{},"https://www.gsk.com/media/3343/preventing-corrupt-practices-and-maintaining-standards-of-documentation.pdf":{},"https://www.gsk.com/media/3344/risk-management-and-legal-compliance.pdf":{},"https://www.gsk.com/media/3345/code-for-dealing-in-securities.pdf":{},"https://www.gsk.com/media/4557/terms-of-reference-audit-risk-committee.pdf":{},"https://www.gsk.com/media/3714/remuneration-policy-2017.pdf":{},"https://www.gsk.com/media/4558/terms-of-reference-remuneration-committee.pdf":{},"https://www.gsk.com/media/1435/nominations-committee-terms-of-reference.pdf":{},"https://www.gsk.com/media/4559/terms-of-reference-science-committee.pdf":{},"https://www.gsk.com/media/3610/responsible-business-supplement-2016.pdf":{},"https://www.gsk.com/media/4560/terms-of-reference-corporate-responsibility-committee.pdf":{},"https://www.gsk.com/media/1438/corporate-administration-and-transactions-committees-terms-of-reference.pdf":{},"https://www.gsk.com/media/2871/arabic-code-of-conduct.pdf":{},"https://www.gsk.com/media/2858/chinese-code-of-conduct.pdf":{},"https://www.gsk.com/media/2860/crzech-code-of-conduct.pdf":{},"https://www.gsk.com/media/2861/french-code-of-conduct.pdf":{},"https://www.gsk.com/media/2862/german-code-of-conduct.pdf":{},"https://www.gsk.com/media/2863/hindi-code-of-conduct.pdf":{},"https://www.gsk.com/media/2864/hungarian-code-of-conduct.pdf":{},"https://www.gsk.com/media/2865/indonesian-code-of-conduct.pdf":{},"https://www.gsk.com/media/2866/italian-code-of-conduct.pdf":{},"https://www.gsk.com/media/2867/japanease-code-of-conduct.pdf":{},"https://www.gsk.com/media/2868/korean-code-of-conduct.pdf":{},"https://www.gsk.com/media/2869/malay-code-of-conduct.pdf":{},"https://www.gsk.com/media/2870/polish-code-of-conduct.pdf":{},"https://www.gsk.com/media/2877/brazil-code-of-conduct.pdf":{},"https://www.gsk.com/media/2876/portugal-code-of-conduct.pdf":{},"https://www.gsk.com/media/2878/romanian-code-of-conduct.pdf":{},"https://www.gsk.com/media/2879/russian-code-of-conduct.pdf":{},"https://www.gsk.com/media/2880/spanish-code-of-conduct.pdf":{},"https://www.gsk.com/media/2881/thai-code-of-conduct.pdf":{},"https://www.gsk.com/media/2859/chinese-tradition-code-of-conduct.pdf":{},"https://www.gsk.com/media/2872/turkish-code-of-conduct.pdf":{},"https://www.gsk.com/media/2873/urdu-code-of-conduct.pdf":{},"https://www.gsk.com/media/2874/vietnamese-code-of-conduct.pdf":{},"https://www.gsk.com/media/2976/anti-bribery-and-corruption-policy-v11.pdf":{},"https://www.gsk.com/media/3916/abac-third-party-guidelines.pdf":{},"https://www.gsk.com/media/2498/working-with-third-parties.pdf":{},"https://www.gsk.com/media/4552/our-code-of-practice.pdf":{},"https://www.gsk.com/media/4871/consumer-healthcare-code-for-promotion-and-scientific-engagement.pdf":{},"https://www.gsk.com/media/2965/technology-transfer-vaccines-policy.pdf":{},"https://www.gsk.com/media/2958/ip-atm-developing-countries-policy.pdf":{},"https://www.gsk.com/media/2980/technology-transfer-capacity-building-and-developing-countries.pdf":{},"https://www.gsk.com/media/3833/the-sustainable-development-goals-july17.pdf":{},"https://www.gsk.com/media/2938/clinical-trials-in-the-developing-world-policy.pdf":{},"https://www.gsk.com/media/2942/incentivising-antibacterial-research.pdf":{},"https://www.gsk.com/media/2929/cloning-technologies-and-stem-cell-research-policy.pdf":{},"https://www.gsk.com/media/2935/biological-diversity-policy.pdf":{},"https://www.gsk.com/media/2946/disclosure-of-clinical-trial-information-policy.pdf":{},"https://www.gsk.com/media/2936/care-welfare-and-treatment-of-animals-policy.pdf":{},"https://www.gsk.com/media/2943/incremental-innovation-policy.pdf":{},"https://www.gsk.com/media/4298/compulsory-licensing-nov17.pdf":{},"https://www.gsk.com/media/2949/evergreening-policy.pdf":{},"https://www.gsk.com/media/2947/disclosure-requirements-in-patent-applications-policy.pdf":{},"https://www.gsk.com/media/2957/regulatory-data-protection-policy.pdf":{},"https://www.gsk.com/media/2939/hazardous-chemicals-management-policy.pdf":{},"https://www.gsk.com/media/2950/genetically-modified-micro-organisms-and-environment-health-safety.pdf":{},"https://www.gsk.com/media/2960/nanotechnology-policy.pdf":{},"https://www.gsk.com/media/2962/ozone-depletion-and-mdi-for-asthma-policy.pdf":{},"https://www.gsk.com/media/2952/pharmaceuticals-in-the-environment-policy.pdf":{},"https://www.gsk.com/media/2937/climate-change-policy.pdf":{},"https://www.gsk.com/media/2956/public-position-on-ozone-depletion-and-ancillary-plant-equipment-policy.pdf":{},"https://www.gsk.com/media/2977/gsk-and-water-stewardship.pdf":{},"https://www.gsk.com/media/2978/gsk-public-policy-on-deforestation-sept16.pdf":{},"https://www.gsk.com/media/4321/falsified-and-substandard-healthcare-products.pdf":{},"https://www.gsk.com/media/2953/pharmacovigilance-policy.pdf":{},"https://www.gsk.com/media/2963/paediatric-medicines-policy.pdf":{},"https://www.gsk.com/media/3369/engagement-with-patient-organisations.pdf":{},"https://www.gsk.com/media/3368/compassionate-use.pdf":{},"https://www.gsk.com/media/4859/conflict-minerals.pdf":{},"https://www.gsk.com/media/2930/competitiveness-investment-criteria-policy.pdf":{},"https://www.gsk.com/media/4503/human-rights-statement-policy.pdf":{},"https://www.gsk.com/media/2959/marketing-practices-policy.pdf":{},"https://www.gsk.com/media/2955/product-donations-policy.pdf":{},"https://www.gsk.com/media/2934/binding-corporate-rules-policy.pdf":{},"https://www.gsk.com/media/2983/tax-strategy.pdf":{},"https://www.gsk.com/media/3374/public-policy-on-political-advocacy.pdf":{},"https://www.gsk.com/media/4661/lethal-injections.pdf":{},"https://www.gsk.com/media/3699/modern-slavery-act-statement.pdf":{},"https://www.gsk.com/media/3742/glaxosmithkline-plc-2017-form-sd-conflict-minerals-disclosure.pdf":{},"https://www.gsk.com/media/3743/glaxosmithkline-plc-2016-form-sd-conflict-minerals-disclosure.pdf":{},"https://www.gsk.com/media/2923/glaxosmithkline-2015-form-sd-conflicts-minerals-disclosure.doc":{},"https://www.gsk.com/media/2897/glaxosmithkline-plc-2014-form-sd-conflict-minerals-disclosure.pdf":{},"https://www.gsk.com/media/5045/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2018.pdf":{},"https://www.gsk.com/media/3902/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2017.pdf":{},"https://www.gsk.com/media/2908/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2016.pdf":{},"https://www.gsk.com/media/2921/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2015.pdf":{},"https://www.gsk.com/media/3198/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2014.pdf":{},"https://www.gsk.com/media/3199/glaxosmithkline-euro-medium-term-note-programme-prospectus-document-2013.pdf":{},"https://www.gsk.com/media/2885/euro-medium-term-note-programme-registration-document.pdf":{},"https://www.gsk.com/media/2884/euro-medium-term-note-programme-prospectus-document.pdf":{},"https://www.gsk.com/media/2886/euro-medium-term-note-programme-supplementry-prospectus-document.pdf":{},"https://www.gsk.com/media/5038/2018-half-year-results-and-interim-management-report-glaxosmithkline-capital-plc.pdf":{},"https://www.gsk.com/media/4799/glaxosmithkline-capital-plc-annual-report-2017.pdf":{},"https://www.gsk.com/media/3896/gsk-capital-plc-30-june-17_final.pdf":{},"https://www.gsk.com/media/3880/glaxosmithkline-capital-plc-signed-2016-annual-report-and-accounts.pdf":{},"https://www.gsk.com/media/2909/half-year-results-glaxosmithkline-capital-plc-2016.pdf":{},"https://www.gsk.com/media/2911/annual-report-glaxosmithkline-capital-plc-2015.pdf":{},"https://www.gsk.com/media/2922/half-year-results-glaxosmithkline-capital-plc-2015.pdf":{},"https://www.gsk.com/media/2896/annual-report-glaxosmithkline-capital-plc-2014.pdf":{},"https://www.gsk.com/media/2902/half-year-results-glaxosmithkline-capital-plc-2014.pdf":{},"https://www.gsk.com/media/2883/annual-report-glaxosmithkline-capital-plc-2013.pdf":{},"https://www.gsk.com/media/2891/half-year-results-glaxosmithkline-capital-plc-2013.pdf":{},"https://www.gsk.com/media/2882/annual-report-glaxosmithkline-capital-plc-2012.pdf":{},"https://www.gsk.com/media/2890/half-year-results-glaxosmithkline-capital-plc-2012.pdf":{},"https://www.gsk.com/media/2894/annual-report-glaxosmithkline-capital-plc-2011.pdf":{},"https://www.gsk.com/media/2889/half-year-results-glaxosmithkline-capital-plc-2011.pdf":{},"https://www.gsk.com/media/2901/annual-report-glaxosmithkline-capital-plc-2010.pdf":{},"https://www.gsk.com/media/2893/annual-report-glaxosmithkline-capital-plc-2009.pdf":{},"https://www.gsk.com/media/2892/annual-report-glaxosmithkline-capital-plc-2008.pdf":{},"https://www.gsk.com/media/3712/gsk-pension-fund-sip.pdf":{},"https://www.gsk.com/media/3703/gsk-pension-scheme-sip.pdf":{},"https://www.gsk.com/media/3705/gw-contracted-out-money-purchase-scheme-sip.pdf":{},"https://www.gsk.com/media/3706/sb-senior-executive-pension-plan-sip.pdf":{},"https://www.gsk.com/media/3702/sb-pension-plan-sip.pdf":{},"https://www.gsk.com/media/3707/corporate-governance-report.pdf":{},"https://www.gsk.com/media/2756/save-the-children-partnership-progress-brochure.pdf":{},"https://www.gsk.com/media/2988/save-the-children-infographic.pdf":{},"https://www.gsk.com/media/1439/disclosure-committee-terms-of-reference.pdf":{},"https://www.gsk.com/media/4852/2018-gm-voting-and-poll-results-announcement.pdf":{},"https://www.gsk.com/media/4798/circular-to-shareholders-and-notice-of-general-meeting.pdf":{},"https://www.gsk.com/media/4780/consumer-healthcare-update-analyst-call-slides.pdf":{},"https://www.gsk.com/media/4783/gsk-consumer-healthcare-update-transcript-27mar18.pdf":{},"https://www.gsk.com/media/1494/gsk-novartis-general-meeting-results.pdf":{},"https://www.gsk.com/media/1493/gsk-novartis-circular.pdf":{},"https://www.gsk.com/media/3347/gsk-and-novartis-transaction-presentation-slides.pdf":{},"https://www.gsk.com/media/3348/novartis-transaction-analyst-investor-teleconf-transcript.pdf":{},"https://www.gsk.com/media/4785/gsk-2018-notice-of-agm.pdf":{},"https://www.gsk.com/media/4853/2018-agm-voting-and-poll-results-announcement.pdf":{},"https://www.gsk.com/media/4784/annual-summary-2017.pdf":{},"https://www.gsk.com/media/3635/gsk-plc-2017-notice-of-meeting.pdf":{},"https://www.gsk.com/media/3715/agm-votig-and-poll-results-2017.pdf":{},"https://www.gsk.com/media/3202/notice-of-meeting-2016.pdf":{},"https://www.gsk.com/media/3203/voting-poll-results-2016.pdf":{},"https://www.gsk.com/media/2592/agm-notice-2015.pdf":{},"https://www.gsk.com/media/3204/voting-poll-results-2015.pdf":{},"https://www.gsk.com/media/2587/agm-notice-2014.pdf":{},"https://www.gsk.com/media/3205/voting-poll-results-2014.pdf":{},"https://www.gsk.com/media/3206/remuneration-policy-2014.pdf":{},"https://www.gsk.com/media/2584/agm-notice-2013.pdf":{},"https://www.gsk.com/media/2585/agm-voting-2013.pdf":{},"https://www.gsk.com/media/2586/articles-of-association.pdf":{},"https://www.gsk.com/media/2580/notice-of-annual-general-meeting.pdf":{},"https://www.gsk.com/media/2582/agm-voting-2012.pdf":{},"https://www.gsk.com/media/2583/articles-of-association.pdf":{},"https://www.gsk.com/media/2578/gsk-2011-notice-of-annual-general-meeting.pdf":{},"https://www.gsk.com/media/2579/gsk-results-of-voting-at-the-2011-annual-general-meeting.pdf":{},"https://www.gsk.com/media/2573/gsk-notice-of-agm-2010.pdf":{},"https://www.gsk.com/media/2575/agm-voting-2010.pdf":{},"https://www.gsk.com/media/2576/articles-of-association.pdf":{},"https://www.gsk.com/media/2577/annual-general-meeting-aw.pdf":{},"https://www.gsk.com/media/2570/gsk-notice-of-agm-2009.pdf":{},"https://www.gsk.com/media/2572/gsk-agm-letter-to-shareholders-2009.pdf":{},"https://www.gsk.com/media/2571/gsk-results-of-voting-at-agms-2009.pdf":{},"https://www.gsk.com/media/2564/gsk-notice-of-agm-2008.pdf":{},"https://www.gsk.com/media/2563/gsk-agm-letter-to-shareholders-2008.pdf":{},"https://www.gsk.com/media/2569/gsk-agm-explanatory-notes-2008.pdf":{},"https://www.gsk.com/media/2568/gsk-memo-articles-of-association.pdf":{},"https://www.gsk.com/media/2567/gsk-2008-agm-poll-results.pdf":{},"https://www.gsk.com/media/2565/2008-annual-general-meeting.pdf":{},"https://www.gsk.com/media/2557/gsk-agm-notice-of-meeting-2007.pdf":{},"https://www.gsk.com/media/2562/gsk-agm-letter-to-shareholders-2007.pdf":{},"https://www.gsk.com/media/2561/gsk-agm-explanatory-notes-2007.pdf":{},"https://www.gsk.com/media/2560/glaxosmithkline-plc-results-of-agm.pdf":{},"https://www.gsk.com/media/2558/annual-general-meeting-23-may-2007.pdf":{},"https://www.gsk.com/media/2552/gsk-agm-notice-of-meeting-2006.pdf":{},"https://www.gsk.com/media/2556/gsk-agm-letter-to-shareholders-2006.pdf":{},"https://www.gsk.com/media/2555/gsk-agm-explanatory-notes-2006.pdf":{},"https://www.gsk.com/media/2554/issued-monday-17-may-2004-london-lse-results-announcement.pdf":{},"https://www.gsk.com/media/2547/gsk-agm-notice-of-meeting-2005.pdf":{},"https://www.gsk.com/media/2551/gsk-agm-letter-to-shareholders-2005.pdf":{},"https://www.gsk.com/media/2550/gsk-agm-explanatory-notes-2005.pdf":{},"https://www.gsk.com/media/2549/agm-voting-2005.pdf":{},"https://www.gsk.com/media/4768/20-f-2017.pdf":{},"https://www.gsk.com/media/4771/20-fa-amendment-no1-2017.pdf":{},"https://www.gsk.com/media/1495/nominee-service-t-c.pdf":{},"https://www.gsk.com/media/1496/transfer-shares-to-beneficial-holder.pdf":{},"https://www.gsk.com/media/1497/request-for-share-certificate-in-own-name.pdf":{},"https://www.gsk.com/media/3609/annual-report-2016.pdf":{},"https://www.gsk.com/media/3636/gsk-plc-2016-annual-summary.pdf":{},"https://www.gsk.com/media/3615/2016-20-f.pdf":{},"https://www.gsk.com/media/3701/glaxosmithkline-annual-report-2016.pdf":{},"https://www.gsk.com/media/4697/gsk-annual-report-2015.pdf":{},"https://www.gsk.com/media/1492/annual-summary-2015.pdf":{},"https://www.gsk.com/media/1487/gsk_responsible_business_supplement_2015.pdf":{},"https://www.gsk.com/media/2717/2015-20f.pdf":{},"https://www.gsk.com/media/1486/gsk-capital-plc_31-12-15_final-ar-and-accounts-for-gsk.pdf":{},"https://www.gsk.com/media/2711/annual-report-2014.pdf":{},"https://www.gsk.com/media/2716/annual-summary-2014.pdf":{},"https://www.gsk.com/media/2739/gsk-responsible-business-supplement-2014.pdf":{},"https://www.gsk.com/media/2709/20-f-2014.pdf":{},"https://www.gsk.com/media/2702/annual-report-2013.pdf":{},"https://www.gsk.com/media/2705/annual-summary-2013.pdf":{},"https://www.gsk.com/media/2748/cr-report-2013.pdf":{},"https://www.gsk.com/media/2700/20-f-2013.pdf":{},"https://www.gsk.com/media/2694/annual-report-2012.pdf":{},"https://www.gsk.com/media/2698/annual-summary-2012.pdf":{},"https://www.gsk.com/media/2737/cr-report-2012.pdf":{},"https://www.gsk.com/media/2695/20-f-2012.pdf":{},"https://www.gsk.com/media/2696/annual-report-2011.pdf":{},"https://www.gsk.com/media/2692/annual-summary-2011.pdf":{},"https://www.gsk.com/media/2736/cr-report-2011.pdf":{},"https://www.gsk.com/media/2693/20-f-2011.pdf":{},"https://www.gsk.com/media/2691/annual-report-2010.pdf":{},"https://www.gsk.com/media/2735/cr-report-2010.pdf":{},"https://www.gsk.com/media/2690/20-f-2010.pdf":{},"https://www.gsk.com/media/2688/annual-report-2009.pdf":{},"https://www.gsk.com/media/2689/annual-summary-2009.pdf":{},"https://www.gsk.com/media/2733/cr-report-2009.pdf":{},"https://www.gsk.com/media/2687/20-f-2009.pdf":{},"https://www.gsk.com/media/2684/annual-report-2008.pdf":{},"https://www.gsk.com/media/2686/annual-summary-2008.pdf":{},"https://www.gsk.com/media/2732/cr-report-2008.pdf":{},"https://www.gsk.com/media/2685/20-f-2008.pdf":{},"https://www.gsk.com/media/2682/annual-report-2007.pdf":{},"https://www.gsk.com/media/2683/annual-review-2007.pdf":{},"https://www.gsk.com/media/2730/cr-report-2007.pdf":{},"https://www.gsk.com/media/2681/20-f-2007.pdf":{},"https://www.gsk.com/media/2679/annual-report-2006.pdf":{},"https://www.gsk.com/media/2680/annual-review-2006.pdf":{},"https://www.gsk.com/media/2729/cr-report-2006.pdf":{},"https://www.gsk.com/media/2678/20-f-2006.pdf":{},"https://www.gsk.com/media/2676/annual-report-2005.pdf":{},"https://www.gsk.com/media/2677/annual-review-2005.pdf":{},"https://www.gsk.com/media/2727/cr-report-2005.pdf":{},"https://www.gsk.com/media/2675/20-f-2005.pdf":{},"https://www.gsk.com/media/2673/annual-report-2004.pdf":{},"https://www.gsk.com/media/2674/annual-review-2004.pdf":{},"https://www.gsk.com/media/2723/cr-report-2004.pdf":{},"https://www.gsk.com/media/2672/20-f-2004.pdf":{},"https://www.gsk.com/media/2669/annual-report-2003.pdf":{},"https://www.gsk.com/media/2670/annual-review-2003.pdf":{},"https://www.gsk.com/media/3229/cr-report-2003.pdf":{},"https://www.gsk.com/media/2668/gsk-2003-form-20f.pdf":{},"https://www.gsk.com/media/2663/annual-report-2002.pdf":{},"https://www.gsk.com/media/2666/annual-review-2002.pdf":{},"https://www.gsk.com/media/2719/cr-report-2002.pdf":{},"https://www.gsk.com/media/2659/annual-report-2001.pdf":{},"https://www.gsk.com/media/2660/annual-review-2001.pdf":{},"https://www.gsk.com/media/4698/annual-report-2000.pdf":{},"https://www.gsk.com/media/2658/annual-review-2000.pdf":{},"https://www.gsk.com/media/5166/q3-2018-results-announcement.pdf":{},"https://www.gsk.com/media/5173/q3-2018-results-slides.pdf":{},"https://www.gsk.com/media/5174/q3-2018-results-transcript.pdf":{},"https://www.gsk.com/media/5171/q3-2018-results-infographic.pdf":{},"https://www.gsk.com/media/5167/q3-2018-us-dollar-translation.pdf":{},"https://www.gsk.com/media/5124/q3-2018-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/5011/q2-2018-results-and-rd-update-announcement.pdf":{},"https://www.gsk.com/media/5029/q2-2018-slides-emma-walmsley.pdf":{},"https://www.gsk.com/media/5030/q2-2018-slides-simon-dingemans.pdf":{},"https://www.gsk.com/media/5041/rd-update-slides-hal-barron.pdf":{},"https://www.gsk.com/media/5039/q2-2018-results-transcript-part-1.pdf":{},"https://www.gsk.com/media/5040/q2-2018-results-transcript-part-2.pdf":{},"https://www.gsk.com/media/5012/q2-2018-results-infographic.pdf":{},"https://www.gsk.com/media/5013/q2-2018-us-dollar-translation.pdf":{},"https://www.gsk.com/media/4939/q2-2018-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/4832/q1-2018-results-announcement.pdf":{},"https://www.gsk.com/media/4838/q1-2018-results-slides.pdf":{},"https://www.gsk.com/media/4843/q1-2018-results-transcript.pdf":{},"https://www.gsk.com/media/4831/q1-2018-results-infographic.pdf":{},"https://www.gsk.com/media/4833/q1-2018-us-dollar-translation.pdf":{},"https://www.gsk.com/media/4795/q1-2018-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf":{},"https://www.gsk.com/media/4628/fy-2017-results-slides.pdf":{},"https://www.gsk.com/media/4631/fy-2017-results-transcript.pdf":{},"https://www.gsk.com/media/4627/fy-2017-results-infographic.pdf":{},"https://www.gsk.com/media/4626/fy-2017-us-dollar-translation.pdf":{},"https://www.gsk.com/media/4565/2017-q4-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/4171/q3-2017-results-announcement.pdf":{},"https://www.gsk.com/media/4173/q3-2017-us-dollar-translation.pdf":{},"https://www.gsk.com/media/4172/q3-2017-results-infographic.pdf":{},"https://www.gsk.com/media/4174/q3-2017-results-transcript.pdf":{},"https://www.gsk.com/media/4097/q3-2017-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/4821/additional-information-for-investors.docx":{},"https://www.gsk.com/media/4758/chairmans-statement.pdf":{},"https://www.gsk.com/media/4757/ceo-s-statement.pdf":{},"https://www.gsk.com/media/4763/strategic-report.pdf":{},"https://www.gsk.com/media/4753/cautionary-statement.pdf":{},"https://www.gsk.com/media/4909/viiv-healthcare-reports-landmark-phase-iii-studies-for-dolutegravir-and-lamivudine.pdf":{},"https://www.gsk.com/media/3463/viiv-announce-phase-iii-results-for-2-drug-regimen.pdf":{},"https://www.gsk.com/media/5230/viiv-meet-the-management-slides.pdf":{},"https://www.gsk.com/media/5218/gsk-acquisition-of-tesaro-investor-call-slides.pdf":{},"https://www.gsk.com/media/5225/agreement-to-acquire-tesaro-investor-call-transcript.pdf":{},"https://www.gsk.com/media/5158/gsk-165-anti-gm-csf-antibody-slides.pdf":{},"https://www.gsk.com/media/5160/gsk-165-anti-gm-csf-antibody-transcript.pdf":{},"https://www.gsk.com/media/5106/consumer-healthcare-investor-event-slides-sept-2018.pdf":{},"https://www.gsk.com/media/5107/consumer-healthcare-investor-event-transcript-sept-2018.pdf":{},"https://www.gsk.com/media/5007/gemini-investor-analyst-update.pdf":{},"https://www.gsk.com/media/5010/gsk-gemini-investor-call-transcript-24july18.pdf":{},"https://www.gsk.com/media/4561/2018-jpm-emma-walmsley-presentation.pdf":{},"https://www.gsk.com/media/4612/final-jp-morgan-presentation-transcript-jan-9-2018-jrm-edits.pdf":{},"https://www.gsk.com/media/4613/final-jp-morgan-qa-transcript-jan-9-2018-jrm-edits.pdf":{},"https://www.gsk.com/media/4483/bcma-investor-event-slides-12-dec-2017.pdf":{},"https://www.gsk.com/media/4493/gsk-bcma-investor-call-12-december-2017.pdf":{},"https://www.gsk.com/media/4492/citi-conference-axel-hoos-fireside-chat-transcript-dec-2017.pdf":{},"https://www.gsk.com/media/4440/evercore-isi-transcript-30-nov-2017.pdf":{},"https://www.gsk.com/media/4425/ssl-intro-to-gsk-master-sw-29-nov-show-file.pdf":{},"https://www.gsk.com/media/4432/gsk-consumerhealthcare.pdf":{},"https://www.gsk.com/media/3881/emma-walmsley-key-priorities.pdf":{},"https://www.gsk.com/media/3882/simon-dingemans-q2-and-financial-outlook.pdf":{},"https://www.gsk.com/media/3891/investor-event-full-transcript.pdf":{},"https://www.gsk.com/media/3599/cowen-37th-annual-healthcare-conference-slides.pdf":{},"https://www.gsk.com/media/3613/cowen-37th-annual-healthcare-conference-transcript.pdf":{},"https://www.gsk.com/media/3505/hiv-analyst-call-presentation.pdf":{},"https://www.gsk.com/media/3504/croi-analyst-call-transcript.pdf":{},"https://www.gsk.com/media/4931/gsk-quick-facts.pdf":{},"https://www.gsk.com/media/3210/about-asthma-infographic.pdf":{},"https://www.gsk.com/media/3211/about-copd.pdf":{},"https://www.gsk.com/media/4294/103115003_mythsmisconceptions_infographic_vfinal_long.pdf":{},"https://www.gsk.com/media/5064/severe-asthma-and-eos_infographic_certified-oct-2015.pdf":{},"https://www.gsk.com/media/3298/world-lupus-day-infographic.pdf":{},"https://www.gsk.com/media/5097/our-approach-to-responsible-business_sept-18.pdf":{},"https://www.gsk.com/media/2538/gsk-materiality-process.pdf":{},"https://www.gsk.com/media/2213/sdg-factsheet-june-2016.pdf":{},"https://www.gsk.com/media/2211/gsk-and-the-decade-of-vaccines-report.pdf":{},"https://www.gsk.com/media/3350/albendazole-donation-programme-infographic.pdf":{},"https://www.gsk.com/media/3290/our-commitment-to-health-workers.pdf":{},"https://www.gsk.com/media/2212/malaria-timeline-full.pdf":{},"https://www.gsk.com/media/4681/uk-gender-pay-gap-report-2017.pdf":{},"https://www.gsk.com/media/5117/employee-volunteering-annual-impact-report-2017-2018.pdf":{},"https://www.gsk.com/media/4733/gsk-value-chain-carbon-footprint.pdf":{},"https://www.gsk.com/media/4774/global-reporting-initiative-gri-index-2017.pdf":{},"https://www.gsk.com/media/4754/detailed-environmental-data-2017.pdf":{},"https://www.gsk.com/media/4752/assurance-statement-2017.pdf":{},"https://www.gsk.com/media/4792/un-global-compact-communication-on-progress-2017.pdf":{},"https://www.gsk.com/media/3633/value-chain-water-footprint.pdf":{},"https://www.gsk.com/media/4736/main-trade-associations.pdf":{},"https://www.gsk.com/media/4725/charitable-grants-report.pdf":{},"https://www.gsk.com/media/2540/2015-humanitarian-product-donations-report.pdf":{},"https://www.gsk.com/media/3482/alzheimer-europe-ae.pdf":{},"https://www.gsk.com/media/2222/european-federation-of-allergy-and-airways-diseases-patients-associations-efa.pdf":{},"https://www.gsk.com/media/2223/european-institute-of-womens-health-eiwh.pdf":{},"https://www.gsk.com/media/3493/european-parkinsons-disease-association-epda.pdf":{},"https://www.gsk.com/media/2215/european-patients-forum-epf.pdf":{},"https://www.gsk.com/media/3483/eurordis-rare-disease-unit.pdf":{},"https://www.gsk.com/media/2218/lupus-europe-le.pdf":{},"https://www.gsk.com/media/2219/pha-europe-rare-disease-unit-pag-disclosure.pdf":{},"https://www.gsk.com/media/2227/israel.pdf":{},"https://www.gsk.com/media/2228/cyprus.pdf":{},"https://www.gsk.com/media/2226/portugal.pdf":{},"https://www.gsk.com/media/4632/slovakia.pdf":{},"https://www.gsk.com/media/4633/asthma-uk.pdf":{},"https://www.gsk.com/media/3396/british-lung-foundation.pdf":{},"https://www.gsk.com/media/4634/first-steps.pdf":{},"https://www.gsk.com/media/3399/genetic-alliance-uk.pdf":{},"https://www.gsk.com/media/4635/jos-cervical-cancer-trust.pdf":{},"https://www.gsk.com/media/4636/meningitis-now.pdf":{},"https://www.gsk.com/media/3395/meningitis-research-foundation.pdf":{},"https://www.gsk.com/media/4637/muscular-dystrophy-uk.pdf":{},"https://www.gsk.com/media/4638/pulmonary-hypertension-association.pdf":{},"https://www.gsk.com/media/4639/sahir-house.pdf":{},"https://www.gsk.com/media/4641/sight-cymru.pdf":{},"https://www.gsk.com/media/4640/target-ovarian-cancer.pdf":{},"https://www.gsk.com/media/3394/wellchild.pdf":{},"https://www.gsk.com/media/2246/argentina.pdf":{},"https://www.gsk.com/media/2247/chile.pdf":{},"https://www.gsk.com/media/2248/ecuadorian.pdf":{},"https://www.gsk.com/media/4647/colombia.pdf":{},"https://www.gsk.com/media/2249/hong-kong.pdf":{},"https://www.gsk.com/media/2252/new-zealand.pdf":{},"https://www.gsk.com/media/3487/panama.pdf":{},"https://www.gsk.com/media/2253/philippines.pdf":{},"https://www.gsk.com/media/4648/russia.pdf":{},"https://www.gsk.com/media/2254/thailand.pdf":{},"https://www.gsk.com/media/2255/ukraine.pdf":{},"https://www.gsk.com/media/2256/confederation-of-meningitis-organisations-como.pdf":{},"https://www.gsk.com/media/2257/international-alliance-of-patient-organizations-iapo.pdf":{},"https://www.gsk.com/media/2259/ipopi-rare-disease-unit.pdf":{},"https://www.gsk.com/media/3720/rainbow-across-borders.pdf":{},"https://www.gsk.com/media/4645/global-asthma-and-allergy-patient-platform-gaapp.pdf":{},"https://www.gsk.com/media/4646/copd-foundation.pdf":{},"https://www.gsk.com/media/3684/global-reporting-initiative-2016.pdf":{},"https://www.gsk.com/media/3612/detailed-environmental-data-2016.pdf":{},"https://www.gsk.com/media/3614/assurance-statement-2016.pdf":{},"https://www.gsk.com/media/3749/united-nations-global-compact-communication-on-progress-2016.pdf":{},"https://www.gsk.com/media/2543/global-reporting-initiative-2015.pdf":{},"https://www.gsk.com/media/3213/detailed-environment-data-2015.pdf":{},"https://www.gsk.com/media/2528/full-assurance-statement-2015.pdf":{},"https://www.gsk.com/media/3212/gsk-response-to-assurance-2016.pdf":{},"https://www.gsk.com/media/3366/united-nations-global-compact-communication-on-progress-2015.pdf":{},"https://www.gsk.com/media/2532/2014-global-reporting-initiative-index.pdf":{},"https://www.gsk.com/media/2530/2014-detailed-environment-metrics.pdf":{},"https://www.gsk.com/media/3234/assurance-statement-2014.pdf":{},"https://www.gsk.com/media/2531/2014-response-to-assurance.pdf":{},"https://www.gsk.com/media/2533/united-nations-global-compact-communication-on-progress-2014.pdf":{},"https://www.gsk.com/media/2742/gri-index-2013.pdf":{},"https://www.gsk.com/media/2751/detailied-environment-data.pdf":{},"https://www.gsk.com/media/2749/assurance-statement.pdf":{},"https://www.gsk.com/media/2743/gsk-response-to-assurance.pdf":{},"https://www.gsk.com/media/2738/gri-index-2012.pdf":{},"https://www.gsk.com/media/2734/cr-review-2010.pdf":{},"https://www.gsk.com/media/2731/cr-review-2007.pdf":{},"https://www.gsk.com/media/2728/cr-review-2006.pdf":{},"https://www.gsk.com/media/2724/ehs-report-2004.pdf":{},"https://www.gsk.com/media/2721/cr-report-2003.pdf":{},"https://www.gsk.com/media/2720/ehs-report-2002.pdf":{},"https://www.gsk.com/media/3814/global-pain-index-2017-report.pdf":{},"https://www.gsk.com/media/4904/gsk-5500-ntd-factsheet-amend-p1_mp_2018-06-13.pdf":{},"https://www.gsk.com/media/4903/3562_gsk_ntd-infographic_p11_horiz_final_130618.pdf":{},"https://www.gsk.com/media/4178/enable-survey-infographic.pdf":{},"https://www.gsk.com/media/3708/asthma-control-test-infographic.pdf":{},"https://www.gsk.com/media/3668/gsk-international-survey-results.pdf":{},"https://www.gsk.com/media/3732/impact-awards-2017-infographic.pdf":{},"https://www.gsk.com/media/3291/the-worlds-first-candidate-vaccine-for-malaria.pdf":{},"https://www.gsk.com/media/3292/delivering-gsks-vaccines.pdf":{},"https://www.gsk.com/media/3293/gsks-contribution.pdf":{},"https://www.gsk.com/media/3466/benefits-of-vaccination.pdf":{},"https://www.gsk.com/media/3372/50-years-rd-in-gsk.pdf":{},"https://www.gsk.com/media/3481/inspiring-young-scientists-infographic.pdf":{},"https://www.gsk.com/media/2526/gsk-responsible-business-supplement-2015-march-2016.pdf":{},"https://www.gsk.com/media/3471/flu-awareness.pdf":{},"https://www.gsk.com/media/2989/ebola-vaccine-journey-infographic.pdf":{},"https://www.gsk.com/media/2537/pulse-impact-annual-report-2015.pdf":{},"https://www.gsk.com/media/4005/politica-de-datos-gsk-colombia-sa-y-gsk-consumer.pdf":{},"https://www.gsk.com/media/1411/industry-declaration-on-combating-antimicrobial-resistance.pdf":{},"https://www.gsk.com/media/1412/industry-roadmap-for-progress-on-amr.pdf":{},"https://www.gsk.com/media/4897/binding-corporate-rules-policy_bulgarian.pdf":{},"https://www.gsk.com/media/4879/binding-corporate-rules-policy_croatian.pdf":{},"https://www.gsk.com/media/4878/binding-corporate-rules-policy_czech.pdf":{},"https://www.gsk.com/media/4906/binding-corporate-rules-policy_danish.pdf":{},"https://www.gsk.com/media/4898/binding-corporate-rules-policy_estonian.pdf":{},"https://www.gsk.com/media/4881/binding-corporate-rules-policy_finnish.pdf":{},"https://www.gsk.com/media/4882/binding-corporate-rules-policy_french.pdf":{},"https://www.gsk.com/media/4910/binding-corporate-rules-policy_german.pdf":{},"https://www.gsk.com/media/4873/binding-corporate-rules-policy_greek.pdf":{},"https://www.gsk.com/media/4880/binding-corporate-rules-policy_hungarian.pdf":{},"https://www.gsk.com/media/4872/binding-corporate-rules-policy_italian.pdf":{},"https://www.gsk.com/media/4899/binding-corporate-rules-policy_latvian.pdf":{},"https://www.gsk.com/media/4900/binding-corporate-rules-policy_lithuanian.pdf":{},"https://www.gsk.com/media/4907/binding-corporate-rules-policy_maltese.pdf":{},"https://www.gsk.com/media/4877/binding-corporate-rules-policy_dutch.pdf":{},"https://www.gsk.com/media/4876/binding-corporate-rules-policy_polish.pdf":{},"https://www.gsk.com/media/4874/binding-corporate-rules-policy_portuguese.pdf":{},"https://www.gsk.com/media/4889/public_policy_on_gsk_s_bcrs-15may2018_romanian.pdf":{},"https://www.gsk.com/media/4875/binding-corporate-rules-policy_slovak.pdf":{},"https://www.gsk.com/media/4890/public_policy_on_gsk_s_bcrs-15may2018_slovenian.pdf":{},"https://www.gsk.com/media/4891/public_policy_on_gsk_s_bcrs-15may2018_spanish.pdf":{},"https://www.gsk.com/media/4892/public_policy_on_gsk_s_bcrs-15may2018_swedish.pdf":{},"https://www.gsk.com/media/2500/emma-walmsley-contract-of-service.pdf":{},"https://www.gsk.com/media/3750/simon-dingemans-contract-of-service.pdf":{},"https://www.gsk.com/media/4539/hal-barron-contract-of-service.pdf":{},"https://www.gsk.com/media/4066/pulse-and-global-volunteering-2016-annual-impact-report.pdf":{},"https://www.gsk.com/media/2158/q4-2014-results-announcement.pdf":{},"https://www.gsk.com/media/2162/q4-2014-analyst-presentation.pdf":{},"https://www.gsk.com/media/2156/q4-2014-analyst-presentation-transcript.pdf":{},"https://www.gsk.com/media/2159/q4-2014-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2161/q4-2014-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2157/q4-2014-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2152/q3-2014-results-announcement.pdf":{},"https://www.gsk.com/media/2155/q3-2014-analyst-webcast-transcript.pdf":{},"https://www.gsk.com/media/2154/q3-2014-launch-metrics-and-pipeline-progress.pdf":{},"https://www.gsk.com/media/2149/restated-finanical-information.xlsx":{},"https://www.gsk.com/media/2151/q3-2014-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2153/q3-2014-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2150/q3-2014-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2146/q2-2014-results-announcement.pdf":{},"https://www.gsk.com/media/2144/q2-2014-analyst-webcast-transcript.pdf":{},"https://www.gsk.com/media/2145/q2-2014-launch-metrics-and-pipeline-progress.pdf":{},"https://www.gsk.com/media/2143/q2-2014-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2147/q2-2014-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2148/q2-2014-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2141/q1-2014-results-announcement.pdf":{},"https://www.gsk.com/media/2138/q1-2014-analyst-webcast-transcript.pdf":{},"https://www.gsk.com/media/2139/q1-2014-launch-metrics-and-pipeline-progress.pdf":{},"https://www.gsk.com/media/2137/q1-2014-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2142/q1-2014-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2140/q1-2014-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2545/full-year-2015-results-announcement.pdf":{},"https://www.gsk.com/media/2184/fy-2015-results-analyst-slides-v1-1.pdf":{},"https://www.gsk.com/media/2183/fy-2015-analysts-transcript.pdf":{},"https://www.gsk.com/media/2190/full-year-2015-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2187/q4-2015-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2546/full-year-2015-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2181/q3-2015-results-announcement.pdf":{},"https://www.gsk.com/media/2182/q3-2015-results-transcript.pdf":{},"https://www.gsk.com/media/2179/q3-2015-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2180/q3-2015-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2178/q3-2015-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2171/q2-2015-results-announcement.pdf":{},"https://www.gsk.com/media/2174/q2-2015-analyst-slide-presentation.pdf":{},"https://www.gsk.com/media/2175/q2-2015-results-transcript.pdf":{},"https://www.gsk.com/media/2172/q2-2015-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2173/q2-2015-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2170/q2-2015-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2168/q1-2015-results-announcement.pdf":{},"https://www.gsk.com/media/2169/q1_2015_results_transcript.pdf":{},"https://www.gsk.com/media/2177/q1-2015-announcement-sales-tables.pdf":{},"https://www.gsk.com/media/2176/q1-2015-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2164/q1-2015-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/3461/q4-2016-results-announcement.pdf":{},"https://www.gsk.com/media/3459/q4-2016-analyst-slide-presentation.pdf":{},"https://www.gsk.com/media/3462/q4-2016-analysts-call-transcript.pdf":{},"https://www.gsk.com/media/3518/q4-results-infographics_final_landscape.pdf":{},"https://www.gsk.com/media/3458/q4-2016-us-dollar-translation.pdf":{},"https://www.gsk.com/media/3460/q4-2016-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2496/2016-q4-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2206/q3-2016-results-announcement.pdf":{},"https://www.gsk.com/media/2208/q3-2016-highlights.pdf":{},"https://www.gsk.com/media/2207/gsk-q3-analysts-26oct16.pdf":{},"https://www.gsk.com/media/2205/q3-2016-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2204/q3-2016-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2203/2016-q3-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2201/q2-2016-27-july-results-announcement.pdf":{},"https://www.gsk.com/media/2544/q2-2016-results-slides.pdf":{},"https://www.gsk.com/media/2202/q2-2016-results-transcript.pdf":{},"https://www.gsk.com/media/2200/q2-2016-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2199/q2-2016-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2198/q2-2016-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2194/q1-2016-results-announcement.pdf":{},"https://www.gsk.com/media/2197/q1-2016-results-transcript-1.pdf":{},"https://www.gsk.com/media/2195/q1-2016-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2193/q1-2016-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2192/2016-q1-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2106/q4-2012-results-announcement.pdf":{},"https://www.gsk.com/media/2107/q4-2012-results-analyst-presentation-colour.pdf":{},"https://www.gsk.com/media/2109/q4-2012-analyst-presentation-bandw.pdf":{},"https://www.gsk.com/media/2108/q4-2012-analyst-presentation-transcript.pdf":{},"https://www.gsk.com/media/2110/q4-2012-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2105/q4-2012-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2103/q3-2012-results-announcement.pdf":{},"https://www.gsk.com/media/2102/q3-2012-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2104/q3-2012-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2100/q2-2012-results-announcement.pdf":{},"https://www.gsk.com/media/2099/q2-2012-analyst-presentation.pdf":{},"https://www.gsk.com/media/2098/q2-2012-analyst-presentation-bandw-for-printing.pdf":{},"https://www.gsk.com/media/2097/q2-2012-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2101/q2-2012-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2094/q1-2012-results-announcement.pdf":{},"https://www.gsk.com/media/2095/q1-2012-simon-dingemans-transcript.pdf":{},"https://www.gsk.com/media/2093/q1-2012-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2096/q1-2012-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2132/q4-2013-results-announcement.pdf":{},"https://www.gsk.com/media/2135/q4-2013-analyst-slide-presentation.pdf":{},"https://www.gsk.com/media/2130/q4-2013-analyst-presentation-transcript.pdf":{},"https://www.gsk.com/media/2129/q4-2013-analyst-investor-tc-transcript.pdf":{},"https://www.gsk.com/media/2128/q4-2013-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2133/q4-2013-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2131/q4-2013-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2126/q3-2013-results-announcement.pdf":{},"https://www.gsk.com/media/2125/q3-2013-interview-transcript.pdf":{},"https://www.gsk.com/media/2124/q3-2013-analyst-webcast-transcript.pdf":{},"https://www.gsk.com/media/2123/q3-2013-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2127/q3-2013-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2134/q3-2013-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2118/q2-2013-results-announcement.pdf":{},"https://www.gsk.com/media/2120/q2-2013-interview-transcript.pdf":{},"https://www.gsk.com/media/2122/q2-2013-analyst-webcast-transcript.pdf":{},"https://www.gsk.com/media/2121/q2-2013-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2117/q2-2013-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2119/q2-2013-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2115/q1-2013-results-announcement.pdf":{},"https://www.gsk.com/media/2113/q1-2013-analyst-presentation-transcript.pdf":{},"https://www.gsk.com/media/2114/q1-2013-analyst-webcast-transcript.pdf":{},"https://www.gsk.com/media/2112/q1-2013-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2116/q1-2013-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2136/q1-2013-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/2090/q4-2011-results-announcement.pdf":{},"https://www.gsk.com/media/2087/q4-2011-andrew-witty-video-transcript.pdf":{},"https://www.gsk.com/media/2089/q4-2011-simon-dingemans-video-transcript.pdf":{},"https://www.gsk.com/media/2085/q4-2011-analyst-presentation.pdf":{},"https://www.gsk.com/media/2091/q4-2011-restated-quarterly-product-analysis.pdf":{},"https://www.gsk.com/media/2086/q4-2011-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2088/q4-2011-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2082/q3-2011-results-announcement.pdf":{},"https://www.gsk.com/media/2083/q3-2011-simon-dingemans-transcript.pdf":{},"https://www.gsk.com/media/2081/q3-2011-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2084/q3-2011-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2079/q2-2011-results-announcement.pdf":{},"https://www.gsk.com/media/2080/q2-2011-analyst-presentation.pdf":{},"https://www.gsk.com/media/2076/q2-2011-analyst-presentation-bw.pdf":{},"https://www.gsk.com/media/2077/q2-2011-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2078/q2-2011-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2073/q1-2011-results-announcement.pdf":{},"https://www.gsk.com/media/2074/q1-2011-andrew-witty-video-transcript.pdf":{},"https://www.gsk.com/media/2075/q1-2011-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2072/q1-2011-us-dollar-translation.pdf":{},"https://www.gsk.com/media/3866/press-release-gsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group-26-july-2017.pdf":{},"https://www.gsk.com/media/3888/investor-event-emma-walmsley-and-simon-dingemans-presentation-transcripts.pdf":{},"https://www.gsk.com/media/3892/investor-event-qa-transcript.pdf":{},"https://www.gsk.com/media/3867/q2-2017-results-video-transcript.pdf":{},"https://www.gsk.com/media/3861/q2-2017-us-dollar-translation.pdf":{},"https://www.gsk.com/media/3865/q2-2017-results-infographic.pdf":{},"https://www.gsk.com/media/3811/2017-q2-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/3696/q1-2017-results-announcement.pdf":{},"https://www.gsk.com/media/3698/gsk-q1-2017-analyst-call-transcript-final.pdf":{},"https://www.gsk.com/media/3691/q1-2017-us-dollar-translation.pdf":{},"https://www.gsk.com/media/3655/q1-2017-pre-announcement-aide-memoire.pdf":{},"https://www.gsk.com/media/3694/q1-2017-results-infographic.pdf":{},"https://www.gsk.com/media/2069/q4-2010-results-announcement.pdf":{},"https://www.gsk.com/media/2068/q4-2010-analyst-presentation-bw.pdf":{},"https://www.gsk.com/media/2067/q4-2010-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2070/q4-2010-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2065/q3-2010-results-announcement.pdf":{},"https://www.gsk.com/media/2064/q3-2010-andrew-witty-video-transcript.pdf":{},"https://www.gsk.com/media/2063/q3-2010-analyst-presentation.pdf":{},"https://www.gsk.com/media/2062/q3-2010-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2066/q3-2010-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2058/q2-2010-results-announcement-1.pdf":{},"https://www.gsk.com/media/2060/q2-2010-analyst-presentation.pdf":{},"https://www.gsk.com/media/2059/q2-2010-restated-quarterly-product-analysis.pdf":{},"https://www.gsk.com/media/2061/q2-2010-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2057/q2-2010-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2055/q1-2010-results-announcement.pdf":{},"https://www.gsk.com/media/2054/q1-2010-andrew-witty-video-transcript.pdf":{},"https://www.gsk.com/media/2053/q1-2010-actual-growth-schedules.pdf":{},"https://www.gsk.com/media/2056/q1-2010-us-dollar-translation.pdf":{},"https://www.gsk.com/media/2497/jpm-2017-pv-presentation.pdf":{},"https://www.gsk.com/media/3365/patrick-vallance-presentation-transcript.pdf":{},"https://www.gsk.com/media/1688/2016-gsk-vaccines-meet-the-management-slides.pdf":{},"https://www.gsk.com/media/3241/2016-gsk-vaccines-meet-the-management-transcript.pdf":{},"https://www.gsk.com/media/2652/gold-man-sachs-seminar-on-hic-and-viiv-healtcare-presentation.pdf":{},"https://www.gsk.com/media/2655/gold-man-sachs-seminar-on-hic-and-viiv-healtcare-transcript.pdf":{},"https://www.gsk.com/media/2654/meet-the-respiratory-management-slides.pdf":{},"https://www.gsk.com/media/2653/meet-the-respiratory-management-transcript.pdf":{},"https://www.gsk.com/media/3243/goldman-sachs-37th-annual-global-healthcare-conference-transcript.pdf":{},"https://www.gsk.com/media/3244/dr-axel-hoos-transcript.pdf":{},"https://www.gsk.com/media/3246/leerink-partners-5th-annual-global-healthcare-conference-transcript.docx":{},"https://www.gsk.com/media/3247/andrew-whitty-jp-morgan-presentation.pdf":{},"https://www.gsk.com/media/3248/andrew-whitty-jp-morgan-transcription.pdf":{},"https://www.gsk.com/media/3249/viiv-bms-investor-transcript-pdf.pdf":{},"https://www.gsk.com/media/1441/r-and-d-event-full-presentation.pdf":{},"https://www.gsk.com/media/1442/randd-day-transcript-full.pdf":{},"https://www.gsk.com/media/1443/randd-day-ceo-introduction.pdf":{},"https://www.gsk.com/media/1444/gsk-rd-day-part1-welcome-and-opening-remarks-sir-andrew-witty_final.pdf":{},"https://www.gsk.com/media/1445/randd-day-pharma-session-1.pdf":{},"https://www.gsk.com/media/1446/gsk-rd-day-part1-hiv-infectious-diseases-respiratory-phi-patrick-vallance-_final.pdf":{},"https://www.gsk.com/media/1448/randd-day-pharma-session-2.pdf":{},"https://www.gsk.com/media/1449/gsk-rd-day-part3-immuno-inflammation-oncology-rare-diseases-patrick-vallance_-final.pdf":{},"https://www.gsk.com/media/1451/randd-day-vaccines-session.pdf":{},"https://www.gsk.com/media/1452/gsk-rdday-part2-vaccines-dr-moncef-slaoui_-final.pdf":{},"https://www.gsk.com/media/1471/gsk-investor-event.pdf":{},"https://www.gsk.com/media/1472/investor-event-transcript.pdf":{},"https://www.gsk.com/media/3511/andrew-witty-investor-event-presentation.pdf":{},"https://www.gsk.com/media/3512/andrew-witty-investor-event-transcript.pdf":{},"https://www.gsk.com/media/1477/moncef-slaoui-investor-event-presentation.pdf":{},"https://www.gsk.com/media/1478/moncef-slaoui-investor-event-transcript.pdf":{},"https://www.gsk.com/media/1479/abbas-hussain-investor-event-presentation.pdf":{},"https://www.gsk.com/media/1480/abbas-hussain-investor-event-transcript.pdf":{},"https://www.gsk.com/media/1481/emma-walmsley-investor-event-presentation.pdf":{},"https://www.gsk.com/media/1482/emma-walmsley-investor-event-transcript.pdf":{},"https://www.gsk.com/media/1483/simon-dingemans-investor-event-presentation.pdf":{},"https://www.gsk.com/media/1484/simon-dingemans-investor-event-transcript.pdf":{},"https://www.gsk.com/media/3513/jpmorgan-healthcare-conference-2015.pdf":{},"https://www.gsk.com/media/3514/jp-morgan-healthcare-conference-2015-transcript.pdf":{},"https://www.gsk.com/media/2605/bank-of-america-healthcare-conderence.pdf":{},"https://www.gsk.com/media/2603/ers-investor-briefing-slides.pdf":{},"https://www.gsk.com/media/2604/ers-ir-broadcast-transcript.pdf":{},"https://www.gsk.com/media/2602/jpmorgan-healthcare-conference-2014.pdf":{},"https://www.gsk.com/media/2601/jpmorgan-healthcare-conference-2014-transcript.pdf":{},"https://www.gsk.com/media/2600/jpmorgan-healthcare-conference-2014-transcript-qa.pdf":{},"https://www.gsk.com/media/2608/leerink-swann-polarxpress-2013.pdf":{},"https://www.gsk.com/media/2609/north-carolina-ceo-forum-speech-2013.pdf":{},"https://www.gsk.com/media/2606/ats-analyst-and-investor-event-2013.pdf":{},"https://www.gsk.com/media/2624/david-redfern-economist-pharma-summit-10-february-2011.pdf":{},"https://www.gsk.com/media/2622/gsk-deirdre-connelly-cbi-annual-pharma-compliance-congress.pdf":{},"https://www.gsk.com/media/2626/jp-morgan-2011-healthcare-conference.pdf":{},"https://www.gsk.com/media/2647/gsks-eddie-gray-speaks-at-ft-pharmaceutical-conference.pdf":{},"https://www.gsk.com/media/2640/clsa-emerging-markets-mark-reilly.pdf":{},"https://www.gsk.com/media/2645/gsks-andrew-witty-features-in-the-economists-the-world-in-2011.pdf":{},"https://www.gsk.com/media/2634/mind-the-medicine-gap-transcript.pdf":{},"https://www.gsk.com/media/2644/andrew-witty-ceo-gsk-presentation-at-credit-suisse-nov-2010.pdf":{},"https://www.gsk.com/media/3260/deirdre-connellys-credit-suisse-presentation.pdf":{},"https://www.gsk.com/media/2643/cowen-healthcare-conference-julian-heslp-cfp.pdf":{},"https://www.gsk.com/media/2638/merrill-lynch-conference-julian-heslp-cfo.pdf":{},"https://www.gsk.com/media/2649/investor-meetings-2010.pdf":{},"https://www.gsk.com/media/3261/dr-thomas-breuers-presentation.pdf":{},"https://www.gsk.com/media/3262/martin-andrews-presentation.pdf":{},"https://www.gsk.com/media/3263/vincent-bruchards-presentation.pdf":{},"https://www.gsk.com/media/2648/simon-harford-gsk-emerging-markets.pdf":{},"https://www.gsk.com/media/2633/28th-a-l-h-lth-c-f-annual-healthcare-conference-jp-morgan.pdf":{},"https://www.gsk.com/media/2607/late-stage-pipeline-review-2013.pdf":{},"https://www.gsk.com/media/2613/late-stage-pipeline-review.pdf":{},"https://www.gsk.com/media/2620/gsk-deirdre-connelly-pharmehr-summit-speech-21-march-2012.pdf":{},"https://www.gsk.com/media/2618/esmo-analyst-presentation-1-oct-2012.pdf":{},"https://www.gsk.com/media/2619/iac-analyst-presentation.pdf":{},"https://www.gsk.com/media/2615/ada-analyst-meeting-2012.pdf":{},"https://www.gsk.com/media/2610/deirdre-connelly-na-pharma-gsk-world-affairs-council-15-may-2012.pdf":{},"https://www.gsk.com/media/2614/rd-seminar.pdf":{},"https://www.gsk.com/media/2611/gsk-simon-dingemans-jp-morgan-10-jan-2012.pdf":{},"https://www.gsk.com/media/3257/gsk-core-reporting-announcement.pdf":{},"https://www.gsk.com/media/2629/gsk-core-reporting-presentation-1-dec-2011.pdf":{},"https://www.gsk.com/media/3258/gsk-core-reporting-historical-restatements.xls":{},"https://www.gsk.com/media/2631/credit-suisse-2011-healthcare-conference.pdf":{},"https://www.gsk.com/media/2627/gsks-ad-rawcliffe-presentation-at-bernstein-pharma-long-view-conference.pdf":{},"https://www.gsk.com/media/3259/martin-andrews-presentation.pdf":{},"https://www.gsk.com/media/2623/summary-of-remarks-made-by-gsk-ceo-the-role-of-innovation-in-addressing-global-health.pdf":{},"https://www.gsk.com/media/2632/abbas-hussain-emerging-markets.pdf":{},"https://www.gsk.com/media/2630/gsks-patrick-vallance-presentation-at-cowen-healthcare-conference.pdf":{},"https://www.gsk.com/media/2621/life-science-conference-2011.pdf":{},"https://www.gsk.com/media/3208/efpia-self-certification.pdf":{},"https://www.gsk.com/media/4964/data-privacy-notice_austria.pdf":{},"https://www.gsk.com/media/4965/data-privacy-notice_belgium_dutch.pdf":{},"https://www.gsk.com/media/4966/data-privacy-notice_belgium_french.pdf":{},"https://www.gsk.com/media/4967/data-privacy-notice_bulgaria.pdf":{},"https://www.gsk.com/media/4968/data-privacy-notice_croatia.pdf":{},"https://www.gsk.com/media/4969/data-privacy-notice_cyprus.pdf":{},"https://www.gsk.com/media/4970/data-privacy-notice_czechia.pdf":{},"https://www.gsk.com/media/4971/data-privacy-notice_denmark.pdf":{},"https://www.gsk.com/media/5049/data-privacy-notice_estonia.pdf":{},"https://www.gsk.com/media/4972/data-privacy-notice_finland.pdf":{},"https://www.gsk.com/media/4973/data-privacy-notice_france.pdf":{},"https://www.gsk.com/media/4974/data-privacy-notice_germany.pdf":{},"https://www.gsk.com/media/4975/data-privacy-notice_greece.pdf":{},"https://www.gsk.com/media/4976/data-privacy-notice_hungary.pdf":{},"https://www.gsk.com/media/4977/data-privacy-notice_ireland.pdf":{},"https://www.gsk.com/media/5046/data-privacy-notice_italy.pdf":{},"https://www.gsk.com/media/4978/data-privacy-notice_latvia.pdf":{},"https://www.gsk.com/media/4979/data-privacy-notice_lithuania.pdf":{},"https://www.gsk.com/media/4980/data-privacy-notice_malta.pdf":{},"https://www.gsk.com/media/4981/data-privacy-notice_norway.pdf":{},"https://www.gsk.com/media/4982/data-privacy-notice_poland.pdf":{},"https://www.gsk.com/media/4983/data-privacy-notice_portugal.pdf":{},"https://www.gsk.com/media/4984/data-privacy-notice_romania.pdf":{},"https://www.gsk.com/media/4985/data-privacy-notice_slovakia.pdf":{},"https://www.gsk.com/media/4986/data-privacy-notice_slovenia.pdf":{},"https://www.gsk.com/media/4987/data-privacy-notice_spain.pdf":{},"https://www.gsk.com/media/4988/data-privacy-notice_sweden.pdf":{},"https://www.gsk.com/media/4989/data-privacy-notice_the_netherlands.pdf":{},"https://www.gsk.com/media/4990/data-privacy-notice_united_kingdom.pdf":{},"https://www.gsk.com/media/2755/bioelectronics-million-dollar-challenge-success-criteria.pdf":{},"https://www.gsk.com/media/3320/capacity-and-capabilities-presentation.pdf":{},"https://www.gsk.com/media/3321/high-containment-capability-presentation.pdf":{},"https://www.gsk.com/media/3322/nanomilling-overview.pdf":{},"https://www.gsk.com/media/3323/manufacturing-brochure.pdf":{},"https://www.gsk.com/media/3324/ulverston-site-brochure.pdf":{},"https://www.gsk.com/media/3325/jurong-site-brochure.docx":{},"https://www.gsk.com/media/2765/gms-product-and-service-information-brochure.pdf":{},"https://www.gsk.com/media/2773/sterile-ampoule-facility.pdf":{},"https://www.gsk.com/media/2769/nasal-spray-brochure.pdf":{},"https://www.gsk.com/media/2767/sterile-high-contrainment-facility-leaflet.pdf":{},"https://www.gsk.com/media/2768/freeze-drying-facility-leaflet.pdf":{},"https://www.gsk.com/media/2772/small-scale-sterile-facility-leaflet.pdf":{},"https://www.gsk.com/media/2770/oral-high-containment-facility.pdf":{},"https://www.gsk.com/media/2766/tablet-production-leaflet.pdf":{},"https://www.gsk.com/media/2757/cephs-customer-catalogue.pdf":{},"https://www.gsk.com/media/2780/worthing-and-mayenne-product-catalogue.pdf":{},"https://www.gsk.com/media/2779/product-pack-brief.pdf":{},"https://www.gsk.com/media/2781/diffcore-development-flyer.pdf":{},"https://www.gsk.com/media/2758/liquid-dispensing-technology-leaflet.pdf":{},"https://www.gsk.com/media/2759/dermatologicals-leaflet.pdf":{},"https://www.gsk.com/media/1410/product-pipeline-march-2016.pdf":{},"https://www.gsk.com/media/4993/2018-gsk-compliance-program-us-operations.pdf":{},"https://www.gsk.com/media/4992/2018-ca-annual-declaration-of-compliance.pdf":{},"https://www.gsk.com/media/2503/safe-needle-disposal-plan-july-1-2010.pdf":{},"https://www.gsk.com/media/841910/q3-2015-results-announcement.pdf":{},"http://www.gsk.com/media/3696/q1-2017-results-announcement.pdf":{},"http://www.gsk.com/investors/reports/q32010/q32010.pdf":{},"https://www.gsk.com/media/3654/gsk-makes-change-to-financial-reporting-framework-11-april-2017.pdf":{},"https://www.gsk.com/media/456576/gsk-publishes-historical-quarterly-restated-financial-information.pdf":{},"https://www.gsk.com/media/583635/restated-finanical-information.xlsx":{},"https://www.gsk.com/media/280477/q3-2011-results-announcement.pdf":{},"https://www.gsk.com/media/280468/q2-2011-results-announcement.pdf":{},"https://www.gsk.com/content/dam/gsk/globals/documents/pdf/media/GSK-White-Paper-Avandia-23-Feb-2010.pdf":{},"http://www.gsk.com/media/downloads/BRC-Haiti-20-Jan-10.pdf":{}},"external":{},"other":{"http://ng.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Nigeria (EN)","status":"new"},"http://www.gsk-china.com/zh-cn/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"ZH","status":"new"},"http://www.gsk-china.com/en-gb/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"EN","status":"new"},"http://hk.gsk.com/en-gb/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"EN","status":"new"},"http://hk.gsk.com/zh-hk/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"ZH","status":"new"},"http://india-pharma.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"India (EN)","status":"new"},"http://id.gsk.com/en-gb/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"EN","status":"new"},"http://id.gsk.com/id-id/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"ID","status":"new"},"http://jp.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Japan (JP)","status":"new"},"http://kz.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Kazakhstan (RU)","status":"new"},"http://kr.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Korea (KO)","status":"new"},"http://my.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Malaysia (EN)","status":"new"},"http://pk.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Pakistan (EN/UR)","status":"new"},"http://sg.gsk.com/en-sg/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Singapore (EN)","status":"new"},"http://tw.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Taiwan (ZH)","status":"new"},"http://tr.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Turkey (TR)","status":"new"},"http://vn.gsk.com/vi-vn/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"VI","status":"new"},"http://vn.gsk.com/en-gb/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"EN","status":"new"},"http://au.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Australia (EN)","status":"new"},"http://nz.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"New Zealand (EN)","status":"new"},"http://at.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Austria (DE)","status":"new"},"http://be.gsk.com/fr/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"FR","status":"new"},"http://be.gsk.com/nl/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"NL","status":"new"},"http://be.gsk.com/en/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"EN","status":"new"},"http://bg.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Bulgaria (BG)","status":"new"},"http://hr.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Croatia (HR)","status":"new"},"http://cz.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Czech Republic (CS)","status":"new"},"http://dk.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Denmark (DA)","status":"new"},"http://ee.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Estonia (ET)","status":"new"},"http://fi.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Finland (FI)","status":"new"},"http://fr.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"France (FR)","status":"new"},"http://de.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Germany (DE)","status":"new"},"http://gr.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Greece (EL)","status":"new"},"http://hu.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Hungary (HU)","status":"new"},"http://ie.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Ireland (EN)","status":"new"},"https://www.gsk.it/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Italy (IT)","status":"new"},"http://be.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Luxembourg (FR/NL/EN)","status":"new"},"http://nl.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Netherlands (NL)","status":"new"},"http://no.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Norway (NB)","status":"new"},"http://pl.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Poland (PL)","status":"new"},"http://ro.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Romania (RO)","status":"new"},"http://ru.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Russia (RU)","status":"new"},"http://rs.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Serbia (SR)","status":"new"},"http://sk.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Slovakia (SK)","status":"new"},"http://si.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Slovenia (SL)","status":"new"},"http://es.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Spain (ES)","status":"new"},"http://se.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Sweden (SV)","status":"new"},"http://www.glaxosmithkline.ch/de-ch/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"DE","status":"new"},"http://www.glaxosmithkline.ch/fr-ch/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"FR","status":"new"},"http://ua.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Ukraine (UK)","status":"new"},"http://uk.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"United Kingdom (EN)","status":"new"},"http://ca.gsk.com/en-ca/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"EN","status":"new"},"http://ca.gsk.com/fr-ca/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"FR","status":"new"},"http://us.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"United States (EN)","status":"new"},"http://ar.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Argentina (ES)","status":"new"},"http://br.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Brazil (PT)","status":"new"},"https://twitter.com/GSK":{"firstFound":"https://www.gsk.com/","txt":"Follow us on Twitter","status":"new"},"https://twitter.com/hashtag/BehindTheScience?src=hash":{"firstFound":"https://www.gsk.com/","txt":"#BehindTheScience","status":"new"},"https://twitter.com/hashtag/VaccinateForLife?src=hash":{"firstFound":"https://www.gsk.com/","txt":"#VaccinateForLife","status":"new"},"https://twitter.com/GSK/status/1071449519437635584":{"firstFound":"https://www.gsk.com/","txt":"about 2 days ago","status":"new"},"https://twitter.com/GSK/status/1071358849335128064":{"firstFound":"https://www.gsk.com/","txt":"about 2 days ago","status":"new"},"https://twitter.com/GSK/status/1071017213002432512":{"firstFound":"https://www.gsk.com/","txt":"about 3 days ago","status":"new"},"https://www.facebook.com/GSK":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"\n                                \n                                    \n                                \n                            ","status":"new"},"http://twitter.com/GSK":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"\n                                \n                                    \n                                \n                            ","status":"new"},"http://www.youtube.com/GSK":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"\n                                \n                                    \n                                \n                            ","status":"new"},"http://www.flickr.com/photos/glaxosmithkline":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"\n                                \n                                    \n                                \n                            ","status":"new"},"http://www.linkedin.com/company/glaxosmithkline":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"\n                                \n                                    \n                                \n                            ","status":"new"},"https://www.instagram.com/gsk/":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"\n                                \n                                    \n                                \n                            ","status":"new"},"":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Business to business","status":"new"},"https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"Supplier website","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/jobDetails.do?functionName=getJobDetail&jobPostId=350168&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/kenya/","txt":"Find information about our career opportunities in Kenya ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=3":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/algeria/","txt":"Find information about our career opportunities in Algeria","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=168":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/philippines/","txt":"Find information about our career opportunities in the Philippines ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/search.do":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/saudi-arabia/","txt":"global application page","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=144":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/morocco/","txt":"Find information about our career opportunities in Morocco","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=63":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/egypt/","txt":"Find information about our career opportunities in Egypt ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=208":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/thailand/","txt":"Find information about our career opportunities in Thailand ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=220":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/united-arab-emirates/","txt":"Find information about our career opportunities in the United Arab Emirates ","status":"new"},"https://sveikata.gsk.lt/lt-lt/_adverse-effect-reportage/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/lithuania/","txt":"Reporting form","status":"new"},"http://www.sveikata.gsk.lt/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/lithuania/","txt":"www.sveikata.gsk.lt","status":"new"},"https://veseliba.gsk.lv/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/latvia/","txt":"https://veseliba.gsk.lv","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=138":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/mexico/","txt":"Find information about our career opportunities in Mexico","status":"new"},"http://www.salud.gsk.com.mx/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/mexico/","txt":"health portal","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=43":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/chile/","txt":"Find information about our career opportunities in Chile","status":"new"},"http://www.salud.gsk.cl/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/chile/","txt":"health portal","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=47":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/colombia/","txt":"Find information about our career opportunities in Colombia","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=62":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/ecuador/","txt":"Find information about our career opportunities in Ecuador ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=60":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/dominican-republic/","txt":"Find information about our career opportunities in Dominican Republic ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=51":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/costa-rica/","txt":"Find information about our career opportunities in Costa Rica","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=64":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/el-salvador/","txt":"Find information about our career opportunities in El Salvador ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=95":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/honduras/","txt":"Find information about our career opportunities in Honduaras ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=89":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/guatemala/","txt":"Find information about our career opportunities in Guatemala ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=106":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/jamaica/","txt":"Find information about our career opportunities in Jamaica ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=167":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/peru/","txt":"Find information about our career opportunities in Peru ","status":"new"},"http://www.salud.gsk.com.pe/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/peru/","txt":"health portal","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=164":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/panama/","txt":"Find information about our career opportunities in Panama","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=212":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/trinidad-tobago/","txt":"Find information about our career opportunities in Trinidad & Tobago ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=224":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/uruguay/","txt":"Find information about our career opportunities in Uruguay","status":"new"},"http://www.facebook.com/GSK":{"firstFound":"https://www.gsk.com/en-gb/contact-us/","txt":"Facebook","status":"new"},"https://supplier.gsk.com/irj/portal/public":{"firstFound":"https://www.gsk.com/en-gb/contact-us/","txt":"Suppliers","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/gateway.do?functionName=searchFromLink&com.peopleclick.cp.formdata.FLD_JPM_COUNTRY=228":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/venezuela/","txt":"Find information about our career opportunities in Venezuela ","status":"new"},"https://www.youtube.com/embed/BxdGvPeS9lo?rel=0":{"firstFound":"https://www.gsk.com/en-gb/research/","txt":"View video on YouTube","status":"new"},"https://innovation.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/about-us/consumer-healthcare/","txt":"Consumer Healthcare External Innovation","status":"new"},"https://www.youtube.com/embed/PZRJ8zdqP7U?rel=0":{"firstFound":"https://www.gsk.com/en-gb/about-us/vaccines/","txt":"View video on YouTube","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/sets/72157626748527760":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/","txt":"GSK Flickr","status":"new"},"http://www.soxlaw.com/":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/sarbanes-oxley-act-2002/","txt":"Sarbanes-Oxley Act of 2002","status":"new"},"https://www.malariamustdie.com/case_02.html":{"firstFound":"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/","txt":"How one mother in Tanzania is helping to protect her family from malaria","status":"new"},"https://www.youtube.com/embed/GsTW6-IL8Rg?rel=0":{"firstFound":"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/","txt":"View video on YouTube","status":"new"},"http://www.who.int/malaria/publications/world-malaria-report-2017/en/":{"firstFound":"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/","txt":"WHO World Malaria Report","status":"new"},"https://www.youtube.com/embed/IVk5GWrDWPs?rel=0":{"firstFound":"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/jacob-tanzania-communication-and-development-centre/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/7kF89pF3L6s?rel=0":{"firstFound":"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/patrick-malaria-patient/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/OuFmb7yd-DI?rel=0":{"firstFound":"https://www.gsk.com/en-gb/about-us/comic-relief-partnership/nsaje-teacher/","txt":"View video on YouTube","status":"new"},"https://youtu.be/_xhm6w-R8FM?rel=0":{"firstFound":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/fb66xAmqoSY?rel=0":{"firstFound":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/","txt":"View video on YouTube","status":"new"},"https://youtu.be/f7oirM95BqQ?rel=0":{"firstFound":"https://www.gsk.com/en-gb/about-us/save-the-children-partnership/","txt":"View video on YouTube","status":"new"},"http://www.msds-gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-prescription-medicines/","txt":"\n                \n                        \n                \n                \n                        Safety Data Sheets (SDS)\n                                            Safety Data Sheets (SDS) and environmental information on prescription medicines\n                \n            ","status":"new"},"https://www.youtube.com/embed/nMjYowpSANU?rel=0":{"firstFound":"https://www.gsk.com/en-gb/about-us/smile-train-partnership/","txt":"View video on YouTube","status":"new"},"https://www.smiletrain.org/our-cause/our-work":{"firstFound":"https://www.gsk.com/en-gb/about-us/smile-train-partnership/","txt":"interactive map","status":"new"},"https://www.facebook.com/StiefelGSK":{"firstFound":"https://www.gsk.com/en-gb/products/stiefel-dermatology/","txt":"\n                \n                        \n                \n                \n                        Like Stiefel on Facebook\n                                               \n                \n            ","status":"new"},"https://twitter.com/stiefel":{"firstFound":"https://www.gsk.com/en-gb/products/stiefel-dermatology/","txt":"\n                \n                        \n                \n                \n                        Follow Stiefel on Twitter\n                                               \n                \n            ","status":"new"},"https://www.viivhealthcare.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/telegraph-article-science-hasnt-answered-all-the-questions-on-hiv/","txt":"ViiV Healthcare","status":"new"},"https://youtu.be/mUfVd_gJ2CM?rel=0":{"firstFound":"https://www.gsk.com/en-gb/products/viiv-healthcare/","txt":"View video on YouTube","status":"new"},"https://www.viivhealthcare.com/supporting-the-community.aspx":{"firstFound":"https://www.gsk.com/en-gb/products/viiv-healthcare/","txt":"listening to and engaging with people living with HIV, healthcare providers and policy makers","status":"new"},"https://www.youtube.com/watch?v=-K9GQWWOKNg&rel=0":{"firstFound":"https://www.gsk.com/en-gb/products/viiv-healthcare/","txt":"View video on YouTube","status":"new"},"https://www.viivhealthcare.com/supporting-the-community/positive-action-programmes.aspx":{"firstFound":"https://www.gsk.com/en-gb/products/viiv-healthcare/","txt":"Positive Action programmes","status":"new"},"https://twitter.com/ViiVHC":{"firstFound":"https://www.gsk.com/en-gb/products/viiv-healthcare/","txt":"\n            \n                    \n            \n                Twitter\n                        ","status":"new"},"https://www.facebook.com/ViiVHealthcare/":{"firstFound":"https://www.gsk.com/en-gb/products/viiv-healthcare/","txt":"\n            \n                    \n            \n                Facebook\n                        ","status":"new"},"https://www.youtube.com/user/viivhealthcare":{"firstFound":"https://www.gsk.com/en-gb/products/viiv-healthcare/","txt":"\n            \n                    \n            \n                YouTube\n                        ","status":"new"},"https://www.linkedin.com/company/viiv-healthcare/":{"firstFound":"https://www.gsk.com/en-gb/products/viiv-healthcare/","txt":"\n            \n                    \n            \n                LinkedIn\n                        ","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=281528&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=134","txt":"View more details","status":"new"},"https://gsk.gradweb.uk.com/graduates2017/Login.aspx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133","txt":"View more details","status":"new"},"https://youtu.be/wHQIyHFbSe4?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/","txt":"View video on YouTube","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=334313&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=134","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=365449&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=372096&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132","txt":"View more details","status":"new"},"https://www.youtube.com/embed/zQI0UaRy9RU?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","txt":"View video on YouTube","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=367569&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=380825&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387621&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://www.theguardian.com/breakthrough-science/2017/sep/08/gsk-consumer-healthcare-a-commitment-to-innovation":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/research-and-development-consumer-healthcare/","txt":"Read more here ","status":"new"},"https://www.youtube.com/embed/lQZN0RYP7e0?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","txt":"View video on YouTube","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=345316&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=134","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=345328&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=303215&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133","txt":"View more details","status":"new"},"https://www.youtube.com/watch?v=I7izpfM0R5k":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/postdoctoral-immunology-catalyst/","txt":"\n            \n                    \n            \n                Step inside our SMART lab in Stevenage, UK\n            The research and collaboration that happens in our SMART labs is a crucial step in developing the medicines of tomorrow.        ","status":"new"},"https://www.youtube.com/embed/OhSTqaveYvY?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","txt":"View video on YouTube","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=362834&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=368400&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=369160&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132","txt":"View more details","status":"new"},"https://www.youtube.com/embed/behg01B2wTg?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","txt":"View video on YouTube","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=360904&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=366875&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=369984&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132","txt":"View more details","status":"new"},"http://uk.gsk.com/en-gb/careers/apprenticeships/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-reinforces-commitment-to-youth-training-with-launch-of-new-uk-apprenticeship-programme/","txt":"http://uk.gsk.com/en-gb/careers/apprenticeships/","status":"new"},"http://ie.gsk.com/ie/careers/apprenticeships/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/","txt":"Ireland","status":"new"},"http://us.gsk.com/en-us/careers/apprenticeships/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/","txt":" US","status":"new"},"http://au.gsk.com/en-au/careers/apprenticeships/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/","txt":"Australia","status":"new"},"http://sg.gsk.com/en-sg/careers/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apprentice-programmes/","txt":"Singapore","status":"new"},"https://gskearlytalent.avature.net/landingpage":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/","txt":"\n            \n                    \n            \n                Connect with us\n            Join our Talent Community to receive updates on careers, news and events         ","status":"new"},"http://flpquiz.gsk.com/gskquiz-stage1":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","txt":"Take the quiz","status":"new"},"http://uk.gsk.com/en-gb/careers/undergraduates/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/work-experience-placements-and-internships/","txt":"\n            \n                    \n            \n                Living in the UK?\n            Are you interested in gaining some valuable work experience? Do you want to spend a week with a company that believes in helping young talent to flourish?        ","status":"new"},"http://us.gsk.com/en-us/careers/internships-and-co-ops/":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/work-experience-placements-and-internships/","txt":"\n            \n                    \n            \n                Living in the USA?\n            With the sheer range of opportunities available, we can accommodate your ambitions and aspirations.        ","status":"new"},"https://www.youtube.com/embed/R1x8fuYjmHc?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/","txt":"View video on YouTube","status":"new"},"https://gskearlytalent.avature.net/registration":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/","txt":"\n            \n                    \n            \n                Start networking\n            Learn more about our Early Talent opportunities and visit us at one of the many events we hold worldwide.        ","status":"new"},"https://youtu.be/R1x8fuYjmHc?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/postdoctoral-immunology-catalyst/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=OCQx8W-1W78&rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-rd-leadership-development-programme/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=LL8DzabEynI&rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-rd-leadership-development-programme/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=l45mVTEaJSk&&rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-rd-leadership-development-programme/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=-5gY8cTdzgM&&rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-rd-leadership-development-programme/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=bg0c-qbsCa8&&rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-rd-leadership-development-programme/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=w1JYugqCqDk&&rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/esprit-rd-leadership-development-programme/","txt":"View video on YouTube","status":"new"},"https://youtu.be/bIqlsOCCmoo?rel=0":{"firstFound":"https://www.gsk.com/en-gb/media/","txt":"View video on YouTube","status":"new"},"http://www.shareview.co.uk/4/Info/Portfolio/Default/en/Home/Markets/Pages/Company-AZ.aspx":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/manage-your-shares/","txt":"www.shareview.co.uk","status":"new"},"tel:03713842991":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/manage-your-shares/","txt":"0371 384 2991","status":"new"},"tel:+4401214157067":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/manage-your-shares/","txt":"+44 (0)121 415 7067","status":"new"},"http://www.shareview.com/drip":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/manage-your-shares/","txt":"www.shareview.com/drip","status":"new"},"http://www.computershare-na.com/bnym_adr/":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/manage-your-shares/","txt":"www.mybnymdr.com","status":"new"},"tel:+18773531154":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/manage-your-shares/","txt":"1 877 353 1154","status":"new"},"tel:+12016806825":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/manage-your-shares/","txt":"+1 201 680 6825","status":"new"},"http://www.prosearchassets.com/":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/asset-reunification-prosearch/","txt":"www.prosearchassets.com","status":"new"},"https://portfolio.shareview.co.uk/7/Portfolio/Default/en/Anonymous/Pages/Login.aspx":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/asset-reunification-prosearch/","txt":"www.shareview.co.uk","status":"new"},"http://www.shareview.co.uk/4/Info/Portfolio/Default/en/Home/Shareholders/Documents/MandateForm.pdf":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/asset-reunification-prosearch/","txt":"Bank Mandate Form (PDF)","status":"new"},"https://www.youtube.com/embed/ZkgucaTqzWM":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"http://www.fca.org.uk/firms/systems-reporting/register":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/share-scam-alert/","txt":"FCA register of authorised firms","status":"new"},"http://www.fca.org.uk/consumers/scams/investment-scams/share-fraud-and-boiler-room-scams/reporting-form":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/share-scam-alert/","txt":"this online form","status":"new"},"http://ec.europa.eu/justice/data-protection/bodies/authorities/index_en.htm":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/shareholder-privacy-notice/","txt":"http://ec.europa.eu/justice/data-protection/bodies/authorities/index_en.htm","status":"new"},"http://equiniti.com/":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/corporate-reporting-archive/","txt":"Equiniti Limited","status":"new"},"tel:08713842991":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/","txt":"0871 384 2991","status":"new"},"tel:4401214157067":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/","txt":"+44(0)121 415 7067","status":"new"},"tel:18888255249":{"firstFound":"https://www.gsk.com/en-gb/investors/corporate-reporting/","txt":"+1 888 825 5249","status":"new"},"http://www.hmrc.gov.uk/so/":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/","txt":"HM Revenue & Customs website","status":"new"},"https://www.contactus.gsk.com/callback/index.html":{"firstFound":"https://www.gsk.com/en-gb/contact-us/customerspatients/","txt":"US","status":"new"},"https://www.youtube.com/watch?v=88IudnHA7gI&feature=youtu.be":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://www.youtube.com/watch?v=bIqlsOCCmoo":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                            \n                                \n                            \n                        ","status":"new"},"https://youtu.be/X62jsj-l6RI":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                            View the webcast\n                                                    ","status":"new"},"https://www.youtube.com/watch?v=uN38SwgjpFY":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=BxdGvPeS9lo":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/embed/yJ5oegkzc0k?rel=0":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://www.youtube.com/embed/bcdvhTAYCMU?rel=0":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://youtu.be/e79PFz9ZdyI":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://youtu.be/OB9-hTupyus":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://youtu.be/3tYDZCpzYvo":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://youtu.be/L-LXVQ_W7Xo":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=1","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://otp.investis.com/clients/uk/GlaxoSmithKline2/rns_new/regulatory-story.aspx?cid=410&newsid=783158":{"firstFound":"https://www.gsk.com/en-gb/investors/stock-exchange-announcements/london-rns-inside-information/","txt":"GSK appoints new CEO","status":"new"},"https://gskmeeting.webex.com/gskmeeting/onstage/g.php?MTID=e2db8169ed31c032d45dc8ce15f9c3c4b":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Webcast","status":"new"},"http://www.veracast.com/webcasts/citigroup/healthcare2018/69105351173.cfm":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"http://wsw.com/webcast/evercore2/gsk/":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"http://www.wsw.com/webcast/cecp5/register.aspx?conf=cecp5&page=index&url=http%3A//www.wsw.com/webcast/cecp5/":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"https://edge.media-server.com/m6/p/xwwzfyer":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"https://cc.talkpoint.com/gold006/061218a_as/?entity=60_CGN84DX":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"http://wsw.com/webcast/jeff113/gsk/":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"https://jpmorgan.metameetings.net/events/healthcare18/sessions/13369-gsk-plc/webcast":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"https://www.veracast.com/webcasts/citigroup/healthcare2017/99205198864.cfm":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"http://www.veracast.com/webcasts/evercoreisi/biopharma2017/13207106558.cfm":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Analyst webcast","status":"new"},"https://www.youtube.com/watch?v=XJSWx31V3so&list=PLvDyxtKlIcnhVGUA9xOKXVSXmKZArLzQs":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Watch the webcast on YouTube","status":"new"},"http://wsw.com/webcast/cowen38/gsk":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=1","txt":"Register for the webcast","status":"new"},"tel:+44020%208047%205000":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"44 (0)20 8047 5000","status":"new"},"http://www.shareview.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"www.shareview.co.uk","status":"new"},"tel:0371%20384%202991":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"0371 384 2991","status":"new"},"tel:+44%20121%20415%207067":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"+44 121 415 7067","status":"new"},"tel:0345%20300 0430":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"0345 300 0430","status":"new"},"tel:+44%20121 415 0105":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"+44 121 415 0105","status":"new"},"tel:0808%20234%204391":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"0808 234 4391","status":"new"},"tel:0808%20234 9321":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"0808 234 9321","status":"new"},"tel:+800%204020 0032":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"+800 4020 0032","status":"new"},"http://www.equateplus.com/":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"www.equateplus.com","status":"new"},"tel:(+44)%20117 240 2520":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"(+44) 117 240 2520","status":"new"},"tel:(+1)%20732 491 0715":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"(+1) 732 491 0715","status":"new"},"tel:(+1)%20866 627 2097":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"(+1) 866 627 2097","status":"new"},"tel:(+61)%203 9415 4824":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"(+61) 3 9415 4824","status":"new"},"tel:+18888255249":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"+1 888 825 5249","status":"new"},"tel:+12157514000":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"+1 215 751 4000","status":"new"},"http://www.mybnymdr.com/":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"www.mybnymdr.com","status":"new"},"tel:+1%20877 353 1154":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"+1 877 353 1154","status":"new"},"tel:+1%20201 680 6825":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"+1 201 680 6825","status":"new"},"http://doingmoreintheus.gsk.com/en-us/map-regions/":{"firstFound":"https://www.gsk.com/en-gb/media/resource-centre/quick-facts/","txt":"what we are doing across the US","status":"new"},"https://twitter.com/gsk_ar":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"@GSK_AR","status":"new"},"https://twitter.com/gsk_au":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"@GSK_AU","status":"new"},"https://twitter.com/gsk_careers":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"@GSK_careers","status":"new"},"https://twitter.com/gsk_conferences":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"@GSK_Conferences","status":"new"},"https://twitter.com/gsk_es":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"@GSK_ES","status":"new"},"https://twitter.com/GSK_IE":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"@GSK_IE","status":"new"},"http://twitter.com/gskus":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"@GSKUS","status":"new"},"https://twitter.com/gskturkiye":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"@GSKTurkiye","status":"new"},"https://en-gb.facebook.com/GSK/":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK","status":"new"},"https://business.facebook.com/GSK-1692211967683262/?business_id=796084830460472":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK Brazil","status":"new"},"https://en-gb.facebook.com/GSKcareers/":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK Careers","status":"new"},"https://www.facebook.com/GSKclinicaltrials/":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK Clinical Trials","status":"new"},"https://www.facebook.com/TalentosGSK":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK Futuros Lideres","status":"new"},"https://www.facebook.com/GSKPharmaceuticalsIndia/":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK India","status":"new"},"https://www.facebook.com/GSKItalia/":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK Italia","status":"new"},"https://www.facebook.com/glaxosmithkline.japan/":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK Japan","status":"new"},"https://www.facebook.com/GSKTurkiye/":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK Turkyie","status":"new"},"https://www.facebook.com/pages/GSK-UK-Students-Graduates/123487331131018":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"GSK UK students and graduates","status":"new"},"https://www.facebook.com/pg/GSK/about/":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"terms and conditions","status":"new"},"https://www.youtube.com/user/gskvision":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"Subscribe to our Youtube channel","status":"new"},"https://www.linkedin.com/company/glaxosmithkline/":{"firstFound":"https://www.gsk.com/en-gb/media/social-media/","txt":"Follow our global LinkedIn account","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/albums":{"firstFound":"https://www.gsk.com/en-gb/media/image-and-video-library/","txt":"Flickr","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/albums/72157626117401499":{"firstFound":"https://www.gsk.com/en-gb/media/image-and-video-library/","txt":"our locations","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/albums/72157626748527760":{"firstFound":"https://www.gsk.com/en-gb/media/image-and-video-library/","txt":"senior company executives","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/albums/72157626243462942/with/5517561688/":{"firstFound":"https://www.gsk.com/en-gb/media/image-and-video-library/","txt":"company heritage","status":"new"},"http://www.youtube.com/c/GSK":{"firstFound":"https://www.gsk.com/en-gb/media/image-and-video-library/","txt":"YouTube","status":"new"},"http://gskmedia.pharmiwebsolutions.com/":{"firstFound":"https://www.gsk.com/en-gb/media/image-and-video-library/","txt":"Video footage library","status":"new"},"http://us.gsk.com/en-us/media/media-contacts/":{"firstFound":"https://www.gsk.com/en-gb/media/media-contact-details/","txt":"USA media contacts","status":"new"},"https://www.youtube.com/embed/lxsRuw4XUPE?rel=0":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/","txt":"View video on YouTube","status":"new"},"http://www.viivhealthcare.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-a-new-specialist-hiv-company-dedicated-to-delivering-advances-in-hiv-treatment-and-care/","txt":"www.viivhealthcare.com","status":"new"},"https://www.youtube.com/watch?v=N1JBWeTmz94&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/helping-women-to-give-birth-safely/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=9Tcukhbxzm0&rel=0":{"firstFound":"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/health-and-well-being-in-communities/","txt":"View video on YouTube","status":"new"},"https://maps.google.com/maps?ll=29.68755,21.355807&z=2&t=m&hl=en-GB&gl=US&mapclient=apiv3":{"firstFound":"https://www.gsk.com/en-gb/research/rd-locations/","txt":"*** IMAGE WITHOUT ALT TEXT ***","status":"new"},"https://www.google.com/intl/en-GB_US/help/terms_maps.html":{"firstFound":"https://www.gsk.com/en-gb/research/rd-locations/","txt":"Terms of Use","status":"new"},"https://www.google.com/maps/@29.6875501,21.355807,2z/data=!10m1!1e1!12b1?source=apiv3&rapsrc=apiv3":{"firstFound":"https://www.gsk.com/en-gb/research/rd-locations/","txt":"Report a map error","status":"new"},"http://www.youtube.com/watch?v=hUhIkkHXtGA&rel=0":{"firstFound":"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/sustainable-development/","txt":"View video on YouTube","status":"new"},"http://www.viivhealthcare.com/about-us.aspx":{"firstFound":"https://www.gsk.com/en-gb/responsibility/access-to-healthcare/sustainable-development/","txt":"Find out more about our work on HIV (ViiV website)","status":"new"},"https://youtu.be/_y2rG5XPZ0c?rel=0":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/sales-and-marketing-practices/","txt":"View video on YouTube","status":"new"},"http://uk.gsk.com/media/278613/gsk-ppg-criteria.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/public-policy-and-patient-advocacy/","txt":"criteria","status":"new"},"http://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=7990322925-77&isListLobbyistView=true":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/public-policy-and-patient-advocacy/","txt":"EU Transparency Register","status":"new"},"http://www.senate.gov/legislative/Public_Disclosure/LDA_reports.html":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/public-policy-and-patient-advocacy/","txt":"the US Federal Lobbying Register","status":"new"},"https://supplier.gsk.com/irj/portal/public?NavigationTarget=navurl://cb5792fd4e6fd9456d1c8fc2e0ce4190&guest_user=SUP_GUEST_EN":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/working-with-third-parties/","txt":"getting paid","status":"new"},"http://2degreesnetwork.hs-sites.com/joingskexchange":{"firstFound":"https://www.gsk.com/en-gb/responsibility/environment/carbon/","txt":"GSK Supplier Exchange","status":"new"},"http://uk.gsk.com/en-gb/responsibility/our-planet/complete-the-cycle/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/complete-the-cycle-how-we-re-recycling-inhalers/","txt":"Complete the Cycle (GSK UK)","status":"new"},"http://fortherecord.payments.us.gsk.com/hcppayments/grants.html":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/charitable-grants/","txt":"Read more ","status":"new"},"http://www.gsk.bg/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"GSK Bulgaria","status":"new"},"http://fr.gsk.com/fr-fr/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"France","status":"new"},"https://de.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Germany","status":"new"},"http://www.glaxosmithkline.ch/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Switzerland","status":"new"},"http://uk.gsk.com/en-gb/responsibility/health-for-all/gsk-impact-awards/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/supporting-community-health-across-the-uk/","txt":"GSK IMPACT Awards","status":"new"},"http://au.gsk.com/en-au/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Australia","status":"new"},"http://ca.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Canada ","status":"new"},"http://www.kr.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Korea","status":"new"},"https://my.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/patient-group-funding/","txt":"Malaysia ","status":"new"},"http://www.sec.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-to-increase-its-ownership-in-theravance/","txt":"http://www.sec.gov/","status":"new"},"http://www.btconferencing.com/globalaccess/?bid=54_attended":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-global-hiv-business-viiv-healthcare-to-acquire-bristol-myers-squibb-s-rd-hiv-assets/","txt":"http://www.btconferencing.com/globalaccess/?bid=54_attended","status":"new"},"http://glaxosmithkline.co.jp/viiv/medical/medicine.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/juluca-dolutegravirrilpivirine-the-first-single-pill-2-drug-regimen-for-the-maintenance-treatment-of-hiv-granted-marketing-approval-by-japan-ministry-of-health-labour-and-welfare/","txt":"http://glaxosmithkline.co.jp/viiv/medical/medicine.html","status":"new"},"https://health.gsk.com/content/healthgskEURedesign/homePage/en_GB/ReportAdverseEvent.html?itemKey=253700&rik=253700&user_locale=en_GB":{"firstFound":"https://www.gsk.com/en-gb/terms-of-use/","txt":"contact us using this form","status":"new"},"https://admin-staging.gsk.com/en-gb/privacy/":{"firstFound":"https://www.gsk.com/en-gb/terms-of-use/","txt":"privacy statement","status":"new"},"http://www.aboutcookies.org/":{"firstFound":"https://www.gsk.com/en-gb/cookie-policy","txt":"www.aboutcookies.org","status":"new"},"https://www.addthis.com/website-tools/overview?utm_source=AddThis%20Tools&utm_medium=image":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/from-academia-to-industry-a-new-challenge/","txt":"AddThis","status":"new"},"https://youtu.be/nHrinQnlir4?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/how-do-consumer-insights-fuel-our-innovation/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/glhr645bf38?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/how-do-consumer-insights-fuel-our-innovation/","txt":"View video on YouTube","status":"new"},"https://ec.europa.eu/info/law/law-topic/data-protection/data-transfers-outside-eu/model-contracts-transfer-personal-data-third-countries_en":{"firstFound":"https://www.gsk.com/en-gb/privacy-notice/","txt":"here","status":"new"},"http://www.w3.org/TR/WCAG20/":{"firstFound":"https://www.gsk.com/en-gb/accessibility/","txt":"World Wide Web Consortium Web Accessibility Initiative (WCAG WAI) 2.0 guidelines.","status":"new"},"http://www.adobe.com/accessibility/index.html":{"firstFound":"https://www.gsk.com/en-gb/accessibility/","txt":"Adobe Accessibility Resource Center.","status":"new"},"tel:+(355) 42 22 50 46":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(355) 42 22 50 46","status":"new"},"tel:+(213) 24 84 32 20":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(213) 24 84 32 20","status":"new"},"tel:+(213) 24 84 32 62":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(213) 24 84 32 62","status":"new"},"tel:+(54) 11 4725 8900":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(54) 11 4725 8900","status":"new"},"tel:+(61) 03 9721 6000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(61) 03 9721 6000","status":"new"},"tel:+(61) 03 9729 5319":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(61) 03 9729 5319","status":"new"},"tel:+(43) 1 970 75 0":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(43) 1 970 75 0","status":"new"},"tel:+(880) 2 985 8870":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(880) 2 985 8870","status":"new"},"tel:+(375) 17 213 20 16":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(375) 17 213 20 16","status":"new"},"tel:+(32) 10 85 85 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(32) 10 85 85 00   ","status":"new"},"tel:+(387) 33 959 000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(387) 33 959 000","status":"new"},"tel:+(0800) 701 22 33":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(0800) 701 22 33","status":"new"},"tel:+(0800) 704 31 89":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(0800) 704 31 89","status":"new"},"tel:+(0800) 021 15 29":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(0800) 021 15 29","status":"new"},"tel:+(359) 2 953 1034":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(359) 2 953 1034","status":"new"},"tel:+(905) 819 3000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(905) 819 3000","status":"new"},"tel:+(1) 800 572 7742":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(1) 800 572 7742","status":"new"},"tel:+(1) 800 203 8771":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(1) 800 203 8771","status":"new"},"tel:+(562) 3829000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(562) 3829000","status":"new"},"tel:+(562) 3829044":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(562) 3829044","status":"new"},"tel:+(86) 21 2301 9800":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(86) 21 2301 9800","status":"new"},"tel:+(571) 417 8686":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(571) 417 8686","status":"new"},"tel:+(506) 2206 6000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(506) 2206 6000","status":"new"},"tel:+(385) 0 1 6051 999":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(385) 0 1 6051 999","status":"new"},"tel:+(357) 223 97000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"+(357) 223 97000","status":"new"},"http://www.nature.com/articles/s41586-018-0705-y":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/cancer-gets-a-sting-with-new-discovery/","txt":"paper","status":"new"},"http://erj.ersjournals.com/content/51/2/1702146":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/copd-is-more-than-a-lung-disease/","txt":"described a group of participants with Multi-Organ Loss of Tissue","status":"new"},"https://youtu.be/qrmak3QJVHU?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/copd-is-more-than-a-lung-disease/","txt":"View video on YouTube","status":"new"},"https://www.linkedin.com/in/ruth-tal-singer-0065b868/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/copd-is-more-than-a-lung-disease/","txt":"Ruth's LinkedIn profile","status":"new"},"https://www.linkedin.com/in/pauline-williams-md-ffpm-fmedsci-072792a/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/from-bench-to-bedside-lessons-in-converting-science-into-impact/","txt":"Pauline Williams’ LinkedIn profile","status":"new"},"https://youtu.be/ijsa37CdXJY?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/welcome-to-the-golden-age-of-vaccine-innovation/","txt":"View video on YouTube","status":"new"},"https://youtu.be/reRjtkwb4Qk?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/welcome-to-the-golden-age-of-vaccine-innovation/","txt":"View video on YouTube","status":"new"},"https://youtu.be/FjAuU5OtIl8?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/welcome-to-the-golden-age-of-vaccine-innovation/","txt":"View video on YouTube","status":"new"},"https://youtu.be/jx_J_VldcNk?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/welcome-to-the-golden-age-of-vaccine-innovation/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/playlist?list=PLvDyxtKlIcngQxuVx4TgrUk_nFnOqlp3p":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/welcome-to-the-golden-age-of-vaccine-innovation/","txt":"Find out more about the science behind vaccines on YouTube","status":"new"},"https://www.gatesfoundation.org/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/overcoming-obstacles-to-end-malaria/","txt":"Bill and Melinda Gates Foundation","status":"new"},"http://www.openlabfoundation.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-welcomes-external-scientists-to-diseases-of-the-developing-world-research-campus/","txt":"www.openlabfoundation.org","status":"new"},"https://youtu.be/OUExK8OgHDI?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/you-me-and-23andme-discovering-new-medicines-through-genetics/","txt":"View video on YouTube","status":"new"},"https://www.23andme.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/you-me-and-23andme-discovering-new-medicines-through-genetics/","txt":"23andMe","status":"new"},"https://www.nature.com/articles/ng.3314":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/you-me-and-23andme-discovering-new-medicines-through-genetics/","txt":"https://www.nature.com/articles/ng.3314","status":"new"},"https://www.mmv.org/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/why-are-we-fighting-malaria-in-the-lab-and-on-the-ground/","txt":"Medicine for Malaria Ventures","status":"new"},"https://www.youtube.com/watch?v=9KhCWhgmPT8&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/overcoming-obstacles-to-end-malaria/","txt":"View video on YouTube","status":"new"},"http://www.path.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/first-results-from-ongoing-phase-iii-trial-show-malaria-vaccine-candidate-rts-sstar-reduces-the-risk-of-malaria-by-half-in-african-children-aged-5-to-17-months/","txt":"www.path.org","status":"new"},"https://www.youtube.com/watch?v=75Pb6_dPIFY":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/complete-the-cycle-how-we-re-recycling-inhalers/","txt":"\n                    \n                        \n                    \n                ","status":"new"},"https://www.youtube.com/watch?v=75Pb6_dPIFY&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/complete-the-cycle-how-we-re-recycling-inhalers/","txt":"View video on YouTube","status":"new"},"https://youtu.be/Ni2bAooDNAg?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/living-with-severe-asthma/","txt":"View video on YouTube","status":"new"},"https://youtu.be/skQfnkKJlhI?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/living-with-severe-asthma/","txt":"View video on YouTube","status":"new"},"https://youtu.be/BQexrhrK9MA?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/living-with-severe-asthma/","txt":"View video on YouTube","status":"new"},"https://www.ncbi.nlm.nih.gov/pubmed/25544991":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/living-with-severe-asthma/","txt":"https://www.ncbi.nlm.nih.gov/pubmed/25544991","status":"new"},"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600410/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/why-are-we-fighting-malaria-in-the-lab-and-on-the-ground/","txt":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600410/","status":"new"},"https://www.youtube.com/embed/vJfxk4vsmoI?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/following-the-journey-of-a-respiratory-medicine/","txt":"View video on YouTube","status":"new"},"https://www.usinlupus.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/lupus-the-search-for-a-cure-continues/","txt":"USinLupus.com","status":"new"},"https://www.youtube.com/embed/Rh2xJSNhJos?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/copd-for-john-just-means-doing-everything-at-a-slower-pace/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/0gRWEHAtzPY?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/making-the-ellipta-inhaler-a-reality/","txt":"View video on YouTube","status":"new"},"https://youtu.be/S0cun5Xsr_E?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/overcoming-the-challenges-of-copd-to-fulfil-a-lifelong-dream/","txt":"View video on YouTube","status":"new"},"https://youtu.be/aX7v7wD4pp8?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/overcoming-the-challenges-of-copd-to-fulfil-a-lifelong-dream/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=CVNsm344p0s&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/the-science-of-shopping/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/nIugMb8upYw?&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/the-science-of-shopping/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/shuTfu3-0ZU?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/i-control-my-asthma-it-doesn-t-control-me/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=MUrAnU047QE&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/youll-outgrow-some-childhood-habits-but-vaccination-is-for-life/","txt":"View video on YouTube","status":"new"},"https://twitter.com/search?q=%23vaccinateforlife&src=typd":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/youll-outgrow-some-childhood-habits-but-vaccination-is-for-life/","txt":"#vaccinateforlife","status":"new"},"http://www.tandfonline.com/doi/full/10.1586/14760584.2014.933077":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/youll-outgrow-some-childhood-habits-but-vaccination-is-for-life/","txt":"http://www.tandfonline.com/doi/full/10.1586/14760584.2014.933077","status":"new"},"http://onlinelibrary.wiley.com/doi/10.1111/ijcp.12646/abstract;jsessionid=A09497EDA97579941A9FB5FDB53731E0.f04t04":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/youll-outgrow-some-childhood-habits-but-vaccination-is-for-life/","txt":"http://onlinelibrary.wiley.com/doi/10.1111/ijcp.12646/abstract;jsessionid=A09497EDA97579941A9FB5FDB53731E0.f04t04","status":"new"},"http://www.sciencedirect.com/science/article/pii/S1052305716303500":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/youll-outgrow-some-childhood-habits-but-vaccination-is-for-life/","txt":"http://www.sciencedirect.com/science/article/pii/S1052305716303500","status":"new"},"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486398/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/youll-outgrow-some-childhood-habits-but-vaccination-is-for-life/","txt":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486398/","status":"new"},"http://www.worldlupusfederation.org/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/from-tv-to-tackling-lupus-why-alex-moved-from-media-to-medicine/","txt":"World Lupus Federation","status":"new"},"http://www.worldlupusday.org/e-report.html":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/from-tv-to-tackling-lupus-why-alex-moved-from-media-to-medicine/","txt":"World Lupus Day Report","status":"new"},"https://youtu.be/_JKreEUaQvM?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/giving-a-bit-back-christine-s-experience-of-clinical-research/","txt":"View video on YouTube","status":"new"},"http://www.asthmacontroltest.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/giving-a-bit-back-christine-s-experience-of-clinical-research/","txt":"Asthma Control Test","status":"new"},"https://www.youtube.com/embed/w8eRd5kmrYI?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/healthcare-in-your-pocket/","txt":"View video on YouTube","status":"new"},"https://www.statista.com/statistics/276623/number-of-apps-available-in-leading-app-stores/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/healthcare-in-your-pocket/","txt":"https://www.statista.com/statistics/276623/number-of-apps-available-in-leading-app-stores/","status":"new"},"https://research2guidance.com/325000-mobile-health-apps-available-in-2017/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/healthcare-in-your-pocket/","txt":"https://research2guidance.com/325000-mobile-health-apps-available-in-2017/","status":"new"},"http://mhealthintelligence.com/news/mhealth-app-market-sees-400-million-growth-in-five-years":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/healthcare-in-your-pocket/","txt":"http://mhealthintelligence.com/news/mhealth-app-market-sees-400-million-growth-in-five-years","status":"new"},"https://youtu.be/b3D5pOW6vFs?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-race-against-malaria-handing-the-baton-to-the-next-generation/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=fjs026r8fi0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/win-for-meningitis-harnessing-the-power-of-inspirational-images-to-create-a-win-for-disease-prevention/","txt":"\n                    \n                        \n                    \n                ","status":"new"},"http://www.bmj.com/content/357/bmj.j1726":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/setting-the-record-straight-why-we-publish-data-both-positive-and-negative/","txt":"published recently in the BMJ","status":"new"},"http://www.clinicaltrials.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-submit-arzerra-ofatumumab-application-to-fda-for-the-treatment-of-advanced-stage-blood-cancer/","txt":"www.clinicaltrials.gov","status":"new"},"https://www.kingsfund.org.uk/projects/gsk-impact-awards":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/supporting-community-health-across-the-uk/","txt":"The King’s Fund","status":"new"},"https://www.youtube.com/watch?v=bLLCCesIYbc&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/supporting-community-health-across-the-uk/","txt":"View video on YouTube","status":"new"},"http://www.unaids.org/en/resources/fact-sheet":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-shares-data-from-its-innovative-portfolio-with-hiv-community-at-ias-2017/","txt":"http://www.unaids.org/en/resources/fact-sheet","status":"new"},"https://www.viivhealthcare.com/what-we-do.aspx":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/hiv-research-focus-on-finding-a-cure/","txt":"ViiV Healthcare","status":"new"},"https://youtu.be/ZZMsd4o3f_4?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/what-are-bioelectronics/","txt":"View video on YouTube","status":"new"},"https://youtu.be/7j_GHlZve7U?rel=0":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"View video on YouTube","status":"new"},"https://www.bloomberg.com/news/articles/2016-06-09/only-one-big-drugmaker-is-working-on-a-nanobot-cure":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/what-are-bioelectronics/","txt":"Only One Big Drugmaker Is Working on a Nanobot Cure","status":"new"},"https://youtu.be/AfmmZDzpFPw?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/helping-patients-with-respiratory-disease/","txt":"View video on YouTube","status":"new"},"https://youtu.be/uuO7C_eJNdE?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/helping-patients-with-respiratory-disease/","txt":"View video on YouTube","status":"new"},"https://youtu.be/vUVvCUzfVzo?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/vaccines-for-preventable-diseases/","txt":"View video on YouTube","status":"new"},"https://youtu.be/OVE38dqcCXc?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/joining-forces-to-fight-malaria/","txt":"View video on YouTube","status":"new"},"https://youtu.be/eXxzzPvjUYM?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/joining-forces-to-fight-malaria/","txt":"View video on YouTube","status":"new"},"http://www.gskscienceeducation.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/stem-inspiring-real-world-scientists/","txt":"schools programmes","status":"new"},"http://www.telegraph.co.uk/education/stem-awards/healthcare/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/stem-inspiring-real-world-scientists/","txt":"Telegraph STEM Awards 2017","status":"new"},"https://youtu.be/GXLXyBIg0ao?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/stem-inspiring-real-world-scientists/","txt":"View video on YouTube","status":"new"},"http://www.copdchoices.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/copd-our-relentless-pursuit-for-better-breathing/","txt":"COPDchoices","status":"new"},"http://www.copdchoices.gsk.com/en-gb/video-library/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/copd-our-relentless-pursuit-for-better-breathing/","txt":"Ann, Bob & Rebecca","status":"new"},"https://www.youtube.com/watch?v=u-C4CulJFls&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/getting-on-target-in-autoimmune-diseases/","txt":"View video on YouTube","status":"new"},"https://youtu.be/zqVnlF58v2o?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/getting-on-target-in-autoimmune-diseases/","txt":"View video on YouTube","status":"new"},"http://www.who.int/mediacentre/factsheets/fs378/en/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/maternal-immunisation-helping-protect-mums-and-babies/","txt":"Childhood vaccination","status":"new"},"http://www.who.int/mediacentre/factsheets/fs178/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-inspiring-innovations-which-help-reduce-child-deaths-in-developing-countries-share-1-million-prize-from-gsk-and-save-the-children/","txt":"http://www.who.int/mediacentre/factsheets/fs178/en/","status":"new"},"http://cdrwww.who.int/immunization/diseases/MNTE_initiative/en/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/maternal-immunisation-helping-protect-mums-and-babies/","txt":"http://cdrwww.who.int/immunization/diseases/MNTE_initiative/en/","status":"new"},"http://www.cdc.gov/features/pertussis/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/maternal-immunisation-helping-protect-mums-and-babies/","txt":"http://www.cdc.gov/features/pertussis/","status":"new"},"http://www.cdc.gov/flu/protect/vaccine/pregnant.htm":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/maternal-immunisation-helping-protect-mums-and-babies/","txt":"http://www.cdc.gov/flu/protect/vaccine/pregnant.htm","status":"new"},"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255794/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/maternal-immunisation-helping-protect-mums-and-babies/","txt":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255794/","status":"new"},"https://www.youtube.com/watch?v=MRHLRXii8Qw&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/tackling-tomorrow-s-health-challenges-today/","txt":"View video on YouTube","status":"new"},"https://en.wikipedia.org/wiki/Albert_Sabin":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/tackling-tomorrow-s-health-challenges-today/","txt":"Albert Sabin","status":"new"},"file:///C:/Users/wd548530/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/GL73I7ZY/Rabies%20Behind%20the%20Science%20feature-FINAL-15%20Sept.doc":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/rabies-educate-vaccinate-eliminate/","txt":"","status":"new"},"http://www.who.int/mediacentre/factsheets/fs099/en/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/rabies-educate-vaccinate-eliminate/","txt":"http://www.who.int/mediacentre/factsheets/fs099/en/#","status":"new"},"https://youtu.be/Nnj31kkwRN8?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/collaboration-unlocking-a-new-approach-to-clinical-trials/","txt":"View video on YouTube","status":"new"},"http://fortune.com/2016/08/18/change-world-companies-profit/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/helping-to-change-the-world/","txt":"published its 2016 list","status":"new"},"http://beta.fortune.com/change-the-world/gsk-1":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/helping-to-change-the-world/","txt":"honored to be ranked #1","status":"new"},"file:///C:/Users/wd548530/Desktop/Humanitarian%20Leadership%20Academy%20-%20Betsy%20Edits%20(2).docx":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/a-new-response-to-humanitarian-crises/","txt":"","status":"new"},"http://www.humanitarianleadershipacademy.org/wp-content/uploads/2016/03/HLA-4-Page-Map-Amend-Low-Res.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/a-new-response-to-humanitarian-crises/","txt":"http://www.humanitarianleadershipacademy.org/wp-content/uploads/2016/03/HLA-4-Page-Map-Amend-Low-Res.pdf","status":"new"},"http://www.un.org/apps/news/story.asp?NewsID=49642":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/a-new-response-to-humanitarian-crises/","txt":"http://www.un.org/apps/news/story.asp?NewsID=49642#.Vwxvtfl97RY","status":"new"},"http://sites.path.org/vietnam/vaccines-and-immunization/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/","txt":"PATH Vietnam","status":"new"},"http://www.path.org/publications/files/ID_vietnam_immreg_fs_2017.pdf":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/","txt":" http://www.path.org/publications/files/ID_vietnam_immreg_fs_2017.pdf","status":"new"},"http://www.healthcareinnovationaward.org/en/home/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/","txt":"Healthcare Innovation Awards","status":"new"},"http://www.vietnamonline.com/destination/ben-tre.html":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/","txt":"http://www.vietnamonline.com/destination/ben-tre.html","status":"new"},"http://databank.worldbank.org/data/reports.aspx?source=2&country=VNM&series=&period":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/","txt":"http://databank.worldbank.org/data/reports.aspx?source=2&country=VNM&series=&period= ","status":"new"},"http://tuoitrenews.vn/society/28733/facebook-now-has-30-million-monthly-active-users-in-vietnam":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/","txt":"http://tuoitrenews.vn/society/28733/facebook-now-has-30-million-monthly-active-users-in-vietnam","status":"new"},"http://orangeunited.gsk.com/orange-united/en/about/our-ambition/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/","txt":"http://orangeunited.gsk.com/orange-united/en/about/our-ambition/","status":"new"},"http://www.healthcareinnovationaward.org/en/2016-award/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-app-that-could-save-lives/","txt":"2016 Healthcare Innovation Award","status":"new"},"https://www.iss-casis.org/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/from-microscope-to-telescope-and-beyond-exploring-with-nasas-casis/","txt":"NASA’s CASIS, the Center for Advancement of Science in Space","status":"new"},"https://www.youtube.com/watch?v=Zz7vZBgKxr8&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/from-microscope-to-telescope-and-beyond-exploring-with-nasas-casis/","txt":"View video on YouTube","status":"new"},"https://youtu.be/GcvTJYbPYFA?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/andy-dundon-the-design-behind-the-device/","txt":"View video on YouTube","status":"new"},"https://youtu.be/ieayI4Y7LCA?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/andy-dundon-the-design-behind-the-device/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=XE1wJYObX2g":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/an-everyday-world-first-in-clinical-trials/","txt":"\n                    \n                        \n                    \n                ","status":"new"},"https://www.youtube.com/watch?v=AoT4Q6NPjco":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/turning-the-tide-on-antibiotic-resistance/","txt":"\n                    \n                        \n                    \n                ","status":"new"},"https://youtu.be/dCIsS9cz6Ag?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/turning-the-tide-on-antibiotic-resistance/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=WNYa2kM7tVY&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/guardian-article-the-30-year-quest-for-a-malaria-vaccine/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=P8jrdAK6tNA&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/guardian-article-the-30-year-quest-for-a-malaria-vaccine/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=QMqOXkCp6nA&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/no-silver-bullet-to-tackle-this-disease/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=93hOfV8hhQM":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/giving-mothers-and-babies-a-healthier-start/","txt":"Video: Chlorhexidine - development story","status":"new"},"https://www.youtube.com/watch?v=J0SvutsCHrU":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/vaccine-manufacture-it-s-complicated/","txt":"\n                    \n                        \n                    \n                ","status":"new"},"http://www.youtube.com/watch?v=J0SvutsCHrU&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/vaccine-manufacture-it-s-complicated/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=TIDTx7tYJVw&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/the-power-of-partnerships-transforming-vaccine-coverage-in-mozambique/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=GvvA65svUeY&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/living-with-lupus-a-patient-perspective/","txt":"View video on YouTube","status":"new"},"http://erj.ersjournals.com/content/early/2016/02/25/13993003.01406-2015":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/take-a-deep-breath-your-lung-microbiome-will-appreciate-it/","txt":"European Respiratory Journal","status":"new"},"https://www.youtube.com/watch?v=ivtbykeFL4U&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/helping-to-further-science-and-research-howard-s-perspective/","txt":"View video on YouTube","status":"new"},"http://www.sxsw.com/interactive/about":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/bioelectronics-at-sxsw-2016/","txt":"SXSW Interactive","status":"new"},"http://schedule.sxsw.com/2016/events/event_PP52190":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/bioelectronics-at-sxsw-2016/","txt":"Inner Space: Bioelectronics and Medicine's Future","status":"new"},"https://www.gskscienceeducation.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/school-leading-the-way-to-inspire-young-scientists/","txt":"found here","status":"new"},"http://www.telegraph.co.uk/sponsored/education/stem-awards/healthcare/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/telegraph-article-science-hasnt-answered-all-the-questions-on-hiv/","txt":"as part of The Telegraph UK STEM Awards","status":"new"},"http://amref.org/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/five-years-40-000-health-workers-11-million-people/","txt":"Amref Health Africa in east Africa","status":"new"},"http://www.careinternational.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/our-people/guardian-article-making-a-change-from-the-inside/","txt":"Care International ","status":"new"},"http://www.savethechildren.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-form-unique-partnership-to-save-the-lives-of-one-million-children/","txt":"www.savethechildren.org.uk","status":"new"},"http://www.umcg.nl/EN/corporate/Paginas/default.aspx":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/outgrowing-asthma-rooting-out-the-reasons-for-asthma-remission/","txt":"Groningen Research Institute for Asthma and Chronic Obstructive Pulmonary Disease","status":"new"},"http://artofsavingalife.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-art-inspired-by-vaccination/","txt":"Artofsavingalife.com","status":"new"},"http://www.tedmed.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-art-inspired-by-vaccination/","txt":"Tedmed.com","status":"new"},"http://artofsavingalife.com/artists/gmb-akash/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-art-inspired-by-vaccination/","txt":"photograph","status":"new"},"http://artofsavingalife.com/artists/katerina-athanasopoulou-2/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-art-inspired-by-vaccination/","txt":"Rupture. A War is Won and Lost","status":"new"},"http://artofsavingalife.com/artists/lang-lang/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/tedmed-2015-art-inspired-by-vaccination/","txt":"Afternoon of a Faun","status":"new"},"https://www.gskscienceeducation.com/en-gb/challenges/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/patients-consumers/stem-in-the-real-world/","txt":"https://www.gskscienceeducation.com/en-gb/challenges/","status":"new"},"http://sg.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"GSK Singapore","status":"new"},"http://sg.gsk.com/en-sg/about-us/sites/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/using-biology-to-increase-quality-and-reduce-carbon-footprint/","txt":"Quality Road in Singapore","status":"new"},"http://www.edb.gov.sg/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/using-biology-to-increase-quality-and-reduce-carbon-footprint/","txt":"Singapore Economic Development Board","status":"new"},"http://sg.gsk.com/en-sg/media/press-releases/2015/gsk-invests-a-further-s-77mil-to-enhance-antibiotic-manufacturing-facility-in-singapore/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/using-biology-to-increase-quality-and-reduce-carbon-footprint/","txt":"GSK announced it would be investing an additional £38M (S$77M) in the Quality Road manufacturing plant in Singapore","status":"new"},"http://www.who.int/en/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/ebola-vaccine-rd/","txt":"WHO","status":"new"},"https://secure.savethechildren.org.uk/donate/?utm_campaign=ppc&utm_medium=ppc&utm_source=ppcbran&sissr=1":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/five-years-40-000-health-workers-11-million-people/","txt":"Save the Children in west and central Africa","status":"new"},"http://www.careinternational.org.uk/?utm_source=google&utm_medium=cpc&utm_term=care%20international&utm_campaign=Brand&gclid=CMv3ttys4sgCFYcTHwodT4MPrw":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/five-years-40-000-health-workers-11-million-people/","txt":"CARE International in Asia","status":"new"},"https://www.youtube.com/watch?v=dL3hQGf7o5w&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/targeting-the-immune-system-through-open-innovation/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=JoBEVmoxQ3c&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/targeting-the-immune-system-through-open-innovation/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=zHOwed5_Jik&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/targeting-the-immune-system-through-open-innovation/","txt":"View video on YouTube","status":"new"},"https://youtu.be/pDIOIX26L-w?list=PLvDyxtKlIcnjkRhOdE7wA8EetZ0TQpUET&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/to-challenge-to-change/to-challenge-to-change/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=QMqOXkCp6nA":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/vaccines-coming-in-from-the-cold/","txt":"Video: Our 30-year quest to develop a malaria vaccine","status":"new"},"https://www.youtube.com/watch?v=74LrBt1_-wY?rel=0&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/ebola-our-fast-track-response/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=74LrBt1_-wY&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/ebola-vaccine-rd/","txt":"View video on YouTube","status":"new"},"http://www.nature.com/nmat/journal/v13/n7/full/nmat3949.html":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/fluorescent-bacteria-nowhere-to-hide/","txt":"published in the journal Nature Materials","status":"new"},"http://www.gavi.org/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/making-our-vaccines-more-accessible/","txt":"Gavi","status":"new"},"http://www.unicef.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/making-our-vaccines-more-accessible/","txt":"UNICEF","status":"new"},"http://www.unicef.org/immunization/polio/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/making-our-vaccines-more-accessible/","txt":"UNICEF’s polio vaccine requirements","status":"new"},"http://www.gatesfoundation.org/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/forming-public-partnerships/","txt":"the Bill and Melinda Gates Foundation","status":"new"},"http://www.hsr.it/research/organization/institutes/sr-tiget/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/cell-and-gene-therapy-a-new-era-of-medicine/","txt":"San Raffaele Telethon Institute for Gene Therapy","status":"new"},"https://www.youtube.com/watch?v=sh7ioHNH2CE&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/why-our-transaction-with-novartis-is-different/","txt":"View video on YouTube","status":"new"},"http://www.nejm.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-oxford-university-phase-i-trial-results-of-an-ebola-candidate-vaccine/","txt":"New England Journal of Medicine","status":"new"},"http://www.wellcome.ac.uk/?gclid=CMbh4vnc0MgCFVEYGwodo6wE2Q":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/ebola-vaccine-rd/","txt":"Wellcome Trust","status":"new"},"http://www.mrc.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/unique-research-alliance-expands-collaboration-opportunities-at-state-of-the-art-medical-imaging-centre/","txt":"www.mrc.ac.uk","status":"new"},"https://www.gov.uk/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/ebola-vaccine-rd/","txt":"UK Government","status":"new"},"https://www.youtube.com/watch?v=74LrBt1_-wY":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/forming-public-partnerships/","txt":"Video: Developing an Ebola vaccine candidate","status":"new"},"https://youtu.be/74LrBt1_-wY?rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/our-humanitarian-response-to-the-ebola-outbreak/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=gxYQrJ9shE0&rel=0":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/access-to-healthcare/the-critical-workers-boosting-children-s-health/","txt":"View video on YouTube","status":"new"},"http://www.nature.com/nbt/journal/v31/n4/full/nbt.2543.html":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/bacteria-friends-or-foes/","txt":"Nature Biotechnology","status":"new"},"http://onlinelibrary.wiley.com/doi/10.1002/ddr.21088/full":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/bacteria-friends-or-foes/","txt":"Drug Development Research","status":"new"},"http://www.nature.com/nature/journal/v500/n7464/full/500505d.html":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/bacteria-friends-or-foes/","txt":"http://www.nature.com/nature/journal/v500/n7464/full/500505d.html","status":"new"},"http://www.who.int/malaria/media/world_malaria_report_2013/en/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/can-mosquitoes-prevent-malaria/","txt":"http://www.who.int/malaria/media/world_malaria_report_2013/en/","status":"new"},"https://www.mrc.ac.uk/research/facilities-and-resources-for-researchers/dementias-platform-uk/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/neuroscience-on-the-brain/","txt":"UK Dementia Platform","status":"new"},"http://theddfund.com/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/innovation/neuroscience-on-the-brain/","txt":"Dementia Discovery Fund","status":"new"},"http://www.fapesp.br/en/":{"firstFound":"https://www.gsk.com/en-gb/behind-the-science/how-we-do-business/green-chemistry/","txt":"São Paulo Research Foundation","status":"new"},"http://uk.gsk.com/en-gb/careers/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/careers/","txt":"UK careers website","status":"new"},"https://www.facebook.com/gskstudentsandgraduates/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/careers/","txt":"UK students & graduates on Facebook","status":"new"},"http://us.gsk.com/en-us/careers/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/careers/","txt":"US careers website","status":"new"},"https://www.facebook.com/FuturosLideresGSK?fref=ts":{"firstFound":"https://www.gsk.com/en-gb/contact-us/careers/","txt":"Latin America graduates on Facebook","status":"new"},"https://gskbd.az1.qualtrics.com/jfe/form/SV_blKINXuOIpC7bXD":{"firstFound":"https://www.gsk.com/en-gb/contact-us/partnerships/","txt":"Pharmaceuticals R&D","status":"new"},"http://innovation.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/","txt":"http://innovation.gsk.com/","status":"new"},"http://www.dpac.gsk.com/partnering.html":{"firstFound":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/","txt":"Discovery Partnerships with Academia website","status":"new"},"http://www.openlabfoundation.org/collaborate/becomePartner.html":{"firstFound":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/","txt":"Tres Cantos website","status":"new"},"https://www.tnwgrc.com/gsk/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/headquarters/","txt":"Speak Up Integrity Lines","status":"new"},"tel:+44 (0)20 8047 5000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/headquarters/","txt":"+44 (0)20 8047 5000","status":"new"},"tel:+1 888 825 5249":{"firstFound":"https://www.gsk.com/en-gb/contact-us/headquarters/","txt":"+1 888 825 5249","status":"new"},"https://youtu.be/AoT4Q6NPjco?rel=0":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/","txt":"View video on YouTube","status":"new"},"http://www.imi.europa.eu/":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/","txt":"Innovative Medicines Initiative","status":"new"},"http://www.phe.gov/about/barda/Pages/default.aspx":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/","txt":"US Biomedical Advanced Research Development Authority ","status":"new"},"https://longitudeprize.org/blog?page=3":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/antibiotics-research/","txt":"Longitude Prize blog site","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/33641498076/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/simon-dingemans/","txt":"download image from Flickr","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/32856154704/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/roger-connor/","txt":"download image from Flickr","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/42533019270/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/james-ford/","txt":"download image from FlickR","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/29765036878/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/dr-hal-barron/","txt":"download image from Flickr","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/33642149276/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/brian-mcnamara/","txt":"download image from Flickr","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/37068002662":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/karenann-terrell-appointed-chief-digital-technology-officer-gsk/","txt":"Download image from FlickR","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/32869418043/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/emma-walmsley/","txt":"download image from Flickr ","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/33542042402/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/claire-thomas/","txt":"download image from Flickr","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/31302628528/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/regis-simard/","txt":"Download image from Flickr","status":"new"},"https://www.coronationfestival.com/the-event/exhibitor-news/141-gsk-was-delighted-to-support-the-coronation-festival-as-a-headline-partner":{"firstFound":"https://www.gsk.com/en-gb/about-us/our-history/meet-jill-a-keeper-of-gsk-s-history/","txt":"Coronation festival","status":"new"},"http://www.horlicks.co.uk/story.html":{"firstFound":"https://www.gsk.com/en-gb/about-us/our-history/meet-jill-a-keeper-of-gsk-s-history/","txt":"Horlicks","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/albums/72157626243462942":{"firstFound":"https://www.gsk.com/en-gb/about-us/our-history/meet-jill-a-keeper-of-gsk-s-history/","txt":"See more photos and artefacts in our FlickR album","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/33544638942/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/david-redfern/","txt":"download image from Flickr","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/36763525640/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/luke-miels/","txt":"download image from Flickr","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/32884994903/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/nick-hirons/","txt":"download image from Flickr","status":"new"},"https://www.flickr.com/photos/glaxosmithkline/33569594451/in/album-72157626748527760/":{"firstFound":"https://www.gsk.com/en-gb/about-us/corporate-executive-team/phil-thomson/","txt":"download image from Flickr","status":"new"},"https://ec.europa.eu/info/strategy/justice-and-fundamental-rights/data-protection/data-transfers-outside-eu/model-contracts-transfer-personal-data-third-countries_en":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"available here","status":"new"},"https://www.sensodyne.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Ireland)","status":"new"},"https://us.sensodyne.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne (USA)","status":"new"},"http://www.sensodyne.com.ar/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne (Argentina)","status":"new"},"https://www.sensodyne.com.au/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Australia)","status":"new"},"https://www.sensodyne.at/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Austria)","status":"new"},"https://www.sensodyne.be/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Belgium)","status":"new"},"https://www.sensodyne.com.br/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Brazil)","status":"new"},"https://www.sensodyne.ca/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Canada)","status":"new"},"https://www.sensodyne.cn/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne (China)","status":"new"},"https://www.sensodyne.fr/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (France)","status":"new"},"https://www.sensodyne.de/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Germany)","status":"new"},"http://www.sensodyne.gr/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Greece)","status":"new"},"https://www.sensodyne.in/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (India)","status":"new"},"https://www.sensodyne.it/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Italy)","status":"new"},"https://hagashimiru.jp/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Japan)","status":"new"},"https://www.sensodyne-me.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (UAE)","status":"new"},"http://sensodyne.nl/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Netherlands)","status":"new"},"http://sensodyne.com.pk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Pakistan)","status":"new"},"http://sensodyne.pt/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Portugal)","status":"new"},"http://sensodyne.ro/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Romania)","status":"new"},"http://sensodyne.co.za/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (South Africa)","status":"new"},"http://sensodyne.es/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Spain)","status":"new"},"https://www.sensodyne.ch/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Switzerland)","status":"new"},"https://www.sensodyne.com.tw/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Taiwan)","status":"new"},"https://www.sensodyne.co.th/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Thailand)","status":"new"},"https://www.sensodyne.com.tr/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"Sensodyne  (Turkey)","status":"new"},"https://www.youtube.com/embed/TVnyHVKxcmk?rel=0":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/sensodyne/","txt":"\n            \n                \n            \n        ","status":"new"},"http://www.biotene.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/biot%C3%A8ne/","txt":"Biotène (UK)","status":"new"},"http://www.biotene.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/biot%C3%A8ne/","txt":"Biotène (USA)","status":"new"},"http://www.biotene.com.au/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/biot%C3%A8ne/","txt":"Biotène (Australia)","status":"new"},"http://www.biotene.eu/fi":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/biot%C3%A8ne/","txt":"Biotène (Finland)","status":"new"},"http://www.biotene.co.il/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/biot%C3%A8ne/","txt":"Biotène (Israel)","status":"new"},"https://www.mydenturecare.com/en-gb/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/polident/","txt":"Polident (UK)","status":"new"},"https://www.mydenturecare.com/en-us/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/polident/","txt":"Polident (USA)","status":"new"},"http://www.polident.com/en_ca/home.html":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/polident/","txt":"Polident (Canada)","status":"new"},"https://www.theraflu.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/theraflu/","txt":"Theraflu (USA)","status":"new"},"http://www.contac.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/contac/","txt":"Contac (Global)","status":"new"},"https://www.parodontax.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/parodontax/","txt":"Parodontax (Global)","status":"new"},"https://www.flonase.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/flonase/","txt":"Flonase (USA)","status":"new"},"https://www.aquafresh.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/aquafresh/","txt":"Aquafresh (UK)","status":"new"},"https://www.aquafresh.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/aquafresh/","txt":"Aquafresh (US)","status":"new"},"http://www.aquafresh.ca/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/oral-health/aquafresh/","txt":"Aquafresh (Canada)","status":"new"},"https://www.nicorette.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/nicorette/","txt":"Nicorette (UK)","status":"new"},"https://www.nicorette.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/nicorette/","txt":"Nicorette (US)","status":"new"},"https://www.voltarol.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/voltaren/","txt":"Voltaren (UK)","status":"new"},"https://www.voltaren.com.au/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/voltaren/","txt":"Voltaren (Australia)","status":"new"},"https://www.voltaren.ca/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/voltaren/","txt":"Voltaren (Canada)","status":"new"},"https://www.nicotinell.co.uk/index.html":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/nicotinell/","txt":"Nicotinell (UK)","status":"new"},"https://www.otrivine.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/otrivin/","txt":"Otrivin (UK)","status":"new"},"http://www.otrivin.com.au/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/otrivin/","txt":"Otrivin (Australia)","status":"new"},"http://www.otrivin.ca/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/otrivin/","txt":"Otrivin (Canada, EN)","status":"new"},"http://www.otrivin.ca/fr/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/otrivin/","txt":"Otrivin (Canada, FR)","status":"new"},"http://www.otrivin.nl/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/otrivin/","txt":"Otrivin (Netherlands)","status":"new"},"https://www.youtube.com/embed/ya2xWM0LYUs":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/respiratory/otrivin/","txt":"\n            \n                \n            \n        ","status":"new"},"http://www.panadol.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/panadol/","txt":"Panadol (UK)","status":"new"},"https://www.panadol.com.au/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/panadol/","txt":"Panadol (Australia)","status":"new"},"https://www.eno.co.in/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/eno/","txt":"Eno (India)","status":"new"},"https://www.excedrin.com/index.shtml/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/excedrin/","txt":"Excedrin (USA)","status":"new"},"https://www.excedrin.pl/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/excedrin/","txt":"Excedrin (Poland)","status":"new"},"https://www.youtube.com/embed/tco5QMTfxKM?rel=0":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/pain-relief/excedrin/","txt":"View video on YouTube","status":"new"},"https://www.tums.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/tums/","txt":"Tums (USA)","status":"new"},"http://www.tums.ca/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/tums/","txt":"Tums (Canada)","status":"new"},"https://www.lamisilat.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/lamisil/","txt":"Lamisil (USA)","status":"new"},"http://www.fenistil.de/index.shtml/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/fenistil/","txt":"Fenistil (Deutschland)","status":"new"},"http://www.horlicks.com.my/schooljourneyinitiative/projects.desktop.html":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/horlicks/","txt":"Horlicks School Journey Initiative website","status":"new"},"http://www.horlicks.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/horlicks/","txt":"Horlicks (US)","status":"new"},"https://www.horlicks.in/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/horlicks/","txt":"Horlicks (India)","status":"new"},"http://www.horlicks.com.my/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/horlicks/","txt":"Horlicks (Malaysia)","status":"new"},"http://www.horlickspakistan.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/horlicks/","txt":"Horlicks (Pakistan)","status":"new"},"http://www.horlicks.com.sg/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/nutrition-and-digestive-health/horlicks/","txt":"Horlicks (Singapore)","status":"new"},"https://www.zovirax.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/zovirax/","txt":"Zovirax (UK)","status":"new"},"http://www.zovirax.com.au/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/zovirax/","txt":"Zovirax (Australia)","status":"new"},"http://www.zovir.dk/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/zovirax/","txt":"Zovir (Denmark)","status":"new"},"http://www.zovicrem.es/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/zovirax/","txt":"Zovi (Spain)","status":"new"},"https://www.zovirax.ru/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/zovirax/","txt":"Zovirax (Russia)","status":"new"},"http://www.abreva.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/abreva/","txt":"Abreva (USA)","status":"new"},"http://www.abreva.ca/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/abreva/","txt":"Abreva (Canada)","status":"new"},"https://www.physiogel.com/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/physiogel/","txt":"Physiogel (Global)","status":"new"},"http://www.physiogel.com.ar/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/physiogel/","txt":"Physiogel (Argentina)","status":"new"},"http://www.physiogel.at/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/physiogel/","txt":"Physiogel (Austria)","status":"new"},"http://www.physiogel.com.au/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/physiogel/","txt":"Physiogel (Australia)","status":"new"},"http://www.fisiogel.com.br/":{"firstFound":"https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/skin-health/physiogel/","txt":"Physiogel (Brazil)","status":"new"},"https://www.peacecorps.gov/about/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/ahsiya-business-operations-usa/","txt":"Peace Corps","status":"new"},"https://www.seedsofpeace.org/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/ahsiya-business-operations-usa/","txt":"Seeds of Peace","status":"new"},"https://www.youtube.com/watch?v=1hHqOm369s0&rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/sofia-manufacturing-and-supply-mexico/","txt":"View video on YouTube","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397462&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397066&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=397452&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397062&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396311&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397445&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396999&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397436&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Human_191499":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397387&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=6","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397460&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=396927&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397379&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397130&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=378336&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=397337&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397442&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397439&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397434&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397432&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397425&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=3","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397421&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=397413&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=4","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=395710&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=4","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397399&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://youtu.be/lZs_Dpri61M?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/martyn-marketing-and-communications-uk/","txt":"View video on YouTube","status":"new"},"https://youtu.be/bimtL7NaxE8?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/martyn-marketing-and-communications-uk/","txt":"View video on YouTube","status":"new"},"https://youtu.be/OyfQ7jJBjaE?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/martyn-marketing-and-communications-uk/","txt":"View video on YouTube","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397240&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=3","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Performance-Marketing-Manager_192141-2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=5","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Investor-Relations-Coordinator_188612-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=5","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397385&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=397143&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=6","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397334&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397328&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397324&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"View more details","status":"new"},"https://youtu.be/XWrkKzejyAM?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/camelia-rd-belgium/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/gdGcZZLvTUY?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/richard-rd-uk/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/c99URnJQ5kc?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/richard-rd-uk/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/Zd9WW_8HvYM?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/richard-rd-uk/","txt":"View video on YouTube","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392640&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392366&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392362&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=356986&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=367075&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=362414&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397403&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Principal-Statistician_189159":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=5","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397230&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=397417&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=4","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397316&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397309&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397305&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397303&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397254&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397193&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397114&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Process-Informatics-Technology-Associate_191485":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393524&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"http://gsk.avature.net/physicians":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/kumaran/","txt":"Physicians talent","status":"new"},"https://youtu.be/t2luzeEUpiA?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/paulo-physician-brazil/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=_y2rG5XPZ0c&rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/adriana-sales-brazil/","txt":"View video on YouTube","status":"new"},"https://youtu.be/J3O-1-mLVzg?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/karandeep-sales-india/","txt":"View video on YouTube","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=395472&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=397438&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=2","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=397429&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=3","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396230&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397371&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397171&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=4","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Sales-Specialist--Pharma---Hyannis--MA_192127":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Edison/Territory-Business-Manager--North-Central-New-Nersey_192000":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://www.youtube.com/embed/bytDbyfSdRM?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/develop-your-career-at-gsk/","txt":"View video on YouTube","status":"new"},"https://youtu.be/J7kditcuTIc?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/apply-now-for-our-future-leaders-graduate-programme/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/watch?v=K_IjL0QK_MY":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/research-and-development-consumer-healthcare/","txt":"\n                \n                        \n                \n                \n                        Our Consumer Healthcare business\n                                            GSK’s consumer healthcare business is an exciting and dynamic environment. Hear about what we do, why we do it and how it creates benefit for customers all over the world.\n                \n            ","status":"new"},"https://www.youtube.com/watch?v=Wgt-kx55u_E":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/research-and-development-consumer-healthcare/","txt":"\n                \n                        \n                \n                \n                        Going behind the science of Consumer Healthcare\n                                            GSK’s consumer healthcare business is an exciting and dynamic environment. Hear about what we do, why we do it and how it creates benefit for customers all over the world.\n                \n            ","status":"new"},"https://www.youtube.com/embed/cfkG51x0R1Q?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/graduate-stories-future-leaders-on-breadth-assignments/","txt":"View video on YouTube","status":"new"},"https://youtu.be/BgWGaUefc_E?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/graduate-stories-future-leaders-on-breadth-assignments/","txt":"View video on YouTube","status":"new"},"http://view.ceros.com/msl/gskquiz-stage1/p/1":{"firstFound":"https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/faqs/","txt":"quiz","status":"new"},"https://www.pih.org/country/sierra-leone":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","txt":"Partners in Health","status":"new"},"https://kawempehomecare.org/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","txt":"Kawempe Home Care","status":"new"},"http://raysofhopehospicejinja.org/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","txt":"Rays of Hope Hospice Jinja","status":"new"},"https://www.tuscuganda.org/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","txt":"Transport for Uganda Sick Children","status":"new"},"https://www.unicef.org/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","txt":"UNICEF","status":"new"},"https://www.owlstonemedical.com/about/news/2017/nov/27/GSK-breath-biopsy-clinical-trial/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/lindsay-rd-uk/","txt":"breath biopsy platform","status":"new"},"https://www.youtube.com/embed/dvGWvB-dzuI?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/teresa-ch-rd-uk/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/results?search_query=%23BehindTheScience":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/teresa-ch-rd-uk/","txt":"#BehindTheScience","status":"new"},"http://us.gsk.com/en-us/about-us/us-community-partnerships/gsk-impact-awards/":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/andrew-legal-us/","txt":"GSK IMPACT Awards","status":"new"},"https://youtu.be/0BZnuI74Uuo?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/jonathan-marketing-and-communications-uk/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/OlNJLKPzXgY?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/kevin-consumer-healthcare-uk/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/sGily75qHzY?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/kevin-consumer-healthcare-uk/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/p_gdn2XZWVU?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/kevin-consumer-healthcare-uk/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/McFf96tL2CQ?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/cecilia-pharmaceuticals-hong-kong/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/DPdC7pFtbNg?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/cecilia-pharmaceuticals-hong-kong/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/HAY7IBV8QH0?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/cecilia-pharmaceuticals-hong-kong/","txt":"View video on YouTube","status":"new"},"http://www.btconferencing.com/globalaccess/?bid=288_attended":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-with-novartis-to-acquire-full-ownership-of-consumer-healthcare-business/","txt":"http://www.btconferencing.com/globalaccess/?bid=288_attended","status":"new"},"https://secure.ctn.co.uk/gsk_sites/gsk/analyst-call/2018-march/home":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-with-novartis-to-acquire-full-ownership-of-consumer-healthcare-business/","txt":"www.gsk.com","status":"new"},"http://www.shareview.co.uk/4/Info/Portfolio/Default/en/Home/Pages/Home.aspx":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/corporate-sponsored-nominee-service/","txt":"Shareview website","status":"new"},"http://secure.ctn.co.uk/Umbracast/gsk/q4/2014-results/home.aspx":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://secure.ctn.co.uk/Umbracast/gsk/q3/2014-results.aspx":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/Webcasting25/Events/GSK/Q2_2014_Results/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/Webcasting23/Events/GSK/Q1_2014_Results/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://secure.ctn.co.uk/sites/gsk/q4/2015-results/home/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://www.youtube.com/watch?v=2W_ibP5jsaQ":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=ZL1fm1VWK-U":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=onYj65X-8-8":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://secure.ctn.co.uk/sites/gsk/q3/2015-results/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://www.youtube.com/watch?v=jTjDToQ5E3s":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                            \n                                \n                            \n                        ","status":"new"},"https://secure.ctn.co.uk/Umbracast/gsk/q2/2015-results/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://www.youtube.com/watch?v=F6_2zZCDwQM":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                            \n                                \n                            \n                        ","status":"new"},"http://secure.ctn.co.uk/Umbracast/gsk/q1/2015-results/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=4","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://youtu.be/74ysile04Fc":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://youtu.be/TnimNqAuJGQ?list=PLvDyxtKlIcnjiUg-7dYnF-h8zJXoI1pFu":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=wvrjBZar6rk":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=3dSWJvicTL4":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=3j_z06rZnvo&feature=youtu.be":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://www.youtube.com/watch?v=aV4uk6Kw5SU":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=pNBPtInpF9A":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/embed/x_jbYuEz1N8?list=PLvDyxtKlIcnj-Krej7SO1isxITacYiWRD&amp;showinfo=0":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://www.youtube.com/watch?v=x_jbYuEz1N8":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=LMxJwi7u1M8":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=-a7BilfWMhY":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://secure.ctn.co.uk/sites/gsk/q1/2016-results/home/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://www.youtube.com/watch?v=hTfkDI0QyOE":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=vK24unuDl8M":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=3","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"http://events.ctn.co.uk/Webcasting17/Events/GSK/Q4_2012_Results/Login?ReturnUrl=/Webcasting17/Events/GSK/Q4_2012_Results/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/ec/ctn/CookieAcceptance_v2/Default.aspx?eventid=1172&type=net&event=eventGlobal_1172":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://merchantcantos.net/gsk/2012/gsk-results-interview-july-2012":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                            CEO Sir Andrew Witty discusses second quarter results\n                                                    ","status":"new"},"http://events.ctn.co.uk/ec/gsk/1132/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://merchantcantos.net/gsk/2012/q1-result-interview":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                            Watch CFO interview for Q1 2012\n                                                    ","status":"new"},"https://www.youtube.com/embed/bIqlsOCCmoo?rel=0":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-q3-sales-of-81-billion-plus3-aer-plus6-cer/","txt":"View video on YouTube","status":"new"},"http://events.ctn.co.uk/Webcasting23/Events/GSK/Q4_2013_Results/Welcome":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/Webcasting20/Events/GSK/Q3_2013_Results/Login?ReturnUrl=/Webcasting20/Events/GSK/Q3_2013_Results/Welcome":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=5","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/Webcasting20/Events/GSK/Q2_2013_Results/Login?ReturnUrl=/Webcasting20/Events/GSK/Q2_2013_Results/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/Webcasting20/Events/GSK/Q1_2013_Results/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=6","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/ec/gsk/1103/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://video.cnbc.com/gallery/?video=3000071637":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                            Watch Andrew Witty on CNBC's \"Squawk on the Street\"\n                                                    ","status":"new"},"http://events.ctn.co.uk/ec/gsk/1072/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=7","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/ec/gsk/1028/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/ec/gsk/978/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://www.youtube.com/watch?v=-Z2HmCuR4HY":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"Watch Q2 2017 results video","status":"new"},"https://www.youtube.com/watch?v=ymlwFhtAG1s":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://www.youtube.com/watch?v=01vRkdJyKcc":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                                        \n                                            \n                                        \n                                    ","status":"new"},"https://youtu.be/7E8YFwEjnp8":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"https://youtu.be/ub_qfSWm0EU":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=2","txt":"\n                            \n                                \n                            \n                        ","status":"new"},"http://events.ctn.co.uk/ec/gsk/935/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/ec/gsk/882":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=8","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/ec/gsk/844":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://events.ctn.co.uk/ec/gsk/804/":{"firstFound":"https://www.gsk.com/en-gb/investors/quarterly-results/?=&p=9","txt":"\n                            Listen to the webcast\n                                                    ","status":"new"},"http://www.23andme.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-23andme-sign-agreement-to-leverage-genetic-insights-for-the-development-of-novel-medicines/","txt":"www.23andMe.com.","status":"new"},"https://www.youtube.com/embed/uN38SwgjpFY?rel=0":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-improvements-in-sales-margins-and-cash-flow-in-q2-2018/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/e79PFz9ZdyI?rel=0":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-improvements-in-sales-margins-and-cash-flow-in-2017/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/OB9-hTupyus?rel=0":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-improvements-in-sales-margins-and-cash-flow-in-2017/","txt":"View video on YouTube","status":"new"},"https://www.youtube.com/embed/3tYDZCpzYvo?rel=0":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-improvements-in-sales-margins-and-cash-flow-in-2017/","txt":"View video on YouTube","status":"new"},"https://gskmedia.pharmiwebsolutions.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-improvements-in-sales-margins-and-cash-flow-in-2017/","txt":"Video footage library","status":"new"},"http://www.edurant.com/hcp/prescribing-information":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-positive-48-week-results-for-first-pivotal-phase-iii-study-for-novel-long-acting-injectable-hiv-treatment-regimen/","txt":"here","status":"new"},"https://urldefense.proofpoint.com/v2/url?u=http-3A__www.janssenlabels.com_package-2Dinsert_product-2Dmonograph_prescribing-2Dinformation_EDURANT-2Dpi.pdf&d=DwMGaQ&c=9wxE0DgWbPxd1HCzjwN8Eaww1--ViDajIU4RXCxgSXE&r=J7wB1SLKWKA1gpwYoceY-y3xkhr4mhsieeIqcp-JNNE&m=CdcV4p0HxpVK7G7c7n0NMFDiNuHcQWwWSxPxU7Cs5NY&s=FembPrhrNjB2_SBd-TjvfGRbCi1XGave-2E-ZpDPeqU&e=":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-shares-data-from-landmark-2-drug-regimen-trials-at-aids-2018/","txt":"http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/EDURANT-pi.pdf","status":"new"},"https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ema.europa.eu_docs_en-5FGB_document-5Flibrary_EPAR-5F-2D-5FProduct-5FInformation_human_002264_WC500118874.pdf&d=DwMGaQ&c=9wxE0DgWbPxd1HCzjwN8Eaww1--ViDajIU4RXCxgSXE&r=J7wB1SLKWKA1gpwYoceY-y3xkhr4mhsieeIqcp-JNNE&m=CdcV4p0HxpVK7G7c7n0NMFDiNuHcQWwWSxPxU7Cs5NY&s=ra-RAn76KyzkyqsvXvDnUqQ7cNiiQ4g-hm0yMY_AhM8&e=":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-shares-data-from-landmark-2-drug-regimen-trials-at-aids-2018/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002264/WC500118874.pdf","status":"new"},"http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(15)00152-8/abstract":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-positive-48-week-results-for-first-pivotal-phase-iii-study-for-novel-long-acting-injectable-hiv-treatment-regimen/","txt":"http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(15)00152-8/abstract","status":"new"},"http://dx.doi.org/10.1016/S0140-6736(17)31917-7":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-positive-48-week-results-for-first-pivotal-phase-iii-study-for-novel-long-acting-injectable-hiv-treatment-regimen/","txt":"http://dx.doi.org/10.1016/S0140-6736(17)31917-7","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT03299049":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-positive-48-week-results-for-second-phase-iii-study-for-novel-long-acting-injectable-hiv-treatment-regimen/","txt":" https://clinicaltrials.gov/ct2/show/NCT03299049","status":"new"},"http://www.us.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/shingrix-approved-in-the-us-for-prevention-of-shingles-in-adults-aged-50-and-over/","txt":"www.us.gsk.com","status":"new"},"http://jpmorgan.metameetings.com/confbook/healthcare17/directlink.php?p=22553":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"Analyst webcast","status":"new"},"https://cc.talkpoint.com/gold006/060716b_ae/?entity=49_7VHVKMO":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"Analyst webcast","status":"new"},"http://wsw.com/webcast/leerink26/register.aspx?conf=leerink26&page=gsk&url=http://wsw.com/webcast/leerink26/gsk/index.aspx":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"Analyst webcast","status":"new"},"http://jpmorgan.metameetings.com/confbook/healthcare16/directlink.php?p=19736":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"Analyst webcast","status":"new"},"https://secure.ctn.co.uk/sites/gsk/randd/2015/":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"Analyst webcast","status":"new"},"https://secure.ctn.co.uk/Umbracast/gsk/q1/2015-investor-event/":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"Analyst webcast","status":"new"},"http://jpmorgan.metameetings.com/confbook/healthcare15/directlink.php?p=16967":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"Analyst webcast","status":"new"},"http://www.veracast.com/webcasts/citigroup/healthcare2014/01108719967.cfm":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"Webcast","status":"new"},"http://cc.talkpoint.com/gold006/061113a_gm/?entity=91_82VFHBH":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=2","txt":"Webcast","status":"new"},"http://www.kyowa-kirin.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-kyowa-hakko-kirin-sign-strategic-commercialisation-deal-in-japan-for-daprodustat-a-potential-new-oral-treatment-for-anaemia-associated-with-chronic-kidney-disease/","txt":"www.kyowa-kirin.com","status":"new"},"http://www.bbc.co.uk/programmes/b00wdjyg":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"Webcast","status":"new"},"http://cc.talkpoint.com/gold006/061510a_mg/?entity=89_8KIEP51":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=4","txt":"Webcast","status":"new"},"https://www.gsk-clinicalstudyregister.com/study/116855?search=study&search_terms=FF%2FUMEC%2FVI+":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-innoviva-report-positive-headline-results-from-impact-study-showing-single-inhaler-triple-therapy-trelegy-ellipta-reduced-copd-exacerbations/","txt":"IMPACT","status":"new"},"https://www.medicines.org.uk/emc/medicine/34357":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/landmark-impact-study-published-in-nejm-shows-significant-benefits-of-trelegy-ellipta-for-patients-with-copd/","txt":"https://www.medicines.org.uk/emc/medicine/34357","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Trelegy/pdf/TRELEGY-PI-MG-IFU.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/landmark-impact-study-published-in-nejm-shows-significant-benefits-of-trelegy-ellipta-for-patients-with-copd/","txt":"here","status":"new"},"http://www.inva.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-efficacy-data-for-anoro-ellipta-in-copd-patients-who-remained-symptomatic-on-tiotropium/","txt":"www.inva.com","status":"new"},"http://ctt.marketwire.com/?release=1225653&id=7535041&type=1&url=http%3a%2f%2fwww.sec.gov%2f":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-us-filing-plans-for-closed-triple-combination-therapy-ffumecvi-in-patients-with-copd/","txt":"www.sec.gov","status":"new"},"http://goldcopd.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-files-regulatory-submission-in-us-for-once-daily-closed-triple-combination-therapy-ffumecvi-for-patients-with-copd/","txt":"http://goldcopd.org","status":"new"},"http://leerink.metameetings.com/webcasts/healthcare13/directlink?p=65":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"Webcast","status":"new"},"http://events.ctn.co.uk/ec/gsk/1139/":{"firstFound":"https://www.gsk.com/en-gb/investors/speeches-presentations/?=&p=3","txt":"Webcast","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-us-regulatory-filing-to-expand-the-use-of-nucala-in-children-with-severe-eosinophilic-asthma/","txt":"US Prescribing Information","status":"new"},"http://www.mothertobaby.org/asthma":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-severe-hypereosinophilic-syndrome/","txt":"www.mothertobaby.org/asthma","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Tivicay/pdf/TIVICAY-PI-PIL.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-fda-approval-to-lower-the-weight-limit-for-dolutegravir-in-children-and-adolescents-living-with-hiv/","txt":"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Tivicay/pdf/TIVICAY-PI-PIL.PDF","status":"new"},"https://www.medicines.org.uk/emc/medicine/28545":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-phase-iii-data-at-aids-2018-from-landmark-gemini-studies/","txt":"https://www.medicines.org.uk/emc/medicine/28545","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Epivir/pdf/EPIVIR-PI-PIL.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-phase-iii-data-at-aids-2018-from-landmark-gemini-studies/","txt":"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Epivir/pdf/EPIVIR-PI-PIL.PDF","status":"new"},"https://www.medicines.org.uk/emc/product/943":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-phase-iii-data-at-aids-2018-from-landmark-gemini-studies/","txt":"https://www.medicines.org.uk/emc/product/943","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02465515":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-from-harmony-outcomes-study-of-albiglutide-published-in-the-lancet/","txt":"NCT02465515","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Tanzeum/pdf/TANZEUM-PI-MG-IFU-COMBINED.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-from-harmony-outcomes-study-of-albiglutide-published-in-the-lancet/","txt":"here.","status":"new"},"https://www.medicines.org.uk/emc/product/1942/smpc":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-from-harmony-outcomes-study-of-albiglutide-published-in-the-lancet/","txt":"here.","status":"new"},"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32261-X/fulltext":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-from-harmony-outcomes-study-of-albiglutide-published-in-the-lancet/","txt":"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32261-X/fulltext","status":"new"},"http://www.diabetes.org/diabetes-basics/statistics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-from-harmony-outcomes-study-of-albiglutide-published-in-the-lancet/","txt":"http://www.diabetes.org/diabetes-basics/statistics/","status":"new"},"http://www.who.int/news-room/fact-sheets/detail/diabetes":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-from-harmony-outcomes-study-of-albiglutide-published-in-the-lancet/","txt":"http://www.who.int/news-room/fact-sheets/detail/diabetes","status":"new"},"https://www.viivhealthcare.com/media/press-releases/2018/viiv-healthcare-submits-regulatory-application-to-european-medicines-agency-for-single-tablet-two-drug-regimen-of-dolutegravir-and-lamivudine-for-treatment-of-hiv.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-chmp-positive-opinion-for-tivicay-eu-label-update-with-gemini-study-data-for-the-2-drug-regimen-of-tivicay-plus-lamivudine/","txt":"https://www.viivhealthcare.com/media/press-releases/2018/viiv-healthcare-submits-regulatory-application-to-european-medicines-agency-for-single-tablet-two-drug-regimen-of-dolutegravir-and-lamivudine-for-treatment-of-hiv.aspx","status":"new"},"https://www.ema.europa.eu/documents/product-information/epivir-epar-product-information_en.pdf%E2%80%8B":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-chmp-positive-opinion-for-tivicay-eu-label-update-with-gemini-study-data-for-the-2-drug-regimen-of-tivicay-plus-lamivudine/","txt":"https://www.ema.europa.eu/documents/product-information/epivir-epar-product-information_en.pdf","status":"new"},"https://www.ema.europa.eu/documents/product-information/epivir-epar-product-information_en.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-chmp-positive-opinion-for-tivicay-eu-label-update-with-gemini-study-data-for-the-2-drug-regimen-of-tivicay-plus-lamivudine/","txt":"https://www.ema.europa.eu/documents/product-information/epivir-epar-product-information_en.pdf","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02831673%20%20":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-chmp-positive-opinion-for-tivicay-eu-label-update-with-gemini-study-data-for-the-2-drug-regimen-of-tivicay-plus-lamivudine/","txt":"https://clinicaltrials.gov/ct2/show/NCT02831673","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02831764%20":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-chmp-positive-opinion-for-tivicay-eu-label-update-with-gemini-study-data-for-the-2-drug-regimen-of-tivicay-plus-lamivudine/","txt":"https://clinicaltrials.gov/ct2/show/NCT02831764 ","status":"new"},"http://www.aeras.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-candidate-vaccine-helps-prevent-active-pulmonary-tuberculosis-in-hiv-negative-adults-in-phase-ii-study/","txt":"www.aeras.org","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002264/WC500118874.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-positive-48-week-results-for-first-pivotal-phase-iii-study-for-novel-long-acting-injectable-hiv-treatment-regimen/","txt":"here","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02938520?term=FLAIR&cond=HIV&rank=2":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-three-year-data-for-investigational-long-acting-injectable-two-drug-hiv-regimen/","txt":"https://clinicaltrials.gov/ct2/show/NCT02938520?term=FLAIR&cond=HIV&rank=2","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02951052?term=ATLAS&cond=HIV&rank=3":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-three-year-data-for-investigational-long-acting-injectable-two-drug-hiv-regimen/","txt":"https://clinicaltrials.gov/ct2/show/NCT02951052?term=ATLAS&cond=HIV&rank=3","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT03299049?term=ATLAS-2M&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-three-year-data-for-investigational-long-acting-injectable-two-drug-hiv-regimen/","txt":"https://clinicaltrials.gov/ct2/show/NCT03299049?term=ATLAS-2M&rank=1","status":"new"},"https://youtu.be/ytNvg4Vs25w?rel=0":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"View video on YouTube","status":"new"},"http://www.nature.com/nature/journal/v496/n7444/full/496159a.html":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"commentary piece in Nature","status":"new"},"http://www.nature.com/nrd/journal/v13/n6/full/nrd4351.html?WT.ec_id=NRD-201406":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"roadmap","status":"new"},"http://www.actionpotentialvc.com/about.aspx":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"Action Potential Venture Capital","status":"new"},"https://youtu.be/HoaoE9OIGb4?rel=0":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"View video on YouTube","status":"new"},"https://youtu.be/NhXtSy-Ccvg?rel=0":{"firstFound":"https://www.gsk.com/en-gb/research/what-we-are-working-on/bioelectronics-research/","txt":"View video on YouTube","status":"new"},"http://www.ebi.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/where-do-you-start-when-developing-a-new-medicine/","txt":"www.ebi.ac.uk","status":"new"},"http://www.nih.gov/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/diseases-of-the-developing-world/","txt":"National Library of Medicine","status":"new"},"http://www.collaborativedrug.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-research-identifies-promising-leads-to-follow-in-search-for-medicines-to-fight-malaria/","txt":"www.collaborativedrug.com/","status":"new"},"http://www.mmv.org/research-development/malaria-box-supporting-information":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/diseases-of-the-developing-world/","txt":"‘malaria box set’","status":"new"},"http://openwetware.org/wiki/OSDDMalaria:GSK_Arylpyrrole_Series:Story_so_far":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/diseases-of-the-developing-world/","txt":"open source drug discovery project","status":"new"},"http://www.mmv.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-us-regulatory-application-for-single-dose-tafenoquine-for-plasmodium-vivax-malaria/","txt":"www.mmv.org","status":"new"},"http://www.tballiance.org/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/diseases-of-the-developing-world/","txt":"Global Alliance for TB Drug Development","status":"new"},"http://www.openlabfoundation.org/researchProjs.html":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/diseases-of-the-developing-world/","txt":"Find out more about current projects at Tres Cantos","status":"new"},"http://www.accesstomedicineindex.org/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/diseases-of-the-developing-world/","txt":"Access to Medicines Index","status":"new"},"http://www.wipo.int/research/en":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/diseases-of-the-developing-world/","txt":"WIPO Re:Search website","status":"new"},"http://www.stevenagecatalyst.com/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/stevenage-bioscience-hub/","txt":"Read more ","status":"new"},"http://www.gsk-clinicalstudyregister.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-2009-corporate-responsibility-report/","txt":"Clinical Study Register","status":"new"},"http://www.clinicalstudydatarequest.com/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/sharing-our-research/patient-level-data/","txt":"Visit the clinical study data request site ","status":"new"},"https://youtu.be/zHOwed5_Jik?rel=0":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/open-innovation/targeting-the-immune-system-through-open-innovation/","txt":"View video on YouTube","status":"new"},"https://www.gsk-clinicalstudyregister.com/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/sharing-our-research/gsk-study-register/","txt":"Visit the GSK Study Register ","status":"new"},"http://www.lupusresearch.org/about-us/mission-statement.html":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"http://www.lupusresearch.org/about-us/mission-statement.html","status":"new"},"http://www.lupusresearch.org/about-us/faq.html":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"http://www.lupusresearch.org/about-us/faq.html","status":"new"},"http://www.lupusresearchinstitute.org/driving-discovery/innovation":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"http://www.lupusresearchinstitute.org/driving-discovery/innovation","status":"new"},"http://www.worldlupusday.org/about-us":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"http://www.worldlupusday.org/about-us","status":"new"},"http://www.fda.gov/ohrms/dockets/98fr/2005d-0106-gdl0001.pdf":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"http://www.fda.gov/ohrms/dockets/98fr/2005d-0106-gdl0001.pdf","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT00137969":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"https://clinicaltrials.gov/ct2/show/NCT00137969","status":"new"},"http://www.lupus.org/answers/entry/what-treatments-are-being-studied-for-lupus":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"http://www.lupus.org/answers/entry/what-treatments-are-being-studied-for-lupus","status":"new"},"https://clinicaltrials.gov/show/NCT00624338":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"https://clinicaltrials.gov/show/NCT00624338","status":"new"},"http://www.prnewswire.com/news-releases/human-genome-sciences-and-glaxosmithkline-announce-positive-phase-3-study-results-for-benlystatm-in-systemic-lupus-erythematosus-62224887.html":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"http://www.prnewswire.com/news-releases/human-genome-sciences-and-glaxosmithkline-announce-positive-phase-3-study-results-for-benlystatm-in-systemic-lupus-erythematosus-62224887.html","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT01262365":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"https://clinicaltrials.gov/ct2/show/NCT01262365","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT01405196":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"https://clinicaltrials.gov/ct2/show/NCT01405196","status":"new"},"http://lupusresearchinstitute.org/lupus-news/2014/11/21/promising-results-lupus-clinical-trials-presented-american-college":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"http://lupusresearchinstitute.org/lupus-news/2014/11/21/promising-results-lupus-clinical-trials-presented-american-college#sthash.8oygxxcl.dpuf","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02446899":{"firstFound":"https://www.gsk.com/_static/iFrame-Infographics/lupusdiscovery/index.html","txt":"https://clinicaltrials.gov/ct2/show/NCT02446899","status":"new"},"http://www.volunteers.gsk.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/become-a-clinical-research-volunteer/","txt":"www.volunteers.gsk.co.uk","status":"new"},"http://annualreport.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/our-use-of-animals/frequently-asked-questions/","txt":"Responsible Business Supplement","status":"new"},"https://iss.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/research/our-approach/trials-in-people/independent-clinical-studies/","txt":"ISS study website","status":"new"},"http://www.partnersinknowledge.com/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/call-for-ime-proposals-on-systemic-lupus-erythematosus-sle/","txt":"www.partnersinknowledge.com","status":"new"},"http://fortherecord.payments.us.gsk.com/hcppayments/payments.html":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/usa/","txt":"Physician Payments Report","status":"new"},"http://www.sacme.org/Resources/Documents/Virtual%20Journal%20Club/Moore_evaluation_article.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/call-for-ime-proposals-on-systemic-lupus-erythematosus-sle/","txt":"http://www.sacme.org/Resources/Documents/Virtual%20Journal%20Club/Moore_evaluation_article.pdf","status":"new"},"http://transparency.efpia.eu/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations","status":"new"},"http://openinnovation.gsk.com/case-study-sherbrooke/index.html":{"firstFound":"https://www.gsk.com/en-gb/partnerships/academic-collaborations/","txt":"here.","status":"new"},"http://openinnovation.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/partnerships/academic-collaborations/","txt":"Discovery Fast Track Challenge website","status":"new"},"http://www.dpac.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-names-winners-of-2014-discovery-fast-track-challenge/","txt":"Discovery Partnerships with Academia","status":"new"},"http://www.wipo.int/research/en/":{"firstFound":"https://www.gsk.com/en-gb/partnerships/neglected-tropical-diseases/","txt":"WIPO Re:Search","status":"new"},"https://www.openlabfoundation.org/collaborate/submitProject.html":{"firstFound":"https://www.gsk.com/en-gb/partnerships/neglected-tropical-diseases/","txt":"submit proposals","status":"new"},"https://www.openlabfoundation.org/contactus.aspx":{"firstFound":"https://www.gsk.com/en-gb/partnerships/neglected-tropical-diseases/","txt":"contact us","status":"new"},"http://www.actionpotentialvc.com/":{"firstFound":"https://www.gsk.com/en-gb/partnerships/venture-funds/","txt":"www.actionpotentialvc.com","status":"new"},"http://www.bioelectronicmedicinesresearch.com/home":{"firstFound":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","txt":"register your interest here","status":"new"},"http://www.youtube.com/watch?v=NhXtSy-Ccvg":{"firstFound":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","txt":"bioelectronic medicines research","status":"new"},"http://www.youtube.com/watch?v=5KKMr_QO0CM&list=PLvDyxtKlIcngDLfvP7IVlFf8OQoJerlyS":{"firstFound":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","txt":"Bioelectronics Medicines Summit","status":"new"},"http://www.bioelectronicmedicinesresearch.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-commits-further-funding-to-advance-bioelectronics-research-with-creation-of-5-million-innovation-challenge-fund/","txt":"GSK’s Innovation Challenge portal","status":"new"},"https://owa.draper.com/owa/,DanaInfo=owa.draper.com,SSL+redir.aspx?C=12guD4BVXkaun74pPdTpGZS2JI8NA9EIsgM6J8tOvpuMiNDGoEUe707Zh9eTXkw9YC-Age2bj5U.&URL=mailto%3ard.bioelectronics-innovation-prize%40gsk.com":{"firstFound":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","txt":"rd.bioelectronics-innovation-prize@gsk.com","status":"new"},"http://survey.gsk.com/GSKBD":{"firstFound":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/","txt":"Pharmaceuticals R&D","status":"new"},"https://uksah.gsk.com/swh_uk_win_ns/communications/employee/employees.htm":{"firstFound":"https://www.gsk.com/en-gb/gsk-employees/","txt":"Sign into this secure employees page","status":"new"},"https://uksah.gsk.com/servicegateway_ext/CbsHelpResult.aspx?id=7D7J6PFN6VFT-2-26048":{"firstFound":"https://www.gsk.com/en-gb/gsk-employees/","txt":"Mobile devices at GSK","status":"new"},"https://swhuk.gsk.com/servicegateway/":{"firstFound":"https://www.gsk.com/en-gb/gsk-employees/","txt":"Access the Service Gateway","status":"new"},"https://password.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/gsk-employees/","txt":"Access the GSK Password Portal","status":"new"},"tel:+(420) 222 001 111":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(420) 222 001 111","status":"new"},"tel:+(45) 36 35 91 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(45) 36 35 91 00","status":"new"},"tel:+(809) 530 0550":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(809) 530 0550","status":"new"},"tel:+(593) 02 299 4700":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(593) 02 299 4700","status":"new"},"tel:+20 (2) 2618-5000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+20 (2) 2618-5000","status":"new"},"tel:+(503) 2510 1300":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(503) 2510 1300","status":"new"},"tel:+(372) 6676 900":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(372) 6676 900","status":"new"},"tel:+(010) 30 30 30":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(010) 30 30 30","status":"new"},"tel:+(01) 39 17 80 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(01) 39 17 80 00","status":"new"},"tel:+(49) 0 89 360 44 0":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(49) 0 89 360 44 0","status":"new"},"tel:+(30) 210 6882 100":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(30) 210 6882 100","status":"new"},"tel:+(502) 2410 0500":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(502) 2410 0500","status":"new"},"tel:+(504) 2275 2200":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(504) 2275 2200","status":"new"},"tel:+800 2220 1135":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+800 2220 1135","status":"new"},"tel:+(852) 3189 8989":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(852) 3189 8989","status":"new"},"tel:+(852) 3189 8931":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(852) 3189 8931","status":"new"},"http://hk.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"GSK Hong Kong","status":"new"},"tel:+(36) 1 225 5300":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(36) 1 225 5300","status":"new"},"tel:+(91) 22 2495 9595":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(91) 22 2495 9595","status":"new"},"tel:+(62) 21 2523 490":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(62) 21 2523 490","status":"new"},"http://id.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"GSK Indonesia","status":"new"},"tel:(+98-21) 26309561":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"(+98-21) 26309561","status":"new"},"tel:+(353) 1 495 5000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(353) 1 495 5000 ","status":"new"},"tel:+(972) 0 3 9297 100":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(972) 0 3 9297 100","status":"new"},"tel:+(972) 3 9297 101":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=2","txt":"+(972) 3 9297 101","status":"new"},"tel:+(39) 045 9218 111":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(39) 045 9218 111","status":"new"},"tel:+(1) 876 9202 199":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(1) 876 9202 199","status":"new"},"tel:+03 5786 5000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+03 5786 5000","status":"new"},"tel:+962 6 5549924":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+962 6 5549924","status":"new"},"tel:+7 (727) 258 28 92":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+7 (727) 258 28 92","status":"new"},"tel:+7 (727) 259 09 96":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+7 (727) 259 09 96","status":"new"},"tel:+(254) 20 6933 200":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(254) 20 6933 200","status":"new"},"tel:+(254) 20 6534 241":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(254) 20 6534 241","status":"new"},"tel:+(080) 901 4100":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(080) 901 4100","status":"new"},"https://kr.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"GSK Korea","status":"new"},"tel:+(371) 6 731 2687":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(371) 6 731 2687","status":"new"},"tel:+961 1 335288":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+961 1 335288 ","status":"new"},"tel:+(85) 2 64 90 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(85) 2 64 90 00","status":"new"},"tel:+(389) 2 3298 766":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(389) 2 3298 766","status":"new"},"tel:+(389) 2 3298 767":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(389) 2 3298 767","status":"new"},"tel:+(356) 21 238 131":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(356) 21 238 131","status":"new"},"tel:+ (55) 5483 8300":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+ (55) 5483 8300","status":"new"},"tel:+(212) 5 22 48 00 02":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(212) 5 22 48 00 02 ","status":"new"},"tel:+(95) 1 220035":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(95) 1 220035","status":"new"},"tel:+(030) 693 8123":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(030) 693 8123","status":"new"},"tel:+(030) 693 8100":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(030) 693 8100","status":"new"},"tel:+(64) 9 367 2900":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(64) 9 367 2900","status":"new"},"tel:+(64) 9 573 1740":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(64) 9 573 1740","status":"new"},"tel:+(234) 1 2711 000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(234) 1 2711 000","status":"new"},"tel:+(22) 70 20 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(22) 70 20 00 ","status":"new"},"tel:+(22) 70 20 04":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"+(22) 70 20 04 ","status":"new"},"tel:+(868) 627 7294":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+(868) 627 7294","status":"new"},"tel:+(216) 71 656 035/ 057":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+(216) 71 656 035/ 057","status":"new"},"tel:+(216) 71 656 036":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+(216) 71 656 036","status":"new"},"tel:+0212 339 44 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+0212 339 44 00","status":"new"},"https://tr.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"GSK Turkey","status":"new"},"tel:+(380) 44 585 51 85":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+(380) 44 585 51 85 ","status":"new"},"tel:+(971) 4 403 7100":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+(971) 4 403 7100","status":"new"},"tel:+(44) 020 8047 5000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+(44) 020 8047 5000","status":"new"},"tel:+(1) 888 825 5249":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+(1) 888 825 5249","status":"new"},"tel:+(598) 2 419 83 33":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+(598) 2 419 83 33","status":"new"},"tel:+58 212 945 2122":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+58 212 945 2122 ","status":"new"},"tel:+(84) 8 3 275 929":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"+(84) 8 3 275 929","status":"new"},"tel:+(111) 475 725":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(111) 475 725","status":"new"},"tel:+(507) 217 1777":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(507) 217 1777","status":"new"},"tel:+(511) 211 9700":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(511) 211 9700","status":"new"},"tel:+(632) 892 0761":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(632) 892 0761","status":"new"},"tel:+0 (61) 860 12 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+0 (61) 860 12 00","status":"new"},"tel:+(351) 21 412 95 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(351) 21 412 95 00","status":"new"},"tel:+(40) 21 302 8208":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(40) 21 302 8208","status":"new"},"tel:+(7) 495 777 89 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(7) 495 777 89 00","status":"new"},"tel:+(00) 966 12653 6788":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(00) 966 12653 6788","status":"new"},"tel:+(381) 11 31 05 700":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(381) 11 31 05 700","status":"new"},"tel:+(65) 6232 8338":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(65) 6232 8338","status":"new"},"tel:+(02) 4826 1111":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(02) 4826 1111 ","status":"new"},"tel:+(386) 01 2802 500":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(386) 01 2802 500","status":"new"},"tel:+(386) 01 2802 585":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(386) 01 2802 585","status":"new"},"tel:+(27) 0 11 745 6000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(27) 0 11 745 6000","status":"new"},"tel:+(27) 0 11 745 6001":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(27) 0 11 745 6001","status":"new"},"tel:+(91) 807 03 00 01":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(91) 807 03 00 01","status":"new"},"tel:+(94) 11 2636 341 / 2":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(94) 11 2636 341 / 2","status":"new"},"tel:+46 8 638 93 00":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+46 8 638 93 00","status":"new"},"tel:+(41) 0 31 862 21 11":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(41) 0 31 862 21 11 ","status":"new"},"tel:+(886) 2 23818 866":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(886) 2 23818 866","status":"new"},"tel:+(662) 659 3000":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"+(662) 659 3000","status":"new"},"http://www.unicef.org/media/files/UN_Commission_Report_September_2012_Final.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/european-agency-endorses-antiseptic-gel-developed-through-gsk-and-save-the-children-partnership-for-newborn-umbilical-cord-infections-in-developing-countries/","txt":"http://www.unicef.org/media/files/UN_Commission_Report_September_2012_Final.pdf","status":"new"},"http://apps.who.int/iris/bitstream/10665/97603/1/9789241506649_eng.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/european-agency-endorses-antiseptic-gel-developed-through-gsk-and-save-the-children-partnership-for-newborn-umbilical-cord-infections-in-developing-countries/","txt":"http://apps.who.int/iris/bitstream/10665/97603/1/9789241506649_eng.pdf","status":"new"},"https://www.viivhealthcare.com/media/58599/us_tivicay.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-approval-of-tivicay-dolutegravir-for-the-treatment-of-hiv-1/","txt":"https://www.viivhealthcare.com/media/58599/us_tivicay.pdf","status":"new"},"http://www.who.int/gho/hiv/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-public-tender-agreement-with-botswana-ministry-of-health-for-dolutegravir/","txt":"http://www.who.int/gho/hiv/en/","status":"new"},"http://www.who.int/hiv/pub/arv/policy-brief-arv-2015/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-public-tender-agreement-with-botswana-ministry-of-health-for-dolutegravir/","txt":"http://www.who.int/hiv/pub/arv/policy-brief-arv-2015/en/","status":"new"},"http://data.worldbank.org/income-level/LMC.%20Last%20accessed%20on%2018.05.2016":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-public-tender-agreement-with-botswana-ministry-of-health-for-dolutegravir/","txt":"http://data.worldbank.org/income-level/LMC. Last accessed on 18.05.2016","status":"new"},"https://amrbenchmark.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-the-amr-benchmark/","txt":"AMR Benchmark","status":"new"},"https://www.amrindustryalliance.org/progress-report/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-the-amr-benchmark/","txt":"AMR Industry Alliance","status":"new"},"http://drive-ab.eu/about/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-the-amr-benchmark/","txt":"DRIVE-AB consortium","status":"new"},"http://www.sanger.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/where-do-you-start-when-developing-a-new-medicine/","txt":"www.sanger.ac.uk/","status":"new"},"https://www.kingsfund.org.uk/sites/files/kf/Voluntary-and-community-sector-in-health-implications-NHS-reforms-The-Kings-Fund-june-2011.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/infographic-impacthealthcare/","txt":"The King’s Fund: The voluntary and community sector in health implications of the proposed NHS reforms report 2011 (PDF)","status":"new"},"http://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/volunteering-in-health-and-social-care-kingsfund-mar13.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/infographic-impacthealthcare/","txt":"The King’s Fund: Volunteering in health and care report 2013 (PDF)","status":"new"},"http://www.kingsfund.org.uk/projects/gsk-impact-awards":{"firstFound":"https://www.gsk.com/en-gb/media/infographic-impacthealthcare/","txt":"The King’s Fund","status":"new"},"http://www.niaid.nih.gov/news/newsreleases/2014/Pages/EbolaVaxCandidate.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/","txt":"press release","status":"new"},"http://www.wellcome.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/image-of-new-antibiotic-in-action-opens-up-new-opportunities-to-combat-antibacterial-resistance/","txt":"The Wellcome Trust","status":"new"},"http://medschool.umaryland.edu/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/","txt":"http://medschool.umaryland.edu/","status":"new"},"http://www.astrazeneca.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/pharmaceutical-industry-and-university-create-manchester-collaborative-centre-for-inflammation-research/","txt":"www.astrazeneca.com","status":"new"},"http://www.frc.org.uk/corporate/ukcgcode.cfm":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/complying-with-the-uk-corporate-governance-code/","txt":"UK Corporate Governance Code – find out more on the Financial Reporting Council website","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397373&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2cgbr%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397358&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397363&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397352&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397350&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397344&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394210&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397342&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397340&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=finance&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397330&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397004&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397302&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=10","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397287&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=10","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397285&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=10","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/HR-Director-Cx_191334":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=10","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/HR-Director--GSF-Vx_191335":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397279&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397266&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397257&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396749&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Upper-Providence/Director--Global-Regulatory-Affairs---Oncology_191357":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Human-Resource-Manager_191500":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Human-Resource-Manager_191501":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=397053&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=397021&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397038&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397002&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Administrative-Assistant---Vaccines---Navy-Yard--PA_191502":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Team-Administrator--Oncology-Global-Medical-Affairs_190377":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394546&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395669&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397159&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397154&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394917&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396285&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396281&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393366&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397120&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397101&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394481&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395875&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396931&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390401&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396357&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396917&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396915&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396912&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396910&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396904&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=396692&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396794&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396871&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396603&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393329&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396840&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396797&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Talent-Acquisition-Leader---R-D_191353-2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396770&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396768&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395646&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396098&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=397253&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397249&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397243&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397234&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397222&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397215&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397211&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397198&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/EHS-Specialist_192005":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396730&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396725&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396694&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=396691&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Operations-Engineer_191064":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396672&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396649&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396668&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396663&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=396656&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396622&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396601&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396437&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396597&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396430&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396639&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395967&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395972&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395969&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395964&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=397427&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=3","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397398&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-York---Upper-Manhattan/Territory-Business-Manager--Upper-Manhattan_192001":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Associate-Chemist_192261":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2cusa&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Associate-Biochemist_192262":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=5","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397405&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=4","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397369&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397367&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397365&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397360&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397355&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=397348&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=7","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397395&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397391&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=6","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Regional-Sales-Director-VIiV--South-New-Jersey--Philadelphia--Maryland--Delaware--Eastern-PA-_191203-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=6","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397377&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=6","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397375&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=6","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397346&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=397338&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397332&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=8","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397327&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=397320&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397322&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=bel%2c%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396879&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397313&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397311&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397307&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=9","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397289&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=10","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397300&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=10","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397293&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2cchn%2c%2c&city=&cl=8680&et=&prog=&p=1","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Quebec---Quebec/Technicien---banque-de-candidatures_192249":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397280&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392393&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=397109&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=397236&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397224&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397212&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397202&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397195&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396741&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397167&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=397048&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397145&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=397116&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Process-Development-Quality-Sr-Manager-USA---Rockeville--MD_187184":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397055&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397050&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397044&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=397017&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=397006&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396986&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396985&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Demand-Planning-Lead_191363":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396954&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396921&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396897&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396695&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396693&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396877&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396820&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396803&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396780&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=396771&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396752&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396744&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396739&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396734&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396733&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396732&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396723&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/QC-Senior-Specialist_187315":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Marietta/Scientist_190185":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Marietta/Title-Packaging-Operator-1st-Shift_190359":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Marietta/Packaging-Operator_190362":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396627&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392455&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396477&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396473&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396420&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396399&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396391&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Associate-Microbiologist_190883":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Lead-Biopharm-Manufacturing-Associate_190478":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---King-of-Prussia/Senior-Compliance-Solutions-Lead_190366":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396342&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396276&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Bio-pharmaceutical-Manufacturing-Supervisor_190176":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395763&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396228&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=396190&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392509&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/QC-Senior-Specialist_187314":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394126&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396160&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396152&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=396092&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388638&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387538&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393473&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393985&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395908&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395859&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=395850&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=395045&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=394405&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395783&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395765&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/QA-Compliance-Specialist_190086":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395738&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395192&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394936&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391738&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395418&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Value-Stream-Manufacturing-Tech-II_188251":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Team-Lead--Pricing-and-Contracts_192263":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Sr-Director-Field-Capability-Strategy-and-Development_191370-3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Contract-and-Rebate-Analyst---RTP_192234":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397268&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397238&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=397036&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=13","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396162&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396138&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397197&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397181&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397178&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397141&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=397132&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397125&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397025&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396197&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395971&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397104&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397092&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=397064&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397060&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397029&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397032&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397014&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395240&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=396926&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396923&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396610&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=396884&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396405&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396194&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396866&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396860&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396850&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396842&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396829&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396812&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396809&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396776&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389040&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396735&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396727&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396717&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396660&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396658&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Digital-Marketing-Manager_190911":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Director--Marketing-Intelligence_188735":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Manager--Brand-Payer-and--Access-Marketing---RTP_188212-2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396395&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393346&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392969&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396324&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396289&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Rhode-Island---Rhode-Island/Shopper-Marketing-Manager---CVS--Providence--RI-_185322-2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Contract-Analytics-Manager_190360":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396169&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396091&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=381588&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396085&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396049&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396018&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396010&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395984&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395947&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394177&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395937&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Analytic-Manager--Payer-Marketing---RTP--NC_188623":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395018&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394934&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394908&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394843&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394622&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394540&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=393629&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394399&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389035&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392279&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395012&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395766&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Global-eCommerce-Manager_189980":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394073&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395692&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395430&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395427&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395381&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395273&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---King-of-Prussia/Biopharm-Process--Control-and-Automation-Engineer_191844":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Director--Head-Medical-Info-and-Capabilities_188083":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394308&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Oncology-Global-Clinical-Development-Scientist_191076":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Oncology-Global-Clinical-Development-Manager_191077":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397085&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Executive-Medical-Director--Nucala-Medical-Leader--US-Medical-Affairs-_189161":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393811&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396615&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396990&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396982&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396979&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396976&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396973&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394616&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Oncology-Global-Clinical-Development-Director_191079":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397165&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393233&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396512&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=396755&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389246&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=397149&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=397134&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397122&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=18","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397106&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Senior-BioPharm-Associate_190893":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Sr-Support-Analyst_186478":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396900&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396891&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Clinical-Biomarker-Operations-Lead_191339":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396783&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396697&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---King-of-Prussia/Associate-Scientist--Downstream-Operations_190479":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396671&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394123&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396970&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396993&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390278&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390282&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=23","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392993&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396619&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396967&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390293&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393968&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Respiratory-Medical-Science-Liaison---Ontario_191808-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396654&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396651&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=36","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395675&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Clinical-Programming-Manager---Oncology_186594":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396495&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396475&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389233&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=396462&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396435&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Director-US-Medical-Affairs_190918":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Innovation-Director--Emerging-Science-Innovation_190919":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Country-Study-Manager_189033":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Country-Study-Manager_189034":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Senior-Scientist-Investigator--Cellular-Biology_189722":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Local-Study-Manager_186124":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396368&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=379718&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396313&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395820&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393840&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396149&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396134&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393296&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396104&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396096&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394005&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394003&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394001&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395924&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395922&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395903&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Scientific-Leader_188386":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395721&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395685&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395601&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Director--Epidemiology---Real-World-Evidence_188751-3":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394830&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=395475&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=395486&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=379748&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397045&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-York---Oak-Hill/Automation---Controls-Engineer_191364":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395652&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=396906&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396864&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396889&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Zebulon/Tehnical-Team-Leader_188776":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396792&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=31","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396737&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396729&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396721&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396719&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=33","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=396716&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396685&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395320&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393565&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-York---Oak-Hill/Production-Engineering_188903":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395495&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=380128&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=384641&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-York---Oak-Hill/Lead-Machine-Maintenance-Mechanic_189131-2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395080&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-York---Oak-Hill/Machine-Maintenance-Mechanic_189136":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394863&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394862&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394790&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394788&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394786&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394543&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Quebec---Quebec/Technicien-utilit-propre_189143":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Production-Maintenance-Mechanic_180833":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Missouri---St-Louis/Site-Regional-Engineering-Lead_187630-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395690&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Production-Maintenance-Mechanic_189328":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Rockville-Biopharm/Senior-Mechanical-Utilities-Engineer_190083":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Marietta/HVAC-Technician--2nd-Shift-_188086":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395463&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395454&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Automation-Technology-Manager_187297":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Senior-Facility-Engineer_189180":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393419&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393416&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392642&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Facility-Maintenance-Tech_186745":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Utility-Manager_185978-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390370&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Marietta/Plant-Utility-Technician---3rd-Shift-_186447":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Bioprocess-Engineer_186345":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392638&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391888&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394416&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394095&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Senior-Process-Safety-Engineer_185134":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=82","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389751&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394069&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Upper-Merion/Process-Engineer_188015":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393731&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393567&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Oak-Hill/Automation-Engineering-Manager_188100":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386427&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391517&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391515&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391218&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389143&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389623&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389241&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387295&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386590&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384301&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=383327&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=381876&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=372687&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Vaccines-Immunization-Specialist---Des-Moines--IA_189991-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=11","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397276&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397270&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397261&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=12","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397191&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397189&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397169&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Sales-Specialist--Pharma---East-Dallas_189994":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=15","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397080&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396997&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=22","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Nova-Scotia--Halifax/Territory-Associate---Halifax-South_191809":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Territory-Business-Manager--Detroit-North_191494":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Illinois---Chicago-North/Territory-Business-Manager--Chicago-North_191497":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=24","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396956&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396955&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=25","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396951&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396945&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396942&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396939&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396936&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396933&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=26","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396886&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=28","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396868&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Georgia---Atlanta-South/Territory-Business-Manager-South-Atlanta_190881":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=29","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396832&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=30","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396703&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396700&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=34","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396674&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=35","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396591&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396583&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396580&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396577&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/District-Sales-Manager--Pharma---North-New-Jersey_190902":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Carolinas/Territory-Business-Manager-Wilmington--NC-Metro_185814":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396574&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396571&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396492&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396489&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396486&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=40","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396468&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396406&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392762&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396407&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396088&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396294&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396291&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396287&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/National-Account-Executive_188993-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Territory-Account-Manager--ViiV--Las-Vegas--NV-Palm-Springs--CA-_188642":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396255&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396209&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Private-Account-Manager--Vaccines---Seattle--WA_189993-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Sales-Specialist--Pharma---Danbury--CT_185846":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396125&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=396093&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396082&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396071&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396024&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396021&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396003&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395994&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395919&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395905&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395017&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395872&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395869&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395866&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Sales-Specialist--Pharma---San-Francisco--CA_186479":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393569&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395677&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395654&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395597&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395592&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395574&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395565&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395558&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395555&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395552&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://gsk.ambertrack.co.uk/graduates2019/bocga.aspx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393981&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393977&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393975&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390348&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393983&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://gsk.ambertrack.co.uk/graduates2019/bot.aspx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390081&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390077&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389700&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://gsk.ambertrack.co.uk/graduates2019/mssc.aspx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"View more details","status":"new"},"https://gsk.ambertrack.co.uk/graduates2019/bmsdds.aspx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"View more details","status":"new"},"https://gsk.ambertrack.co.uk/graduates2019/rdra.aspx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"View more details","status":"new"},"https://gsk.ambertrack.co.uk/graduates2019/rdch.aspx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"View more details","status":"new"},"https://youtu.be/W4KRC32rfX4?rel=0":{"firstFound":"https://www.gsk.com/en-gb/careers/meet-our-people/debleena-marketing-and-communications-india/","txt":"View video on YouTube","status":"new"},"http://scholar.google.co.uk/scholar?q=eosinophilic+granulomatosis+with+polyangiitis&hl=en&as_sdt=0&as_vis=1&oi=scholart":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-data-presented-at-ers-further-supports-its-industry-leading-respiratory-medicines-portfolio/","txt":"eosinophilic granulomatosis with polyangiitis","status":"new"},"https://gsk.to/2wXFur8":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-receives-positive-chmp-opinion-supporting-expanded-copd-indication-in-europe/","txt":"https://gsk.to/2wXFur8","status":"new"},"https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/nucala/pi/home.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-new-data-on-the-long-term-efficacy-safety-of-nucala-for-the-treatment-of-severe-asthma-with-an-eosinophilic-phenotype/","txt":"US Prescribing Information Nucala","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003860/WC500198037.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-new-data-on-the-long-term-efficacy-safety-of-nucala-for-the-treatment-of-severe-asthma-with-an-eosinophilic-phenotype/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003860/WC500198037.pdf","status":"new"},"http://www.who.int/respiratory/copd/diagnosis/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-once-daily-single-inhaler-triple-therapy-receives-positive-opinion-from-the-chmp-in-europe-for-appropriate-patients-with-copd/","txt":"http://www.who.int/respiratory/copd/diagnosis/en/","status":"new"},"https://gsk.to/2Ntfdu9":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-results-of-indirect-treatment-comparisons-of-nucala-to-benralizumab-and-reslizumab-for-severe-eosinophilic-asthma/","txt":"https://gsk.to/2Ntfdu9","status":"new"},"https://www.erswhitebook.org/files/public/Chapters/11_childhood_asthma.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/chmp-recommend-nucala-mepolizumab-for-the-treatment-of-severe-eosinophilic-asthma-paediatric-patients-in-europe/","txt":"https://www.erswhitebook.org/files/public/Chapters/11_childhood_asthma.pdf","status":"new"},"https://gsk.to/2uL0HDJ":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-adaptimmune-complete-transition-of-ny-eso-spear-t-cell-therapy-programme-to-gsk/","txt":"https://gsk.to/2uL0HDJ","status":"new"},"https://www.globenewswire.com/Tracker?data=0uwX6I7HSRVoDQJWxNJTV4EiOirQz6vdhdgDPKnSCLeD3QLfah4-Xamacku_cMJZ7Jt0eNIEJnBGVrPYycq_-eUoy7nkd86fLIE-7lx_9lg=":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-adaptimmune-complete-transition-of-ny-eso-spear-t-cell-therapy-programme-to-gsk/","txt":"http://www.adaptimmune.com","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003860/human_med_001933.jsp&mid=WC0b01ac058001d124":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/european-commission-approves-nucala-mepolizumab-for-the-treatment-of-children-with-severe-asthma/","txt":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003860/human_med_001933.jsp&mid=WC0b01ac058001d124","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Juluca/pdf/JULUCA-PI-PIL.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/juluca-approved-in-us-as-first-2-drug-regimen-once-daily-single-pill/","txt":"See full prescribing information for JULUCA","status":"new"},"https://www.medicines.org.uk/emc/product/9246":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-shares-data-from-landmark-2-drug-regimen-trials-at-aids-2018/","txt":"https://www.medicines.org.uk/emc/product/9246","status":"new"},"http://www.ema.europa.eu/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-regulatory-update-on-avandia-following-ema-and-fda-reviews/","txt":"www.ema.europa.eu","status":"new"},"https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-PI-01956-1&d=2018062916114622483":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-shares-data-from-landmark-2-drug-regimen-trials-at-aids-2018/","txt":"https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-PI-01956-1&d=2018062916114622483","status":"new"},"http://apps.who.int/iris/bitstream/10665/128494/1/9789241507585_eng.pdf?ua=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment/","txt":"http://apps.who.int/iris/bitstream/10665/128494/1/9789241507585_eng.pdf?ua=1","status":"new"},"http://www.who.int/mediacentre/factsheets/fs360/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment/","txt":"http://www.who.int/mediacentre/factsheets/fs360/en/","status":"new"},"http://www.euro.who.int/en/health-topics/communicable-diseases/hivaids/data-and-statistics/infographic-newly-diagnosed-hiv-infections-in-the-who-european-region,-2016":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-gains-chmp-positive-opinion-for-juluca-dolutegravirrilpivirine-in-europe/","txt":"http://www.euro.who.int/en/health-topics/communicable-diseases/hivaids/data-and-statistics/infographic-newly-diagnosed-hiv-infections-in-the-who-european-region,-2016","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02429791?term=dolutegravir+AND+sword&cond=HIV&rank=3":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-eu-marketing-authorisation-for-juluca-dolutegravirrilpivirine-the-first-2-drug-regimen-once-daily-single-pill-for-the-treatment-of-hiv/","txt":"https://clinicaltrials.gov/ct2/show/NCT02429791?term=dolutegravir+AND+sword&cond=HIV&rank=3","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02422797?term=dolutegravir+AND+sword&cond=HIV&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-eu-marketing-authorisation-for-juluca-dolutegravirrilpivirine-the-first-2-drug-regimen-once-daily-single-pill-for-the-treatment-of-hiv/","txt":"https://clinicaltrials.gov/ct2/show/NCT02422797?term=dolutegravir+AND+sword&cond=HIV&rank=1","status":"new"},"http://www.fda.gov/medwatch":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-statement-in-response-to-fda-advisory-committees-vote-on-safety-of-avandia-rosiglitazone/","txt":"www.fda.gov/medwatch","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02938520?term=FLAIR+Cabotegravir&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-phase-iii-programme-to-evaluate-a-long-acting-injectable-hiv-treatment-regimen/","txt":"https://clinicaltrials.gov/ct2/show/NCT02938520?term=FLAIR+Cabotegravir&rank=1","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Benlysta/pdf/BENLYSTA-PI-MG.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-results-from-phase-iii-bliss-sc-study-of-benlysta-belimumab-administered-subcutaneously-in-patients-with-systemic-lupus-erythematosus/","txt":"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Benlysta/pdf/BENLYSTA-PI-MG.PDF","status":"new"},"https://www.medicines.org.uk/emc/search/?q=Relvar&dt=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-eu-approval-for-labelling-update-to-relvar-ellipta-in-patients-with-asthma/","txt":"EU Prescribing Information for Relvar Ellipta.","status":"new"},"https://www.medicines.org.uk/emc/medicine/2317/SPC/Seretide+100,+250,+500+Accuhaler":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-advair-diskus-achieves-primary-endpoint-in-laba-safety-study-of-patients-with-asthma/","txt":"https://www.medicines.org.uk/emc/medicine/2317/SPC/Seretide+100,+250,+500+Accuhaler","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Advair_Diskus/pdf/ADVAIR-DISKUS-PI-MG.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-advair-diskus-achieves-primary-endpoint-in-laba-safety-study-of-patients-with-asthma/","txt":"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Advair_Diskus/pdf/ADVAIR-DISKUS-PI-MG.PDF","status":"new"},"http://www.thelancet.com/lanchi/video":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-clinical-data-demonstrate-high-vaccine-efficacy-of-fluarix-tetra-influenza-vaccine-in-children-6-35-months-of-age/","txt":"http://www.thelancet.com/lanchi/video","status":"new"},"http://www.who.int/mediacentre/factsheets/fs211/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-approval-for-expanded-indication-for-fluarix-tetra-influenza-vaccine-for-ages-six-months-and-older/","txt":"http://www.who.int/mediacentre/factsheets/fs211/en/","status":"new"},"http://www.who.int/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-clinical-data-demonstrate-high-vaccine-efficacy-of-fluarix-tetra-influenza-vaccine-in-children-6-35-months-of-age/","txt":"http://www.who.int/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf","status":"new"},"http://www.who.int/immunization/sage/meetings/2012/april/1_J.Bresee_SAGE_DB_Final.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-approval-for-expanded-indication-for-fluarix-tetra-influenza-vaccine-for-ages-six-months-and-older/","txt":"http://www.who.int/immunization/sage/meetings/2012/april/1_J.Bresee_SAGE_DB_Final.pdf","status":"new"},"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111961/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-approval-for-expanded-indication-for-fluarix-tetra-influenza-vaccine-for-ages-six-months-and-older/","txt":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111961/","status":"new"},"https://www.clinicaltrials.gov/ct2/show/NCT02729051?term=FF%2FUMEC%2FVI&cond=copd&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-submits-landmark-impact-data-to-european-medicines-agency-to-support-expanded-label-for-trelegy-ellipta/","txt":"NCT02729051","status":"new"},"http://goldcopd.org/wp-content/uploads/2016/12/wms-GOLD-2017-Pocket-Guide.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-once-daily-single-inhaler-triple-therapy-receives-positive-opinion-from-the-chmp-in-europe-for-appropriate-patients-with-copd/","txt":"http://goldcopd.org/wp-content/uploads/2016/12/wms-GOLD-2017-Pocket-Guide.pdf","status":"new"},"http://www.aidsinfo.nih.gov/guidelines":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-phase-iii-programme-evaluating-a-two-drug-regimen-combining-dolutegravir-and-lamivudine-for-hiv-1-treatment/","txt":"www.aidsinfo.nih.gov/guidelines","status":"new"},"http://www.who.int/hiv/pub/arv/arv-2016/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-phase-iii-programme-evaluating-a-two-drug-regimen-combining-dolutegravir-and-lamivudine-for-hiv-1-treatment/","txt":"http://www.who.int/hiv/pub/arv/arv-2016/en/","status":"new"},"http://health.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-announce-positive-top-line-results-from-pivotal-trial-of-arzerra-ofatumumab-combined-with-chlorambucil-in-previously-untreated-chronic-lymphocytic-leukaemia/","txt":"health.gsk.com","status":"new"},"https://www.fda.gov/forpatients/approvals/fast/ucm405397.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-meningitis-b-vaccine-bexsero-receives-breakthrough-therapy-designation-from-us-fda-for-prevention-of-invasive-meningococcal-disease-in-children-2-10-years-of-age/","txt":"https://www.fda.gov/forpatients/approvals/fast/ucm405397.htm","status":"new"},"https://www.fda.gov/ForPatients/Approvals/Fast/ucm405399.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-meningitis-b-vaccine-bexsero-receives-breakthrough-therapy-designation-from-us-fda-for-prevention-of-invasive-meningococcal-disease-in-children-2-10-years-of-age/","txt":"https://www.fda.gov/ForPatients/Approvals/Fast/ucm405399.htm","status":"new"},"https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-meningitis-b-vaccine-bexsero-receives-breakthrough-therapy-designation-from-us-fda-for-prevention-of-invasive-meningococcal-disease-in-children-2-10-years-of-age/","txt":"https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report.pdf","status":"new"},"http://www.who.int/mediacentre/factsheets/fs141/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/real-world-data-shows-83-percent-effectiveness-for-bexsero-in-infants-in-first-year-of-uk-national-meningitis-b-immunisation-programme/","txt":"http://www.who.int/mediacentre/factsheets/fs141/en/","status":"new"},"http://dx.doi.org/10.1016/j.vaccine.2015.11.05":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-meningitis-b-vaccine-bexsero-receives-breakthrough-therapy-designation-from-us-fda-for-prevention-of-invasive-meningococcal-disease-in-children-2-10-years-of-age/","txt":"http://dx.doi.org/10.1016/j.vaccine.2015.11.05","status":"new"},"https://www.medicines.org.uk/emc/medicine/28407":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/real-world-data-shows-83-percent-effectiveness-for-bexsero-in-infants-in-first-year-of-uk-national-meningitis-b-immunisation-programme/","txt":"https://www.medicines.org.uk/emc/medicine/28407","status":"new"},"http://www.medicines.org.uk/emc/search/?q=Relvar&dt=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-of-once-daily-closed-triple-combination-therapy-ffumecvi-in-patients-with-asthma/","txt":"EU Prescribing Information for Relvar Ellipta.","status":"new"},"https://www.gsksource.com/gskprm/htdocs/documents/BREO-ELLIPTA-PI-MG.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-gains-approval-in-japan-for-the-treatment-of-asthma/","txt":"US Prescribing information BREO ELLIPTA","status":"new"},"https://www.sec.gov/Archives/edgar/data/1131399/000119312516510261/d32974dex410.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-promising-new-data-for-priority-bcma-asset-from-its-emerging-oncology-pipeline-at-59th-ash-meeting/","txt":"https://www.sec.gov/Archives/edgar/data/1131399/000119312516510261/d32974dex410.htm","status":"new"},"https://www.cancer.net/cancer-types/multiple-myeloma/statistics":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-promising-new-data-for-priority-bcma-asset-from-its-emerging-oncology-pipeline-at-59th-ash-meeting/","txt":"https://www.cancer.net/cancer-types/multiple-myeloma/statistics","status":"new"},"https://en.wikipedia.org/wiki/Red_bone_marrow":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-data-supports-the-safety-and-efficacy-of-gsk-s-shingrix-in-preventing-shingles-in-autologous-haematopoietic-stem-cell-transplant-patients/","txt":"red bone marrow","status":"new"},"https://en.wikipedia.org/wiki/Multipotent_hematopoietic_stem_cell":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-data-supports-the-safety-and-efficacy-of-gsk-s-shingrix-in-preventing-shingles-in-autologous-haematopoietic-stem-cell-transplant-patients/","txt":" haematopoietic stem cells","status":"new"},"https://en.wikipedia.org/wiki/Chemotherapy":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-data-supports-the-safety-and-efficacy-of-gsk-s-shingrix-in-preventing-shingles-in-autologous-haematopoietic-stem-cell-transplant-patients/","txt":"chemotherapy","status":"new"},"https://en.wikipedia.org/wiki/Radiotherapy":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-data-supports-the-safety-and-efficacy-of-gsk-s-shingrix-in-preventing-shingles-in-autologous-haematopoietic-stem-cell-transplant-patients/","txt":"radiotherapy","status":"new"},"https://en.wikipedia.org/wiki/Bone_marrow":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-data-supports-the-safety-and-efficacy-of-gsk-s-shingrix-in-preventing-shingles-in-autologous-haematopoietic-stem-cell-transplant-patients/","txt":"bone marrow","status":"new"},"https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm581491.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-data-supports-the-safety-and-efficacy-of-gsk-s-shingrix-in-preventing-shingles-in-autologous-haematopoietic-stem-cell-transplant-patients/","txt":"https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm581491.htm","status":"new"},"https://bloodcell.transplant.hrsa.gov/research/transplant_data/transplant_activity_report/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-data-supports-the-safety-and-efficacy-of-gsk-s-shingrix-in-preventing-shingles-in-autologous-haematopoietic-stem-cell-transplant-patients/","txt":"https://bloodcell.transplant.hrsa.gov/research/transplant_data/transplant_activity_report/index.html#numbers","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT03164564":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-start-of-phase-iii-study-of-long-acting-cabotegravir-for-hiv-prevention-in-women/","txt":"https://clinicaltrials.gov/ct2/show/NCT03164564","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02720094?term=NCT02720094&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-start-of-phase-iii-study-of-long-acting-cabotegravir-for-hiv-prevention-in-women/","txt":"https://clinicaltrials.gov/ct2/show/NCT02720094?term=NCT02720094&rank=1","status":"new"},"http://ec.europa.eu/health/documents/community-register/index_en.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-receives-european-marketing-authorisation-for-the-treatment-of-asthma-and-copd/","txt":"http://ec.europa.eu/health/documents/community-register/index_en.htm","status":"new"},"http://www.gsk-clinicalstudyregister.com/study/116853":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-us-filing-plans-for-closed-triple-combination-therapy-ffumecvi-in-patients-with-copd/","txt":"FULFIL","status":"new"},"http://www.atsjournals.org/doi/pdf/10.1164/rccm.201703-0449OC":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-once-daily-single-inhaler-triple-therapy-receives-positive-opinion-from-the-chmp-in-europe-for-appropriate-patients-with-copd/","txt":"published ","status":"new"},"https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/trelegy/pi/home.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-once-daily-single-inhaler-triple-therapy-gains-marketing-authorisation-in-europe-for-the-treatment-of-copd/","txt":"https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/trelegy/pi/home.html","status":"new"},"https://www.fda.gov/regulatoryinformation/lawsenforcedbyfda/significantamendmentstothefdcact/fdasia/ucm341027.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-investigational-bcma-antibody-drug-conjugate-receives-breakthrough-therapy-designation-from-us-fda-for-relapsed-and-refractory-multiple-myeloma/","txt":"https://www.fda.gov/regulatoryinformation/lawsenforcedbyfda/significantamendmentstothefdcact/fdasia/ucm341027.htm","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000660.jsp":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-investigational-bcma-antibody-drug-conjugate-receives-breakthrough-therapy-designation-from-us-fda-for-relapsed-and-refractory-multiple-myeloma/","txt":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000660.jsp","status":"new"},"https://www.fda.gov/forindustry/developingproductsforrarediseasesconditions/howtoapplyfororphanproductdesignation/default.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-investigational-bcma-antibody-drug-conjugate-receives-breakthrough-therapy-designation-from-us-fda-for-relapsed-and-refractory-multiple-myeloma/","txt":"https://www.fda.gov/forindustry/developingproductsforrarediseasesconditions/howtoapplyfororphanproductdesignation/default.htm","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000029.jsp":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-investigational-bcma-antibody-drug-conjugate-receives-breakthrough-therapy-designation-from-us-fda-for-relapsed-and-refractory-multiple-myeloma/","txt":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000029.jsp","status":"new"},"https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203975s000lbl.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-study-demonstrates-superiority-of-anoro-ellipta-to-stiolto-respimat-in-improving-lung-function-in-chronic-obstructive-pulmonary-disease/","txt":"US Prescribing Information for Anoro Ellipta","status":"new"},"http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-study-demonstrates-superiority-of-anoro-ellipta-to-stiolto-respimat-in-improving-lung-function-in-chronic-obstructive-pulmonary-disease/","txt":"http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/","status":"new"},"http://www.who.int/respiratory/copd/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-study-demonstrates-superiority-of-anoro-ellipta-to-stiolto-respimat-in-improving-lung-function-in-chronic-obstructive-pulmonary-disease/","txt":"http://www.who.int/respiratory/copd/en/","status":"new"},"https://atom.cancer.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/public-private-consortium-aims-to-cut-preclinical-cancer-drug-discovery-from-six-years-to-just-one/","txt":"ATOM","status":"new"},"http://www.nature.com/nrd/journal/v9/n3/pdf/nrd3078.pdf?foxtrotcallback=true":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/public-private-consortium-aims-to-cut-preclinical-cancer-drug-discovery-from-six-years-to-just-one/","txt":"approximately six years","status":"new"},"http://www.ascopost.com/issues/january-25-2017/what-precisely-is-precision-oncology-and-will-it-work/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/public-private-consortium-aims-to-cut-preclinical-cancer-drug-discovery-from-six-years-to-just-one/","txt":"precision oncology","status":"new"},"http://www.ucsf.edu/news":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/public-private-consortium-aims-to-cut-preclinical-cancer-drug-discovery-from-six-years-to-just-one/","txt":"www.ucsf.edu/news","status":"new"},"http://www.llnl.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/public-private-consortium-aims-to-cut-preclinical-cancer-drug-discovery-from-six-years-to-just-one/","txt":"www.llnl.gov","status":"new"},"https://frederick.cancer.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/public-private-consortium-aims-to-cut-preclinical-cancer-drug-discovery-from-six-years-to-just-one/","txt":"Frederick National Laboratory for Cancer Research","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/cdc-s-advisory-committee-on-immunization-practices-recommends-shingrix-as-the-preferred-vaccine-for-the-prevention-of-shingles-for-adults-aged-50-and-up/","txt":"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF","status":"new"},"http://www.roivant.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/roivant-subsidiary-dermavant-sciences-signs-agreement-with-gsk-to-purchase-rights-to-tapinarof/","txt":"www.roivant.com","status":"new"},"http://www.dermavant.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/roivant-subsidiary-dermavant-sciences-signs-agreement-with-gsk-to-purchase-rights-to-tapinarof/","txt":"www.dermavant.com","status":"new"},"http://ec.europa.eu/health/documents/community-register/2018/20180607141119/anx_141119_en.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/infants-may-now-be-protected-against-meningitis-b-with-fewer-doses-adding-flexibility-to-vaccination-schedules/","txt":"European Commission approval","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/03/news_detail_002925.jsp&mid=WC0b01ac058004d5c1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-eu-marketing-authorisation-for-juluca-dolutegravirrilpivirine-the-first-2-drug-regimen-once-daily-single-pill-for-the-treatment-of-hiv/","txt":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/03/news_detail_002925.jsp&mid=WC0b01ac058004d5c1","status":"new"},"http://www.orchard-tx.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-strategic-agreement-to-transfer-rare-disease-gene-therapy-portfolio-to-orchard-therapeutics/","txt":"www.orchard-tx.com","status":"new"},"http://dx.doi.org/10.1016/S0140-6736(16)30374-9":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-strategic-agreement-to-transfer-rare-disease-gene-therapy-portfolio-to-orchard-therapeutics/","txt":"http://dx.doi.org/10.1016/S0140-6736(16)30374-9","status":"new"},"https://www.ncbi.nlm.nih.gov/pubmed/23845947":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-strategic-agreement-to-transfer-rare-disease-gene-therapy-portfolio-to-orchard-therapeutics/","txt":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002753/human_med_001720.jsp&mid=WC0b01ac058001d124":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/triumeq-dolutegravirabacavirlamivudine-single-tablet-regimen-receives-positive-chmp-opinion-in-europe-for-the-treatment-of-hiv/","txt":"dolutegravir","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002264/human_med_001513.jsp&mid=WC0b01ac058001d124":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-gains-chmp-positive-opinion-for-juluca-dolutegravirrilpivirine-in-europe/","txt":"rilpivirine.","status":"new"},"https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM581605.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/shingrix-approved-in-europe-and-japan-for-the-prevention-of-shingles-in-adults-aged-50-and-over/","txt":"https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM581605.pdf","status":"new"},"https://ca.gsk.com/media/1350788/shingrix_pm-2017-10-13.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/shingrix-approved-in-europe-and-japan-for-the-prevention-of-shingles-in-adults-aged-50-and-over/","txt":"https://ca.gsk.com/media/1350788/shingrix_pm-2017-10-13.pdf","status":"new"},"https://www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/shingrix-approved-in-europe-and-japan-for-the-prevention-of-shingles-in-adults-aged-50-and-over/","txt":"https://www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","status":"new"},"http://healthycanadians.gc.ca/publications/healthy-living-vie-saine/4-canadian-immunization-guide-canadien-immunisation/index-eng.php?page=8":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-first-approval-of-shingrix-in-canada/","txt":"http://healthycanadians.gc.ca/publications/healthy-living-vie-saine/4-canadian-immunization-guide-canadien-immunisation/index-eng.php?page=8","status":"new"},"https://www.healthgsk.jp/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-for-nucala-mepolizumab-in-japan/","txt":"https://www.healthgsk.jp/","status":"new"},"http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwjDlYmi-eXUAhVG7hoKHXAzD8QQFggiMAA&url=http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fabout_us%2Fgeneral%2Fgeneral_content_000094.jsp&usg=AFQjCNHIG9wwf1wxqpBDYv62tTBFcQ0TiQ":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-innoviva-report-positive-headline-results-from-impact-study-showing-single-inhaler-triple-therapy-trelegy-ellipta-reduced-copd-exacerbations/","txt":"Committee for Medicinal Products for Human Use (CHMP) ","status":"new"},"https://clinicaltrials.gov/ct2/show/study/NCT01706198?term=Salford+Lung+Study&rank=12":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-significantly-improved-asthma-control-in-salford-lung-study-patients-compared-with-their-usual-care/","txt":"clintrials.gov","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Breo_Ellipta/pdf/BREO-ELLIPTA-PI-MG.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-from-pioneering-salford-lung-study-in-asthma-published-in-the-lancet-and-presented-at-european-respiratory-congress/","txt":"US Prescribing Information for Breo Ellipta","status":"new"},"https://www.youtube.com/embed/2yjabh_QFVU?rel=0":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-respiratory-data-from-pipeline-to-clinical-practice-at-ers/","txt":"View video on YouTube","status":"new"},"http://www.viivhealthcare.com./":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/switching-to-a-dolutegravir-regimen-from-a-boosted-protease-inhibitor-regimen-maintained-viral-suppression-and-improved-lipid-fractions-in-patients-with-hiv-and-high-cardiovascular-risk/","txt":"www.viivhealthcare.com","status":"new"},"http://www.edurant.com/shared/product/Edurant/EDURANT-PI.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment/","txt":"Product Information","status":"new"},"https://www.gsk-clinicalstudyregister.com/study/205687?search=study&b%22b%27%27%22":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-nasal-polyps/","txt":"The pivotal phase III study","status":"new"},"http://www.medicines.org.uk/emc/medicine/22716/PIL/Synflorix+suspension+for+injection+in+pre-filled+syringe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/synflorix-receives-positive-opinion-from-the-chmp-in-europe-for-additional-pneumonia-indication/","txt":"Electronic Medicines Compendium ","status":"new"},"http://www.who.int/immunization/monitoring_surveillance/burden/estimates/Pneumo_hib/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-synflorix-receives-chmp-positive-opinion-for-major-label-extension/","txt":"http://www.who.int/immunization/monitoring_surveillance/burden/estimates/Pneumo_hib/en/","status":"new"},"https://www.mmv.org/partnering/pdp-model":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-mmv-announce-positive-headline-phase-iii-results-showing-single-dose-tafenoquine-reduces-risk-of-relapse-in-patients-with-plasmodium-vivax-malaria/","txt":"product development partnership (PDP)","status":"new"},"https://www.mmv.org/research-development/mmv-supported-projects":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-mmv-announce-positive-headline-phase-iii-results-showing-single-dose-tafenoquine-reduces-risk-of-relapse-in-patients-with-plasmodium-vivax-malaria/","txt":"portfolio","status":"new"},"https://www.mmv.org/partnering/who-we-work-0":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-mmv-announce-positive-headline-phase-iii-results-showing-single-dose-tafenoquine-reduces-risk-of-relapse-in-patients-with-plasmodium-vivax-malaria/","txt":"partnership network","status":"new"},"http://www.almasanaproject.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-innovations-to-tackle-under-five-deaths-win-us-1-million-healthcare-innovation-award-from-gsk-and-save-the-children/","txt":"/","status":"new"},"http://www.ahdpak.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-innovations-to-tackle-under-five-deaths-win-us-1-million-healthcare-innovation-award-from-gsk-and-save-the-children/","txt":"http://www.ahdpak.org/","status":"new"},"http://sinergiasong.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-innovations-to-tackle-under-five-deaths-win-us-1-million-healthcare-innovation-award-from-gsk-and-save-the-children/","txt":"http://sinergiasong.org/","status":"new"},"http://armman.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-innovations-to-tackle-under-five-deaths-win-us-1-million-healthcare-innovation-award-from-gsk-and-save-the-children/","txt":"http://armman.org/","status":"new"},"http://www.healthcareinnovationaward.org/en/previous-winners/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-innovations-to-tackle-under-five-deaths-win-us-1-million-healthcare-innovation-award-from-gsk-and-save-the-children/","txt":"http://www.healthcareinnovationaward.org/en/previous-winners/","status":"new"},"http://us.gsk.com/media/495344/151030_gsk_role-of-the-eosinophil-in-sa_infographic.jpg":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-musca-study-shows-nucala-mepolizumab-significantly-improves-quality-of-life-and-lung-function-in-severe-asthma-patients-with-an-eosinophilic-phenotype/","txt":"GSK’s infographic","status":"new"},"http://www.nejm.org/doi/full/10.1056/NEJMoa1702079?query=featured_home":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-nejm-publication-of-positive-phase-iii-study-investigating-mepolizumab-in-patients-with-eosinophilic-granulomatosis-with-polyangiitis-egpa/","txt":"http://www.nejm.org/doi/full/10.1056/NEJMoa1702079?query=featured_home","status":"new"},"http://www.msd.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/togo-becomes-first-country-in-africa-to-validate-the-elimination-of-lymphatic-filariasis-as-a-public-health-problem/","txt":"www.msd.com","status":"new"},"https://twitter.com/msdbewell?lang=en":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/togo-becomes-first-country-in-africa-to-validate-the-elimination-of-lymphatic-filariasis-as-a-public-health-problem/","txt":"Twitter","status":"new"},"https://www.gsk-clinicalstudyregister.com/study/200622?search=study&":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-severe-hypereosinophilic-syndrome/","txt":"The pivotal phase III study","status":"new"},"https://us.gsk.com/en-us/media/press-releases/2014/gsk-announces-start-of-phase-iii-programme-for-mepolizumab-in-patients-with-copd/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-with-mepolizumab-in-patients-with-severe-hypereosinophilic-syndrome/","txt":"phase III","status":"new"},"http://www.lshtm.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-scholarships-to-recognise-retiring-ceo-sir-andrew-witty-s-contribution-to-global-health/","txt":"www.lshtm.ac.uk","status":"new"},"http://www.lshtm.ac.uk/study/funding/masters_scholarships.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-scholarships-to-recognise-retiring-ceo-sir-andrew-witty-s-contribution-to-global-health/","txt":"www.lshtm.ac.uk/study/funding/masters_scholarships.html","status":"new"},"https://us.gsk.com/en-us/media/infographics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-musca-study-shows-nucala-mepolizumab-significantly-improves-quality-of-life-and-lung-function-in-severe-asthma-patients-with-an-eosinophilic-phenotype/","txt":"MUSCA infographic","status":"new"},"https://flic.kr/p/Y1EFmm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/luke-miels-appointed-president-global-pharmaceuticals-gsk/","txt":"Download image from FlickR","status":"new"},"http://www.hptn.org/research/studies/176":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-start-of-phase-iii-study-evaluating-long-acting-cabotegravir-for-hiv-prevention/","txt":"www.hptn.org/research/studies/176","status":"new"},"https://www.gsk-clinicalstudyregister.com/study/205715?search=compound&compound=fluticasone-furoate-vilanterol-umeclidinium-bromide":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-iii-study-of-once-daily-closed-triple-combination-therapy-ffumecvi-in-patients-with-asthma/","txt":"CAPTAIN","status":"new"},"http://www.edurant.com/shared/prescribing-information-edurant.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-positive-results-from-first-phase-iii-studies-of-two-drug-hiv-treatment-regimen/","txt":"Please see full Product Information for more details","status":"new"},"file:///C:/Users/ss463089/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/FFIFGN0Q/161216_DTG%20PAED%20EU%20APPROVAL_PRESS%20RELEASE_FINAL.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-chmp-positive-opinion-to-lower-the-age-and-weight-limit-for-tivicay-dolutegravir-in-children-and-adolescents-living-with-hiv-in-europe/","txt":"","status":"new"},"http://www.medicines.org.uk/emc/medicine/28545":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-chmp-positive-opinion-to-lower-the-age-and-weight-limit-for-tivicay-dolutegravir-in-children-and-adolescents-living-with-hiv-in-europe/","txt":"he full EU SmPC for Tivicay® (dolutegravir)","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/002753/WC500218158.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-chmp-positive-opinion-to-lower-the-age-and-weight-limit-for-tivicay-dolutegravir-in-children-and-adolescents-living-with-hiv-in-europe/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/002753/WC500218158.pdf","status":"new"},"http://impaactnetwork.org/studies/P1093.asp":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-fda-approval-to-lower-the-weight-limit-for-dolutegravir-in-children-and-adolescents-living-with-hiv/","txt":"http://impaactnetwork.org/studies/P1093.asp","status":"new"},"https://www.viivhealthcare.com/media/press-releases/2016/june/viiv-healthcare-announces-fda-approval-to-lower-the-weight-limit-for-dolutegravir-in-children-and-adolescents-living-with-hiv.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-chmp-positive-opinion-to-lower-the-age-and-weight-limit-for-tivicay-dolutegravir-in-children-and-adolescents-living-with-hiv-in-europe/","txt":"https://www.viivhealthcare.com/media/press-releases/2016/june/viiv-healthcare-announces-fda-approval-to-lower-the-weight-limit-for-dolutegravir-in-children-and-adolescents-living-with-hiv.aspx","status":"new"},"http://glaxosmithkline.co.jp/healthcare/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-gains-approval-in-japan-for-the-treatment-of-asthma/","txt":"http://glaxosmithkline.co.jp/healthcare/","status":"new"},"https://www.nhlbi.nih.gov/health/health-topics/topics/copd/atrisk.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/data-published-on-anoro-ellipta-demonstrate-improved-lung-function-compared-to-tiotropium/","txt":"https://www.nhlbi.nih.gov/health/health-topics/topics/copd/atrisk.html","status":"new"},"file:///C:/Users/pt810653/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/N9DV3O2Q/Relvar%20Ellipta%20gains%20approval%20in%20Japan%20for%20use%20in%20patients%20with%20COPD%2002_12_16%20LSE%20announcement.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-10025-mcg-gains-approval-in-japan-for-use-in-patients-with-copd/","txt":"","status":"new"},"http://www.cdc.gov/shingles/hcp/clinical-overview.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/pivotal-phase-iii-study-of-gsk-shingles-candidate-vaccine-meets-its-primary-endpoint/","txt":"http://www.cdc.gov/shingles/hcp/clinical-overview.html","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02951052?term=ATLAS+cabotegravir&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-phase-iii-programme-to-evaluate-a-long-acting-injectable-hiv-treatment-regimen/","txt":"https://clinicaltrials.gov/ct2/show/NCT02951052?term=ATLAS+cabotegravir&rank=1","status":"new"},"http://www.helppreventdisease.com/adult_vaccines/influenza/4-strain-flu-vaccine.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-approval-for-expanded-indication-for-flulaval-quadrivalent-influenza-vaccine-for-infants-6-months-and-older/","txt":"ChooseMoreChooseFour.com","status":"new"},"http://www.flu.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-seeking-expanded-indication-for-flulaval-quadrivalent-influenza-vaccine-for-infants-6-mosplus/","txt":"www.flu.gov","status":"new"},"http://www.cdc.gov/flu":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-seeking-expanded-indication-for-flulaval-quadrivalent-influenza-vaccine-for-infants-6-mosplus/","txt":"www.cdc.gov/flu","status":"new"},"http://us.gsk.com/en-us/media/press-kits/flulaval-quadrivalent-for-infants-6-months-and-older/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-approval-for-expanded-indication-for-flulaval-quadrivalent-influenza-vaccine-for-infants-6-months-and-older/","txt":"full US Prescribing Information for FluLaval® Quadrivalent","status":"new"},"http://www.cdc.gov/arthritis/basics/rheumatoid.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-new-data-from-phase-iii-studies-of-sirukumab-in-adult-patients-with-moderately-to-severely-active-rheumatoid-arthritis/","txt":"http://www.cdc.gov/arthritis/basics/rheumatoid.htm","status":"new"},"http://www.jacionline.org/article/S0091-6749(16)30891-0/fulltext":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-data-published-for-gsk-s-nucala-investigating-hospitalisation-reduction-in-severe-asthma-patients-with-an-eosinophilic-phenotype/","txt":"http://www.jacionline.org/article/S0091-6749(16)30891-0/fulltext","status":"new"},"http://www.cdc.gov/shingles/hcp/clinical-overview.html%20on%206%20Sept%202016":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-candidate-shingles-vaccine-shows-high-efficacy-against-shingles-and-its-complications-in-adults-aged-70-years-and-over-in-phase-iii-study-published-in-nejm/","txt":"http://www.cdc.gov/shingles/hcp/clinical-overview.html on 6 Sept 2016","status":"new"},"http://www.gsk-clinicalstudyregister.com/study/116853?search=compound&compound=fluticasone-furoate-vilanterol-umeclidinium-bromide":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-positive-results-from-phase-iii-fulfil-study-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-copd-at-ers-international-congress/","txt":"FULFIL","status":"new"},"http://www.clinicaltrials.gov/ct2/show/NCT02164513?term=nct02164513&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-initiation-of-phase-iii-programme-with-fixed-dose-triple-combination-treatment-ffumecvi-in-patients-with-copd/","txt":"IMPACT","status":"new"},"http://www.medicines.org.uk/emc/medicine/11882":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fulfil-study-shows-superiority-of-closed-triple-combination-therapy-ffumecvi-versus-symbicort-turbohaler-in-improving-lung-function-and-health-related-quality-of-life-in-copd-patients/","txt":"http://www.medicines.org.uk/emc/medicine/11882","status":"new"},"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/294245/JCVI_Statement_on_MenB.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/real-world-data-shows-83-percent-effectiveness-for-bexsero-in-infants-in-first-year-of-uk-national-meningitis-b-immunisation-programme/","txt":"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/294245/JCVI_Statement_on_MenB.pdf","status":"new"},"http://dx.doi.org/10.1016/j.vaccine.2015.11.057":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-bexsero-achieves-primary-and-secondary-endpoints-with-reduced-3-dose-schedule-2plus1-in-safety-and-immunogenicity-study-in-infants-and-children/","txt":"http://dx.doi.org/10.1016/j.vaccine.2015.11.057","status":"new"},"http://www.medicines.org.uk/emc/medicine/28407/SPC/Bexsero+Meningococcal+Group+B+vaccine+for+injection+in+pre-filled+syringe/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/real-world-data-shows-83-percent-effectiveness-for-bexsero-in-infants-in-first-year-of-uk-national-meningitis-b-immunisation-programme/","txt":"http://www.medicines.org.uk/emc/medicine/28407/SPC/Bexsero+Meningococcal+Group+B+vaccine+for+injection+in+pre-filled+syringe/","status":"new"},"http://ec.europa.eu/health/documents/community-register/html/h886.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-data-from-two-studies-evaluating-the-efficacy-and-safety-of-incruse-ellipta-when-added-to-relvar-breo-ellipta-in-patients-with-copd/","txt":"http://ec.europa.eu/health/documents/community-register/html/h886.htm","status":"new"},"https://www.gsksource.com/gskprm/htdocs/documents/ANORO-ELLIPTA-PI-MG.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-results-from-studies-comparing-anoro-ellipta-with-seretide-diskus-and-advair-diskus-in-patients-with-copd/","txt":"https://www.gsksource.com/gskprm/htdocs/documents/ANORO-ELLIPTA-PI-MG.PDF","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002751/WC500168424.pdf%20%20":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-continued-commitment-to-innovative-respiratory-research-demonstrated-in-european-respiratory-society-congress-data-presentations/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002751/WC500168424.pdf ","status":"new"},"file:///C:/Users/wd548530/Desktop/ViiV%20Healthcare%20launches%20phase%20III%20programme%20evaluating%20a%20two-drug%20regim%20%20%20.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-launches-phase-iii-programme-evaluating-a-two-drug-regimen-combining-dolutegravir-and-lamivudine-for-hiv-1-treatment/","txt":"","status":"new"},"file:///C:/Users/mt918781/Desktop/GSK%20and%20Verily%20to%20establish%20Galvani%20Bioelectronics%20%E2%80%93%20new%20company%20dedicated%20to%20development%20of%20bioelectronic%20medicines%20010816.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-verily-to-establish-galvani-bioelectronics-a-new-company-dedicated-to-the-development-of-bioelectronic-medicines/","txt":"[1]","status":"new"},"file:///C:/Users/wd548530/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/GL73I7ZY/ARIA%20study%20shows%20superior%20efficacy%20of%20Triumeq%20for%20treatment-na%C3%AFve%20women%20living%20with%20HIV%2018_07_16.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/aria-study-shows-superior-efficacy-of-triumeq-for-treatment-na%C3%AFve-women-living-with-hiv/","txt":"","status":"new"},"http://www.unaids.org/sites/default/files/media_asset/20151027_UNAIDS_PCB37_15_18_EN_rev1.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/aria-study-shows-superior-efficacy-of-triumeq-for-treatment-na%C3%AFve-women-living-with-hiv/","txt":"http://www.unaids.org/sites/default/files/media_asset/20151027_UNAIDS_PCB37_15_18_EN_rev1.pdf","status":"new"},"http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/factsheet/2012/20120417_FS_adolescentsyoungpeoplehiv_en.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/aria-study-shows-superior-efficacy-of-triumeq-for-treatment-na%C3%AFve-women-living-with-hiv/","txt":"www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/factsheet/2012/20120417_FS_adolescentsyoungpeoplehiv_en.pdf","status":"new"},"http://gsk.to/1j78aBQ":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-1-million-innovation-prize-for-bioelectronics-research/","txt":"http://gsk.to/1j78aBQ","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2017_EFPIA_HCPO_Methodological_Note_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2017_EFPIA_HCPO_Infographic_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF ","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2016_EFPIA_HCPO_Methodological_Note_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2016_EFPIA_HCPO_Infographic_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_AT_2015_EFPIA_HCPO_Methodological_Note_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"PDF","status":"new"},"https://www.betransparent.be/en/consult-the-register/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/belgium/","txt":"Consult the register","status":"new"},"https://www.betransparent.be/fr/consulter-le-registre/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/belgium/","txt":"Consulter le registre","status":"new"},"https://www.betransparent.be/nl/raadpleeg-het-transparantieregister/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/belgium/","txt":"Raadpleeg het register","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2017_EFPIA_HCPO_Methodological_Note_BULGARSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2017_EFPIA_HCPO_Infographic_BULGARSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2016_EFPIA_HCPO_Methodological_Note_BULGARSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2016_EFPIA_HCPO_Infographic_BULGARSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_BG_2015_EFPIA_HCPO_Methodological_Note_BULGARIAN.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2017_EFPIA_HCPO_Methodological_Note_HRVATSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2017_EFPIA_HCPO_Infographic_HRVATSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2016_EFPIA_HCPO_Methodological_Note_HRVATSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2016_EFPIA_HCPO_Infographic_HRVATSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HR_2015_EFPIA_HCPO_Methodological_Note_CROATIA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CY_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CY_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CY_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CY_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CY_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CY_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CY_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CY_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CZ_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CZ_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CZ_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CZ_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CZ_2017_EFPIA_HCPO_Methodological_Note_CZECH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CZ_2017_EFPIA_HCPO_Infographic_CZECH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CZ_2016_EFPIA_HCPO_Methodological_Note_CZECH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CZ_2015_EFPIA_HCPO_Methodological_Note_CZECH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/","txt":"PDF","status":"new"},"https://laegemiddelstyrelsen.dk/da/godkendelse/samarbejde-med-virksomhed":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/denmark/","txt":"Lægemiddelstyrelsens hjemmeside","status":"new"},"http://dk.gsk.com/da-dk/ansvarlighed/stoette-og-donationer/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/denmark/","txt":"GSK Denmarks hjemmeside","status":"new"},"http://www.enli.dk/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/denmark/","txt":"hjemmeside","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":" PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2017_EFPIA_HCPO_Methodological_Note_EESTI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":" PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2017_EFPIA_HCPO_Infographic_EESTI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2016_EFPIA_HCPO_Methodological_Note_EESTI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2016_EFPIA_HCPO_Infographic_EESTI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_EE_2015_EFPIA_HCPO_Methodological_Note_EESTI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2017_EFPIA_HCPO_Methodological_Note_SUOMEKSI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2017_EFPIA_HCPO_Infographic_SUOMEKSI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2016_EFPIA_HCPO_Methodological_Note_SUOMEKSI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2016_EFPIA_HCPO_Infographic_SUOMEKSI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FI_2015_EFPIA_HCPO_Methodological_Note_SUOMI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"PDF","status":"new"},"http://www.transparence.sante.gouv.fr/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"Ministry for Social Affairs and Health","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2017_EFPIA_HCPO_Methodological_Note_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2017_EFPIA_HCPO_Infographic_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2016_EFPIA_HCPO_Methodological_Note_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2016_EFPIA_HCPO_Infographic_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2015_EFPIA_HCPO_Methodological_Note_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_FR_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"PDF","status":"new"},"https://www.transparence.sante.gouv.fr/flow/main?execution=e3s1":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"a form","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2017_EFPIA_HCPO_Methodological_Note_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2017_EFPIA_HCPO_Infographic_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2016_EFPIA_HCPO_Methodological_Note_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2016_EFPIA_HCPO_Infographic_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2015_EFPIA_HCPO_Methodological_Note_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_DE_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GR_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GR_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GR_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GR_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GR_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GR_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GR_2017_EFPIA_HCPO_Methodological_Note_HELLAS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GR_2016_EFPIA_HCPO_Methodological_Note_HELLAS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GR_2015_EFPIA_HCPO_Methodological_Note_HELLAS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2017_EFPIA_HCPO_Methodological_Note_MAGYAR.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2017_EFPIA_HCPO_Infographic_MAGYAR.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2016_EFPIA_HCPO_Methodological_Note_MAGYAR.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2016_EFPIA_HCPO_Infographic_MAGYAR.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_HU_2015_EFPIA_HCPO_Methodological_Note_MAGYAR.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"PDF","status":"new"},"http://www.transferofvalue.ie/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ireland/","txt":"www.transferofvalue.ie","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2017_EFPIA_HCPO_Methodological_Note_ITALIANO.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2017_EFPIA_HCPO_Infographic_ITALIANO.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2016_EFPIA_HCPO_Methodological_Note_ITALIANO.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2016_EFPIA_HCPO_Infographic_ITALIANO.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_IT_2015_EFPIA_HCPO_Methodological_Note_ITALIANO.PDF":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2017_EFPIA_HCPO_Methodological_Note_LATVISKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2017_EFPIA_HCPO_Infographic_LATVISKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2016_EFPIA_HCPO_Methodological_Note_LATVISKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2016_EFPIA_HCPO_Infographic_LATVISKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LV_2015_EFPIA_HCPO_Methodological_Note_LATVISKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2017_EFPIA_HCPO_Methodological_Note_LIETUVISKAI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2017_EFPIA_HCPO_Infographic_LIETUVISKAI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2016_EFPIA_HCPO_Methodological_Note_LIETUVISKAI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2016_EFPIA_HCPO_Infographic_LIETUVISKAI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LT_2015_EFPIA_HCPO_Methodological_Note_LIETUVISKAI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"PDF","status":"new"},"http://www.apl-pharma.lu/transparence.htm":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"Consult the register","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2017_EFPIA_HCPO_Methodological_Note_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2016_EFPIA_HCPO_Methodological_Note_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2016_EFPIA_HCPO_Infographic_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2015_EFPIA_HCPO_Methodological_Note_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_LU_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_MT_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/malta/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_MT_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/malta/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_MT_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/malta/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_MT_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/malta/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_MT_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/malta/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_MT_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/malta/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_MT_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/malta/","txt":"PDF","status":"new"},"https://www.transparantieregister.nl/nl-nl/home":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/netherlands/","txt":"https://www.transparantieregister.nl/nl-nl/home","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NL_2017_EFPIA_Aggregate_R&D_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/netherlands/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NL_2016_EFPIA_Aggregate_R&D_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/netherlands/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NL_2015_EFPIA_Aggregate_R&D_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/netherlands/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2017_EFPIA_HCPO_Methodological_Note_NORSK.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2016_EFPIA_HCPO_Methodological_Note_NORSK.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2016_EFPIA_HCPO_Infographic_NORSK.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_NO_2015_EFPIA_HCPO_Methodological_Note_NORSK.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/norway/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.PDF":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2017_EFPIA_HCPO_Methodological_Note_POLSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2017_EFPIA_HCPO_Infographic_POLSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2016_EFPIA_HCPO_Methodological_Note_POLSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2016_EFPIA_HCPO_Infographic_POLSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_PL_2015_EFPIA_HCPO_Methodological_Note_POLSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"PDF","status":"new"},"https://placotrans.infarmed.pt/publico/listagempublica.aspx":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/portugal/","txt":"transparency website","status":"new"},"http://www.anm.ro/sponsori_2014/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/","txt":"For 2014","status":"new"},"http://web.anm.ro/L95/sponsor_list.asp":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/","txt":"pentru 2015","status":"new"},"https://www.anm.ro/sponsorizari/afisare-2016/sponsori":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/","txt":"pentru 2016","status":"new"},"https://www.anm.ro/sponsorizari/afisare-2017/sponsori":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/","txt":"pentru 2017","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RO_2017_EFPIA_Aggregate_R&D_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RO_2016_EFPIA_Aggregate_R&D_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RO_2015_EFPIA_Aggregate_R&D_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/","txt":"PDF","status":"new"},"http://www.anm.ro/explore/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/","txt":"pentru 2014","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2017_EFPIA_HCPO_Methodological_Note_RUSSKIY.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2017_EFPIA_HCPO_Infographic_RUSSKIY.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2016_EFPIA_HCPO_Methodological_Note_RUSSKIY.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2016_EFPIA_HCPO_Infographic_RUSSKIY.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RU_2015_EFPIA_HCPO_Methodological_Note_RUSSKIY.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2017_EFPIA_HCPO_Methodological_Note_SRPSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2016_EFPIA_HCPO_Methodological_Note_SRPSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2016_EFPIA_HCPO_Infographic_SRPSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_RS_2015_EFPIA_HCPO_Methodological_Note_SRPSKI.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"PDF","status":"new"},"https://team.gsk.com/sites/EFPIA%20Publication2016/FINAL%20Loc%20disclosures%20texts%20with%20LINKS/sanja.s.panjeskovic@gsk.com%20":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"sanja.s.panjeskovic@gsk.com","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SK_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SK_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SK_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SK_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SK_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SK_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SK_2017_EFPIA_HCPO_Methodological_Note_SLOVAK.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"PDF ","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SK_2016_EFPIA_HCPO_Methodological_Note_SLOVAK.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SK_2015_EFPIA_HCPO_Methodological_Note_SLOVAK.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2017_EFPIA_HCPO_Methodological_Note_SLOVENSCINA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2017_EFPIA_HCPO_Infographic_SLOVENSCINA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2016_EFPIA_HCPO_Methodological_Note_SLOVENSCINA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2016_EFPIA_HCPO_Infographic_SLOVENSCINA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SI_2015_EFPIA_HCPO_Methodological_Note_SLOVENSCINA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2017_EFPIA_HCPO_Methodological_Note_ESPANOL.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2017_EFPIA_HCPO_Infographic_ESPANOL.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2016_EFPIA_HCPO_Methodological_Note_ESPANOL.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2016_EFPIA_HCPO_Infographic_ESPANOL.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2015_EFPIA_HCPO_Methodological_Note_ESPANOL.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_ES_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF ","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2017_EFPIA_HCPO_Methodological_Note_SVENSKA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2016_EFPIA_HCPO_Methodological_Note_SVENSKA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2016_EFPIA_HCPO_Infographic_SVENSKA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_SE_2015_EFPIA_HCPO_Methodological_Note_SVENSKA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2017_EFPIA_HCPO_Methodological_Note_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2017_EFPIA_HCPO_Infographic_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2016_EFPIA_HCPO_Methodological_Note_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2016_EFPIA_HCPO_Infographic_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2015_EFPIA_HCPO_Methodological_Note_DEUTSCH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2017_EFPIA_HCPO_Methodological_Note_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF ","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2017_EFPIA_HCPO_Infographic_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF ","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2016_EFPIA_HCPO_Methodological_Note_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2016_EFPIA_HCPO_Infographic_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2015_EFPIA_HCPO_Methodological_Note_FRANCAIS.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF ","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_CH_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2017_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2017_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2016_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2016_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2016_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2015_EFPIA_HCPO_Disclosure_Report.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2015_EFPIA_HCPO_Methodological_Note_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2017_EFPIA_HCPO_Methodological_Note_UKRAYINSKA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2017_EFPIA_HCPO_Infographic_UKRAYINSKA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2016_EFPIA_HCPO_Methodological_Note_UKRAYINSKA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2016_EFPIA_HCPO_Infographic_UKRAYINSKA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_UA_2015_EFPIA_HCPO_Methodological_Note_UKRAYINSKA.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"PDF","status":"new"},"http://www.disclosureuk.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/united-kingdom/","txt":"www.disclosureuk.org.uk","status":"new"},"http://efpiadisclosurecode.gsk.com/GSK_GB_2017_EFPIA_HCPO_Infographic_ENGLISH.pdf":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/united-kingdom/","txt":"PDF","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395968&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=396447&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396594&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396589&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Omnichannel-Marketing-Analyst_190912-2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=38","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396545&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396543&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396470&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=396458&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396455&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396412&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=369209&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396393&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Sr-Manager--Category-Regulatory-Affairs_191068":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Sr-Financial-Analyst_191198":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Global-Procurement--Innovation-Manager_188464-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Quebec---Quebec/Chef--Affaires-rglementaires-globales_188998-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Project-Manager_190888-2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=43","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396389&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=44","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396359&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396334&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396330&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396329&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=45","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396305&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396303&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Texas---Richardson/DevOps-Engineer_185815-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Snr-Workspace-Engineer---Mac-Platforms_190074":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=46","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394825&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395890&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396244&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=47","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396221&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396219&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396186&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/US-External-Engagement-Cooridinator-Analyst--Medical-Governance-and-Compliance-2_186746":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396147&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396116&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=396101&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=50","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396046&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=51","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=395992&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=395988&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=397204&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=14","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Value-Stream-Manufacturing-Tech-II_188253":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Value-Stream-Manufacturing-Associate_188254":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Value-Stream-Manufacturing-Associate_188255":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395403&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=395325&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395316&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395198&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-York---Oak-Hill/First-Line-Leader_188639":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395104&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394981&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394905&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394895&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394845&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394835&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394813&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394755&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394742&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394736&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394700&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=gsk&bu=&r=&city=&et=&prog=&p=59","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Senior-Manufactoring-Associate_188362":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Process-Engineer_188913":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394556&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394484&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394413&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394380&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394316&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394310&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394207&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394202&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=394196&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394158&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394156&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394104&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394099&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393843&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393959&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392616&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Value-Stream-Manufacturing-Tech-II_186896":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Production-Manufacturing-Operations_186900":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Manufacturing-Technician-II_186905":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394182&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394061&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394048&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393920&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Communications-Manager_188261":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393835&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393837&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393722&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Copy-Writer---Editor_188402":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393675&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393649&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389031&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384579&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393384&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393327&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389831&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393170&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Manager--Market-Intelligence--channel-_186324":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391564&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Director--Market-Intelligence--Metrics-and-Performance-Reporting--Oncology_186926-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Head--Global-Oncology-Communications_186751":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Manager--Commercial-Insights--Oncology-_186466":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Director-Commercial-Insights--Oncology-_186467":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392307&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392872&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392840&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392797&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391996&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Manager-Trade---Pharmacy_170533":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392215&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392228&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392238&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392301&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392304&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392311&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392503&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392506&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392511&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392539&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=103","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395334&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395265&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Clinical-Development-Physician-Project-Leader--Immuno-Oncology_189327-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395072&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394504&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395024&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395021&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Massachusetts---Cambridge/Synthetic-Medicinal-Chemist_189040":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Drug-Product-Engineer--Process-Modeling-_186456":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394931&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Durham/XMLNAME--Home-Based-in-Anytown--USA--Medical-Expert--Respiratory-US-Medical-Affairs_187640":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Global-Oncology-Medical-Affairs-Leader---ICOS_185977-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394018&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394013&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394011&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Clinical-Biomarker-Lead_187029":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393877&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Global-Franchise-Medical-Scientific-Director---NY-ESO-_186743":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393768&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Senior-Clinical-Biomarker-Lead_187027":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Principal-Clinical-Data-Manager_188057":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Drug-Delivery-Formulation-Scientist_188598":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394547&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393549&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393870&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394226&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/BioPharm-Manufacturing-Associate-II_188469":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Clinical-Research-Development-Lead--Zoster_186433-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394100&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Safety-Physician_188381":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393579&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Upper-Providence/Director-of-Oncology-Clinical-Operations-Strategy---Capabilities_188084":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---King-of-Prussia/Senior-Scientist_185202":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393116&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393412&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393378&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393356&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384314&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393175&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393133&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Director--Customer-Strategy---Planning_189861":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Sales-Specialist--Pharma---Lower-Manhattan--NYC_185844":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Sales-Specialist--Pharma---Lower-Manhattan--NYC_185845":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395546&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395530&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395524&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=60","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=395471&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395437&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395420&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Territory-Account-Manager--ViiV---Las-Vegas--NV_187162":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395415&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395400&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=63","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395389&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395378&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395373&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395370&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395367&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395364&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395358&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395352&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395304&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395275&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395207&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395155&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395150&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395144&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395138&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395135&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395132&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395129&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395123&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395120&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395117&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395114&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395052&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Arkansas---Bentonville/Customer-Sales-Manager-Sam-s-Club_189331":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Specialty-Care-Territory-Manager--Severe-Asthma---Ottawa_189711":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Sales-Specialist--Pharma---Conway--AR_189038-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Sales-Specialist--Pharma---Joensboro--AR_189041":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Territory-Business-Manager-Tampa-South-Sarasota_188272":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394806&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=16","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397147&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=17","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395862&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=19","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396564&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=39","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396428&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391117&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393895&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393292&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385588&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393172&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386589&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392958&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"http://www.lupus.org/about/statistics-on-lupus%20Last%20accessed%20October%202015":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-results-from-phase-iii-bliss-sc-study-of-benlysta-belimumab-administered-subcutaneously-in-patients-with-systemic-lupus-erythematosus/","txt":"http://www.lupus.org/about/statistics-on-lupus Last accessed October 2015","status":"new"},"http://www.theravance.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-phase-2b-results-for-once-daily-fluticasone-furoate-in-the-treatment-of-asthma/","txt":"www.theravance.com","status":"new"},"file:///C:/Users/ts733903/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/4SYFSUHD/100616_DTG%20PAED%20FDA%20APPROVAL_PRESS%20RELEASE_FINAL.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-fda-approval-to-lower-the-weight-limit-for-dolutegravir-in-children-and-adolescents-living-with-hiv/","txt":"[5]","status":"new"},"http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Gap_report_en.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-fda-approval-to-lower-the-weight-limit-for-dolutegravir-in-children-and-adolescents-living-with-hiv/","txt":"http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Gap_report_en.pdf","status":"new"},"http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_en_1.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-fda-approval-to-lower-the-weight-limit-for-dolutegravir-in-children-and-adolescents-living-with-hiv/","txt":"http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_en_1.pdf","status":"new"},"http://www.telethon.it/en":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-ospedale-san-raffaele-announce-publication-of-pivotal-safety-and-efficacy-of-gene-therapy-for-children-with-ada-scid/","txt":"www.telethon.it/en","status":"new"},"http://www.hsr.it/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion-in-europe-for-strimvelis-the-first-gene-therapy-to-treat-very-rare-disease-ada-scid/","txt":"www.hsr.it","status":"new"},"http://www.tiget.it/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-ospedale-san-raffaele-announce-eu-regulatory-submission-for-gene-therapy-to-treat-rare-disease-ada-scid/","txt":"http://www.tiget.it/","status":"new"},"http://www.bloodjournal.org/content/early/2016/04/29/blood-2016-01-688226":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/strimvelistm-receives-european-marketing-authorisation-to-treat-very-rare-disease-ada-scid/","txt":"http://www.bloodjournal.org/content/early/2016/04/29/blood-2016-01-688226","status":"new"},"http://www.bloodjournal.org/content/early/2016/04/29/blood-2016-01-688226?sso-checked=true":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-ospedale-san-raffaele-announce-publication-of-pivotal-safety-and-efficacy-of-gene-therapy-for-children-with-ada-scid/","txt":"Blood journal","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002751/WC500168424.pdf%20":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-efficacy-data-for-anoro-ellipta-in-copd-patients-who-remained-symptomatic-on-tiotropium/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002751/WC500168424.pdf ","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT01339923?term=NCT01339923&rank=1,":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-bexsero-achieves-primary-and-secondary-endpoints-with-reduced-3-dose-schedule-2plus1-in-safety-and-immunogenicity-study-in-infants-and-children/","txt":"clinicaltrials.gov","status":"new"},"http://www.telethon.it/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion-in-europe-for-strimvelis-the-first-gene-therapy-to-treat-very-rare-disease-ada-scid/","txt":"www.telethon.it/en/","status":"new"},"http://www.miltenyibiotec.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-miltenyi-biotec-establish-cell-and-gene-therapy-collaboration/","txt":"www.miltenyibiotec.com","status":"new"},"http://www.openinnovation.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-names-winners-of-2014-discovery-fast-track-challenge/","txt":"Discovery Fast Track Challenge","status":"new"},"http://lup.sagepub.com/content/early/2016/02/18/0961203315625119.full.pdf+html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-long-term-organ-damage-analysis-published-for-gsk-s-benlysta-belimumab/","txt":"http://lup.sagepub.com/content/early/2016/02/18/0961203315625119.full.pdf+html","status":"new"},"http://www.lupus.org/about/statistics-on-lupus":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-long-term-organ-damage-analysis-published-for-gsk-s-benlysta-belimumab/","txt":"http://www.lupus.org/about/statistics-on-lupus","status":"new"},"http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf?ua=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-first-phase-ii-hiv-prevention-study-results-for-investigational-long-acting-injectable-cabotegravir/","txt":"http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf?ua=1","status":"new"},"http://apps.who.int/iris/bitstream/10665/198064/1/9789241509893_eng.pdf?ua=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-first-phase-ii-hiv-prevention-study-results-for-investigational-long-acting-injectable-cabotegravir/","txt":"http://apps.who.int/iris/bitstream/10665/198064/1/9789241509893_eng.pdf?ua=1","status":"new"},"file:///C:/Users/pt810653/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/7Y49VRZ0/ViiV%20Healthcare%20announces%20phase%20II%20study%20results%20for%20first%20two%20drug%20long-acting%20injectable%20regimen%20for%20HIV-1%20treatment%2023_02_2016.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment/","txt":"[ii]","status":"new"},"http://apps.who.int/iris/bitstream/10665/75236/1/9789241599818_eng.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-inspiring-innovations-which-help-reduce-child-deaths-in-developing-countries-share-1-million-prize-from-gsk-and-save-the-children/","txt":"http://apps.who.int/iris/bitstream/10665/75236/1/9789241599818_eng.pdf","status":"new"},"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Flulaval/pdf/FLULAVAL.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-regulatory-submission-seeking-expanded-indication-for-flulaval-quadrivalent-influenza-vaccine-for-infants-6-mosplus/","txt":"GSKsource.com","status":"new"},"http://www.adaptimmune.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-adaptimmune-expand-strategic-immunotherapy-collaboration/","txt":"http://www.adaptimmune.com","status":"new"},"https://www.ifpma.org/partners-2/declaration-by-the-pharmaceutical-biotechnology-and-diagnostics-industries-on-combating-antimicrobial-resistance-amr/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/global-pharmaceutical-industry-calls-on-governments-to-work-with-them-to-beat-the-rising-threat-of-drug-resistance/","txt":"https://www.ifpma.org/partners-2/declaration-by-the-pharmaceutical-biotechnology-and-diagnostics-industries-on-combating-antimicrobial-resistance-amr/","status":"new"},"http://www.amr-review.org/industry-declaration":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/global-pharmaceutical-industry-calls-on-governments-to-work-with-them-to-beat-the-rising-threat-of-drug-resistance/","txt":"www.amr-review.org/industry-declaration","status":"new"},"http://bit.ly/1Okot9c":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/comic-relief-and-gsk-form-five-year-partnership-to-fight-malaria-and-strengthen-health-systems/","txt":"http://bit.ly/1Okot9c","status":"new"},"http://www.ema.europa.eu./":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-european-marketing-authorisation-to-expand-indication-for-volibris-in-treatment-of-pulmonary-arterial-hypertension/","txt":"www.ema.europa.eu","status":"new"},"https://www.nhlbi.nih.gov/health/health-topics/topics/pah":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-chmp-positive-opinion-to-expand-indication-for-volibris-in-pulmonary-arterial-hypertension/","txt":"https://www.nhlbi.nih.gov/health/health-topics/topics/pah","status":"new"},"https://www.gsksource.com/pharma/content/gsk/source/us/en/brands.html?type=Prescription":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-nucala-mepolizumab-receives-approval-from-us-fda/","txt":"US Prescribing Information Nucala","status":"new"},"http://us.gsk.com/en-us/media/press-kits/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-nucala-mepolizumab-receives-approval-from-us-fda/","txt":"GSK’s infographic","status":"new"},"http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-merck-to-study-immunotherapy-combination-as-potential-cancer-treatment/","txt":"http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf","status":"new"},"http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_mg.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-merck-to-study-immunotherapy-combination-as-potential-cancer-treatment/","txt":"http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_mg.pdf","status":"new"},"http://www.merck.com/clinicaltrials":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-merck-to-study-immunotherapy-combination-as-potential-cancer-treatment/","txt":"www.merck.com/clinicaltrials","status":"new"},"http://www.merck.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-merck-to-study-immunotherapy-combination-as-potential-cancer-treatment/","txt":"www.merck.com","status":"new"},"http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov&esheet=51161738&newsitemid=20150813005036&lan=en-US&anchor=www.sec.gov&index=7&md5=97a19e1756ccbd00f2c3a79e4e15e52e":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-merck-to-study-immunotherapy-combination-as-potential-cancer-treatment/","txt":"www.sec.gov","status":"new"},"http://www.cdc.gov/shingles/hcp/clinical-overview.html%20on%2015th%20April%202015":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-candidate-shingles-vaccine-demonstrates-90-efficacy-against-shingles-in-people-70-years-of-age-and-over/","txt":"www.cdc.gov/shingles/hcp/clinical-overview.html on 15th April 2015","status":"new"},"http://www.ncbi.nlm.nih.gov/pubmed/17920770":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-candidate-shingles-vaccine-demonstrates-90-efficacy-against-shingles-in-people-70-years-of-age-and-over/","txt":"Pharmacologic management of neuropathic pain: evidence-based recommendations.","status":"new"},"https://www.gsksource.com/gskprm/htdocs/documents/INCRUSE-ELLIPTA-PI-PIL.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-new-data-comparing-incruse-ellipta-to-tiotropium-and-glycopyrronium-in-patients-with-copd/","txt":"https://www.gsksource.com/gskprm/htdocs/documents/INCRUSE-ELLIPTA-PI-PIL.PDF","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002809/WC500167430.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-new-data-comparing-incruse-ellipta-to-tiotropium-and-glycopyrronium-in-patients-with-copd/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002809/WC500167430.pdf","status":"new"},"http://dx.doi.org/10.1016/S0140-6736(15)60692-4":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-new-data-comparing-incruse-ellipta-to-tiotropium-and-glycopyrronium-in-patients-with-copd/","txt":"http://dx.doi.org/10.1016/S0140-6736(15)60692-4","status":"new"},"file:///C:/Users/pt810653/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/7Y49VRZ0/GSK%20presents%20post-hoc%20analysis%20of%20Anoro%20Ellipta%20%2027_09_15%20(2).docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-post-hoc-analysis-of-anoro-ellipta-data-assessing-markers-of-copd-deterioration-compared-to-tiotropium-or-placebo-using-a-novel-composite-endpoint/","txt":"[2]","status":"new"},"http://www.medicines.org.uk/emc/medicine/28949/SPC/Anoro+Ellipta+55+micrograms+22+micrograms+inhalation+powder%2c+pre-dispensed/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/data-published-on-anoro-ellipta-demonstrate-improved-lung-function-compared-to-tiotropium/","txt":"http://www.medicines.org.uk/emc/medicine/28949/SPC/Anoro+Ellipta+55+micrograms+22+micrograms+inhalation+powder%2c+pre-dispensed/","status":"new"},"http://www.thrxinc.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-data-from-two-studies-evaluating-the-efficacy-and-safety-of-incruse-ellipta-when-added-to-relvar-breo-ellipta-in-patients-with-copd/","txt":"www.thrxinc.com","status":"new"},"http://dx.doi.org/10.1016/S0140-6736(15)60692-4%20":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-post-hoc-analysis-of-anoro-ellipta-data-assessing-markers-of-copd-deterioration-compared-to-tiotropium-or-placebo-using-a-novel-composite-endpoint/","txt":"http://dx.doi.org/10.1016/S0140-6736(15)60692-4","status":"new"},"file:///C:/Users/pt810653/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/7Y49VRZ0/Press%20release%20-%20New%20Phase%20IIIb-IV%20data%20show%20switching%20to%20once-daily%20Triumeq%20maintains%20HIV%20viral%20suppression%20(2).docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-phase-iiibiv-data-show-switching-to-once-daily-triumeq-maintains-hiv-viral-suppression/","txt":"[vii]","status":"new"},"http://ctt.marketwire.com/?release=1205670&id=6553315&type=1&url=http%3a%2f%2fwww.thrxinc.com%2f":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-results-from-the-summit-copd-cv-survival-study/","txt":"www.thrxinc.com","status":"new"},"http://www.who.int/mediacentre/factsheets/fs310/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-results-from-the-summit-copd-cv-survival-study/","txt":"http://www.who.int/mediacentre/factsheets/fs310/en/","status":"new"},"http://www.nejm.org/doi/full/10.1056/NEJMoa1413687":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-nejm-publication-of-phase-3b4-study-of-ambrisentan-and-tadalafil-as-first-line-combination-treatment-in-patients-with-pulmonary-arterial-hypertension/","txt":"www.nejm.org/doi/full/10.1056/NEJMoa1413687","status":"new"},"file:///C:/Users/pt810653/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/7Y49VRZ0/Synflorix%2019A%20CHMP%20positive%20opinion_Global%20press%20release_FINAL2.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-synflorix-receives-chmp-positive-opinion-for-major-label-extension/","txt":"[x]","status":"new"},"https://www.julkari.fi/bitstream/handle/10024/90866/URN_ISBN_978-952-245-652-6.pdf?sequence=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-synflorix-receives-chmp-positive-opinion-for-major-label-extension/","txt":"https://www.julkari.fi/bitstream/handle/10024/90866/URN_ISBN_978-952-245-652-6.pdf?sequence=1","status":"new"},"http://www.gavi.org/funding/pneumococcal-amc/manufacturers/supply-agreements":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-synflorix-receives-chmp-positive-opinion-for-major-label-extension/","txt":"http://www.gavi.org/funding/pneumococcal-amc/manufacturers/supply-agreements","status":"new"},"http://www.thelancet.com/journals/lancet/issue/vol386no9988/PIIS0140-6736(15)X6149-6":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-malaria-candidate-vaccine-mosquirix-rts-s-receives-positive-opinion-from-european-regulators-for-the-prevention-of-malaria-in-young-children-in-sub-saharan-africa/","txt":"386 (9988","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395760&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395958&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392788&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=54","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395825&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=55","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395800&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=56","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395741&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395259&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393076&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Senior-Manager---Regulatory-Affairs_189723":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Category-Regulatory-Affairs-Manager---Nutrition---Digestive-Health_189731":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Senior-Project-Manager_190071":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=58","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395611&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395612&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=59","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395480&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395477&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395473&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395465&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=61","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395461&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394482&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Digital-Counsel_189009":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=62","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395347&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=64","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395330&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395291&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395263&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-York---Oak-Hill/Site-Procurement-Specialist-Oak-Hill---Oral-Care_185068-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/SDI-Wireless-Engineer_189730-2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/RTP/Site-Reliability-Engineer_189856":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395173&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395167&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395164&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=67","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394855&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395047&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395027&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=69","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395015&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394983&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394946&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394930&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394922&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394897&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393664&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Warehouse-Sampler---Receiver_186155-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Training-Support-Coordinator_185469":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Production-Supervisor_185626":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Manufacturing-Operator_183191":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Op-Tech---Packaging_186930":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Manufacturing-Associate_186902":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393614&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393466&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393438&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/Value-Stream-Manufacturing-Tech-I_186893":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Arkansas---Bentonville/Team-Leader-Customer-Supply---CPFR-Bentonville--AR--Wal-Mart-Sams-_186912":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388719&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393410&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393406&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393371&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393354&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393350&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393310&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392420&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393268&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393184&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393183&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393093&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/OQ-Specialist_185123":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392999&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=98","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Quebec---Quebec/Candidature-spontane---Journalier-de-production_186837":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392887&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392863&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392766&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=392690&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392294&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392091&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Montana---Hamilton/QC-Microbiology-Specialist-II_185354":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---King-of-Prussia/Raw-Material-and-Compendial-Specialist_185199":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=391999&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391940&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391824&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391763&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391697&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392562&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392273&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392270&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392341&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392323&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392436&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392415&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392370&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392338&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392335&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392332&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392329&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392326&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392314&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392289&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392285&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392282&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392267&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392255&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392252&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392204&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392201&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392193&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=380827&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389019&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387907&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390509&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391486&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391481&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391004&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391293&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391125&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391031&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390108&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390011&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387736&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387985&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393126&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392837&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Statistical-Geneticist-Investigator_186293":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Statistical-Genetics-Director_186297":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392859&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=392731&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/Sr-Statistician_185980":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392728&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392688&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392531&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391855&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392372&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392121&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391989&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386740&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391936&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Upper-Providence/Principle-Scientist---Investigator--Biopharmaceutical-Product-Sciences_183333":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391615&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390962&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390866&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=383948&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390821&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390414&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385811&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390102&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390086&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390024&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388573&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389600&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389877&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387677&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387032&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=379552&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=382174&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---California---Los-Angeles-South/Regional-Account-Specialist--DSO-Accounts-Los-Angeles-South-South-Bay_186747":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395013&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394971&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=71","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394886&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Territory-Business-Manager-South-Seattle-Metro_185969":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-Jersey---Warren/Territory-Business-Manager-Buffalo--NY-Metro_185673":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394847&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394832&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394827&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394803&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=73","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394796&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394754&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394720&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394705&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394693&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394690&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394652&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394619&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394610&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394601&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394586&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394582&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=392952&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394458&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=394407&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392231&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392234&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394362&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394321&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=80","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394209&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394141&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394037&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393893&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393863&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393860&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393796&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393705&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=88","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Territory-Business-Manager-Westchester-White-Plains--NY_186889":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393529&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393443&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=91","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=396895&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=20","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=397027&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=21","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396746&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=32","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396410&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Senior-Patent-Counsel_185189-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388503&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385921&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391304&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390426&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388352&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389466&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394453&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394179&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393275&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393964&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393634&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393403&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=92","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393066&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392582&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388774&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391894&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391755&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388282&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387584&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394996&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=70","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394892&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pt-br/gateway.do?functionName=viewFromLink&jobPostId=394779&localeCode=pt-br":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394678&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394625&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=76","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394549&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393282&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394107&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394109&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394083&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393990&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393786&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393335&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392890&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392610&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=102","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394763&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393924&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=79","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394170&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394168&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393923&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Nebraska---Lincoln/Site-Procurement-Specialist---Lincoln--NE_185073":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394118&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393829&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=87","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393739&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=87","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393512&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393511&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393505&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393490&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393493&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393337&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393273&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393110&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393108&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393106&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393105&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392891&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=99","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392359&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392356&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392353&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=105","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391870&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388276&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391892&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391874&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391747&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390047&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389306&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=376990&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388698&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384390&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386567&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385842&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384151&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=372825&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394893&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394890&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394777&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394718&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Maryland---Rockville/EHSS-Environmental-Advisor_188787":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=72","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394180&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387380&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=107","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391654&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=382539&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388796&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=380320&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387213&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395977&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Philadelphia/Regulatory-Advertisting-and-Promotion-Policy-Director--Oncology-_188090":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Warren-NJ/Global-Regulatory-Intelligence---Policy--Senior-Lead_186858":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385174&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=381116&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=374173&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"http://www.eclipse-copd.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/three-year-results-from-eclipse-study-indicate-that-copd-patients-may-require-prevention-strategies-to-manage-exacerbations-regardless-of-disease-severity/","txt":"www.eclipse-copd.com","status":"new"},"file:///C:/Users/jjc21387/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/Z0SZ6A6R/GSK%20presents%20data%20at%20ATS%20on%20the%20role%20of%20blood%20eosinophil%20levels%20as%20a%20potential%20biomarker%20in%20the%20treatment%20of%20COPD%2019%20May%20FINAL.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-data-at-ats-on-the-role-of-blood-eosinophil-levels-as-a-potential-biomarker-in-the-treatment-of-copd/","txt":"[vi]","status":"new"},"http://www.gsk-clinicalstudyregister.com/files/pdf/23674.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-data-at-ats-on-the-role-of-blood-eosinophil-levels-as-a-potential-biomarker-in-the-treatment-of-copd/","txt":"http://www.gsk-clinicalstudyregister.com/files/pdf/23674.pdf","status":"new"},"http://dx.doi.org/10.1016/S2213-2600(15)00106-X":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-presents-data-at-ats-on-the-role-of-blood-eosinophil-levels-as-a-potential-biomarker-in-the-treatment-of-copd/","txt":"http://dx.doi.org/10.1016/S2213-2600(15)00106-X","status":"new"},"https://youtu.be/AE9MWKIUNbM":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-unc-chapel-hill-announce-novel-partnership-to-accelerate-search-for-hiv-cure/","txt":"https://youtu.be/AE9MWKIUNbM","status":"new"},"http://www.viivhealthcare.com/media/press-releases/2014/june/viiv-healthcare-announces-new-collaboration-with-janssen.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-begins-phase-iii-programme-with-dolutegravirrilpivirine-combination-for-hiv-maintenance-therapy/","txt":"ViiV Healthcare announces new collaboration with Janssen","status":"new"},"http://www.edurant.com/sites/default/files/EDURANT-PI.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-new-collaboration-with-janssen-to-investigate-single-tablet-regimen-for-maintenance-treatment-of-hiv-1/","txt":"http://www.edurant.com/sites/default/files/EDURANT-PI.pdf","status":"new"},"http://www.telethon.it/en/about-us":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-ospedale-san-raffaele-announce-eu-regulatory-submission-for-gene-therapy-to-treat-rare-disease-ada-scid/","txt":"www.telethon.it/en/about-us","status":"new"},"http://us.gsk.com/media/454020/adult-asthma-infographic-final.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-breo-ellipta-for-the-treatment-of-adults-with-asthma-in-the-us/","txt":"adult asthma","status":"new"},"http://ctt.marketwire.com/?release=1135978&id=4497022&type=1&url=http%3a%2f%2fwww.thrxinc.com%2f":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/data-published-on-anoro-ellipta-demonstrate-improved-lung-function-compared-to-tiotropium/","txt":"www.thrxinc.com","status":"new"},"http://www.malariavaccine.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/first-results-from-ongoing-phase-iii-trial-show-malaria-vaccine-candidate-rts-sstar-reduces-the-risk-of-malaria-by-half-in-african-children-aged-5-to-17-months/","txt":"www.malariavaccine.org","status":"new"},"http://www.lung.org/finding-cures/our-research/trend-reports/asthma-trend-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-outcome-of-us-fda-advisory-committee-on-breo-ellipta-in-asthma/","txt":"http://www.lung.org/finding-cures/our-research/trend-reports/asthma-trend-report.pdf","status":"new"},"http://us.gsk.com/products/assets/us_anoro_ellipta.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/anoro-umeclidinium-vilanterol-receives-positive-opinion-from-the-chmp-in-europe-for-the-treatment-of-copd/","txt":"http://us.gsk.com/products/assets/us_anoro_ellipta.pdf","status":"new"},"https://www.gsksource.com/gskprm/htdocs/documents/MEKINIST-PI-PIL.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-gains-accelerated-fda-approval-for-combination-use-of-mekinist-trametinib-and-tafinlar-dabrafenib/","txt":"https://www.gsksource.com/gskprm/htdocs/documents/MEKINIST-PI-PIL.PDF","status":"new"},"https://www.gsksource.com/gskprm/htdocs/documents/TAFINLAR-PI-MG.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-gains-accelerated-fda-approval-for-combination-use-of-mekinist-trametinib-and-tafinlar-dabrafenib/","txt":"https://www.gsksource.com/gskprm/htdocs/documents/TAFINLAR-PI-MG.PDF","status":"new"},"http://www.gsk.com.au/resources.ashx/prescriptionmedicinesproductschilddataproinfo/1990/FileName/A5A6DF2E45A98313AE02F68DA2B2203B/Trametinib_Tablet_PI_001_Approved.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-combined-use-of-mekinist-trametinib-and-tafinlar-dabrafenib-in-europe/","txt":"http://www.gsk.com.au/resources.ashx/prescriptionmedicinesproductschilddataproinfo/1990/FileName/A5A6DF2E45A98313AE02F68DA2B2203B/Trametinib_Tablet_PI_001_Approved.pdf","status":"new"},"https://www.gsksource.com/gskprm/htdocs/documents/PROMACTA-PI-MG-COMBINED.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-results-of-phase-iii-petit2-study-of-eltrombopag-promacta-revolade-in-paediatric-patients-with-chronic-immune-thrombocytopenia/","txt":"https://www.gsksource.com/gskprm/htdocs/documents/PROMACTA-PI-MG-COMBINED.PDF","status":"new"},"file:///C:/Users/dg928010/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/DEBOKXLV/Four%20initiatives%20from%20across%20Africa%20win%20share%20of%20global%20US$1%20million%20Healthcare%20Innovation%20Award%20%2029_01_15.docx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-initiatives-from-across-africa-win-share-of-global-us-1-million-healthcare-innovation-award/","txt":"[1]","status":"new"},"http://data.worldbank.org/indicator/SH.DYN.MORT":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-initiatives-from-across-africa-win-share-of-global-us-1-million-healthcare-innovation-award/","txt":"http://data.worldbank.org/indicator/SH.DYN.MORT","status":"new"},"http://www.ox.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-oxford-university-phase-i-trial-results-of-an-ebola-candidate-vaccine/","txt":"Oxford University","status":"new"},"http://www.who.int/wer/2013/wer8805.pdf?ua=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-its-price-freeze-commitment-to-ten-years-for-countries-graduating-from-gavi-support/","txt":"http://www.who.int/wer/2013/wer8805.pdf?ua=1","status":"new"},"http://gsk.com/en-gb/investors/shareholder-information/general-meeting":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/publication-of-circular-and-notice-of-general-meeting-relating-to-the-proposed-major-transaction-with-novartis/","txt":"http://gsk.com/en-gb/investors/shareholder-information/general-meeting","status":"new"},"http://www.morningstar.co.uk/uk/NSM":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/publication-of-circular-and-notice-of-general-meeting-relating-to-the-proposed-major-transaction-with-novartis/","txt":"www.morningstar.co.uk/uk/NSM","status":"new"},"http://www.sciencedirect.com/science/article/pii/S0954611114003345":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/data-published-on-anoro-ellipta-demonstrate-improved-lung-function-compared-to-tiotropium/","txt":"Respiratory Medicine","status":"new"},"http://www.stiefel.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-stiefel-to-create-new-world-leading-specialist-dermatology-business/","txt":"www.stiefel.com","status":"new"},"http://www.nlm.nih.gov/medlineplus/ency/article/000882.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/stiefel-a-gsk-company-announces-start-of-phase-iii-study-of-subcutaneous-ofatumumab-for-pemphigus-vulgaris/","txt":"http://www.nlm.nih.gov/medlineplus/ency/article/000882.htm","status":"new"},"http://www.nhs.uk/conditions/pemphigus-vulgaris/pages/definition.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/stiefel-a-gsk-company-announces-start-of-phase-iii-study-of-subcutaneous-ofatumumab-for-pemphigus-vulgaris/","txt":"http://www.nhs.uk/conditions/pemphigus-vulgaris/pages/definition.aspx","status":"new"},"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60868-X/fulltext":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-overall-survival-results-from-phase-iii-break-3-study-of-tafinlar-dabrafenib-in-patients-with-braf-v600e-mutant-metastatic-melanoma/","txt":"Hauschild a, et al Lancet 2012; 380; 358-65","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002604/WC500149671.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-overall-survival-results-from-phase-iii-break-3-study-of-tafinlar-dabrafenib-in-patients-with-braf-v600e-mutant-metastatic-melanoma/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002604/WC500149671.pdf","status":"new"},"http://www.countdown2015mnch.org/documents/2012Report/2012-complete-no-profiles.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/international-collaboration-to-develop-inhaled-form-of-oxytocin-to-manage-bleeding-after-childbirth-in-developing-countries/","txt":"Building a Future for Women and Children: The 2012 Report, WHO & UNICEF, (2012)","status":"new"},"http://www.gsk-china.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-china-investigation-outcome/","txt":"www.gsk-china.com","status":"new"},"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706606/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-data-presented-at-ers-demonstrate-potential-of-blood-eosinophil-levels-to-help-inform-copd-treatment-decisions/","txt":"PMC free article","status":"new"},"http://www.ncbi.nlm.nih.gov/pubmed/18046901":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-data-presented-at-ers-demonstrate-potential-of-blood-eosinophil-levels-to-help-inform-copd-treatment-decisions/","txt":"PubMed","status":"new"},"http://www.ncbi.nlm.nih.gov/pubmed/21680942":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-data-presented-at-ers-demonstrate-potential-of-blood-eosinophil-levels-to-help-inform-copd-treatment-decisions/","txt":"PubMed","status":"new"},"http://gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-england-journal-of-medicine-and-ers-publish-positive-results-from-gsk-phase-iii-studies-of-mepolizumab-in-patients-with-severe-eosinophilic-asthma/","txt":"www.gsk.com","status":"new"},"http://www.catestonline.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-gold-and-the-copd-foundation-announce-formation-of-a-new-external-expert-governance-board-for-the-copd-assessment-test-cat/","txt":"www.catestonline.org","status":"new"},"http://journals.lww.com/jaids/Abstract/publishahead/Bioequivalence_of_a_Dolutegravir,_Abacavir_and.97920.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/triumeq-dolutegravirabacavirlamivudine-single-tablet-regimen-receives-positive-chmp-opinion-in-europe-for-the-treatment-of-hiv/","txt":"http://journals.lww.com/jaids/Abstract/publishahead/Bioequivalence_of_a_Dolutegravir,_Abacavir_and.97920.aspx","status":"new"},"http://www.cdc.gov/hiv/basics/index.html%0d%20(Accessed%20August%202014":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-eu-marketing-authorisation-for-triumeq-dolutegravirabacavirlamivudine-a-new-once-daily-single-pill-regimen-for-the-treatment-of-hiv/","txt":" (Accessed August 2014","status":"new"},"http://www.nhs.uk/conditions/HIV/Pages/Introduction.aspx.%20(Accessed%2018":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-eu-marketing-authorisation-for-triumeq-dolutegravirabacavirlamivudine-a-new-once-daily-single-pill-regimen-for-the-treatment-of-hiv/","txt":"http://www.nhs.uk/conditions/HIV/Pages/Introduction.aspx. (Accessed 18","status":"new"},"http://us.gsk.com/en-us/media/press-kits/promacta-eltrombopag/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsks-promacta-eltrombopag-receives-fda-approval-of-an-additional-indication/","txt":"http://us.gsk.com/en-us/media/press-kits/promacta-eltrombopag/","status":"new"},"http://www.aamds.org/about/aplastic-anemia/causes":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsks-promacta-eltrombopag-receives-fda-approval-of-an-additional-indication/","txt":"Published 23 April 2013","status":"new"},"http://www.aamds.org/about/aplastic-anemia/causes.%20Accessed%2023%20June%202014":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsks-promacta-eltrombopag-receives-fda-approval-of-an-additional-indication/","txt":"http://www.aamds.org/about/aplastic-anemia/causes. Accessed 23 June 2014","status":"new"},"http://www.cdc.gov/hiv/basics/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-fda-approval-for-triumeq-abacavir-dolutegravir-and-lamivudine-a-new-single-pill-regimen-for-the-treatment-of-hiv-1-infection/","txt":"http://www.cdc.gov/hiv/basics/index.html.","status":"new"},"http://www.nhs.uk/conditions/HIV/Pages/Introduction.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-fda-approval-for-triumeq-abacavir-dolutegravir-and-lamivudine-a-new-single-pill-regimen-for-the-treatment-of-hiv-1-infection/","txt":"http://www.nhs.uk/conditions/HIV/Pages/Introduction.aspx","status":"new"},"http://www.cdc.gov/hiv/pdf/research_mmp_StagesofCare.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-fda-approval-for-triumeq-abacavir-dolutegravir-and-lamivudine-a-new-single-pill-regimen-for-the-treatment-of-hiv-1-infection/","txt":"http://www.cdc.gov/hiv/pdf/research_mmp_StagesofCare.pdf. Accessed July 28","status":"new"},"http://www.lungusa.org/finding-cures/our-research/trend-reports/asthma-trend-report.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-fda-approval-for-arnuity-ellipta-fluticasone-furoate-in-the-usa-for-the-treatment-of-asthma/","txt":"www.lungusa.org/finding-cures/our-research/trend-reports/asthma-trend-report.pdf","status":"new"},"https://www.gsksource.com/gskprm/htdocs/documents/ARZERRA.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-fda-approval-for-arzerra/","txt":"https://www.gsksource.com/gskprm/htdocs/documents/ARZERRA.PDF","status":"new"},"http://www.genmab.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-submit-arzerra-ofatumumab-application-to-fda-for-the-treatment-of-advanced-stage-blood-cancer/","txt":"www.genmab.com","status":"new"},"http://www.flonase.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-flonase-allergy-relief-for-sale-over-the-counter-in-the-united-states/","txt":"www.Flonase.com","status":"new"},"http://www.acaai.org/allergist/news/Pages/Allergy_Facts.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-flonase-allergy-relief-for-sale-over-the-counter-in-the-united-states/","txt":"http://www.acaai.org/allergist/news/Pages/Allergy_Facts.aspx","status":"new"},"http://www.acaai.org/allergist/allergies/Types/rhinitis/Pages/allergic-diseases-cognitive-impairment.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-flonase-allergy-relief-for-sale-over-the-counter-in-the-united-states/","txt":"http://www.acaai.org/allergist/allergies/Types/rhinitis/Pages/allergic-diseases-cognitive-impairment.aspx","status":"new"},"http://www.aaapc.us/wp-content/uploads/2013/01/National-Impact-of-Allergies.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-flonase-allergy-relief-for-sale-over-the-counter-in-the-united-states/","txt":"http://www.aaapc.us/wp-content/uploads/2013/01/National-Impact-of-Allergies.pdf","status":"new"},"http://www.aafa.org/display.cfm?id=7&sub=92&cont=529":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-flonase-allergy-relief-for-sale-over-the-counter-in-the-united-states/","txt":"http://www.aafa.org/display.cfm?id=7&sub=92&cont=529","status":"new"},"http://www.nlm.nih.gov/medlineplus/ency/article/000813.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-flonase-allergy-relief-for-sale-over-the-counter-in-the-united-states/","txt":"http://www.nlm.nih.gov/medlineplus/ency/article/000813.htm","status":"new"},"http://www.who.int/immunization/policy/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-eu-regulatory-submission-for-malaria-vaccine-candidate-rts-s/","txt":"http://www.who.int/immunization/policy/en/","status":"new"},"http://www.medicines.org.uk/EMC/medicine/20386/SPC/Celsentri+150mg+film-coated+tablets/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-phase-iii-data/","txt":"http://www.medicines.org.uk/EMC/medicine/20386/SPC/Celsentri+150mg+film-coated+tablets/","status":"new"},"http://www.medicines.org.uk/emc/medicine/23164/SPC/Celsentri+300mg+film-coated+tablets/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-phase-iii-data/","txt":"http://www.medicines.org.uk/emc/medicine/23164/SPC/Celsentri+300mg+film-coated+tablets/","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394764&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=74","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394712&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=75","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394502&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394370&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=78","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394211&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=80","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394200&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=81","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---North-Carolina---Research-Triangle-Park/Tech-Consultant--Directory-Services_188438":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=83","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394046&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393875&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Pennsylvania---Upper-Providence/Network-Services-Engineer_188374-2":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=85","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393607&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=86","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=391660&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391496&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391269&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391055&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386423&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390639&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390560&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390368&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390090&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389864&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389856&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389840&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389592&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389434&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389432&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389315&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389314&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389422&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389418&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389286&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388460&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=388384&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388332&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387927&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387496&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387071&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=382969&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386967&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386715&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=385137&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=379772&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386518&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386523&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388432&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387493&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=&city=&et=&prog=&cl=8680&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386990&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385794&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385191&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=378310&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=380302&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=383963&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=381512&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=370039&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=363378&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=366741&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=354134&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393342&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393159&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Field-Worker---USA/Consumer-Healthcare-Oral-Healthcare-Divisional-Sales-Manager--LA-South-Southbay_186147-1":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393143&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393056&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393043&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393037&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393035&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393022&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393018&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393016&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393014&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393012&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=97","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392755&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=100","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392527&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392521&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Territory-Associate---Scarborough_186410":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Territory-Associate---Windsor_186450":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392422&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392197&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=106","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392187&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada---Ontario---Mississauga/Territory-Associate---Vancouver_185335":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392134&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392033&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392027&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=107","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389483&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=381590&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391944&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391926&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391848&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391828&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=109","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391792&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391790&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391788&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391780&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391778&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391509&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=391494&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391070&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390926&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394257&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391463&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391359&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391007&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391006&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391467&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385627&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390143&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390140&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=382080&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387934&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384819&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384816&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384423&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=383772&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=372824&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394124&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=82","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=373665&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393517&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390398&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=95","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---New-York---Oak-Hill/EHS-Advisor_185349":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=110","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=396908&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=27","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395715&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396624&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=37","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=396466&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=41","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=395497&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=42","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=396217&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396106&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=48","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=396156&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=395822&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=49","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=395332&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=65","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=395250&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=66","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=395094&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=68","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386725&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=52","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=395974&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=53","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388055&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=57","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=394552&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=77","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=390905&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=84","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393609&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=89","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393467&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=90","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393191&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=93","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/fr-fr/gateway.do?functionName=viewFromLink&jobPostId=393286&localeCode=fr-fr":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389138&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393194&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=94","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=393092&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=96","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392990&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es-mx/gateway.do?functionName=viewFromLink&jobPostId=392717&localeCode=es-mx":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=98","txt":"View more details","status":"new"},"http://www.cancer.org/cancer/leukemia-chroniclymphocyticcll/detailedguide/leukemia-chronic-lymphocytic-new-research":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-eu-authorisation-for-arzerra/","txt":"http://www.cancer.org/cancer/leukemia-chroniclymphocyticcll/detailedguide/leukemia-chronic-lymphocytic-key-statistics. Accessed 27 May 2014","status":"new"},"http://globocan.iarc.fr/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-eu-authorisation-for-arzerra/","txt":"http://globocan.iarc.fr","status":"new"},"http://myg.sk/HealthcareInnovationAward":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-offer-1-million-award-for-healthcare-innovations-in-developing-countries-that-reduce-child-deaths/","txt":"http://myg.sk/HealthcareInnovationAward","status":"new"},"http://data.worldbank.org/country":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-offer-1-million-award-for-healthcare-innovations-in-developing-countries-that-reduce-child-deaths/","txt":"http://data.worldbank.org/country","status":"new"},"http://europa.eu/about-eu/countries/index_en.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-offer-1-million-award-for-healthcare-innovations-in-developing-countries-that-reduce-child-deaths/","txt":"http://europa.eu/about-eu/countries/index_en.htm","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000581/human_med_000878.jsp&mid=WC0b01ac058001d124":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/triumeq-dolutegravirabacavirlamivudine-single-tablet-regimen-receives-positive-chmp-opinion-in-europe-for-the-treatment-of-hiv/","txt":"abacavir/lamivudine.","status":"new"},"http://www.cancer.gov/cancertopics/pdq/treatment/myelodysplastic/Patient/page1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-the-start-of-a-phase-iii-study-with-eltrombopag-in-patients-with-myelodysplastic-syndromes/","txt":"http://www.cancer.gov/cancertopics/pdq/treatment/myelodysplastic/Patient/page1","status":"new"},"http://www.tanzeumrems.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-us-approval-for-once-weekly-type-2-diabetes-treatment-tanzeum-albiglutide/","txt":"www.TANZEUMREMS.com","status":"new"},"http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-new-initiatives-to-improve-access-to-dolutegravir-licence-to-the-medicines-patent-pool/","txt":"http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/ gr2013/UNAIDS_Global_Report_2013_en.pdf","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT01957163?term=200109&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-data-from-two-studies-evaluating-the-efficacy-and-safety-of-incruse-ellipta-when-added-to-relvar-breo-ellipta-in-patients-with-copd/","txt":"200109","status":"new"},"https://clinicaltrials.gov/ct2/show/NCT02119286?term=200110&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-data-from-two-studies-evaluating-the-efficacy-and-safety-of-incruse-ellipta-when-added-to-relvar-breo-ellipta-in-patients-with-copd/","txt":"200110","status":"new"},"http://ec.europa.eu/health/documents/community-register/html/h922.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-positive-data-from-two-studies-evaluating-the-efficacy-and-safety-of-incruse-ellipta-when-added-to-relvar-breo-ellipta-in-patients-with-copd/","txt":"http://ec.europa.eu/health/documents/community-register/html/h922.htm","status":"new"},"http://www.alttotrials.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/lapatinib-clinical-trial-update/","txt":"http://www.alttotrials.com","status":"new"},"https://www.gsksource.com/gskprm/htdocs/documents/TYKERB-PI-PIL.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-iii-altto-results-for-anti-her2-therapy-combination-in-the-adjuvant-breast-cancer-treatment-setting/","txt":"https://www.gsksource.com/gskprm/htdocs/documents/TYKERB-PI-PIL.PDF","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001131/human_med_001300.jsp&mid=WC0b01ac058001d124":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-fda-approval-for-arzerra-ofatumumab/","txt":"Summary of Product Characteristics","status":"new"},"http://www.gsk-clinicalstudyregister.com/study/OMB110911?study_ids=OMB110911":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-fda-approval-for-arzerra-ofatumumab/","txt":"http://www.gsk-clinicalstudyregister.com/study/OMB110911?study_ids=OMB110911#ps","status":"new"},"http://www.gsk-clinicalstudyregister.com/study/115991?study_ids=omb115991":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-fda-approval-for-arzerra-ofatumumab/","txt":"http://www.gsk-clinicalstudyregister.com/study/115991?study_ids=omb115991#ps","status":"new"},"http://www.copdcoalition.eu/about-copd/key-facts":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/anoro-umeclidiniumvilanterol-gains-marketing-authorisation-in-europe-for-the-treatment-of-copd/","txt":"http://www.copdcoalition.eu/about-copd/key-facts","status":"new"},"http://www.gsk.ca/english/docs-pdf/product-monographs/mekinist.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-combined-use-of-mekinist-trametinib-and-tafinlar-dabrafenib-in-europe/","txt":"http://www.gsk.ca/english/docs-pdf/product-monographs/mekinist.pdf","status":"new"},"http://us.gsk.com/products/assets/us_mekinist.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-headline-results-for-phase-iii-study-of-the-combination-of-tafinlar-dabrafenib-and-mekinist-trametinib-in-metastatic-melanoma/","txt":"http://us.gsk.com/products/assets/us_mekinist.pdf","status":"new"},"http://us.gsk.com/en-us/media/press-kits/arzerra-ofatumumab/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-fda-approval-for-arzerra/","txt":"http://us.gsk.com/en-us/media/press-kits/arzerra-ofatumumab/","status":"new"},"http://www.idf.org/diabetesatlas/download-book":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-us-approval-for-once-weekly-type-2-diabetes-treatment-tanzeum-albiglutide/","txt":"http://www.idf.org/diabetesatlas/download-book","status":"new"},"http://us.gsk.com/products/assets/us_votrient.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/results-from-phase-iii-patient-preference-study-of-gsk-s-votrient-pazopanib-vs-sutent-sunitinib-in-advanced-renal-cell-carcinoma-published-in-journal-of-clinical-oncology/","txt":"http://us.gsk.com/products/assets/us_votrient.pdf","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001141/WC500094272.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/results-from-phase-iii-patient-preference-study-of-gsk-s-votrient-pazopanib-vs-sutent-sunitinib-in-advanced-renal-cell-carcinoma-published-in-journal-of-clinical-oncology/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001141/WC500094272.pdf","status":"new"},"http://www.jco.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/results-from-phase-iii-patient-preference-study-of-gsk-s-votrient-pazopanib-vs-sutent-sunitinib-in-advanced-renal-cell-carcinoma-published-in-journal-of-clinical-oncology/","txt":"www.jco.org","status":"new"},"http://www.who.int/hiv/pub/guidelines/arv2013/arvs2013upplement_march2014/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-new-initiatives-to-improve-access-to-dolutegravir-licence-to-the-medicines-patent-pool/","txt":"http://www.who.int/hiv/pub/guidelines/arv2013/arvs2013upplement_march2014/en/","status":"new"},"http://erj.ersjournals.com/external-ref?link_type=CLINTRIALGOV&access_num=NCT01313676":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/patient-recruitment-completes-in-landmark-relvar-breo-ellipta-study-to-understand-mortality-and-morbidity-summit-in-copd/","txt":"NCT01313676","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002673/human_med_001708.jsp&mid=WC0b01ac058001d124":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/patient-recruitment-completes-in-landmark-relvar-breo-ellipta-study-to-understand-mortality-and-morbidity-summit-in-copd/","txt":"EMA EPAR including summary of product characteristics","status":"new"},"http://dpac.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-kicks-off-2014-discovery-fast-track-challenge-for-academic-drug-hunters-in-europe-canada-and-usa/","txt":"GSK’s Discovery Partnerships with Academia","status":"new"},"http://us.gsk.com/products/assets/us_tafinlar.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-headline-results-for-phase-iii-study-of-the-combination-of-tafinlar-dabrafenib-and-mekinist-trametinib-in-metastatic-melanoma/","txt":"http://us.gsk.com/products/assets/us_tafinlar.pdf","status":"new"},"http://www.viivhealthcare.com/our-medicines.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-s-new-hiv-medicine-tivicaytm-dolutegravir-is-approved-in-europe/","txt":"www.viivhealthcare.com/our-medicines.aspx","status":"new"},"http://www.prosensa.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-prosensa-announce-start-of-phase-iii-study-of-investigational-duchenne-muscular-dystrophy-medication/","txt":"www.prosensa.com","status":"new"},"https://www.clinicalstudydatarequest.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-adds-detailed-clinical-trial-data-to-multi-sponsor-request-system-as-part-of-continued-commitment-to-data-transparency/","txt":"clinicalstudydatarequest.com","status":"new"},"http://www.idea-point.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-adds-detailed-clinical-trial-data-to-multi-sponsor-request-system-as-part-of-continued-commitment-to-data-transparency/","txt":"ideaPoint","status":"new"},"http://us.gsk.com/en-us/media/press-kits/mekinist-trametinib-in-combination-with-tafinlar-dabrafenib/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-gains-accelerated-fda-approval-for-combination-use-of-mekinist-trametinib-and-tafinlar-dabrafenib/","txt":"http://us.gsk.com/en-us/media/press-kits/mekinist-trametinib-in-combination-with-tafinlar-dabrafenib/","status":"new"},"http://www.aspenpharma.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-reaches-agreement-to-divest-non-core-over-the-counter-otc-brands-in-international-markets-for-164-million/","txt":"http://www.aspenpharma.com/","status":"new"},"http://www.suntory.com/softdrink/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-to-divest-lucozade-and-ribena-for-135-billion/","txt":"http://www.suntory.com/softdrink/index.html","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR%20Summary_for_the_public/human/000721/WC500024634.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-cervarix-two-dose-schedule-receives-european-marketing-authorisation/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR Summary_for_the_public/human/000721/WC500024634.pdf","status":"new"},"http://globocan.iarc.fr/factsheets/cancers/cervix.asp":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-enters-new-commitment-with-the-gavi-alliance-to-supply-cervical-cancer-vaccine-for-girls-in-the-world-s-poorest-countries/","txt":"http://globocan.iarc.fr/factsheets/cancers/cervix.asp","status":"new"},"http://screening.iarc.fr/doc/WHO_vaccine_guidelines_2006.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/landmark-study-for-gsk-s-cervical-cancer-vaccine-published-in-the-lancet/","txt":"Guidelines to assure the quality, safety and efficacy of recombinant Human Papillomavirus virus-like particle vaccines","status":"new"},"http://www.eurogin.com/2013/images/pdf/EUROGIN-2013-Abstracts-Part-2.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-cervarix-two-dose-schedule-receives-european-marketing-authorisation/","txt":"http://www.eurogin.com/2013/images/pdf/EUROGIN-2013-Abstracts-Part-2.pdf","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000721/WC500024634.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-cervarix-two-dose-schedule-receives-european-marketing-authorisation/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000721/WC500024634.pdf","status":"new"},"http://www.mmv.org/research-development/rd-portfolio":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-mmv-announce-fda-breakthrough-therapy-designation-for-tafenoquine-for-plasmodium-vivax-malaria/","txt":"portfolio","status":"new"},"http://www.nhlbi.nih.gov/resources/docs/2012_ChartBook_508.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/breo-ellipta-gains-us-approval-for-the-treatment-of-copd/","txt":"http://www.nhlbi.nih.gov/resources/docs/2012_ChartBook_508.pdf","status":"new"},"http://us.gsk.com/en-us/products/prescription-medicines-and-vaccines/%20f":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-receive-priority-review-from-fda-for-arzerra-ofatumumab-as-1st-line-treatment-for-chronic-lymphocytic-leukaemia-cll/","txt":"http://us.gsk.com/en-us/products/prescription-medicines-and-vaccines/ f","status":"new"},"http://www.sebi.gov.in/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-voluntary-open-offer-to-increase-stake-in-its-pharmaceuticals-subsidiary-in-india/","txt":"www.sebi.gov.in","status":"new"},"http://www.bseindia.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-voluntary-open-offer-to-increase-stake-in-its-pharmaceuticals-subsidiary-in-india/","txt":"www.bseindia.com","status":"new"},"http://www.nseindia.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-voluntary-open-offer-to-increase-stake-in-its-pharmaceuticals-subsidiary-in-india/","txt":"www.nseindia.com","status":"new"},"http://www.nature.com/nm/journal/v19/n12/full/nm.2077.html?WT.ec_id=NM-201312":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/update-regarding-2010-nature-medicine-study/","txt":"Nature Medicine","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392753&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=101","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=392606&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=101","txt":"View more details","status":"new"},"https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Mississauga/Bilingual-HR-Service-Centre-Representative_173009":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=103","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/sk/gateway.do?functionName=viewFromLink&jobPostId=389640&localeCode=sk":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=104","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389316&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390652&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=115","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384590&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390329&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&=+Government+Affairs%2cbu&r=%2c%2c&city=%2c&et=%2c&prog=%2c&cl=8680&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390327&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390324&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390322&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=390129&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=117","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/es/gateway.do?functionName=viewFromLink&jobPostId=390015&localeCode=es":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=118","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=380106&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389727&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389724&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389647&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389596&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389555&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389358&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388976&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388857&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=383379&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=387360&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386858&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=125","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386296&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385916&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385768&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=126","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384880&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384217&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384008&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=382792&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=381784&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=381778&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=381738&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=378941&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=378682&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=129","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=378429&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=377838&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=377720&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389819&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=386046&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388014&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=108","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391721&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391716&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=111","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391313&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=112","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391312&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=113","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=391002&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=114","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=390580&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=116","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389850&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=119","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=376798&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=376795&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=376792&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=376315&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=376053&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=374715&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=131","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=372579&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=371652&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=132","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/pl/gateway.do?functionName=viewFromLink&jobPostId=363977&localeCode=pl":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=133","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=378541&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=120","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389433&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389318&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=121","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=389116&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=122","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388800&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=388515&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=123","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=387774&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=124","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=385130&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=384890&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=127","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=382606&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=128","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=377926&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=377676&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/en-us/gateway.do?functionName=viewFromLink&jobPostId=377654&localeCode=en-us":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=376817&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=376804&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"https://careers.peopleclick.com/careerscp/client_gsk/external1931/zh-cn/gateway.do?functionName=viewFromLink&jobPostId=376801&localeCode=zh-cn":{"firstFound":"https://www.gsk.com/en-gb/careers/careers-search/?q=&bu=&r=%2c%2c%2c&city=&cl=8680&et=&prog=&p=130","txt":"View more details","status":"new"},"http://ec.europa.eu/health/documents/community-register/html/h508.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/synflorix-receives-european-marketing-authorisation-for-additional-pneumonia-indication/","txt":"http://ec.europa.eu/health/documents/community-register/html/h508.htm","status":"new"},"http://www.unicef.org/publications/files/APR_Progress_Report_2013_9_Sept_2013.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/synflorix-receives-european-marketing-authorisation-for-additional-pneumonia-indication/","txt":"http://www.unicef.org/publications/files/APR_Progress_Report_2013_9_Sept_2013.pdf","status":"new"},"http://www.cdc.gov/flu/avianflu/h5n1-people.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/h5n1-vaccine-approved-by-the-us-fda-as-pandemic-influenza-preparedness-measure/","txt":"http://www.cdc.gov/flu/avianflu/h5n1-people.htm","status":"new"},"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376516.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-responds-to-fda-decision-on-avandia-rosiglitazone/","txt":"eased restrictions on patient access","status":"new"},"http://www.clinicaltrials.gov/show/NCT01263015":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/","txt":"http://www.clinicaltrials.gov/show/NCT01263015","status":"new"},"http://clinicaltrials.gov/show/NCT01227824":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/","txt":"http://clinicaltrials.gov/show/NCT01227824","status":"new"},"http://clinicaltrials.gov/show/NCT01231516":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/","txt":"http://clinicaltrials.gov/show/NCT01231516","status":"new"},"http://www.amicusrx.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-amicus-therapeutics-expand-fabry-disease-collaboration/","txt":"http://www.amicusrx.com","status":"new"},"http://www.amicusrx.com/default.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-amicus-therapeutics-announce-revised-fabry-agreement/","txt":"Amicus Therapeutics","status":"new"},"http://www.amicusrx.com/fabry.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-amicus-therapeutics-announce-revised-fabry-agreement/","txt":"migalastat HCl","status":"new"},"http://www.amicusrx.com/pompe.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-amicus-therapeutics-announce-revised-fabry-agreement/","txt":"AT2220 (duvoglustat HCl)","status":"new"},"https://www.viivhealthcare.com/media/press-releases/2013/october/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-european-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/","txt":"https://www.viivhealthcare.com/media/press-releases/2013/october/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv.aspx","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/10/news_detail_001927.jsp&mid=WC0b01ac058004d5c1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/synflorix-receives-positive-opinion-from-the-chmp-in-europe-for-additional-pneumonia-indication/","txt":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/10/news_detail_001927.jsp&mid=WC0b01ac058004d5c1","status":"new"},"http://clinicaltrials.gov/show/NCT01449929":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/","txt":"http://clinicaltrials.gov/show/NCT01449929","status":"new"},"http://clinicaltrials.gov/show/NCT01622790":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/","txt":"http://clinicaltrials.gov/show/NCT01622790","status":"new"},"http://clinicaltrials.gov/show/NCT01910402":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/","txt":"http://clinicaltrials.gov/show/NCT01910402","status":"new"},"https://www.viivhealthcare.com/media/70430/us_epzicom.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-regulatory-submission-for-a-single-tablet-regimen-combining-dolutegravir-with-abacavir-and-lamivudine-for-people-living-with-hiv/","txt":"https://www.viivhealthcare.com/media/70430/us_epzicom.pdf","status":"new"},"http://us.gsk.com/en-us/products/prescription-medicines-and-vaccines/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-vote-from-fda-panel-for-pazopanib-in-certain-advanced-soft-tissue-sarcomas/","txt":"Product section","status":"new"},"http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-037124.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-and-genmab-announce-submission-to-us-regulatory-authorities-for-arzerra-ofatumumab-as-1st-line-treatment-of-chronic-lymphocytic-leukaemia-cll/","txt":"Estimated Number of New Cancer Cases and Deaths by Sex, US, 2013","status":"new"},"http://us.gsk.com/html/medicines/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submissions-in-the-eu-us-for-new-indications-for-promacta-revolade/","txt":"Products","status":"new"},"http://www.barclays.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-barclays-form-partnership-to-increase-access-to-healthcare-and-promote-economic-development-in-zambia/","txt":"http://www.barclays.com/","status":"new"},"http://www.statista.com/statistics/263746/total-population-in-japan/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/relvar-ellipta-gains-approval-in-japan-for-the-treatment-of-asthma/","txt":"http://www.statista.com/statistics/263746/total-population-in-japan/","status":"new"},"http://www.cdc.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-a-multi-year-agreement-with-barda-to-supply-the-us-government-with-anthrax-treatment/","txt":"http://www.cdc.gov/","status":"new"},"http://ec.europa.eu/health/documents/community-register/html/index_en.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-european-authorisation-for-nimenrix-meningococcal-group-a-c-w-135-and-y-conjugate-vaccine/","txt":"http://ec.europa.eu/health/documents/community-register/html/index_en.htm","status":"new"},"http://www.melanoma.org/learn-more/melanoma-101/staging-melanoma":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/two-new-gsk-oral-oncology-treatments-braf-inhibitor-tafinlar-dabrafenib-capsules-and-the-first-mek-inhibitor-mekinist-trametinib-tablets-approved-by-fda-as-single-agent-therapies/","txt":"http://www.melanoma.org/learn-more/melanoma-101/staging-melanoma","status":"new"},"https://www.aimatmelanoma.org/en/aim-for-answers/stages-of-melanoma/brain-metastates.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-from-the-european-commission-for-tafinlar/","txt":"https://www.aimatmelanoma.org/en/aim-for-answers/stages-of-melanoma/brain-metastates.html","status":"new"},"http://ec.europa.eu/health/documents/community-register/html/index_en.htm).":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-from-the-european-commission-for-additional-indication-tyverb-lapatinib/","txt":"http://ec.europa.eu/health/documents/community-register/html/index_en.htm).","status":"new"},"http://www.who.int/cancer/detection/breastcancer/en/index1.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-from-the-european-commission-for-additional-indication-tyverb-lapatinib/","txt":"http://www.who.int/cancer/detection/breastcancer/en/index1.html","status":"new"},"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852551/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-from-the-european-commission-for-additional-indication-tyverb-lapatinib/","txt":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852551/","status":"new"},"http://www.cancer.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-submit-arzerra-ofatumumab-application-to-fda-for-the-treatment-of-advanced-stage-blood-cancer/","txt":"Global Cancer Facts and Figures 2007","status":"new"},"http://www.breastcancer.org/symptoms/diagnosis/her2":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-marketing-authorisation-from-the-european-commission-for-additional-indication-tyverb-lapatinib/","txt":"http://www.breastcancer.org/symptoms/diagnosis/her2","status":"new"},"http://www.who.int/mediacentre/factsheets/fs331/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-adds-to-its-commitment-to-gavi-alliance-to-help-protect-millions-more-children-against-infectious-diseases/","txt":"http://www.who.int/mediacentre/factsheets/fs331/en/","status":"new"},"http://www.cervicalcanceraction.org/pubs/CCA_reportcard_med-res.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-enters-new-commitment-with-the-gavi-alliance-to-supply-cervical-cancer-vaccine-for-girls-in-the-world-s-poorest-countries/","txt":"http://www.cervicalcanceraction.org/pubs/CCA_reportcard_med-res.pdf","status":"new"},"http://www.innocentive.com/ar/challenge/9933399":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-launch-1-million-award-to-discover-new-healthcare-innovations-for-reducing-child-deaths/","txt":"http://www.innocentive.com/ar/challenge/9933399","status":"new"},"http://www.gsk-clinicalstudyregister.com/result_detail.jsp?protocolId=110655&studyId=3BE47FC7-ACBB-4989-90E4-67DA3015AEF6&compound=pazopanib":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-late-stage-clinical-data-for-votrient-pazopanib-following-chemotherapy-in-women-with-advanced-epithelial-ovarian-cancer/","txt":"GSK Clinical Trial Register: Result Summary for 110655","status":"new"},"https://wcms.prd.digital-marketing.com/content/gsk/en/media/press-releases/2013/GSK-announces-late-stage-clinical-data-for-Votrient.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-late-stage-clinical-data-for-votrient-pazopanib-following-chemotherapy-in-women-with-advanced-epithelial-ovarian-cancer/","txt":"","status":"new"},"http://www.okairos.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-strengthens-vaccines-business-with-acquisition-of-okairos/","txt":"www.okairos.com","status":"new"},"http://us.gsk.com/en-us/products/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-announce-positive-top-line-results-from-pivotal-trial-of-arzerra-ofatumumab-combined-with-chlorambucil-in-previously-untreated-chronic-lymphocytic-leukaemia/","txt":"http://us.gsk.com/en-us/products/","status":"new"},"https://wcms.prd.digital-marketing.com/content/gsk/en/media/press-releases/2013/two-new-gsk-oral-oncology-treatments--braf-inhibitor-tafinlar---.html?cq_ck=1369861040372":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/two-new-gsk-oral-oncology-treatments-braf-inhibitor-tafinlar-dabrafenib-capsules-and-the-first-mek-inhibitor-mekinist-trametinib-tablets-approved-by-fda-as-single-agent-therapies/","txt":"","status":"new"},"http://www.skincancer.org/skin-cancer-information/melanoma":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/two-new-gsk-oral-oncology-treatments-braf-inhibitor-tafinlar-dabrafenib-capsules-and-the-first-mek-inhibitor-mekinist-trametinib-tablets-approved-by-fda-as-single-agent-therapies/","txt":"http://www.skincancer.org/skin-cancer-information/melanoma","status":"new"},"http://www.cancer.gov/cancertopics/types/melanoma":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/two-new-gsk-oral-oncology-treatments-braf-inhibitor-tafinlar-dabrafenib-capsules-and-the-first-mek-inhibitor-mekinist-trametinib-tablets-approved-by-fda-as-single-agent-therapies/","txt":"http://www.cancer.gov/cancertopics/types/melanoma","status":"new"},"http://seer.cancer.gov/statfacts/html/melan.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/two-new-gsk-oral-oncology-treatments-braf-inhibitor-tafinlar-dabrafenib-capsules-and-the-first-mek-inhibitor-mekinist-trametinib-tablets-approved-by-fda-as-single-agent-therapies/","txt":"http://seer.cancer.gov/statfacts/html/melan.html","status":"new"},"http://www.cancernetwork.com/cancer-management/moles-melanomas/article/10165/1802671":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/two-new-gsk-oral-oncology-treatments-braf-inhibitor-tafinlar-dabrafenib-capsules-and-the-first-mek-inhibitor-mekinist-trametinib-tablets-approved-by-fda-as-single-agent-therapies/","txt":"http://www.cancernetwork.com/cancer-management/moles-melanomas/article/10165/1802671","status":"new"},"http://1millionhealthworkers.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers-in-sub-saharan-africa/","txt":"http://1millionhealthworkers.org/","status":"new"},"http://www.un.org/millenniumgoals/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers-in-sub-saharan-africa/","txt":"Millennium Development Goals","status":"new"},"http://unsdsn.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers-in-sub-saharan-africa/","txt":"Sustainable Development Solutions Network","status":"new"},"https://www.facebook.com/1millionhealthworkers":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers-in-sub-saharan-africa/","txt":"Follow the campaign on Facebook","status":"new"},"http://1millionhealthworkers.org/blog/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers-in-sub-saharan-africa/","txt":"Follow the campaign blog","status":"new"},"https://twitter.com/1Mhealthworkers":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers-in-sub-saharan-africa/","txt":"Follow the campaign on Twitter","status":"new"},"http://instagram.com/1millionhealthworkers":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers-in-sub-saharan-africa/","txt":"Follow the campaign on Instagram","status":"new"},"http://us.gsk.com/en-us/home/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/breo-ellipta-gains-us-approval-for-the-treatment-of-copd/","txt":"http://us.gsk.com/en-us/home/","status":"new"},"http://apps.who.int/rhl/gynaecology/cancer/cd001035_broutetn_com/en/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-enters-new-commitment-with-the-gavi-alliance-to-supply-cervical-cancer-vaccine-for-girls-in-the-world-s-poorest-countries/","txt":"http://apps.who.int/rhl/gynaecology/cancer/cd001035_broutetn_com/en/index.html","status":"new"},"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000721/WC500024632.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-enters-new-commitment-with-the-gavi-alliance-to-supply-cervical-cancer-vaccine-for-girls-in-the-world-s-poorest-countries/","txt":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-Product_Information/human/000721/WC500024632.pdf","status":"new"},"https://clinicalstudydata.gsk.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-gives-update-on-plans-to-share-detailed-clinical-trial-data-as-part-of-its-commitment-to-transparency/","txt":"online system","status":"new"},"http://www.euro.who.int/en/what-we-do/health-topics/communicable-diseases/influenza":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/the-uk-government-signs-influenza-pandemic-contract-with-glaxosmithkline-for-relenza/","txt":"Information about pandemic influenza","status":"new"},"http://www.pei.de/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-first-four-strain-seasonal-influenza-vaccine-granted-marketing-authorisation-in-germany-and-the-uk/","txt":"www.pei.de","status":"new"},"http://www.who.int/mediacentre/factsheets/fs211/en/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-first-four-strain-seasonal-influenza-vaccine-granted-marketing-authorisation-in-germany-and-the-uk/","txt":"http://www.who.int/mediacentre/factsheets/fs211/en/index.html","status":"new"},"http://us.gsk.com/en-us/media/infographics/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/500-000-endowment-gift-from-the-glaxosmithkline-foundation-expands-program-to-help-patients-with-cancer-and-their-families-at-the-children-s-hospital-of-philadelphia/","txt":"Click here to view an infographic about the Fund","status":"new"},"http://twitter.com/GSKUS":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-votrient-for-treatment-of-patients-with-certain-types-of-advanced-soft-tissue-sarcoma/","txt":"@GSKUS","status":"new"},"http://www.chop.edu/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/500-000-endowment-gift-from-the-glaxosmithkline-foundation-expands-program-to-help-patients-with-cancer-and-their-families-at-the-children-s-hospital-of-philadelphia/","txt":"www.chop.edu","status":"new"},"http://www.scientistsinsport.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-launches-london-2012-initiative-with-king-s-college-london-to-inspire-young-people-into-science-careers/","txt":"www.scientistsinsport.com","status":"new"},"http://flu.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-glaxosmithkline-s-four-strain-seasonal-influenza-vaccine-for-use-in-the-us/","txt":"http://flu.gov","status":"new"},"http://www.cdc.gov/flu/about/season/flu-season-2012-2013.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-glaxosmithkline-s-four-strain-seasonal-influenza-vaccine-for-use-in-the-us/","txt":"http://www.cdc.gov/flu/about/season/flu-season-2012-2013.htm","status":"new"},"https://wcms.prd.digital-marketing.com/content/gsk/en/media/press-releases/2012/millions-children-in-Pakistan-protected-against-pneumococcal-disease.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/millions-of-children-in-pakistan-to-be-protected-against-pneumococcal-disease-with-gsk-s-synflorix/","txt":"","status":"new"},"http://www.gavialliance.org/support/nvs/pneumococcal/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/first-african-country-introduces-gsk-s-pneumococcal-vaccine-through-innovative-financing-mechanism/","txt":"GAVI Alliance 2007. The Pneumococcal AMC: Ready to save lives.","status":"new"},"http://www.niaid.nih.gov/topics/pneumococal/Pages/PneumococcalDisease.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-pneumococcal-vaccine-agreement-with-gavi-alliance/","txt":"Pneumococcal Diseases","status":"new"},"http://www.who.int/immunization_monitoring/burden/GDB_Hib_Sp_Results_Database.xls":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/millions-of-children-in-pakistan-to-be-protected-against-pneumococcal-disease-with-gsk-s-synflorix/","txt":"World Health Organization. Estimated Hib and pneumococcal deaths for children under 5 years of ag","status":"new"},"http://www.shionogi.co.jp/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/shionogi-viiv-healthcare-announces-initial-data-from-pivotal-phase-iii-study-of-dolutegravir-in-hiv/","txt":"http://www.shionogi.co.jp/","status":"new"},"http://www.shionogi.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/shionogi-viiv-healthcare-announces-initial-data-from-pivotal-phase-iii-study-of-dolutegravir-in-hiv/","txt":"http://www.shionogi.com/","status":"new"},"http://www.medicines.org.uk/EMC/searchresults.aspx?term=Synflorix&searchtype=QuickSearch":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submission-for-a-new-indication-for-synflorix-in-europe/","txt":"Synflorix page on eMC","status":"new"},"http://ec.europa.eu/health/documents/community-register/html/index_en.htm%29.":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/european-commission-grants-marketing-authorisation-for-pazopanib-votrient-in-the-treatment-of-certain-advanced-soft-tissue-sarcoma-subtypes/","txt":"http://ec.europa.eu/health/documents/community-register/html/index_en.htm).","status":"new"},"http://www.biomerieux.com/servlet/srt/bio/portail/home":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submissions-in-the-eu-and-us-for-dabrafenib-and-trametinib/","txt":"bioMérieux","status":"new"},"http://www.maximuscle.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-to-strengthen-nutritional-healthcare-business-with-acquisition-of-maxinutrition/","txt":"www.maximuscle.com","status":"new"},"http://www.lucozade.com/about/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-pre-broadcast-statement-on-bbc-panorama-the-truth-about-sports-products-19-july-2012/","txt":"Lucozade","status":"new"},"http://www.maxifuel.com/who-is-maxinutrition":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-pre-broadcast-statement-on-bbc-panorama-the-truth-about-sports-products-19-july-2012/","txt":"Maxinutrition ","status":"new"},"http://www.globenewswire.com/newsroom/ctr?d=232050&l=4&a=Study%20011&u=http://www.clinicaltrials.gov/ct2/show/NCT00925301?term=at1001&rank=3":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-amicus-therapeutics-expand-fabry-disease-collaboration/","txt":"Study 011","status":"new"},"http://www.globenewswire.com/newsroom/ctr?d=241035&l=10&a=Study%20012&u=http://www.clinicaltrials.gov/ct2/show/NCT01218659?term=at1001&rank=1":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-amicus-therapeutics-expand-fabry-disease-collaboration/","txt":"Study 012","status":"new"},"http://www.globenewswire.com/newsroom/ctr?d=241035&l=10&a=Study%20013&u=http://www.clinicaltrials.gov/ct2/show/NCT01196871?term=at1001&rank=5":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-amicus-therapeutics-expand-fabry-disease-collaboration/","txt":"Study 013","status":"new"},"http://www.flickr.com/photos/glaxosmithkline/sets/72157630556532696/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-celebrates-its-role-in-supporting-the-biggest-anti-doping-operation-in-the-history-of-the-olympic-games/","txt":"http://www.flickr.com/photos/glaxosmithkline/sets/72157630556532696/","status":"new"},"https://www.yousendit.com/download/QlVqYUlsaTFqY3BvZE1UQw":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-celebrates-its-role-in-supporting-the-biggest-anti-doping-operation-in-the-history-of-the-olympic-games/","txt":"https://www.yousendit.com/download/QlVqYUlsaTFqY3BvZE1UQw","status":"new"},"http://www.hgsi.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/human-genome-sciences-and-glaxosmithkline-announce-positive-phase-3-study-results-for-benlysta-in-systemic-lupus-erythematosus/","txt":"www.hgsi.com","status":"new"},"http://us.gsk.com/html/media-news/settlement-press-kit.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-concludes-previously-announced-agreement-in-principle-to-resolve-multiple-investigations-with-us-government-and-numerous-states/","txt":"http://us.gsk.com/html/media-news/settlement-press-kit.html","status":"new"},"https://wcms.prd.digital-marketing.com/content/gsk/en.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submissions-for-two-influenza-vaccines/","txt":"www.gsk.com","status":"new"},"http://www.xenoport.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-xenoport-resubmit-new-drug-application-for-solzira-in-restless-legs-syndrome/","txt":"www.XenoPort.com","status":"new"},"http://www.epsrc.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-epsrc-announce-creation-of-new-chair-in-sustainable-chemistry-at-the-university-of-nottingham/","txt":"http://www.epsrc.ac.uk/","status":"new"},"http://www.nottingham.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/","txt":"United Kingdom","status":"new"},"http://www.nottingham.edu.cn/en/index.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/","txt":"China","status":"new"},"http://www.nottingham.edu.my/index.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/","txt":"Malaysia","status":"new"},"http://www.nottingham.ac.uk/news/pressreleases/2012/january/bucking-the-trend.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/","txt":"most popular","status":"new"},"http://www.nottingham.ac.uk/news/pressreleases/2011/december/greenestcampus.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/","txt":"‘the world’s greenest university’","status":"new"},"http://www.nottingham.ac.uk/news/pressreleases/2011/november/queensanniversaryprize.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/","txt":"Queen’s Anniversary Prize","status":"new"},"http://www.nottingham.ac.uk/impactcampaign":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/","txt":"Impact: The Nottingham Campaign","status":"new"},"http://www.twitter.com/UoNPressOffice":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-epsrc-announce-creation-of-new-chair-in-sustainable-chemistry-at-the-university-of-nottingham/","txt":"follow us on Twitter","status":"new"},"http://gsk.to/K3jT3O":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-secures-future-of-local-playing-fields-with-fields-in-trust-as-part-of-london-2012-legacy/","txt":"http://gsk.to/K3jT3O","status":"new"},"http://www.fieldsintrust.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-secures-future-of-local-playing-fields-with-fields-in-trust-as-part-of-london-2012-legacy/","txt":"http://www.fieldsintrust.org/","status":"new"},"http://www.qe2fields.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-secures-future-of-local-playing-fields-with-fields-in-trust-as-part-of-london-2012-legacy/","txt":"http://www.qe2fields.com/","status":"new"},"http://www.kingsfund.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/community-healthcare-charities-receive-300-000-from-glaxosmithkline-in-recognition-of-their-work/","txt":"www.kingsfund.org.uk/","status":"new"},"http://www.stiefel.com/content/dam/stiefel/globals/documents/pdf/US_Fabior.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/stiefel-receives-us-fda-approval-of-fabior-foam-01/","txt":"full US Prescribing Information","status":"new"},"http://www.niams.nih.gov/Health_Info/Acne/default.asp":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/stiefel-receives-us-fda-approval-of-fabior-foam-01/","txt":"Questions and Answers about Acne","status":"new"},"http://www.nottingham.ac.uk/news":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/","txt":"More news…","status":"new"},"http://www.kenes.com/espid09/posters/abstract660.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/millions-of-children-in-the-world-s-poorest-countries-could-receive-vaccination-against-rotavirus-diarrhoeal-disease-under-new-offer-made-by-gsk-to-the-gavi-alliance/","txt":"www.kenes.com/espid09/posters/abstract660.htm","status":"new"},"http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=102&abstractID=83283":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-votrient-for-treatment-of-patients-with-certain-types-of-advanced-soft-tissue-sarcoma/","txt":"study","status":"new"},"http://www.gsksource.com/gskprm/htdocs/documents/VOTRIENT-PI-MG.PDF":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/fda-approves-votrient-for-treatment-of-patients-with-certain-types-of-advanced-soft-tissue-sarcoma/","txt":"http://www.gsksource.com/gskprm/htdocs/documents/VOTRIENT-PI-MG.PDF","status":"new"},"http://www.omega-pharma.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-provides-further-update-on-divestment-of-non-core-over-the-counter-otc-brands/","txt":"www.omega-pharma.com/","status":"new"},"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001212/human_med_001412.jsp&mid=WC0b01ac058001d124":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-gsk-announces-submissions-for-two-influenza-vaccines/","txt":"EMA website","status":"new"},"http://www.nweh.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/innovative-uk-research-project-to-study-the-value-medicines-bring-to-patients-in-the-real-world/","txt":"www.nweh.org.uk/","status":"new"},"http://www.crncc.nihr.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/innovative-uk-research-project-to-study-the-value-medicines-bring-to-patients-in-the-real-world/","txt":"www.crncc.nihr.ac.uk/","status":"new"},"http://www.twitter.com/nhssalford":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/innovative-uk-research-project-to-study-the-value-medicines-bring-to-patients-in-the-real-world/","txt":"www.twitter.com/nhssalford","status":"new"},"http://www.facebook.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/innovative-uk-research-project-to-study-the-value-medicines-bring-to-patients-in-the-real-world/","txt":"www.facebook.com/","status":"new"},"http://www.salford.nhs.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/innovative-uk-research-project-to-study-the-value-medicines-bring-to-patients-in-the-real-world/","txt":"www.salford.nhs.uk/","status":"new"},"http://www.srft.nhs.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/innovative-uk-research-project-to-study-the-value-medicines-bring-to-patients-in-the-real-world/","txt":"www.srft.nhs.uk/","status":"new"},"http://www.unitingtocombatntds.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-joins-new-global-partnership-to-help-defeat-ten-neglected-tropical-diseases-by-2020/","txt":"www.UnitingToCombatNTDs.org","status":"new"},"http://www.who.int/lymphatic_filariasis/policy/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-joins-new-global-partnership-to-help-defeat-ten-neglected-tropical-diseases-by-2020/","txt":"http://www.who.int/lymphatic_filariasis/policy/en/","status":"new"},"http://www.who.int/immunization_standards/vaccine_quality/pq_suppliers/en":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-pneumococcal-vaccine-agreement-with-gavi-alliance/","txt":"WHO list of vaccines for purchase by UN agencies as of February 2010","status":"new"},"http://www.helpforheroes.org.uk/how_we_spend.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-help-for-heroes-partner-to-support-the-rehabilitation-of-wounded-servicemen-and-women-in-the-uk/","txt":"www.helpforheroes.org.uk/how_we_spend.html","status":"new"},"http://us.gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-636298.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/regulatory-update-glaxosmithkline-submits-additional-information-for-candidate-meningococcal-and-hib-combination-vaccine/","txt":"September 2011 Complete Response letter","status":"new"},"http://www.medicines.org.uk/EMC/medicine/20204/SPC/Cervarix/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/data-published-in-the-lancet-oncology-support-high-efficacy-previously-demonstrated-by-cervarixreg-hpv-16-and-18-vaccine-against-precancerous-cervical-lesions/","txt":"here","status":"new"},"http://www.who.int/neglected_diseases/diseases/en":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-joins-wipo-research-open-innovation-platform-as-part-of-its-commitment-to-tackling-diseases-of-the-developing-world/","txt":"17 NTDs","status":"new"},"http://www.wiporesearch.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-joins-wipo-research-open-innovation-platform-as-part-of-its-commitment-to-tackling-diseases-of-the-developing-world/","txt":"www.wipoReSearch.org","status":"new"},"http://www.who.int/mediacentre/news/statements/2011/deworming_tabs_201109_09/en/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-gives-update-on-agreement-with-world-health-organization-to-support-de-worming-of-school-age-children-in-endemic-countries/","txt":"here","status":"new"},"http://www.srone.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/jens-eckstein-named-president-of-sr-one-gsk-s-venture-healthcare-group/","txt":"www.srone.com","status":"new"},"http://farm7.static.flickr.com/6194/6120166743_a884e367b2_z.jpg":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-gsk-shows-sign-of-things-to-come-at-london-2012-olympic-and-paralympic-games/","txt":"GSK House transformation","status":"new"},"http://farm7.static.flickr.com/6206/6120166723_0799fe7e5f_z.jpg":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-gsk-shows-sign-of-things-to-come-at-london-2012-olympic-and-paralympic-games/","txt":"GSK House transformation","status":"new"},"http://farm7.static.flickr.com/6196/6120166707_88eaef54b4_z.jpg":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-gsk-shows-sign-of-things-to-come-at-london-2012-olympic-and-paralympic-games/","txt":"GSK House transformation","status":"new"},"http://www.enigmadiagnostics.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-enigma-diagnostics-announce-commercial-partnership-to-develop-point-of-care-influenza-diagnostics/","txt":"www.enigmadiagnostics.com","status":"new"},"http://www.emea.europa.eu/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-european-commission-approval-to-market-alli-orlistat-60mg/","txt":"www.emea.europa.eu","status":"new"},"http://www.ncbi.nlm.nih.gov/pubmed/16088792":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-new-approval-for-rotarix-and-significant-new-indication-for-lamictalreg-lamotrigine-in-japan/","txt":"J Infect Dis.","status":"new"},"http://www.nice.org.uk/guidance/index.jsp?action=download&o=30194":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-new-approval-for-rotarix-and-significant-new-indication-for-lamictalreg-lamotrigine-in-japan/","txt":"Available","status":"new"},"http://sign.ac.uk/guidelines/published/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-receives-new-approval-for-rotarix-and-significant-new-indication-for-lamictalreg-lamotrigine-in-japan/","txt":"Available","status":"new"},"http://www.valeant.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/retigabine-regulatory-update/","txt":"www.valeant.com","status":"new"},"http://www.gsk.com./":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-s-pazopanib-improved-progression-free-survival-in-adults-with-certain-soft-tissue-sarcomas/","txt":"www.gsk.com.","status":"new"},"http://www.kingsfund.org.uk/current_projects/gsk_impact_awards/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/young-peoples-health-charity-steps-forward-to-claim-top-accolade-and-35-000/","txt":"GSK Impact Awards 2011 Winners.","status":"new"},"http://www.gmecuk.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/unique-research-alliance-expands-collaboration-opportunities-at-state-of-the-art-medical-imaging-centre/","txt":"http://www.gmecuk.com/","status":"new"},"http://www.imperial.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/unique-research-alliance-expands-collaboration-opportunities-at-state-of-the-art-medical-imaging-centre/","txt":"www.imperial.ac.uk","status":"new"},"http://www.kcl.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/unique-research-alliance-expands-collaboration-opportunities-at-state-of-the-art-medical-imaging-centre/","txt":"www.kcl.ac.uk","status":"new"},"http://www.ucl.ac.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/unique-research-alliance-expands-collaboration-opportunities-at-state-of-the-art-medical-imaging-centre/","txt":"www.ucl.ac.uk","status":"new"},"https://www.partnersinknowledge.com/home/default.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-payments-for-research-consulting-and-advising-by-us-healthcare-professionals/","txt":"www.partnersinknowledge.com","status":"new"},"http://www.epilepsyfoundation.org/about/types/types/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-valeant-receive-european-authorisation-for-trobalt-retigabine/","txt":"http://www.epilepsyfoundation.org/about/types/types/","status":"new"},"http://www.tolerx.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-tolerx-announce-phase-iii-defend-1-study-of-otelixizumab-in-type-1-diabetes-did-not-meet-its-primary-endpoint/","txt":"www.tolerx.com","status":"new"},"http://www.hgsi.com/images/Benlysta/pdf/benlysta_pi.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-fda-approval-of-benlystareg-belimumab-for-the-treatment-of-systemic-lupus-erythematosus/","txt":"Full US prescribing information","status":"new"},"http://www.hgsi.com/images/Benlysta/pdf/benlysta_medguide.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-fda-approval-of-benlystareg-belimumab-for-the-treatment-of-systemic-lupus-erythematosus/","txt":"Medication guide for Benlysta (belimumab)","status":"new"},"http://www.age-concern-cardiff.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/","txt":"www.age-concern-cardiff.org.uk","status":"new"},"http://www.alzheimers-dementia.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/","txt":"www.alzheimers-dementia.org.uk","status":"new"},"http://www.bodyandsoulcharity.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/","txt":"www.bodyandsoulcharity.org","status":"new"},"http://www.workitoutatbrook.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/","txt":"www.workitoutatbrook.org.uk","status":"new"},"http://www.bryncynonstrategy.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/","txt":"www.bryncynonstrategy.org.uk","status":"new"},"http://www.niemannpick.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/","txt":"www.niemannpick.org.uk","status":"new"},"http://www.project6.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/","txt":"www.project6.org.uk","status":"new"},"http://www.stepforward-web.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/","txt":"www.stepforward-web.org","status":"new"},"http://www.backuptrust.org.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/reward-for-charities-bridging-gaps-in-health-care-provision/","txt":"www.backuptrust.org.uk","status":"new"},"http://www.sensodyne.co.uk/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/world-s-first-everyday-fluoride-toothpaste-with-novamin-technology-that-can-repair-sensitive-teeth/","txt":"www.sensodyne.co.uk","status":"new"},"http://www.pfizer.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/david-redfern-appointed-as-new-chairman-of-viiv-healthcare/","txt":"www.pfizer.com","status":"new"},"http://www.who.int/immunization/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-paediatric-pneumococcal-candidate-vaccine-synflorix-receives-positive-opinion-in-europe/","txt":"WHO Pneumoccocal Conjugate Vaccine for childhood immunization","status":"new"},"http://www.who.int/immunization/wer8212pneumococcus_child_Mar07_position_paper.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/synflorix-glaxosmithkline-s-pneumococcal-vaccine-receives-european-authorisation/","txt":"www.who.int/immunization/wer8212pneumococcus_child_Mar07_position_paper.pdf","status":"new"},"http://www.libertyproperty.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-moving-to-new-building-at-philadelphia-navy-yard/","txt":"www.libertyproperty.com","status":"new"},"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021071s038lbl.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-revises-us-avandia-label-to-include-new-restrictions-on-use/","txt":"New US Avandia Label","status":"new"},"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021410s026lbl.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-revises-us-avandia-label-to-include-new-restrictions-on-use/","txt":"New US Avandamet label","status":"new"},"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021700s010lbl.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-revises-us-avandia-label-to-include-new-restrictions-on-use/","txt":"New US Avandaryl label","status":"new"},"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61354-2/abstract":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-publication-of-bliss-52-phase-lll-study-results-for-benlysta-in-the-lancet/","txt":"The Lancet ","status":"new"},"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61546-2/fulltext":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-publication-of-bliss-52-phase-lll-study-results-for-benlysta-in-the-lancet/","txt":"A Comment","status":"new"},"http://www.actelion.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-actelion-discontinue-clinical-development-of-almorexant/","txt":"www.actelion.com","status":"new"},"http://www.dentsply.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-dentsply-international-sign-global-agreement-to-create-a-portfolio-of-co-branded-professional-oral-care-products/","txt":"www.dentsply.com","status":"new"},"http://www.chemocentryx.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-exercises-option-to-progress-development-of-chemocentryx-s-traficet-en-for-the-treatment-of-inflammatory-bowel-diseases/","txt":"www.chemocentryx.com","status":"new"},"http://www.impaxlabs.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-impax-pharmaceuticals-enter-global-agreement-to-develop-and-commercialise-a-late-stage-compound-for-parkinson-s-disease/","txt":"www.impaxlabs.com","status":"new"},"http://www.maxifuel.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-to-strengthen-nutritional-healthcare-business-with-acquisition-of-maxinutrition/","txt":"www.maxifuel.com","status":"new"},"http://www.maxitone.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-to-strengthen-nutritional-healthcare-business-with-acquisition-of-maxinutrition/","txt":"www.maxitone.com","status":"new"},"http://legacy2.gsk.com/media/press-releases/2010/phase-iii-study-in-her2-positive-advanced-breast-cancer-shows-overall-survival-benefit-when-tykerb-is-combined-with-paclitaxel.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/phase-iii-study-in-her2-positive-advanced-breast-cancer-shows-overall-survival-benefit-when-tykerb-is-combined-with-paclitaxel/","txt":"","status":"new"},"http://www.fiocruz.br/cgi/cgilua.exe/sys/start.htm?UserActiveTemplate=template%5Ffiocruz&tpl=home":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-fiocruz-extend-innovative-collaboration-to-research-and-develop-new-medicines-for-neglected-tropical-diseases/","txt":"the Fiocruz website","status":"new"},"http://www.amicustherapeutics.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-amicus-therapeutics-enter-exclusive-worldwide-agreement-to-develop-and-commercialise-amigal-for-fabry-disease/","txt":"www.amicustherapeutics.com","status":"new"},"http://www.telethon.it/english/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-fondazione-san-raffaele-to-collaborate-on-gene-therapy-for-rare-diseases/","txt":"the Telethon website","status":"new"},"http://www.sanraffaele.org/EN_Home/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-fondazione-san-raffaele-to-collaborate-on-gene-therapy-for-rare-diseases/","txt":"the San Raffaele website","status":"new"},"http://www.sanraffaele.org/ENG-home/research/divisions_centers_institutes_research_programs/TIGET/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-fondazione-san-raffaele-to-collaborate-on-gene-therapy-for-rare-diseases/","txt":"The San Raffaele Telethon Institute for Gene Therapy","status":"new"},"http://www.nejm.org/doi/full/10.1056/NEJMoa0805817":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-fondazione-telethon-and-fondazione-san-raffaele-to-collaborate-on-gene-therapy-for-rare-diseases/","txt":"http://www.nejm.org/doi/full/10.1056/NEJMoa0805817","status":"new"},"http://www.niaid.nih.gov/news/newsreleases/2010/Pages/Herpevac.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-herpevac-trial-for-women-evaluating-simplirix-herpes-simplex-vaccine/","txt":"www.niaid.nih.gov/news/newsreleases/2010/Pages/Herpevac.aspx","status":"new"},"http://www.niaid.nih.gov/news/QA/pages/HerpevacQA.aspx":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-herpevac-trial-for-women-evaluating-simplirix-herpes-simplex-vaccine/","txt":"www.niaid.nih.gov/news/QA/pages/HerpevacQA.aspx","status":"new"},"http://www.fda.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-launches-new-specialist-unit-to-research-and-develop-medicines-for-rare-diseases/","txt":"www.fda.gov","status":"new"},"http://www.liberatefrompain.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-bjd-collaborate-on-a-new-educational-programme-to-reduce-global-burden-of-joint-pain/","txt":"www.liberatefrompain.com","status":"new"},"http://www.bjdonline.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-bjd-collaborate-on-a-new-educational-programme-to-reduce-global-burden-of-joint-pain/","txt":"www.bjdonline.org","status":"new"},"http://www.lymphomation.org/statistics.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-announce-start-of-ofatumumab-phase-iii-combination-study-in-non-hodgkin-s-lymphoma/","txt":"Surveillance Epidemiology and End Results (SEER) Cancer Statistics Review 1975-2006 , National Cancer Institute.","status":"new"},"http://theoncologist.alphamedpress.org/cgi/content/full/7/3/217":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-announce-start-of-ofatumumab-phase-iii-combination-study-in-non-hodgkin-s-lymphoma/","txt":"Cheson, Bruce D. Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies. Journal of Clinical Oncology. July 20, 2010 vol.28 no. 21 3525-3530","status":"new"},"http://www.glpg.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/galapagos-reaches-agreement-to-acquire-glaxosmithkline-research-centre-in-zagreb-croatia/","txt":"www.glpg.com","status":"new"},"http://www.cdc.gov/vaccines/vpd-vac/shingles/dis-faqs.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-commences-phase-iii-clinical-trials-to-develop-herpes-zoster-vaccine-for-the-prevention-of-shingles/","txt":"Shingles Disease: Questions and Answers","status":"new"},"http://www.nature.com/nature/journal/vaop/ncurrent/full/nature09197.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/image-of-new-antibiotic-in-action-opens-up-new-opportunities-to-combat-antibacterial-resistance/","txt":"; E-pub ahead of print publication","status":"new"},"http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/image-of-new-antibiotic-in-action-opens-up-new-opportunities-to-combat-antibacterial-resistance/","txt":"The bacterial challenge: time to react","status":"new"},"http://www.anacor.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-exercises-option-on-anacor-s-novel-antibiotic-for-the-treatment-of-gram-negative-infections/","txt":"www.anacor.com","status":"new"},"http://www.avandia.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/large-long-term-study-shows-avandia-has-no-increased-overall-cardiovascular-risk-compared-to-other-commonly-used-diabetes-medicines/","txt":"www.AVANDIA.com","status":"new"},"http://www.fda.gov/AdvisoryCommittees/Calendar/ucm214612.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/data-support-avandia-rosiglitazone-maleate-cardiovascular-safety-profile/","txt":"comprehensive review","status":"new"},"http://www.cdc.gov/nchs/data/nhis/earlyrelease/201006_14.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/data-support-avandia-rosiglitazone-maleate-cardiovascular-safety-profile/","txt":"Ref CDC website","status":"new"},"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218492.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/data-support-avandia-rosiglitazone-maleate-cardiovascular-safety-profile/","txt":"briefing document","status":"new"},"http://www.biomed-singapore.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-edb-commit-35-million-usd-in-funding-to-support-research-in-green-and-sustainable-manufacturing-in-singapore/","txt":"www.biomed-singapore.com","status":"new"},"http://www.aptuit.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-aptuit-finalise-agreement-for-aptuit-to-acquire-gsk-s-research-operations-in-italy/","txt":"www.aptuit.com","status":"new"},"http://www.aptuit.com/Verona":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-aptuit-finalise-agreement-for-aptuit-to-acquire-gsk-s-research-operations-in-italy/","txt":"http://www.aptuit.com/Verona","status":"new"},"http://www.medivir.se/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-enters-agreement-with-medivir-for-exclusive-rights-to-cold-sore-treatment-xerclear/","txt":"www.medivir.se","status":"new"},"http://www.mpa.se/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-enters-agreement-with-medivir-for-exclusive-rights-to-cold-sore-treatment-xerclear/","txt":"www.mpa.se","status":"new"},"http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213836.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-revised-product-labels-for-serevent-and-advair/","txt":"click here","status":"new"},"http://www.ebi.ac.uk/chembl/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-research-identifies-promising-leads-to-follow-in-search-for-medicines-to-fight-malaria/","txt":"www.ebi.ac.uk/chembl/","status":"new"},"http://pubchem.ncbi.nlm.nih.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/new-research-identifies-promising-leads-to-follow-in-search-for-medicines-to-fight-malaria/","txt":"http://pubchem.ncbi.nlm.nih.gov/","status":"new"},"http://www.gsk-korea.co.kr/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-presence-in-asia-with-new-strategic-alliance-in-south-korea/","txt":"www.gsk-korea.co.kr","status":"new"},"http://en.donga.co.kr/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-extends-presence-in-asia-with-new-strategic-alliance-in-south-korea/","txt":"http://en.donga.co.kr/","status":"new"},"http://www.lupus.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/human-genome-sciences-and-glaxosmithkline-announce-positive-phase-3-study-results-for-benlysta-in-systemic-lupus-erythematosus/","txt":"www.lupus.org","status":"new"},"http://www.lupusresearchinstitute.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/human-genome-sciences-and-glaxosmithkline-announce-positive-phase-3-study-results-for-benlysta-in-systemic-lupus-erythematosus/","txt":"www.lupusresearchinstitute.org","status":"new"},"http://www.niams.nih.gov/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/human-genome-sciences-and-glaxosmithkline-announce-positive-phase-3-study-results-for-benlysta-in-systemic-lupus-erythematosus/","txt":"www.niams.nih.gov","status":"new"},"http://www.elef.rheumanet.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/human-genome-sciences-and-glaxosmithkline-announce-positive-phase-3-study-results-for-benlysta-in-systemic-lupus-erythematosus/","txt":"www.elef.rheumanet.org","status":"new"},"http://www.isispharm.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-isis-pharmaceuticals-collaborate-on-rna-therapeutics-for-rare-and-infectious-diseases/","txt":"www.isispharm.com","status":"new"},"http://www-dep.iarc.fr/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-opinions-in-europe-for-tyverb-lapatinib-and-votrient-pazopanib/","txt":"GLOBOCAN Report, 2002","status":"new"},"http://www.orpha.net/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-launches-new-specialist-unit-to-research-and-develop-medicines-for-rare-diseases/","txt":"www.orpha.net","status":"new"},"http://us.gsk.com/products/assets/us_tykerb.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-tykerb-receives-accelerated-approval-for-first-line-combination-treatment-of-hormone-receptor-positive-her2pluserbb2plus-metastatic-breast-cancer/","txt":"http://us.gsk.com/products/assets/us_tykerb.pdf","status":"new"},"http://www.who.int/immunization_monitoring/burden/rotavirus_deaths_2004_chart_b.jpg":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/rotarix-significantly-reduced-severe-rotavirus-gastroenteritis-in-african-babies-during-their-first-year-of-life/","txt":"Rotavirus deaths under 5 years of age per 100,000 population under five (and number of deaths) by country","status":"new"},"http://gsk-us.com/html/responsibility/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-publishes-speaking-consulting-fees-paid-to-us-healthcare-professionals/","txt":"www.us-gsk.com","status":"new"},"http://www.gskoncology.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-study-showed-targeted-therapy-combination-achieved-14-month-overall-survival-in-patients-with-advanced-breast-cancer/","txt":"www.gskoncology.com","status":"new"},"http://www.rocheusa.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-study-showed-targeted-therapy-combination-achieved-14-month-overall-survival-in-patients-with-advanced-breast-cancer/","txt":"Roche Laboratories Inc","status":"new"},"http://www.intercell.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-intercell-form-strategic-alliance-to-develop-and-commercialise-innovative-needle-free-patch-based-vaccines/","txt":"www.intercell.com","status":"new"},"http://www.london2012.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announced-as-tier-3-sponsor-as-london-2012-anti-doping-plans-confirmed/","txt":"www.london2012.com","status":"new"},"http://blog.london2012.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-announced-as-tier-3-sponsor-as-london-2012-anti-doping-plans-confirmed/","txt":"http://blog.london2012.com","status":"new"},"http://www.gilead.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-gilead-announce-agreement-to-commercialise-viread-for-chronic-hepatitis-b-in-key-asian-countries/","txt":"www.gilead.com","status":"new"},"http://www.viread.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-gilead-announce-agreement-to-commercialise-viread-for-chronic-hepatitis-b-in-key-asian-countries/","txt":"www.Viread.com","status":"new"},"http://www.hepsera.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-gilead-announce-agreement-to-commercialise-viread-for-chronic-hepatitis-b-in-key-asian-countries/","txt":"www.Hepsera.com","status":"new"},"http://www.who.int/tobacco/research/cessation/about/en/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-nabi-announce-agreement-for-nicvax-a-vaccine-for-nicotine-addiction/","txt":"www.who.int/tobacco/research/cessation/about/en/index.html","status":"new"},"http://emc.medicines.org.uk/medicine/20204/SPC/Cervarix":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-cervarix-becomes-the-first-cervical-cancer-vaccine-to-gain-approval-in-japan/","txt":"http://emc.medicines.org.uk/medicine/20204/SPC/Cervarix","status":"new"},"http://www.ceedd.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-prosensa-form-alliance-to-fight-duchenne-muscular-dystrophy/","txt":"www.ceedd.com","status":"new"},"http://www.prosensa.eu/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-prosensa-form-alliance-to-fight-duchenne-muscular-dystrophy/","txt":"www.prosensa.eu","status":"new"},"http://www.who.int/mediacentre/factsheets/fs286/en/index.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-expands-presence-in-china-through-strategic-cooperation-to-form-a-joint-venture-on-paediatric-vaccines/","txt":"World Health Organization. (2008). Measles Fact Sheet","status":"new"},"http://www.wpro.who.int/china/sites/epi/overview.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-expands-presence-in-china-through-strategic-cooperation-to-form-a-joint-venture-on-paediatric-vaccines/","txt":"Vaccinating China’s children","status":"new"},"http://www.upch.com.cn/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-upch-to-launch-lucozade-across-china/","txt":"www.upch.com.cn","status":"new"},"http://www.who.int/csr/disease/dengue/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-brazil-s-fiocruz-form-partnership-for-new-rd-effort-and-increased-vaccine-access/","txt":"http://www.who.int/csr/disease/dengue/en/","status":"new"},"http://www.sabin.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-brazil-s-fiocruz-form-partnership-for-new-rd-effort-and-increased-vaccine-access/","txt":"www.sabin.org","status":"new"},"http://www.amgen.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/amgen-to-collaborate-with-gsk-to-commercialize-denosumab-in-europe-for-postmenopausal-osteoporosis-pmo/","txt":"www.amgen.com","status":"new"},"http://en.wikipedia.org/wiki/DNA":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-enigma-diagnostics-announce-commercial-partnership-to-develop-point-of-care-influenza-diagnostics/","txt":"DNA","status":"new"},"http://www.who.int/vaccine_research/diseases/hpv/en":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/who-grants-prequalification-to-cervarix-gsk-s-vaccine-to-help-combat-cervical-cancer-in-developing-nations/","txt":"Human papillomavirus infection and cervical cancer","status":"new"},"http://www.alnylam.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/alnylam-joins-gsk-in-donating-intellectual-property-to-patent-pool-for-neglected-tropical-diseases/","txt":"www.alnylam.com","status":"new"},"http://www.cancerhelp.org.uk/help/default.asp?page=1673":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/landmark-study-for-gsk-s-cervical-cancer-vaccine-published-in-the-lancet/","txt":"Cancer Research UK","status":"new"},"http://www.who.int/vaccine_research/diseases/hpv/en/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/landmark-study-for-gsk-s-cervical-cancer-vaccine-published-in-the-lancet/","txt":"World Health Organization. Initiative for Vaccine Research","status":"new"},"http://www.chromatherapeutics.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-chroma-therapeutics-form-alliance-to-develop-novel-macrophage-targeted-drugs/","txt":"www.chromatherapeutics.com","status":"new"},"http://www.drreddys.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-a-strategic-alliance-with-dr-reddy-s-to-further-accelerate-sales-growth-in-emerging-markets/","txt":"www.drreddys.com","status":"new"},"http://www.fda.gov/Safety/MedWatch/default.htm":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/large-long-term-study-shows-avandia-has-no-increased-overall-cardiovascular-risk-compared-to-other-commonly-used-diabetes-medicines/","txt":"www.fda.gov/medwatch","status":"new"},"http://www.gskcancermedia.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-seek-european-marketing-authorisation-of-arzerra-ofatumumab-in-advanced-stage-blood-cancer/","txt":"www.gskcancermedia.com","status":"new"},"http://www.nhlbi.nih.gov/health/dci/Diseases/Itp/ITP_WhatIs.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-with-revolade-and-arzerra-for-difficult-to-treat-blood-disorders/","txt":"National Heart, Lung, and Blood Institute: Diseases and Conditions Index","status":"new"},"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Sungaran%20R%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-with-revolade-and-arzerra-for-difficult-to-treat-blood-disorders/","txt":"Sungaran R","status":"new"},"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Markovic%20B%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-with-revolade-and-arzerra-for-difficult-to-treat-blood-disorders/","txt":"Markovic B","status":"new"},"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Chong%20BH%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-with-revolade-and-arzerra-for-difficult-to-treat-blood-disorders/","txt":"Chong BH","status":"new"},"http://formularyjournal.modernmedicine.com/formulary/ClinicalPharmacology/ArticleStandard/article/detail/574905":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-with-revolade-and-arzerra-for-difficult-to-treat-blood-disorders/","txt":"Jan 1, 2009 Formulary","status":"new"},"http://www.cancerhelp.org.uk/help/default.asp?page=28782":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/positive-results-with-revolade-and-arzerra-for-difficult-to-treat-blood-disorders/","txt":"About monoclonal antibodies","status":"new"},"http://www.concertpharma.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-concert-pharmaceuticals-form-alliance-to-develop-novel-deuterium-modified-drugs/","txt":"www.concertpharma.com","status":"new"},"http://www.who.int/csr/swine_flu/swine_flu_faq.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/emergence-of-a-new-h1n1-influenza-a-strain-swine-influenza/","txt":"http://www.who.int/csr/swine_flu/swine_flu_faq.pdf","status":"new"},"http://www.hivfutures.com/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-pfizer-announce-innovative-agreement-to-create-a-new-world-leading-specialist-hiv-company/","txt":"www.hivfutures.com","status":"new"},"http://www.who.int/vaccine_research/diseases/ari/en/index6.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/synflorix-glaxosmithkline-s-pneumococcal-vaccine-receives-european-authorisation/","txt":"www.who.int/vaccine_research/diseases/ari/en/index6.html","status":"new"},"http://www.nice.org.uk/guidance/index.jsp?action=folder&o=434455":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/nice-refuses-funding-for-advanced-breast-cancer-treatment-tyverb-lapatinib/","txt":"NICE FAD publication","status":"new"},"http://emc.medicines.org.uk/medicine/20929/SPC/Tyverb":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/nice-refuses-funding-for-advanced-breast-cancer-treatment-tyverb-lapatinib/","txt":"Tyverb® (lapatinib) Summary of Product Characteristics","status":"new"},"http://www.nice.org.uk/media/88A/F2/SupplementaryAdviceTACEoL.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/nice-refuses-funding-for-advanced-breast-cancer-treatment-tyverb-lapatinib/","txt":"Appraising life extending end of life treatments","status":"new"},"http://www.unitefordiabetes.org/assets/files/About_diabetes.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-phase-iii-programme-for-novel-type-2-diabetes-medication-syncria-albiglutide/","txt":"Wake-up Call to Halt Global Diabetes Epidemic","status":"new"},"http://www.cdc.gov/mmwr/preview":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-phase-iii-programme-for-novel-type-2-diabetes-medication-syncria-albiglutide/","txt":"State-specific Incidence of Diabetes Among Adults","status":"new"},"http://www.idf.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-phase-iii-programme-for-novel-type-2-diabetes-medication-syncria-albiglutide/","txt":"Diabetes Prevalence","status":"new"},"http://diabetes.niddk.nih.gov/dm/pubs/insulinresistance/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-initiates-phase-iii-programme-for-novel-type-2-diabetes-medication-syncria-albiglutide/","txt":"Insulin Resistance","status":"new"},"https://win.idenix.com/exchange/Amy.Sullivan/Inbox/draft%20of%20release%20with%20teri%27s%20notes.EML/3Q07%20earnings%20draft%201.doc/Local%20Settings/Temporary%20Internet%20Files/Local%20Settings/Temporary%20Internet%20Files/OLK73/www.idenix.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-idenix-pharmaceuticals-sign-worldwide-license-agreement-for-idx899-a-novel-nnrti-for-the-treatment-of-hiv/","txt":"www.idenix.com","status":"new"},"http://cancer.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-seek-european-marketing-authorisation-of-arzerra-ofatumumab-in-advanced-stage-blood-cancer/","txt":"http://cancer.org/","status":"new"},"http://www.emea.europa.eu/pdfs/human/comp/opinion/48024408en.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-seek-european-marketing-authorisation-of-arzerra-ofatumumab-in-advanced-stage-blood-cancer/","txt":"www.emea.europa.eu/pdfs/human/comp/opinion/48024408en.pdf","status":"new"},"http://www.cancer.gov/cancertopics/factsheet/Sites-Types/WM":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-submit-arzerra-ofatumumab-application-to-fda-for-the-treatment-of-advanced-stage-blood-cancer/","txt":"Waldenstrom Macroglobulinemia: Questions and Answers","status":"new"},"http://documents.cancer.org/6893.00/6893.00.pdf":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-submit-arzerra-ofatumumab-application-to-fda-for-the-treatment-of-advanced-stage-blood-cancer/","txt":"Chronic Lymphocytic Leukemia","status":"new"},"http://www.pneumoadip.org/":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-paediatric-pneumococcal-candidate-vaccine-synflorix-receives-positive-opinion-in-europe/","txt":"PneumoADip report","status":"new"},"http://www.who.int/vaccine_research/diseases/ari/en/index5.html":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-s-paediatric-pneumococcal-candidate-vaccine-synflorix-receives-positive-opinion-in-europe/","txt":"WHO fact sheet","status":"new"}},"mailto":{"mailto:Sa.aermi-saudi@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/saudi-arabia/","txt":"Sa.aermi-saudi@gsk.com","status":"new"},"mailto:gsk.bangladesh-info@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"gsk.bangladesh-info@gsk.com","status":"new"},"mailto:bd.adverse-event@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/bangladesh/","txt":"bd.adverse-event@gsk.com","status":"new"},"mailto:by.contact@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"by.contact@gsk.com","status":"new"},"mailto:gskcyprus@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/cyprus/","txt":"gskcyprus@gsk.com","status":"new"},"mailto:info.lt@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/lithuania/","txt":"info.lt@gsk.com","status":"new"},"mailto:Sviesuole.X.Navasinskiene@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"Sviesuole.X.Navasinskiene@gsk.com","status":"new"},"mailto:LV-Epasts@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"LV-Epasts@gsk.com","status":"new"},"mailto:sabine.x.puke@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/latvia/","txt":"sabine.x.puke@gsk.com","status":"new"},"mailto:lv-epasts@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/latvia/","txt":"lv-epasts@gsk.com","status":"new"},"mailto:apoio.consumidor@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/portugal/","txt":"apoio.consumidor@gsk.com","status":"new"},"mailto:co.servicio-cliente@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/colombia/","txt":"co.servicio-cliente@gsk.com","status":"new"},"mailto:oax74237@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=1","txt":"oax74237@gsk.com","status":"new"},"mailto:heritage.archives@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/about-us/our-history/gsk-heritage-archives/","txt":"heritage.archives@gsk.com","status":"new"},"mailto:shrrelations@cpushareownerservices.com":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"shrrelations@cpushareownerservices.com","status":"new"},"mailto:DPO@equiniti.com":{"firstFound":"https://www.gsk.com/en-gb/investors/shareholder-information/shareholder-privacy-notice/","txt":"DPO@equiniti.com","status":"new"},"mailto:cf.treasury@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/investors/debt-investors/","txt":"cf.treasury@gsk.com","status":"new"},"mailto:GSK.Investor-Relations@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"GSK.Investor-Relations@gsk.com","status":"new"},"mailto:GSKLTI@computershare.com":{"firstFound":"https://www.gsk.com/en-gb/investors/investors-contact-details/","txt":"GSKLTI@computershare.com","status":"new"},"mailto:corporate.media@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-epsrc-announce-creation-of-new-chair-in-sustainable-chemistry-at-the-university-of-nottingham/","txt":"corporate.media@gsk.com","status":"new"},"mailto:sarah.j.spencer@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/media/media-contact-details/","txt":"sarah.j.spencer@gsk.com","status":"new"},"mailto:lishan.x.soon@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/media/media-contact-details/","txt":"lishan.x.soon@gsk.com","status":"new"},"mailto:csr.contact@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/","txt":"csr.contact@gsk.com","status":"new"},"mailto:GSKClinicalSupportHD@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/compassionate-use-expanded-access/","txt":"GSKClinicalSupportHD@gsk.com","status":"new"},"mailto:environmental-sustainability@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/environment/carbon/","txt":"GSK’s Environmental Sustainability team","status":"new"},"mailto:community.partnerships@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/funding-requests/","txt":"community.partnerships@gsk.com","status":"new"},"mailto:AT.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"AT.CPA@gsk.com","status":"new"},"mailto:BE-NL.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"BE-NL.CPA@gsk.com","status":"new"},"mailto:BG.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"BG.CPA@gsk.com","status":"new"},"mailto:HR.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"HR.CPA@gsk.com","status":"new"},"mailto:CY-MT.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"CY-MT.CPA@gsk.com","status":"new"},"mailto:CZ.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"CZ.CPA@gsk.com","status":"new"},"mailto:DK.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"DK.CPA@gsk.com","status":"new"},"mailto:EE.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"EE.CPA@gsk.com","status":"new"},"mailto:FI.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"FI.CPA@gsk.com","status":"new"},"mailto:FR.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"FR.CPA@gsk.com","status":"new"},"mailto:%20DE.Datenschutz-GSK-Pharma@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":" DE.Datenschutz-GSK-Pharma@gsk.com","status":"new"},"mailto:%20DE.Datenschutz-GSK-ConsHealth@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":" DE.Datenschutz-GSK-ConsHealth@gsk.com","status":"new"},"mailto:%20DE.Datenschutz-ViiVHealthcare@viivhealthcare.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":" DE.Datenschutz-ViiVHealthcare@viivhealthcare.com","status":"new"},"mailto:%20DE.Datenschutz-GSK-Vacc-Marburg@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":" DE.Datenschutz-GSK-Vacc-Marburg@gsk.com","status":"new"},"mailto:%20DE.Datenschutz-GSK-Bio-Dresden@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":" DE.Datenschutz-GSK-Bio-Dresden@gsk.com","status":"new"},"mailto:%20DE.Datenschutz-GSK-Cellzome@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":" DE.Datenschutz-GSK-Cellzome@gsk.com","status":"new"},"mailto:GR.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"GR.CPA@gsk.com","status":"new"},"mailto:HU.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"HU.CPA@gsk.com","status":"new"},"mailto:UK.Ireland-CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"UK.Ireland-CPA@gsk.com","status":"new"},"mailto:IT.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"IT.CPA@gsk.com","status":"new"},"mailto:LV.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"LV.CPA@gsk.com","status":"new"},"mailto:LT.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"LT.CPA@gsk.com","status":"new"},"mailto:NO.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"NO.CPA@gsk.com","status":"new"},"mailto:PL.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"PL.CPA@gsk.com","status":"new"},"mailto:ES-PT-IL.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"ES-PT-IL.CPA@gsk.com","status":"new"},"mailto:RO.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"RO.CPA@gsk.com","status":"new"},"mailto:SK.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"SK.CPA@gsk.com","status":"new"},"mailto:SI.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"SI.CPA@gsk.com","status":"new"},"mailto:SE.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"SE.CPA@gsk.com","status":"new"},"mailto:CH.CPA@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/privacy-contact-information/","txt":"CH.CPA@gsk.com","status":"new"},"mailto:vaccinespartnering@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/","txt":"vaccinespartnering@gsk.com","status":"new"},"mailto:rd.bioelectronics@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/partnerships/","txt":"rd.bioelectronics@gsk.com","status":"new"},"mailto:Trust.InScience@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/","txt":"trust.inscience@gsk.com","status":"new"},"mailto:Customer.relations@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/customerspatients/","txt":"UK","status":"new"},"mailto:grupoglaxo@axa-assistance.com.co":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/colombia/pol%C3%ADtica-ambiental-y-pol%C3%ADtica-de-protecci%C3%B3n-de-datos-de-gsk-colombia/","txt":"grupoglaxo@axa-assistance.com.co","status":"new"},"mailto:col.ehs@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/colombia/pol%C3%ADtica-ambiental-y-pol%C3%ADtica-de-protecci%C3%B3n-de-datos-de-gsk-colombia/","txt":"col.ehs@gsk.com","status":"new"},"mailto:col.protecciondatospersonales@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/colombia/pol%C3%ADtica-ambiental-y-pol%C3%ADtica-de-protecci%C3%B3n-de-datos-de-gsk-colombia/","txt":"col.protecciondatospersonales@gsk.com","status":"new"},"mailto:Nick.J.Hirons@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"Nick.J.Hirons@gsk.com","status":"new"},"mailto:veronique.r.roedolf@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"veronique.r.roedolf@gsk.com","status":"new"},"mailto:Guy.AS.Wingate@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"Guy.AS.Wingate@gsk.com","status":"new"},"mailto:Michael.L.Shaw@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"neil.e.falkingham@gsk.com","status":"new"},"mailto:Rob.R.MacRae@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"Rob.R.MacRae@gsk.com","status":"new"},"mailto:dominique.x.giulini@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"dominique.x.giulini@gsk.com","status":"new"},"mailto:Dominique.x.guilini@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/about-us/governance/global-compliance/overview/","txt":"","status":"new"},"mailto:EU.DPO@GSK.com":{"firstFound":"https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","txt":"EU.DPO@GSK.com","status":"new"},"mailto:ww.earlytalentrecruitment@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/careers/postgraduate-opportunities/applying-for-our-esprit-programme/","txt":"ww.earlytalentrecruitment@gsk.com","status":"new"},"mailto:future.leaders@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/careers/warning-against-fraudulent-internet-recruitment-activities/","txt":"future.leaders@gsk.com","status":"new"},"mailto:GSK.VaccinesIME@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/vaccines-independent-medical-education/","txt":"GSK.VaccinesIME@gsk.com","status":"new"},"mailto:ww.respiratoryime@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/respiratory-independent-medical-education/","txt":"ww.respiratoryime@gsk.com","status":"new"},"mailto:ww.lupusime@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/call-for-ime-proposals-on-systemic-lupus-erythematosus-sle/","txt":"ww.lupusime@gsk.com","status":"new"},"mailto:rd.bioelectronics-proposals@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","txt":"GSK team","status":"new"},"mailto:consumerpartnering@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/","txt":"","status":"new"},"mailto:rd_bioelectronics@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/partnerships/contact-ussubmit-an-idea/","txt":"rd.bioelectronics@gsk.com","status":"new"},"mailto:contract.manufacturing@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/business-to-business/contract-manufacturing/foams-liquids-and-topicals/","txt":"contract.manufacturing@gsk.com","status":"new"},"mailto:kaz.med@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"kaz.med@gsk.com","status":"new"},"mailto:nl.consumer-relations@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"nl.consumer-relations@gsk.com","status":"new"},"mailto:no.firmapost@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=3","txt":"no.firmapost@gsk.com","status":"new"},"mailto:Ua.office@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=5","txt":"Ua.office@gsk.com","status":"new"},"mailto:Recepcia.sk@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"Recepcia.sk@gsk.com","status":"new"},"mailto:swiss.info@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/?=&p=4","txt":"swiss.info@gsk.com","status":"new"},"mailto:stephen.rouse@admin.ox.ac.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/","txt":"stephen.rouse@admin.ox.ac.uk","status":"new"},"mailto:h.jamison@wellcome.ac.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/","txt":"h.jamison@wellcome.ac.uk","status":"new"},"mailto:Carmel.turner@headoffice.mrc.ac.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/","txt":"Carmel.turner@headoffice.mrc.ac.uk","status":"new"},"mailto:Kenny-Ferguson@dfid.gov.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/","txt":"Kenny-Ferguson@dfid.gov.uk","status":"new"},"mailto:catherine.a.hartley@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/","txt":"catherine.a.hartley@gsk.com","status":"new"},"mailto:chardwick@som.umaryland.edu":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/","txt":"chardwick@som.umaryland.edu","status":"new"},"mailto:Sebastien.Desprez@adaptimmune.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-adaptimmune-complete-transition-of-ny-eso-spear-t-cell-therapy-programme-to-gsk/","txt":"Sebastien.Desprez@adaptimmune.com","status":"new"},"mailto:Juli.Miller@adaptimmune.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-adaptimmune-complete-transition-of-ny-eso-spear-t-cell-therapy-programme-to-gsk/","txt":"Juli.Miller@adaptimmune.com","status":"new"},"mailto:GGallanagh@webershandwick.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/four-innovations-to-tackle-under-five-deaths-win-us-1-million-healthcare-innovation-award-from-gsk-and-save-the-children/","txt":"GGallanagh@webershandwick.com","status":"new"},"mailto:jlawrence@taskforce.org":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/togo-becomes-first-country-in-africa-to-validate-the-elimination-of-lymphatic-filariasis-as-a-public-health-problem/","txt":"jlawrence@taskforce.org","status":"new"},"mailto:ysodahlon@taskforce.org":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/togo-becomes-first-country-in-africa-to-validate-the-elimination-of-lymphatic-filariasis-as-a-public-health-problem/","txt":"ysodahlon@taskforce.org","status":"new"},"mailto:barbara.b.masser-mayerl@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/austria/","txt":"barbara.b.masser-mayerl@gsk.com","status":"new"},"mailto:Elisabeth.e.vandamme@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"Elisabeth.e.vandamme@gsk.com","status":"new"},"mailto:elisabeth.e.vandamme@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/luxembourg/","txt":"elisabeth.e.vandamme@gsk.com","status":"new"},"mailto:Vasilena.k.vizeva@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/bulgaria/","txt":"Vasilena.k.vizeva@gsk.com","status":"new"},"mailto:efpia.disclosure-croatia@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/croatia/","txt":"efpia.disclosure-croatia@gsk.com","status":"new"},"mailto:michelle.d.chivers@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/cyprus/","txt":"michelle.d.chivers@gsk.com","status":"new"},"mailto:jakub.j.hofmann@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/czech-republic/","txt":"jakub.j.hofmann@gsk.com","status":"new"},"mailto:anna.v.dammert@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/finland/","txt":"anna.v.dammert@gsk.com","status":"new"},"mailto:ann.x.asser@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/estonia/","txt":"ann.x.asser@gsk.com","status":"new"},"mailto:victoria.v.morel@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/france/","txt":"victoria.v.morel@gsk.com","status":"new"},"mailto:claudia.c.kubacki@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"claudia.c.kubacki@gsk.com","status":"new"},"mailto:Claudia.C.Kubacki@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/germany/","txt":"Claudia.C.Kubacki@gsk.com","status":"new"},"mailto:Vasilia.x.Papagiannopoulou@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/greece/","txt":"Vasilia.x.Papagiannopoulou@gsk.com","status":"new"},"mailto:adrienn.x.fuko@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/hungary/","txt":"adrienn.x.fuko@gsk.com","status":"new"},"mailto:Jacinta.8.collins@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ireland/","txt":" ","status":"new"},"mailto:maria-ilaria.i.ventura@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/italy/","txt":"maria-ilaria.i.ventura@gsk.com","status":"new"},"mailto:Sviesuole.x.navasinskiene@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/lithuania/","txt":"Sviesuole.x.navasinskiene@gsk.com","status":"new"},"mailto:mt.info@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/malta/","txt":"mt.info@gsk.com","status":"new"},"mailto:media@gsk.nl":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/netherlands/","txt":"media@gsk.nl","status":"new"},"mailto:Urszula.m.karniewicz@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"Urszula.m.karniewicz@gsk.com","status":"new"},"mailto:urszula.m.karniewicz@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/poland/","txt":"urszula.m.karniewicz@gsk.com","status":"new"},"mailto:joao.x.duarte@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/portugal/","txt":"joao.x.duarte@gsk.com","status":"new"},"mailto:ro.media@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/romania/","txt":"ro.media@gsk.com","status":"new"},"mailto:evald.u.gherbst@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/russia/","txt":"evald.u.gherbst@gsk.com","status":"new"},"mailto:sanja.s.panjeskovic@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/serbia-and-montenegro/","txt":"sanja.s.panjeskovic@gsk.com","status":"new"},"mailto:efpia.disclosure-slovakia@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"efpia.disclosure-slovakia@gsk.com","status":"new"},"mailto:sk.media@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovakia/","txt":"sk.media@gsk.com","status":"new"},"mailto:alja.k.plevnik@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/slovenia/","txt":"alja.k.plevnik@gsk.com","status":"new"},"mailto:m-dolores.a.sanchez-de-puerta@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/spain/","txt":"m-dolores.a.sanchez-de-puerta@gsk.com","status":"new"},"mailto:hanna.a.lodin@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/sweden/","txt":"hanna.a.lodin@gsk.com","status":"new"},"mailto:urs.b.kientsch@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"urs.b.kientsch@gsk.com","status":"new"},"mailto:sonja.x.luz@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/switzerland/","txt":"sonja.x.luz@gsk.com","status":"new"},"mailto:yana.s.syrovatka@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"yana.s.syrovatka@gsk.com","status":"new"},"mailto:maryna.kuzemko@180prpa.com.ua":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"maryna.kuzemko@180prpa.com.ua","status":"new"},"mailto:anna.dziuba@180prpa.com.ua":{"firstFound":"https://www.gsk.com/en-gb/responsibility/operating-responsibly/engaging-with-healthcare-professionals/europe/ukraine/","txt":"anna.dziuba@180prpa.com.ua","status":"new"},"mailto:estonia@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/estonia/","txt":"estonia@gsk.com","status":"new"},"mailto:estoniansafety@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/contact-us/worldwide/estonia/","txt":"estoniansafety@gsk.com","status":"new"},"mailto:investor.relations@theravance.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-theravance-commence-phase-iii-horizon-programme-to-develop-a-next-generation-treatment-for-copd/","txt":"investor.relations@theravance.com\n\n","status":"new"},"mailto:investor.relations@thrxinc.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/anoro-ellipta-umeclidiniumvilanterol-gains-approval-in-japan-for-the-treatment-of-copd/","txt":"investor.relations@thrxinc.com","status":"new"},"mailto:r.gravesen@genmab.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-genmab-announce-positive-top-line-results-from-pivotal-trial-of-arzerra-ofatumumab-combined-with-chlorambucil-in-previously-untreated-chronic-lymphocytic-leukaemia/","txt":"r.gravesen@genmab.com","status":"new"},"mailto:spellegrino@amicusrx.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-amicus-therapeutics-expand-fabry-disease-collaboration/","txt":"spellegrino@amicusrx.com","status":"new"},"mailto:dan@purecommunicationsinc.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-amicus-therapeutics-expand-fabry-disease-collaboration/","txt":"dan@purecommunicationsinc.com","status":"new"},"mailto:psingh@burnesscommunications.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/first-results-from-ongoing-phase-iii-trial-show-malaria-vaccine-candidate-rts-sstar-reduces-the-risk-of-malaria-by-half-in-african-children-aged-5-to-17-months/","txt":"psingh@burnesscommunications.com","status":"new"},"mailto:kmertes@path.org":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/first-results-from-ongoing-phase-iii-trial-show-malaria-vaccine-candidate-rts-sstar-reduces-the-risk-of-malaria-by-half-in-african-children-aged-5-to-17-months/","txt":"kmertes@path.org","status":"new"},"mailto:dpoland@path.org":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/malaria-vaccine-candidate-reduces-disease-over-18-months-of-follow-up-in-late-stage-study-of-more-than-15-000-infants-and-young-children/","txt":"dpoland@path.org","status":"new"},"mailto:sethelston@path.org":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/malaria-vaccine-candidate-reduces-disease-over-18-months-of-follow-up-in-late-stage-study-of-more-than-15-000-infants-and-young-children/","txt":"sethelston@path.org","status":"new"},"mailto:j.campbell@savethechildren.org.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-form-unique-partnership-to-save-the-lives-of-one-million-children/","txt":"j.campbell@savethechildren.org.uk","status":"new"},"mailto:e.sharman@savethechildren.org.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-form-unique-partnership-to-save-the-lives-of-one-million-children/","txt":"e.sharman@savethechildren.org.uk","status":"new"},"mailto:trowbridge@ei.columbia.edu":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/grant-to-help-coordinate-campaign-to-train-one-million-community-health-workers-in-sub-saharan-africa/","txt":"trowbridge@ei.columbia.edu","status":"new"},"mailto:salis@email.chop.edu":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/500-000-endowment-gift-from-the-glaxosmithkline-foundation-expands-program-to-help-patients-with-cancer-and-their-families-at-the-children-s-hospital-of-philadelphia/","txt":"salis@email.chop.edu","status":"new"},"mailto:jennifer.l.armstrong@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/500-000-endowment-gift-from-the-glaxosmithkline-foundation-expands-program-to-help-patients-with-cancer-and-their-families-at-the-children-s-hospital-of-philadelphia/","txt":"Jennifer.L.Armstrong@gsk.com","status":"new"},"mailto:Investor.relations@theravance.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-theravance-commence-maba-phase-iib-copd-study/","txt":"Investor.relations@theravance.com","status":"new"},"mailto:HGStender@dfking.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-commences-tender-offer-to-acquire-human-genome-sciences-for-us-1300-per-share-in-cash/","txt":"HGStender@dfking.com","status":"new"},"mailto:pressoffice@epsrc.ac.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-epsrc-announce-creation-of-new-chair-in-sustainable-chemistry-at-the-university-of-nottingham/","txt":"pressoffice@epsrc.ac.uk","status":"new"},"mailto:nicholas.king@nottingham.ac.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-epsrc-announce-creation-of-new-chair-in-sustainable-chemistry-at-the-university-of-nottingham/","txt":"nicholas.king@nottingham.ac.uk","status":"new"},"mailto:c.j.moody@nottingham.ac.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-university-of-nottingham-collaborate-to-create-centre-of-excellence-for-sustainable-chemistry/","txt":"c.j.moody@nottingham.ac.uk","status":"new"},"mailto:prcomms@helpforheroes.org.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-help-for-heroes-partner-to-support-the-rehabilitation-of-wounded-servicemen-and-women-in-the-uk/","txt":"prcomms@helpforheroes.org.uk","status":"new"},"mailto:gtiberend@tiberend.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-enigma-diagnostics-announce-collaboration-on-assay-development-and-commercialisation-of-enigma-s-ml-platform/","txt":"gtiberend@tiberend.com","status":"new"},"mailto:mobiletbright@tiberend.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-enigma-diagnostics-announce-collaboration-on-assay-development-and-commercialisation-of-enigma-s-ml-platform/","txt":"tbright@tiberend.com","status":"new"},"mailto:kathryn@theyatesnetwork.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-tolerx-announce-phase-iii-defend-1-study-of-otelixizumab-in-type-1-diabetes-did-not-meet-its-primary-endpoint/","txt":"kathryn@theyatesnetwork.com","status":"new"},"mailto:h.husted@genmab.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-announce-amendment-to-ofatumumab-agreement/","txt":"h.husted@genmab.com","status":"new"},"mailto:smartin@skynet.be":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-bjd-collaborate-on-a-new-educational-programme-to-reduce-global-burden-of-joint-pain/","txt":"smartin@skynet.be","status":"new"},"mailto:ir@glpg.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/galapagos-reaches-agreement-to-acquire-glaxosmithkline-research-centre-in-zagreb-croatia/","txt":"ir@glpg.com","status":"new"},"mailto:dominik.werner@lonza.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-agreement-with-lonza-to-secure-capacity-and-expertise-in-biological-manufacturing-to-support-ongoing-development-of-gsk-s-biopharmaceuticals-portfolio/","txt":"dominik.werner@lonza.com","status":"new"},"mailto:dirk.oehlers@lonza.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-signs-agreement-with-lonza-to-secure-capacity-and-expertise-in-biological-manufacturing-to-support-ongoing-development-of-gsk-s-biopharmaceuticals-portfolio/","txt":"dirk.oehlers@lonza.com","status":"new"},"mailto:zhi_wei_loh@edb.gov.sg":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-edb-commit-35-million-usd-in-funding-to-support-research-in-green-and-sustainable-manufacturing-in-singapore/","txt":"zhi_wei_loh@edb.gov.sg","status":"new"},"mailto:equek@golinharris.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-edb-commit-35-million-usd-in-funding-to-support-research-in-green-and-sustainable-manufacturing-in-singapore/","txt":"equek@golinharris.com","status":"new"},"mailto:Joanna.Disley@aptuit.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-aptuit-finalise-agreement-for-aptuit-to-acquire-gsk-s-research-operations-in-italy/","txt":"Joanna.Disley@aptuit.com","status":"new"},"mailto:krystle.ficco@fkhealth.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-aptuit-finalise-agreement-for-aptuit-to-acquire-gsk-s-research-operations-in-italy/","txt":"krystle.ficco@fkhealth.com","status":"new"},"mailto:medinfo@hgsi.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-human-genome-sciences-announce-full-presentation-at-acr-of-positive-phase-3-study-results-for-benlysta-in-systemic-lupus-erythematosus/","txt":"medinfo@hgsi.com","status":"new"},"mailto:Claire.E.Dixon@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-consumer-healthcare-warns-consumers-of-potential-health-risks-associated-with-long-term-excessive-use-of-zinc-containing-denture-adhesives/","txt":"Claire.E.Dixon@gsk.com","status":"new"},"mailto:Malesia.A.Dunn@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-consumer-healthcare-warns-consumers-of-potential-health-risks-associated-with-long-term-excessive-use-of-zinc-containing-denture-adhesives/","txt":"Malesia.A.Dunn@gsk.com","status":"new"},"mailto:Larry.M.Mulligan-Gibbs@gsk.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-consumer-healthcare-warns-consumers-of-potential-health-risks-associated-with-long-term-excessive-use-of-zinc-containing-denture-adhesives/","txt":"Larry.M.Mulligan-Gibbs@gsk.com","status":"new"},"mailto:deborah.cordingley@enigmadiagnostics.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-enigma-diagnostics-announce-commercial-partnership-to-develop-point-of-care-influenza-diagnostics/","txt":"deborah.cordingley@enigmadiagnostics.com","status":"new"},"mailto:gtiberend@rlcinc.com_":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/gsk-and-enigma-diagnostics-announce-commercial-partnership-to-develop-point-of-care-influenza-diagnostics/","txt":"gtiberend@rlcinc.com","status":"new"},"mailto:clinical_trials@hgsi.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/human-genome-sciences-and-glaxosmithkline-announce-positive-phase-3-study-results-for-benlysta-in-systemic-lupus-erythematosus/","txt":"clinical_trials@hgsi.com","status":"new"},"mailto:hth@genmab.com":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-genmab-submit-arzerra-ofatumumab-application-to-fda-for-the-treatment-of-advanced-stage-blood-cancer/","txt":"hth@genmab.com","status":"new"},"mailto:emma@gunpowdermedia.co.uk":{"firstFound":"https://www.gsk.com/en-gb/media/press-releases/community-healthcare-charities-receive-300-000-from-glaxosmithkline-in-recognition-of-their-work/","txt":"emma@gunpowdermedia.co.uk","status":"new"}},"callto":{},"errors":[]}